
<html lang="en"     class="pb-page"  data-request-id="8c31181f-ab37-447b-b211-fe4faac07728"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm400378w;issue:issue:10.1021/jmcmar.2014.57.issue-2;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="KLIFS: A Knowledge-Based Structural Database To Navigate Kinase–Ligand Interaction Space" /></meta><meta name="dc.Creator" content="Oscar P. J.  van Linden" /></meta><meta name="dc.Creator" content="Albert J.  Kooistra" /></meta><meta name="dc.Creator" content="Rob  Leurs" /></meta><meta name="dc.Creator" content="Iwan J. P.  de Esch" /></meta><meta name="dc.Creator" content="Chris  de Graaf" /></meta><meta name="dc.Description" content="Protein kinases regulate the majority of signal transduction pathways in cells and have become important targets for the development of designer drugs. We present a systematic analysis of kinase–li..." /></meta><meta name="Description" content="Protein kinases regulate the majority of signal transduction pathways in cells and have become important targets for the development of designer drugs. We present a systematic analysis of kinase–li..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 20, 2013" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm400378w" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm400378w" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm400378w" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm400378w" /></link>
        
    
    

<title>KLIFS: A Knowledge-Based Structural Database To Navigate Kinase–Ligand Interaction Space | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm400378w" /></meta><meta property="og:title" content="KLIFS: A Knowledge-Based Structural Database To Navigate Kinase–Ligand Interaction Space" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0022.jpeg" /></meta><meta property="og:description" content="Protein kinases regulate the majority of signal transduction pathways in cells and have become important targets for the development of designer drugs. We present a systematic analysis of kinase–ligand interactions in all regions of the catalytic cleft of all 1252 human kinase–ligand cocrystal structures present in the Protein Data Bank (PDB). The kinase–ligand interaction fingerprints and structure database (KLIFS) contains a consistent alignment of 85 kinase ligand binding site residues that enables the identification of family specific interaction features and classification of ligands according to their binding modes. We illustrate how systematic mining of kinase–ligand interaction space gives new insights into how conserved and selective kinase interaction hot spots can accommodate the large diversity of chemical scaffolds in kinase ligands. These analyses lead to an improved understanding of the structural requirements of kinase binding that will be useful in ligand discovery and design studies." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm400378w"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm400378w">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm400378w&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm400378w&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm400378w&amp;href=/doi/10.1021/jm400378w" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 2</span><span class="cit-fg-pageRange">, 249-277</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/2" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm400887j" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">KLIFS: A Knowledge-Based Structural Database To Navigate Kinase–Ligand Interaction Space</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Oscar+P.+J.++van+Linden">Oscar P. J. van Linden</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Albert+J.++Kooistra">Albert J. Kooistra</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rob++Leurs">Rob Leurs</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Iwan+J.+P.++de+Esch">Iwan J. P. de Esch</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chris++de+Graaf">Chris de Graaf</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Division of Medicinal Chemistry, Faculty of Sciences, Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands</span></div><div class="corresp-info"><strong>*</strong>Phone: +31-20598-7553. E-mail: <a href="/cdn-cgi/l/email-protection#a5c68bc1c08bc2d7c4c4c3e5d3d08bcbc9"><span class="__cf_email__" data-cfemail="7c1f521819521b0e1d1d1a3c0a09521210">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm400378w&amp;href=/doi/10.1021%2Fjm400378w" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 2</span><span class="cit-pageRange">, 249–277</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 13, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 March 2013</li><li><span class="item_label"><b>Published</b> online</span>20 September 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 January 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm400378w" title="DOI URL">https://doi.org/10.1021/jm400378w</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D249%26pageCount%3D29%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DOscar%2BP.%2BJ.%2Bvan%2BLinden%252C%2BAlbert%2BJ.%2BKooistra%252C%2BRob%2BLeurs%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D2%26contentID%3Djm400378w%26title%3DKLIFS%253A%2BA%2BKnowledge-Based%2BStructural%2BDatabase%2BTo%2BNavigate%2BKinase%25E2%2580%2593Ligand%2BInteraction%2BSpace%26numPages%3D29%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D277%26publicationDate%3DJanuary%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm400378w"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">8360</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">148</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm400378w" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;KLIFS: A Knowledge-Based Structural Database To Navigate Kinase–Ligand Interaction Space&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Oscar&quot;,&quot;last_name&quot;:&quot;P. J. van Linden&quot;},{&quot;first_name&quot;:&quot;Albert&quot;,&quot;last_name&quot;:&quot;J. Kooistra&quot;},{&quot;first_name&quot;:&quot;Rob&quot;,&quot;last_name&quot;:&quot;Leurs&quot;},{&quot;first_name&quot;:&quot;Iwan&quot;,&quot;last_name&quot;:&quot;J. P. de Esch&quot;},{&quot;first_name&quot;:&quot;Chris&quot;,&quot;last_name&quot;:&quot;de Graaf&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;20&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;249-277&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm400378w&quot;},&quot;abstract&quot;:&quot;Protein kinases regulate the majority of signal transduction pathways in cells and have become important targets for the development of designer drugs. We present a systematic analysis of kinase–ligand interactions in all regions of the catalytic cleft of all 1252 human kinase–ligand cocrystal structures present in the Protein Data Bank (PDB). The kinase–ligand interaction fingerprints and structure database (KLIFS) contains a consistent alignment of 85 kinase ligand binding site residues that enables the identification of family specific interaction features and classification of ligands according to their binding modes. We illustrate how systematic mining of kinase–ligand interaction space gives new insights into how conserved and selective kinase interaction hot spots can accommodate the large diversity of chemical scaffolds in kinase ligands. These analyses lead to an improved understanding of the structural requirements of kinase binding that will be useful in ligand discovery and design studies.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400378w&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400378w" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400378w&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400378w" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400378w&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400378w" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm400378w&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400378w&amp;href=/doi/10.1021/jm400378w" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm400378w" /></input><a href="/doi/pdf/10.1021/jm400378w" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (19 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm400378w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm400378w%26sid%3Dliteratum%253Aachs%26pmid%3D23941661%26genre%3Darticle%26aulast%3Dvan%2BLinden%26date%3D2014%26atitle%3DKLIFS%253A%2BA%2BKnowledge-Based%2BStructural%2BDatabase%2BTo%2BNavigate%2BKinase%25E2%2580%2593Ligand%2BInteraction%2BSpace%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D2%26spage%3D249%26epage%3D277%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292580" title="Binding modes">Binding modes</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291880" title="Crystal structure">Crystal structure</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/2" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jmcmar.2014.57.issue-2/production/jmcmar.2014.57.issue-2.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0022.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Protein kinases regulate the majority of signal transduction pathways in cells and have become important targets for the development of designer drugs. We present a systematic analysis of kinase–ligand interactions in all regions of the catalytic cleft of all 1252 human kinase–ligand cocrystal structures present in the Protein Data Bank (PDB). The kinase–ligand interaction fingerprints and structure database (KLIFS) contains a consistent alignment of 85 kinase ligand binding site residues that enables the identification of family specific interaction features and classification of ligands according to their binding modes. We illustrate how systematic mining of kinase–ligand interaction space gives new insights into how conserved and selective kinase interaction hot spots can accommodate the large diversity of chemical scaffolds in kinase ligands. These analyses lead to an improved understanding of the structural requirements of kinase binding that will be useful in ligand discovery and design studies.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1 Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36033" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36033" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Protein kinases are enzymes that catalyze the transfer of the γ-phosphate moiety of ATP to the hydroxyl groups of tyrosine, serine, or threonine residues of their substrates.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The large family of kinase proteins plays an important role in key signal transduction pathways, and kinases have therefore become drug targets of great interest in the past 2 decades.<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2-4)</a> Currently, 518 protein kinases are known to be encoded in the human genome and are divided into so-called conventional and atypical protein kinases. The conventional protein kinases consist of the largest group and, based on their sequence similarity in the catalytic domain, are subclassified into eight major groups, namely, AGC, CAMK, CK1, CMGC, STE, TK, TKL, and other.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> In Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> an overview of the number of families, subfamilies, and kinases is given. The atypical protein kinases (15 families, not shown) have little or no sequence similarity to the members of the protein kinase superfamily.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Overview of the Number of Families, Subfamilies, and Kinases in Each Group of the Conventional Human Protein Kinases</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">group<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">human kinases</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AGC</td><td class="colsep0 rowsep0" align="left">63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CAMK</td><td class="colsep0 rowsep0" align="left">74</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CK1</td><td class="colsep0 rowsep0" align="left">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CMGC</td><td class="colsep0 rowsep0" align="left">61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">STE</td><td class="colsep0 rowsep0" align="left">47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TK</td><td class="colsep0 rowsep0" align="left">90</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TKL</td><td class="colsep0 rowsep0" align="left">43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">other</td><td class="colsep0 rowsep0" align="left">88</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">The eight major groups are AGC (PKA, PKG, and PKC containing families), CAMK (calcium/calmodulin-dependent protein kinase), CK1 (casein kinase 1), CMGC (CDK, MAPK, GSK3, and CLK containing families), STE (homologues of yeast sterile 7, sterile 11, sterile 20 kinases), TK (tyrosine kinase), TKL (tyrosine kinase-like), other (protein kinases that do not fit any of the major groups). A graphical representation of the human kinome tree is presented in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B.</p></div></div></div><div class="NLM_p">Deregulation of protein kinase function is a key feature in several pathophysiological processes, making protein kinases import targets for pharmaceutical intervention in a number of therapeutic areas,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> including oncology,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> neurology,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> immunology,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> cardiology,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and infectious disease.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Small molecule kinase inhibitors have been developed, and a number of kinase inhibiting chemical entities have successfully entered the market for the treatment of patients in several therapeutic areas (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21 ref22 ref23 ref24 ref25 ref26 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21 ref22 ref23 ref24 ref25 ref26 ref27 ref28 ref29">(11-29)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Molecular structures of 20 approved small molecule kinase inhibitors. For these inhibitors crystal structures are available in the PDB with the exception of <b>9</b> (regorafenib), <b>11</b> (ruxolitinib), <b>16</b> (pazopanib), <b>18b</b> (dabrafenib),<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and <b>18c</b> (trametinib).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Atoms that make hydrogen bond interactions with the kinase hinge region and gatekeeper residue are colored red and green, respectively. The blue colored atoms extend out of the protein and into the solvent, while the orange colored atoms interact in the hydrophobic back pocket(s) (see Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> and Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). References to PDB entries are provided in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Table S1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">1.1 Kinase Ligand Binding Sites</h3><div class="NLM_p">The kinase domain consists of a C-terminal domain and a N-terminal domain that are connected via a hinge (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> ATP hydrogen-bonds to the backbone of the hinge, and the vast majority of inhibitors also hydrogen-bond to this region. The N-terminal domain largely consists of β-sheets, while the C-terminal domain is built up mostly by α helices. Important structural features of the kinase domain are the G-rich loop (glycine-rich loop, g.l in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), the gatekeeper residue (aa<sup>GK.45</sup> preceding the hinge region), the αC-helix in the N-terminal domain, the conserved lysine residue (K<sup>III.17</sup> in β-sheet III) which forms a salt bridge with the conserved glutamate residue E<sup>αC.24</sup> in the αC-helix and the DFG<sup>xDFG.81-83</sup> motif.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The current analysis focuses on the catalytic cleft located between the N-terminal lobe and C-terminal lobe, which contains the ATP binding site and is the major focus of kinase inhibitor development. This region can be divided into a front cleft (containing the ATP binding site), gate area, and back cleft (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> In Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> an overview of different pockets that are present in the front and back clefts are schematically presented.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Structure of the kinase domain, with important structural elements labeled and a close-up of the kinase catalytic cleft with carbon atoms Cα shown as spheres. The front cleft, gate area, and back cleft are indicated. (B) Conservation of the 85 amino acids in the catalytic cleft of 1252 kinase-inhibitor complexes. The same residue numbering scheme is used consistently throughout the manuscript: [amino acid]<sup>[kinase region in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A].[residue number in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B]</sup> (e.g., K<sup>III.17</sup>, the conserved lysine residue in β sheet III, residue number 17). Abbreviations for definition of kinase binding site regions are as follows: I–VIII = β-sheets I–VIII; g.l. = G-rich loop, b.l. = loop connecting αC-helix to IV; GK = gatekeeper; linker = loop connecting the hinge to αD-helix; c.l. = catalytic loop; xDFG = DFG-motif plus one preceding amino acid residue; a.l. = activation loop.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Most kinase inhibitors developed so far bind in the adenine pocket (AP), which is located in the front cleft (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A, <b>3</b>) and make one to three hydrogen-bond interactions to residues 46 and 48 of the hinge region.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> A strategy to increase the potency and selectivity of kinase inhibitors is to design and synthesize molecules that target hydrophobic pockets in the back cleft (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A, <b>3</b>).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> A complementary design approach is to accommodate polar inhibitor–kinase interactions with conserved parts in the kinase domain (e.g., hinge region in the front cleft, DFG-motif and K<sup>III.17</sup> in the gate area, and E<sup>αC.24</sup> in the back cleft). Both strategies will be discussed in sections <a class="ref internalNav" href="#sec2" aria-label="3">3</a>–<a class="ref internalNav" href="#sec5" aria-label="6">6</a>. Within the catalytic cleft several selectivity pockets can be addressed by small molecule inhibitors.<a onclick="showRef(event, 'ref30 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref32">(30, 32)</a> In the front cleft, a pocket located between the solvent exposed loop (linker) and the DFG-motif (xDFG) may be present, termed front pocket I (FP-I). A second pocket, located between the G-rich loop (g.l.) and β-sheet III, is termed front pocket II (FP-II). In the back cleft multiple pockets exist (BP-I, BP-II, BP-III, BP-IV, BP-V, as defined by Liao),<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> which differ in size depending on the activation state of the kinase (e.g., DFG-in or -out, αC-helix-in or -out).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> A conformational change of the DFG-motif (positions 81–83, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A, <b>3</b>) from the “in” to the “out” conformation results in the formation of an inactive state of the kinase. This DFG-flip opens up the larger hydrophobic region in the back cleft, which was first demonstrated by the development of <b>6</b> (imatinib, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Stabilization of specific DFG conformations (<a class="ref internalNav" href="#sec4" aria-label="section 5">section 5</a>) has been used as a successful kinase inhibitor design strategy (sections <a class="ref internalNav" href="#sec2" aria-label="3">3</a>–<a class="ref internalNav" href="#sec5" aria-label="6">6</a>).<a onclick="showRef(event, 'ref2 ref30 ref33'); return false;" href="javascript:void(0);" class="ref ref2 ref30 ref33">(2, 30, 33)</a> The ease of access to the back cleft is determined by the size of the gatekeeper (GK), a residue preceding the hinge region and located on β-sheet V (position 45, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Incorporation of functional groups that can selectively target the GK residue(s) of the desired kinase(s) and/or make unfavorable interactions with the region around the GK of undesired kinase targets has been a successful approach in kinase inhibitor design (<a class="ref internalNav" href="#sec2_2" aria-label="section 3.2">section 3.2</a>).</div><div class="NLM_p">Different types of kinase inhibitors can be defined: type I inhibitors that bind to the active DFG-in conformation, type II inhibitors that bind to the inactive DFG-out conformation, type I1/2 inhibitors that bind in the DFG-in conformation but extend into the back pockets, type III inhibitors that form ternary complexes with the kinase and ATP, allosteric type IV inhibitors that target protein kinases distal to the ATP binding pocket, and type V bisubstrate and bivalent inhibitors that combine different inhibitor classes.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> However, these types I–V classifications do not allow proper and consistent classification of the diversity in kinase ligand binding modes observed in kinase crystal structures and do not account for the many different combinations of subpockets that inhibitors can address in different kinase conformations.</div><div class="NLM_p">Back pocket I (BP-I) is located in the gate area between residues of the xDFG-motif, β-sheets III and V, conserved Lys<sup>III.17</sup>, and αC-helix (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). BP-I can be divided into two subpockets. BP-I-B is a larger pocket that is located in the center of the gate area through which access to other back pockets is facilitated. The smaller BP-I-A is located at the top of the gate area and is formed by residues of β-sheets III and V, conserved Lys<sup>III.17</sup>, and αC-helix. BP-I-A and BP-I-B are available in both DFG-in and DFG-out kinases and can be targeted by type I and type II inhibitors. Between the DFG-motif and αC-helix a pocket may exist, while the kinase is in a DFG-in fashion, termed back pocket II-in (BP-II-in). Outward shifting of the αC-helix (αC-out), while the kinase is in a DFG-in fashion, results in the formation of a larger back pocket II-in, termed back pocket II-A-in (BP-II-A-in). This pocket consists of residues of the DFG-motif, αC-helix, back loop (b.l.), and β-sheets IV and V.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Schematic overview of available pockets in the catalytic cleft in both DFG-in (A) and DFG-out (B) kinases. The color coding for the front cleft, gate area, back cleft, and backbone of the hinge, DFG-motif, and αC-helix is similar to that of Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. (A) Schematic binding mode of <b>15</b> in ABL1 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2gqg">2gqg</a>, DFG-in, 3D binding mode is presented in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B). (B) Schematic binding mode of <b>7</b> in ABL1 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3cs9">3cs9</a>, DFG-out, 3D binding mode is presented in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>D).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Significant enlargement of BP-II-in occurs upon a DFG-flip toward a DFG-out kinase. The resulting pocket is termed back pocket II-out (BP-II-out). Between αC-helix and β-sheet IV, a back pocket may exist in both DFG-in and DFG-out kinases, termed BP-II-B. Back pocket III (BP-III) is a pocket that is accessible only in the DFG-out form of the kinase. The pocket is located in the basement of BP-II-out, between the DFG-out-motif, back loop (b.l.), αC- and αE-helix, β-sheet VI, and conserved histidine 68 residue of HRD motif in the catalytic loop (c.l). Two partially hydrophobic back pockets (BP-IV and -V) are located between the αC-helix, DFG(-out) motif, β-sheet VI, catalytic loop (c.l.), and the activation loop (a.l.). These pockets are partially solvent exposed.</div><div class="NLM_p last">The high structural similarity in the kinase domains and the utilization of conserved kinase–ligand interactions make it difficult to design selective kinase inhibitors.<a onclick="showRef(event, 'ref30 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref30 ref36 ref37">(30, 36, 37)</a> In addition, kinase domains are flexible protein structures and ligand induced conformational changes are commonly observed, which raise both challenges and opportunities for rational design of novel inhibitors.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The focus on the kinase front cleft in kinase ligand design has resulted in the discovery of a large number of chemically diverse heteroaromatic scaffolds that can bind the kinase hinge region.<a onclick="showRef(event, 'ref34 ref38'); return false;" href="javascript:void(0);" class="ref ref34 ref38">(34, 38)</a> The design and/or optimization of many kinase ligands has been supported by X-ray crystallography and structure-based ligand design approaches (e.g., refs <a onclick="showRef(event, 'ref39 ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref39 ref40 ref41 ref42">39−42</a>). As a result, kinases are one of most represented protein families in the Protein Data Bank (PDB).<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(-43, 44)</a> The sheer numbers and diversity of ligand bound kinase structures make this protein class a particularly interesting system to investigate the details of molecular interactions using chemogenomics approaches.<a onclick="showRef(event, 'ref45 ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref45 ref46 ref47">(45-47)</a> Identification of the molecular determinants of kinase–ligand interactions will be beneficial for the design of ligands with specific selectivity profiles<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> and discovery of ligands for novel kinase targets.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div></div><div id="sec1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">1.2 Structure-Based Mining of Kinase–Ligand Interaction Space</h3><div class="NLM_p">Classification of kinase–ligand cocrystal structures and analysis of kinase–ligand interaction patterns have been reported, but these studies have focused on specific interaction features, including conserved hinge backbone interactions,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> utilization of hydrophobic back pockets,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> stabilization of inactivated DFG-out forms,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> interactions of inhibitors with the P-loop,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> and hydrogen bonding of ligands with the DFG-motif and E<sup>αC.24</sup> in DFG-in or DFG-out kinases.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Previous kinase–ligand interaction analyses were furthermore based on relatively small crystal structure subsets (of 50–600 complexes) compared to the total number of 1252 ligand-bound kinase domain crystal structures currently available in the Protein Data Bank.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Ghose et al.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> performed an analysis on 409 kinase–inhibitor complexes from the PDB. The authors focused on the kinase hinge region and categorized the inhibitors in ligand core structures that bind to the kinase hinge by making one, two, or three hydrogen bond interactions. McGregor et al.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> aligned 220 small molecule protein kinase inhibitor complexes and presented a pharmacophore map of the inhibitors in the adenine binding site. Deng et al.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> used structural interaction fingerprints for the analysis of 89 kinase–inhibitor crystal structures from the PDB and were able to reveal similarities and diversity between small molecule binding interactions of 54 small molecule kinase ligands. A structural comparison of protein kinase ATP-binding sites for the functional classification of the protein kinase family has been performed by Kinnings et al.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> In a set of 354 kinase crystal structures they were able to detect subtle differences in binding site conformation within different protein kinases, such as differences in activation states and ligand-induced conformational changes.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Patel and Doerksen performed analyses of protein conformational variability and interactions of ligands with 11 P-loop residues using a database of 607 ligand bound human kinase crystal structures.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Recently, Vidović et al.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> described the reshuffling of fragments of 936 cocrystallized ATP-competitive kinase inhibitors and generated ∼150 000 new ligand structures after considering both receptor-based similarity constraints and ligand-based filters.</div><div class="NLM_p last">Databases annotating kinase sequences and phylogenetic classification,<a onclick="showRef(event, 'ref5 ref54 ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref5 ref54 ref55 ref56">(5, 54-56)</a> structures,<a onclick="showRef(event, 'ref55 ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref55 ref57 ref58">(55, 57, 58)</a> pathways,<a onclick="showRef(event, 'ref59 ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref59 ref60 ref61">(59-61)</a> and inhibitors<a onclick="showRef(event, 'ref57 ref62'); return false;" href="javascript:void(0);" class="ref ref57 ref62">(57, 62)</a> are widely available. While some are commercial, others are open access. For example, the sc-PDB, a database of druggable binding sites in proteins, contains 1148 kinase binding sites that are clustered and aligned according to protein kinase subtype.<a onclick="showRef(event, 'ref44 ref63'); return false;" href="javascript:void(0);" class="ref ref44 ref63">(44, 63)</a> So far, however, a comprehensive and systematic structure-based analysis that describes kinase–ligand interaction features in all different regions of the kinase ligand binding site is lacking. In the current study we present the first systematic and consistent analysis of kinase–ligand interaction patterns in <i>all</i> regions of the catalytic site of <i>all</i> currently available human kinase crystal structures. For this extensive analysis of the <i>kinase–ligand interactome</i>, we have constructed a database of all 1252 aligned human kinase–ligand cocrystal structures present in the Protein Data Bank (<a href="http://www.pdb.org" class="extLink">www.pdb.org</a>)<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> and used molecular interaction fingerprints (IFP)<a onclick="showRef(event, 'ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref64 ref65">(64, 65)</a> to map the kinase–ligand interactions (Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). The kinase–ligand interaction fingerprints and structure database (KLIFS, Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A) contains the most up to date, comprehensive, and freely available overview of human kinase structures containing the catalytic domain, comprising 1734 crystal structures (covering 190 different kinases) in contrast to, for example, the Kinase SARfari (version 5.00),<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> which contains ∼630 crystal structures of human kinases (covering ∼105 different kinases). The amount of structures in the KLIFS database and the fact that it is freely available already make it different from other structural kinase databases. However, it especially differs in the setup and annotation of all the crystal structures. The superposition of all structures, the extraction of the binding pockets, dissection of the full crystal structure, annotation of the DFG-in, -out, and -out-like conformation, and the generated interaction profiles (IFP) make it especially suitable for ligand design and structure-based optimization. The consistent manner of the database creation allows for an easy (visual) comparison of multiple structures, cocrystallized inhibitors, and their interactions profiles. When used in combination with docking, the overlay of ligand binding poses of a compound in multiple kinases in combination with their aligned pockets can give insight into the next steps for ligand optimization in order to obtain more (or less) selective compounds. The observed interaction patterns for each part of the catalytic cleft and the corresponding inhibitor (sub)structures provide clues for scaffold hopping and targeting of new/extra interactions. The final KLIFS database contains a consistent 3D alignment and numbering of the 85 kinase ligand binding site residues (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B) with their corresponding ligand structures and interaction fingerprint bit-strings. The same residue numbering scheme is consistently used throughout the manuscript:<ul class="NLM_list-list_type-label"><li><p class="inline">[amino acid]<sup>[kinase region in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A].[residue number in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B]</sup></p></li></ul>(e.g., K<sup>III.17</sup>, the conserved lysine residue in β sheet III, residue number 17). This enables the identification of family- or group-specific interaction features and classification of ligands according to their binding modes. Our binding mode analysis focused on the following kinase–ligand interaction features:<table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">1.</td><td colspan="5" valign="top" class="paragraph"><p class="last">binding site topology and amino acid sequence analysis (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B) for the identification of conserved and diverse regions in the kinase ligand binding site (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>);</p></td></tr><tr class="li1"><td valign="top">2.</td><td colspan="5" valign="top" class="paragraph"><p class="last">hydrogen-bond interaction patterns at the hinge region (residues 46–48, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A);</p></td></tr><tr class="li1"><td valign="top">3.</td><td colspan="5" valign="top" class="paragraph"><p class="last">polar interactions with conserved residues K<sup>III.17</sup>, E<sup>αC.24</sup>, and the DFG-motif (residues 81–83, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A);</p></td></tr><tr class="li1"><td valign="top">4.</td><td colspan="5" valign="top" class="paragraph"><p class="last">hydrophobic contacts in the catalytic cleft and hydrophobic back pockets (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A);</p></td></tr><tr class="li1"><td valign="top">5.</td><td colspan="5" valign="top" class="paragraph"><p class="last">types of interactions made to the gatekeeper residue number 45 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A);</p></td></tr><tr class="li1"><td valign="top">6.</td><td colspan="5" valign="top" class="paragraph"><p class="last">kinase flexibility, including conformation of the DFG-motif, position of α-helix C (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A).</p></td></tr></table>The 85 amino acids included in our analysis cover the binding modes and interactions of types I, I1/2,<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> II, and III (e.g., MEK) inhibitors. However, the MEK specific pocket is partly built up by an α-helix that is present in the activation loop of MEK kinases.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> The amino acids that build up this specific α-helix were omitted in the alignment protocol and pocket selection (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). We illustrate how systematic mining of kinase–ligand interaction space can give insights into how conserved and selective kinase interaction hot spots in the different regions of the kinase binding site can accommodate the large diversity of chemical scaffolds observed in kinase ligands.</div></div></div><div id="seca" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">2 Kinase–Ligand Complexes</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41445" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41445" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">2.1 Construction Database of Structurally Aligned Human Kinase–Ligand Complexes</h3><div class="NLM_p">For the systematic analysis of the available human kinase crystal structures from the PDB, we designed a customized structural alignment protocol (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A). This robust alignment enabled large-scale comparison of the kinase structures for the detection of structural similarities and differences within the kinase structures. By use of the Uniprot accession number, these structures were annotated and grouped into kinase classes (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B). Non-kinase-domain-containing structures were discarded, which resulted in a total of 1734 kinase domain structures, of which 1257 contained a ligand, 234 are apo-structures, and 242 are ATP/ADP/staurosporine or ATP/staurosporine-analogue containing structures. The structures cover 190 unique kinases, of which 129 have structures containing a ligand. All 1734 structures were split into different chains and alternative locations, resulting in a total number of 3391 unique chains/alternative locations (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). In total 2346 of these chains were ligand-bound structures, of which 1252 (five problematic complexes were discarded; see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) were unique ligand–protein chains with an IFP that were used for further analysis (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B). The extracted structures were then aligned to a specifically constructed kinase-template set. This set contains 24 structures of kinases representative of all eight eukaryotic protein kinase (ePK) groups (three structures per group), which were manually aligned with a focus on known conserved patterns (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Table S2). After that, the structures were superimposed onto the template after which the pocket and ligand were extracted from the complex. Details about this procedure are described in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. The construction of the KLIFS database has resulted in an updatable framework containing a large number of superimposed crystal structures. The database enables extensive analysis of class- and family-specific features and facilitates future recognition of kinase specific elements because of the continued addition of new crystal structures.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Flowchart of the KLIFS database preparation. GI numbers<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> (i, 946) and mRNA RefSeq IDs<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> (ii, 630) were collected for all human kinases and converted into 2125 Uniprot entries.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> By use of the Uniprot entries, all available human protein structures in the PDB were collected (iii, 2373). A sequence similarity check was performed to select structures that contain a kinase domain (iv, 1734). Structures with a kinase domain were aligned against a structural reference alignment (v). After extraction of cofactors, ATP containing structures, etc., the KLIFS database was created (vi, 1257) that contains separate MOL2 files for the pocket and ligand (vii). (B) Phylogenetic tree of the human kinome. The number of human kinase–ligand complexes and kinase apo structures present in the KLIFS database is presented for each group. (C) Interaction fingerprint bit-string panel contains an example of an IFP analysis, using the pocket and ligand information (viii, 1252), and describes the binding mode of two distinct kinase inhibitors. Different interaction types (hydrophobic (gray), aromatic face-to-face (dark green), aromatic face-to-edge (light green), protein H-bond acceptor to ligand H-bond donor (red), protein H-bond donor to ligand H-bond acceptor (dark blue), negatively ionizable group in the protein to positively ionizable group in the ligand (orange), and positively ionizable group in the protein to negatively ionizable group in the ligand (cyan)) define the IFP.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> From the IFP bit-string, inhibitor positioning in catalytic cleft, H-bond interaction patterns with the protein, and probing of selectivity pockets can be derived (ix). The numbers between brackets refer to the number of kinase structures or the paragraph number in which the binding modes in these pockets are discussed. The kinome tree depicted in 4B was prepared using Kinome Mapper from Reaction Biology.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">2.2 Mining the KLIFS Database: Kinase–Ligand Binding Mode Classification</h3><div class="NLM_p last">Interaction fingerprint<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> analysis was conducted to describe the binding mode of the ligands in the complexes. An example of the (condensed) IFP strings of two inhibitors is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>C. For each amino acid in the catalytic cleft, seven types of protein–ligand interactions are determined. The presence of a certain type of interaction results in the type-setting of a “1” in the bit-string; otherwise a “0” is used to indicate the absence of the interaction. The following seven types of interactions are summarized in one bit-string; bit 1 = hydrophobic contact (HYD); bit 2 = face to face aromatic interactions (F–F); bit 3 = face to edge aromatic interactions (F–E); bit 4 = protein H-bond donor (DON); bit 5 = protein H-bond acceptor (ACC); bit 6 = protein cationic interactions (ION<sup>+</sup>), and bit 7 = protein anionic interactions (ION<sup>–</sup>). From Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>C it is apparent that the binding mode of the inhibitor that is described by the top IFP string is different from the binding mode of the inhibitor that is described by the lower IFP string. The upper inhibitor is a front cleft binder, since no hydrophobic contacts are made with residues in the back cleft area. The lower inhibitor, however, extends into the kinase back cleft as indicated by the hydrophobic contacts made to the back cleft amino acids. Furthermore, this inhibitor forms a hydrogen bond with the conserved E<sup>αC.24</sup> by donating a hydrogen to this amino acid. By use of the generated IFP strings, the inhibitors are classified based on their location in the catalytic cleft. Searching for specific IFP bit combinations enables the extraction of inhibitors that target specific selectivity pockets in the kinases or form specific hydrogen bond interactions. An example describing the different binding modes of four marketed kinase inhibitors is presented in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>. An overview of all the interactions made by the 1252 inhibitors in the three main areas of the catalytic cleft (front cleft, gate area, and back cleft) is shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. Amino acids with zero interactions are not shown in the table.</div></div><div id="sec1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">2.3 Sequence Conservation and Variability in Kinase Ligand Binding Cavities</h3><div class="NLM_p">In the catalytic cleft, conserved residues and motifs are present. For example, the G-rich loop, which contains a conserved GxGxxG motif, is present (g.l.4, g.l.6, and g.l.9, respectively, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), where position 8 is often a phenylalanine (F) or tyrosine (Y) residue (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). In β-sheet III, a highly conserved lysine residue (K<sup>III.17</sup>) is present, which forms a salt bridge with a conserved glutamate residue on the αC-helix (E<sup>αC.24</sup>) in many kinase structures. On the catalytic loop, the HRD triad (c.l.68–70) and an asparagine residue at position 75 (c.l.75) are clearly present. Another highly conserved motif is the DFG-motif (xDFG.80–83). Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> gives an overview of the conserved residues and motifs in the catalytic clefts of the aligned human ligand bound kinase structures.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Conserved Residues (%) in Catalytic Cleft of Ligand Bound Crystal Structures</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">residue/motif</th><th class="colsep0 rowsep0" align="center">location</th><th class="colsep0 rowsep0" align="center">position</th><th class="colsep0 rowsep0" align="center">conservation (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GxGxxG</td><td class="colsep0 rowsep0" align="left">front cleft</td><td class="colsep0 rowsep0" align="left">g.l.4/g.l.6/g.l.9</td><td class="colsep0 rowsep0" align="left">98/100/81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">F (Y)</td><td class="colsep0 rowsep0" align="left">front cleft</td><td class="colsep0 rowsep0" align="left">g.l.8</td><td class="colsep0 rowsep0" align="left">68 (19)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">V</td><td class="colsep0 rowsep0" align="left">front cleft</td><td class="colsep0 rowsep0" align="left">II.11</td><td class="colsep0 rowsep0" align="left">94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">VA</td><td class="colsep0 rowsep0" align="left">front cleft</td><td class="colsep0 rowsep0" align="left">III.14/III.15</td><td class="colsep0 rowsep0" align="left">64/96</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HRD</td><td class="colsep0 rowsep0" align="left">front cleft (DFG-in)/back cleft (DFG-out)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">c.l.68–70</td><td class="colsep0 rowsep0" align="left">90/88/99</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">K (A)</td><td class="colsep0 rowsep0" align="left">front cleft</td><td class="colsep0 rowsep0" align="left">c.l.72</td><td class="colsep0 rowsep0" align="left">71 (26)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">front cleft</td><td class="colsep0 rowsep0" align="left">c.l.75</td><td class="colsep0 rowsep0" align="left">97</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">M/T/F/L/V</td><td class="colsep0 rowsep0" align="left">gate area</td><td class="colsep0 rowsep0" align="left">V.45</td><td class="colsep0 rowsep0" align="left">33/20/19/18/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">K</td><td class="colsep0 rowsep0" align="left">gate area</td><td class="colsep0 rowsep0" align="left">III.17</td><td class="colsep0 rowsep0" align="left">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">V/I/L/T</td><td class="colsep0 rowsep0" align="left">gate area</td><td class="colsep0 rowsep0" align="left">b.l.36</td><td class="colsep0 rowsep0" align="left">53/24/9/7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">A/S/G/T/C</td><td class="colsep0 rowsep0" align="left">gate area</td><td class="colsep0 rowsep0" align="left">xDFG.80</td><td class="colsep0 rowsep0" align="left">33/13/12/12/9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DFG</td><td class="colsep0 rowsep0" align="left">gate area</td><td class="colsep0 rowsep0" align="left">xDFG.81–83</td><td class="colsep0 rowsep0" align="left">99/88/98</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">E</td><td class="colsep0 rowsep0" align="left">back cleft</td><td class="colsep0 rowsep0" align="left">αC.24</td><td class="colsep0 rowsep0" align="left">99</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">L/M/Y/H</td><td class="colsep0 rowsep0" align="left">back cleft</td><td class="colsep0 rowsep0" align="left">αC.28</td><td class="colsep0 rowsep0" align="left">53/27/7/3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">The HRD motif is part of the front cleft in DFG-in kinases and part of the back cleft in DFG-out kinases.</p></div></div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">3 Analysis of Kinase–Ligand Interactions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16223" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16223" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> gives an overview of the binding modes of four approved kinase inhibitors and illustrates the different binding locations and interaction patterns. The c-MET inhibitor <b>14</b> (crizotinib, Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2wgj">2wgj</a>)<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> is a front cleft binder and makes polar interactions solely to the hinge region while probing into a selectivity pocket in the front cleft (FP-I) with the halogen substituted phenyl ring. Inhibitor <b>15</b> (dasatinib) extends into the kinase gate area region of ABL1 and is involved in hydrogen bonding with the gatekeeper (GK) residue T<sup>V.45</sup> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2gqg">2gqg</a>).<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> The phenyl ring of <b>15</b> binds in the gate area in a selectivity pocket BP-I-B, while the chlorine atom of <b>15</b> probes up into a smaller selectivity pocket (BP-I-A, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A, Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). The EGFR inhibitor <b>5</b> (lapatinib, Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>C, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1xkk">1xkk</a>)<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> extends further into the back cleft, while the kinase is in a DFG-in fashion. The chlorine atom of <b>5</b> occupies BP-I-A. The central phenyl ring occupies BP-I-B, and the right-most phenyl ring occupies BP-II-A-in (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). The ABL1 inhibitor <b>7</b> (nilotinib, Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>D, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3cs9">3cs9</a>)<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> binds a DFG-out conformation of the protein and probes extra selectivity pockets in the back cleft, including BP-I-A (methyl moiety), BP-1-B (central phenyl ring), BP-II-out (right-most phenyl ring), BP-III (CF<sub>3</sub> moiety), and BP-IV (imidazole ring). By use of the IFP patterns of the 1252 aligned kinase–ligand complexes (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), the inhibitors were divided into front cleft and back cleft binders (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). The current analysis provides an overview of inhibitors binding in the different selectivity pockets in the front and back clefts. For the group of front cleft binders, hydrogen bond interaction combinations that are used to increase ligand-binding potency are described.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Ligand–protein interaction fingerprint (IFP) analysis<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> of four marketed kinase inhibitors:<a onclick="showRef(event, 'ref13 ref14 ref18'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref18">(13, 14, 18)</a> binding poses of (A) <b>14</b> (cyan carbon atoms) in c-MET (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2wgj">2wgj</a>),<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> (B) <b>15</b> (cyan carbon atoms) in ABL1 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2gqg">2gqg</a>),<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> (C) <b>5</b> (cyan carbon atoms) in EGFR (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1xkk">1xkk</a>),<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (D) <b>7</b> (cyan carbon atoms) in ABL1 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3cs9">3cs9</a>).<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Important binding residues are depicted as sticks with salmon colored carbon atoms. Oxygen, nitrogen, and sulfur atoms are colored red, blue, and yellow, respectively. H-Bonds described in the text are depicted by gold colored dots. The viewing orientation and colors used for proteins and ligands are used consistently throughout the manuscript. (E) IFP bit-strings describing the binding poses of ligands <b>14</b>, <b>15</b>, <b>5</b>, and <b>7</b> (A–D), encoding different interaction types with each residue in the binding site. For reasons of clarity, only the bit strings of the residues that are visible in the corresponding images above are shown. IFP color coding is as indicated in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>. This is presented in this fashion consistently throughout the manuscript. 2D structures of the molecules are presented in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> or <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Figure S1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. IFP Analysis on the 1252 Aligned Ligand Bound Structures<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0007.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>Table a</sup><p class="last">The table is divided in a front cleft, back cleft and gate area. The total number of different interaction types (HYD, F–F, F–E, DON, ACC, ION+, ION–) for each residue (AA, see Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B for residue numbering) of the binding pocket is presented. Amino acids with zero interactions are not shown. Abbreviations: AA, amino acid number; HYD, hydrophobic contacts; F–F, face to face aromatic interactions; F–E, face to edge aromatic interactions; DON, protein H-bond donor; ACC, protein H-bond acceptor; ION+, protein cationic interactions; ION–, protein anionic interactions.</p></div></div><div></div></div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13">3.1 H-Bond Interaction Patterns with the Hinge</h3><div class="NLM_p">H-bond interactions with the hinge region are highly conserved interactions that are observed in >88% of all human kinase–ligand cocrystal structures (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). The backbone amide nitrogen atom of aa<sup>hinge.48</sup> donates a H-bond to the ligand in over 86% of the kinase structures (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, entry 2), while the backbone carbonyl oxygen atoms of aa<sup>hinge.46</sup> and/or aa<sup>hinge.48</sup> accept a H-bond from the ligand in >35% of the cases (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, entries 1 and 3). There are, however, different ways in which ligands can form H-bond interactions with the backbone oxygen atom of aa<sup>hinge.46</sup> and/or backbone nitrogen atom and/or oxygen atom of aa<sup>hinge.48</sup> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). In general four different binding modes with the hinge region can be distinguished:</div><div id="secz" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> (1) Three H-Bond Interactions with the Hinge</h4><div class="NLM_p last">CDK2 inhibitor <b>19</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2vtl">2vtl</a>)<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> illustrates how ligands can fully utilize the hydrogen bonding capacity of the kinase hinge backbone region. The 1<i>H</i>-pyrazole-3-carboxamide group can simultaneously accept an H-bond from aa<sup>hinge.48</sup> while donating H-bonds to aa<sup>hinge.46</sup> and aa<sup>hinge.48</sup>. Other examples of chemical scaffolds that can facilitate three H-bond interactions with the hinge are 9<i>H</i>-purin-2-amine (e.g., <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1e1v">1e1v</a>),<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> 2<i>H</i>-pyrazolo[4,3-<i>d</i>]pyrimidin-7-amine (e.g., <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3pj8">3pj8</a>),<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> and 1<i>H</i>-indazol-3-amine (e.g., <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3qd4">3qd4</a>).<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Thirteen percent of the structures contain a ligand that forms three hydrogen bonds with the hinge region (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, entry 10).</div></div><div id="secw" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> (2) Two H-Bond Interactions with the Hinge Backbone</h4><div class="NLM_p last">The number of inhibitors that binds via two hydrogen bonds does this predominantly in a donor–acceptor fashion, either by interacting with aa<sup>hinge.48</sup> and aa<sup>hinge.46</sup> simultaneously (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, entry 8, e.g., inhibitor <b>14</b> in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A) or by interacting with aa<sup>hinge.48</sup> alone (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, entry 7, e.g., inhibitor <b>15</b> in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B). Examples of groups that can form H-bonds with aa<sup>hinge.48</sup> and aa<sup>hinge.46</sup> at the same time are amino pyrimidines (e.g., <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4dfl">4dfl</a>),<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> 9<i>H</i>-purin-6-amines (e.g., <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3rwp">3rwp</a>),<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> indazoles (e.g., <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3v8s">3v8s</a>),<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> thieno[3,2-<i>c</i>]pyridin-4-amines (e.g., <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3tjc">3tjc</a>),<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> or phenols (e.g., <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3p0m">3p0m</a>).<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Chemical scaffolds that can simultaneously accept and donate H-bonds with aa<sup>hinge.48</sup> are amino pyrimidines (e.g., <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4e93">4e93</a>),<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> pyrazolo[1,5-<i>a</i>]pyrimidin-7-amines (e.g., <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2vts">2vts</a>),<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> thiazolo[5,4-<i>b</i>]pyridin-2-amines (e.g., <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4dbn">4dbn</a>),<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> 3,4-dihydro-1,8-naphthyridin-2(1<i>H</i>)-ones (e.g., <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3q96">3q96</a>),<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> or more complex ring systems like <i>N</i>-(pyrimidin-4-yl)thiazol-2-amines (as exemplified by the binding mode of <b>15</b> with Abl, Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B).<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Recently a new pyrrolo[2,3-<i>d</i>]thiazole scaffold was disclosed, which has been cocrystallized with focal adhesion kinase (FAK, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3pxk">3pxk</a>).<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></div></div><div id="secx" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> (3) One Single H-Bond Interaction with the Hinge Backbone</h4><div class="NLM_p last">More than a quarter of the inhibitors that form a single hydrogen bond with the hinge do so with the amide nitrogen atom of aa<sup>hinge.48</sup>, as illustrated by the binding mode of <b>5</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, entry 5, Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>C). Other examples of such scaffolds include imidazo[1,2-<i>b</i>]pyridazines (e.g., <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4dym">4dym</a>),<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> quinolines (e.g., <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ue4">3ue4</a>),<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> isoquinolines (e.g., <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3tku">3tku</a>),<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> but also pyrrolo[2,1-<i>f</i>][1,2,4]triazine C6-ketones (e.g., <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3s4q">3s4q</a>)<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> and 2,2-dimethylbenzo[<i>d</i>][1,3]dioxoles (e.g., <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3raw">3raw</a>).<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Merely 2% of the inhibitors form a single hydrogen bond by donating a hydrogen to the backbone carbonyl oxygen of aa<sup>hinge.46</sup> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, entry 6, e.g., <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3t9i">3t9i</a>,<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3c4e">3c4e</a>,<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3dcv">3dcv</a><a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a>) or aa<sup>hinge.48</sup> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, entry 4, e.g., <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ycs">2ycs</a><a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a>).</div></div><div id="secy" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> (4) No or Alternative Interactions with Hinge Region</h4><div class="NLM_p">In addition to H-bond patterns presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, kinase inhibitors can adopt alternative binding modes with the hinge backbone. The 6,7-dichloroindoline moiety of the CLK3 inhibitor (<i>E</i>)-ethyl 3-(2-amino-1-cyanovinyl)-6,7-dichloro-1-methyl-1<i>H</i>-indole-2-carboxylate (<b>20</b>, <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Figure S1), for example, forms only a single halogen bond with the aa<sup>hinge.46</sup> carbonyl oxygen (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2wu7">2wu7</a>),<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> while the 4,5,6,7-tetrabromo-1<i>H</i>-benzo[<i>d</i>][1,2,3]triazole moiety of the inhibitor 3-(4,5,6,7-tetrabromo-1<i>H</i>-benzotriazol-1-yl)propan-1-ol (<b>21</b>, <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Figure S1) (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ofm">3ofm</a>)<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> forms two halogen bonds<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> with the hinge backbone carbonyl oxygen atoms of aa<sup>hinge.48</sup> and aa<sup>hinge.46</sup> in CK2. In addition to H-bonds and halogen bonds, kinase–ligand interactions with the hinge can be mediated by CH–O hydrogen bonds with backbone carbonyl atoms,<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> as exemplified by the binding mode of 4 (bosutinib, Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>B, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ue4">3ue4</a>)<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> in ABL1 and <b>5</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>C, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1xkk">1xkk</a>)<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> in EGFR. The quinoline C-2 CH of <b>4</b> and the quinazoline C-2 CH of <b>5</b> not only do accept a H-bond from the backbone amide nitrogen of M<sup>hinge.48</sup> but also form a CH H-bond with the carbonyl oxygen of Q<sup>hinge.46</sup> and E<sup>hinge.46</sup>, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>C, Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>B). However, these CH–O bonds are <i>not</i> identified as H-bond interactions with the current IFP analysis method.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> An example of this is inhibitor <b>22</b>, which makes two CH–O bonds to the kinase hinge region of Pim1 that are not picked up in the IFP analysis (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1yi3">1yi3</a>).<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> An interesting conformational rearrangement, called hinge flip or glycine flip, can occur at the hinge region. The hinge flip involves an approximate 180° flip of the G<sup>linker.49</sup> residue, which rotates the backbone carbonyl oxygen atom of hinge.48 away from the ATP binding site and the backbone NH of G<sup>linker.49</sup> into the ATP binding site.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> Since only 46 of all 518 kinases have a glycine residue at position aa<sup>hinge.49</sup> and are therefore able to perform a hinge flip, exploiting the newly introduced H-bond donor can be used by inhibitors to gain selectivity toward these kinases.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> There are 32 crystal structures of kinase–inhibitor complexes (all p38), in which the inhibitor binds to the flipped hinge region. Examples include structures in DFG-in (e.g., <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1m7q">1m7q</a>),<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> DFG-out-like (e.g., <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3hp2">3hp2</a>),<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> and DFG-out (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, hinge pattern 13, e.g., <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1kv2">1kv2</a>)<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> kinases. An overview of the H-bonding patterns at the hinge region is presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Eleven different combinations of H-bond interactions with aa<sup>hinge.48</sup> and aa<sup>hinge.46</sup> were defined using the IFP bit-strings of the kinase–inhibitor complexes. Hinge H-bond interaction pattern 4, for example, specifically identifies the kinase–inhibitor complexes in which the inhibitor only donates an H-bond to aa<sup>hinge.48</sup> (while no other H-bonds are formed with the hinge region).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Analysis of Kinase–Ligand Hydrogen-Bonding Patterns at the Hinge Region (See Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">hinge.48<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" align="center">hinge.46<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="2" align="center">structures</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">hinge H-bond interaction pattern</th><th class="colsep0 rowsep0" align="center">acc (C═O)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">don (N-H)<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">acc (C═O)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">% inhibitors</th><th class="colsep0 rowsep0" align="center">no. inhibitors</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0/1</td><td class="colsep0 rowsep0" align="left">0/1</td><td class="colsep0 rowsep0" align="left">38</td><td class="colsep0 rowsep0" align="left">481</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">0/1</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0/1</td><td class="colsep0 rowsep0" align="left">86</td><td class="colsep0 rowsep0" align="left">1077</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">0/1</td><td class="colsep0 rowsep0" align="left">0/1</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">35</td><td class="colsep0 rowsep0" align="left">442</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">28</td><td class="colsep0 rowsep0" align="left">352</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">300</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">257</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"><1</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">168</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">147</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">0/1</td><td class="colsep0 rowsep0" align="left">0/1</td><td class="colsep0 rowsep0" align="left">0/1</td><td class="colsep0 rowsep0" align="left">88</td><td class="colsep0 rowsep0" align="left">1105</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">1<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0/1</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">32</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">See Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> for residue numbering in the hinge region.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">H-bond interaction between kinase backbone carbonyl oxygen (H-bond acceptor) and ligand H-bond donor.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">H-bond interaction between kinase backbone amide nitrogen (H-bond donor) and ligand H-bond acceptor.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Hinge flipped kinase H-bond interaction between kinase backbone amide nitrogen (H-bond donor) of linker.49 and ligand H-bond acceptor.</p></div></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19">3.2 Kinase–Ligand Interactions in the Catalytic Cleft</h3><div class="NLM_p">A schematic overview of binding modes of inhibitors that probe into selectivity pockets in the front cleft (FP-I, FP-II), gate area, and back cleft (BP-I, BP-II, BP-III, BP-IV, BP-V) is presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. The PDB entries associated with inhibitors that probe into the presented selectivity pockets are indicated, together with a reference to the figure in which the 3D binding mode is shown. Aromatic face–face/edge interactions are predominantly made in the front cleft, with the aa<sup>hinge.47</sup>. Eight percent of the inhibitors are involved in aromatic interactions with aa<sup>g.l.8</sup> on the G-loop. Ionic interactions are scarcely present in the kinase–inhibitor complexes. The majority of these types of interactions occur in the solvent exposed part of the kinases at aa<sup>linker.52</sup>. Typically, solubilizing groups on the kinase inhibitors tend to bind here.</div><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20">3.2.1 Front Cleft Binders</h4><div class="NLM_p">In 799 complexes, compounds were assigned to be front cleft binders, of which 78 were identified as nonhinge binders. These compounds either were not involved in hydrogen bonding with the hinge or interact with the hinge via halogen-bonding or CH-bonding. Interactions of the inhibitors in the front cleft mainly consist of hydrophobic interactions (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). More specifically, 84% of all inhibitors make hydrophobic contacts with amino acids I.3, II.11, III.15, and VII.77 of β-sheets I, II, III, and VII, respectively. These residues are relatively conserved among kinases (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) and line the so-called “adenine pocket” (AP) that binds ring systems in kinase inhibitors that mimic the adenine ring of ATP.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Extensive hydrophobic contacts are also made with the kinase hinge (>89% with aa<sup>hinge.47</sup>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Schematic Overview of Inhibitor Binding Modes in the Kinase Catalytic Cleft<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0008.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0009.gif" alt="" id="GRAPHIC-d283e1908-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0010.gif" alt="" id="GRAPHIC-d283e1909-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0011.gif" alt="" id="GRAPHIC-d283e1910-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0012.gif" alt="" id="GRAPHIC-d283e1911-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>Table a</sup><p class="last">The hinge amino acids hinge.48 and hinge.46, gatekeeper (GK<sup>V.45</sup>) and DFG-motif are shown. Subpockets are indicated as colored spheres: AP, gray; FP-1, orange; xI, magenta; BP-I, yellow; BP-II-in (A and B, DFG-in), green; BP-II-out, red; BP-III, cyan; BP-IV, blue; BP-V, blue.</p></div></div><div></div></div></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22">3.2.2 Hydrogen-Bond Interactions at the Gate Area (GK/K<sup>III.7</sup>/xDFG)</h4><div class="NLM_p">From the compounds that solely bind in the front cleft, 339 compounds make stabilizing hydrogen-bond interactions at the gate area. Hydrogen bonding at the gate area can occur with the side chains of the gatekeeper<sup>V.45</sup> and K<sup>III.17</sup> and with the xDFG-motif. When X<sup>xDFG.80</sup> is, for example, a Ser of Thr residue, the side chain of this residue acts as a hydrogen-bond donor in 30 structures, as illustrated by the binding mode of inhibitor <b>23</b> in complex with PDK1 (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>A, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1uu9">1uu9</a>).<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> The Erk2 inhibitor <b>24</b> is involved in simultaneously hydrogen-bonding with the gatekeeper<sup>V.45</sup> and K<sup>III.17</sup> by respectively donating and accepting a hydrogen for hydrogen bonding (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>B, Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ojg">2ojg</a>).<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> The conserved D<sup>xDFG.81</sup> residue can act as a hydrogen-bond acceptor via its side chain acid moiety and is involved as an hydrogen-bond acceptor in 107 structures. This is illustrated by the binding mode of <b>25</b> in Chk1, which makes hydrogen bonds to D<sup>xDFG.81</sup> and K<sup>III.17</sup> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>C, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3tki">3tki</a>).<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> The Nek2 inhibitor <b>26</b> makes hydrogen bond interactions to protonated K<sup>III.17</sup> and NH atom of the D<sup>xDFG.81</sup> and stabilizes the kinase DFG-out-like conformation of Nek2, without extending into the back cleft (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>D, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2xk4">2xk4</a>).<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> The conserved D<sup>xDFG.81</sup> residue can act as a hydrogen-bond donor via its backbone NH (72 cases), stabilizing both DFG-in and -out-like conformations. F<sup>xDFG.82</sup> and G<sup>xDFG.83</sup> of the xDFG-motif are not involved in hydrogen bonding interactions with front cleft binders.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0013.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Hydrogen-bond interactions at the gate area. (A) Inhibitor <b>23</b> in complex with PDK1 is involved in hydrogen-bonding to the gate area by accepting a hydrogen bond from T<sup>xDFG.80</sup>(<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1uu9">1uu9</a>).<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> (B) Inhibitor <b>24</b> in complex with Erk2 is involved in hydrogen-bonding to the gate area by donating a hydrogen bond to the gatekeeper Q<sup>V.45</sup> and accepting a hydrogen bond from the protonated K<sup>III.17</sup> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ojg">2ojg</a>).<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> (C) Inhibitor <b>25</b> in complex with Chk1 is involved in hydrogen bonding to the gate area by accepting a hydrogen bond from the protonated K<sup>III.17</sup> and donating a hydrogen bond to the side chain of the catalytic D<sup>xDFG8</sup> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3tki">3tki</a>).<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> (D) Inhibitor <b>26</b> stabilizes a DFG-out-like form of the NEK2 kinase by interacting with protonated K<sup>III.17</sup> and the amide nitrogen atom of the D<sup>xDFG81</sup> backbone. (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2xk4">2xk4</a>).<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> Rendering and IFP color coding are as indicated in Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23">3.2.3 Subpockets in the Front Cleft (FP-I/FP-II)</h4><div class="NLM_p">Potency and selectivity of inhibitors binding in the front cleft may also be achieved by addressing subpockets in the front cleft. The inhibitor (3<i>Z</i>)-5-[(2,6-dichlorobenzyl)sulfonyl]-3-[(3,5-dimethyl-4-{[(2<i>R</i>)-2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl]carbonyl}-1<i>H</i>-pyrrol-2-yl)methylene]-1,3-dihydro-2<i>H</i>-indol-2-one (<b>27</b>, PHA-665752,<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a><a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Figure S1) bound c-MET crystal structure (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2wkm">2wkm</a>, not shown)<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> was used to design inhibitor <b>14</b> to more effectively bind in FP-I of c-MET (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A, Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2wgj">2wgj</a>).<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> The 2-aminopyridine core of <b>14</b> allowed the 3-benzyloxy group to more efficiently reach FP-I than the 2,6-dichlorophenyl group of <b>27</b> (resulting in a better ligand efficiency).<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> FP-I is accommodated not only in c-MET (in 16 structures) but also in AurA, CDK2, JAK2, AKT1, and others (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). In some kinases, FP-I can be considerably deep, while in other kinases FP-I is shallower and accommodates, for example, a halogen atom.</div><div class="NLM_p">A combination of fragment-based screening and structure-guided scaffold hopping enabled the discovery of ROCK1 inhibitor <b>28</b> that binds into FP-II, another front cleft pocket located in the G-loop (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>A, Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3v8s">3v8s</a>).<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Ligand efficiency (LE) analysis was used to guide the fragment optimization process and indicated that the ethylene linker is the optimal spacer that allows the phenyl group to reach deep in this hydrophobic pocket. FP-II is also occupied in several other kinases, including PDK1, Jak2, AKT1, PKA-C, AurA, and others (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Moreover, FP-II might also be induced in other kinases because of the relative flexibility of the G-loop.</div><div class="NLM_p">Interestingly, there are several kinases that accommodate ligands in both FP-I and FP-II simultaneously, including Akt1, Akt2, Jak2, TBK1, and others (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Inhibitor <b>12</b> (tofacitinib), for example, is a JAK3 inhibitor with an excellent selectivity profile<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> that is approved for the treatment of rheumatoid arthritis (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>B, Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3lxk">3lxk</a>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Inhibitor <b>12</b> probes into FP-I with its piperidine C7 methyl group and FP-II with its nitrile group. Computational analysis using Watermap suggested that the C7 methyl and nitrile groups are involved in the displacement of unfavorable water molecules in FP-I and FP-II that might contribute to the binding affinity of <b>12</b> toward JAK3 and other JAK isozymes.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p">Identification of inhibitors for PKB using a fragment-based approach led to the identification of <b>29</b>, which was optimized into <b>30</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>C).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Both fragments were soaked in non-human PKA-PKB chimera crystals (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2uw3">2uw3</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2uw4">2uw4</a>, respectively, crystal structures not shown) and optimized into <b>31</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>D, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2uw9">2uw9</a>).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> This compound probes with the chlorine substituted phenyl ring up into FP-II.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0014.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Utilization of pockets in the front cleft. (A) Compound <b>28</b> probes into FP-II of ROCK1 with the phenyl ring (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3v8s">3v8s</a>).<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> (B) The JAK inhibitor <b>12</b> in complex with JAK3 probes FP-I with its methylpiperidine moiety and FP-II with the nitrile group (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3lxk">3lxk</a>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Another example of a compound binding in FP-I is shown by the binding mode of <b>14</b> in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A. (C) Via a fragment-based approach, <b>29</b> and <b>30</b> were identified and optimized into <b>31</b>. (D) PKB inhibitor <b>31</b> in complex with human PKBβ (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2uw9">2uw9</a>).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The chlorophenyl ring probes up into FP-II. Rendering and IFP color coding are as indicated in Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24">3.3 Kinase–Ligand Interactions in the Back Cleft</h3><div class="NLM_p">For inhibitor potency and selectivity, growing inhibitors from the front cleft into the back cleft is a frequently used optimization strategy.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> In the back cleft a number of hydrophobic subpockets (BP-I, BP-II, BP-III, BP-IV, BP-V) may be available in the kinase<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> that can be addressed by the appropriate substituents. Here we describe to what extent these subpockets are used by inhibitors in the kinase set.</div><div id="sec2_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25">3.3.1 Back Pocket I (BP-I-A and BP-I-B)</h4><div class="NLM_p">The gate area connects the front cleft (AP, FP) with the back cleft. Back pocket I-B (BP-I-B) is a large pocket that is located in the center of this gate area that gives access to other back pockets. Back pocket I-A (BP-I-A) is located at the top of the gate area and is formed by residues III.15, III.17, αC.28, V.40, V.41, and the gatekeeper V.45. The accessibility of the smaller BP-I-A pocket is largely dependent on the size of the gatekeeper<sup>V.45</sup> residue, and BP-I-A is targeted by both DFG-in and DFG-out inhibitors. Inhibitor <b>32</b> (tozasertib) stabilizes ABL1 in the active DFG-in conformation and binds BP-I-B with its apolar cyclopropyl group (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>A, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2f4j">2f4j</a>).<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> The fact that <b>32</b> does not form a H-bond with the gatekeeper explains why <b>32</b> (unlike, for example, <b>6</b>) is also effective against, for example, the ABL1 T315I<sup>V.45</sup> mutant.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Examples of inhibitors targeting BP-I-A and BP-I-B are the drugs <b>2</b> (erlotinib) and <b>4</b>, as illustrated by the binding mode of <b>4</b> in Abl1 (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>B, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ue4">3ue4</a>, DFG-out-like).<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Inhibitor <b>4</b> stabilizes the DFG-out-like conformation of Abl1 via face-to-edge π interactions with F<sup>xDFG.82</sup> and by completely enveloping gatekeeper T<sup>V.45</sup> with both the nitrile group and the 5-methoxy group of the aniline ring. The phenylalanine of the DFG motif F<sup>xDFG.82</sup> accounts for 13% of the face–edge interactions in all the complexes. A total number of 162 compounds target BP-I without extending further into the back cleft (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). This binding mode is observed for many different kinase types, including p38, JNK3, EGFR, EphB4, BTK, SRC, and others.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0015.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Front cleft binders entering the gate area (BP-I-A, BP-I-B). (A) Inhibitor <b>32</b> in complex with ABL1 forms three hydrogen bonds to the kinase hinge and curves back into gate area and probes BP-I-B, while it is hydrogen bonding with the D<sup>xDFG.81</sup> side chain (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2f4j">2f4j</a>).<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> (B) ABL1 in complex with inhibitor <b>4</b>. The substituted phenyl ring probes BP-I-B, while the methoxy group probes up into BP-I-A. The kinase is in the DFG-out-like conformation (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ue4">3ue4</a>).<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> (C) The hybrid compound <b>33</b> penetrates into BP-I-B of Jak2 and forms hydrogen bonds with the backbone of F<sup>xDFG.82</sup> and side chain of E<sup>αC.24</sup> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3kck">3kck</a>).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Rendering and IFP color coding are as indicated in Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Cyclization of a hybrid between two pyrrolopyridine fragment ligands of Jak2 resulted in a new kinase inhibitor scaffold that was further optimized by SAR, yielding <b>33</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>C, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3kck">3kck</a>).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Compound <b>33</b> penetrates the gate area via BP-I-B and forms two H-bonds with the backbone of F<sup>xDFG.82</sup> and side chain of E<sup>αC.24</sup>, via a para-substituted OH group.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div></div><div id="sec2_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26">3.3.2 Back Pocket II: DFG-in (BP-II-in)</h4><div class="NLM_p">Back pocket II is situated in the back cleft, between the DFG-motif and αC-helix. The size of BP-II depends on the position of the αC-helix and status of the DFG-motif (i.e., -in or -out). Compound <b>34</b> in complex with p38α illustrates the probing of the small BP-II in a DFG-in kinase (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>A, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3s4q">3s4q</a>).<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> The αC-helix is in the active “in” position in this structure. Cyclopropyl or heterocyclic amide substituents allow H-bond interactions between the amide group and E<sup>C.24</sup> in the αC-helix and are sterically compatible with the relatively small BP-II in p38-DFG-in.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a></div><div class="NLM_p">Our analysis identified 39 structures with front cleft binding compounds targeting BP-II in DFG-in kinases, including p38, HCK, FGFR1, FMS, and others (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). The binding mode of <b>5</b> in EGFR (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>B, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1xkk">1xkk</a>, Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>)<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> illustrates the opening up of the larger BP-II (BP-II-A) with a larger hydrophobic substituent that shifts the αC-helix outward in an “out” position.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> SAR studies show a subtle preference for the optimal 3-fluorine substituent (over Br and CF<sub>3</sub> subtituents) and the unsubstituted benzyloxy ring analogue<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> that is in line with the well-defined hydrophobic BP-II-A subpocket. Inhibitors that bind into BP-II, BP-II-A, or BP-II-b with large ring systems tend to disrupt the usually well-conserved salt bridge between K<sup>III.17</sup> and E<sup><b>α</b>C.24</sup> (e.g., Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>B, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1xkk">1xkk</a>;<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>C, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3efk">3efk</a>;<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>D, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3sls">3sls</a><a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a>). Twenty-two structures contain compounds that target the deeper buried BP-II-A in DFG-in kinases, including EGFR, BRAF, ErbB2, ALK, BTK, and TIE2 (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). In CDK2 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3pxz">3pxz</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3py1">3py1</a>),<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> PEK (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4g31">4g31</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4g34">4g34</a>),<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> and c-Met (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2rfn">2rfn</a>,<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3efj">3efj</a>,<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3efk">3efk</a>,<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3u6h">3u6h</a>,<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3u6i">3u6i</a><a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a>) a pocket between β sheet IV and the αC-helix is probed, designated BP-II-B. The c-Met inhibitor <b>35</b> illustrates the binding mode in which BP-II-B is reached by penetrating the gate area while binding at the hinge region (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>C, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3efk">3efk</a>, Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>).<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Interestingly, in MEK kinase inhibitors can bind BP-II from a MEK specific allosteric pocket that is completely separated from the ATP binding site as illustrated by <b>36 (</b>UCB1353770,<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>D, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3sls">3sls</a>),<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> which binds into BP-II-A-in (with the iodinated phenyl ring) and BP-II-in (with the thiophene ring).</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0016.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Compounds targeting BP-II and subpockets of BP-II. (A) Compound <b>34</b> extends through the gate area into BP-II, while the p38α kinase is in the DFG-in form (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3s4q">3s4q</a>).<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> (B) Compound <b>5</b> probes into the deeper buried BP-II-A of the DFG-in EGFR kinase (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1xkk">1xkk</a>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (C) The inhibitor <b>35</b>, probes into BP-II-B of c-Met, with the fluorophenyl ring (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3efk">3efk</a>).<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> (D) Binding mode of the MEK inhibitor <b>36</b>, which probes BP-II in MEK-1 (<a href="https://" class="ext-link">3sls</a>).<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> Rendering and IFP color coding are as indicated in Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27">3.3.3 Back Pocket II: DFG-out (BP-II-out)</h4><div class="NLM_p">Comparison of the cocrystal structures of VEGFR2 naphthamide inhibitors<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a><b>37</b> and <b>38</b> illustrates how differences in the size of substituents pointing toward the hydrophobic back pocket can influence the activation state of the kinase (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>). While the cyclopropyl group of <b>37</b> is compatible with a DFG-in conformation and probes into BP-II-in (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>A, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3b8r">3b8r</a>), the larger para-Cl phenyl ring of <b>38</b> induces VEGFR2 to assume a DFG-out conformation and probes into BP-II-out (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>B, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3b8q">3b8q</a>). Our analysis identified 12 structures with compounds targeting BP-II in the DFG-out form of the kinase.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0017.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Switching from probing BP-II-in, toward probing BP-II-out. (A) The cyclopropyl group of <b>37</b> probes BP-II-in of VEGFR2 in the DFG-in form (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3b8r">3b8r</a>).<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> (B) The para-Cl phenyl ring of <b>38</b> (cyan carbon atoms) induces a DFG-out form of VEGFR2 and probes deep into BP-II-out (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3b8q">3b8q</a>).<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Rendering and IFP color code are as indicated in Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The formation of a H-bond with the D<sup>xDFG.81</sup> backbone NH and one or two hydrogen bonds with the side chain carboxylate of E<sup>αC.24</sup>, as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>, is a commonly observed hydrogen-bonding motif for DFG-out back cleft binders and involves H-bond interaction with the preserved K<sup>III.17</sup>–E<sup>αC.24</sup> salt bridge.</div></div><div id="sec2_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28">3.3.4 Back Pockets III (BP-III), IV (BP-IV), and V (BP-V)</h4><div class="NLM_p">Back pockets III, IV, and V are available only in the DFG-out form of the kinase. BP-III is buried behind BP-II. This pocket can be probed by DFG-out stabilizing compounds, which extend through the gate area and interact with the hinge region, as illustrated by the binding mode of the clinical candidate <b>39</b> (foretinib)<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> in c-MET (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>A, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3lq8">3lq8</a>).<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> Inhibitor <b>39</b> forms hydrogen bonds with both the backbone NH atoms of D<sup>xDFG.81</sup> and side chain of K<sup>III.17</sup>, stabilizing the kinase DFG-out form and extending the <i>N</i>-(4-fluorophenyl)cyclopropanecarboxamide moiety deep into the hydrophobic back pocket III, while the cyclopropyl ring of the inhibitor is binding into BP-II-out.</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0018.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Compounds binding in DFG-out pockets. (A) Inhibitor <b>39</b> probes BP-III of the DFG-out c-Met kinase (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3lq8">3lq8</a>).<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> (B) Inhibitor <b>40</b> in complex with the αC-helix disrupted DFG-out PDK1. The 3,4-difluorobenzyl moiety probes into BP-III (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3nax">3nax</a>).<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> (C) Inhibitor <b>6</b> in complex with DFG-out LCK. The methylpiperazine ring binds in the partially hydrophobic BP-IV (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2pl0">2pl0</a>).<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> (D) Inhibitor <b>41</b> in complex with DFG-out ABL1. The <i>tert</i>-butyl moiety probes into BP-III, while the quinoline ring binds in BP-V (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3qri">3qri</a>).<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Rendering and IFP color coding are as indicated in Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The selective PDK1 inhibitor <b>40</b> probes into BP-III with the 3,4-difluorobenzyl moiety (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>B, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3nax">3nax</a>).<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> This compound binds PDK1 in a rather unique binding mode, in which the αC-helix of PDK1 is disrupted in order to accommodate the pyridinone ring.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> Inhibitor <b>6</b> extends into BP-II in the DFG-out form of LCK, while the piperazine ring binds in the partially hydrophobic BP-IV (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>C, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2pl0">2pl0</a>).<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> The “switch-control” inhibitor <b>41</b> (rebastinib) has efficacy against the majority of relevant CML-resistance mutants and stabilizes a type II inactive conformation in ABL1 by forming a H-bond interaction with E<sup><b>α</b>C.20</sup> (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>D, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3qri">3qri</a>).<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> This residue forms an ionic interaction with R386 (not shown) and keeps ABL1 in an inactive DFG-out conformation. Inhibitor <b>41</b> binds in BP-III with its <i>tert</i>-butyl moiety and binds another partially hydrophobic back pocket, BP-V with its quinoline ring.</div><div class="NLM_p">Interestingly, the back pockets can be addressed by fragment-based design, as demonstrated for p38α. The initial fragment hit <b>42</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>A, DFG-in, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1w7h">1w7h</a>)<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> binds at the hinge region and probes into BP-I. This compound was merged with <b>43</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>B, DFG-out, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1w82">1w82</a>),<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> which binds in BP-I, -II, -III, and -V, into <b>44</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>C, DFG-out, crystal structure not shown, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1wbn">1wbn</a>). Optimization of <b>44</b> led to <b>45</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>D, DFG-out, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1w83">1w83</a>), which binds at the hinge and probes and binds into BP-I (central chlorophenyl ring), BP-II-out (right-most phenyl ring), BP-III (morpholino substituent on right-most phenyl ring), and BP-V (chloro substituent on right-most phenyl ring).<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Our analysis identified 23 complexes in which the inhibitor did not bind the front cleft but solely in the gate area and back cleft probing BP-II, BP-III, and BP-V (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>).</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0019.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Fragment based optimization of a BP-III targeting p38 inhibitor. (A) Fragment <b>42</b> binds to the hinge via two hydrogen bonds and probes into the gate area (DFG-in, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1w7h">1w7h</a>).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (B) Fragment <b>43</b> in the DFG-out form of p38 probing BP-III with its trimethyl group (DFG-out, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1w82">1w82</a>).<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> (C) Fragment linking of <b>42</b> and <b>43</b> into <b>44</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1wbn">1wbn</a>) and (D) subsequent optimization of <b>44</b> into <b>45</b> (DFG-out, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1w83">1w83</a>).<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Rendering and IFP color coding are as indicated in Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a> illustrates how the structural alignment of kinase–ligand complexes in KLIFS allows the identification of kinase inhibitor merging design strategies by analyzing the superimposed kinase ligand scaffolds described in different studies.<a onclick="showRef(event, 'ref39 ref104 ref124 ref125 ref126'); return false;" href="javascript:void(0);" class="ref ref39 ref104 ref124 ref125 ref126">(39, 104, 124-126)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>A shows how compound <b>46</b> binds the hinge and back pockets BP-I-A and BP-I-B of p38 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1wbw">1wbw</a>),<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> while compound <b>47</b> binds back pockets BP-I-B, BP-II-out, and BP-III but does not interact with adenine pocket AP (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3o8u">3o8u</a>).<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a></div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0020.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Identification of kinase inhibitor merging strategies by analysis of superimposed kinase inhibitor scaffolds of p38 (panels A–C) that target different binding pockets (schematic depiction in panel D). Inhibitor <b>46</b> (orange carbon atoms, orange ribbon) occupies the AP and binds BP-I-A and BP-I-B (DFG-in, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1wbw">1wbw</a>),<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> while inhibitor <b>47</b> (green, DFG-out, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3o8u">3o8u</a>)<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> and inhibitor <b>48</b> (cream, DFG-out, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3nnv">3nnv</a>)<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> do not target the AP but bind BP-I-A, BP-I-B, BP-II-out, BP-III, and BP-V. Inhibitor <b>49</b> (gold, DFG-out, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1kv2">1kv2</a>)<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> binds BP-I-A, BP-I-B, BP-II-out, BP-III, and BP-V and targets the hinge. Rendering and IFP color coding are as indicated in Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Both <b>46</b> (IC<sub>50</sub> = 44 μM) and <b>47</b> (IC<sub>50</sub> = 17–21 μM)<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> inhibit p38 with moderate potency. Inhibitor <b>48</b> (DP-437,<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3nnv">3nnv</a>)<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> shares the naphthalene scaffold of <b>46</b> and the <i>tert</i>-butylpyrazoleurea scaffold of <b>47</b> that maintain conserved binding modes in back pockets BP-I-A/BP-I-A and BP-III, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>B). Compound <b>48</b> further extends into BP-V with a hydroxymethylphenyl group and has a significantly higher potency for p38 (IC<sub>50</sub> = 27 nM) than <b>46</b> and <b>47</b>.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>C shows how <b>49</b> (BIRB 796,<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1kv2">1kv2</a>)<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> covers all binding pockets occupied by compounds <b>46</b>, <b>47</b>, and <b>48</b> and combines a naphthalene (shared with <b>46</b> and <b>48</b>), <i>tert</i>-butylpyrazoleurea (shared with <b>47</b> and <b>48</b>), and a substituted phenyl group (shared with <b>48</b>) with a morpholino group that targets the hinge in the adenosine pocket (like <b>46</b>). Binding kinetics studies indicate that <b>49</b> has a 1700-fold slower dissociation rate (<i>k</i><sub>off</sub> = 8.3 × 10<sup>–6</sup>) than <b>47</b> (<i>k</i><sub>off</sub> = 1.4 × 10<sup>–1</sup>) and a significantly higher potency (IC<sub>50</sub> = 8–97 nM, depending on assay preincubation time).<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> This structure–kinetics relationship (SKR) suggests that targeting back pockets BP-II/III/V in combination with the AP pocket (including the hinge) can be an attractive strategy to design kinase inhibitors with improved residence time.</div></div><div id="sec2_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29">3.3.5 Covalent Binders of Kinases</h4><div class="NLM_p last">Irreversible binding of a ligand to a specific target can be used to substantially decrease the off-rate from the target and maintain a longer effect. Systematic search for covalent binders identified 12 kinase crystal structures in which a ligand links to a cysteine residue (in all cases included in the 85 kinase–ligand binding site residues) of EGFR (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2j5f">2j5f</a>,<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2jiv">2jiv</a>,<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> and <a href="https://" class="ext-link">3ika</a><a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a>), ErbB4 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2r4b">2r4b</a><a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a>), ITK (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3t9t">3t9t</a>,<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4hcu">4hcu</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4hcv">4hcv</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4hct">4hct</a><a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a>), JNK3 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3v6r">3v6r</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3v6s">3v6s</a><a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a>), PDK1 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3pwy">3pwy</a><a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a>), and RSK-2 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4d9u">4d9u</a><a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a>). In the cases mentioned above, the inhibitors covalently bind to a cysteine residue at position aa<sup>II.11</sup> (RSK-2), aa<sup>linker.52</sup> (EGFR, ErbB4, ITK, and PDK1), or aa<sup>αD.54</sup> (JNK3).</div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">4 Ligand Scaffold Requirements To Bind Kinase Subpockets</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27070" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27070" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a> gives an overview of representative scaffolds that bind in the different areas and subpockets of the kinase catalytic cleft. The requirements of the different groups are area and subpocket specific and give insights into the kinase ligand design toolkit. This toolkit can be used as a recipe for the design of novel kinase ligands. At the solvent exposed part, where inhibitors exit the kinase via the “linker” region in the proteins, a variety of polar substituents are found. Typical substituents are morpholines or piperazines. In the adenosine pocket, flat aromatic heterocycles are the majority of scaffolds found to bind at the hinge region. Usually one hydrogen bond acceptor is present, in addition to one or two hydrogen-bond donors. In FP-I hydrophobic interactions are made with apolar moieties like substituted phenyl or piperidine rings. FP-II can be targeted with apolar or polar structures, e.g., halogenated phenyl rings or nitriles. BP-I-A is often targeted by hydrophobic ortho substituents (e.g., methyl groups and halogens) on phenyl rings. However, depending on the kinase type, BP-I-A can accommodate larger substituents, like phenyl or naphthalene rings. In a DFG-in kinase, BP-II is rather small and is typically probed with smaller, hydrophobic substituents. Hydrogen bonding with E<sup>αC.24</sup> is possible by the addition of hydrogen bond donors (e.g., hydroxyl groups) to the substituents. BP-II-A and -B in the DFG-in kinase can accommodate larger moieties, like halogenated phenyl rings. A typical feature of BP-II-A probing substituents is the presence of a linker, which enables the sharp turn needed to reach this pocket after entering the gate area. BP-III is targeted by large groups, like <i>tert</i>-butyl groups but also morpholines. The partially hydrophobic back pockets IV and V are solvent exposed and can be targeted with groups like methylpiperazines and morpholines. The current KLIFS kinase–ligand structure-based analysis is complementary to ligand (kinase affinity profile) based analyses,<a onclick="showRef(event, 'ref38 ref47 ref136'); return false;" href="javascript:void(0);" class="ref ref38 ref47 ref136">(38, 47, 136)</a> as KLIFS identifies the molecular determinants of kinase affinity and selectivity and gives explicit insights into the binding modes and interactions of chemical scaffolds of ligands in kinase binding sites.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Analysis of Scaffold Types in the Different Areas of the Catalytic Cleft</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0021.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>Table a</sup><p class="last">See Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> for an overview of different regions in kinase binding site.</p></div><div class="footnote" id="t6fn2"><sup>Table b</sup><p class="last">General description of scaffold type.</p></div><div class="footnote" id="t6fn3"><sup>Table c</sup><p class="last">Predominant pharmacophoric element: HBA (H-bond acceptor), HBD (H-bond donor), HYD (hydrophobic).</p></div><div class="footnote" id="t6fn4"><sup>Table d</sup><p class="last">Examples of scaffolds representing the general description and predominant pharmacophoric element.</p></div></div><div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">5 DFG-Motif Conformation and α-Helix C Position</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21476" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21476" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">For all ligand bound structures, the conformation of the DFG-motif was determined and structures were divided into three main groups: DFG-in, -out-like, and -out (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). In the DFG-in conformation, the D<sup>xDFG.81</sup> side chain is oriented toward the ATP binding site while the F<sup>xDFG.82</sup> side chain is located in the back cleft (see Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A). In the DFG-out conformation, this orientation is flipped 180° and the backbone is shifted toward the ATP binding site, thereby enlarging the volume of the back cleft and presenting the DFG-out F<sup>xDFG.82</sup> residue as part of the BP-I-B pocket (see Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>D). For the DFG-out-like conformation, multiple modes exist. In Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>D, the DFG-motif is flipped 180° compared to a DFG-in form; however, the backbone is not shifted toward ATP binding site and the back cleft is not accessible. Structures in which the side chains of D<sup>xDFG.81</sup> and F<sup>xDFG.82</sup> both point toward the back cleft and others exist. Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a> gives an overview of the number of structures and the status of the DFG-motif.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Status of the DFG-Motif Conformation and Position of α-Helix C</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">structures</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">structural element<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">status</th><th class="colsep0 rowsep0" align="center">% structures</th><th class="colsep0 rowsep0" align="center">no. structures</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DFG-motif</td><td class="colsep0 rowsep0" align="left">in</td><td class="colsep0 rowsep0" align="left">85</td><td class="colsep0 rowsep0" align="left">1061</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">out-like</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">out</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">121</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"><1</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">αC</td><td class="colsep0 rowsep0" align="left">in</td><td class="colsep0 rowsep0" align="left">55</td><td class="colsep0 rowsep0" align="left">690</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">out-like</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">142</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">out</td><td class="colsep0 rowsep0" align="left">33</td><td class="colsep0 rowsep0" align="left">418</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"><1</td><td class="colsep0 rowsep0" align="left">2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Location DFG-motif and α-helix C are indicated in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">na = The status of this structural element could not be determined.</p></div></div></div><div class="NLM_p last">To determine the position of the αC-helix, we measured the distance between the Cα carbon atoms of D<sup>xDFG.81</sup> and E<sup>αC.24</sup> (See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). This resulted in the identification of two main clusters of distances between the DFG-motif and the αC-helix. Structures with a short DFG-αC-helix distance (4–7.2 Å) were marked αC-in, while structures with long distance (9.3–14 Å) were marked as αC-out. Structures with distances in between these clusters were marked as αC-out-like structures. In Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>, an overview of the number of structures, the DFG conformation, and the position of the αC-helix is presented.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34">6 Possible Applications of KLIFS in Kinase Ligand Discovery and Design</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32533" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32533" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The KLIFS database offers insights into the structural requirements of kinase binding that will be useful in future structure-based ligand discovery and design studies. Examples of possible applications are the following:</div><div class="NLM_p">(i) Definition of protein–ligand constraints and postprocessing rules to drive virtual screening campaigns for the discovery of new kinase ligands.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> Exclusion of docking poses that do not form specific hinge H-bond interactions has, for example, been shown to minimize false positives in retrospective virtual screening experiments against multiple kinase crystal structures.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> Moreover, protein–ligand interaction fingerprint scoring approaches (based on binding mode similarity to known kinase–ligand cocrystal structures) have been shown to be superior to standard docking scoring functions in retrospective kinase structure-based virtual screening studies.<a onclick="showRef(event, 'ref51 ref64'); return false;" href="javascript:void(0);" class="ref ref51 ref64">(51, 64)</a> Also in prospective virtual screening studies, H-bond constraints have, for example, been successfully used to filter docking simulations to identify novel EphA4 inhibiting fragments.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a></div><div class="NLM_p">(ii) Design of new chemical groups that can accommodate the same interactions with the kinase binding site (scaffold hopping).<a onclick="showRef(event, 'ref34 ref53 ref140'); return false;" href="javascript:void(0);" class="ref ref34 ref53 ref140">(34, 53, 140)</a></div><div class="NLM_p">(iii) Guiding of ligand optimization, e.g., where to place specific polar or hydrophobic group in the optimization of known (or new) kinase ligand scaffolds. An interesting approach is fragment-based drug discovery, for example, as demonstrated for PKB (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>)<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> and p38 (Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a> and Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>).<a onclick="showRef(event, 'ref39 ref104 ref124 ref125 ref126'); return false;" href="javascript:void(0);" class="ref ref39 ref104 ref124 ref125 ref126">(39, 104, 124-126)</a> The examples illustrate that different pockets can be addressed by different fragment-based drug discovery strategies, either by growing out the initial fragment into a hydrophobic front pocket (as demonstrated for FP-II, Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>)<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> or by merging overlapping fragments (Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a> and Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>).<a onclick="showRef(event, 'ref39 ref104 ref125 ref126'); return false;" href="javascript:void(0);" class="ref ref39 ref104 ref125 ref126">(39, 104, 125, 126)</a></div><div class="NLM_p last">(iv) Offer new insights into kinase selectivity by linking ligand and kinase properties.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Several chemogenomic/proteochemometric models combining ligand and residue information of kinases have been constructed and, for example, applied to (retrospectively) predict kinase selectivity profiles.<a onclick="showRef(event, 'ref47 ref53 ref141'); return false;" href="javascript:void(0);" class="ref ref47 ref53 ref141">(47, 53, 141)</a> Retrospective studies have shown that classification of kinases by structure-based alignment of their ligand binding site is feasible.<a onclick="showRef(event, 'ref46 ref142 ref143'); return false;" href="javascript:void(0);" class="ref ref46 ref142 ref143">(46, 142, 143)</a> Incorporation of more detailed structure-based information regarding (selective) kinase–ligand interactions in such chemogenomic studies could therefore be an interesting approach for future kinome wide in silico ligand-profiling studies. In this way KLIFS will offer a knowledge-based chemogenomics platform that can help to overcome problems in kinase drug discovery associated with crowded IP space<a onclick="showRef(event, 'ref144 ref145'); return false;" href="javascript:void(0);" class="ref ref144 ref145">(144, 145)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) and kinase selectivity in the future.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">7 Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81555" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81555" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Cross family ligand binding features were studied in a thorough analysis of kinase–ligand interaction patterns, covering all regions of the catalytic site of all currently available human kinase crystal structures. A database of 1252 aligned human kinase–ligand cocrystal structures present in the Protein Data Bank (PDB) has been constructed, and the different kinase–ligand interaction features were mapped by using molecular interaction fingerprints (KLIFS, periodically updated and accessible on the Web at <a href="http://www.vu-compmedchem.nl" class="extLink">http://www.vu-compmedchem.nl</a>). Identification of family- or group-specific interaction features and classification of ligands according to their binding modes was possible by using a consistent alignment and numbering of the 85 kinase ligand binding site residues. Novel insights into how conserved and selective kinase interaction hot spots can accommodate the large diversity of chemical scaffolds observed in kinase ligands are presented by systematic mining of kinase–ligand interaction space. Requirements for ligand scaffolds to bind kinase subpockets are presented. These studies lead to an improved understanding of the structural requirements of kinase binding that will be useful in future ligand discovery and design studies.</div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36"><a href="/doi/suppl/10.1021/jm400378w">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08785" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08785" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">2D structures of compounds that are not presented in other figures, a list of crystal structures of approved kinase inhibitors in the PDB, a table of all crystal structures used for the structural reference alignment, and the methodology of the KLIFS database preparation and analysis, including description of PDB collection, kinase domain sequence alignment, pocket selection, database creation, IFP generation, and DFG and αC-helix classification. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>. The KLIFS database is periodically updated and accessible on the Web at <a href="http://www.vu-compmedchem.nl" class="extLink">http://www.vu-compmedchem.nl</a>, including all structure files and corresponding annotations.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400378w/suppl_file/jm400378w_si_001.pdf">jm400378w_si_001.pdf (414.21 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm400378w" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27871" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27871" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chris de Graaf</span> - <span class="hlFld-Affiliation affiliation">Division of Medicinal Chemistry,
Faculty of Sciences, Amsterdam Institute for Molecules, Medicines
and Systems (AIMMS), VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#9af9b4feffb4fde8fbfbfcdaecefb4f4f6"><span class="__cf_email__" data-cfemail="3e5d105a5b10594c5f5f587e484b105052">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Oscar P. J. van Linden</span> - <span class="hlFld-Affiliation affiliation">Division of Medicinal Chemistry,
Faculty of Sciences, Amsterdam Institute for Molecules, Medicines
and Systems (AIMMS), VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Albert J. Kooistra</span> - <span class="hlFld-Affiliation affiliation">Division of Medicinal Chemistry,
Faculty of Sciences, Amsterdam Institute for Molecules, Medicines
and Systems (AIMMS), VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rob Leurs</span> - <span class="hlFld-Affiliation affiliation">Division of Medicinal Chemistry,
Faculty of Sciences, Amsterdam Institute for Molecules, Medicines
and Systems (AIMMS), VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Iwan J. P. de Esch</span> - <span class="hlFld-Affiliation affiliation">Division of Medicinal Chemistry,
Faculty of Sciences, Amsterdam Institute for Molecules, Medicines
and Systems (AIMMS), VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>O.P.J.v.L. and A.J.K. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54327" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54327" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Oscar P. J. van Linden</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=BIO-d283e3507-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Oscar P. J. van Linden</b> performed his Ph.D. research on fragment-based drug design (FBDD) of small molecule EphA4 receptor tyrosine kinase inhibitors in the Division of Medicinal Chemistry at the VU University Amsterdam. He then joined ZoBio as a postdoctoral researcher, where he worked on the development of lead compounds against epigenetic drug targets. Recently, Oscar was appointed Head of Medicinal Chemistry within ZoBio, where he is currently responsible for the hit-to-lead optimization of fragments for a variety of pharmaceutically interesting drug targets.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Albert J. Kooistra</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=BIO-d283e3512-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Albert J. Kooistra</b> obtained his B.Sc. degree in Telematics at the University of Twente and his M.Sc. degree in Bioinformatics at the VU University Amsterdam (cum laude). In the meantime he worked for several years as a software designer and developer for a small company. Starting 2010 he is carrying out his Ph.D. research in the Division of Medicinal Chemistry at the VU University Amsterdam on the development of virtual screening tools (EDprints) and virtual (fragment) screening protocols for mainly GPCRs, as well as performing chemogenomic and structural analyses covering multiple protein families.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Rob Leurs</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=BIO-d283e3517-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Rob Leurs</b> performed his Ph.D. research on G-protein-coupled receptors and obtained his Ph.D. degree from VU University in 1991. After a postdoctoral fellowship at INSERM in Paris, he was awarded with a 5-year fellowship of the Royal Netherlands Academy of Arts and Sciences. Rob Leurs is now Full Professor and Head of the Division of Medicinal Chemistry. He was awarded the Galenus Research Prize in 1997, the Organon Award for Pharmacology in 2000, and both a Pfizer Academic Award and a STW/NWO Pionieer Grant in 2001. His research focuses on G-protein-coupled receptors, and he is cofounder of Griffin Discoveries, a company that valorizes the G-protein-coupled receptor expertise, and is currently involved in the discovery and development of histamine receptor ligands.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Iwan J. P. de Esch</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=BIO-d283e3522-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Iwan J. P. de Esch</b> performed his Ph.D. studies at the Department of Pharmacochemistry at VU University Amsterdam. He became a Research Associate in the Drug Design Group at the University of Cambridge in 1998. Dr. De Esch cofounded De Novo Pharmaceuticals in 2000. He returned to academia in 2003 and is now Associate Professor in the Division of Medicinal Chemistry. Dr. de Esch is cofounder of IOTA Pharmaceuticals and also cofounder of Griffin Pharmaceuticals, thereby contributing to the valorization of the fragment-based drug discovery and the GPCR research line of the academic group. In 2011, he was awarded the Galenus Research Price for his work on fragment-based drug discovery.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Chris de Graaf</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=BIO-d283e3527-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Chris de Graaf</b> performed his Ph.D. research in the Division Molecular Toxicology at VU University Amsterdam on computational ligand binding mode and affinity predictions in cytochrome P450 enzymes (2002-2006, cum laude). He then joined the Structural Chemogenomics group at Université de Strasbourg as a postdoctoral fellow and worked in collaboration with AstraZeneca Pharmaceuticals on the development of novel G-protein-coupled receptor modeling techniques (2006–2008). In 2009 Dr. De Graaf was appointed Assistant Professor in the Division Medicinal Chemistry at VU University Amsterdam to develop in silico modeling methods that complement synthetic medicinal chemistry and molecular pharmacology programs. In 2009 he obtained a Veni grant (NWO) to set up a research line in the computational prediction of protein–ligand interactions.</p></figure></div><div class="ack" id="ACK-d283e3532-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46463" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46463" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research was financially supported by The Netherlands Organization for Scientific Research (NWO VENI Grant 700.59.408 to C.d.G.) and Technology Foundation STW. We thank Joost Uitdehaag and Guido Zaman (Netherlands Translational Research Center, NTRC) and Folkert Verkaar (Medicinal Chemistry Division, VU University Amsterdam) for scientific discussions.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i44" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i44"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i45" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i45"> Abbreviations Used</h2><tr><td class="NLM_term">AP</td><td class="NLM_def"><p class="first last">adenine pocket</p></td></tr><tr><td class="NLM_term">BP</td><td class="NLM_def"><p class="first last">back pocket</p></td></tr><tr><td class="NLM_term">ePK</td><td class="NLM_def"><p class="first last">eukaryotic protein kinase</p></td></tr><tr><td class="NLM_term">FP</td><td class="NLM_def"><p class="first last">front pocket</p></td></tr><tr><td class="NLM_term">GK</td><td class="NLM_def"><p class="first last">gatekeeper</p></td></tr><tr><td class="NLM_term">IFP</td><td class="NLM_def"><p class="first last">interaction fingerprint</p></td></tr><tr><td class="NLM_term">KLIFS</td><td class="NLM_def"><p class="first last">kinase–ligand interaction fingerprints and structure database</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72851" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72851" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 145 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pogacic, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rellos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullock, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">20523</span><span class="NLM_x">–</span> <span class="NLM_lpage">20528</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=20523-20528&author=O.+Fedorovauthor=B.+Marsdenauthor=V.+Pogacicauthor=P.+Rellosauthor=S.+M%C3%BCllerauthor=A.+N.+Bullockauthor=J.+Schwallerauthor=M.+Sundstr%C3%B6mauthor=S.+Knapp&title=A+systematic+interaction+map+of+validated+kinase+inhibitors+with+Ser%2FThr+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DMarsden%26aufirst%3DB.%26aulast%3DPogacic%26aufirst%3DV.%26aulast%3DRellos%26aufirst%3DP.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DBullock%26aufirst%3DA.%2BN.%26aulast%3DSchwaller%26aufirst%3DJ.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DA%2520systematic%2520interaction%2520map%2520of%2520validated%2520kinase%2520inhibitors%2520with%2520Ser%252FThr%2520kinases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D20523%26epage%3D20528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Targeting cancer with small molecule kinase inhibitors</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1038%2Fnrc2559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=19104514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1yg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=28-39&author=J.+Zhangauthor=P.+L.+Yangauthor=N.+S.+Gray&title=Targeting+cancer+with+small+molecule+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer with small molecule kinase inhibitors</span></div><div class="casAuthors">Zhang, Jianming; Yang, Priscilla L.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-39</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Deregulation of kinase activity has emerged as a major mechanism by which cancer cells evade normal physiol. constraints on growth and survival.  To date, 11 kinase inhibitors have received US Food and Drug Administration approval as cancer treatments, and there are considerable efforts to develop selective small mol. inhibitors for a host of other kinases that are implicated in cancer and other diseases.  Herein we discuss the current challenges in the field, such as designing selective inhibitors and developing strategies to overcome resistance mutations.  This Review provides a broad overview of some of the approaches currently used to discover and characterize new kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriSM3BN_uEz7Vg90H21EOLACvtfcHk0lgyJb0LOsv4kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1yg&md5=35bc38f414cd21eef5e61ce181b580fb</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrc2559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2559%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DP.%2BL.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DTargeting%2520cancer%2520with%2520small%2520molecule%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D28%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">The (un)targeted cancer kinome</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1038%2Fnchembio.297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=20154661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFGntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=166-169&author=O.+Fedorovauthor=S.+Mullerauthor=S.+Knapp&title=The+%28un%29targeted+cancer+kinome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The (un)targeted cancer kinome</span></div><div class="casAuthors">Fedorov, Oleg; Mueller, Susanne; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">166-169</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review and discussion.  The complexity of cancer signaling and the resulting difficulties in target selection have strongly biased kinase drug discovery towards clin. validated targets.  Recently, novel kinase targets that are uncharacterized have emerged from genome sequencing and RNAi studies.  Chem. probes are urgently needed to functionally annotate these kinases and to stimulate new drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwcnq0-qjPirVg90H21EOLACvtfcHk0lgpggHiC1Qbxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFGntbk%253D&md5=198ae8d39d40247e17aef5e9de0f2a99</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.297%26sid%3Dliteratum%253Aachs%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DMuller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DThe%2520%2528un%2529targeted%2520cancer%2520kinome%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D166%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Muller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Targeting kinases for the treatment of inflammatory diseases</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">867</span><span class="NLM_x">–</span> <span class="NLM_lpage">881</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=867-881&author=S.+Mullerauthor=S.+Knapp&title=Targeting+kinases+for+the+treatment+of+inflammatory+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DTargeting%2520kinases%2520for%2520the%2520treatment%2520of%2520inflammatory%2520diseases%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2010%26volume%3D5%26spage%3D867%26epage%3D881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Manning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whyte, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudarsanam, S.</span><span> </span><span class="NLM_article-title">The protein kinase complement of the human genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">1912</span><span class="NLM_x">–</span> <span class="NLM_lpage">1934</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1126%2Fscience.1075762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=12471243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1912-1934&author=G.+Manningauthor=D.+B.+Whyteauthor=R.+Martinezauthor=T.+Hunterauthor=S.+Sudarsanam&title=The+protein+kinase+complement+of+the+human+genome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Kinase Complement of the Human Genome</span></div><div class="casAuthors">Manning, G.; Whyte, D. B.; Martinez, R.; Hunter, T.; Sudarsanam, S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5600</span>),
    <span class="NLM_cas:pages">1912-1916, 1933-1934</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We have catalogued the protein kinase complement of the human genome (the "kinome") using public and proprietary genomic, complementary DNA, and expressed sequence tag (EST) sequences.  This provides a starting point for comprehensive anal. of protein phosphorylation in normal and disease states, as well as a detailed view of the current state of human genome anal. through a focus on one large gene family.  We identify 518 putative protein kinase genes, of which 71 have not previously been reported or described as kinases, and we extend or correct the protein sequences of 56 more kinases.  New genes include members of well-studied families as well as previously unidentified families, some of which are conserved in model organisms.  Classification and comparison with model organism kinomes identified orthologous groups and highlighted expansions specific to human and other lineages.  We also identified 106 protein kinase pseudogenes.  Chromosomal mapping revealed several small clusters of kinase genes and revealed that 244 kinases map to disease loci or cancer amplicons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTj1hf_0cQcrVg90H21EOLACvtfcHk0lgpggHiC1Qbxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D&md5=b3def83bace52257a3252a3347b8bb92</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1075762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1075762%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DG.%26aulast%3DWhyte%26aufirst%3DD.%2BB.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DSudarsanam%26aufirst%3DS.%26atitle%3DThe%2520protein%2520kinase%2520complement%2520of%2520the%2520human%2520genome%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1912%26epage%3D1934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">Protein kinases—the major drug targets of the twenty-first century?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=309-315&author=P.+Cohen&title=Protein+kinases%E2%80%94the+major+drug+targets+of+the+twenty-first+century%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DProtein%2520kinases%25E2%2580%2594the%2520major%2520drug%2520targets%2520of%2520the%2520twenty-first%2520century%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2002%26volume%3D1%26spage%3D309%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Chico, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Eldik, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watterson, D. M.</span><span> </span><span class="NLM_article-title">Targeting protein kinases in central nervous system disorders</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">892</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1038%2Fnrd2999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=19876042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCjtrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=892-909&author=L.+K.+Chicoauthor=L.+J.+Van+Eldikauthor=D.+M.+Watterson&title=Targeting+protein+kinases+in+central+nervous+system+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein kinases in central nervous system disorders</span></div><div class="casAuthors">Chico, Laura K.; Van Eldik, Linda J.; Watterson, D. Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">892-909</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein kinases are a growing drug target class in disorders in peripheral tissues, but the development of kinase-targeted therapies for central nervous system (CNS) diseases remains a challenge, largely owing to issues assocd. specifically with CNS drug discovery.  However, several candidate therapeutics that target CNS protein kinases are now in various stages of preclin. and clin. development.  We review candidate compds. and discuss selected CNS protein kinases that are emerging as important therapeutic targets.  In addn., we analyze trends in small-mol. properties that correlate with key challenges in CNS drug discovery, such as blood-brain barrier penetrance and cytochrome P 450-mediated metab., and discuss the potential of future approaches that will integrate mol.-fragment expansion with pharmacoinformatics to address these challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzQo2JmuPNlrVg90H21EOLACvtfcHk0lhpP9IiEq4F9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCjtrzO&md5=4dc1f6b7542e59c99f91525d37c49973</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrd2999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2999%26sid%3Dliteratum%253Aachs%26aulast%3DChico%26aufirst%3DL.%2BK.%26aulast%3DVan%2BEldik%26aufirst%3DL.%2BJ.%26aulast%3DWatterson%26aufirst%3DD.%2BM.%26atitle%3DTargeting%2520protein%2520kinases%2520in%2520central%2520nervous%2520system%2520disorders%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D892%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">Targeting protein kinases for the development of anti-inflammatory drugs</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2Fj.ceb.2009.01.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=19217767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVCksrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=317-324&author=P.+Cohen&title=Targeting+protein+kinases+for+the+development+of+anti-inflammatory+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein kinases for the development of anti-inflammatory drugs</span></div><div class="casAuthors">Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">317-324</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In recent years, protein kinases have become the pharmaceutical industry's most studied class of drug target, and some 10 protein kinase inhibitors have so far been approved for the treatment of cancer.  However, whether safe drugs that modulate protein kinase activities can also be developed for the treatment of chronic diseases, where they may need to be taken for decades, is an issue that is still unresolved.  A no. of compds. that inhibit the p38α MAPK have entered clin. trials for the treatment of rheumatoid arthritis and psoriasis, but side effects have prevented their progression to Phase III clin. trials.  Here the author briefly reviews the potential problems in targeting p38 MAPK and discusses other protein kinases that regulate the innate immune system, such as Tpl2, MAPKAP-K2/3, MSK1/2, and IRAK4, which may be better targets for the treatment of chronic inflammatory diseases, and NIK, which is an attractive target for the treatment of multiple myeloma, a late stage B-cell malignancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSeBhN9qJzqrVg90H21EOLACvtfcHk0lhpP9IiEq4F9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVCksrg%253D&md5=b7e7a33f18d0c8c1e33160c092cf411b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2009.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2009.01.015%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DTargeting%2520protein%2520kinases%2520for%2520the%2520development%2520of%2520anti-inflammatory%2520drugs%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2009%26volume%3D21%26spage%3D317%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Kumar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, K. M.</span><span> </span><span class="NLM_article-title">Kinase inhibitors for cardiovascular disease</span> <span class="citation_source-journal">J. Mol. Cell. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2Fj.yjmcc.2006.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=17059822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1Cnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2007&pages=1-11&author=R.+Kumarauthor=V.+P.+Singhauthor=K.+M.+Baker&title=Kinase+inhibitors+for+cardiovascular+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase inhibitors for cardiovascular disease</span></div><div class="casAuthors">Kumar, Rajesh; Singh, Vivek P.; Baker, Kenneth M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Over the last decade, there was substantial progress toward understanding the pathophysiol. and treatment of cardiovascular diseases (CVDs).  Elucidating cellular responses to the extracellular environment and signal transduction mechanisms have provided the opportunity to explore novel mol. therapeutic approaches for the treatment of CVDs.  Neurohormonal stimulation was implicated in these diseases; blockade of the renin-angiotensin and β-adrenergic systems are examples of therapeutic effectiveness.  There are multiple cell signaling cascades, some of which are beneficial or compensatory and others deleterious.  The balance between these pathways, which in large part is dictated by the cellular environment, dets. the outcome as a diseased or non-diseased state.  Selective targeting of signaling pathways using protein kinase inhibitors, would have a potential advantage over receptor blockers.  We review potential protein kinase targets and recent evidence supporting therapeutic interventional value in CVDs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOvrcVNUqdprVg90H21EOLACvtfcHk0lhpP9IiEq4F9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1Cnuw%253D%253D&md5=8b05f4f7c07fb4b704089caeee02e7c3</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.yjmcc.2006.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yjmcc.2006.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DSingh%26aufirst%3DV.%2BP.%26aulast%3DBaker%26aufirst%3DK.%2BM.%26atitle%3DKinase%2520inhibitors%2520for%2520cardiovascular%2520disease%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D2007%26volume%3D42%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Doerig, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billker, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endicott, J.</span><span> </span><span class="NLM_article-title">Protein kinases as targets for antimalarial intervention: kinomics, structure-based design, transmission-blockade, and targeting host cell enzymes</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Proteins Proteomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1754</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2Fj.bbapap.2005.08.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=16271522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlags7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1754&publication_year=2005&pages=132-150&author=C.+Doerigauthor=O.+Billkerauthor=D.+Prattauthor=J.+Endicott&title=Protein+kinases+as+targets+for+antimalarial+intervention%3A+kinomics%2C+structure-based+design%2C+transmission-blockade%2C+and+targeting+host+cell+enzymes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinases as targets for antimalarial intervention: Kinomics, structure-based design, transmission-blockade, and targeting host cell enzymes</span></div><div class="casAuthors">Doerig, Christian; Billker, Oliver; Pratt, David; Endicott, Jane</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1754</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">132-150</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The surge of interest in protein kinases as targets for chemotherapeutic intervention in a no. of diseases such as cancer and neurodegenerative disorders has stimulated research aimed at detg. whether enzymes of this class might also be considered as targets in the context of diseases caused by parasitic protists.  Here, we present an overview of recent developments in this field, concg. (i) on the benefits gained from the availability of genomic databases for a no. of parasitic protozoa, (ii) on the emerging field of structure-aided design of inhibitors targeting protein kinases of parasitic protists, (iii) on the concept known as transmission-blockade, whereby kinases implicated in the development of the parasite in their arthropod vector might be targeted to interfere with disease transmission, and (iv) on the possibility of controlling parasitic diseases through the inhibition of host cell protein kinases that are required for the establishment of infection by the parasites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbWgJzDzDmiLVg90H21EOLACvtfcHk0lg6rkWLDGcR4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlags7nP&md5=d826579930268e41ef81ee49cc8a6784</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2005.08.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2005.08.027%26sid%3Dliteratum%253Aachs%26aulast%3DDoerig%26aufirst%3DC.%26aulast%3DBillker%26aufirst%3DO.%26aulast%3DPratt%26aufirst%3DD.%26aulast%3DEndicott%26aufirst%3DJ.%26atitle%3DProtein%2520kinases%2520as%2520targets%2520for%2520antimalarial%2520intervention%253A%2520kinomics%252C%2520structure-based%2520design%252C%2520transmission-blockade%252C%2520and%2520targeting%2520host%2520cell%2520enzymes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2005%26volume%3D1754%26spage%3D132%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Solowiej, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergqvist, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTigue, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marrone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quenzer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobbs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diehl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, B. W.</span><span> </span><span class="NLM_article-title">Characterizing the effects of the juxtamembrane domain on vascular endothelial growth factor receptor-2 enzymatic activity, autophosphorylation, and inhibition by axitinib</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7019</span><span class="NLM_x">–</span> <span class="NLM_lpage">7031</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi900522y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=7019-7031&author=J.+Solowiejauthor=S.+Bergqvistauthor=M.+A.+McTigueauthor=T.+Marroneauthor=T.+Quenzerauthor=M.+Cobbsauthor=K.+Ryanauthor=R.+S.+Kaniaauthor=W.+Diehlauthor=B.+W.+Murray&title=Characterizing+the+effects+of+the+juxtamembrane+domain+on+vascular+endothelial+growth+factor+receptor-2+enzymatic+activity%2C+autophosphorylation%2C+and+inhibition+by+axitinib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fbi900522y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi900522y%26sid%3Dliteratum%253Aachs%26aulast%3DSolowiej%26aufirst%3DJ.%26aulast%3DBergqvist%26aufirst%3DS.%26aulast%3DMcTigue%26aufirst%3DM.%2BA.%26aulast%3DMarrone%26aufirst%3DT.%26aulast%3DQuenzer%26aufirst%3DT.%26aulast%3DCobbs%26aufirst%3DM.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DDiehl%26aufirst%3DW.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26atitle%3DCharacterizing%2520the%2520effects%2520of%2520the%2520juxtamembrane%2520domain%2520on%2520vascular%2520endothelial%2520growth%2520factor%2520receptor-2%2520enzymatic%2520activity%252C%2520autophosphorylation%252C%2520and%2520inhibition%2520by%2520axitinib%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D7019%26epage%3D7031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Golas, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arndt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Etienne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nardin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boschelli, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boschelli, F.</span><span> </span><span class="NLM_article-title">SKI-606, a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases, is a potent antiproliferative agent against chronic myelogenous leukemia cells in culture and causes regression of K562 xenografts in nude mice</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=12543790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1Krsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=375-381&author=J.+M.+Golasauthor=K.+Arndtauthor=C.+Etienneauthor=J.+Lucasauthor=D.+Nardinauthor=J.+Gibbonsauthor=P.+Frostauthor=F.+Yeauthor=D.+H.+Boschelliauthor=F.+Boschelli&title=SKI-606%2C+a+4-anilino-3-quinolinecarbonitrile+dual+inhibitor+of+Src+and+Abl+kinases%2C+is+a+potent+antiproliferative+agent+against+chronic+myelogenous+leukemia+cells+in+culture+and+causes+regression+of+K562+xenografts+in+nude+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">SKI-606, a 4-Anilino-3-quinolinecarbonitrile Dual Inhibitor of Src and Abl Kinases, Is a Potent Antiproliferative Agent against Chronic Myelogenous Leukemia Cells in Culture and Causes Regression of K562 Xenografts in Nude Mice</span></div><div class="casAuthors">Golas, Jennifer M.; Arndt, Kim; Etienne, Carlo; Lucas, Judy; Nardin, Danielle; Gibbons, James; Frost, Philip; Ye, Fei; Boschelli, Diane H.; Boschelli, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">375-381</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Constitutive tyrosine kinase activity of Bcr-Abl promotes proliferation and survival of chronic myelogenous leukemia (CML) cells.  Inhibition of Bcr-Abl tyrosine kinase activity or signaling proteins activated by Bcr-Abl in CML cells blocks proliferation and causes apoptotic cell death.  The selective Abl kinase inhibitor, STI-571 (marketed as Gleevec), is toxic to CML cells in culture, causes regression of CML tumors in nude mice, and is currently used to treat CML patients.  Here we describe a p.o. active, dual Src/Abl kinase inhibitor with potent antiproliferative activity against CML cells in culture.  This 4-anilino-3-quinolinecarbonitrile (SKI-606) ablates tyrosine phosphorylation of Bcr-Abl in CML cells and of v-Abl expressed in fibroblasts.  SKI-606 inhibits phosphorylation of cellular proteins, including STAT5, at concns. that inhibit proliferation in CML cells.  Phosphorylation of the autoactivation site of the Src family kinases Lyn and/or Hck is also reduced by treatment with SKI-606.  Once daily oral administration of this compd. at 100 mg/kg for 5 days causes complete regression of large K562 xenografts in nude mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ0DM9Z0QjjLVg90H21EOLACvtfcHk0lhylouAbuqlJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1Krsg%253D%253D&md5=e7b5e5ffee0238543dc9c31b7e86b3d2</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGolas%26aufirst%3DJ.%2BM.%26aulast%3DArndt%26aufirst%3DK.%26aulast%3DEtienne%26aufirst%3DC.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DNardin%26aufirst%3DD.%26aulast%3DGibbons%26aufirst%3DJ.%26aulast%3DFrost%26aufirst%3DP.%26aulast%3DYe%26aufirst%3DF.%26aulast%3DBoschelli%26aufirst%3DD.%2BH.%26aulast%3DBoschelli%26aufirst%3DF.%26atitle%3DSKI-606%252C%2520a%25204-anilino-3-quinolinecarbonitrile%2520dual%2520inhibitor%2520of%2520Src%2520and%2520Abl%2520kinases%252C%2520is%2520a%2520potent%2520antiproliferative%2520agent%2520against%2520chronic%2520myelogenous%2520leukemia%2520cells%2520in%2520culture%2520and%2520causes%2520regression%2520of%2520K562%2520xenografts%2520in%2520nude%2520mice%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D375%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Zou, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arango, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koudriakova, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Los, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span> </span><span class="NLM_article-title">An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">4408</span><span class="NLM_x">–</span> <span class="NLM_lpage">4417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1158%2F0008-5472.CAN-06-4443" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=17483355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltVyrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=4408-4417&author=H.+Y.+Zouauthor=Q.+Liauthor=J.+H.+Leeauthor=M.+E.+Arangoauthor=S.+R.+McDonnellauthor=S.+Yamazakiauthor=T.+B.+Koudriakovaauthor=G.+Altonauthor=J.+J.+Cuiauthor=P.-P.+Kungauthor=M.+D.+Nambuauthor=G.+Losauthor=S.+L.+Benderauthor=B.+Mroczkowskiauthor=J.+G.+Christensen&title=An+orally+available+small-molecule+inhibitor+of+c-Met%2C+PF-2341066%2C+exhibits+cytoreductive+antitumor+efficacy+through+antiproliferative+and+antiangiogenic+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms</span></div><div class="casAuthors">Zou, Helen Y.; Li, Qiuhua; Lee, Joseph H.; Arango, Maria E.; McDonnell, Scott R.; Yamazaki, Shinji; Koudriakova, Tatiana B.; Alton, Gordon; Cui, Jingrong J.; Kung, Pei-Pei; Nambu, Mitchell D.; Los, Gerrit; Bender, Steven L.; Mroczkowski, Barbara; Christensen, James G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4408-4417</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The c-Met receptor tyrosine kinase and its ligand, hepatocyte growth factor (HGF), have been implicated in the progression of several human cancers and are attractive therapeutic targets.  PF-2341066 was identified as a potent, orally bioavailable, ATP-competitive small-mol. inhibitor of the catalytic activity of c-Met kinase.  PF-2341066 was selective for c-Met (and anaplastic lymphoma kinase) compared with a panel of >120 diverse tyrosine and serine-threonine kinases.  PF-2341066 potently inhibited c-Met phosphorylation and c-Met-dependent proliferation, migration, or invasion of human tumor cells in vitro (IC50 values, 5-20 nmol/L).  In addn., PF-2341066 potently inhibited HGF-stimulated endothelial cell survival or invasion and serum-stimulated tubulogenesis in vitro, suggesting that this agent also exhibits antiangiogenic properties.  PF-2341066 showed efficacy at well-tolerated doses, including marked cytoreductive antitumor activity, in several tumor models that expressed activated c-Met.  The antitumor efficacy of PF-2341066 was dose dependent and showed a strong correlation to inhibition of c-Met phosphorylation in vivo.  Near-maximal inhibition of c-Met activity for the full dosing interval was necessary to maximize the efficacy of PF-2341066.  Addnl. mechanism-of-action studies showed dose-dependent inhibition of c-Met-dependent signal transduction, tumor cell proliferation (Ki67), induction of apoptosis (caspase-3), and redn. of microvessel d. (CD31).  These results indicated that the antitumor activity of PF-2341066 may be mediated by direct effects on tumor cell growth or survival as well as antiangiogenic mechanisms.  Collectively, these results show the therapeutic potential of targeting c-Met with selective small-mol. inhibitors for the treatment of human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEAWtGPOBHC7Vg90H21EOLACvtfcHk0lhylouAbuqlJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltVyrsbg%253D&md5=798bf93e6cf8d5e9897e27485cba9002</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-4443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-4443%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DArango%26aufirst%3DM.%2BE.%26aulast%3DMcDonnell%26aufirst%3DS.%2BR.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DKoudriakova%26aufirst%3DT.%2BB.%26aulast%3DAlton%26aufirst%3DG.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DKung%26aufirst%3DP.-P.%26aulast%3DNambu%26aufirst%3DM.%2BD.%26aulast%3DLos%26aufirst%3DG.%26aulast%3DBender%26aufirst%3DS.%2BL.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26atitle%3DAn%2520orally%2520available%2520small-molecule%2520inhibitor%2520of%2520c-Met%252C%2520PF-2341066%252C%2520exhibits%2520cytoreductive%2520antitumor%2520efficacy%2520through%2520antiproliferative%2520and%2520antiangiogenic%2520mechanisms%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D4408%26epage%3D4417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">O’Hare, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoffregen, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manley, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mestan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan-Jacob, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrich, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, M. W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druker, B. J.</span><span> </span><span class="NLM_article-title">In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">4500</span><span class="NLM_x">–</span> <span class="NLM_lpage">4505</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=4500-4505&author=T.+O%E2%80%99Hareauthor=D.+K.+Waltersauthor=E.+P.+Stoffregenauthor=T.+Jiaauthor=P.+W.+Manleyauthor=J.+Mestanauthor=S.+W.+Cowan-Jacobauthor=F.+Y.+Leeauthor=M.+C.+Heinrichauthor=M.+W.+N.+Deiningerauthor=B.+J.+Druker&title=In+vitro+activity+of+Bcr-Abl+inhibitors+AMN107+and+BMS-354825+against+clinically+relevant+imatinib-resistant+Abl+kinase+domain+mutants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Hare%26aufirst%3DT.%26aulast%3DWalters%26aufirst%3DD.%2BK.%26aulast%3DStoffregen%26aufirst%3DE.%2BP.%26aulast%3DJia%26aufirst%3DT.%26aulast%3DManley%26aufirst%3DP.%2BW.%26aulast%3DMestan%26aufirst%3DJ.%26aulast%3DCowan-Jacob%26aufirst%3DS.%2BW.%26aulast%3DLee%26aufirst%3DF.%2BY.%26aulast%3DHeinrich%26aufirst%3DM.%2BC.%26aulast%3DDeininger%26aufirst%3DM.%2BW.%2BN.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26atitle%3DIn%2520vitro%2520activity%2520of%2520Bcr-Abl%2520inhibitors%2520AMN107%2520and%2520BMS-354825%2520against%2520clinically%2520relevant%2520imatinib-resistant%2520Abl%2520kinase%2520domain%2520mutants%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D4500%26epage%3D4505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Moyer, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacci, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiOrio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doty, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neveu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollack, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pustilnik, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theleman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, P.</span><span> </span><span class="NLM_article-title">Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4838</span><span class="NLM_x">–</span> <span class="NLM_lpage">4848</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=9354447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADyaK2sXnt12nsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=4838-4848&author=J.+D.+Moyerauthor=E.+G.+Barbacciauthor=K.+K.+Iwataauthor=L.+Arnoldauthor=B.+Bomanauthor=A.+Cunninghamauthor=C.+DiOrioauthor=J.+Dotyauthor=M.+J.+Morinauthor=M.+P.+Moyerauthor=M.+Neveuauthor=V.+A.+Pollackauthor=L.+R.+Pustilnikauthor=M.+M.+Reynoldsauthor=D.+Sloanauthor=A.+Thelemanauthor=P.+Miller&title=Induction+of+apoptosis+and+cell+cycle+arrest+by+CP-358%2C774%2C+an+inhibitor+of+epidermal+growth+factor+receptor+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of apoptosis and cell cycle arrest by CP-358774, an inhibitor of epidermal growth factor receptor tyrosine kinase</span></div><div class="casAuthors">Moyer, James D.; Barbacci, Elsa G.; Iwata, Kenneth K.; Arnold, Lee; Boman, Bruce; Cunningham, Ann; Diorio, Catherine; Doty, Jonathan; Morin, Michael J.; Moyer, Mikel P.; Neveu, Mark; Pollack, Vincent A.; Pustilnik, Leslie R.; Reynolds, Margaret M.; Sloan, Don; Theleman, April; Miller, Penny</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4838-4848</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The epidermal growth factor receptor (EGFR) is overexpressed in a significant percentage of carcinomas and contributes to the malignant phenotype.  CP-358774 is a directly acting inhibitor of human EGFR tyrosine kinase with an IC50 of 2 nM and reduces EGFR autophosphorylation in intact tumor cells with an IC50 of 20 nM.  This inhibition is selective for EGFR tyrosine kinase relative to other tyrosine kinases we have examd., both in assays of isolated kinases and whole cells.  At doses of 100 mg/kg, CP-358774 completely prevents EGF-induced autophosphorylation of EGFR in human HN5 tumors growing as xenografts in athymic mice and of the hepatic EGFR of the treated mice.  CP-358774 inhibits the proliferation of DiFi human colon tumor cells at submicromolar concns. in cell culture and blocks cell cycle progression at the G1 phase.  This inhibitor produces a marked accumulation of retinoblastoma protein in its underphosphorylated form and accumulation of p27KIP1 in DiFi cells, which may contribute to the cell cycle block.  Inhibition of the EGFR also triggers apoptosis in these cells as detd. by formation of DNA fragments and other criteria.  These results indicate that CP-358774 has potential for the treatment of tumors that are dependent on the EGFR pathway for proliferation or survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpghArQOnGlkbVg90H21EOLACvtfcHk0ljk-i_pujKRQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnt12nsr4%253D&md5=0a6e9697bf290d8e7c44cbe2a125e0b1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoyer%26aufirst%3DJ.%2BD.%26aulast%3DBarbacci%26aufirst%3DE.%2BG.%26aulast%3DIwata%26aufirst%3DK.%2BK.%26aulast%3DArnold%26aufirst%3DL.%26aulast%3DBoman%26aufirst%3DB.%26aulast%3DCunningham%26aufirst%3DA.%26aulast%3DDiOrio%26aufirst%3DC.%26aulast%3DDoty%26aufirst%3DJ.%26aulast%3DMorin%26aufirst%3DM.%2BJ.%26aulast%3DMoyer%26aufirst%3DM.%2BP.%26aulast%3DNeveu%26aufirst%3DM.%26aulast%3DPollack%26aufirst%3DV.%2BA.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DReynolds%26aufirst%3DM.%2BM.%26aulast%3DSloan%26aufirst%3DD.%26aulast%3DTheleman%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DP.%26atitle%3DInduction%2520of%2520apoptosis%2520and%2520cell%2520cycle%2520arrest%2520by%2520CP-358%252C774%252C%2520an%2520inhibitor%2520of%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D4838%26epage%3D4848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Wakeling, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guy, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodburn, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashton, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curry, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, K. H.</span><span> </span><span class="NLM_article-title">ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">5749</span><span class="NLM_x">–</span> <span class="NLM_lpage">5754</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=12384534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD38XotFyktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=5749-5754&author=A.+E.+Wakelingauthor=S.+P.+Guyauthor=J.+R.+Woodburnauthor=S.+E.+Ashtonauthor=B.+J.+Curryauthor=A.+J.+Barkerauthor=K.+H.+Gibson&title=ZD1839+%28Iressa%29%3A+an+orally+active+inhibitor+of+epidermal+growth+factor+signaling+with+potential+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">ZD1839 (Iressa): An orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy</span></div><div class="casAuthors">Wakeling, Alan E.; Guy, Simon P.; Woodburn, Jim R.; Ashton, Susan E.; Curry, Brenda J.; Barker, Andrew J.; Gibson, Keith H.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5749-5754</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The epidermal growth factor receptor (EGFR) is a promising target for anticancer therapy because of its role in tumor growth, metastasis and angiogenesis, and tumor resistance to chemotherapy and radiotherapy.  We have developed a low-mol.-wt. EGFR tyrosine kinase inhibitor (EGFR-TKI), ZD1839 (Iressa).  ZD1839, a substituted anilinoquinazoline, is a potent EGFR-TKI (IC50 = 0.033 μM) that selectively inhibits EGF-stimulated tumor cell growth (IC50 = 0.054 μM) and that blocks EGF-stimulated EGFR autophosphorylation in tumor cells.  In studies with mice bearing a range of human tumor-derived xenografts, ZD1839 given p.o. once a day inhibited tumor growth in a dose-dependent manner.  The level of expression of EGFR did not det. xenograft tumor sensitivity to ZD1839.  Long-term ZD1839 (>3 mo) treatment of mice bearing A431 xenografts was well tolerated, and ZD1839 completely inhibited tumor growth and induced regression of established tumors.  No drug-resistant tumors appeared during ZD1839 treatment, but some tumors regrew after drug withdrawal.  These studies indicate the potential utility of ZD1839 in the treatment of many human tumors and indicate that continuous once-a-day p.o. dosing might be a suitable therapeutic regimen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkoHZ9zL06abVg90H21EOLACvtfcHk0ljk-i_pujKRQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotFyktr8%253D&md5=f5f86c652786db476a2d23b5bbd1a9e9</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWakeling%26aufirst%3DA.%2BE.%26aulast%3DGuy%26aufirst%3DS.%2BP.%26aulast%3DWoodburn%26aufirst%3DJ.%2BR.%26aulast%3DAshton%26aufirst%3DS.%2BE.%26aulast%3DCurry%26aufirst%3DB.%2BJ.%26aulast%3DBarker%26aufirst%3DA.%2BJ.%26aulast%3DGibson%26aufirst%3DK.%2BH.%26atitle%3DZD1839%2520%2528Iressa%2529%253A%2520an%2520orally%2520active%2520inhibitor%2520of%2520epidermal%2520growth%2520factor%2520signaling%2520with%2520potential%2520for%2520cancer%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D5749%26epage%3D5754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Dar, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Small molecule recognition of c-Src via the imatinib-binding conformation</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1015</span><span class="NLM_x">–</span> <span class="NLM_lpage">1022</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2Fj.chembiol.2008.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=18940662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1KmsrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=1015-1022&author=A.+C.+Darauthor=M.+S.+Lopezauthor=K.+M.+Shokat&title=Small+molecule+recognition+of+c-Src+via+the+imatinib-binding+conformation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Recognition of c-Src via the Imatinib-Binding Conformation</span></div><div class="casAuthors">Dar, Arvin C.; Lopez, Michael S.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1015-1022</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: The cancer drug, Imatinib, is a selective Abl kinase inhibitor that does not inhibit the closely related kinase c-Src.  This one drug and its ability to selectively inhibit Abl over c-Src has been a guiding principle in virtually all kinase drug discovery efforts in the last 15 years.  A prominent hypothesis explaining the selectivity of Imatinib is that Abl has an intrinsic ability to adopt an inactive conformation (termed DFG-out), whereas c-Src appears to pay a high intrinsic energetic penalty for adopting this conformation, effectively excluding Imatinib from its ATP pocket.  This explanation of the difference in binding affinity of Imatinib for Abl vs. c-Src makes the striking prediction that it would not be possible to design an inhibitor that binds to the DFG-out conformation of c-Src with high affinity.  The authors report the discovery of a series of such inhibitors.  The authors use structure-activity relationships and x-ray crystallog. to confirm the authors' findings.  These studies suggest that small mols. are capable of inducing the generally unfavorable DFG-out conformation in c-Src.  Structural comparison between c-Src in complex with these inhibitors allows the authors to speculate on the differential selectivity of Imatinib for c-Src and Abl.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgbxnfmxtR-LVg90H21EOLACvtfcHk0lhlV9egfJCr1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1KmsrfP&md5=f1047f4a56359511939164a3c2604cb6</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2008.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2008.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DDar%26aufirst%3DA.%2BC.%26aulast%3DLopez%26aufirst%3DM.%2BS.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DSmall%2520molecule%2520recognition%2520of%2520c-Src%2520via%2520the%2520imatinib-binding%2520conformation%26jtitle%3DChem.%2520Biol.%26date%3D2008%26volume%3D15%26spage%3D1015%26epage%3D1022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Wood, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truesdale, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickerson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennisi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lackey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alligood, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusnak, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shewchuk, L.</span><span> </span><span class="NLM_article-title">A unique structure for epidermal growth factor receptor bound to GW572016 (lapatinib)</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">6652</span><span class="NLM_x">–</span> <span class="NLM_lpage">6659</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1158%2F0008-5472.CAN-04-1168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=15374980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsFOlu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=6652-6659&author=E.+R.+Woodauthor=A.+T.+Truesdaleauthor=O.+B.+McDonaldauthor=D.+Yuanauthor=A.+Hassellauthor=S.+H.+Dickersonauthor=B.+Ellisauthor=C.+Pennisiauthor=E.+Horneauthor=K.+Lackeyauthor=K.+J.+Alligoodauthor=D.+W.+Rusnakauthor=T.+M.+Gilmerauthor=L.+Shewchuk&title=A+unique+structure+for+epidermal+growth+factor+receptor+bound+to+GW572016+%28lapatinib%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells</span></div><div class="casAuthors">Wood, Edgar R.; Truesdale, Anne T.; McDonald, Octerloney B.; Yuan, Derek; Hassell, Anne; Dickerson, Scott H.; Ellis, Byron; Pennisi, Christopher; Horne, Earnest; Lackey, Karen; Alligood, Krystal J.; Rusnak, David W.; Gilmer, Tona M.; Shewchuk, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6652-6659</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">GW572016 (Lapatinib) is a tyrosine kinase inhibitor in clin. development for cancer that is a potent dual inhibitor of epidermal growth factor receptor (EGFR, ErbB-1) and ErbB-2.  The authors detd. the crystal structure of EGFR bound to GW572016.  The compd. is bound to an inactive-like conformation of EGFR that is very different from the active-like structure bound by the selective EGFR inhibitor OSI-774 (Tarceva) described previously.  Surprisingly, the authors found that GW572016 has a very slow off-rate from the purified intracellular domains of EGFR and ErbB-2 compared with OSI-774 and another EGFR selective inhibitor, ZD-1839 (Iressa).  Treatment of tumor cells with these inhibitors results in down-regulation of receptor tyrosine phosphorylation.  The authors evaluated the duration of the drug effect after washing away free compd. and found that the rate of recovery of receptor phosphorylation in the tumor cells reflected the inhibitor off-rate from the purified intracellular domain.  The slow off-rate of GW572016 correlates with a prolonged down-regulation of receptor tyrosine phosphorylation in tumor cells.  The differences in the off-rates of these drugs and the ability of GW572016 to inhibit ErbB-2 can be explained by the enzyme-inhibitor structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXjJPy6XYk4rVg90H21EOLACvtfcHk0liz-mAw-ru09Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsFOlu7g%253D&md5=788d92fc5db9f1ecf9d3fbf3142e5c9f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-1168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-1168%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DE.%2BR.%26aulast%3DTruesdale%26aufirst%3DA.%2BT.%26aulast%3DMcDonald%26aufirst%3DO.%2BB.%26aulast%3DYuan%26aufirst%3DD.%26aulast%3DHassell%26aufirst%3DA.%26aulast%3DDickerson%26aufirst%3DS.%2BH.%26aulast%3DEllis%26aufirst%3DB.%26aulast%3DPennisi%26aufirst%3DC.%26aulast%3DHorne%26aufirst%3DE.%26aulast%3DLackey%26aufirst%3DK.%26aulast%3DAlligood%26aufirst%3DK.%2BJ.%26aulast%3DRusnak%26aufirst%3DD.%2BW.%26aulast%3DGilmer%26aufirst%3DT.%2BM.%26aulast%3DShewchuk%26aufirst%3DL.%26atitle%3DA%2520unique%2520structure%2520for%2520epidermal%2520growth%2520factor%2520receptor%2520bound%2520to%2520GW572016%2520%2528lapatinib%2529%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D6652%26epage%3D6659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Kumar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knick, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crouthamel, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopper, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onori, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truesdale, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epperly, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boloor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stafford, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luttrell, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, M.</span><span> </span><span class="NLM_article-title">Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">2012</span><span class="NLM_x">–</span> <span class="NLM_lpage">2021</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1158%2F1535-7163.MCT-07-0193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=17620431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsV2jsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=2012-2021&author=R.+Kumarauthor=V.+B.+Knickauthor=S.+K.+Rudolphauthor=J.+H.+Johnsonauthor=R.+M.+Crosbyauthor=M.-C.+Crouthamelauthor=T.+M.+Hopperauthor=C.+G.+Millerauthor=L.+E.+Harringtonauthor=J.+A.+Onoriauthor=R.+J.+Mullinauthor=T.+M.+Gilmerauthor=A.+T.+Truesdaleauthor=A.+H.+Epperlyauthor=A.+Boloorauthor=J.+A.+Staffordauthor=D.+K.+Luttrellauthor=M.+Cheung&title=Pharmacokinetic-pharmacodynamic+correlation+from+mouse+to+human+with+pazopanib%2C+a+multikinase+angiogenesis+inhibitor+with+potent+antitumor+and+antiangiogenic+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity</span></div><div class="casAuthors">Kumar, Rakesh; Knick, Victoria B.; Rudolph, Sharon K.; Johnson, Jennifer H.; Crosby, Renae M.; Crouthamel, Ming-Chih; Hopper, Teresa M.; Miller, Charles G.; Harrington, Laura E.; Onori, James A.; Mullin, Robert J.; Gilmer, Tona M.; Truesdale, Anne T.; Epperly, Andrea H.; Boloor, Amogh; Stafford, Jeffrey A.; Luttrell, Deirdre K.; Cheung, Mui</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2012-2021</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">With the development of targeted therapeutics, esp. for small-mol. inhibitors, it is important to understand whether the obsd. in vivo efficacy correlates with the modulation of desired/intended target in vivo.  The authors have developed a small-mol. inhibitor of all three vascular endothelial growth factor (VEGF) receptors (VEGFR), platelet-derived growth factor receptor, and c-Kit tyrosine kinases, pazopanib (GW786034), which selectively inhibits VEGF-induced endothelial cell proliferation.  It has good oral exposure and inhibits angiogenesis and tumor growth in mice.  Because bolus administration of the compd. results in large differences in Cmax and Ctrough, the authors investigated the effect of continuous infusion of a VEGFR inhibitor on tumor growth and angiogenesis.  GW771806, which has similar enzyme and cellular profiles to GW786034, was used for these studies due to higher soly. requirements for infusion studies.  Comparing the pharmacokinetics by two different routes of administration (bolus p.o. dosing and continuous infusion), the authors showed that the antitumor and antiangiogenic activity of VEGFR inhibitors is dependent on steady-state concn. of the compd. above a threshold.  The steady-state concn. required for these effects is consistent with the concn. required for the inhibition of VEGF-induced VEGFR2 phosphorylation in mouse lungs.  Furthermore, the steady-state concn. of pazopanib detd. from preclin. activity showed a strong correlation with the pharmacodynamic effects and antitumor activity in the phase I clin. trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3hDCy5B0DMLVg90H21EOLACvtfcHk0liz-mAw-ru09Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsV2jsrk%253D&md5=b0dde2f214757af0a1d5c73f71555207</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0193%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DKnick%26aufirst%3DV.%2BB.%26aulast%3DRudolph%26aufirst%3DS.%2BK.%26aulast%3DJohnson%26aufirst%3DJ.%2BH.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DCrouthamel%26aufirst%3DM.-C.%26aulast%3DHopper%26aufirst%3DT.%2BM.%26aulast%3DMiller%26aufirst%3DC.%2BG.%26aulast%3DHarrington%26aufirst%3DL.%2BE.%26aulast%3DOnori%26aufirst%3DJ.%2BA.%26aulast%3DMullin%26aufirst%3DR.%2BJ.%26aulast%3DGilmer%26aufirst%3DT.%2BM.%26aulast%3DTruesdale%26aufirst%3DA.%2BT.%26aulast%3DEpperly%26aufirst%3DA.%2BH.%26aulast%3DBoloor%26aufirst%3DA.%26aulast%3DStafford%26aufirst%3DJ.%2BA.%26aulast%3DLuttrell%26aufirst%3DD.%2BK.%26aulast%3DCheung%26aufirst%3DM.%26atitle%3DPharmacokinetic-pharmacodynamic%2520correlation%2520from%2520mouse%2520to%2520human%2520with%2520pazopanib%252C%2520a%2520multikinase%2520angiogenesis%2520inhibitor%2520with%2520potent%2520antitumor%2520and%2520antiangiogenic%2520activity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D2012%26epage%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Wilhelm, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adnane, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schütz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thierauch, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zopf, D.</span><span> </span><span class="NLM_article-title">Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1002%2Fijc.25864" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=21170960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltFGlu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2011&pages=245-255&author=S.+M.+Wilhelmauthor=J.+Dumasauthor=L.+Adnaneauthor=M.+Lynchauthor=C.+A.+Carterauthor=G.+Sch%C3%BCtzauthor=K.-H.+Thierauchauthor=D.+Zopf&title=Regorafenib+%28BAY+73-4506%29%3A+a+new+oral+multikinase+inhibitor+of+angiogenic%2C+stromal+and+oncogenic+receptor+tyrosine+kinases+with+potent+preclinical+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Regorafenib (BAY 73-4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity</span></div><div class="casAuthors">Wilhelm, Scott M.; Dumas, Jacques; Adnane, Lila; Lynch, Mark; Carter, Christopher A.; Schuetz, Gunnar; Thierauch, Karl-Heinz; Zopf, Dieter</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">245-255</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Angiogenesis, a crit. driver of tumor development, is controlled by interconnected signaling pathways.  Vascular endothelial growth factor receptor (VEGFR) 2 and tyrosine kinase with Ig and epidermal growth factor homol. domain 2 play crucial roles in the biol. of normal and tumor vasculature.  Regorafenib (BAY 73-4506), a novel oral multikinase inhibitor, potently inhibits these endothelial cell kinases in biochem. and cellular kinase phosphorylation assays.  Furthermore, regorafenib inhibits addnl. angiogenic kinases (VEGFR1/3, platelet-derived growth factor receptor-β and fibroblast growth factor receptor 1) and the mutant oncogenic kinases KIT, RET and B-RAF.  The antiangiogenic effect of regorafenib was demonstrated in vivo by dynamic contrast-enhanced magnetic resonance imaging.  Regorafenib administered once orally at 10 mg/kg significantly decreased the extravasation of Gadomer in the vasculature of rat GS9L glioblastoma tumor xenografts.  In a daily (qd)×4 dosing study, the pharmacodynamic effects persisted for 48 h after the last dosing and correlated with tumor growth inhibition (TGI).  A significant redn. in tumor microvessel area was obsd. in a human colorectal xenograft after qd×5 dosing at 10 and 30 mg/kg.  Regorafenib exhibited potent dose-dependent TGI in various preclin. human xenograft models in mice, with tumor shrinkages obsd. in breast MDA-MB-231 and renal 786-O carcinoma models.  Pharmacodynamic analyses of the breast model revealed strong redn. in staining of proliferation marker Ki-67 and phosphorylated extracellular regulated kinases 1/2.  These data demonstrate that regorafenib is a well-tolerated, orally active multikinase inhibitor with a distinct target profile that may have therapeutic benefit in human malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtQpQXfCq04rVg90H21EOLACvtfcHk0lgkl4aMfklKPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltFGlu7c%253D&md5=13eee29ef1f1f03fd1ed311ea613f566</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fijc.25864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.25864%26sid%3Dliteratum%253Aachs%26aulast%3DWilhelm%26aufirst%3DS.%2BM.%26aulast%3DDumas%26aufirst%3DJ.%26aulast%3DAdnane%26aufirst%3DL.%26aulast%3DLynch%26aufirst%3DM.%26aulast%3DCarter%26aufirst%3DC.%2BA.%26aulast%3DSch%25C3%25BCtz%26aufirst%3DG.%26aulast%3DThierauch%26aufirst%3DK.-H.%26aulast%3DZopf%26aufirst%3DD.%26atitle%3DRegorafenib%2520%2528BAY%252073-4506%2529%253A%2520a%2520new%2520oral%2520multikinase%2520inhibitor%2520of%2520angiogenic%252C%2520stromal%2520and%2520oncogenic%2520receptor%2520tyrosine%2520kinases%2520with%2520potent%2520preclinical%2520antitumor%2520activity%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2011%26volume%3D129%26spage%3D245%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Quintás-Cardam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaddi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manshouri, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherle, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caulder, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waeltz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covington, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarjian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verstovsek, S.</span><span> </span><span class="NLM_article-title">Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">3109</span><span class="NLM_x">–</span> <span class="NLM_lpage">3117</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=3109-3117&author=A.+Quint%C3%A1s-Cardamauthor=K.+Vaddiauthor=P.+Liuauthor=T.+Manshouriauthor=J.+Liauthor=P.+A.+Scherleauthor=E.+Caulderauthor=X.+Wenauthor=Y.+Liauthor=P.+Waeltzauthor=M.+Ruparauthor=T.+Burnauthor=Y.+Loauthor=J.+Kelleyauthor=M.+Covingtonauthor=S.+Shepardauthor=J.+D.+Rodgersauthor=P.+Haleyauthor=H.+Kantarjianauthor=J.+S.+Fridmanauthor=S.+Verstovsek&title=Preclinical+characterization+of+the+selective+JAK1%2F2+inhibitor+INCB018424%3A+therapeutic+implications+for+the+treatment+of+myeloproliferative+neoplasms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQuint%25C3%25A1s-Cardam%26aufirst%3DA.%26aulast%3DVaddi%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DManshouri%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DScherle%26aufirst%3DP.%2BA.%26aulast%3DCaulder%26aufirst%3DE.%26aulast%3DWen%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWaeltz%26aufirst%3DP.%26aulast%3DRupar%26aufirst%3DM.%26aulast%3DBurn%26aufirst%3DT.%26aulast%3DLo%26aufirst%3DY.%26aulast%3DKelley%26aufirst%3DJ.%26aulast%3DCovington%26aufirst%3DM.%26aulast%3DShepard%26aufirst%3DS.%26aulast%3DRodgers%26aufirst%3DJ.%2BD.%26aulast%3DHaley%26aufirst%3DP.%26aulast%3DKantarjian%26aufirst%3DH.%26aulast%3DFridman%26aufirst%3DJ.%2BS.%26aulast%3DVerstovsek%26aufirst%3DS.%26atitle%3DPreclinical%2520characterization%2520of%2520the%2520selective%2520JAK1%252F2%2520inhibitor%2520INCB018424%253A%2520therapeutic%2520implications%2520for%2520the%2520treatment%2520of%2520myeloproliferative%2520neoplasms%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26spage%3D3109%26epage%3D3117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Wilhelm, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNabola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shujath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gawlak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eveleigh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adnane, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auclair, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gedrich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voznesensky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedl, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Post, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollag, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trail, P. A.</span><span> </span><span class="NLM_article-title">BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">7099</span><span class="NLM_x">–</span> <span class="NLM_lpage">7109</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=7099-7109&author=S.+M.+Wilhelmauthor=C.+Carterauthor=L.+Tangauthor=D.+Wilkieauthor=A.+McNabolaauthor=H.+Rongauthor=C.+Chenauthor=X.+Zhangauthor=P.+Vincentauthor=M.+McHughauthor=Y.+Caoauthor=J.+Shujathauthor=S.+Gawlakauthor=D.+Eveleighauthor=B.+Rowleyauthor=L.+Liuauthor=L.+Adnaneauthor=M.+Lynchauthor=D.+Auclairauthor=I.+Taylorauthor=R.+Gedrichauthor=A.+Voznesenskyauthor=B.+Riedlauthor=L.+E.+Postauthor=G.+Bollagauthor=P.+A.+Trail&title=BAY+43-9006+exhibits+broad+spectrum+oral+antitumor+activity+and+targets+the+RAF%2FMEK%2FERK+pathway+and+receptor+tyrosine+kinases+involved+in+tumor+progression+and+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilhelm%26aufirst%3DS.%2BM.%26aulast%3DCarter%26aufirst%3DC.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DWilkie%26aufirst%3DD.%26aulast%3DMcNabola%26aufirst%3DA.%26aulast%3DRong%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DVincent%26aufirst%3DP.%26aulast%3DMcHugh%26aufirst%3DM.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DShujath%26aufirst%3DJ.%26aulast%3DGawlak%26aufirst%3DS.%26aulast%3DEveleigh%26aufirst%3DD.%26aulast%3DRowley%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DAdnane%26aufirst%3DL.%26aulast%3DLynch%26aufirst%3DM.%26aulast%3DAuclair%26aufirst%3DD.%26aulast%3DTaylor%26aufirst%3DI.%26aulast%3DGedrich%26aufirst%3DR.%26aulast%3DVoznesensky%26aufirst%3DA.%26aulast%3DRiedl%26aufirst%3DB.%26aulast%3DPost%26aufirst%3DL.%2BE.%26aulast%3DBollag%26aufirst%3DG.%26aulast%3DTrail%26aufirst%3DP.%2BA.%26atitle%3DBAY%252043-9006%2520exhibits%2520broad%2520spectrum%2520oral%2520antitumor%2520activity%2520and%2520targets%2520the%2520RAF%252FMEK%252FERK%2520pathway%2520and%2520receptor%2520tyrosine%2520kinases%2520involved%2520in%2520tumor%2520progression%2520and%2520angiogenesis%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D7099%26epage%3D7109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Mendel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laird, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreck, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrams, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngai, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carver, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haznedar, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukbuntherng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirazian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherrington, J. M.</span><span> </span><span class="NLM_article-title">In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">337</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=12538485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1OrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=327-337&author=D.+B.+Mendelauthor=A.+D.+Lairdauthor=X.+Xinauthor=S.+G.+Louieauthor=J.+G.+Christensenauthor=G.+Liauthor=R.+E.+Schreckauthor=T.+J.+Abramsauthor=T.+J.+Ngaiauthor=L.+B.+Leeauthor=L.+J.+Murrayauthor=J.+Carverauthor=E.+Chanauthor=K.+G.+Mossauthor=J.+O.+Haznedarauthor=J.+Sukbuntherngauthor=R.+A.+Blakeauthor=L.+Sunauthor=C.+Tangauthor=T.+Millerauthor=S.+Shirazianauthor=G.+McMahonauthor=J.+M.+Cherrington&title=In+vivo+antitumor+activity+of+SU11248%2C+a+novel+tyrosine+kinase+inhibitor+targeting+vascular+endothelial+growth+factor+and+platelet-derived+growth+factor+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">In Vivo Antitumor Activity of SU11248, a Novel Tyrosine Kinase Inhibitor Targeting Vascular Endothelial Growth Factor and Platelet-derived Growth Factor Receptors: Determination of a Pharmacokinetic/Pharmacodynamic Relationship</span></div><div class="casAuthors">Mendel, Dirk B.; Laird, A. Douglas; Xin, Xiaohua; Louie, Sharianne G.; Christensen, James G.; Li, Guangmin; Schreck, Randall E.; Abrams, Tinya J.; Ngai, Theresa J.; Lee, Leslie B.; Murray, Lesley J.; Carver, Jeremy; Chan, Emily; Moss, Katherine G.; Haznedar, Joshua O.; Sukbuntherng, Juthamas; Blake, Robert A.; Sun, Li; Tang, Cho; Miller, Todd; Shirazian, Sheri; McMahon, Gerald; Cherrington, Julie M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">327-337</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">One challenging aspect in the clin. development of molecularly targeted therapies, which represent a new and promising approach to treating cancers, has been the identification of a biol. active dose rather than a max. tolerated dose.  The goal of the present study was to identify a pharmacokinetic/pharmacodynamic relationship in preclin. models that could be used to help guide selection of a clin. dose.  SU11248, a novel small mol. receptor tyrosine kinase inhibitor with direct antitumor as well as antiangiogenic activity via targeting the vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), KIT, and FLT3 receptor tyrosine kinases, was used as the pharmacol. agent in these studies.  In mouse xenograft models, SU11248 exhibited broad and potent antitumor activity causing regression, growth arrest, or substantially reduced growth of various established xenografts derived from human or rat tumor cell lines.  To predict the target SU11248 exposure required to achieve antitumor activity in mouse xenograft models, we directly measured target phosphorylation in tumor xenografts before and after SU11248 treatment and correlated this with plasma inhibitor levels.  In target modulation studies in vivo, SU11248 selectively inhibited Flk-1/KDR (VEGF receptor 2) and PDGF receptor β phosphorylation (in a time- and dose-dependent manner) when plasma concns. of inhibitor reached or exceeded 50-100 ng/mL.  Similar results were obtained in a functional assay of VEGF-induced vascular permeability in vivo.  Const. inhibition of VEGFR2 and PDGF receptor β phosphorylation was not required for efficacy; at highly efficacious doses, inhibition was sustained for 12 h of a 24-h dosing interval.  The pharmacokinetic/pharmacodynamic relationship established for SU11248 in these preclin. studies has aided in the design, selection, and evaluation of dosing regimens being tested in human trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH8BrUNdo50rVg90H21EOLACvtfcHk0lg0GoaR5H0skg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1OrtA%253D%253D&md5=faafdec68a96d6cdf02ab347f69422b6</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMendel%26aufirst%3DD.%2BB.%26aulast%3DLaird%26aufirst%3DA.%2BD.%26aulast%3DXin%26aufirst%3DX.%26aulast%3DLouie%26aufirst%3DS.%2BG.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DSchreck%26aufirst%3DR.%2BE.%26aulast%3DAbrams%26aufirst%3DT.%2BJ.%26aulast%3DNgai%26aufirst%3DT.%2BJ.%26aulast%3DLee%26aufirst%3DL.%2BB.%26aulast%3DMurray%26aufirst%3DL.%2BJ.%26aulast%3DCarver%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DE.%26aulast%3DMoss%26aufirst%3DK.%2BG.%26aulast%3DHaznedar%26aufirst%3DJ.%2BO.%26aulast%3DSukbuntherng%26aufirst%3DJ.%26aulast%3DBlake%26aufirst%3DR.%2BA.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DMiller%26aufirst%3DT.%26aulast%3DShirazian%26aufirst%3DS.%26aulast%3DMcMahon%26aufirst%3DG.%26aulast%3DCherrington%26aufirst%3DJ.%2BM.%26atitle%3DIn%2520vivo%2520antitumor%2520activity%2520of%2520SU11248%252C%2520a%2520novel%2520tyrosine%2520kinase%2520inhibitor%2520targeting%2520vascular%2520endothelial%2520growth%2520factor%2520and%2520platelet-derived%2520growth%2520factor%2520receptors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2003%26volume%3D9%26spage%3D327%26epage%3D337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Carlomagno, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitagliano, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciardiello, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortora, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vecchio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontanini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fusco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santoro, M.</span><span> </span><span class="NLM_article-title">ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">7284</span><span class="NLM_x">–</span> <span class="NLM_lpage">7290</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=7284-7290&author=F.+Carlomagnoauthor=D.+Vitaglianoauthor=T.+Guidaauthor=F.+Ciardielloauthor=G.+Tortoraauthor=G.+Vecchioauthor=A.+J.+Ryanauthor=G.+Fontaniniauthor=A.+Fuscoauthor=M.+Santoro&title=ZD6474%2C+an+orally+available+inhibitor+of+KDR+tyrosine+kinase+activity%2C+efficiently+blocks+oncogenic+RET+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarlomagno%26aufirst%3DF.%26aulast%3DVitagliano%26aufirst%3DD.%26aulast%3DGuida%26aufirst%3DT.%26aulast%3DCiardiello%26aufirst%3DF.%26aulast%3DTortora%26aufirst%3DG.%26aulast%3DVecchio%26aufirst%3DG.%26aulast%3DRyan%26aufirst%3DA.%2BJ.%26aulast%3DFontanini%26aufirst%3DG.%26aulast%3DFusco%26aufirst%3DA.%26aulast%3DSantoro%26aufirst%3DM.%26atitle%3DZD6474%252C%2520an%2520orally%2520available%2520inhibitor%2520of%2520KDR%2520tyrosine%2520kinase%2520activity%252C%2520efficiently%2520blocks%2520oncogenic%2520RET%2520kinases%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D7284%26epage%3D7290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Bollag, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spevak, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habets, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shellooe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marimuthu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K. Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artis, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Andrea, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koehler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stumm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grippo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puzanov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McArthur, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sosman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flaherty, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nathanson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolop, K.</span><span> </span><span class="NLM_article-title">Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">467</span><span class="NLM_x">, </span> <span class="NLM_fpage">596</span><span class="NLM_x">–</span> <span class="NLM_lpage">599</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1038%2Fnature09454" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=20823850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1ajtbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=467&publication_year=2010&pages=596-599&author=G.+Bollagauthor=P.+Hirthauthor=J.+Tsaiauthor=J.+Zhangauthor=P.+N.+Ibrahimauthor=H.+Choauthor=W.+Spevakauthor=C.+Zhangauthor=Y.+Zhangauthor=G.+Habetsauthor=E.+A.+Burtonauthor=B.+Wongauthor=G.+Tsangauthor=B.+L.+Westauthor=B.+Powellauthor=R.+Shellooeauthor=A.+Marimuthuauthor=H.+Nguyenauthor=K.+Y.+J.+Zhangauthor=D.+R.+Artisauthor=J.+Schlessingerauthor=F.+Suauthor=B.+Higginsauthor=R.+Iyerauthor=K.+D%E2%80%99Andreaauthor=A.+Koehlerauthor=M.+Stummauthor=P.+S.+Linauthor=R.+J.+Leeauthor=J.+Grippoauthor=I.+Puzanovauthor=K.+B.+Kimauthor=A.+Ribasauthor=G.+A.+McArthurauthor=J.+A.+Sosmanauthor=P.+B.+Chapmanauthor=K.+T.+Flahertyauthor=X.+Xuauthor=K.+L.+Nathansonauthor=K.+Nolop&title=Clinical+efficacy+of+a+RAF+inhibitor+needs+broad+target+blockade+in+BRAF-mutant+melanoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma</span></div><div class="casAuthors">Bollag, Gideon; Hirth, Peter; Tsai, James; Zhang, Jiazhong; Ibrahim, Prabha N.; Cho, Hanna; Spevak, Wayne; Zhang, Chao; Zhang, Ying; Habets, Gaston; Burton, Elizabeth A.; Wong, Bernice; Tsang, Garson; West, Brian L.; Powell, Ben; Shellooe, Rafe; Marimuthu, Adhirai; Nguyen, Hoa; Zhang, Kam Y. J.; Artis, Dean R.; Schlessinger, Joseph; Su, Fei; Higgins, Brian; Iyer, Raman; D'Andrea, Kurt; Koehler, Astrid; Stumm, Michael; Lin, Paul S.; Lee, Richard J.; Grippo, Joseph; Puzanov, Igor; Kim, Kevin B.; Ribas, Antoni; McArthur, Grant A.; Sosman, Jeffrey A.; Chapman, Paul B.; Flaherty, Keith T.; Xu, Xiaowei; Nathanson, Katherine L.; Nolop, Keith</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">467</span>
        (<span class="NLM_cas:issue">7315</span>),
    <span class="NLM_cas:pages">596-599</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">B-RAF is the most frequently mutated protein kinase in human cancers.  The finding that oncogenic mutations in BRAF are common in melanoma, followed by the demonstration that these tumors are dependent on the RAF/MEK/ERK pathway, offered hope that inhibition of B-RAF kinase activity could benefit melanoma patients.  Herein, we describe the structure-guided discovery of PLX4032 (RG7204), a potent inhibitor of oncogenic B-RAF kinase activity.  Preclin. expts. demonstrated that PLX4032 selectively blocked the RAF/MEK/ERK pathway in BRAF mutant cells and caused regression of BRAF mutant xenografts.  Toxicol. studies confirmed a wide safety margin consistent with the high degree of selectivity, enabling Phase 1 clin. trials using a cryst. formulation of PLX4032 (ref. 5).  In a subset of melanoma patients, pathway inhibition was monitored in paired biopsy specimens collected before treatment initiation and following 2 wk of treatment.  This anal. revealed substantial inhibition of ERK phosphorylation, yet clin. evaluation did not show tumor regressions.  At higher drug exposures afforded by a new amorphous drug formulation, greater than 80% inhibition of ERK phosphorylation in the tumors of patients correlated with clin. response.  Indeed, the Phase 1 clin. data revealed a remarkably high 81% response rate in metastatic melanoma patients treated at an oral dose of 960 mg twice daily.  These data demonstrate that BRAF-mutant melanomas are highly dependent on B-RAF kinase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpYwlns1EfcLVg90H21EOLACvtfcHk0ljqBUGvDcAOTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1ajtbfK&md5=8a26d0ab41970f39a109ddafff2f17b4</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnature09454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09454%26sid%3Dliteratum%253Aachs%26aulast%3DBollag%26aufirst%3DG.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DTsai%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DIbrahim%26aufirst%3DP.%2BN.%26aulast%3DCho%26aufirst%3DH.%26aulast%3DSpevak%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHabets%26aufirst%3DG.%26aulast%3DBurton%26aufirst%3DE.%2BA.%26aulast%3DWong%26aufirst%3DB.%26aulast%3DTsang%26aufirst%3DG.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DShellooe%26aufirst%3DR.%26aulast%3DMarimuthu%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DK.%2BY.%2BJ.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DF.%26aulast%3DHiggins%26aufirst%3DB.%26aulast%3DIyer%26aufirst%3DR.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DK.%26aulast%3DKoehler%26aufirst%3DA.%26aulast%3DStumm%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DP.%2BS.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26aulast%3DGrippo%26aufirst%3DJ.%26aulast%3DPuzanov%26aufirst%3DI.%26aulast%3DKim%26aufirst%3DK.%2BB.%26aulast%3DRibas%26aufirst%3DA.%26aulast%3DMcArthur%26aufirst%3DG.%2BA.%26aulast%3DSosman%26aufirst%3DJ.%2BA.%26aulast%3DChapman%26aufirst%3DP.%2BB.%26aulast%3DFlaherty%26aufirst%3DK.%2BT.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DNathanson%26aufirst%3DK.%2BL.%26aulast%3DNolop%26aufirst%3DK.%26atitle%3DClinical%2520efficacy%2520of%2520a%2520RAF%2520inhibitor%2520needs%2520broad%2520target%2520blockade%2520in%2520BRAF-mutant%2520melanoma%26jtitle%3DNature%26date%3D2010%26volume%3D467%26spage%3D596%26epage%3D599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">O’Hare, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shakespeare, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eide, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adrian, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyner, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loriaux, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbin, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wardwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ning, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keats, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundaramoorthi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snodgrass, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Commodore, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalgarno, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, M. W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clackson, T.</span><span> </span><span class="NLM_article-title">AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">412</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=401-412&author=T.+O%E2%80%99Hareauthor=W.+C.+Shakespeareauthor=X.+Zhuauthor=C.+A.+Eideauthor=V.+M.+Riveraauthor=F.+Wangauthor=L.+T.+Adrianauthor=T.+Zhouauthor=W.-S.+Huangauthor=Q.+Xuauthor=C.+A.+Metcalfauthor=J.+W.+Tynerauthor=M.+M.+Loriauxauthor=A.+S.+Corbinauthor=S.+Wardwellauthor=Y.+Ningauthor=J.+A.+Keatsauthor=Y.+Wangauthor=R.+Sundaramoorthiauthor=M.+Thomasauthor=D.+Zhouauthor=J.+Snodgrassauthor=L.+Commodoreauthor=T.+K.+Sawyerauthor=D.+C.+Dalgarnoauthor=M.+W.+N.+Deiningerauthor=B.+J.+Drukerauthor=T.+Clackson&title=AP24534%2C+a+pan-BCR-ABL+inhibitor+for+chronic+myeloid+leukemia%2C+potently+inhibits+the+T315I+mutant+and+overcomes+mutation-based+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Hare%26aufirst%3DT.%26aulast%3DShakespeare%26aufirst%3DW.%2BC.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DEide%26aufirst%3DC.%2BA.%26aulast%3DRivera%26aufirst%3DV.%2BM.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DAdrian%26aufirst%3DL.%2BT.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DW.-S.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DMetcalf%26aufirst%3DC.%2BA.%26aulast%3DTyner%26aufirst%3DJ.%2BW.%26aulast%3DLoriaux%26aufirst%3DM.%2BM.%26aulast%3DCorbin%26aufirst%3DA.%2BS.%26aulast%3DWardwell%26aufirst%3DS.%26aulast%3DNing%26aufirst%3DY.%26aulast%3DKeats%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSundaramoorthi%26aufirst%3DR.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DSnodgrass%26aufirst%3DJ.%26aulast%3DCommodore%26aufirst%3DL.%26aulast%3DSawyer%26aufirst%3DT.%2BK.%26aulast%3DDalgarno%26aufirst%3DD.%2BC.%26aulast%3DDeininger%26aufirst%3DM.%2BW.%2BN.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DClackson%26aufirst%3DT.%26atitle%3DAP24534%252C%2520a%2520pan-BCR-ABL%2520inhibitor%2520for%2520chronic%2520myeloid%2520leukemia%252C%2520potently%2520inhibits%2520the%2520T315I%2520mutant%2520and%2520overcomes%2520mutation-based%2520resistance%26jtitle%3DCancer%2520Cell%26date%3D2009%26volume%3D16%26spage%3D401%26epage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Chrencik, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patny, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korniski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmons, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gormley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommers, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenbrink, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, T. E.</span><span> </span><span class="NLM_article-title">Structural and thermodynamic characterization of the TYK2 and JAK3 kinase domains in complex with CP-690550 and CMP-6</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">400</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">433</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2Fj.jmb.2010.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=20478313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1ylt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=2010&pages=413-433&author=J.+E.+Chrencikauthor=A.+Patnyauthor=I.+K.+Leungauthor=B.+Korniskiauthor=T.+L.+Emmonsauthor=T.+Hallauthor=R.+A.+Weinbergauthor=J.+A.+Gormleyauthor=J.+M.+Williamsauthor=J.+E.+Dayauthor=J.+L.+Hirschauthor=J.+R.+Kieferauthor=J.+W.+Leoneauthor=H.+D.+Fischerauthor=C.+D.+Sommersauthor=H.-C.+Huangauthor=E.+J.+Jacobsenauthor=R.+E.+Tenbrinkauthor=A.+G.+Tomasselliauthor=T.+E.+Benson&title=Structural+and+thermodynamic+characterization+of+the+TYK2+and+JAK3+kinase+domains+in+complex+with+CP-690550+and+CMP-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6</span></div><div class="casAuthors">Chrencik, Jill E.; Patny, Akshay; Leung, Iris K.; Korniski, Brian; Emmons, Thomas L.; Hall, Troii; Weinberg, Robin A.; Gormley, Jennifer A.; Williams, Jennifer M.; Day, Jacqueline E.; Hirsch, Jeffrey L.; Kiefer, James R.; Leone, Joseph W.; Fischer, H. David; Sommers, Cynthia D.; Huang, Horng-Chih; Jacobsen, E. J.; Tenbrink, Ruth E.; Tomasselli, Alfredo G.; Benson, Timothy E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">400</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">413-433</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Janus kinases (JAKs) are crit. regulators of cytokine pathways and attractive targets of therapeutic value in both inflammatory and myeloproliferative diseases.  Although the crystal structures of active JAK1 and JAK2 kinase domains have been reported recently with the clin. compd. CP-690550, the structures of both TYK2 and JAK3 with CP-690550 have remained outstanding.  Here, we report the crystal structures of TYK2, a first in class structure, and JAK3 in complex with PAN-JAK inhibitors CP-690550 ((3R,4R)-3-[4-methyl-3-[N-methyl-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropionitrile) and CMP-6 (tetracyclic pyridone 2-t-butyl-9-fluoro-3,6-dihydro-7H-benz[h]-imidaz[4,5-f]isoquinoline-7-one), both of which bind in the ATP-binding cavities of both JAK isoenzymes in orientations similar to that obsd. in crystal structures of JAK1 and JAK2.  Addnl., a complete thermodn. characterization of JAK/CP-690550 complex formation was completed by isothermal titrn. calorimetry, indicating the crit. role of the nitrile group from the CP-690550 compd.  Finally, computational anal. using WaterMap further highlights the crit. positioning of the CP-690550 nitrile group in the displacement of an unfavorable water mol. beneath the glycine-rich loop.  Taken together, the data emphasize the outstanding properties of the kinome-selective JAK inhibitor CP-690550, as well as the challenges in obtaining JAK isoenzyme-selective inhibitors due to the overall structural and sequence similarities between the TYK2, JAK1, JAK2 and JAK3 isoenzymes.  Nevertheless, subtle amino acid variations of residues lining the ligand-binding cavity of the JAK enzymes, as well as the global positioning of the glycine-rich loop, might provide the initial clues to obtaining JAK-isoenzyme selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5dnGkvq0jPbVg90H21EOLACvtfcHk0lg-tvV5Rr6r8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1ylt7g%253D&md5=1b1efc3d6f913143dc9113e4ac1c4c60</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2010.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2010.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DChrencik%26aufirst%3DJ.%2BE.%26aulast%3DPatny%26aufirst%3DA.%26aulast%3DLeung%26aufirst%3DI.%2BK.%26aulast%3DKorniski%26aufirst%3DB.%26aulast%3DEmmons%26aufirst%3DT.%2BL.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26aulast%3DGormley%26aufirst%3DJ.%2BA.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DDay%26aufirst%3DJ.%2BE.%26aulast%3DHirsch%26aufirst%3DJ.%2BL.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DLeone%26aufirst%3DJ.%2BW.%26aulast%3DFischer%26aufirst%3DH.%2BD.%26aulast%3DSommers%26aufirst%3DC.%2BD.%26aulast%3DHuang%26aufirst%3DH.-C.%26aulast%3DJacobsen%26aufirst%3DE.%2BJ.%26aulast%3DTenbrink%26aufirst%3DR.%2BE.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26atitle%3DStructural%2520and%2520thermodynamic%2520characterization%2520of%2520the%2520TYK2%2520and%2520JAK3%2520kinase%2520domains%2520in%2520complex%2520with%2520CP-690550%2520and%2520CMP-6%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D400%26spage%3D413%26epage%3D433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Greger, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastman, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleam, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smitheman, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickerson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laquerre, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmer, T. M.</span><span> </span><span class="NLM_article-title">Combinations of BRAF, MEK, and PI3K/mTOR inhibitors overcome acquired resistance to the BRAF inhibitor GSK2118436 dabrafenib, mediated by NRAS or MEK mutations</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">920</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1158%2F1535-7163.MCT-11-0989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=22389471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC38Xltl2ntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=909-920&author=J.+G.+Gregerauthor=S.+D.+Eastmanauthor=V.+Zhangauthor=M.+R.+Bleamauthor=A.+M.+Hughesauthor=K.+N.+Smithemanauthor=S.+H.+Dickersonauthor=S.+G.+Laquerreauthor=L.+Liuauthor=T.+M.+Gilmer&title=Combinations+of+BRAF%2C+MEK%2C+and+PI3K%2FmTOR+inhibitors+overcome+acquired+resistance+to+the+BRAF+inhibitor+GSK2118436+dabrafenib%2C+mediated+by+NRAS+or+MEK+mutations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Combinations of BRAF, MEK, and PI3K/mTOR Inhibitors Overcome Acquired Resistance to the BRAF Inhibitor GSK2118436 Dabrafenib, Mediated by NRAS or MEK Mutations</span></div><div class="casAuthors">Greger, James G.; Eastman, Stephen D.; Zhang, Vivian; Bleam, Maureen R.; Hughes, Ashley M.; Smitheman, Kimberly N.; Dickerson, Scott H.; Laquerre, Sylvie G.; Liu, Li; Gilmer, Tona M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">909-920</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Recent results from clin. trials with the BRAF inhibitors GSK2118436 (dabrafenib) and PLX4032 (vemurafenib) have shown encouraging response rates; however, the duration of response has been limited.  To identify determinants of acquired resistance to GSK2118436 and strategies to overcome the resistance, we isolated GSK2118436 drug-resistant clones from the A375 BRAFV600E and the YUSIT1 BRAFV600K melanoma cell lines.  These clones also showed reduced sensitivity to the allosteric mitogen-activated protein/extracellular signal-regulated kinase (MEK) inhibitor GSK1120212 (trametinib).  Genetic characterization of these clones identified an in-frame deletion in MEK1 (MEK1K59del) or NRAS mutation (NRASQ61K and/or NRASA146T) with and without MEK1P387S in the BRAFV600E background and NRASQ61K in the BRAFV600K background.  Stable knockdown of NRAS with short hairpin RNA partially restored GSK2118436 sensitivity in mutant NRAS clones, whereas expression of NRASQ61K or NRASA146T in the A375 parental cells decreased sensitivity to GSK2118436.  Similarly, expression of MEK1K59del, but not MEK1P387S, decreased sensitivity of A375 cells to GSK2118436.  The combination of GSK2118436 and GSK1120212 effectively inhibited cell growth, decreased ERK phosphorylation, decreased cyclin D1 protein, and increased p27kip1 protein in the resistant clones.  Moreover, the combination of GSK2118436 or GSK1120212 with the phosphoinositide 3-kinase/mTOR inhibitor GSK2126458 enhanced cell growth inhibition and decreased S6 ribosomal protein phosphorylation in these clones.  Our results show that NRAS and/or MEK mutations contribute to BRAF inhibitor resistance in vitro, and the combination of GSK2118436 and GSK1120212 overcomes this resistance.  In addn., these resistant clones respond to the combination of GSK2126458 with GSK2118436 or GSK1120212.  Clin. trials are ongoing or planned to test these combinations.  Mol Cancer Ther; 11(4); 909-20.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-aBjkeaBsgLVg90H21EOLACvtfcHk0lgViKwxz4tEog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xltl2ntbY%253D&md5=416c0679440a16f76f3622e0b26cf3a2</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0989%26sid%3Dliteratum%253Aachs%26aulast%3DGreger%26aufirst%3DJ.%2BG.%26aulast%3DEastman%26aufirst%3DS.%2BD.%26aulast%3DZhang%26aufirst%3DV.%26aulast%3DBleam%26aufirst%3DM.%2BR.%26aulast%3DHughes%26aufirst%3DA.%2BM.%26aulast%3DSmitheman%26aufirst%3DK.%2BN.%26aulast%3DDickerson%26aufirst%3DS.%2BH.%26aulast%3DLaquerre%26aufirst%3DS.%2BG.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DGilmer%26aufirst%3DT.%2BM.%26atitle%3DCombinations%2520of%2520BRAF%252C%2520MEK%252C%2520and%2520PI3K%252FmTOR%2520inhibitors%2520overcome%2520acquired%2520resistance%2520to%2520the%2520BRAF%2520inhibitor%2520GSK2118436%2520dabrafenib%252C%2520mediated%2520by%2520NRAS%2520or%2520MEK%2520mutations%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2012%26volume%3D11%26spage%3D909%26epage%3D920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Gilmartin, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleam, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minthorn, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rominger, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erskine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zappacosta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laquerre, S. G.</span><span> </span><span class="NLM_article-title">GSK1120212 (JTP-74057) is an inhibitor of MEK activity and activation with favorable pharmacokinetic properties for sustained in vivo pathway inhibition</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">989</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1158%2F1078-0432.CCR-10-2200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=21245089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXis1eit7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=989-1000&author=A.+G.+Gilmartinauthor=M.+R.+Bleamauthor=A.+Groyauthor=K.+G.+Mossauthor=E.+A.+Minthornauthor=S.+G.+Kulkarniauthor=C.+M.+Romingerauthor=S.+Erskineauthor=K.+E.+Fisherauthor=J.+Yangauthor=F.+Zappacostaauthor=R.+Annanauthor=D.+Suttonauthor=S.+G.+Laquerre&title=GSK1120212+%28JTP-74057%29+is+an+inhibitor+of+MEK+activity+and+activation+with+favorable+pharmacokinetic+properties+for+sustained+in+vivo+pathway+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">GSK1120212 (JTP-74057) Is an Inhibitor of MEK Activity and Activation with Favorable Pharmacokinetic Properties for Sustained In Vivo Pathway Inhibition</span></div><div class="casAuthors">Gilmartin, Aidan G.; Bleam, Maureen R.; Groy, Arthur; Moss, Katherine G.; Minthorn, Elisabeth A.; Kulkarni, Swarupa G.; Rominger, Cynthia M.; Erskine, Symon; Fisher, Kelly E.; Yang, Jing-Song; Zappacosta, Francesca; Annan, Roland; Sutton, David; Laquerre, Sylvie G.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">989-1000</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Despite their preclin. promise, previous MEK inhibitors have shown little benefit for patients.  This likely reflects the narrow therapeutic window for MEK inhibitors due to the essential role of the P42/44 MAPK pathway in many nontumor tissues.  GSK1120212 is a potent and selective allosteric inhibitor of the MEK1 and MEK2 (MEK1/2) enzymes with promising antitumor activity in a phase I clin. trial (ASCO 2010).  Our studies characterize GSK1120212' enzymic, cellular, and in vivo activities, describing its unusually long circulating half-life.  Exptl. Design: Enzymic studies were conducted to det. GSK1120212 inhibition of recombinant MEK, following or preceding RAF kinase activation.  Cellular studies examd. GSK1120212 inhibition of ERK1 and 2 phosphorylation (p-ERK1/2) as well as MEK1/2 phosphorylation and activation.  Further studies explored the sensitivity of cancer cell lines, and drug pharmacokinetics and efficacy in multiple tumor xenograft models.  Results: In enzymic and cellular studies, GSK1120212 inhibits MEK1/2 kinase activity and prevents Raf-dependent MEK phosphorylation (S217 for MEK1), producing prolonged p-ERK1/2 inhibition.  Potent cell growth inhibition was evident in most tumor lines with mutant BRAF or Ras.  In xenografted tumor models, GSK1120212 orally dosed once daily had a long circulating half-life and sustained suppression of p-ERK1/2 for more than 24 h; GSK1120212 also reduced tumor Ki67, increased p27Kip1/CDKN1B, and caused tumor growth inhibition in multiple tumor models.  The largest antitumor effect was among tumors harboring mutant BRAF or Ras.  Conclusions: GSK1120212 combines high potency, selectivity, and long circulating half-life, offering promise for successfully targeting the narrow therapeutic window anticipated for clin. MEK inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMOQvgszKIfbVg90H21EOLACvtfcHk0lgViKwxz4tEog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXis1eit7k%253D&md5=6154be5fa0afb034c6a5995508d7ea9e</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-10-2200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-10-2200%26sid%3Dliteratum%253Aachs%26aulast%3DGilmartin%26aufirst%3DA.%2BG.%26aulast%3DBleam%26aufirst%3DM.%2BR.%26aulast%3DGroy%26aufirst%3DA.%26aulast%3DMoss%26aufirst%3DK.%2BG.%26aulast%3DMinthorn%26aufirst%3DE.%2BA.%26aulast%3DKulkarni%26aufirst%3DS.%2BG.%26aulast%3DRominger%26aufirst%3DC.%2BM.%26aulast%3DErskine%26aufirst%3DS.%26aulast%3DFisher%26aufirst%3DK.%2BE.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DZappacosta%26aufirst%3DF.%26aulast%3DAnnan%26aufirst%3DR.%26aulast%3DSutton%26aufirst%3DD.%26aulast%3DLaquerre%26aufirst%3DS.%2BG.%26atitle%3DGSK1120212%2520%2528JTP-74057%2529%2520is%2520an%2520inhibitor%2520of%2520MEK%2520activity%2520and%2520activation%2520with%2520favorable%2520pharmacokinetic%2520properties%2520for%2520sustained%2520in%2520vivo%2520pathway%2520inhibition%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26spage%3D989%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Liao, J. J.</span><span> </span><span class="NLM_article-title">Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0608107" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1Cmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=409-424&author=J.+J.+Liao&title=Molecular+recognition+of+protein+kinase+binding+pockets+for+design+of+potent+and+selective+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Recognition of Protein Kinase Binding Pockets for Design of Potent and Selective Kinase Inhibitors</span></div><div class="casAuthors">Liao, Jeffrey Jie-Lou</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">409-424</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Many kinase inhibitors have failed in preclin. or clin. development because of the lack of such selectivity that induces intolerable side effects, mostly because the catalytic cleft is highly conserved in sequence and conformation.  Systematic anal. of the crystal structures of protein kinases can offer insight into the design of highly selective kinase inhibitors to overcome these effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroDTl2SBUfbbVg90H21EOLACvtfcHk0lgxkH0biBGxcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1Cmsg%253D%253D&md5=77542d3ba589bd834a0d2b97a24eea05</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm0608107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0608107%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DJ.%2BJ.%26atitle%3DMolecular%2520recognition%2520of%2520protein%2520kinase%2520binding%2520pockets%2520for%2520design%2520of%2520potent%2520and%2520selective%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D409%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">McGregor, M. J.</span><span> </span><span class="NLM_article-title">A pharmacophore map of small molecule protein kinase inhibitors</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2374</span><span class="NLM_x">–</span> <span class="NLM_lpage">2382</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci700244t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFKksL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=2374-2382&author=M.+J.+McGregor&title=A+pharmacophore+map+of+small+molecule+protein+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A Pharmacophore Map of Small Molecule Protein Kinase Inhibitors</span></div><div class="casAuthors">McGregor, Malcolm J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2374-2382</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein kinases have emerged as one of the major drug target classes that are amenable to the development of small mol. inhibitors.  They share a conserved structural similarity in the region of the ATP binding site, where most inhibitors interact.  Using a pharmacophore approach, we have explored the features of protein-ligand interactions for a set of 220 kinase crystal structures from the Protein Data Bank (PDB).  The resulting "pharmacophore map" shows the interactions made by all ligands with their receptors simultaneously.  This gives insight that has been applied in the design of kinase screening sets and combinatorial libraries.  An algorithm is described that scores small mol. structures for goodness of fit to the resulting binding site description obtained from the anal.  The algorithm identifies a pose that is close to the crystal structure pose for the majority of ligands, with only the 2D chem. structure as input and no knowledge of the crystal structure from which it was derived.  Application of the algorithm to a test screening set gave a useful enrichment of active compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-PlOGvAO_Z7Vg90H21EOLACvtfcHk0lgxkH0biBGxcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFKksL%252FO&md5=38d2b55c3fbb1232fd7d091f95414633</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fci700244t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci700244t%26sid%3Dliteratum%253Aachs%26aulast%3DMcGregor%26aufirst%3DM.%2BJ.%26atitle%3DA%2520pharmacophore%2520map%2520of%2520small%2520molecule%2520protein%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2007%26volume%3D47%26spage%3D2374%26epage%3D2382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Rational design of inhibitors that bind to inactive kinase conformations</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1038%2Fnchembio799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=16783341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFGjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=358-364&author=Y.+Liuauthor=N.+S.+Gray&title=Rational+design+of+inhibitors+that+bind+to+inactive+kinase+conformations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design of inhibitors that bind to inactive kinase conformations</span></div><div class="casAuthors">Liu, Yi; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">358-364</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The majority of kinase inhibitors, known as type I inhibitors that have been developed so far target the ATP binding site of the kinase in its active conformation, in which the activation loop is phosphorylated.  Recently, crystal structures of inhibitors such as imatinib, BIRB796, and sorafenib (BAY43-9006), known as type II inhibitors, have revealed a new binding mode that exploits an addnl. binding site immediately adjacent to the region occupied by ATP.  This pocket is made accessible by an activation-loop rearrangement that is characteristic of kinases in an inactive conformation.  The examn. of binding features of known type II inhibitors is discussed and a pharmacophore model currently used in the design of a new generation of structurally diverse type II inhibitors is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxahsMPlhgDbVg90H21EOLACvtfcHk0lg0mDzlsb825g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFGjs7g%253D&md5=4a9347a44a2cf4a412c9741fdcc5696b</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnchembio799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio799%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DRational%2520design%2520of%2520inhibitors%2520that%2520bind%2520to%2520inactive%2520kinase%2520conformations%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2006%26volume%3D2%26spage%3D358%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Liao, J. J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, R. C.</span><span> </span><span class="NLM_article-title">Targeting protein multiple conformations: a structure-based strategy for kinase drug design</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1394</span><span class="NLM_x">–</span> <span class="NLM_lpage">1407</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.2174%2F156802607781696783" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=17692028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1SmtbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=1394-1407&author=J.+J.+L.+Liaoauthor=R.+C.+Andrews&title=Targeting+protein+multiple+conformations%3A+a+structure-based+strategy+for+kinase+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein multiple conformations: a structure-based strategy for kinase drug design</span></div><div class="casAuthors">Liao, Jeffrey Jie-Lou; Andrews, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1394-1407</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Multiple conformations of a protein kinase target offer an opportunity to design small-mol. inhibitors with distinct but clin. useful profiles.  This article analyzes and classifies the binding pockets in the kinase catalytic cleft in different conformational states.  Targeting kinase multiple conformations as an emerging strategy in the field is exemplified with important small-mol. agents in the clinic.  The structure-based anal. in the paper provides a rationale for thwarting the development of drug-resistant mutations in antikinase therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWOkJq0JBN2rVg90H21EOLACvtfcHk0lg0mDzlsb825g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1SmtbrF&md5=db6aa8c76bf20857cfe31c71625ffa9e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.2174%2F156802607781696783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607781696783%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DJ.%2BJ.%2BL.%26aulast%3DAndrews%26aufirst%3DR.%2BC.%26atitle%3DTargeting%2520protein%2520multiple%2520conformations%253A%2520a%2520structure-based%2520strategy%2520for%2520kinase%2520drug%2520design%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D1394%26epage%3D1407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Ghose, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbertz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pippin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvino, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallamo, J. P.</span><span> </span><span class="NLM_article-title">Knowledge based prediction of ligand binding modes and rational inhibitor design for kinase drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5149</span><span class="NLM_x">–</span> <span class="NLM_lpage">5171</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800475y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWmurnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5149-5171&author=A.+K.+Ghoseauthor=T.+Herbertzauthor=D.+A.+Pippinauthor=J.+M.+Salvinoauthor=J.+P.+Mallamo&title=Knowledge+based+prediction+of+ligand+binding+modes+and+rational+inhibitor+design+for+kinase+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Knowledge Based Prediction of Ligand Binding Modes and Rational Inhibitor Design for Kinase Drug Discovery</span></div><div class="casAuthors">Ghose, Arup K.; Herbertz, Torsten; Pippin, Douglas A.; Salvino, Joseph M.; Mallamo, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5149-5171</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review describing the use of Protein Data Bank (PDB) entries specifically for kinase inhibitor drug discovery.  Topics discussed include: the current state of structure-aided ligand design, kinase structure queries and extn. from the PDB, alignment of protein structures, structural classification of ligands, anal. of ligands and binding modes, and ligand design strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDINDYVE15cbVg90H21EOLACvtfcHk0lg0mDzlsb825g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWmurnM&md5=a1afc4d6c7f6fa4dd6aa9da8d78f1ee3</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm800475y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800475y%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DHerbertz%26aufirst%3DT.%26aulast%3DPippin%26aufirst%3DD.%2BA.%26aulast%3DSalvino%26aufirst%3DJ.%2BM.%26aulast%3DMallamo%26aufirst%3DJ.%2BP.%26atitle%3DKnowledge%2520based%2520prediction%2520of%2520ligand%2520binding%2520modes%2520and%2520rational%2520inhibitor%2520design%2520for%2520kinase%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5149%26epage%3D5171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Lamba, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, I.</span><span> </span><span class="NLM_article-title">New directions in targeting protein kinases: focusing upon true allosteric and bivalent inhibitors</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2936</span><span class="NLM_x">–</span> <span class="NLM_lpage">2945</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.2174%2F138161212800672813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=22571662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFaltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=2936-2945&author=V.+Lambaauthor=I.+Ghosh&title=New+directions+in+targeting+protein+kinases%3A+focusing+upon+true+allosteric+and+bivalent+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">New directions in targeting protein kinases: focusing upon true allosteric and bivalent inhibitors</span></div><div class="casAuthors">Lamba, Vandana; Ghosh, Indraneel</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2936-2945</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Over the past decade, therapeutics that target subsets of the 518 human protein kinases have played a vital role in the fight against cancer.  Protein kinases are typically targeted at the ATP-binding cleft by type I and II inhibitors; however, the high sequence and structural homol. shared by protein kinases, esp. at the ATP-binding site, inherently leads to polypharmacol.  In order to discover or design truly selective protein kinase inhibitors as both pharmacol. reagents and safer therapeutic leads, new efforts are needed to target kinases outside the ATP cleft.  Recent advances include the serendipitous discovery of type III inhibitors that bind a site proximal to the ATP pocket as well as the truly allosteric type IV inhibitors that target protein kinases distal to the substrate-binding pocket.  These new classes of inhibitors are often selective, but usually display moderate affinities.  Here, the authors discuss the different classes of inhibitors with an emphasis on bisubstrate and bivalent inhibitors (type V) that combine different inhibitor classes.  These inhibitors have the potential to couple the high affinity and potency of traditional active site-targeted small-mol. inhibitors with the selectivity of inhibitors that target the protein kinase surface outside ATP cleft.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkIIgeMxhCrrVg90H21EOLACvtfcHk0lglUDcOPIg2TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFaltrk%253D&md5=36a44e36709507b5053bfdfe7d09e5e9</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2174%2F138161212800672813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161212800672813%26sid%3Dliteratum%253Aachs%26aulast%3DLamba%26aufirst%3DV.%26aulast%3DGhosh%26aufirst%3DI.%26atitle%3DNew%2520directions%2520in%2520targeting%2520protein%2520kinases%253A%2520focusing%2520upon%2520true%2520allosteric%2520and%2520bivalent%2520inhibitors%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2012%26volume%3D18%26spage%3D2936%26epage%3D2945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">Comprehensive analysis of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1046</span><span class="NLM_x">–</span> <span class="NLM_lpage">1051</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1038%2Fnbt.1990" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=22037378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1046-1051&author=M.+I.+Davisauthor=J.+P.+Huntauthor=S.+Herrgardauthor=P.+Ciceriauthor=L.+M.+Wodickaauthor=G.+Pallaresauthor=M.+Hockerauthor=D.+K.+Treiberauthor=P.+P.+Zarrinkar&title=Comprehensive+analysis+of+kinase+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Davis, Mindy I.; Hunt, Jeremy P.; Herrgard, Sanna; Ciceri, Pietro; Wodicka, Lisa M.; Pallares, Gabriel; Hocker, Michael; Treiber, Daniel K.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1046-1051</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We tested the interaction of 72 kinase inhibitors with 442 kinases covering >80% of the human catalytic protein kinome.  Our data show that, as a class, type II inhibitors are more selective than type I inhibitors, but that there are important exceptions to this trend.  The data further illustrate that selective inhibitors have been developed against the majority of kinases targeted by the compds. tested.  Anal. of the interaction patterns reveals a class of 'group-selective' inhibitors broadly active against a single subfamily of kinases, but selective outside that subfamily.  The data set suggests compds. to use as tools to study kinases for which no dedicated inhibitors exist.  It also provides a foundation for further exploring kinase inhibitor biol. and toxicity, as well as for studying the structural basis of the obsd. interaction patterns.  Our findings will help to realize the direct enabling potential of genomics for drug development and basic research about cellular signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEZnKVs6Xt5rVg90H21EOLACvtfcHk0lglUDcOPIg2TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK&md5=67639f702cb48ffb2c60e9a250f0df5e</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1990%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DHocker%26aufirst%3DM.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DComprehensive%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D1046%26epage%3D1051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Karaman, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraoni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">A quantitative analysis of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1038%2Fnbt1358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=18183025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=127-132&author=M.+W.+Karamanauthor=S.+Herrgardauthor=D.+K.+Treiberauthor=P.+Gallantauthor=C.+E.+Atteridgeauthor=B.+T.+Campbellauthor=K.+W.+Chanauthor=P.+Ciceriauthor=M.+I.+Davisauthor=P.+T.+Edeenauthor=R.+Faraoniauthor=M.+Floydauthor=J.+P.+Huntauthor=D.+J.+Lockhartauthor=Z.+V.+Milanovauthor=M.+J.+Morrisonauthor=G.+Pallaresauthor=H.+K.+Patelauthor=S.+Pritchardauthor=L.+M.+Wodickaauthor=P.+P.+Zarrinkar&title=A+quantitative+analysis+of+kinase+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Karaman, Mazen W.; Herrgard, Sanna; Treiber, Daniel K.; Gallant, Paul; Atteridge, Corey E.; Campbell, Brian T.; Chan, Katrina W.; Ciceri, Pietro; Davis, Mindy I.; Edeen, Philip T.; Faraoni, Raffaella; Floyd, Mark; Hunt, Jeremy P.; Lockhart, Daniel J.; Milanov, Zdravko V.; Morrison, Michael J.; Pallares, Gabriel; Patel, Hitesh K.; Pritchard, Stephanie; Wodicka, Lisa M.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-132</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets.  The biol. consequences of multikinase activity are poorly defined, and an important step toward understanding the relationship between selectivity, efficacy and safety is the exploration of how inhibitors interact with the human kinome.  The authors present interaction maps for 38 kinase inhibitors across a panel of 317 kinases representing >50% of the predicted human protein kinome.  The data constitute the most comprehensive study of kinase inhibitor selectivity to date and reveal a wide diversity of interaction patterns.  To enable a global anal. of the results, the authors introduce the concept of a selectivity score as a general tool to quantify and differentiate the obsd. interaction patterns.  The authors further investigate the impact of panel size and find that small assay panels do not provide a robust measure of selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiArJSq2_lPrVg90H21EOLACvtfcHk0ljA3XPEeKUAiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D&md5=346265d412853ced636ad4128ed8a76f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fnbt1358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1358%26sid%3Dliteratum%253Aachs%26aulast%3DKaraman%26aufirst%3DM.%2BW.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DCampbell%26aufirst%3DB.%2BT.%26aulast%3DChan%26aufirst%3DK.%2BW.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFaraoni%26aufirst%3DR.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DMorrison%26aufirst%3DM.%2BJ.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DPritchard%26aufirst%3DS.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DA%2520quantitative%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D127%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Aronov, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClain, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moody, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murcko, M. A.</span><span> </span><span class="NLM_article-title">Kinase-likeness and kinase-privileged fragments: toward virtual polypharmacology</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1214</span><span class="NLM_x">–</span> <span class="NLM_lpage">1222</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701021b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1214-1222&author=A.+M.+Aronovauthor=B.+McClainauthor=C.+S.+Moodyauthor=M.+A.+Murcko&title=Kinase-likeness+and+kinase-privileged+fragments%3A+toward+virtual+polypharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm701021b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701021b%26sid%3Dliteratum%253Aachs%26aulast%3DAronov%26aufirst%3DA.%2BM.%26aulast%3DMcClain%26aufirst%3DB.%26aulast%3DMoody%26aufirst%3DC.%2BS.%26aulast%3DMurcko%26aufirst%3DM.%2BA.%26atitle%3DKinase-likeness%2520and%2520kinase-privileged%2520fragments%253A%2520toward%2520virtual%2520polypharmacology%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1214%26epage%3D1222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Gill, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederickson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleasby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodhead, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodhead, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congreve, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devine, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tisi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Reilly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seavers, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhoti, H.</span><span> </span><span class="NLM_article-title">Identification of novel p38alpha MAP kinase inhibitors using fragment-based lead generation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">414</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049575n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=414-26&author=A.+L.+Gillauthor=M.+Fredericksonauthor=A.+Cleasbyauthor=S.+J.+Woodheadauthor=M.+G.+Carrauthor=A.+J.+Woodheadauthor=M.+T.+Walkerauthor=M.+S.+Congreveauthor=L.+A.+Devineauthor=D.+Tisiauthor=M.+O%E2%80%99Reillyauthor=L.+C.+Seaversauthor=D.+J.+Davisauthor=J.+Curryauthor=R.+Anthonyauthor=A.+Padovaauthor=C.+W.+Murrayauthor=R.+A.+Carrauthor=H.+Jhoti&title=Identification+of+novel+p38alpha+MAP+kinase+inhibitors+using+fragment-based+lead+generation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm049575n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049575n%26sid%3Dliteratum%253Aachs%26aulast%3DGill%26aufirst%3DA.%2BL.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DWoodhead%26aufirst%3DS.%2BJ.%26aulast%3DCarr%26aufirst%3DM.%2BG.%26aulast%3DWoodhead%26aufirst%3DA.%2BJ.%26aulast%3DWalker%26aufirst%3DM.%2BT.%26aulast%3DCongreve%26aufirst%3DM.%2BS.%26aulast%3DDevine%26aufirst%3DL.%2BA.%26aulast%3DTisi%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%26aulast%3DSeavers%26aufirst%3DL.%2BC.%26aulast%3DDavis%26aufirst%3DD.%2BJ.%26aulast%3DCurry%26aufirst%3DJ.%26aulast%3DAnthony%26aufirst%3DR.%26aulast%3DPadova%26aufirst%3DA.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DCarr%26aufirst%3DR.%2BA.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520novel%2520p38alpha%2520MAP%2520kinase%2520inhibitors%2520using%2520fragment-based%2520lead%2520generation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D414%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Hartshorn, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleasby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederickson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tickle, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhoti, H.</span><span> </span><span class="NLM_article-title">Fragment-based lead discovery using X-ray crystallography</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0495778" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFCiu7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=403-13&author=M.+J.+Hartshornauthor=C.+W.+Murrayauthor=A.+Cleasbyauthor=M.+Fredericksonauthor=I.+J.+Tickleauthor=H.+Jhoti&title=Fragment-based+lead+discovery+using+X-ray+crystallography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Lead Discovery Using X-ray Crystallography</span></div><div class="casAuthors">Hartshorn, Michael J.; Murray, Christopher W.; Cleasby, Anne; Frederickson, Martyn; Tickle, Ian J.; Jhoti, Harren</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">403-413</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment screening offers an alternative to traditional screening for discovering new leads in drug discovery programs.  This paper describes a fragment screening methodol. based on high throughput x-ray crystallog.  The method is illustrated against five proteins (p38 MAP kinase, CDK2, thrombin, RNase A, and PTP1B).  The fragments identified have weak potency (>100 μM) but are efficient binders relative to their size and may therefore represent suitable starting points for evolution to good quality lead compds.  The examples illustrate that a range of mol. interactions (i.e., lipophilic, charge-charge, neutral hydrogen bonds) can drive fragment binding and also that fragments can induce protein movement.  The authors believe that the method has great potential for the discovery of novel lead compds. against a range of targets, and the companion paper illustrates how lead compds. have been identified for p38 MAP kinase starting from fragments such as those described in this paper.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeepqN9_V8prVg90H21EOLACvtfcHk0ljT7N7PwCmisQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFCiu7nK&md5=41f6e394812669bde519ab7366fea9d6</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm0495778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0495778%26sid%3Dliteratum%253Aachs%26aulast%3DHartshorn%26aufirst%3DM.%2BJ.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DTickle%26aufirst%3DI.%2BJ.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DFragment-based%2520lead%2520discovery%2520using%2520X-ray%2520crystallography%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D403%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Saxty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodhead, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdonk, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyatt, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barford, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R. A.</span><span> </span><span class="NLM_article-title">Identification of inhibitors of protein kinase B using fragment-based lead discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2293</span><span class="NLM_x">–</span> <span class="NLM_lpage">2296</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070091b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksVKjur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2293-2296&author=G.+Saxtyauthor=S.+J.+Woodheadauthor=V.+Berdiniauthor=T.+G.+Daviesauthor=M.+L.+Verdonkauthor=P.+G.+Wyattauthor=R.+G.+Boyleauthor=D.+Barfordauthor=R.+Downhamauthor=M.+D.+Garrettauthor=R.+A.+Carr&title=Identification+of+inhibitors+of+protein+kinase+B+using+fragment-based+lead+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Inhibitors of Protein Kinase B Using Fragment-Based Lead Discovery</span></div><div class="casAuthors">Saxty, Gordon; Woodhead, Steven J.; Berdini, Valerio; Davies, Thomas G.; Verdonk, Marcel L.; Wyatt, Paul G.; Boyle, Robert G.; Barford, David; Downham, Robert; Garrett, Michelle D.; Carr, Robin A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2293-2296</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using fragment-based screening techniques, 5-methyl-4-phenyl-1H-pyrazole (IC50 80 μM) was identified as a novel, low mol. wt. inhibitor of protein kinase B (PKB).  Herein we describe the rapid elaboration of highly potent and ligand efficient analogs using a fragment growing approach.  Iterative structure-based design was supported by protein-ligand structure detns. using a PKA-PKB "chimera" and a final protein-ligand structure of a lead compd. in PKBβ itself.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlCYaIT8Xn87Vg90H21EOLACvtfcHk0ljT7N7PwCmisQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksVKjur8%253D&md5=2a09e4bbaca1493be8e215927e7e72e1</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm070091b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070091b%26sid%3Dliteratum%253Aachs%26aulast%3DSaxty%26aufirst%3DG.%26aulast%3DWoodhead%26aufirst%3DS.%2BJ.%26aulast%3DBerdini%26aufirst%3DV.%26aulast%3DDavies%26aufirst%3DT.%2BG.%26aulast%3DVerdonk%26aufirst%3DM.%2BL.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DBoyle%26aufirst%3DR.%2BG.%26aulast%3DBarford%26aufirst%3DD.%26aulast%3DDownham%26aufirst%3DR.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DCarr%26aufirst%3DR.%2BA.%26atitle%3DIdentification%2520of%2520inhibitors%2520of%2520protein%2520kinase%2520B%2520using%2520fragment-based%2520lead%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2293%26epage%3D2296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ledeboer, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuccola, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shlyakter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogan, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennani, Y. L.</span><span> </span><span class="NLM_article-title">A novel chemotype of kinase inhibitors: discovery of 3,4-ring fused 7-azaindoles and deazapurines as potent JAK2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=153-156&author=T.+Wangauthor=M.+W.+Ledeboerauthor=J.+P.+Duffyauthor=A.+C.+Pierceauthor=H.+J.+Zuccolaauthor=E.+Blockauthor=D.+Shlyakterauthor=J.+K.+Hoganauthor=Y.+L.+Bennani&title=A+novel+chemotype+of+kinase+inhibitors%3A+discovery+of+3%2C4-ring+fused+7-azaindoles+and+deazapurines+as+potent+JAK2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DLedeboer%26aufirst%3DM.%2BW.%26aulast%3DDuffy%26aufirst%3DJ.%2BP.%26aulast%3DPierce%26aufirst%3DA.%2BC.%26aulast%3DZuccola%26aufirst%3DH.%2BJ.%26aulast%3DBlock%26aufirst%3DE.%26aulast%3DShlyakter%26aufirst%3DD.%26aulast%3DHogan%26aufirst%3DJ.%2BK.%26aulast%3DBennani%26aufirst%3DY.%2BL.%26atitle%3DA%2520novel%2520chemotype%2520of%2520kinase%2520inhibitors%253A%2520discovery%2520of%25203%252C4-ring%2520fused%25207-azaindoles%2520and%2520deazapurines%2520as%2520potent%2520JAK2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D153%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Bernstein, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koetzle, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brice, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennard, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimanouchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasumi, M.</span><span> </span><span class="NLM_article-title">The Protein Data Bank</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1111%2Fj.1432-1033.1977.tb11885.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=923582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADyaE1cXhslKkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1977&pages=319-324&author=F.+C.+Bernsteinauthor=T.+F.+Koetzleauthor=G.+J.+B.+Williamsauthor=E.+F.+Meyerauthor=M.+D.+Briceauthor=J.+R.+Rodgersauthor=O.+Kennardauthor=T.+Shimanouchiauthor=M.+Tasumi&title=The+Protein+Data+Bank"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Data Bank.  A computer-based archival file for macromolecular structures</span></div><div class="casAuthors">Bernstein, Frances C.; Koetzle, Thomas F.; Williams, Graheme J. B.; Meyer, Edgar F., Jr.; Brice, Michael D.; Rodgers, John R.; Kennard, Olga; Shimanouchi, Takehiko; Tasumi, Mitsuo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">319-24</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">The Protein Data Bank is a computer-based archival file for macromol. structures.  The Bank stores in a uniform format at. coordinates and partial bond connectivities, as derived from crystallog. studies.  Text included in each data entry gives pertinent information for the structure at hand (e.g., species from which the mol. was obtained, resoln. of diffraction data, literature citations, and specifications of secondary structure).  In addn. to at. coordinates and connectivities, the Protein Data Bank stores structure factors and phases, although these latter data are not placed in any uniform format.  Input of data to the Bank and general maintenance functions are carried out at Brookhaven National Lab.  All data stored in the Bank are available on magnetic tape for public distribution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGromu-1LkSAkLVg90H21EOLACvtfcHk0lgb1vh4bAVmlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXhslKkug%253D%253D&md5=2eceab71b303b040300e47107130321b</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1977.tb11885.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1977.tb11885.x%26sid%3Dliteratum%253Aachs%26aulast%3DBernstein%26aufirst%3DF.%2BC.%26aulast%3DKoetzle%26aufirst%3DT.%2BF.%26aulast%3DWilliams%26aufirst%3DG.%2BJ.%2BB.%26aulast%3DMeyer%26aufirst%3DE.%2BF.%26aulast%3DBrice%26aufirst%3DM.%2BD.%26aulast%3DRodgers%26aufirst%3DJ.%2BR.%26aulast%3DKennard%26aufirst%3DO.%26aulast%3DShimanouchi%26aufirst%3DT.%26aulast%3DTasumi%26aufirst%3DM.%26atitle%3DThe%2520Protein%2520Data%2520Bank%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1977%26volume%3D80%26spage%3D319%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Kellenberger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schalon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bret, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span> </span><span class="NLM_article-title">sc-PDB: an annotated database of druggable binding sites from the Protein Data Bank</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">727</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci050372x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFCgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2006&pages=717-727&author=E.+Kellenbergerauthor=P.+Mullerauthor=C.+Schalonauthor=G.+Bretauthor=N.+Foataauthor=D.+Rognan&title=sc-PDB%3A+an+annotated+database+of+druggable+binding+sites+from+the+Protein+Data+Bank"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">sc-PDB: An Annotated Database of Druggable Binding Sites from the Protein Data Bank</span></div><div class="casAuthors">Kellenberger, Esther; Muller, Pascal; Schalon, Claire; Bret, Guillaume; Foata, Nicolas; Rognan, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">717-727</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The s.c.-PDB is a collection of 6,415 three-dimensional structures of binding sites found in the Protein Data Bank (PDB).  Binding sites were extd. from all high-resoln. crystal structures in which a complex between a protein cavity and a small-mol.-wt. ligand could be identified.  Importantly, ligands are considered from a pharmacol. and not a structural point of view.  Therefore, solvents, detergents, and most metal ions are not stored in the s.c.-PDB.  Ligands are classified into four main categories: nucleotides (< 4-mer), peptides (< 9-mer), cofactors, and org. compds.  The corresponding binding site is formed by all protein residues (including amino acids, cofactors, and important metal ions) with at least one atom within 6.5 Å of any ligand atom.  The database was carefully annotated by browsing several protein databases (PDB, UniProt, and GO) and storing, for every s.c.-PDB entry, the following features: protein name, function, source, domain and mutations, ligand name, and structure.  The repository of ligands has also been archived by diversity anal. of mol. scaffolds, and several chemoinformatics descriptors were computed to better understand the chem. space covered by stored ligands.  The s.c.-PDB may be used for several purposes: (i) screening a collection of binding sites for predicting the most likely target(s) of any ligand, (ii) analyzing the mol. similarity between different cavities, and (iii) deriving rules that describe the relationship between ligand pharmacophoric points and active-site properties.  The database is periodically updated and accessible on the web at http://bioinfo-pharma.u-strasbg.fr/scPDB/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNlZ_WkpBUQrVg90H21EOLACvtfcHk0lgb1vh4bAVmlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFCgtQ%253D%253D&md5=d035f998192ff55026c619b38f4b82ab</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fci050372x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci050372x%26sid%3Dliteratum%253Aachs%26aulast%3DKellenberger%26aufirst%3DE.%26aulast%3DMuller%26aufirst%3DP.%26aulast%3DSchalon%26aufirst%3DC.%26aulast%3DBret%26aufirst%3DG.%26aulast%3DFoata%26aufirst%3DN.%26aulast%3DRognan%26aufirst%3DD.%26atitle%3Dsc-PDB%253A%2520an%2520annotated%2520database%2520of%2520druggable%2520binding%2520sites%2520from%2520the%2520Protein%2520Data%2520Bank%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2006%26volume%3D46%26spage%3D717%26epage%3D727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Harris, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A. P.</span><span> </span><span class="NLM_article-title">Chemogenomics: structuring the drug discovery process to gene families</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">880</span><span class="NLM_x">–</span> <span class="NLM_lpage">888</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=880-888&author=C.+J.+Harrisauthor=A.+P.+Stevens&title=Chemogenomics%3A+structuring+the+drug+discovery+process+to+gene+families"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DC.%2BJ.%26aulast%3DStevens%26aufirst%3DA.%2BP.%26atitle%3DChemogenomics%253A%2520structuring%2520the%2520drug%2520discovery%2520process%2520to%2520gene%2520families%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2006%26volume%3D11%26spage%3D880%26epage%3D888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Weill, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span> </span><span class="NLM_article-title">Alignment-free ultra-high-throughput comparison of druggable protein-ligand binding sites</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">135</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci900349y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjt1yjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=123-135&author=N.+Weillauthor=D.+Rognan&title=Alignment-free+ultra-high-throughput+comparison+of+druggable+protein-ligand+binding+sites"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Alignment-Free Ultra-High-Throughput Comparison of Druggable Protein-Ligand Binding Sites</span></div><div class="casAuthors">Weill, Nathanael; Rognan, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">123-135</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inferring the biol. function of a protein from its three-dimensional structure as well as explaining why a drug may bind to various targets is of crucial importance to modern drug discovery.  Here we present a generic 4833-integer vector describing druggable protein-ligand binding sites that can be applied to any protein and any binding cavity.  The fingerprint registers counts of pharmacophoric triplets from the Cα at. coordinates of binding-site-lining residues.  Starting from a customized data set of diverse protein-ligand binding site pairs, the most appropriate metric and a similarity threshold could be defined for similar binding sites.  The method (FuzCav) has been used in various scenarios: (i) screening a collection of 6000 binding sites for similarity to different queries; (ii) classifying protein families (serine endopeptidases, protein kinases) by binding site diversity; (iii) discriminating adenine-binding cavities from decoys.  The fingerprint generation and comparison supports ultra-high throughput (ca. 1000 measures/s), does not require prior alignment of protein binding sites, and is able to detect local similarity among subpockets.  It is thus particularly well suited to the functional annotation of novel genomic structures with low sequence identity to known X-ray templates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7OYklk3JFxLVg90H21EOLACvtfcHk0lhx3WBgUwwkGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjt1yjsg%253D%253D&md5=541a9800a3aa0891f179316412f1df24</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fci900349y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci900349y%26sid%3Dliteratum%253Aachs%26aulast%3DWeill%26aufirst%3DN.%26aulast%3DRognan%26aufirst%3DD.%26atitle%3DAlignment-free%2520ultra-high-throughput%2520comparison%2520of%2520druggable%2520protein-ligand%2520binding%2520sites%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D123%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Niijima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiraishi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuno, Y.</span><span> </span><span class="NLM_article-title">Dissecting kinase profiling data to predict activity and understand cross-reactivity of kinase inhibitors</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">901</span><span class="NLM_x">–</span> <span class="NLM_lpage">912</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci200607f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Clsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=901-912&author=S.+Niijimaauthor=A.+Shiraishiauthor=Y.+Okuno&title=Dissecting+kinase+profiling+data+to+predict+activity+and+understand+cross-reactivity+of+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Dissecting Kinase Profiling Data to Predict Activity and Understand Cross-Reactivity of Kinase Inhibitors</span></div><div class="casAuthors">Niijima, Satoshi; Shiraishi, Akira; Okuno, Yasushi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">901-912</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of selective and multitargeted kinase inhibitors has received much attention, because cross-reactivity with unintended targets may cause toxic side effects, while it can also give rise to efficacious multitargeted drugs.  Here we describe a deconvolution approach to dissecting kinase profiling data in order to gain knowledge about cross-reactivity of inhibitors from large-scale profiling data.  This approach not only enables activity predictions of given compds. on a kinome-wide scale, but also allows to ext. residue-fragment pairs that are assocd. with activity.  We demonstrate its effectiveness using a large-scale public chemogenomics data set and also apply our proposed model to a recently published bioactivity data set.  We further illustrate that the preference of given compds. for kinases of interest is better understood by residue-fragment pairs, which could provide both biol. and chem. insights into cross-reactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNgeRgAJen8LVg90H21EOLACvtfcHk0lhx3WBgUwwkGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Clsbo%253D&md5=5b3d8d0938f8109e21d17a3fb3c9da30</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fci200607f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci200607f%26sid%3Dliteratum%253Aachs%26aulast%3DNiijima%26aufirst%3DS.%26aulast%3DShiraishi%26aufirst%3DA.%26aulast%3DOkuno%26aufirst%3DY.%26atitle%3DDissecting%2520kinase%2520profiling%2520data%2520to%2520predict%2520activity%2520and%2520understand%2520cross-reactivity%2520of%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D901%26epage%3D912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Insights for the development of specific kinase inhibitors by targeted structural genomics</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=365-72&author=O.+Fedorovauthor=M.+Sundstromauthor=B.+Marsdenauthor=S.+Knapp&title=Insights+for+the+development+of+specific+kinase+inhibitors+by+targeted+structural+genomics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DSundstrom%26aufirst%3DM.%26aulast%3DMarsden%26aufirst%3DB.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DInsights%2520for%2520the%2520development%2520of%2520specific%2520kinase%2520inhibitors%2520by%2520targeted%2520structural%2520genomics%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D365%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Patel, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doerksen, R. J.</span><span> </span><span class="NLM_article-title">Protein kinase-inhibitor database: structural variability of and inhibitor interactions with the protein kinase P-loop</span> <span class="citation_source-journal">J. Proteome Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">4433</span><span class="NLM_x">–</span> <span class="NLM_lpage">4442</span></span><div class="citationLinks">[<a href="/doi/10.1021/pr100662s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXps1WhsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=4433-4442&author=R.+Y.+Patelauthor=R.+J.+Doerksen&title=Protein+kinase-inhibitor+database%3A+structural+variability+of+and+inhibitor+interactions+with+the+protein+kinase+P-loop"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Protein Kinase-Inhibitor Database: Structural Variability of and Inhibitor Interactions with the Protein Kinase P-Loop</span></div><div class="casAuthors">Patel, Ronak Y.; Doerksen, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteome Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4433-4442</span>CODEN:
                <span class="NLM_cas:coden">JPROBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-3893</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-based drug design of protein-kinase inhibitors has been facilitated by availability of an enormous no. of structures in the Protein Databank (PDB), systematic analyses of which can provide insight into the factors that govern ligand-protein kinase interactions and into the conformational variability of the protein kinases.  A nonredundant database contg. 755 unique, curated, and annotated PDB protein kinase-inhibitor complexes (each consisting of a single protein kinase chain, a ligand, and water mols. around the ligand) was created.  With this dataset, analyses were performed of protein conformational variability and interactions of ligands with 11 P-loop residues.  Anal. of ligand-protein interactions included ligand atom preference, ligand-protein hydrogen bonds, and the no. and position of crystallog. water mols. around important P-loop residues.  Anal. of variability in the conformation of the P-loop considered backbone and side-chain dihedral angles, and solvent accessible surface area (SASA).  A distorted conformation of the P-loop was obsd. for some of the protein kinase structures.  Lower SASA was obsd. for the hydrophobic residue in β1 of several members of the AGC family of protein kinases.  The authors' systematic studies were performed amino acid-by-amino acid, which is unusual for analyses of protein kinase-inhibitor complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6z-PG0UgDDbVg90H21EOLACvtfcHk0ljkQp_28ON2lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXps1WhsL8%253D&md5=28fc939adbc1d1791a09e63a4c582053</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fpr100662s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fpr100662s%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DR.%2BY.%26aulast%3DDoerksen%26aufirst%3DR.%2BJ.%26atitle%3DProtein%2520kinase-inhibitor%2520database%253A%2520structural%2520variability%2520of%2520and%2520inhibitor%2520interactions%2520with%2520the%2520protein%2520kinase%2520P-loop%26jtitle%3DJ.%2520Proteome%2520Res.%26date%3D2010%26volume%3D9%26spage%3D4433%26epage%3D4442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Zuccotto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casale, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angiolini, M.</span><span> </span><span class="NLM_article-title">Through the “gatekeeper door”: exploiting the active kinase conformation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2681</span><span class="NLM_x">–</span> <span class="NLM_lpage">2694</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=2681-2694&author=F.+Zuccottoauthor=E.+Ardiniauthor=E.+Casaleauthor=M.+Angiolini&title=Through+the+%E2%80%9Cgatekeeper+door%E2%80%9D%3A+exploiting+the+active+kinase+conformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZuccotto%26aufirst%3DF.%26aulast%3DArdini%26aufirst%3DE.%26aulast%3DCasale%26aufirst%3DE.%26aulast%3DAngiolini%26aufirst%3DM.%26atitle%3DThrough%2520the%2520%25E2%2580%259Cgatekeeper%2520door%25E2%2580%259D%253A%2520exploiting%2520the%2520active%2520kinase%2520conformation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D53%26spage%3D2681%26epage%3D2694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Deng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuaqui, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, J.</span><span> </span><span class="NLM_article-title">Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030331x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps1yrsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=337-344&author=Z.+Dengauthor=C.+Chuaquiauthor=J.+Singh&title=Structural+interaction+fingerprint+%28SIFt%29%3A+a+novel+method+for+analyzing+three-dimensional+protein-ligand+binding+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Interaction Fingerprint (SIFt): A Novel Method for Analyzing Three-Dimensional Protein-Ligand Binding Interactions</span></div><div class="casAuthors">Deng, Zhan; Chuaqui, Claudio; Singh, Juswinder</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">337-344</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Representing and understanding the three-dimensional (3D) structural information of protein-ligand complexes is a crit. step in the rational drug discovery process.  Traditional anal. methods are proving inadequate and inefficient in dealing with the massive amt. of structural information being generated from x-ray crystallog., NMR, and in silico approaches such as structure-based docking expts.  Here, we present SIFt (structural interaction fingerprint), a novel method for representing and analyzing 3D protein-ligand binding interactions.  Key to this approach is the generation of an interaction fingerprint that translates 3D structural binding information from a protein-ligand complex into a one-dimensional binary string.  Each fingerprint represents the "structural interaction profile" of the complex that can be used to organize, analyze, and visualize the rich amt. of information encoded in ligand-receptor complexes and also to assist database mining.  We have applied SIFt to tackle three common tasks in structure-based drug design.  The first involved the anal. and organization of a typical set of results generated from a docking study.  Using SIFt, docking poses with similar binding modes were identified, clustered, and subsequently compared with conventional scoring function information.  A second application of SIFt was to analyze ∼90 known x-ray crystal structures of protein kinase-inhibitor complexes obtained from the Protein Databank.  Using SIFt, we were able to organize the structures and reveal striking similarities and diversity between their small mol. binding interactions.  Finally, we have shown how SIFt can be used as an effective mol. filter during the virtual chem. library screening process to select mols. with desirable binding mode(s) and/or desirable interaction patterns with the protein target.  In summary, SIFt shows promise to fully leverage the wealth of information being generated in rational drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkjji1ni0HHbVg90H21EOLACvtfcHk0ljkQp_28ON2lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps1yrsrs%253D&md5=a652b70184155c107202cbe3bc74596a</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm030331x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030331x%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DZ.%26aulast%3DChuaqui%26aufirst%3DC.%26aulast%3DSingh%26aufirst%3DJ.%26atitle%3DStructural%2520interaction%2520fingerprint%2520%2528SIFt%2529%253A%2520a%2520novel%2520method%2520for%2520analyzing%2520three-dimensional%2520protein-ligand%2520binding%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D337%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Kinnings, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, R. M.</span><span> </span><span class="NLM_article-title">Binding site similarity analysis for the functional classification of the protein kinase family</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">318</span><span class="NLM_x">–</span> <span class="NLM_lpage">329</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci800289y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltF2qsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=318-329&author=S.+L.+Kinningsauthor=R.+M.+Jackson&title=Binding+site+similarity+analysis+for+the+functional+classification+of+the+protein+kinase+family"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Binding Site Similarity Analysis for the Functional Classification of the Protein Kinase Family</span></div><div class="casAuthors">Kinnings, Sarah L.; Jackson, Richard M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">318-329</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Methods for analyzing complete gene families are becoming of increasing importance to the drug discovery process, because similarities and differences within a family are often the key to understanding functional differences that can be exploited in drug design.  We undertake a large-scale structural comparison of protein kinase ATP-binding sites using a geometric hashing method.  Subsequently, we propose a relevant classification of the protein kinase family based on the structural similarity of its binding sites.  Our classification is not only able to reveal the great diversity of different protein kinases and therefore their different potential for inhibitor selectivity, but it is also able to distinguish subtle differences within binding site conformation reflecting the protein activation state.  Furthermore, using exptl. inhibition profiling, we demonstrate that our classification can be used to identify protein kinase binding sites that are known exptl. to bind the same drug, demonstrating that it has potential as an inverse (protein) virtual screening tool, by identifying which other sites have the potential to bind a given drug.  In this way the cross-reactivities of the anticancer drugs Tarceva and Gleevec are rationalized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6kpf80r8s5LVg90H21EOLACvtfcHk0ljxBK8ofMEOpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltF2qsg%253D%253D&md5=742343601ca1e3c0549fa4f383c2566b</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fci800289y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci800289y%26sid%3Dliteratum%253Aachs%26aulast%3DKinnings%26aufirst%3DS.%2BL.%26aulast%3DJackson%26aufirst%3DR.%2BM.%26atitle%3DBinding%2520site%2520similarity%2520analysis%2520for%2520the%2520functional%2520classification%2520of%2520the%2520protein%2520kinase%2520family%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2009%26volume%3D49%26spage%3D318%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Vidović, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muskal, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schurer, S. C.</span><span> </span><span class="NLM_article-title">Novel kinase inhibitors by reshuffling ligand functionalities across the human kinome</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3107</span><span class="NLM_x">–</span> <span class="NLM_lpage">3115</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci3003842" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Wjt7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=3107-3115&author=D.+Vidovi%C4%87author=S.+M.+Muskalauthor=S.+C.+Schurer&title=Novel+kinase+inhibitors+by+reshuffling+ligand+functionalities+across+the+human+kinome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Kinase Inhibitors by Reshuffling Ligand Functionalities Across the Human Kinome</span></div><div class="casAuthors">Vidovic, Dusica; Muskal, Steven M.; Schurer, Stephan C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3107-3115</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein kinases remain among the most versatile and prospective therapeutic drug targets with currently 15 distinct compds. approved for use in humans and numerous clin. development programs.  The vast majority of kinase inhibitors bind at the ATP site.  Here we present an integrated work-flow to amplify the rapidly increasing space of structurally resolved small mol. kinase ligands to generate novel inhibitors.  Our approach considers both receptor-based similarity constraints in co-complexes and ligand-based filtering/refinement methods to generate novel, drug-like matter.  After building a comprehensive database of the structural kinome and identifying ATP-competitive ligands, we leverage local site similarities and site alignments to shuffle ligand fragments across the kinome.  After extensive curation and standardization, our automated protocol starting from 936 cocrystal ATP-competitive binding sites generated about 150 000 new ligand structures among them over 26 000 lead-/drug-like compds.; the majority of those are novel based on structural similarity and scaffolds.  In a retrospective anal. we demonstrate that our protocol produced known potent kinase inhibitors and we show how docking can be applied to prioritize the most likely efficacious compds.  Our workflow emulates a common strategy in medicinal chem. to identify and swap corresponding moieties from known inhibitors to generate novel and potent leads.  Here, we systematize and automate this approach leveraging available knowledge covering the entire human Kinome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2rUakSgslBLVg90H21EOLACvtfcHk0ljxBK8ofMEOpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Wjt7nP&md5=b3339f93e20d0aa07d57519454fd3baf</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fci3003842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci3003842%26sid%3Dliteratum%253Aachs%26aulast%3DVidovi%25C4%2587%26aufirst%3DD.%26aulast%3DMuskal%26aufirst%3DS.%2BM.%26aulast%3DSchurer%26aufirst%3DS.%2BC.%26atitle%3DNovel%2520kinase%2520inhibitors%2520by%2520reshuffling%2520ligand%2520functionalities%2520across%2520the%2520human%2520kinome%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D3107%26epage%3D3115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Buzko, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">A kinase sequence database: sequence alignments and family assignment</span> <span class="citation_source-journal">Bioinformatics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1274</span><span class="NLM_x">–</span> <span class="NLM_lpage">1275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2002&pages=1274-1275&author=O.+Buzkoauthor=K.+M.+Shokat&title=A+kinase+sequence+database%3A+sequence+alignments+and+family+assignment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuzko%26aufirst%3DO.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DA%2520kinase%2520sequence%2520database%253A%2520sequence%2520alignments%2520and%2520family%2520assignment%26jtitle%3DBioinformatics%26date%3D2002%26volume%3D18%26spage%3D1274%26epage%3D1275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Niedner, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzko, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haste, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribskov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span> </span><span class="NLM_article-title">Protein kinase resource: an integrated environment for phosphorylation research</span> <span class="citation_source-journal">Proteins: Struct., Funct., Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2006&pages=78-86&author=R.+H.+Niednerauthor=O.+V.+Buzkoauthor=N.+M.+Hasteauthor=A.+Taylorauthor=M.+Gribskovauthor=S.+S.+Taylor&title=Protein+kinase+resource%3A+an+integrated+environment+for+phosphorylation+research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNiedner%26aufirst%3DR.%2BH.%26aulast%3DBuzko%26aufirst%3DO.%2BV.%26aulast%3DHaste%26aufirst%3DN.%2BM.%26aulast%3DTaylor%26aufirst%3DA.%26aulast%3DGribskov%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26atitle%3DProtein%2520kinase%2520resource%253A%2520an%2520integrated%2520environment%2520for%2520phosphorylation%2520research%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Bioinf.%26date%3D2006%26volume%3D63%26spage%3D78%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span>Kinase.com: Genomics, Evolution and Function of Protein Kinases. <a href="http://www.kinase.com" class="extLink">http://www.kinase.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kinase.com%3A+Genomics%2C+Evolution+and+Function+of+Protein+Kinases.+http%3A%2F%2Fwww.kinase.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span>Kinase SARfari. <a href="http://www.ebi.ac.uk/chembl/sarfari/kinasesarfari" class="extLink">http://www.ebi.ac.uk/chembl/sarfari/kinasesarfari</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kinase+SARfari.+http%3A%2F%2Fwww.ebi.ac.uk%2Fchembl%2Fsarfari%2Fkinasesarfari."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Y.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobilio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span> </span><span class="NLM_article-title">An enriched structural kinase database to enable kinome-wide structure-based analyses and drug discovery</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">763</span><span class="NLM_x">–</span> <span class="NLM_lpage">774</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1002%2Fpro.355" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=20135687" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktFyrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=763-774&author=N.+Brooijmansauthor=Y.-W.+Changauthor=D.+Mobilioauthor=R.+A.+Dennyauthor=C.+Humblet&title=An+enriched+structural+kinase+database+to+enable+kinome-wide+structure-based+analyses+and+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">An enriched structural kinase database to enable kinome-wide structure-based analyses and drug discovery</span></div><div class="casAuthors">Brooijmans, Natasja; Chang, Yu-Wei; Mobilio, Dominick; Denny, Rajiah A.; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">763-774</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The development of a kinase structural database, the kinase knowledge base (KKB), is described.  It covers all human kinase domain structures that have been deposited in the Protein Data Bank.  All structures are renumbered using a common scheme, which enables efficient cross-comparisons and multiple queries of interest to the kinase field.  The common numbering scheme is also used to automatically annotate conserved residues and motifs, and conformationally classify the structures based on the DFG-loop and Helix C. Analyses of residue conservation in the ATP binding site using the full human-kinome-sequence alignment lead to the identification of a conserved hydrogen bond between the hinge region backbone and a glycine in the specificity surface.  Furthermore, 90% of kinases are found to have at least one stabilizing interaction for the hinge region, which has not been described before.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxGHmLofxIH7Vg90H21EOLACvtfcHk0lhHx1IEkdFKSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktFyrtb8%253D&md5=d6b66fb4114b942060e6dba7d1da9c96</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fpro.355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.355%26sid%3Dliteratum%253Aachs%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DChang%26aufirst%3DY.-W.%26aulast%3DMobilio%26aufirst%3DD.%26aulast%3DDenny%26aufirst%3DR.%2BA.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DAn%2520enriched%2520structural%2520kinase%2520database%2520to%2520enable%2520kinome-wide%2520structure-based%2520analyses%2520and%2520drug%2520discovery%26jtitle%3DProtein%2520Sci.%26date%3D2010%26volume%3D19%26spage%3D763%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Koike, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagi, T.</span><span> </span><span class="NLM_article-title">Kinase pathway database: an integrated protein-kinase and NLP-based protein-interaction resource</span> <span class="citation_source-journal">Genome Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1231</span><span class="NLM_x">–</span> <span class="NLM_lpage">1243</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1101%2Fgr.835903" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=12799355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksFegs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1231-1243&author=A.+Koikeauthor=Y.+Kobayashiauthor=T.+Takagi&title=Kinase+pathway+database%3A+an+integrated+protein-kinase+and+NLP-based+protein-interaction+resource"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase pathway database: An integrated protein-kinase and NLP-based protein-interaction resource</span></div><div class="casAuthors">Koike, Asako; Kobayashi, Yoshiyuki; Takagi, Toshihisa</div><div class="citationInfo"><span class="NLM_cas:title">Genome Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6a</span>),
    <span class="NLM_cas:pages">1231-1243</span>CODEN:
                <span class="NLM_cas:coden">GEREFS</span>;
        ISSN:<span class="NLM_cas:issn">1088-9051</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Protein kinases play a crucial role in the regulation of cellular functions.  Various kinds of information about these mols. are important for understanding signaling pathways and organism characteristics.  We have developed the Kinase Pathway Database, an integrated database involving major completely sequenced eukaryotes.  It contains the classification of protein kinases and their functional conservation, ortholog tables among species, protein-protein, protein-gene, and protein-compd. interaction data, domain information, and structural information.  It also provides an automatic pathway graphic image interface.  The protein, gene, and compd. interactions are automatically extd. from abstrs. for all genes and proteins by natural-language processing (NLP).  The method of automatic extn. uses phrase patterns and the GENA protein, gene, and compd. name dictionary, which was developed by our group.  With this database, pathways are easily compared among species using data with more than 47,000 protein interactions and protein kinase ortholog tables.  The database is available for querying and browsing at http://kinasedb.ontol.ims.u-tokyo.ac.jp/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6TI4Fd6KGy7Vg90H21EOLACvtfcHk0lhHx1IEkdFKSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksFegs74%253D&md5=823277b26108ce1d36ce808a0aa2b8cc</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1101%2Fgr.835903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgr.835903%26sid%3Dliteratum%253Aachs%26aulast%3DKoike%26aufirst%3DA.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DTakagi%26aufirst%3DT.%26atitle%3DKinase%2520pathway%2520database%253A%2520an%2520integrated%2520protein-kinase%2520and%2520NLP-based%2520protein-interaction%2520resource%26jtitle%3DGenome%2520Res.%26date%3D2003%26volume%3D13%26spage%3D1231%26epage%3D1243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span>Phospho.ELM: A Database of S/T/Y Phosphorylation Sites. <a href="http://phospho.elm.eu.org/" class="extLink">http://phospho.elm.eu.org/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Phospho.ELM%3A+A+Database+of+S%2FT%2FY+Phosphorylation+Sites.+http%3A%2F%2Fphospho.elm.eu.org%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Dinkel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chica, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Via, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diella, F.</span><span> </span><span class="NLM_article-title">Phospho.ELM: a database of phosphorylation sites—update 2011</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">D261</span><span class="NLM_x">–</span> <span class="NLM_lpage">D267</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=D261-D267&author=H.+Dinkelauthor=C.+Chicaauthor=A.+Viaauthor=C.+M.+Gouldauthor=L.+J.+Jensenauthor=T.+J.+Gibsonauthor=F.+Diella&title=Phospho.ELM%3A+a+database+of+phosphorylation+sites%E2%80%94update+2011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDinkel%26aufirst%3DH.%26aulast%3DChica%26aufirst%3DC.%26aulast%3DVia%26aufirst%3DA.%26aulast%3DGould%26aufirst%3DC.%2BM.%26aulast%3DJensen%26aufirst%3DL.%2BJ.%26aulast%3DGibson%26aufirst%3DT.%2BJ.%26aulast%3DDiella%26aufirst%3DF.%26atitle%3DPhospho.ELM%253A%2520a%2520database%2520of%2520phosphorylation%2520sites%25E2%2580%2594update%25202011%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2011%26volume%3D39%26spage%3DD261%26epage%3DD267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Bellis, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akhtar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Lazikani, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bento, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaulton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hersey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruger, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Light, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGlinchey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauch, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overington, J. P.</span><span> </span><span class="NLM_article-title">Collation and data-mining of literature bioactivity data for drug discovery</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1365</span><span class="NLM_x">–</span> <span class="NLM_lpage">1370</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1042%2FBST0391365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=21936816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1ajs73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=1365-1370&author=L.+J.+Bellisauthor=R.+Akhtarauthor=B.+Al-Lazikaniauthor=F.+Atkinsonauthor=A.+P.+Bentoauthor=J.+Chambersauthor=M.+Daviesauthor=A.+Gaultonauthor=A.+Herseyauthor=K.+Ikedaauthor=F.+A.+Krugerauthor=Y.+Lightauthor=S.+McGlincheyauthor=R.+Santosauthor=B.+Stauchauthor=J.+P.+Overington&title=Collation+and+data-mining+of+literature+bioactivity+data+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Collation and data-mining of literature bioactivity data for drug discovery</span></div><div class="casAuthors">Bellis, Louisa J.; Akhtar, Ruth; Al-Lazikani, Bissan; Atkinson, Francis; Bento, A. Patricia; Chambers, Jon; Davies, Mark; Gaulton, Anna; Hersey, Anne; Ikeda, Kazuyoshi; Krueger, Felix A.; Light, Yvonne; McGlinchey, Shaun; Santos, Rita; Stauch, Benjamin; Overington, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1365-1370</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The challenge of translating the huge amt. of genomic and biochem. data into new drugs is a costly and challenging task.  Historically, there has been comparatively little focus on linking the biochem. and chem. worlds.  To address this need, we have developed ChEMBL, an online resource of small-mol. SAR (structure-activity relationship) data, which can be used to support chem. biol., lead discovery and target selection in drug discovery.  The database contains the abstracted structures, properties and biol. activities for over 700000 distinct compds. and in excess of more than 3 million bioactivity records abstracted from over 40000 publications.  Addnl. public domain resources can be readily integrated into the same data model (e.g. PubChem BioAssay data).  The compds. in ChEMBL are largely extd. from the primary medicinal chem. literature, and are therefore usually  drug-like' or  lead-like' small mols. with full exptl. context.  The data cover a significant fraction of the discovery of modern drugs, and are useful in a wide range of drug design and discovery tasks.  In addn. to the compd. data, ChEMBL also contains information for over 8000 protein, cell line and whole-organism  targets', with over 4000 of those being proteins linked to their underlying genes.  The database is searchable both chem., using an interactive compd. sketch tool, protein sequences, family hierarchies, SMILES strings, compd. research codes and key words, and biol., using a variety of gene identifiers, protein sequence similarity and protein families.  The information retrieved can then be readily filtered and downloaded into various formats.  ChEMBL can be accessed online at https://www.ebi.ac.uk/chembldb.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBU0D0lDPl9bVg90H21EOLACvtfcHk0liwE-ZFBLALIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1ajs73L&md5=77c9e09de8274d03045dae5312f4869d</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1042%2FBST0391365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0391365%26sid%3Dliteratum%253Aachs%26aulast%3DBellis%26aufirst%3DL.%2BJ.%26aulast%3DAkhtar%26aufirst%3DR.%26aulast%3DAl-Lazikani%26aufirst%3DB.%26aulast%3DAtkinson%26aufirst%3DF.%26aulast%3DBento%26aufirst%3DA.%2BP.%26aulast%3DChambers%26aufirst%3DJ.%26aulast%3DDavies%26aufirst%3DM.%26aulast%3DGaulton%26aufirst%3DA.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DIkeda%26aufirst%3DK.%26aulast%3DKruger%26aufirst%3DF.%2BA.%26aulast%3DLight%26aufirst%3DY.%26aulast%3DMcGlinchey%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DR.%26aulast%3DStauch%26aufirst%3DB.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26atitle%3DCollation%2520and%2520data-mining%2520of%2520literature%2520bioactivity%2520data%2520for%2520drug%2520discovery%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2011%26volume%3D39%26spage%3D1365%26epage%3D1370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Meslamani, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellenberger, E.</span><span> </span><span class="NLM_article-title">sc-PDB: a database for identifying variations and multiplicity of “druggable” binding sites in proteins</span> <span class="citation_source-journal">Bioinformatics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1324</span><span class="NLM_x">–</span> <span class="NLM_lpage">1326</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2011&pages=1324-1326&author=J.+Meslamaniauthor=D.+Rognanauthor=E.+Kellenberger&title=sc-PDB%3A+a+database+for+identifying+variations+and+multiplicity+of+%E2%80%9Cdruggable%E2%80%9D+binding+sites+in+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeslamani%26aufirst%3DJ.%26aulast%3DRognan%26aufirst%3DD.%26aulast%3DKellenberger%26aufirst%3DE.%26atitle%3Dsc-PDB%253A%2520a%2520database%2520for%2520identifying%2520variations%2520and%2520multiplicity%2520of%2520%25E2%2580%259Cdruggable%25E2%2580%259D%2520binding%2520sites%2520in%2520proteins%26jtitle%3DBioinformatics%26date%3D2011%26volume%3D27%26spage%3D1324%26epage%3D1326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Marcou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span> </span><span class="NLM_article-title">Optimizing fragment and scaffold docking by use of molecular interaction fingerprints</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci600342e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12iurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=195-207&author=G.+Marcouauthor=D.+Rognan&title=Optimizing+fragment+and+scaffold+docking+by+use+of+molecular+interaction+fingerprints"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Optimizing Fragment and Scaffold Docking by Use of Molecular Interaction Fingerprints</span></div><div class="casAuthors">Marcou, Gilles; Rognan, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">195-207</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein-ligand interaction fingerprints have been used to postprocess docking poses of three ligand data sets: a set of 40 low-mol.-wt. compds. from the Protein Data Bank, a collection of 40 scaffolds from pharmaceutically relevant protein ligands, and a database of 19 scaffolds extd. from true cdk2 inhibitors seeded in 2230 scaffold decoys.  Four popular docking tools (FlexX, Glide, Gold, and Surflex) were used to generate poses for ligands of the three data sets.  In all cases, scoring by the similarity of interaction fingerprints to a given ref. was statistically superior to conventional scoring functions in posing low-mol.-wt. fragments, predicting protein-bound scaffold coordinates according to the known binding mode of related ligands, and screening a scaffold library to enrich a hit list in true cdk2-targeted scaffolds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHLbVKxK-BfLVg90H21EOLACvtfcHk0liwE-ZFBLALIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12iurzL&md5=0c9137a39d40fbcc83546aec17b595ba</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fci600342e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci600342e%26sid%3Dliteratum%253Aachs%26aulast%3DMarcou%26aufirst%3DG.%26aulast%3DRognan%26aufirst%3DD.%26atitle%3DOptimizing%2520fragment%2520and%2520scaffold%2520docking%2520by%2520use%2520of%2520molecular%2520interaction%2520fingerprints%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2007%26volume%3D47%26spage%3D195%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">de Graaf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kooistra, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vischer, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuijer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiroishi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Esch, I. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurs, R.</span><span> </span><span class="NLM_article-title">Crystal structure-based virtual screening for fragment-like ligands of the human histamine H1 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8195</span><span class="NLM_x">–</span> <span class="NLM_lpage">8206</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2011589" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8195-8206&author=C.+de+Graafauthor=A.+J.+Kooistraauthor=H.+F.+Vischerauthor=V.+Katritchauthor=M.+Kuijerauthor=M.+Shiroishiauthor=S.+Iwataauthor=T.+Shimamuraauthor=R.+C.+Stevensauthor=I.+J.+P.+de+Eschauthor=R.+Leurs&title=Crystal+structure-based+virtual+screening+for+fragment-like+ligands+of+the+human+histamine+H1+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm2011589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2011589%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BGraaf%26aufirst%3DC.%26aulast%3DKooistra%26aufirst%3DA.%2BJ.%26aulast%3DVischer%26aufirst%3DH.%2BF.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DKuijer%26aufirst%3DM.%26aulast%3DShiroishi%26aufirst%3DM.%26aulast%3DIwata%26aufirst%3DS.%26aulast%3DShimamura%26aufirst%3DT.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DLeurs%26aufirst%3DR.%26atitle%3DCrystal%2520structure-based%2520virtual%2520screening%2520for%2520fragment-like%2520ligands%2520of%2520the%2520human%2520histamine%2520H1%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8195%26epage%3D8206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Ohren, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavlovsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitehead, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuffa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConnell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spessard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banotai, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebolt-Leopold, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudley, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flamme, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warmus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tecle, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasemann, C. A.</span><span> </span><span class="NLM_article-title">Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1192</span><span class="NLM_x">–</span> <span class="NLM_lpage">1197</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1038%2Fnsmb859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=15543157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVens7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=1192-1197&author=J.+F.+Ohrenauthor=H.+Chenauthor=A.+Pavlovskyauthor=C.+Whiteheadauthor=E.+Zhangauthor=P.+Kuffaauthor=C.+Yanauthor=P.+McConnellauthor=C.+Spessardauthor=C.+Banotaiauthor=W.+T.+Muellerauthor=A.+Delaneyauthor=C.+Omerauthor=J.+Sebolt-Leopoldauthor=D.+T.+Dudleyauthor=I.+K.+Leungauthor=C.+Flammeauthor=J.+Warmusauthor=M.+Kaufmanauthor=S.+Barrettauthor=H.+Tecleauthor=C.+A.+Hasemann&title=Structures+of+human+MAP+kinase+kinase+1+%28MEK1%29+and+MEK2+describe+novel+noncompetitive+kinase+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition</span></div><div class="casAuthors">Ohren, Jeffrey F.; Chen, Huifen; Pavlovsky, Alexander; Whitehead, Christopher; Zhang, Erli; Kuffa, Peter; Yan, Chunhong; McConnell, Patrick; Spessard, Cindy; Banotai, Craig; Mueller, W. Thomas; Delaney, Amy; Omer, Charles; Sebolt-Leopold, Judith; Dudley, David T.; Leung, Iris K.; Flamme, Cathlin; Warmus, Joseph; Kaufman, Michael; Barrett, Stephen; Tecle, Haile; Hasemann, Charles A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1192-1197</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">MEK1 and MEK2 kinases are closely related, dual-specificity tyrosine/threonine protein kinases found in the Ras/Raf/MEK/ERK MAP kinase (MAPK) signaling pathway.  Approx. 30% of all human cancers have a constitutively activated MAPK pathway, and constitutive activation of MEK1 results in cellular transformation.  Here, the authors present the x-ray crystal structures of human MEK1 and MEK2 kinases, each detd. as a ternary complex with MgATP and an inhibitor to a resoln. of 2.4 and 3.2 Å, resp.  The structures revealed that MEK1 and MEK2 each had a unique inhibitor-binding pocket adjacent to the MgATP-binding site.  The presence of the potent inhibitors induced several conformational changes in the unphosphorylated MEK1 and MEK2 kinases that locked them into a closed but catalytically inactive species.  Thus, the structures reported here reveal a novel, noncompetitive mechanism for protein kinase inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIY9begVVfW7Vg90H21EOLACvtfcHk0lgFu3qYp4XQVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVens7jM&md5=79ebbc2e3a9cdd3fbecb8bb35ea9dba3</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fnsmb859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb859%26sid%3Dliteratum%253Aachs%26aulast%3DOhren%26aufirst%3DJ.%2BF.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DPavlovsky%26aufirst%3DA.%26aulast%3DWhitehead%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DE.%26aulast%3DKuffa%26aufirst%3DP.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DMcConnell%26aufirst%3DP.%26aulast%3DSpessard%26aufirst%3DC.%26aulast%3DBanotai%26aufirst%3DC.%26aulast%3DMueller%26aufirst%3DW.%2BT.%26aulast%3DDelaney%26aufirst%3DA.%26aulast%3DOmer%26aufirst%3DC.%26aulast%3DSebolt-Leopold%26aufirst%3DJ.%26aulast%3DDudley%26aufirst%3DD.%2BT.%26aulast%3DLeung%26aufirst%3DI.%2BK.%26aulast%3DFlamme%26aufirst%3DC.%26aulast%3DWarmus%26aufirst%3DJ.%26aulast%3DKaufman%26aufirst%3DM.%26aulast%3DBarrett%26aufirst%3DS.%26aulast%3DTecle%26aufirst%3DH.%26aulast%3DHasemann%26aufirst%3DC.%2BA.%26atitle%3DStructures%2520of%2520human%2520MAP%2520kinase%2520kinase%25201%2520%2528MEK1%2529%2520and%2520MEK2%2520describe%2520novel%2520noncompetitive%2520kinase%2520inhibition%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D11%26spage%3D1192%26epage%3D1197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><a href="http://sequoia.ucsf.edu/ksd/" class="extLink">http://sequoia.ucsf.edu/ksd/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fsequoia.ucsf.edu%2Fksd%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><a href="http://kinase.com/human/kinome/" class="extLink">http://kinase.com/human/kinome/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fkinase.com%2Fhuman%2Fkinome%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><a href="http://biodbnet.abcc.ncifcrf.gov/" class="extLink">http://biodbnet.abcc.ncifcrf.gov/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fbiodbnet.abcc.ncifcrf.gov%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran-DubeÌ, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pairish, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botrous, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTigue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grodsky, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padrique, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timofeevski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span> </span><span class="NLM_article-title">Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6342</span><span class="NLM_x">–</span> <span class="NLM_lpage">6363</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2007613" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVegtLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6342-6363&author=J.+J.+Cuiauthor=M.+Tran-Dube%C3%8Cauthor=H.+Shenauthor=M.+Nambuauthor=P.-P.+Kungauthor=M.+Pairishauthor=L.+Jiaauthor=J.+Mengauthor=L.+Funkauthor=I.+Botrousauthor=M.+McTigueauthor=N.+Grodskyauthor=K.+Ryanauthor=E.+Padriqueauthor=G.+Altonauthor=S.+Timofeevskiauthor=S.+Yamazakiauthor=Q.+Liauthor=H.+Zouauthor=J.+Christensenauthor=B.+Mroczkowskiauthor=S.+Benderauthor=R.+S.+Kaniaauthor=M.+P.+Edwards&title=Structure+based+drug+design+of+crizotinib+%28PF-02341066%29%2C+a+potent+and+selective+dual+inhibitor+of+mesenchymal-epithelial+transition+factor+%28c-MET%29+kinase+and+anaplastic+lymphoma+kinase+%28ALK%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal-Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)</span></div><div class="casAuthors">Cui, J. Jean; Tran-Dube, Michelle; Shen, Hong; Nambu, Mitchell; Kung, Pei-Pei; Pairish, Mason; Jia, Lei; Meng, Jerry; Funk, Lee; Botrous, Iriny; McTigue, Michele; Grodsky, Neil; Ryan, Kevin; Padrique, Ellen; Alton, Gordon; Timofeevski, Sergei; Yamazaki, Shinji; Li, Qiuhua; Zou, Helen; Christensen, James; Mroczkowski, Barbara; Bender, Steve; Kania, Robert S.; Edwards, Martin P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6342-6363</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Because of the crit. roles of aberrant signaling in cancer, both c-MET and ALK receptor tyrosine kinases are attractive oncol. targets for therapeutic intervention.  The cocrystal structure of 3 (PHA-665752), bound to c-MET kinase domain, revealed a novel ATP site environment, which served as the target to guide parallel, multiattribute drug design.  A novel 2-amino-5-aryl-3-benzyloxypyridine series was created to more effectively make the key interactions achieved with 3.  In the novel series, the 2-aminopyridine core allowed a 3-benzyloxy group to reach into the same pocket as the 2,6-dichlorophenyl group of 3 via a more direct vector and thus with a better ligand efficiency (LE).  Further optimization of the lead series generated the clin. candidate crizotinib (PF-02341066), which demonstrated potent in vitro and in vivo c-MET kinase and ALK inhibition, effective tumor growth inhibition, and good pharmaceutical properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHs_cKJ-U3t7Vg90H21EOLACvtfcHk0liW7GC6RJFeaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVegtLrN&md5=dbab4c1b3e7c76180dbad04be2b6a474</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjm2007613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2007613%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DTran-Dube%25C3%258C%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DNambu%26aufirst%3DM.%26aulast%3DKung%26aufirst%3DP.-P.%26aulast%3DPairish%26aufirst%3DM.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DMeng%26aufirst%3DJ.%26aulast%3DFunk%26aufirst%3DL.%26aulast%3DBotrous%26aufirst%3DI.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DGrodsky%26aufirst%3DN.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DPadrique%26aufirst%3DE.%26aulast%3DAlton%26aufirst%3DG.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DBender%26aufirst%3DS.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DStructure%2520based%2520drug%2520design%2520of%2520crizotinib%2520%2528PF-02341066%2529%252C%2520a%2520potent%2520and%2520selective%2520dual%2520inhibitor%2520of%2520mesenchymal-epithelial%2520transition%2520factor%2520%2528c-MET%2529%2520kinase%2520and%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6342%26epage%3D6363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newitt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittekind, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borzillerri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klei, H. E.</span><span> </span><span class="NLM_article-title">The structure of dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutants</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">5790</span><span class="NLM_x">–</span> <span class="NLM_lpage">5797</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=5790-5797&author=J.+S.+Tokarskiauthor=J.+A.+Newittauthor=C.+Y.+Changauthor=J.+D.+Chengauthor=M.+Wittekindauthor=S.+E.+Kieferauthor=K.+Kishauthor=F.+Y.+Leeauthor=R.+Borzillerriauthor=L.+J.+Lombardoauthor=D.+Xieauthor=Y.+Zhangauthor=H.+E.+Klei&title=The+structure+of+dasatinib+%28BMS-354825%29+bound+to+activated+ABL+kinase+domain+elucidates+its+inhibitory+activity+against+imatinib-resistant+ABL+mutants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DNewitt%26aufirst%3DJ.%2BA.%26aulast%3DChang%26aufirst%3DC.%2BY.%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26aulast%3DWittekind%26aufirst%3DM.%26aulast%3DKiefer%26aufirst%3DS.%2BE.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DF.%2BY.%26aulast%3DBorzillerri%26aufirst%3DR.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DXie%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKlei%26aufirst%3DH.%2BE.%26atitle%3DThe%2520structure%2520of%2520dasatinib%2520%2528BMS-354825%2529%2520bound%2520to%2520activated%2520ABL%2520kinase%2520domain%2520elucidates%2520its%2520inhibitory%2520activity%2520against%2520imatinib-resistant%2520ABL%2520mutants%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D5790%26epage%3D5797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Weisberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manley, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitenstein, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan-Jacob, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntly, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fendrich, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall-Meyers, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mestan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daley, G. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavazza, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, J. D.</span><span> </span><span class="NLM_article-title">Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2Fj.ccr.2005.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=15710326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitFygu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=129-141&author=E.+Weisbergauthor=P.+W.+Manleyauthor=W.+Breitensteinauthor=J.+Bruggenauthor=S.+W.+Cowan-Jacobauthor=A.+Rayauthor=B.+Huntlyauthor=D.+Fabbroauthor=G.+Fendrichauthor=E.+Hall-Meyersauthor=A.+L.+Kungauthor=J.+Mestanauthor=G.+Q.+Daleyauthor=L.+Callahanauthor=L.+Catleyauthor=C.+Cavazzaauthor=M.+Azamauthor=D.+Neubergauthor=R.+D.+Wrightauthor=D.+G.+Gillilandauthor=J.+D.+Griffin&title=Characterization+of+AMN107%2C+a+selective+inhibitor+of+native+and+mutant+Bcr-Abl"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl</span></div><div class="casAuthors">Weisberg, Ellen; Manley, Paul W.; Breitenstein, Werner; Brueggen, Josef; Cowan-Jacob, Sandra W.; Ray, Arghya; Huntly, Brian; Fabbro, Doriano; Fendrich, Gabriele; Hall-Meyers, Elizabeth; Kung, Andrew L.; Mestan, Juergen; Daley, George Q.; Callahan, Linda; Catley, Laurie; Cavazza, Cara; Mohammed, Azam; Neuberg, Donna; Wright, Renee D.; Gilliland, D. Gary; Griffin, James D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">129-141</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The Bcr-Abl tyrosine kinase oncogene causes chronic myelogenous leukemia (CML) and Philadelphia chromosome-pos. (Ph+) acute lymphoblastic leukemia (ALL).  We describe a novel selective inhibitor of Bcr-Abl, AMN107 (IC50 < 30 nM), which is significantly more potent than imatinib, and active against a no. of imatinib-resistant Bcr-Abl mutants.  Crystallog. anal. of Abl-AMN107 complexes provides a structural explanation for the differential activity of AMN107 and imatinib against imatinib-resistant Bcr-Abl.  Consistent with its in vitro and pharmacokinetic profile, AMN107 prolonged survival of mice injected with Bcr-Abl-transformed hematopoietic cell lines or primary marrow cells, and prolonged survival in imatinib-resistant CML mouse models.  AMN107 is a promising new inhibitor for the therapy of CML and Ph+ ALL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow6QF3qX2uO7Vg90H21EOLACvtfcHk0lhqIEOXaTX2NQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitFygu7o%253D&md5=d28e1a54b982951f8d3e6ef1d2d3b2eb</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2005.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2005.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DWeisberg%26aufirst%3DE.%26aulast%3DManley%26aufirst%3DP.%2BW.%26aulast%3DBreitenstein%26aufirst%3DW.%26aulast%3DBruggen%26aufirst%3DJ.%26aulast%3DCowan-Jacob%26aufirst%3DS.%2BW.%26aulast%3DRay%26aufirst%3DA.%26aulast%3DHuntly%26aufirst%3DB.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DFendrich%26aufirst%3DG.%26aulast%3DHall-Meyers%26aufirst%3DE.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DMestan%26aufirst%3DJ.%26aulast%3DDaley%26aufirst%3DG.%2BQ.%26aulast%3DCallahan%26aufirst%3DL.%26aulast%3DCatley%26aufirst%3DL.%26aulast%3DCavazza%26aufirst%3DC.%26aulast%3DAzam%26aufirst%3DM.%26aulast%3DNeuberg%26aufirst%3DD.%26aulast%3DWright%26aufirst%3DR.%2BD.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26aulast%3DGriffin%26aufirst%3DJ.%2BD.%26atitle%3DCharacterization%2520of%2520AMN107%252C%2520a%2520selective%2520inhibitor%2520of%2520native%2520and%2520mutant%2520Bcr-Abl%26jtitle%3DCancer%2520Cell%26date%3D2005%26volume%3D7%26spage%3D129%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Wyatt, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodhead, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulstridge, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devine, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Early, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feltell, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Reilly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reule, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seavers, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Squires, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trewartha, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolford, A. J.</span><span> </span><span class="NLM_article-title">Identification of <i>N</i>-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1<i>H</i>-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4986</span><span class="NLM_x">–</span> <span class="NLM_lpage">4999</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800382h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4986-4999&author=P.+G.+Wyattauthor=A.+J.+Woodheadauthor=V.+Berdiniauthor=J.+A.+Boulstridgeauthor=M.+G.+Carrauthor=D.+M.+Crossauthor=D.+J.+Davisauthor=L.+A.+Devineauthor=T.+R.+Earlyauthor=R.+E.+Feltellauthor=E.+J.+Lewisauthor=R.+L.+McMenaminauthor=E.+F.+Navarroauthor=M.+A.+O%E2%80%99Brienauthor=M.+O%E2%80%99Reillyauthor=M.+Reuleauthor=G.+Saxtyauthor=L.+C.+Seaversauthor=D.+M.+Smithauthor=M.+S.+Squiresauthor=G.+Trewarthaauthor=M.+T.+Walkerauthor=A.+J.+Woolford&title=Identification+of+N-%284-piperidinyl%29-4-%282%2C6-dichlorobenzoylamino%29-1H-pyrazole-3-carboxamide+%28AT7519%29%2C+a+novel+cyclin+dependent+kinase+inhibitor+using+fragment-based+X-ray+crystallography+and+structure+based+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm800382h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800382h%26sid%3Dliteratum%253Aachs%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DWoodhead%26aufirst%3DA.%2BJ.%26aulast%3DBerdini%26aufirst%3DV.%26aulast%3DBoulstridge%26aufirst%3DJ.%2BA.%26aulast%3DCarr%26aufirst%3DM.%2BG.%26aulast%3DCross%26aufirst%3DD.%2BM.%26aulast%3DDavis%26aufirst%3DD.%2BJ.%26aulast%3DDevine%26aufirst%3DL.%2BA.%26aulast%3DEarly%26aufirst%3DT.%2BR.%26aulast%3DFeltell%26aufirst%3DR.%2BE.%26aulast%3DLewis%26aufirst%3DE.%2BJ.%26aulast%3DMcMenamin%26aufirst%3DR.%2BL.%26aulast%3DNavarro%26aufirst%3DE.%2BF.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DM.%2BA.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%26aulast%3DReule%26aufirst%3DM.%26aulast%3DSaxty%26aufirst%3DG.%26aulast%3DSeavers%26aufirst%3DL.%2BC.%26aulast%3DSmith%26aufirst%3DD.%2BM.%26aulast%3DSquires%26aufirst%3DM.%2BS.%26aulast%3DTrewartha%26aufirst%3DG.%26aulast%3DWalker%26aufirst%3DM.%2BT.%26aulast%3DWoolford%26aufirst%3DA.%2BJ.%26atitle%3DIdentification%2520of%2520N-%25284-piperidinyl%2529-4-%25282%252C6-dichlorobenzoylamino%2529-1H-pyrazole-3-carboxamide%2520%2528AT7519%2529%252C%2520a%2520novel%2520cyclin%2520dependent%2520kinase%2520inhibitor%2520using%2520fragment-based%2520X-ray%2520crystallography%2520and%2520structure%2520based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4986%26epage%3D4999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Arris, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvert, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endicott, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garman, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewsbury, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrie, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, W.</span><span> </span><span class="NLM_article-title">Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2797</span><span class="NLM_x">–</span> <span class="NLM_lpage">2804</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990628o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2797-2804&author=C.+E.+Arrisauthor=F.+T.+Boyleauthor=A.+H.+Calvertauthor=N.+J.+Curtinauthor=J.+A.+Endicottauthor=E.+F.+Garmanauthor=A.+E.+Gibsonauthor=B.+T.+Goldingauthor=S.+Grantauthor=R.+J.+Griffinauthor=P.+Jewsburyauthor=L.+N.+Johnsonauthor=A.+M.+Lawrieauthor=D.+R.+Newellauthor=M.+E.+Nobleauthor=E.+A.+Sausvilleauthor=R.+Schultzauthor=W.+Yu&title=Identification+of+novel+purine+and+pyrimidine+cyclin-dependent+kinase+inhibitors+with+distinct+molecular+interactions+and+tumor+cell+growth+inhibition+profiles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fjm990628o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990628o%26sid%3Dliteratum%253Aachs%26aulast%3DArris%26aufirst%3DC.%2BE.%26aulast%3DBoyle%26aufirst%3DF.%2BT.%26aulast%3DCalvert%26aufirst%3DA.%2BH.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DGarman%26aufirst%3DE.%2BF.%26aulast%3DGibson%26aufirst%3DA.%2BE.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26aulast%3DGrant%26aufirst%3DS.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DJewsbury%26aufirst%3DP.%26aulast%3DJohnson%26aufirst%3DL.%2BN.%26aulast%3DLawrie%26aufirst%3DA.%2BM.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DNoble%26aufirst%3DM.%2BE.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26aulast%3DSchultz%26aufirst%3DR.%26aulast%3DYu%26aufirst%3DW.%26atitle%3DIdentification%2520of%2520novel%2520purine%2520and%2520pyrimidine%2520cyclin-dependent%2520kinase%2520inhibitors%2520with%2520distinct%2520molecular%2520interactions%2520and%2520tumor%2520cell%2520growth%2520inhibition%2520profiles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2797%26epage%3D2804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Jorda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havlicek, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNae, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walkinshaw, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturc, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navratilova, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuzma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mistrik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strnad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krystof, V.</span><span> </span><span class="NLM_article-title">Pyrazolo[4,3-<i>d</i>]pyrimidine bioisostere of roscovitine: evaluation of a novel selective inhibitor of cyclin-dependent kinases with antiproliferative activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2980</span><span class="NLM_x">–</span> <span class="NLM_lpage">2993</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200064p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2980-2993&author=R.+Jordaauthor=L.+Havlicekauthor=I.+W.+McNaeauthor=M.+D.+Walkinshawauthor=J.+Vollerauthor=A.+Sturcauthor=J.+Navratilovaauthor=M.+Kuzmaauthor=M.+Mistrikauthor=J.+Bartekauthor=M.+Strnadauthor=V.+Krystof&title=Pyrazolo%5B4%2C3-d%5Dpyrimidine+bioisostere+of+roscovitine%3A+evaluation+of+a+novel+selective+inhibitor+of+cyclin-dependent+kinases+with+antiproliferative+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjm200064p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200064p%26sid%3Dliteratum%253Aachs%26aulast%3DJorda%26aufirst%3DR.%26aulast%3DHavlicek%26aufirst%3DL.%26aulast%3DMcNae%26aufirst%3DI.%2BW.%26aulast%3DWalkinshaw%26aufirst%3DM.%2BD.%26aulast%3DVoller%26aufirst%3DJ.%26aulast%3DSturc%26aufirst%3DA.%26aulast%3DNavratilova%26aufirst%3DJ.%26aulast%3DKuzma%26aufirst%3DM.%26aulast%3DMistrik%26aufirst%3DM.%26aulast%3DBartek%26aufirst%3DJ.%26aulast%3DStrnad%26aufirst%3DM.%26aulast%3DKrystof%26aufirst%3DV.%26atitle%3DPyrazolo%255B4%252C3-d%255Dpyrimidine%2520bioisostere%2520of%2520roscovitine%253A%2520evaluation%2520of%2520a%2520novel%2520selective%2520inhibitor%2520of%2520cyclin-dependent%2520kinases%2520with%2520antiproliferative%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2980%26epage%3D2993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Medina, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackledge, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duquenne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heerding, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romeril, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherzer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bobko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chadderton, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumble, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardiner, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudakin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campobasso, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axten, J. M.</span><span> </span><span class="NLM_article-title">Structure-based design of potent and selective 3-phosphoinositide-dependent kinase-1 (PDK1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1871</span><span class="NLM_x">–</span> <span class="NLM_lpage">1895</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101527u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVWksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1871-1895&author=J.+R.+Medinaauthor=C.+J.+Beckerauthor=C.+W.+Blackledgeauthor=C.+Duquenneauthor=Y.+Fengauthor=S.+W.+Grantauthor=D.+Heerdingauthor=W.+H.+Liauthor=W.+H.+Millerauthor=S.+P.+Romerilauthor=D.+Scherzerauthor=A.+Shuauthor=M.+A.+Bobkoauthor=A.+R.+Chaddertonauthor=M.+Dumbleauthor=C.+M.+Gardinerauthor=S.+Gilbertauthor=Q.+Liuauthor=S.+K.+Rabindranauthor=V.+Sudakinauthor=H.+Xiangauthor=P.+G.+Bradyauthor=N.+Campobassoauthor=P.+Wardauthor=J.+M.+Axten&title=Structure-based+design+of+potent+and+selective+3-phosphoinositide-dependent+kinase-1+%28PDK1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Potent and Selective 3-Phosphoinositide-Dependent Kinase-1 (PDK1) Inhibitors</span></div><div class="casAuthors">Medina, Jesus R.; Becker, Christopher J.; Blackledge, Charles W.; Duquenne, Celine; Feng, Yanhong; Grant, Seth W.; Heerding, Dirk; Li, William H.; Miller, William H.; Romeril, Stuart P.; Scherzer, Daryl; Shu, Arthur; Bobko, Mark A.; Chadderton, Antony R.; Dumble, Melissa; Gardiner, Christine M.; Gilbert, Seth; Liu, Qi; Rabindran, Sridhar K.; Sudakin, Valery; Xiang, Hong; Brady, Pat G.; Campobasso, Nino; Ward, Paris; Axten, Jeffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1871-1895</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphoinositide-dependent protein kinase-1 (PDK1) is a master regulator of the AGC family of kinases and an integral component of the PI3K/AKT/mTOR pathway.  As this pathway is among the most commonly deregulated across all cancers, a selective inhibitor of PDK1 might have utility as an anticancer agent.  Herein, the lead optimization of compd. I (R1 = R2 = H) toward highly potent and selective PDK1 inhibitors via a structure-based design strategy is described.  A series of (amino)(aminopyrimidinyl)indazoles I (R1 = H, Me, Et; R2 = Me, i-Pr, PhNH, 1-piperidinyl, etc.) was synthesized, and the inhibiting activity of the products towards PDK1 was studied.  The most potent and selective inhibitors, e.g. I [R1 = Me; R2 = (3S,6R)-3-(cyclohexylaminocarbonyl)-6-methyl-1-piperidinyl], demonstrated submicromolar activity as measured by inhibition of phosphorylation of PDK1 substrates as well as antiproliferative activity against a subset of AML cell lines.  In addn., redn. of phosphorylation of PDK1 substrates was demonstrated in vivo in mice bearing OCl-AML2 xenografts.  These observations demonstrate the utility of these mols. as tools to further delineate the biol. of PDK1 and the potential pharmacol. uses of a PDK1 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd83HnbHh5j7Vg90H21EOLACvtfcHk0li5enE2XxvqKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVWksrk%253D&md5=2911a5b7dbfa944a7c523da0be1026ac</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjm101527u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101527u%26sid%3Dliteratum%253Aachs%26aulast%3DMedina%26aufirst%3DJ.%2BR.%26aulast%3DBecker%26aufirst%3DC.%2BJ.%26aulast%3DBlackledge%26aufirst%3DC.%2BW.%26aulast%3DDuquenne%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DGrant%26aufirst%3DS.%2BW.%26aulast%3DHeerding%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DW.%2BH.%26aulast%3DMiller%26aufirst%3DW.%2BH.%26aulast%3DRomeril%26aufirst%3DS.%2BP.%26aulast%3DScherzer%26aufirst%3DD.%26aulast%3DShu%26aufirst%3DA.%26aulast%3DBobko%26aufirst%3DM.%2BA.%26aulast%3DChadderton%26aufirst%3DA.%2BR.%26aulast%3DDumble%26aufirst%3DM.%26aulast%3DGardiner%26aufirst%3DC.%2BM.%26aulast%3DGilbert%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DSudakin%26aufirst%3DV.%26aulast%3DXiang%26aufirst%3DH.%26aulast%3DBrady%26aufirst%3DP.%2BG.%26aulast%3DCampobasso%26aufirst%3DN.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DAxten%26aufirst%3DJ.%2BM.%26atitle%3DStructure-based%2520design%2520of%2520potent%2520and%2520selective%25203-phosphoinositide-dependent%2520kinase-1%2520%2528PDK1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1871%26epage%3D1895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Forns, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteve, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taboada, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orellana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maldonado, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreno, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramis, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miralpeix, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, B.</span><span> </span><span class="NLM_article-title">Pyrazine-based Syk kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2784</span><span class="NLM_x">–</span> <span class="NLM_lpage">2788</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2784-2788&author=P.+Fornsauthor=C.+Esteveauthor=L.+Taboadaauthor=J.+A.+Alonsoauthor=A.+Orellanaauthor=M.+Maldonadoauthor=C.+Carrenoauthor=I.+Ramisauthor=M.+Lopezauthor=M.+Miralpeixauthor=B.+Vidal&title=Pyrazine-based+Syk+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DForns%26aufirst%3DP.%26aulast%3DEsteve%26aufirst%3DC.%26aulast%3DTaboada%26aufirst%3DL.%26aulast%3DAlonso%26aufirst%3DJ.%2BA.%26aulast%3DOrellana%26aufirst%3DA.%26aulast%3DMaldonado%26aufirst%3DM.%26aulast%3DCarreno%26aufirst%3DC.%26aulast%3DRamis%26aufirst%3DI.%26aulast%3DLopez%26aufirst%3DM.%26aulast%3DMiralpeix%26aufirst%3DM.%26aulast%3DVidal%26aufirst%3DB.%26atitle%3DPyrazine-based%2520Syk%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2784%26epage%3D2788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Murphy, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxi, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chappie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermolieff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferre, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greasley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kablaoui, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazmirski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kupchinsky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingardo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marx, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanis, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X. H.</span><span> </span><span class="NLM_article-title">Discovery of novel, potent, and selective inhibitors of 3-phosphoinositide-dependent kinase (PDK1)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8490</span><span class="NLM_x">–</span> <span class="NLM_lpage">8500</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201019k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8490-8500&author=S.+T.+Murphyauthor=G.+Altonauthor=S.+Baileyauthor=S.+M.+Baxiauthor=B.+J.+Burkeauthor=T.+A.+Chappieauthor=J.+Ermolieffauthor=R.+Ferreauthor=S.+Greasleyauthor=M.+Hickeyauthor=J.+Humphreyauthor=N.+Kablaouiauthor=J.+Kathauthor=S.+Kazmirskiauthor=M.+Krausauthor=S.+Kupchinskyauthor=J.+Liauthor=L.+Lingardoauthor=M.+A.+Marxauthor=D.+Richterauthor=S.+P.+Tanisauthor=K.+Tranauthor=W.+Vernierauthor=Z.+Xieauthor=M.+J.+Yinauthor=X.+H.+Yu&title=Discovery+of+novel%2C+potent%2C+and+selective+inhibitors+of+3-phosphoinositide-dependent+kinase+%28PDK1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fjm201019k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201019k%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DS.%2BT.%26aulast%3DAlton%26aufirst%3DG.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DBaxi%26aufirst%3DS.%2BM.%26aulast%3DBurke%26aufirst%3DB.%2BJ.%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DErmolieff%26aufirst%3DJ.%26aulast%3DFerre%26aufirst%3DR.%26aulast%3DGreasley%26aufirst%3DS.%26aulast%3DHickey%26aufirst%3DM.%26aulast%3DHumphrey%26aufirst%3DJ.%26aulast%3DKablaoui%26aufirst%3DN.%26aulast%3DKath%26aufirst%3DJ.%26aulast%3DKazmirski%26aufirst%3DS.%26aulast%3DKraus%26aufirst%3DM.%26aulast%3DKupchinsky%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLingardo%26aufirst%3DL.%26aulast%3DMarx%26aufirst%3DM.%2BA.%26aulast%3DRichter%26aufirst%3DD.%26aulast%3DTanis%26aufirst%3DS.%2BP.%26aulast%3DTran%26aufirst%3DK.%26aulast%3DVernier%26aufirst%3DW.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DYin%26aufirst%3DM.%2BJ.%26aulast%3DYu%26aufirst%3DX.%2BH.%26atitle%3DDiscovery%2520of%2520novel%252C%2520potent%252C%2520and%2520selective%2520inhibitors%2520of%25203-phosphoinositide-dependent%2520kinase%2520%2528PDK1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8490%26epage%3D8500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Li, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pireddu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haura, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schonbrunn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span> </span><span class="NLM_article-title">Fragment-based and structure-guided discovery and optimization of rho kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2474</span><span class="NLM_x">–</span> <span class="NLM_lpage">2478</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201289r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFems70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2474-2478&author=R.+Liauthor=M.+P.+Martinauthor=Y.+Liuauthor=B.+Wangauthor=R.+A.+Patelauthor=J.-Y.+Zhuauthor=N.+Sunauthor=R.+Piredduauthor=N.+J.+Lawrenceauthor=J.+Liauthor=E.+B.+Hauraauthor=S.-S.+Sungauthor=W.+C.+Guidaauthor=E.+Schonbrunnauthor=S.+M.+Sebti&title=Fragment-based+and+structure-guided+discovery+and+optimization+of+rho+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based and Structure-Guided Discovery and Optimization of Rho Kinase Inhibitors</span></div><div class="casAuthors">Li, Rongshi; Martin, Mathew P.; Liu, Yan; Wang, Binglin; Patel, Ronil A.; Zhu, Jin-Yi; Sun, Nan; Pireddu, Roberta; Lawrence, Nicholas J.; Li, Jiannong; Haura, Eric B.; Sung, Shen-Shu; Guida, Wayne C.; Schonbrunn, Ernst; Sebti, Said M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2474-2478</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using high concn. biochem. assays and fragment-based screening assisted by structure-guided design, we discovered a novel class of Rho-kinase inhibitors.  Compd. 18 (I) was equipotent for ROCK1 (IC50 = 650 nM) and ROCK2 (IC50 = 670 nM), whereas compd. 24 was more selective for ROCK2 (IC50 = 100 nM) over ROCK1 (IC50 = 1690 nM).  The crystal structure of the compd. 18-ROCK1 complex revealed that 18 is a type 1 inhibitor that binds the hinge region in the ATP binding site.  Compds. 18 and 24 inhibited potently the phosphorylation of the ROCK substrate MLC2 in intact human breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX0qbi1-9GyLVg90H21EOLACvtfcHk0ljofN7h_hUFpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFems70%253D&md5=ed3298d8fa7148d6c6a0599eb3886779</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fjm201289r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201289r%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DR.%26aulast%3DMartin%26aufirst%3DM.%2BP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DZhu%26aufirst%3DJ.-Y.%26aulast%3DSun%26aufirst%3DN.%26aulast%3DPireddu%26aufirst%3DR.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHaura%26aufirst%3DE.%2BB.%26aulast%3DSung%26aufirst%3DS.-S.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DSchonbrunn%26aufirst%3DE.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26atitle%3DFragment-based%2520and%2520structure-guided%2520discovery%2520and%2520optimization%2520of%2520rho%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2474%26epage%3D2478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Schenkel, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deak, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emkey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunaydin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivieri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pistillo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geuns-Meyer, S.</span><span> </span><span class="NLM_article-title">Discovery of potent and highly selective thienopyridine Janus kinase 2 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8440</span><span class="NLM_x">–</span> <span class="NLM_lpage">8450</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200911r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8440-8450&author=L.+B.+Schenkelauthor=X.+Huangauthor=A.+Chengauthor=H.+L.+Deakauthor=E.+Dohertyauthor=R.+Emkeyauthor=Y.+Guauthor=H.+Gunaydinauthor=J.+L.+Kimauthor=J.+Leeauthor=R.+Lobergauthor=P.+Olivieriauthor=J.+Pistilloauthor=J.+Tangauthor=Q.+Wanauthor=H.+L.+Wangauthor=S.+W.+Wangauthor=M.+C.+Wellsauthor=B.+Wuauthor=V.+Yuauthor=L.+Liuauthor=S.+Geuns-Meyer&title=Discovery+of+potent+and+highly+selective+thienopyridine+Janus+kinase+2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fjm200911r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200911r%26sid%3Dliteratum%253Aachs%26aulast%3DSchenkel%26aufirst%3DL.%2BB.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DA.%26aulast%3DDeak%26aufirst%3DH.%2BL.%26aulast%3DDoherty%26aufirst%3DE.%26aulast%3DEmkey%26aufirst%3DR.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLoberg%26aufirst%3DR.%26aulast%3DOlivieri%26aufirst%3DP.%26aulast%3DPistillo%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DH.%2BL.%26aulast%3DWang%26aufirst%3DS.%2BW.%26aulast%3DWells%26aufirst%3DM.%2BC.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DGeuns-Meyer%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520highly%2520selective%2520thienopyridine%2520Janus%2520kinase%25202%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8440%26epage%3D8450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Koester, H.; Craan, T.; Brass, S.; Heine, A.; Klebe, G.</span><span> </span><span class="NLM_article-title">Human cAMP-Dependent Protein Kinase in Complex with an Inhibitor</span>. Protein Data Bank (PDB),<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.2210/pdb3p0m/pdb</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.2210%2Fpdb3p0m%2Fpdb" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=H.+Koester&author=T.+Craan&author=S.+Brass&author=A.+Heine&author=G.+Klebe&title=Human+cAMP-Dependent+Protein+Kinase+in+Complex+with+an+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.2210%2Fpdb3p0m%2Fpdb&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.2210%252Fpdb3p0m%252Fpdb%26sid%3Dliteratum%253Aachs%26aulast%3DKoester%26aufirst%3DH.%26atitle%3DHuman%2520cAMP-Dependent%2520Protein%2520Kinase%2520in%2520Complex%2520with%2520an%2520Inhibitor%26jtitle%3DProtein%2520Data%2520Bank%2520%2528PDB%2529%26date%3D2012%26doi%3D10.2210%2Fpdb3p0m%2Fpdb" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Hellwig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miduturu, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salah, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hur, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smithgall, T. E.</span><span> </span><span class="NLM_article-title">Small-molecule inhibitors of the c-Fes protein-tyrosine kinase</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">529</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2Fj.chembiol.2012.01.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=22520759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvFyhsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=529-540&author=S.+Hellwigauthor=C.+V.+Miduturuauthor=S.+Kandaauthor=J.+Zhangauthor=P.+Filippakopoulosauthor=E.+Salahauthor=X.+Dengauthor=H.+G.+Choiauthor=W.+Zhouauthor=W.+Hurauthor=S.+Knappauthor=N.+S.+Grayauthor=T.+E.+Smithgall&title=Small-molecule+inhibitors+of+the+c-Fes+protein-tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule Inhibitors of the c-Fes Protein-Tyrosine Kinase</span></div><div class="casAuthors">Hellwig, Sabine; Miduturu, Chandra V.; Kanda, Shigeru; Zhang, Jianming; Filippakopoulos, Panagis; Salah, Eidarus; Deng, Xianming; Choi, Hwan Geun; Zhou, Wenjun; Hur, Wooyoung; Knapp, Stefan; Gray, Nathanael S.; Smithgall, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">529-540</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The c-Fes protein-tyrosine kinase modulates cellular signaling pathways governing differentiation, the innate immune response, and vasculogenesis.  Here, we report the identification of types I and II kinase inhibitors with potent activity against c-Fes both in vitro and in cell-based assays.  One of the most potent inhibitors is the previously described anaplastic lymphoma kinase inhibitor TAE684.  The crystal structure of TAE684 in complex with the c-Fes SH2-kinase domain showed excellent shape complementarity with the ATP-binding pocket and a key role for the gatekeeper methionine in the inhibitory mechanism.  TAE684 and two pyrazolopyrimidines with nanomolar potency against c-Fes in vitro were used to establish a role for this kinase in osteoclastogenesis, illustrating the value of these inhibitors as tool compds. to probe the diverse biol. functions assocd. with this unique kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAe24jiEkQf7Vg90H21EOLACvtfcHk0lhUSgpyFwtniw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvFyhsbo%253D&md5=6c2cde2ae6d412684b0a12dd47b58b56</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.01.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.01.020%26sid%3Dliteratum%253Aachs%26aulast%3DHellwig%26aufirst%3DS.%26aulast%3DMiduturu%26aufirst%3DC.%2BV.%26aulast%3DKanda%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DSalah%26aufirst%3DE.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DHur%26aufirst%3DW.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DSmithgall%26aufirst%3DT.%2BE.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520the%2520c-Fes%2520protein-tyrosine%2520kinase%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D529%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Okaniwa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirose, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yabuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakoi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsutsumi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tottori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aertgeerts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, T.</span><span> </span><span class="NLM_article-title">Design and synthesis of novel DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors. 1. Exploration of [5,6]-fused bicyclic scaffolds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3452</span><span class="NLM_x">–</span> <span class="NLM_lpage">3478</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300126x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3452-3478&author=M.+Okaniwaauthor=M.+Hiroseauthor=T.+Imadaauthor=T.+Ohashiauthor=Y.+Hayashiauthor=T.+Miyazakiauthor=T.+Aritaauthor=M.+Yabukiauthor=K.+Kakoiauthor=J.+Katoauthor=T.+Takagiauthor=T.+Kawamotoauthor=S.+Yaoauthor=A.+Sumitaauthor=S.+Tsutsumiauthor=T.+Tottoriauthor=H.+Okiauthor=B.+C.+Sangauthor=J.+Yanoauthor=K.+Aertgeertsauthor=S.+Yoshidaauthor=T.+Ishikawa&title=Design+and+synthesis+of+novel+DFG-out+RAF%2Fvascular+endothelial+growth+factor+receptor+2+%28VEGFR2%29+inhibitors.+1.+Exploration+of+%5B5%2C6%5D-fused+bicyclic+scaffolds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fjm300126x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300126x%26sid%3Dliteratum%253Aachs%26aulast%3DOkaniwa%26aufirst%3DM.%26aulast%3DHirose%26aufirst%3DM.%26aulast%3DImada%26aufirst%3DT.%26aulast%3DOhashi%26aufirst%3DT.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DMiyazaki%26aufirst%3DT.%26aulast%3DArita%26aufirst%3DT.%26aulast%3DYabuki%26aufirst%3DM.%26aulast%3DKakoi%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DJ.%26aulast%3DTakagi%26aufirst%3DT.%26aulast%3DKawamoto%26aufirst%3DT.%26aulast%3DYao%26aufirst%3DS.%26aulast%3DSumita%26aufirst%3DA.%26aulast%3DTsutsumi%26aufirst%3DS.%26aulast%3DTottori%26aufirst%3DT.%26aulast%3DOki%26aufirst%3DH.%26aulast%3DSang%26aufirst%3DB.%2BC.%26aulast%3DYano%26aufirst%3DJ.%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DIshikawa%26aufirst%3DT.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520DFG-out%2520RAF%252Fvascular%2520endothelial%2520growth%2520factor%2520receptor%25202%2520%2528VEGFR2%2529%2520inhibitors.%25201.%2520Exploration%2520of%2520%255B5%252C6%255D-fused%2520bicyclic%2520scaffolds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3452%26epage%3D3478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Gould, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adhikari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aertgeerts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afroze, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chouitar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffey, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">England, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsyth, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaulin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenspan, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iartchouk, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janowick, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langston, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paske, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renou, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rezaei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sintchak, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroud, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tregay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veiby, O. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vos, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyskocil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, K. M.</span><span> </span><span class="NLM_article-title">Design and optimization of potent and orally bioavailable tetrahydronaphthalene Raf inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1836</span><span class="NLM_x">–</span> <span class="NLM_lpage">1846</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101479y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVWls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1836-1846&author=A.+E.+Gouldauthor=R.+Adamsauthor=S.+Adhikariauthor=K.+Aertgeertsauthor=R.+Afrozeauthor=C.+Blackburnauthor=E.+F.+Calderwoodauthor=R.+Chauauthor=J.+Chouitarauthor=M.+O.+Duffeyauthor=D.+B.+Englandauthor=C.+Farrerauthor=N.+Forsythauthor=K.+Garciaauthor=J.+Gaulinauthor=P.+D.+Greenspanauthor=R.+Guoauthor=S.+J.+Harrisonauthor=S.+C.+Huangauthor=N.+Iartchoukauthor=D.+Janowickauthor=M.+S.+Kimauthor=B.+Kulkarniauthor=S.+P.+Langstonauthor=J.+X.+Liuauthor=L.+T.+Maauthor=S.+Menonauthor=H.+Mizutaniauthor=E.+Paskeauthor=C.+C.+Renouauthor=M.+Rezaeiauthor=R.+S.+Rowlandauthor=M.+D.+Sintchakauthor=M.+D.+Smithauthor=S.+G.+Stroudauthor=M.+Tregayauthor=Y.+Tianauthor=O.+P.+Veibyauthor=T.+J.+Vosauthor=S.+Vyskocilauthor=J.+Williamsauthor=T.+Xuauthor=J.+J.+Yangauthor=J.+Yanoauthor=H.+Zengauthor=D.+M.+Zhangauthor=Q.+Zhangauthor=K.+M.+Galvin&title=Design+and+optimization+of+potent+and+orally+bioavailable+tetrahydronaphthalene+Raf+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Optimization of Potent and Orally Bioavailable Tetrahydronaphthalene Raf Inhibitors</span></div><div class="casAuthors">Gould, Alexandra E.; Adams, Ruth; Adhikari, Sharmila; Aertgeerts, Kathleen; Afroze, Roushan; Blackburn, Christopher; Calderwood, Emily F.; Chau, Ryan; Chouitar, Jouhara; Duffey, Matthew O.; England, Dylan B.; Farrer, Cheryl; Forsyth, Nancy; Garcia, Khristofer; Gaulin, Jeffery; Greenspan, Paul D.; Guo, Ribo; Harrison, Sean J.; Huang, Shih-Chung; Iartchouk, Natalia; Janowick, Dave; Kim, Mi-Sook; Kulkarni, Bheemashankar; Langston, Steven P.; Liu, Jane X.; Ma, Li-Ting; Menon, Saurabh; Mizutani, Hirotake; Paske, Erin; Renou, Christelle C.; Rezaei, Mansoureh; Rowland, R. Scott; Sintchak, Michael D.; Smith, Michael D.; Stroud, Stephen G.; Tregay, Ming; Tian, Yuan; Veiby, Ole P.; Vos, Tricia J.; Vyskocil, Stepan; Williams, Juliet; Xu, Tianlin; Yang, Johnny J.; Yano, Jason; Zeng, Hongbo; Zhang, Dong Mei; Zhang, Qin; Galvin, Katherine M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1836-1846</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of mutant B-Raf signaling, through either direct inhibition of the enzyme or inhibition of MEK, the direct substrate of Raf, has been demonstrated preclinically to inhibit tumor growth.  Very recently, treatment of B-Raf mutant melanoma patients with a selective B-Raf inhibitor has resulted in promising preliminary evidence of antitumor activity.  This article describes the design and optimization of tetrahydronaphthalene-derived compds. as potent inhibitors of the Raf pathway in vitro and in vivo.  These compds. possess good pharmacokinetic properties in rodents and inhibit B-Raf mutant tumor growth in mouse xenograft models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNulHRlb4oULVg90H21EOLACvtfcHk0lhm1l15OC_z5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVWls7g%253D&md5=568fb1b26a6685df082ac0337494a9c5</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fjm101479y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101479y%26sid%3Dliteratum%253Aachs%26aulast%3DGould%26aufirst%3DA.%2BE.%26aulast%3DAdams%26aufirst%3DR.%26aulast%3DAdhikari%26aufirst%3DS.%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DAfroze%26aufirst%3DR.%26aulast%3DBlackburn%26aufirst%3DC.%26aulast%3DCalderwood%26aufirst%3DE.%2BF.%26aulast%3DChau%26aufirst%3DR.%26aulast%3DChouitar%26aufirst%3DJ.%26aulast%3DDuffey%26aufirst%3DM.%2BO.%26aulast%3DEngland%26aufirst%3DD.%2BB.%26aulast%3DFarrer%26aufirst%3DC.%26aulast%3DForsyth%26aufirst%3DN.%26aulast%3DGarcia%26aufirst%3DK.%26aulast%3DGaulin%26aufirst%3DJ.%26aulast%3DGreenspan%26aufirst%3DP.%2BD.%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DHarrison%26aufirst%3DS.%2BJ.%26aulast%3DHuang%26aufirst%3DS.%2BC.%26aulast%3DIartchouk%26aufirst%3DN.%26aulast%3DJanowick%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DM.%2BS.%26aulast%3DKulkarni%26aufirst%3DB.%26aulast%3DLangston%26aufirst%3DS.%2BP.%26aulast%3DLiu%26aufirst%3DJ.%2BX.%26aulast%3DMa%26aufirst%3DL.%2BT.%26aulast%3DMenon%26aufirst%3DS.%26aulast%3DMizutani%26aufirst%3DH.%26aulast%3DPaske%26aufirst%3DE.%26aulast%3DRenou%26aufirst%3DC.%2BC.%26aulast%3DRezaei%26aufirst%3DM.%26aulast%3DRowland%26aufirst%3DR.%2BS.%26aulast%3DSintchak%26aufirst%3DM.%2BD.%26aulast%3DSmith%26aufirst%3DM.%2BD.%26aulast%3DStroud%26aufirst%3DS.%2BG.%26aulast%3DTregay%26aufirst%3DM.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DVeiby%26aufirst%3DO.%2BP.%26aulast%3DVos%26aufirst%3DT.%2BJ.%26aulast%3DVyskocil%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DJ.%2BJ.%26aulast%3DYano%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DD.%2BM.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DGalvin%26aufirst%3DK.%2BM.%26atitle%3DDesign%2520and%2520optimization%2520of%2520potent%2520and%2520orally%2520bioavailable%2520tetrahydronaphthalene%2520Raf%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1836%26epage%3D1846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Koolman, H.; Heinrich, T.; Musil, D.</span><span> </span><span class="NLM_article-title">Co-Crystal Structures of FAK with an Unprecedented Pyrrolo[2,3-<i>d</i>]thiazole</span>. Protein Data Bank (PDB),<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.2210/pdb3pxk/pdb</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.2210%2Fpdb3pxk%2Fpdb" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=H.+Koolman&author=T.+Heinrich&author=D.+Musil&title=Co-Crystal+Structures+of+FAK+with+an+Unprecedented+Pyrrolo%5B2%2C3-d%5Dthiazole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.2210%2Fpdb3pxk%2Fpdb&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.2210%252Fpdb3pxk%252Fpdb%26sid%3Dliteratum%253Aachs%26aulast%3DKoolman%26aufirst%3DH.%26atitle%3DCo-Crystal%2520Structures%2520of%2520FAK%2520with%2520an%2520Unprecedented%2520Pyrrolo%255B2%252C3-d%255Dthiazole%26jtitle%3DProtein%2520Data%2520Bank%2520%2528PDB%2529%26date%3D2012%26doi%3D10.2210%2Fpdb3pxk%2Fpdb" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Chaikuad, A.; Sanvitale, C.; Cooper, C.; Canning, P.; Mahajan, P.; Daga, N.; Petrie, K.; Alfano, I.; Gileadi, O.; Fedorov, O.; Krojer, T.; Filippakopoulos, P.; Muniz, J. R. C.; von Delft, F.; Weigelt, J.; Arrowsmith, C. H.; Edwards, A. M.; Bountra, C.; Bullock, A.; Consortium, S. G.</span><span> </span><span class="NLM_article-title">Crystal Structure of the ACVR1 Kinase Domain in Complex with the Imidazo[1,2-<i>b</i>]pyridazine Inhibitor K00135</span>. Protein Data Bank (PDB),<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.2210/pdb4dym/pdb</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.2210%2Fpdb4dym%2Fpdb" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+Chaikuad&author=C.+Sanvitale&author=C.+Cooper&author=P.+Canning&author=P.+Mahajan&author=N.+Daga&author=K.+Petrie&author=I.+Alfano&author=O.+Gileadi&author=O.+Fedorov&author=T.+Krojer&author=P.+Filippakopoulos&author=J.+R.+C.+Muniz&author=F.+von+Delft&author=J.+Weigelt&author=C.+H.+Arrowsmith&author=A.+M.+Edwards&author=C.+Bountra&author=A.+Bullock&author=S.+G.+Consortium&title=Crystal+Structure+of+the+ACVR1+Kinase+Domain+in+Complex+with+the+Imidazo%5B1%2C2-b%5Dpyridazine+Inhibitor+K00135"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.2210%2Fpdb4dym%2Fpdb&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.2210%252Fpdb4dym%252Fpdb%26sid%3Dliteratum%253Aachs%26aulast%3DChaikuad%26aufirst%3DA.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520ACVR1%2520Kinase%2520Domain%2520in%2520Complex%2520with%2520the%2520Imidazo%255B1%252C2-b%255Dpyridazine%2520Inhibitor%2520K00135%26jtitle%3DProtein%2520Data%2520Bank%2520%2528PDB%2529%26date%3D2012%26doi%3D10.2210%2Fpdb4dym%2Fpdb" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Levinson, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxer, S. G.</span><span> </span><span class="NLM_article-title">Structural and spectroscopic analysis of the kinase inhibitor bosutinib and an isomer of bosutinib binding to the Abl tyrosine kinase domain</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e29828</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1371%2Fjournal.pone.0029828" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=22493660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvFekt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e29828&author=N.+M.+Levinsonauthor=S.+G.+Boxer&title=Structural+and+spectroscopic+analysis+of+the+kinase+inhibitor+bosutinib+and+an+isomer+of+bosutinib+binding+to+the+Abl+tyrosine+kinase+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and spectroscopic analysis of the kinase inhibitor bosutinib and an isomer of bosutinib binding to the Abl tyrosine kinase domain</span></div><div class="casAuthors">Levinson, Nicholas M.; Boxer, Steven G.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e29828</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Chronic myeloid leukemia (CML) is caused by the kinase activity of the BCR-Abl fusion protein.  The Abl inhibitors imatinib, nilotinib and dasatinib are currently used to treat CML, but resistance to these inhibitors is a significant clin. problem.  The kinase inhibitor bosutinib has shown efficacy in clin. trials for imatinib-resistant CML, but its binding mode is unknown.  We present the 2.4 Å structure of bosutinib bound to the kinase domain of Abl, which explains the inhibitor's activity against several imatinib-resistant mutants, and reveals that similar inhibitors that lack a nitrile moiety could be effective against the common T315I mutant.  We also report that two distinct chem. compds. are currently being sold under the name "bosutinib", and report spectroscopic and structural characterizations of both.  We show that the fluorescence properties of these compds. allow inhibitor binding to be measured quant., and that the IR absorption of the nitrile group reveals a different electrostatic environment in the conserved ATP-binding sites of Abl and Src kinases.  Exploiting such differences could lead to inhibitors with improved selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpV2tAfVGUdSbVg90H21EOLACvtfcHk0lhcGw_hNMxYwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvFekt7o%253D&md5=4a8a00c6786d62293a05fe5ddd757174</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0029828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0029828%26sid%3Dliteratum%253Aachs%26aulast%3DLevinson%26aufirst%3DN.%2BM.%26aulast%3DBoxer%26aufirst%3DS.%2BG.%26atitle%3DStructural%2520and%2520spectroscopic%2520analysis%2520of%2520the%2520kinase%2520inhibitor%2520bosutinib%2520and%2520an%2520isomer%2520of%2520bosutinib%2520binding%2520to%2520the%2520Abl%2520tyrosine%2520kinase%2520domain%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De29828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Heikkila, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheatley, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crighton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroder, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boakes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mezna, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rushbrooke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnbull, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, M. F.</span><span> </span><span class="NLM_article-title">Co-crystal structures of inhibitors with MRCKbeta, a key regulator of tumor cell invasion</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e24825</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e24825&author=T.+Heikkilaauthor=E.+Wheatleyauthor=D.+Crightonauthor=E.+Schroderauthor=A.+Boakesauthor=S.+J.+Kayeauthor=M.+Meznaauthor=L.+Pangauthor=M.+Rushbrookeauthor=A.+Turnbullauthor=M.+F.+Olson&title=Co-crystal+structures+of+inhibitors+with+MRCKbeta%2C+a+key+regulator+of+tumor+cell+invasion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeikkila%26aufirst%3DT.%26aulast%3DWheatley%26aufirst%3DE.%26aulast%3DCrighton%26aufirst%3DD.%26aulast%3DSchroder%26aufirst%3DE.%26aulast%3DBoakes%26aufirst%3DA.%26aulast%3DKaye%26aufirst%3DS.%2BJ.%26aulast%3DMezna%26aufirst%3DM.%26aulast%3DPang%26aufirst%3DL.%26aulast%3DRushbrooke%26aufirst%3DM.%26aulast%3DTurnbull%26aufirst%3DA.%26aulast%3DOlson%26aufirst%3DM.%2BF.%26atitle%3DCo-crystal%2520structures%2520of%2520inhibitors%2520with%2520MRCKbeta%252C%2520a%2520key%2520regulator%2520of%2520tumor%2520cell%2520invasion%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De24825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Dyckman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillooly, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newitt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span> </span><span class="NLM_article-title">Discovery of pyrrolo[2,1-<i>f</i>][1,2,4]triazine C6-ketones as potent, orally active p38α MAP kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4633</span><span class="NLM_x">–</span> <span class="NLM_lpage">4637</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4633-4637&author=A.+J.+Dyckmanauthor=T.+Liauthor=S.+Pittauthor=R.+Zhangauthor=D.+R.+Shenauthor=K.+W.+McIntyreauthor=K.+M.+Gilloolyauthor=D.+J.+Shusterauthor=A.+M.+Doweykoauthor=J.+S.+Sackauthor=K.+Kishauthor=S.+E.+Kieferauthor=J.+A.+Newittauthor=H.+Zhangauthor=P.+H.+Maratheauthor=M.+McKinnonauthor=J.+C.+Barrishauthor=J.+H.+Doddauthor=G.+L.+Schievenauthor=K.+Leftheris&title=Discovery+of+pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazine+C6-ketones+as+potent%2C+orally+active+p38%CE%B1+MAP+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DGillooly%26aufirst%3DK.%2BM.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DKiefer%26aufirst%3DS.%2BE.%26aulast%3DNewitt%26aufirst%3DJ.%2BA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMarathe%26aufirst%3DP.%2BH.%26aulast%3DMcKinnon%26aufirst%3DM.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DDodd%26aufirst%3DJ.%2BH.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazine%2520C6-ketones%2520as%2520potent%252C%2520orally%2520active%2520p38%25CE%25B1%2520MAP%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4633%26epage%3D4637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Filippakopoulos, P.; Fedorov, O.; King, O.; Bullock, A.; Muniz, J. R. C.; von Delft, F.; Arrowsmith, C. H.; Edwards, A. M.; Weigelt, J.; Bountra, C.; Knapp, S.; Consortium, S. G.</span><span> </span><span class="NLM_article-title">Crystal Structure of Human CDC-like Kinase 3 Isoform in Complex with Leucettine L41</span>. Protein Data Bank (PDB),<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.2210/pdb3raw/pdb</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.2210%2Fpdb3raw%2Fpdb" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=P.+Filippakopoulos&author=O.+Fedorov&author=O.+King&author=A.+Bullock&author=J.+R.+C.+Muniz&author=F.+von+Delft&author=C.+H.+Arrowsmith&author=A.+M.+Edwards&author=J.+Weigelt&author=C.+Bountra&author=S.+Knapp&author=S.+G.+Consortium&title=Crystal+Structure+of+Human+CDC-like+Kinase+3+Isoform+in+Complex+with+Leucettine+L41"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.2210%2Fpdb3raw%2Fpdb&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.2210%252Fpdb3raw%252Fpdb%26sid%3Dliteratum%253Aachs%26aulast%3DFilippakopoulos%26aufirst%3DP.%26atitle%3DCrystal%2520Structure%2520of%2520Human%2520CDC-like%2520Kinase%25203%2520Isoform%2520in%2520Complex%2520with%2520Leucettine%2520L41%26jtitle%3DProtein%2520Data%2520Bank%2520%2528PDB%2529%26date%3D2012%26doi%3D10.2210%2Fpdb3raw%2Fpdb" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Nishiguchi, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atallah, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellamacina, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feucht, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klivansky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindvall, M.</span><span> </span><span class="NLM_article-title">Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6366</span><span class="NLM_x">–</span> <span class="NLM_lpage">6369</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2Fj.bmcl.2011.08.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=21945284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12jtr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6366-6369&author=G.+A.+Nishiguchiauthor=G.+Atallahauthor=C.+Bellamacinaauthor=M.+T.+Burgerauthor=Y.+Dingauthor=P.+H.+Feuchtauthor=P.+D.+Garciaauthor=W.+Hanauthor=L.+Klivanskyauthor=M.+Lindvall&title=Discovery+of+novel+3%2C5-disubstituted+indole+derivatives+as+potent+inhibitors+of+Pim-1%2C+Pim-2%2C+and+Pim-3+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases</span></div><div class="casAuthors">Nishiguchi, Gisele A.; Atallah, Gordana; Bellamacina, Cornelia; Burger, Matthew T.; Ding, Yu; Feucht, Paul H.; Garcia, Pablo D.; Han, Woo-Seok; Klivansky, Liana; Lindvall, Mika</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6366-6369</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of novel 3,5-disubstituted indole e. g., I and pyrazolopyridine e. g., II derivs. as potent and selective inhibitors of all three members of the Pim kinase family is described.  High throughput screen identified a pan-Pim kinase inhibitor with a promiscuous scaffold.  Guided by structure-based drug design, SAR of the series afforded a highly selective indole chemotype that was further developed into a potent set of compds. against Pim-1, 2, and 3 (Pim-1 and Pim-3: IC50 ≤ 2 nM and Pim-2: IC50 ≤ 100 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraW5ZPCZ1p-7Vg90H21EOLACvtfcHk0lgdS-cvWaplRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12jtr%252FK&md5=9b8f859027daa006c85b6bbf7696ef18</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.08.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.08.105%26sid%3Dliteratum%253Aachs%26aulast%3DNishiguchi%26aufirst%3DG.%2BA.%26aulast%3DAtallah%26aufirst%3DG.%26aulast%3DBellamacina%26aufirst%3DC.%26aulast%3DBurger%26aufirst%3DM.%2BT.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DFeucht%26aufirst%3DP.%2BH.%26aulast%3DGarcia%26aufirst%3DP.%2BD.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DKlivansky%26aufirst%3DL.%26aulast%3DLindvall%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520novel%25203%252C5-disubstituted%2520indole%2520derivatives%2520as%2520potent%2520inhibitors%2520of%2520Pim-1%252C%2520Pim-2%252C%2520and%2520Pim-3%2520protein%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6366%26epage%3D6369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Tsai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bremer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillette, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sproesser, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smalley, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marimuthu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settachatgul, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shellooe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantwell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habets, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artis, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herlyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollag, G.</span><span> </span><span class="NLM_article-title">Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">3041</span><span class="NLM_x">–</span> <span class="NLM_lpage">3046</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1073%2Fpnas.0711741105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=18287029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtVSitrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=3041-3046&author=J.+Tsaiauthor=J.+T.+Leeauthor=W.+Wangauthor=J.+Zhangauthor=H.+Choauthor=S.+Mamoauthor=R.+Bremerauthor=S.+Gilletteauthor=J.+Kongauthor=N.+K.+Haassauthor=K.+Sproesserauthor=L.+Liauthor=K.+S.+Smalleyauthor=D.+Fongauthor=Y.+L.+Zhuauthor=A.+Marimuthuauthor=H.+Nguyenauthor=B.+Lamauthor=J.+Liuauthor=I.+Cheungauthor=J.+Riceauthor=Y.+Suzukiauthor=C.+Luuauthor=C.+Settachatgulauthor=R.+Shellooeauthor=J.+Cantwellauthor=S.+H.+Kimauthor=J.+Schlessingerauthor=K.+Y.+Zhangauthor=B.+L.+Westauthor=B.+Powellauthor=G.+Habetsauthor=C.+Zhangauthor=P.+N.+Ibrahimauthor=P.+Hirthauthor=D.+R.+Artisauthor=M.+Herlynauthor=G.+Bollag&title=Discovery+of+a+selective+inhibitor+of+oncogenic+B-Raf+kinase+with+potent+antimelanoma+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity</span></div><div class="casAuthors">Tsai, James; Lee, John T.; Wang, Weiru; Zhang, Jiazhong; Cho, Hanna; Mamo, Shumeye; Bremer, Ryan; Gillette, Sam; Kong, Jun; Haass, Nikolas K.; Sproesser, Katrin; Li, Ling; Smalley, Keiran S. M.; Fong, Daniel; Zhu, Yong-Liang; Marimuthu, Adhirai; Nguyen, Hoa; Lam, Billy; Liu, Jennifer; Cheung, Ivana; Rice, Julie; Suzuki, Yoshihisa; Luu, Catherine; Settachatgul, Calvin; Shellooe, Rafe; Cantwell, John; Kim, Sung-Hou; Schlessinger, Joseph; Zhang, Kam Y. J.; West, Brian L.; Powell, Ben; Habets, Gaston; Zhang, Chao; Ibrahim, Prabha N.; Hirth, Peter; Artis, Dean R.; Herlyn, Meenhard; Bollag, Gideon</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3041-3046</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">BRAFV600E is the most frequent oncogenic protein kinase mutation known.  Furthermore, inhibitors targeting "active" protein kinases have demonstrated significant utility in the therapeutic repertoire against cancer.  Therefore, the authors pursued the development of specific kinase inhibitors targeting B-Raf, and the V600E allele in particular.  By using a structure-guided discovery approach, a potent and selective inhibitor of active B-Raf has been discovered.  PLX4720, a 7-azaindole deriv. that inhibits B-RafV600E with an IC50 of 13 nM, defines a class of kinase inhibitor with marked selectivity in both biochem. and cellular assays.  PLX4720 preferentially inhibits the active B-RafV600E kinase compared with a broad spectrum of other kinases, and potent cytotoxic effects are also exclusive to cells bearing the V600E allele.  Consistent with the high degree of selectivity, ERK phosphorylation is potently inhibited by PLX4720 in B-RafV600E-bearing tumor cell lines but not in cells lacking oncogenic B-Raf.  In melanoma models, PLX4720 induces cell cycle arrest and apoptosis exclusively in B-RafV600E-pos. cells.  In B-RafV600E-dependent tumor xenograft models, orally dosed PLX4720 causes significant tumor growth delays, including tumor regressions, without evidence of toxicity.  The work described here represents the entire discovery process, from initial identification through structural and biol. studies in animal models to a promising therapeutic for testing in cancer patients bearing B-RafV600E-driven tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPX53IQCbDJ7Vg90H21EOLACvtfcHk0lg1PxOlAIw8Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtVSitrk%253D&md5=273b94202f99984e6eb24723d0c6141f</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0711741105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0711741105%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%2BT.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DCho%26aufirst%3DH.%26aulast%3DMamo%26aufirst%3DS.%26aulast%3DBremer%26aufirst%3DR.%26aulast%3DGillette%26aufirst%3DS.%26aulast%3DKong%26aufirst%3DJ.%26aulast%3DHaass%26aufirst%3DN.%2BK.%26aulast%3DSproesser%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DSmalley%26aufirst%3DK.%2BS.%26aulast%3DFong%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DY.%2BL.%26aulast%3DMarimuthu%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DLam%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DCheung%26aufirst%3DI.%26aulast%3DRice%26aufirst%3DJ.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DLuu%26aufirst%3DC.%26aulast%3DSettachatgul%26aufirst%3DC.%26aulast%3DShellooe%26aufirst%3DR.%26aulast%3DCantwell%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DK.%2BY.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DHabets%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DIbrahim%26aufirst%3DP.%2BN.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DHerlyn%26aufirst%3DM.%26aulast%3DBollag%26aufirst%3DG.%26atitle%3DDiscovery%2520of%2520a%2520selective%2520inhibitor%2520of%2520oncogenic%2520B-Raf%2520kinase%2520with%2520potent%2520antimelanoma%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D3041%26epage%3D3046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Shafer, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindvall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellamacina, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gesner, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yabannavar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, A.</span><span> </span><span class="NLM_article-title">4-(1<i>H</i>-Indazol-5-yl)-6-phenylpyrimidin-2(1<i>H</i>)-one analogs as potent CDC7 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4482</span><span class="NLM_x">–</span> <span class="NLM_lpage">4485</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4482-4485&author=C.+M.+Shaferauthor=M.+Lindvallauthor=C.+Bellamacinaauthor=T.+G.+Gesnerauthor=A.+Yabannavarauthor=W.+Jiaauthor=S.+Linauthor=A.+Walter&title=4-%281H-Indazol-5-yl%29-6-phenylpyrimidin-2%281H%29-one+analogs+as+potent+CDC7+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShafer%26aufirst%3DC.%2BM.%26aulast%3DLindvall%26aufirst%3DM.%26aulast%3DBellamacina%26aufirst%3DC.%26aulast%3DGesner%26aufirst%3DT.%2BG.%26aulast%3DYabannavar%26aufirst%3DA.%26aulast%3DJia%26aufirst%3DW.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DWalter%26aufirst%3DA.%26atitle%3D4-%25281H-Indazol-5-yl%2529-6-phenylpyrimidin-2%25281H%2529-one%2520analogs%2520as%2520potent%2520CDC7%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4482%26epage%3D4485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Lountos, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jobson, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tropea, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Self, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waugh, D. S.</span><span> </span><span class="NLM_article-title">Structural characterization of inhibitor complexes with checkpoint kinase 2 (Chk2), a drug target for cancer therapy</span> <span class="citation_source-journal">J. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">301</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2011&pages=292-301&author=G.+T.+Lountosauthor=A.+G.+Jobsonauthor=J.+E.+Tropeaauthor=C.+R.+Selfauthor=G.+Zhangauthor=Y.+Pommierauthor=R.+H.+Shoemakerauthor=D.+S.+Waugh&title=Structural+characterization+of+inhibitor+complexes+with+checkpoint+kinase+2+%28Chk2%29%2C+a+drug+target+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLountos%26aufirst%3DG.%2BT.%26aulast%3DJobson%26aufirst%3DA.%2BG.%26aulast%3DTropea%26aufirst%3DJ.%2BE.%26aulast%3DSelf%26aufirst%3DC.%2BR.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DShoemaker%26aufirst%3DR.%2BH.%26aulast%3DWaugh%26aufirst%3DD.%2BS.%26atitle%3DStructural%2520characterization%2520of%2520inhibitor%2520complexes%2520with%2520checkpoint%2520kinase%25202%2520%2528Chk2%2529%252C%2520a%2520drug%2520target%2520for%2520cancer%2520therapy%26jtitle%3DJ.%2520Struct.%2520Biol.%26date%3D2011%26volume%3D176%26spage%3D292%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenreich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullock, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szklarczyk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trappe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bracher, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2Fj.chembiol.2010.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=21276940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlarsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=67-76&author=O.+Fedorovauthor=K.+Huberauthor=A.+Eisenreichauthor=P.+Filippakopoulosauthor=O.+Kingauthor=A.+N.+Bullockauthor=D.+Szklarczykauthor=L.+J.+Jensenauthor=D.+Fabbroauthor=J.+Trappeauthor=U.+Rauchauthor=F.+Bracherauthor=S.+Knapp&title=Specific+CLK+inhibitors+from+a+novel+chemotype+for+regulation+of+alternative+splicing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Specific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing</span></div><div class="casAuthors">Fedorov, Oleg; Huber, Kilian; Eisenreich, Andreas; Filippakopoulos, Panagis; King, Oliver; Bullock, Alex N.; Szklarczyk, Damian; Jensen, Lars J.; Fabbro, Doriano; Trappe, Jorg; Rauch, Ursula; Bracher, Franz; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-76</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">There is a growing recognition of the importance of protein kinases in the control of alternative splicing.  To define the underlying regulatory mechanisms, highly selective inhibitors are needed.  Here, we report the discovery and characterization of the dichloroindolyl enaminonitrile KH-CB19, a potent and highly specific inhibitor of the CDC2-like kinase isoforms 1 and 4 (CLK1/CLK4).  Cocrystal structures of KH-CB19 with CLK1 and CLK3 revealed a non-ATP mimetic binding mode, conformational changes in helix αC and the phosphate binding loop and halogen bonding to the kinase hinge region.  KH-CB19 effectively suppressed phosphorylation of SR (serine/arginine) proteins in cells, consistent with its expected mechanism of action.  Chem. inhibition of CLK1/CLK4 generated a unique pattern of splicing factor dephosphorylation and had at low nM concn. a profound effect on splicing of the two tissue factor isoforms flTF (full-length TF) and asHTF (alternatively spliced human TF).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqnKjNEjPBHbVg90H21EOLACvtfcHk0ljL-3G3orbHig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlarsLw%253D&md5=b2b17a9934f15f2d0d9a76a8d3179e95</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2010.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2010.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DHuber%26aufirst%3DK.%26aulast%3DEisenreich%26aufirst%3DA.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DKing%26aufirst%3DO.%26aulast%3DBullock%26aufirst%3DA.%2BN.%26aulast%3DSzklarczyk%26aufirst%3DD.%26aulast%3DJensen%26aufirst%3DL.%2BJ.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DTrappe%26aufirst%3DJ.%26aulast%3DRauch%26aufirst%3DU.%26aulast%3DBracher%26aufirst%3DF.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DSpecific%2520CLK%2520inhibitors%2520from%2520a%2520novel%2520chemotype%2520for%2520regulation%2520of%2520alternative%2520splicing%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D67%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Bischoff, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raaf, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bretner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Issinger, O. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niefind, K.</span><span> </span><span class="NLM_article-title">Structure of the human protein kinase CK2 catalytic subunit CK2alpha' and interaction thermodynamics with the regulatory subunit CK2beta</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">407</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2011&pages=1-12&author=N.+Bischoffauthor=B.+Olsenauthor=J.+Raafauthor=M.+Bretnerauthor=O.+G.+Issingerauthor=K.+Niefind&title=Structure+of+the+human+protein+kinase+CK2+catalytic+subunit+CK2alpha%27+and+interaction+thermodynamics+with+the+regulatory+subunit+CK2beta"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBischoff%26aufirst%3DN.%26aulast%3DOlsen%26aufirst%3DB.%26aulast%3DRaaf%26aufirst%3DJ.%26aulast%3DBretner%26aufirst%3DM.%26aulast%3DIssinger%26aufirst%3DO.%2BG.%26aulast%3DNiefind%26aufirst%3DK.%26atitle%3DStructure%2520of%2520the%2520human%2520protein%2520kinase%2520CK2%2520catalytic%2520subunit%2520CK2alpha%2527%2520and%2520interaction%2520thermodynamics%2520with%2520the%2520regulatory%2520subunit%2520CK2beta%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D407%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Pierce, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandretto, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, G. W.</span><span> </span><span class="NLM_article-title">Kinase inhibitors and the case for CH···O hydrogen bonds in protein–ligand binding</span> <span class="citation_source-journal">Proteins: Structure, Function, Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">–</span> <span class="NLM_lpage">576</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1002%2Fprot.10259" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=12402365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD38XptlGru7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2002&pages=567-576&author=A.+C.+Pierceauthor=K.+L.+Sandrettoauthor=G.+W.+Bemis&title=Kinase+inhibitors+and+the+case+for+CH%C2%B7%C2%B7%C2%B7O+hydrogen+bonds+in+protein%E2%80%93ligand+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase inhibitors and the case for CH···O hydrogen bonds in protein-ligand binding</span></div><div class="casAuthors">Pierce, Albert C.; Sandretto, Kathryn L.; Bemis, Guy W.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Genetics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">567-576</span>CODEN:
                <span class="NLM_cas:coden">PSFGEY</span>;
        ISSN:<span class="NLM_cas:issn">0887-3585</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Although the hydrogen bond is known to be an important mediator of intermol. interactions, there has yet to be an anal. of the role of CH···O hydrogen bonds in protein-ligand complexes.  In this work, we present evidence for such nonstandard hydrogen bonds from a survey of arom. ligands in 184 kinase crystal structures and 358 high-resoln. structures from the Protein Data Bank.  CH groups adjacent to the pos. charged nitrogen of nicotinamide exhibit geometric preferences strongly suggestive of hydrogen bonding interactions, as do heterocyclic CH groups in kinase ligands, while other arom. CH groups do not exhibit these characteristics.  Ab initio calcns. reveal a considerable range of CH···O hydrogen bonding potentials among different arom. ring systems, with nicotinamide and heterocycles preferred in kinase inhibitors showing particularly favorable interactions.  These results provide compelling evidence for the existence of CH···O hydrogen bonds in protein-ligand interactions, as well as information on the relative strength of various arom. CH donors.  Such knowledge will be of considerable value in protein modeling, ligand design, and structure-activity anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0ALx7F6vIXLVg90H21EOLACvtfcHk0ljL-3G3orbHig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptlGru7c%253D&md5=641cc069501f9243df3ddc35cd3aa449</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1002%2Fprot.10259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.10259%26sid%3Dliteratum%253Aachs%26aulast%3DPierce%26aufirst%3DA.%2BC.%26aulast%3DSandretto%26aufirst%3DK.%2BL.%26aulast%3DBemis%26aufirst%3DG.%2BW.%26atitle%3DKinase%2520inhibitors%2520and%2520the%2520case%2520for%2520CH%25C2%25B7%25C2%25B7%25C2%25B7O%2520hydrogen%2520bonds%2520in%2520protein%25E2%2580%2593ligand%2520binding%26jtitle%3DProteins%253A%2520Structure%252C%2520Function%252C%2520Bioinf.%26date%3D2002%26volume%3D49%26spage%3D567%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Stamos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sliwkowski, M. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenbrot, C.</span><span> </span><span class="NLM_article-title">Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">46265</span><span class="NLM_x">–</span> <span class="NLM_lpage">46272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1074%2Fjbc.M207135200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=12196540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD38XovFKhsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=46265-46272&author=J.+Stamosauthor=M.+X.+Sliwkowskiauthor=C.+Eigenbrot&title=Structure+of+the+epidermal+growth+factor+receptor+kinase+domain+alone+and+in+complex+with+a+4-anilinoquinazoline+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor</span></div><div class="casAuthors">Stamos, Jennifer; Sliwkowski, Mark X.; Eigenbrot, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">46265-46272</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The crystal structure of the kinase domain from the epidermal growth factor receptor (EGFRK) including forty amino acids from the carboxyl-terminal tail has been detd. to 2.6-Å resoln., both with and without an EGFRK-specific inhibitor currently in Phase III clin. trials as an anti-cancer agent, erlotinib (OSI-774, CP-358,774, Tarceva).  The EGFR family members are distinguished from all other known receptor tyrosine kinases in possessing constitutive kinase activity without a phosphorylation event within their kinase domains.  Despite its lack of phosphorylation, we find that the EGFRK activation loop adopts a conformation similar to that of the phosphorylated active form of the kinase domain from the insulin receptor.  Surprisingly, key residues of a putative dimerization motif lying between the EGFRK domain and carboxyl-terminal substrate docking sites are found in close contact with the kinase domain.  Significant intermol. contacts involving the carboxyl-terminal tail are discussed with respect to receptor oligomerization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsObp1WYFaC7Vg90H21EOLACvtfcHk0ljL-3G3orbHig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovFKhsL4%253D&md5=c63c60b93756bd45fb2375c56ba38941</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M207135200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M207135200%26sid%3Dliteratum%253Aachs%26aulast%3DStamos%26aufirst%3DJ.%26aulast%3DSliwkowski%26aufirst%3DM.%2BX.%26aulast%3DEigenbrot%26aufirst%3DC.%26atitle%3DStructure%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520kinase%2520domain%2520alone%2520and%2520in%2520complex%2520with%2520a%25204-anilinoquinazoline%2520inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D46265%26epage%3D46272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Jacobs, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swenson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hare, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, K.</span><span> </span><span class="NLM_article-title">Pim-1 ligand-bound structures reveal the mechanism of serine/threonine kinase inhibition by LY294002</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">13728</span><span class="NLM_x">–</span> <span class="NLM_lpage">13734</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=13728-13734&author=M.+D.+Jacobsauthor=J.+Blackauthor=O.+Futerauthor=L.+Swensonauthor=B.+Hareauthor=M.+Flemingauthor=K.+Saxena&title=Pim-1+ligand-bound+structures+reveal+the+mechanism+of+serine%2Fthreonine+kinase+inhibition+by+LY294002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJacobs%26aufirst%3DM.%2BD.%26aulast%3DBlack%26aufirst%3DJ.%26aulast%3DFuter%26aufirst%3DO.%26aulast%3DSwenson%26aufirst%3DL.%26aulast%3DHare%26aufirst%3DB.%26aulast%3DFleming%26aufirst%3DM.%26aulast%3DSaxena%26aufirst%3DK.%26atitle%3DPim-1%2520ligand-bound%2520structures%2520reveal%2520the%2520mechanism%2520of%2520serine%252Fthreonine%2520kinase%2520inhibition%2520by%2520LY294002%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D13728%26epage%3D13734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Xing, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shieh, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selness, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devadas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hope, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compton, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stegeman, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broadus, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walden, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monahan, J. B.</span><span> </span><span class="NLM_article-title">Structural bioinformatics-based prediction of exceptional selectivity of p38 MAP kinase inhibitor PH-797804</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6402</span><span class="NLM_x">–</span> <span class="NLM_lpage">6411</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi900655f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=6402-6411&author=L.+Xingauthor=H.+S.+Shiehauthor=S.+R.+Selnessauthor=R.+V.+Devrajauthor=J.+K.+Walkerauthor=B.+Devadasauthor=H.+R.+Hopeauthor=R.+P.+Comptonauthor=J.+F.+Schindlerauthor=J.+L.+Hirschauthor=A.+G.+Bensonauthor=R.+G.+Kurumbailauthor=R.+A.+Stegemanauthor=J.+M.+Williamsauthor=R.+M.+Broadusauthor=Z.+Waldenauthor=J.+B.+Monahan&title=Structural+bioinformatics-based+prediction+of+exceptional+selectivity+of+p38+MAP+kinase+inhibitor+PH-797804"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1021%2Fbi900655f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi900655f%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DL.%26aulast%3DShieh%26aufirst%3DH.%2BS.%26aulast%3DSelness%26aufirst%3DS.%2BR.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DWalker%26aufirst%3DJ.%2BK.%26aulast%3DDevadas%26aufirst%3DB.%26aulast%3DHope%26aufirst%3DH.%2BR.%26aulast%3DCompton%26aufirst%3DR.%2BP.%26aulast%3DSchindler%26aufirst%3DJ.%2BF.%26aulast%3DHirsch%26aufirst%3DJ.%2BL.%26aulast%3DBenson%26aufirst%3DA.%2BG.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DStegeman%26aufirst%3DR.%2BA.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DBroadus%26aufirst%3DR.%2BM.%26aulast%3DWalden%26aufirst%3DZ.%26aulast%3DMonahan%26aufirst%3DJ.%2BB.%26atitle%3DStructural%2520bioinformatics-based%2520prediction%2520of%2520exceptional%2520selectivity%2520of%2520p38%2520MAP%2520kinase%2520inhibitor%2520PH-797804%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D6402%26epage%3D6411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Martz, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baur, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schattel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goettert, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer-Wrangowski, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, S. A.</span><span> </span><span class="NLM_article-title">Targeting the hinge glycine flip and the activation loop: novel approach to potent p38α inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7862</span><span class="NLM_x">–</span> <span class="NLM_lpage">7874</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300951u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1SlsrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7862-7874&author=K.+E.+Martzauthor=A.+Dornauthor=B.+Baurauthor=V.+Schattelauthor=M.+I.+Goettertauthor=S.+C.+Mayer-Wrangowskiauthor=D.+Rauhauthor=S.+A.+Laufer&title=Targeting+the+hinge+glycine+flip+and+the+activation+loop%3A+novel+approach+to+potent+p38%CE%B1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Hinge Glycine Flip and the Activation Loop: Novel Approach to Potent p38α Inhibitors</span></div><div class="casAuthors">Martz, Kathrin E.; Dorn, Angelika; Baur, Benjamin; Schattel, Verena; Goettert, Marcia I.; Mayer-Wrangowski, Svenja C.; Rauh, Daniel; Laufer, Stefan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7862-7874</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The p38 MAP kinase is a key player in signaling pathways regulating the biosynthesis of inflammatory cytokines.  Small mol. p38 inhibitors suppress the prodn. of these cytokines.  Therefore p38 is a promising drug target for novel anti-inflammatory drugs.  In this study, we report novel dibenzepinones, dibenzoxepines, and benzosuberones as p38α MAP kinase inhibitors.  Previously reported dibenzepinones and dibenzoxepines were chem. modified by introduction of functional groups or removal of a Ph ring.  This should result in targeting of the hydrophobic region I, the "deep pocket", and the hinge glycine flip of the kinase.  Potent inhibitors with IC50 values in the single digit nanomolar range (up to 3 nM) were identified.  Instead of targeting the "deep pocket" in the DFG-out conformation, interactions with the DFG-motif in the in-conformation could be obsd. by protein x-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9ZkVG97Ru-bVg90H21EOLACvtfcHk0lgg77F7uqZlbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1SlsrbP&md5=c1e76ed9bac1b5c1c4c5b4c630c845b8</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Fjm300951u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300951u%26sid%3Dliteratum%253Aachs%26aulast%3DMartz%26aufirst%3DK.%2BE.%26aulast%3DDorn%26aufirst%3DA.%26aulast%3DBaur%26aufirst%3DB.%26aulast%3DSchattel%26aufirst%3DV.%26aulast%3DGoettert%26aufirst%3DM.%2BI.%26aulast%3DMayer-Wrangowski%26aufirst%3DS.%2BC.%26aulast%3DRauh%26aufirst%3DD.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DTargeting%2520the%2520hinge%2520glycine%2520flip%2520and%2520the%2520activation%2520loop%253A%2520novel%2520approach%2520to%2520potent%2520p38%25CE%25B1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7862%26epage%3D7874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Stelmach, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pivnichny, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hop, C. E. C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strauss, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Keefe, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmatz, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaller, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, J. B.</span><span> </span><span class="NLM_article-title">Design and synthesis of potent, orally bioavailable dihydroquinazolinone inhibitors of p38 MAP kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">280</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2FS0960-894X%2802%2900752-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=12482439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVemu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=277-280&author=J.+E.+Stelmachauthor=L.+Liuauthor=S.+B.+Patelauthor=J.+V.+Pivnichnyauthor=G.+Scapinauthor=S.+Singhauthor=C.+E.+C.+A.+Hopauthor=Z.+Wangauthor=J.+R.+Straussauthor=P.+M.+Cameronauthor=E.+A.+Nicholsauthor=S.+J.+O%E2%80%99Keefeauthor=E.+A.+O%E2%80%99Neillauthor=D.+M.+Schmatzauthor=C.+D.+Schwartzauthor=C.+M.+Thompsonauthor=D.+M.+Zallerauthor=J.+B.+Doherty&title=Design+and+synthesis+of+potent%2C+orally+bioavailable+dihydroquinazolinone+inhibitors+of+p38+MAP+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of potent, orally bioavailable dihydroquinazolinone inhibitors of p38 MAP kinase</span></div><div class="casAuthors">Stelmach, John E.; Liu, Luping; Patel, Sangita B.; Pivnichny, James V.; Scapin, Giovanna; Singh, Suresh; Hop, Cornelis E. C. A.; Wang, Zhen; Strauss, John R.; Cameron, Patricia M.; Nichols, Elizabeth A.; O'Keefe, Stephen J.; O'Neill, Edward A.; Schmatz, Dennis M.; Schwartz, Cheryl D.; Thompson, Chris M.; Zaller, Dennis M.; Doherty, James B.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">277-280</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The development of potent, orally bioavailable (in rat) and selective dihydroquinazolinone inhibitors I (R = CO2Me, R1 = H, Br, 2-FC6H4, etc.; R = OMe, R1 = 2-Cl-4-FC6H3, 2,4-F2C6H3, 2-ClC6H4), II (R1 = 2-Cl-4-FC6H3, 2,4-F2C6H3, 2-ClC6H4, X = none, O, NH, CH2, CO, Y = CH, N) and III (R2 = Me, Et, CHMe2, etc.) of p38α MAP kinase is described.  For example, III (R2 = CMe3) was prepd. via the Still coupling of I (R = OSO2CF3, R1 = 2-Cl-4-FC6H3) with 1-tert-butyl-4-(trimethylstannyl)-1,2,3,6-tetrahydropyridine.  These analogs are hybrids of a pyridinylimidazole p38α inhibitor reported by Merck Research Labs. and VX-745.  Optimization of the C-5 Ph and the C-7 piperidinyl substituents led to the identification of III (R2 = CMe3) which gave excellent suppression of TNF-α prodn. in LPS-stimulated whole blood (IC50=10 nM) and good oral exposure in rats (F=68%, AUCn PO=0.58 μM h).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeEsr0ksZsw7Vg90H21EOLACvtfcHk0lgg77F7uqZlbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVemu7c%253D&md5=489ab070411bc48e879737d57d98d745</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900752-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900752-7%26sid%3Dliteratum%253Aachs%26aulast%3DStelmach%26aufirst%3DJ.%2BE.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DPivnichny%26aufirst%3DJ.%2BV.%26aulast%3DScapin%26aufirst%3DG.%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DHop%26aufirst%3DC.%2BE.%2BC.%2BA.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DStrauss%26aufirst%3DJ.%2BR.%26aulast%3DCameron%26aufirst%3DP.%2BM.%26aulast%3DNichols%26aufirst%3DE.%2BA.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DS.%2BJ.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DE.%2BA.%26aulast%3DSchmatz%26aufirst%3DD.%2BM.%26aulast%3DSchwartz%26aufirst%3DC.%2BD.%26aulast%3DThompson%26aufirst%3DC.%2BM.%26aulast%3DZaller%26aufirst%3DD.%2BM.%26aulast%3DDoherty%26aufirst%3DJ.%2BB.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%252C%2520orally%2520bioavailable%2520dihydroquinazolinone%2520inhibitors%2520of%2520p38%2520MAP%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D277%26epage%3D280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Selness, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monahan, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devadas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durley, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shieh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hepperle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rucker, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jerome, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marrufo, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Promo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickory, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvira, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naing, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blevis-Bal, R.</span><span> </span><span class="NLM_article-title">Discovery of N-substituted pyridinones as potent and selective inhibitors of p38 kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5851</span><span class="NLM_x">–</span> <span class="NLM_lpage">5856</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2Fj.bmcl.2009.08.082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=19751974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtF2hurrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5851-5856&author=S.+R.+Selnessauthor=R.+V.+Devrajauthor=J.+B.+Monahanauthor=T.+L.+Boehmauthor=J.+K.+Walkerauthor=B.+Devadasauthor=R.+C.+Durleyauthor=R.+Kurumbailauthor=H.+Shiehauthor=L.+Xingauthor=M.+Hepperleauthor=P.+V.+Ruckerauthor=K.+D.+Jeromeauthor=A.+G.+Bensonauthor=L.+D.+Marrufoauthor=H.+M.+Madsenauthor=J.+Hitchcockauthor=T.+J.+Owenauthor=L.+Christieauthor=M.+A.+Promoauthor=B.+S.+Hickoryauthor=E.+Alviraauthor=W.+Naingauthor=R.+Blevis-Bal&title=Discovery+of+N-substituted+pyridinones+as+potent+and+selective+inhibitors+of+p38+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-substituted pyridinones as potent and selective inhibitors of p38 kinase</span></div><div class="casAuthors">Selness, Shaun R.; Devraj, Rajesh V.; Monahan, Joseph B.; Boehm, Terri L.; Walker, John K.; Devadas, Balekudru; Durley, Richard C.; Kurumbail, Ravi; Shieh, Huey; Xing, Li; Hepperle, Michael; Rucker, Paul V.; Jerome, Kevin D.; Benson, Alan G.; Marrufo, Laura D.; Madsen, Heather M.; Hitchcock, Jeff; Owen, Tom J.; Christie, Lance; Promo, Michele A.; Hickory, Brian S.; Alvira, Edgardo; Naing, Win; Blevis-Bal, Radhika</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5851-5856</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The identification and evolution of a series of potent and selective p38 inhibitors is described.  P38 inhibitors based on a N-benzyl pyridinone high-throughput screening hit were prepd. and their SAR explored.  Their design was guided by ligand bound co-crystals of p38α.  These efforts resulted in the identification of I and II as orally active inhibitors of p38 with significant efficacy in both acute and chronic models of inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraSKP6sKqHObVg90H21EOLACvtfcHk0lhTHLdmAC4JTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtF2hurrL&md5=bd43337cce34422c9501586a27857f5c</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.082%26sid%3Dliteratum%253Aachs%26aulast%3DSelness%26aufirst%3DS.%2BR.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DMonahan%26aufirst%3DJ.%2BB.%26aulast%3DBoehm%26aufirst%3DT.%2BL.%26aulast%3DWalker%26aufirst%3DJ.%2BK.%26aulast%3DDevadas%26aufirst%3DB.%26aulast%3DDurley%26aufirst%3DR.%2BC.%26aulast%3DKurumbail%26aufirst%3DR.%26aulast%3DShieh%26aufirst%3DH.%26aulast%3DXing%26aufirst%3DL.%26aulast%3DHepperle%26aufirst%3DM.%26aulast%3DRucker%26aufirst%3DP.%2BV.%26aulast%3DJerome%26aufirst%3DK.%2BD.%26aulast%3DBenson%26aufirst%3DA.%2BG.%26aulast%3DMarrufo%26aufirst%3DL.%2BD.%26aulast%3DMadsen%26aufirst%3DH.%2BM.%26aulast%3DHitchcock%26aufirst%3DJ.%26aulast%3DOwen%26aufirst%3DT.%2BJ.%26aulast%3DChristie%26aufirst%3DL.%26aulast%3DPromo%26aufirst%3DM.%2BA.%26aulast%3DHickory%26aufirst%3DB.%2BS.%26aulast%3DAlvira%26aufirst%3DE.%26aulast%3DNaing%26aufirst%3DW.%26aulast%3DBlevis-Bal%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520N-substituted%2520pyridinones%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520p38%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5851%26epage%3D5856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Pargellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churchill, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grob, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, J.</span><span> </span><span class="NLM_article-title">Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1038%2Fnsb770" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1Kisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=268-272&author=C.+Pargellisauthor=L.+Tongauthor=L.+Churchillauthor=P.+F.+Cirilloauthor=T.+Gilmoreauthor=A.+G.+Grahamauthor=P.+M.+Grobauthor=E.+R.+Hickeyauthor=N.+Mossauthor=S.+Pavauthor=J.+Regan&title=Inhibition+of+p38+MAP+kinase+by+utilizing+a+novel+allosteric+binding+site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site</span></div><div class="casAuthors">Pargellis, Christopher; Tong, Liang; Churchill, Laurie; Cirillo, Pier F.; Gilmore, Thomas; Graham, Anne G.; Grob, Peter M.; Hickey, Eugene R.; Moss, Neil; Pav, Susan; Regan, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">268-272</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">The p38 MAP kinase plays a crucial role in regulating the prodn. of proinflammatory cytokines, such as tumor necrosis factor and interleukin-1.  Blocking this kinase may offer an effective therapy for treating many inflammatory diseases.  Here we report a new allosteric binding site for a diaryl urea class of highly potent and selective inhibitors against human p38 MAP kinase.  The formation of this binding site requires a large conformational change not obsd. previously for any of the protein Ser/Thr kinases.  This change is in the highly conserved Asp-Phe-Gly motif within the active site of the kinase.  Soln. studies demonstrate that this class of compds. has slow binding kinetics, consistent with the requirement for conformational change.  Improving interactions in this allosteric pocket, as well as establishing binding interactions in the ATP pocket, enhanced the affinity of the inhibitors by 12,000-fold.  One of the most potent compds. in this series, BIRB 796, has picomolar affinity for the kinase and low nanomolar inhibitory activity in cell culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqT8_QT7_pbYrVg90H21EOLACvtfcHk0lhTHLdmAC4JTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1Kisbk%253D&md5=68850ecdbe08df4285ba38cfa2c93ea4</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1038%2Fnsb770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb770%26sid%3Dliteratum%253Aachs%26aulast%3DPargellis%26aufirst%3DC.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DChurchill%26aufirst%3DL.%26aulast%3DCirillo%26aufirst%3DP.%2BF.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DA.%2BG.%26aulast%3DGrob%26aufirst%3DP.%2BM.%26aulast%3DHickey%26aufirst%3DE.%2BR.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DRegan%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520p38%2520MAP%2520kinase%2520by%2520utilizing%2520a%2520novel%2520allosteric%2520binding%2520site%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D268%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Komander, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kular, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuttelkopf, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prakash, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrido-Franco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Aalten, D. M.</span><span> </span><span class="NLM_article-title">Interactions of LY333531 and other bisindolyl maleimide inhibitors with PDK1</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=215-226&author=D.+Komanderauthor=G.+S.+Kularauthor=A.+W.+Schuttelkopfauthor=M.+Deakauthor=K.+R.+Prakashauthor=J.+Bainauthor=M.+Elliottauthor=M.+Garrido-Francoauthor=A.+P.+Kozikowskiauthor=D.+R.+Alessiauthor=D.+M.+van+Aalten&title=Interactions+of+LY333531+and+other+bisindolyl+maleimide+inhibitors+with+PDK1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKomander%26aufirst%3DD.%26aulast%3DKular%26aufirst%3DG.%2BS.%26aulast%3DSchuttelkopf%26aufirst%3DA.%2BW.%26aulast%3DDeak%26aufirst%3DM.%26aulast%3DPrakash%26aufirst%3DK.%2BR.%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DGarrido-Franco%26aufirst%3DM.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3Dvan%2BAalten%26aufirst%3DD.%2BM.%26atitle%3DInteractions%2520of%2520LY333531%2520and%2520other%2520bisindolyl%2520maleimide%2520inhibitors%2520with%2520PDK1%26jtitle%3DStructure%26date%3D2004%26volume%3D12%26spage%3D215%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Aronov, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germann, U. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janetka, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltais, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Botella, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namchuk, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straub, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X.</span><span> </span><span class="NLM_article-title">Flipped out: structure-guided design of selective pyrazolylpyrrole ERK inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1280</span><span class="NLM_x">–</span> <span class="NLM_lpage">1287</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061381f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1280-1287&author=A.+M.+Aronovauthor=C.+Bakerauthor=G.+W.+Bemisauthor=J.+Caoauthor=G.+Chenauthor=P.+J.+Fordauthor=U.+A.+Germannauthor=J.+Greenauthor=M.+R.+Haleauthor=M.+Jacobsauthor=J.+W.+Janetkaauthor=F.+Maltaisauthor=G.+Martinez-Botellaauthor=M.+N.+Namchukauthor=J.+Straubauthor=Q.+Tangauthor=X.+Xie&title=Flipped+out%3A+structure-guided+design+of+selective+pyrazolylpyrrole+ERK+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1021%2Fjm061381f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061381f%26sid%3Dliteratum%253Aachs%26aulast%3DAronov%26aufirst%3DA.%2BM.%26aulast%3DBaker%26aufirst%3DC.%26aulast%3DBemis%26aufirst%3DG.%2BW.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DFord%26aufirst%3DP.%2BJ.%26aulast%3DGermann%26aufirst%3DU.%2BA.%26aulast%3DGreen%26aufirst%3DJ.%26aulast%3DHale%26aufirst%3DM.%2BR.%26aulast%3DJacobs%26aufirst%3DM.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26aulast%3DMaltais%26aufirst%3DF.%26aulast%3DMartinez-Botella%26aufirst%3DG.%26aulast%3DNamchuk%26aufirst%3DM.%2BN.%26aulast%3DStraub%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DQ.%26aulast%3DXie%26aufirst%3DX.%26atitle%3DFlipped%2520out%253A%2520structure-guided%2520design%2520of%2520selective%2520pyrazolylpyrrole%2520ERK%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1280%26epage%3D1287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Dudkin, V. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreatsoulas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrington, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikuta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stirdivant, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drakas, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobell, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepp-Lorenzino, L.</span><span> </span><span class="NLM_article-title">Pyridyl aminothiazoles as potent inhibitors of Chk1 with slow dissociation rates</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2609</span><span class="NLM_x">–</span> <span class="NLM_lpage">2612</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2609-2612&author=V.+Y.+Dudkinauthor=K.+Rickertauthor=C.+Kreatsoulasauthor=C.+Wangauthor=K.+L.+Arringtonauthor=M.+E.+Fraleyauthor=G.+D.+Hartmanauthor=Y.+Yanauthor=M.+Ikutaauthor=S.+M.+Stirdivantauthor=R.+A.+Drakasauthor=E.+S.+Walshauthor=K.+Hamiltonauthor=C.+A.+Buserauthor=R.+B.+Lobellauthor=L.+Sepp-Lorenzino&title=Pyridyl+aminothiazoles+as+potent+inhibitors+of+Chk1+with+slow+dissociation+rates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDudkin%26aufirst%3DV.%2BY.%26aulast%3DRickert%26aufirst%3DK.%26aulast%3DKreatsoulas%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DArrington%26aufirst%3DK.%2BL.%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DIkuta%26aufirst%3DM.%26aulast%3DStirdivant%26aufirst%3DS.%2BM.%26aulast%3DDrakas%26aufirst%3DR.%2BA.%26aulast%3DWalsh%26aufirst%3DE.%2BS.%26aulast%3DHamilton%26aufirst%3DK.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26aulast%3DLobell%26aufirst%3DR.%2BB.%26aulast%3DSepp-Lorenzino%26aufirst%3DL.%26atitle%3DPyridyl%2520aminothiazoles%2520as%2520potent%2520inhibitors%2520of%2520Chk1%2520with%2520slow%2520dissociation%2520rates%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2609%26epage%3D2612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Whelligan, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solanki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K.-M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mas-Droux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barillari, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grummitt, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Montfort, R. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayliss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelder, S.</span><span> </span><span class="NLM_article-title">Aminopyrazine inhibitors binding to an unusual inactive conformation of the mitotic kinase Nek2: SAR and structural characterization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7682</span><span class="NLM_x">–</span> <span class="NLM_lpage">7698</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1008727" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Krs7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7682-7698&author=D.+K.+Whelliganauthor=S.+Solankiauthor=D.+Taylorauthor=D.+W.+Thomsonauthor=K.-M.+J.+Cheungauthor=K.+Boxallauthor=C.+Mas-Drouxauthor=C.+Barillariauthor=S.+Burnsauthor=C.+G.+Grummittauthor=I.+Collinsauthor=R.+L.+M.+van+Montfortauthor=G.+W.+Aherneauthor=R.+Baylissauthor=S.+Hoelder&title=Aminopyrazine+inhibitors+binding+to+an+unusual+inactive+conformation+of+the+mitotic+kinase+Nek2%3A+SAR+and+structural+characterization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Aminopyrazine Inhibitors Binding to an Unusual Inactive Conformation of the Mitotic Kinase Nek2: SAR and Structural Characterization</span></div><div class="casAuthors">Whelligan, Daniel K.; Solanki, Savade; Taylor, Dawn; Thomson, Douglas W.; Cheung, Kwai-Ming J.; Boxall, Kathy; Mas-Droux, Corine; Barillari, Caterina; Burns, Samantha; Grummitt, Charles G.; Collins, Ian; van Montfort, Rob L. M.; Aherne, G. Wynne; Bayliss, Richard; Hoelder, Swen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7682-7698</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report herein the first systematic exploration of inhibitors of the mitotic kinase Nek2.  Starting from HTS hit aminopyrazine I, compds. with improved activity were identified using structure-based design.  Our structural biol. investigations reveal two notable observations.  First, I and related compds. bind to an unusual, inactive conformation of the kinase which to the best of our knowledge has not been reported for other types of kinase inhibitors.  Second, a phenylalanine residue at the center of the ATP pocket strongly affects the ability of the inhibitor to bind to the protein.  The implications of these observations are discussed, and the work described here defines key features for potent and selective Nek2 inhibition, which will aid the identification of more advanced inhibitors of Nek2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhzgVaRXbQkrVg90H21EOLACvtfcHk0lhLbwlbCgoGtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Krs7nI&md5=d1a4af6869319bed0a340e8ff7db4397</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1021%2Fjm1008727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1008727%26sid%3Dliteratum%253Aachs%26aulast%3DWhelligan%26aufirst%3DD.%2BK.%26aulast%3DSolanki%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DD.%26aulast%3DThomson%26aufirst%3DD.%2BW.%26aulast%3DCheung%26aufirst%3DK.-M.%2BJ.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DMas-Droux%26aufirst%3DC.%26aulast%3DBarillari%26aufirst%3DC.%26aulast%3DBurns%26aufirst%3DS.%26aulast%3DGrummitt%26aufirst%3DC.%2BG.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3Dvan%2BMontfort%26aufirst%3DR.%2BL.%2BM.%26aulast%3DAherne%26aufirst%3DG.%2BW.%26aulast%3DBayliss%26aufirst%3DR.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DAminopyrazine%2520inhibitors%2520binding%2520to%2520an%2520unusual%2520inactive%2520conformation%2520of%2520the%2520mitotic%2520kinase%2520Nek2%253A%2520SAR%2520and%2520structural%2520characterization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7682%26epage%3D7698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuruganti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruslim, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramphal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherrington, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendel, D. B.</span><span> </span><span class="NLM_article-title">A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">7345</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=7345-55&author=J.+G.+Christensenauthor=R.+Schreckauthor=J.+Burrowsauthor=P.+Kurugantiauthor=E.+Chanauthor=P.+Leauthor=J.+Chenauthor=X.+Wangauthor=L.+Ruslimauthor=R.+Blakeauthor=K.+E.+Lipsonauthor=J.+Ramphalauthor=S.+Doauthor=J.+J.+Cuiauthor=J.+M.+Cherringtonauthor=D.+B.+Mendel&title=A+selective+small+molecule+inhibitor+of+c-Met+kinase+inhibits+c-Met-dependent+phenotypes+in+vitro+and+exhibits+cytoreductive+antitumor+activity+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DSchreck%26aufirst%3DR.%26aulast%3DBurrows%26aufirst%3DJ.%26aulast%3DKuruganti%26aufirst%3DP.%26aulast%3DChan%26aufirst%3DE.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DRuslim%26aufirst%3DL.%26aulast%3DBlake%26aufirst%3DR.%26aulast%3DLipson%26aufirst%3DK.%2BE.%26aulast%3DRamphal%26aufirst%3DJ.%26aulast%3DDo%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DCherrington%26aufirst%3DJ.%2BM.%26aulast%3DMendel%26aufirst%3DD.%2BB.%26atitle%3DA%2520selective%2520small%2520molecule%2520inhibitor%2520of%2520c-Met%2520kinase%2520inhibits%2520c-Met-dependent%2520phenotypes%2520in%2520vitro%2520and%2520exhibits%2520cytoreductive%2520antitumor%2520activity%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D7345%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Young, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeliger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggs, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyan, J.</span><span> </span><span class="NLM_article-title">Structure of the kinase domain of an imatinib-resistant Abl mutant in complex with the aurora kinase inhibitor VX-680</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1014</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1158%2F0008-5472.CAN-05-2788" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=16424036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsFOhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=1007-1014&author=M.+A.+Youngauthor=N.+P.+Shahauthor=L.+H.+Chaoauthor=M.+Seeligerauthor=Z.+V.+Milanovauthor=W.+H.+Biggsauthor=D.+K.+Treiberauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhartauthor=C.+L.+Sawyersauthor=J.+Kuriyan&title=Structure+of+the+kinase+domain+of+an+imatinib-resistant+Abl+mutant+in+complex+with+the+aurora+kinase+inhibitor+VX-680"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the Kinase Domain of an Imatinib-Resistant Abl Mutant in Complex with the Aurora Kinase Inhibitor VX-680</span></div><div class="casAuthors">Young, Matthew A.; Shah, Neil P.; Chao, Luke H.; Seeliger, Markus; Milanov, Zdravko V.; Biggs, William H., III; Treiber, Daniel K.; Patel, Hitesh K.; Zarrinkar, Patrick P.; Lockhart, David J.; Sawyers, Charles L.; Kuriyan, John</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1007-1014</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We present a high-resoln. (2.0 Å) crystal structure of the catalytic domain of a mutant form of the Abl tyrosine kinase (H396P; Abl-1a numbering) that is resistant to the Abl inhibitor imatinib.  The structure is detd. in complex with the small-mol. inhibitor VX-680 (Vertex Pharmaceuticals, Cambridge, MA), which blocks the activity of various imatinib-resistant mutant forms of Abl, including one (T315I) that is resistant to both imatinib and BMS-354825 (dasatinib), a dual Src/Abl inhibitor that seems to be clin. effective against all other imatinib-resistant forms of BCR-Abl.  VX-680 is shown to have significant inhibitory activity against BCR-Abl bearing the T315I mutation in patient-derived samples.  The Abl kinase domain bound to VX-680 is not phosphorylated on the activation loop in the crystal structure but is nevertheless in an active conformation, previously unobserved for Abl and inconsistent with the binding of imatinib.  The adoption of an active conformation is most likely the result of synergy between the His396Pro mutation, which destabilizes the inactive conformation required for imatinib binding, and the binding of VX-680, which favors the active conformation through hydrogen bonding and steric effects.  VX-680 is bound to Abl in a mode that accommodates the substitution of isoleucine for threonine at residue 315 (the "gatekeeper" position).  The avoidance of the innermost cavity of the Abl kinase domain by VX-680 and the specific recognition of the active conformation explain the effectiveness of this compd. against mutant forms of BCR-Abl, including those with mutations at the gatekeeper position.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNV6YSmt1NWrVg90H21EOLACvtfcHk0lhLbwlbCgoGtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsFOhtw%253D%253D&md5=a31ed99bdc51cf266c8c10dfceb1800c</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-2788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-2788%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DM.%2BA.%26aulast%3DShah%26aufirst%3DN.%2BP.%26aulast%3DChao%26aufirst%3DL.%2BH.%26aulast%3DSeeliger%26aufirst%3DM.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26aulast%3DKuriyan%26aufirst%3DJ.%26atitle%3DStructure%2520of%2520the%2520kinase%2520domain%2520of%2520an%2520imatinib-resistant%2520Abl%2520mutant%2520in%2520complex%2520with%2520the%2520aurora%2520kinase%2520inhibitor%2520VX-680%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D1007%26epage%3D1014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Petrov, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockerill, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickerson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mook, R. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusnak, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lackey, K. E.</span><span> </span><span class="NLM_article-title">Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4686</span><span class="NLM_x">–</span> <span class="NLM_lpage">4691</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2Fj.bmcl.2006.05.090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=16777410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsFOlu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4686-4691&author=K.+G.+Petrovauthor=Y.-M.+Zhangauthor=M.+Carterauthor=G.+S.+Cockerillauthor=S.+Dickersonauthor=C.+A.+Gauthierauthor=Y.+Guoauthor=R.+A.+Mookauthor=D.+W.+Rusnakauthor=A.+L.+Walkerauthor=E.+R.+Woodauthor=K.+E.+Lackey&title=Optimization+and+SAR+for+dual+ErbB-1%2FErbB-2+tyrosine+kinase+inhibition+in+the+6-furanylquinazoline+series"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series</span></div><div class="casAuthors">Petrov, Kimberly G.; Zhang, Yue-Mei; Carter, Malcolm; Cockerill, G. Stuart; Dickerson, Scott; Gauthier, Cassandra A.; Guo, Yu; Mook, Robert A.; Rusnak, David W.; Walker, Ann L.; Wood, Edgar R.; Lackey, Karen E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4686-4691</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Synthetic modifications on a 6-furanylquinazoline scaffold to optimize the dual ErbB-1/ErbB-2 tyrosine kinase inhibition afforded consistent SAR whereby a 4-(3-fluorobenzyloxy)-3-haloanilino structure provided the best enzyme potency and cellular selectivity.  Changes made to the 6-furanyl group had little impact on the enzyme activity, but appeared to dramatically affect the cellular efficacy.  The discovery of lapatinib emerged from this work.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtejUjyH9in7Vg90H21EOLACvtfcHk0ljO62OAbveCfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsFOlu7o%253D&md5=946712927ab1a7940ea3ef2fea7574b5</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.05.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.05.090%26sid%3Dliteratum%253Aachs%26aulast%3DPetrov%26aufirst%3DK.%2BG.%26aulast%3DZhang%26aufirst%3DY.-M.%26aulast%3DCarter%26aufirst%3DM.%26aulast%3DCockerill%26aufirst%3DG.%2BS.%26aulast%3DDickerson%26aufirst%3DS.%26aulast%3DGauthier%26aufirst%3DC.%2BA.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DMook%26aufirst%3DR.%2BA.%26aulast%3DRusnak%26aufirst%3DD.%2BW.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26aulast%3DWood%26aufirst%3DE.%2BR.%26aulast%3DLackey%26aufirst%3DK.%2BE.%26atitle%3DOptimization%2520and%2520SAR%2520for%2520dual%2520ErbB-1%252FErbB-2%2520tyrosine%2520kinase%2520inhibition%2520in%2520the%25206-furanylquinazoline%2520series%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4686%26epage%3D4691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">D’Angelo, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booker, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fellows, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan-Lefko, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rainbeau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reider, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rex, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegmund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasker, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dussault, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. S.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of potent c-Met inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5766</span><span class="NLM_x">–</span> <span class="NLM_lpage">5779</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8006189" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5766-5779&author=N.+D.+D%E2%80%99Angeloauthor=S.+F.+Bellonauthor=S.+K.+Bookerauthor=Y.+Chengauthor=A.+Coxonauthor=C.+Dominguezauthor=I.+Fellowsauthor=D.+Hoffmanauthor=R.+Hungateauthor=P.+Kaplan-Lefkoauthor=M.+R.+Leeauthor=C.+Liauthor=L.+Liuauthor=E.+Rainbeauauthor=P.+J.+Reiderauthor=K.+Rexauthor=A.+Siegmundauthor=Y.+Sunauthor=A.+S.+Taskerauthor=N.+Xiauthor=S.+Xuauthor=Y.+Yangauthor=Y.+Zhangauthor=T.+L.+Burgessauthor=I.+Dussaultauthor=T.+S.+Kim&title=Design%2C+synthesis%2C+and+biological+evaluation+of+potent+c-Met+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1021%2Fjm8006189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8006189%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Angelo%26aufirst%3DN.%2BD.%26aulast%3DBellon%26aufirst%3DS.%2BF.%26aulast%3DBooker%26aufirst%3DS.%2BK.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DDominguez%26aufirst%3DC.%26aulast%3DFellows%26aufirst%3DI.%26aulast%3DHoffman%26aufirst%3DD.%26aulast%3DHungate%26aufirst%3DR.%26aulast%3DKaplan-Lefko%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DRainbeau%26aufirst%3DE.%26aulast%3DReider%26aufirst%3DP.%2BJ.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DSiegmund%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DTasker%26aufirst%3DA.%2BS.%26aulast%3DXi%26aufirst%3DN.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBurgess%26aufirst%3DT.%2BL.%26aulast%3DDussault%26aufirst%3DI.%26aulast%3DKim%26aufirst%3DT.%2BS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520potent%2520c-Met%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5766%26epage%3D5779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Meier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brookings, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceska, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMillan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saville, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mushtaq, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savva, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, R. A.</span><span> </span><span class="NLM_article-title">Engineering human MEK-1 for structural studies: a case study of combinatorial domain hunting</span> <span class="citation_source-journal">J. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">177</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2012&pages=329-334&author=C.+Meierauthor=D.+C.+Brookingsauthor=T.+A.+Ceskaauthor=C.+Doyleauthor=H.+Gongauthor=D.+McMillanauthor=G.+P.+Savilleauthor=A.+Mushtaqauthor=D.+Knightauthor=S.+Reichauthor=L.+H.+Pearlauthor=K.+A.+Powellauthor=R.+Savvaauthor=R.+A.+Allen&title=Engineering+human+MEK-1+for+structural+studies%3A+a+case+study+of+combinatorial+domain+hunting"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeier%26aufirst%3DC.%26aulast%3DBrookings%26aufirst%3DD.%2BC.%26aulast%3DCeska%26aufirst%3DT.%2BA.%26aulast%3DDoyle%26aufirst%3DC.%26aulast%3DGong%26aufirst%3DH.%26aulast%3DMcMillan%26aufirst%3DD.%26aulast%3DSaville%26aufirst%3DG.%2BP.%26aulast%3DMushtaq%26aufirst%3DA.%26aulast%3DKnight%26aufirst%3DD.%26aulast%3DReich%26aufirst%3DS.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DPowell%26aufirst%3DK.%2BA.%26aulast%3DSavva%26aufirst%3DR.%26aulast%3DAllen%26aufirst%3DR.%2BA.%26atitle%3DEngineering%2520human%2520MEK-1%2520for%2520structural%2520studies%253A%2520a%2520case%2520study%2520of%2520combinatorial%2520domain%2520hunting%26jtitle%3DJ.%2520Struct.%2520Biol.%26date%3D2012%26volume%3D177%26spage%3D329%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Betzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubbers, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakkaraj, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georg, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schonbrunn, E.</span><span> </span><span class="NLM_article-title">Discovery of a potential allosteric ligand binding site in CDK2</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">492</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb100410m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1Gisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=492-501&author=S.+Betziauthor=R.+Alamauthor=M.+Martinauthor=D.+J.+Lubbersauthor=H.+Hanauthor=S.+R.+Jakkarajauthor=G.+I.+Georgauthor=E.+Schonbrunn&title=Discovery+of+a+potential+allosteric+ligand+binding+site+in+CDK2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potential Allosteric Ligand Binding Site in CDK2</span></div><div class="casAuthors">Betzi, Stephane; Alam, Riazul; Martin, Mathew; Lubbers, Donna J.; Han, Huijong; Jakkaraj, Sudhakar R.; Georg, Gunda I.; Schonbrunn, Ernst</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">492-501</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclin-dependent kinases (CDKs) are key regulatory enzymes in cell cycle progression and transcription.  Aberrant activity of CDKs has been implicated in a no. of medical conditions, and numerous small mol. CDK inhibitors have been reported as potential drug leads.  However, these inhibitors exclusively bind to the ATP site, which is largely conserved among protein kinases, and clin. trials have not resulted in viable drug candidates, attributed in part to the lack of target selectivity.  CDKs are unique among protein kinases, as their functionality strictly depends on assocn. with their partner proteins, the cyclins.  In an effort to identify potential target sites for disruption of the CDK-cyclin interaction, we probed the extrinsic fluorophore 8-anilino-1-naphthalene sulfonate (ANS) with human CDK2 and cyclin A using fluorescence spectroscopy and protein crystallog.  ANS interacts with free CDK2 in a satn.-dependent manner with an apparent Kd of 37 μM, and cyclin A displaced ANS from CDK2 with an EC50 value of 0.6 μM.  Co-crystal structures with ANS alone and in ternary complex with ATP site-directed inhibitors revealed two ANS mols. bound adjacent to one another, away from the ATP site, in a large pocket that extends from the DFG region above the C-helix.  Binding of ANS is accompanied by substantial structural changes in CDK2, resulting in a C-helix conformation that is incompatible for cyclin A assocn.  These findings indicate the potential of the ANS binding pocket as a new target site for allosteric inhibitors disrupting the interaction of CDKs and cyclins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGlhg8YO4Yl7Vg90H21EOLACvtfcHk0lh9X7LHM7NjZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1Gisb4%253D&md5=893aed13b1638f7626fbb4851014fe6e</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1021%2Fcb100410m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb100410m%26sid%3Dliteratum%253Aachs%26aulast%3DBetzi%26aufirst%3DS.%26aulast%3DAlam%26aufirst%3DR.%26aulast%3DMartin%26aufirst%3DM.%26aulast%3DLubbers%26aufirst%3DD.%2BJ.%26aulast%3DHan%26aufirst%3DH.%26aulast%3DJakkaraj%26aufirst%3DS.%2BR.%26aulast%3DGeorg%26aufirst%3DG.%2BI.%26aulast%3DSchonbrunn%26aufirst%3DE.%26atitle%3DDiscovery%2520of%2520a%2520potential%2520allosteric%2520ligand%2520binding%2520site%2520in%2520CDK2%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2011%26volume%3D6%26spage%3D492%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Axten, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romeril, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heerding, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minthorn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mencken, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigethy, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomberlin, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassell, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahler, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shewchuk, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gampe, R. T.</span><span> </span><span class="NLM_article-title">Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1<i>H</i>-indol-5-yl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7193</span><span class="NLM_x">–</span> <span class="NLM_lpage">7207</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300713s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7193-7207&author=J.+M.+Axtenauthor=J.+R.+Medinaauthor=Y.+Fengauthor=A.+Shuauthor=S.+P.+Romerilauthor=S.+W.+Grantauthor=W.+H.+Liauthor=D.+A.+Heerdingauthor=E.+Minthornauthor=T.+Menckenauthor=C.+Atkinsauthor=Q.+Liuauthor=S.+Rabindranauthor=R.+Kumarauthor=X.+Hongauthor=A.+Goetzauthor=T.+Stanleyauthor=J.+D.+Taylorauthor=S.+D.+Sigethyauthor=G.+H.+Tomberlinauthor=A.+M.+Hassellauthor=K.+M.+Kahlerauthor=L.+M.+Shewchukauthor=R.+T.+Gampe&title=Discovery+of+7-methyl-5-%281-%7B%5B3-%28trifluoromethyl%29phenyl%5Dacetyl%7D-2%2C3-dihydro-1H-indol-5-yl%29-7H-pyrrolo%5B2%2C3-d%5Dpyrimidin-4-amine+%28GSK2606414%29%2C+a+potent+and+selective+first-in-class+inhibitor+of+protein+kinase+R+%28PKR%29-like+endoplasmic+reticulum+kinase+%28PERK%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1021%2Fjm300713s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300713s%26sid%3Dliteratum%253Aachs%26aulast%3DAxten%26aufirst%3DJ.%2BM.%26aulast%3DMedina%26aufirst%3DJ.%2BR.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DShu%26aufirst%3DA.%26aulast%3DRomeril%26aufirst%3DS.%2BP.%26aulast%3DGrant%26aufirst%3DS.%2BW.%26aulast%3DLi%26aufirst%3DW.%2BH.%26aulast%3DHeerding%26aufirst%3DD.%2BA.%26aulast%3DMinthorn%26aufirst%3DE.%26aulast%3DMencken%26aufirst%3DT.%26aulast%3DAtkins%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DRabindran%26aufirst%3DS.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DHong%26aufirst%3DX.%26aulast%3DGoetz%26aufirst%3DA.%26aulast%3DStanley%26aufirst%3DT.%26aulast%3DTaylor%26aufirst%3DJ.%2BD.%26aulast%3DSigethy%26aufirst%3DS.%2BD.%26aulast%3DTomberlin%26aufirst%3DG.%2BH.%26aulast%3DHassell%26aufirst%3DA.%2BM.%26aulast%3DKahler%26aufirst%3DK.%2BM.%26aulast%3DShewchuk%26aufirst%3DL.%2BM.%26aulast%3DGampe%26aufirst%3DR.%2BT.%26atitle%3DDiscovery%2520of%25207-methyl-5-%25281-%257B%255B3-%2528trifluoromethyl%2529phenyl%255Dacetyl%257D-2%252C3-dihydro-1H-indol-5-yl%2529-7H-pyrrolo%255B2%252C3-d%255Dpyrimidin-4-amine%2520%2528GSK2606414%2529%252C%2520a%2520potent%2520and%2520selective%2520first-in-class%2520inhibitor%2520of%2520protein%2520kinase%2520R%2520%2528PKR%2529-like%2520endoplasmic%2520reticulum%2520kinase%2520%2528PERK%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7193%26epage%3D7207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Bellon, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan-Lefko, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rex, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dussault, I.</span><span> </span><span class="NLM_article-title">c-Met inhibitors with novel binding mode show activity against several hereditary papillary renal cell carcinoma-related mutations</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">2675</span><span class="NLM_x">–</span> <span class="NLM_lpage">2683</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=2675-2683&author=S.+F.+Bellonauthor=P.+Kaplan-Lefkoauthor=Y.+Yangauthor=Y.+Zhangauthor=J.+Moriguchiauthor=K.+Rexauthor=C.+W.+Johnsonauthor=P.+E.+Roseauthor=A.+M.+Longauthor=A.+B.+O%E2%80%99Connorauthor=Y.+Guauthor=A.+Coxonauthor=T.+S.+Kimauthor=A.+Taskerauthor=T.+L.+Burgessauthor=I.+Dussault&title=c-Met+inhibitors+with+novel+binding+mode+show+activity+against+several+hereditary+papillary+renal+cell+carcinoma-related+mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBellon%26aufirst%3DS.%2BF.%26aulast%3DKaplan-Lefko%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMoriguchi%26aufirst%3DJ.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DC.%2BW.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DLong%26aufirst%3DA.%2BM.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DA.%2BB.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DT.%2BS.%26aulast%3DTasker%26aufirst%3DA.%26aulast%3DBurgess%26aufirst%3DT.%2BL.%26aulast%3DDussault%26aufirst%3DI.%26atitle%3Dc-Met%2520inhibitors%2520with%2520novel%2520binding%2520mode%2520show%2520activity%2520against%2520several%2520hereditary%2520papillary%2520renal%2520cell%2520carcinoma-related%2520mutations%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D2675%26epage%3D2683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Norman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fellows, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Angelo, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rex, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dussault, I.</span><span> </span><span class="NLM_article-title">Structure-based design of novel class II c-Met inhibitors: 1. Identification of pyrazolone-based derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1858</span><span class="NLM_x">–</span> <span class="NLM_lpage">1867</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201330u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1858-1867&author=M.+H.+Normanauthor=L.+Liuauthor=M.+Leeauthor=N.+Xiauthor=I.+Fellowsauthor=N.+D.+D%E2%80%99Angeloauthor=C.+Dominguezauthor=K.+Rexauthor=S.+F.+Bellonauthor=T.+S.+Kimauthor=I.+Dussault&title=Structure-based+design+of+novel+class+II+c-Met+inhibitors%3A+1.+Identification+of+pyrazolone-based+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Fjm201330u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201330u%26sid%3Dliteratum%253Aachs%26aulast%3DNorman%26aufirst%3DM.%2BH.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DXi%26aufirst%3DN.%26aulast%3DFellows%26aufirst%3DI.%26aulast%3DD%25E2%2580%2599Angelo%26aufirst%3DN.%2BD.%26aulast%3DDominguez%26aufirst%3DC.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DBellon%26aufirst%3DS.%2BF.%26aulast%3DKim%26aufirst%3DT.%2BS.%26aulast%3DDussault%26aufirst%3DI.%26atitle%3DStructure-based%2520design%2520of%2520novel%2520class%2520II%2520c-Met%2520inhibitors%253A%25201.%2520Identification%2520of%2520pyrazolone-based%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1858%26epage%3D1867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polverino, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bready, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choquette, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMelfi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doerr, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neervannan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potashman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roveto, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrag, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starnes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teffera, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanon, R.</span><span> </span><span class="NLM_article-title">Evaluation of a series of naphthamides as potent, orally active vascular endothelial growth factor receptor-2 tyrosine kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1668</span><span class="NLM_x">–</span> <span class="NLM_lpage">1680</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701098w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1668-1680&author=M.+M.+Weissauthor=J.-C.+Harmangeauthor=A.+J.+Polverinoauthor=D.+Bauerauthor=L.+Berryauthor=V.+Berryauthor=G.+Borgauthor=J.+Breadyauthor=D.+Chenauthor=D.+Choquetteauthor=A.+Coxonauthor=T.+DeMelfiauthor=N.+Doerrauthor=J.+Estradaauthor=J.+Flynnauthor=R.+F.+Graceffaauthor=S.+P.+Harrimanauthor=S.+Kaufmanauthor=D.+S.+Laauthor=A.+Longauthor=S.+Neervannanauthor=V.+F.+Patelauthor=M.+Potashmanauthor=K.+Regalauthor=P.+M.+Rovetoauthor=M.+L.+Schragauthor=C.+Starnesauthor=A.+Taskerauthor=Y.+Tefferaauthor=D.+A.+Whittingtonauthor=R.+Zanon&title=Evaluation+of+a+series+of+naphthamides+as+potent%2C+orally+active+vascular+endothelial+growth+factor+receptor-2+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1021%2Fjm701098w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701098w%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DPolverino%26aufirst%3DA.%2BJ.%26aulast%3DBauer%26aufirst%3DD.%26aulast%3DBerry%26aufirst%3DL.%26aulast%3DBerry%26aufirst%3DV.%26aulast%3DBorg%26aufirst%3DG.%26aulast%3DBready%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DChoquette%26aufirst%3DD.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DDeMelfi%26aufirst%3DT.%26aulast%3DDoerr%26aufirst%3DN.%26aulast%3DEstrada%26aufirst%3DJ.%26aulast%3DFlynn%26aufirst%3DJ.%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DHarriman%26aufirst%3DS.%2BP.%26aulast%3DKaufman%26aufirst%3DS.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLong%26aufirst%3DA.%26aulast%3DNeervannan%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DPotashman%26aufirst%3DM.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DRoveto%26aufirst%3DP.%2BM.%26aulast%3DSchrag%26aufirst%3DM.%2BL.%26aulast%3DStarnes%26aufirst%3DC.%26aulast%3DTasker%26aufirst%3DA.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DZanon%26aufirst%3DR.%26atitle%3DEvaluation%2520of%2520a%2520series%2520of%2520naphthamides%2520as%2520potent%252C%2520orally%2520active%2520vascular%2520endothelial%2520growth%2520factor%2520receptor-2%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1668%26epage%3D1680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmer, T. M.</span><span> </span><span class="NLM_article-title">Synergistic effects of foretinib with HER-targeted agents in MET and HER1- or HER2-coactivated tumor cells</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">518</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1158%2F1535-7163.MCT-10-0698" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=21252284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVCrsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=518-530&author=L.+Liuauthor=H.+Shiauthor=Y.+Liuauthor=A.+Andersonauthor=J.+Petersonauthor=J.+Gregerauthor=A.-M.+Martinauthor=T.+M.+Gilmer&title=Synergistic+effects+of+foretinib+with+HER-targeted+agents+in+MET+and+HER1-+or+HER2-coactivated+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic Effects of Foretinib with HER-Targeted Agents in MET and HER1- or HER2-Coactivated Tumor Cells</span></div><div class="casAuthors">Liu, Li; Shi, Hong; Liu, Yuan; Anderson, Amber; Peterson, John; Greger, James; Martin, Anne-Marie; Gilmer, Tona M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">518-530</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The HER and MET receptor tyrosine kinases (RTK) are coactivated in a subset of human tumors.  This study characterizes MET and HER expression and signaling in a panel of human tumor cell lines and the differential susceptibility of these cell lines to single agents or combinations of foretinib, a multikinase MET inhibitor, with HER-targeted agents, erlotinib or lapatinib.  Most MET-amplified tumor lines without HER1 or HER2 amplification are sensitive to foretinib, whereas MET-amplified lines with HER1 or HER2 amplification are more sensitive to the combination of foretinib with lapatinib or erlotinib.  Interestingly, MET-overexpressing tumor cell lines with HER1 or HER2 amplification also exhibited reduced sensitivity to lapatinib or erlotinib in the presence of hepatocyte growth factor (HGF), indicating MET activation can decrease the effectiveness of HER1/2 inhibitors in some cell lines.  Consistent with this observation, the effect of HGF on lapatinib or erlotinib sensitivity in these cells was reversed by foretinib, other MET inhibitors, or siRNA to MET.  Western blot analyses showed that combining foretinib with erlotinib or lapatinib effectively decreased the phosphorylation of MET, HER1, HER2, HER3, AKT, and ERK in these cells.  Furthermore, HER2-pos. advanced or metastatic breast cancer patients treated with lapatinib who had higher tumor MET expression showed shorter progression-free survival (19.29 wk in MET-high patients vs. 28.14 wk in MET-low patients, P < 0.0225).  These data suggest that combination therapy with foretinib and HER-targeted agents should be tested as a treatment option for HER1- or HER2-pos. patients with MET-amplified or -overexpressing tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFGurHJ0AthrVg90H21EOLACvtfcHk0lgw3Y1yWoGKPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVCrsrg%253D&md5=4e33b2abefafb8decd9bb6f4f31b5c75</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-10-0698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-10-0698%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DAnderson%26aufirst%3DA.%26aulast%3DPeterson%26aufirst%3DJ.%26aulast%3DGreger%26aufirst%3DJ.%26aulast%3DMartin%26aufirst%3DA.-M.%26aulast%3DGilmer%26aufirst%3DT.%2BM.%26atitle%3DSynergistic%2520effects%2520of%2520foretinib%2520with%2520HER-targeted%2520agents%2520in%2520MET%2520and%2520HER1-%2520or%2520HER2-coactivated%2520tumor%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D518%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Qian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Won, K.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mock, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lougheed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakes, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentzien, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaks, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wooster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greshock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joly, A. H.</span><span> </span><span class="NLM_article-title">Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">8009</span><span class="NLM_x">–</span> <span class="NLM_lpage">8016</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=8009-8016&author=F.+Qianauthor=S.+Engstauthor=K.+Yamaguchiauthor=P.+Yuauthor=K.-A.+Wonauthor=L.+Mockauthor=T.+Louauthor=J.+Tanauthor=C.+Liauthor=D.+Tamauthor=J.+Lougheedauthor=F.+M.+Yakesauthor=F.+Bentzienauthor=W.+Xuauthor=T.+Zaksauthor=R.+Woosterauthor=J.+Greshockauthor=A.+H.+Joly&title=Inhibition+of+tumor+cell+growth%2C+invasion%2C+and+metastasis+by+EXEL-2880+%28XL880%2C+GSK1363089%29%2C+a+novel+inhibitor+of+HGF+and+VEGF+receptor+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DF.%26aulast%3DEngst%26aufirst%3DS.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DWon%26aufirst%3DK.-A.%26aulast%3DMock%26aufirst%3DL.%26aulast%3DLou%26aufirst%3DT.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DTam%26aufirst%3DD.%26aulast%3DLougheed%26aufirst%3DJ.%26aulast%3DYakes%26aufirst%3DF.%2BM.%26aulast%3DBentzien%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DZaks%26aufirst%3DT.%26aulast%3DWooster%26aufirst%3DR.%26aulast%3DGreshock%26aufirst%3DJ.%26aulast%3DJoly%26aufirst%3DA.%2BH.%26atitle%3DInhibition%2520of%2520tumor%2520cell%2520growth%252C%2520invasion%252C%2520and%2520metastasis%2520by%2520EXEL-2880%2520%2528XL880%252C%2520GSK1363089%2529%252C%2520a%2520novel%2520inhibitor%2520of%2520HGF%2520and%2520VEGF%2520receptor%2520tyrosine%2520kinases%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D8009%26epage%3D8016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Nagashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shumway, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sathyanarayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolinski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilhack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiznerowicz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutterbach, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paweletz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allison, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klippel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bobkova, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewczak, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, B.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollock, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blume-Jensen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Northrup, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, J. N.</span><span> </span><span class="NLM_article-title">Genetic and pharmacological inhibition of PDK1 in cancer cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">6433</span><span class="NLM_x">–</span> <span class="NLM_lpage">6448</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=6433-6448&author=K.+Nagashimaauthor=S.+D.+Shumwayauthor=S.+Sathyanarayananauthor=A.+H.+Chenauthor=B.+Dolinskiauthor=Y.+Xuauthor=H.+Keilhackauthor=T.+Nguyenauthor=M.+Wiznerowiczauthor=L.+Liauthor=B.+A.+Lutterbachauthor=A.+Chiauthor=C.+Paweletzauthor=T.+Allisonauthor=Y.+Yanauthor=S.+K.+Munshiauthor=A.+Klippelauthor=M.+Krausauthor=E.+V.+Bobkovaauthor=S.+Deshmukhauthor=Z.+Xuauthor=U.+Muellerauthor=A.+A.+Szewczakauthor=B.-S.+Panauthor=V.+Richonauthor=R.+Pollockauthor=P.+Blume-Jensenauthor=A.+Northrupauthor=J.+N.+Andersen&title=Genetic+and+pharmacological+inhibition+of+PDK1+in+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNagashima%26aufirst%3DK.%26aulast%3DShumway%26aufirst%3DS.%2BD.%26aulast%3DSathyanarayanan%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DA.%2BH.%26aulast%3DDolinski%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DWiznerowicz%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLutterbach%26aufirst%3DB.%2BA.%26aulast%3DChi%26aufirst%3DA.%26aulast%3DPaweletz%26aufirst%3DC.%26aulast%3DAllison%26aufirst%3DT.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DMunshi%26aufirst%3DS.%2BK.%26aulast%3DKlippel%26aufirst%3DA.%26aulast%3DKraus%26aufirst%3DM.%26aulast%3DBobkova%26aufirst%3DE.%2BV.%26aulast%3DDeshmukh%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DMueller%26aufirst%3DU.%26aulast%3DSzewczak%26aufirst%3DA.%2BA.%26aulast%3DPan%26aufirst%3DB.-S.%26aulast%3DRichon%26aufirst%3DV.%26aulast%3DPollock%26aufirst%3DR.%26aulast%3DBlume-Jensen%26aufirst%3DP.%26aulast%3DNorthrup%26aufirst%3DA.%26aulast%3DAndersen%26aufirst%3DJ.%2BN.%26atitle%3DGenetic%2520and%2520pharmacological%2520inhibition%2520of%2520PDK1%2520in%2520cancer%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D6433%26epage%3D6448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Jacobs, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hare, B. J.</span><span> </span><span class="NLM_article-title">Classifying protein kinase structures guides use of ligand-selectivity profiles to predict inactive conformations: structure of lck/imatinib complex</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1451</span><span class="NLM_x">–</span> <span class="NLM_lpage">1460</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2008&pages=1451-1460&author=M.+D.+Jacobsauthor=P.+R.+Caronauthor=B.+J.+Hare&title=Classifying+protein+kinase+structures+guides+use+of+ligand-selectivity+profiles+to+predict+inactive+conformations%3A+structure+of+lck%2Fimatinib+complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJacobs%26aufirst%3DM.%2BD.%26aulast%3DCaron%26aufirst%3DP.%2BR.%26aulast%3DHare%26aufirst%3DB.%2BJ.%26atitle%3DClassifying%2520protein%2520kinase%2520structures%2520guides%2520use%2520of%2520ligand-selectivity%2520profiles%2520to%2520predict%2520inactive%2520conformations%253A%2520structure%2520of%2520lck%252Fimatinib%2520complex%26jtitle%3DProteins%26date%3D2008%26volume%3D70%26spage%3D1451%26epage%3D1460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Chan, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wise, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ensinger, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haack, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patt, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petillo, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutkoski, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telikepalli, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogeti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evangelista, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavrilescu, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarides, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaleskas, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Etten, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, D. L.</span><span> </span><span class="NLM_article-title">Conformational control inhibition of the BCR-ABL1 tyrosine kinase, including the gatekeeper T315I mutant, by the switch-control inhibitor DCC-2036</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">556</span><span class="NLM_x">–</span> <span class="NLM_lpage">568</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2Fj.ccr.2011.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=21481795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXks1Wqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=556-568&author=W.+W.+Chanauthor=S.+C.+Wiseauthor=M.+D.+Kaufmanauthor=Y.+M.+Ahnauthor=C.+L.+Ensingerauthor=T.+Haackauthor=M.+M.+Hoodauthor=J.+Jonesauthor=J.+W.+Lordauthor=W.+P.+Luauthor=D.+Millerauthor=W.+C.+Pattauthor=B.+D.+Smithauthor=P.+A.+Petilloauthor=T.+J.+Rutkoskiauthor=H.+Telikepalliauthor=L.+Vogetiauthor=T.+Yaoauthor=L.+Chunauthor=R.+Clarkauthor=P.+Evangelistaauthor=L.+C.+Gavrilescuauthor=K.+Lazaridesauthor=V.+M.+Zaleskasauthor=L.+J.+Stewartauthor=R.+A.+Van+Ettenauthor=D.+L.+Flynn&title=Conformational+control+inhibition+of+the+BCR-ABL1+tyrosine+kinase%2C+including+the+gatekeeper+T315I+mutant%2C+by+the+switch-control+inhibitor+DCC-2036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational Control Inhibition of the BCR-ABL1 Tyrosine Kinase, Including the Gatekeeper T315I Mutant, by the Switch-Control Inhibitor DCC-2036</span></div><div class="casAuthors">Chan, Wayne W.; Wise, Scott C.; Kaufman, Michael D.; Ahn, Yu-Mi; Ensinger, Carol L.; Haack, Torsten; Hood, Molly M.; Jones, Jennifer; Lord, John W.; Lu, Wei-Ping; Miller, David; Patt, William C.; Smith, Bryan D.; Petillo, Peter A.; Rutkoski, Thomas J.; Telikepalli, Hanumaiah; Vogeti, Lakshminarayana; Yao, Tony; Chun, Lawrence; Clark, Robin; Evangelista, Peter; Gavrilescu, L. Cristina; Lazarides, Katherine; Zaleskas, Virginia M.; Stewart, Lance J.; Van Etten, Richard A.; Flynn, Daniel L.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">556-568</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Acquired resistance to ABL1 tyrosine kinase inhibitors (TKIs) through ABL1 kinase domain mutations, particularly the gatekeeper mutant T315I, is a significant problem for patients with chronic myeloid leukemia (CML).  Using structure-based drug design, we developed compds. that bind to residues (Arg386/Glu282) ABL1 uses to switch between inactive and active conformations.  The lead "switch-control" inhibitor, DCC-2036, potently inhibits both unphosphorylated and phosphorylated ABL1 by inducing a type II inactive conformation, and retains efficacy against the majority of clin. relevant CML-resistance mutants, including T315I.  DCC-2036 inhibits BCR-ABL1T315I-expressing cell lines, prolongs survival in mouse models of T315I mutant CML and B-lymphoblastic leukemia, and inhibits primary patient leukemia cells expressing T315I in vitro and in vivo, supporting its clin. development in TKI-resistant Ph+ leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPJdMSW1VeYbVg90H21EOLACvtfcHk0lhNkhXwh0vDjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXks1Wqsbg%253D&md5=1d7fae5f3719a8240b144b906dc5f2c7</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2011.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2011.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DW.%2BW.%26aulast%3DWise%26aufirst%3DS.%2BC.%26aulast%3DKaufman%26aufirst%3DM.%2BD.%26aulast%3DAhn%26aufirst%3DY.%2BM.%26aulast%3DEnsinger%26aufirst%3DC.%2BL.%26aulast%3DHaack%26aufirst%3DT.%26aulast%3DHood%26aufirst%3DM.%2BM.%26aulast%3DJones%26aufirst%3DJ.%26aulast%3DLord%26aufirst%3DJ.%2BW.%26aulast%3DLu%26aufirst%3DW.%2BP.%26aulast%3DMiller%26aufirst%3DD.%26aulast%3DPatt%26aufirst%3DW.%2BC.%26aulast%3DSmith%26aufirst%3DB.%2BD.%26aulast%3DPetillo%26aufirst%3DP.%2BA.%26aulast%3DRutkoski%26aufirst%3DT.%2BJ.%26aulast%3DTelikepalli%26aufirst%3DH.%26aulast%3DVogeti%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DT.%26aulast%3DChun%26aufirst%3DL.%26aulast%3DClark%26aufirst%3DR.%26aulast%3DEvangelista%26aufirst%3DP.%26aulast%3DGavrilescu%26aufirst%3DL.%2BC.%26aulast%3DLazarides%26aufirst%3DK.%26aulast%3DZaleskas%26aufirst%3DV.%2BM.%26aulast%3DStewart%26aufirst%3DL.%2BJ.%26aulast%3DVan%2BEtten%26aufirst%3DR.%2BA.%26aulast%3DFlynn%26aufirst%3DD.%2BL.%26atitle%3DConformational%2520control%2520inhibition%2520of%2520the%2520BCR-ABL1%2520tyrosine%2520kinase%252C%2520including%2520the%2520gatekeeper%2520T315I%2520mutant%252C%2520by%2520the%2520switch-control%2520inhibitor%2520DCC-2036%26jtitle%3DCancer%2520Cell%26date%3D2011%26volume%3D19%26spage%3D556%26epage%3D568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Namboodiri, H. V.; Springman, E. B.; Karpusas, M.; Bukhtiyarova, M.; Ramcharan, J.</span><span> </span><span class="NLM_article-title">Conformational Plasticity of p38 MAP Kinase DFG Motif Mutants in Response to Inhibitor Binding</span>. Protein Data Bank (PDB),<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.2210/pdb3o8u/pdb</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.2210%2Fpdb3o8u%2Fpdb" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=H.+V.+Namboodiri&author=E.+B.+Springman&author=M.+Karpusas&author=M.+Bukhtiyarova&author=J.+Ramcharan&title=Conformational+Plasticity+of+p38+MAP+Kinase+DFG+Motif+Mutants+in+Response+to+Inhibitor+Binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.2210%2Fpdb3o8u%2Fpdb&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.2210%252Fpdb3o8u%252Fpdb%26sid%3Dliteratum%253Aachs%26aulast%3DNamboodiri%26aufirst%3DH.%2BV.%26atitle%3DConformational%2520Plasticity%2520of%2520p38%2520MAP%2520Kinase%2520DFG%2520Motif%2520Mutants%2520in%2520Response%2520to%2520Inhibitor%2520Binding%26jtitle%3DProtein%2520Data%2520Bank%2520%2528PDB%2529%26date%3D2012%26doi%3D10.2210%2Fpdb3o8u%2Fpdb" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Kluter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grutter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naqvi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabiller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simard, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Getlik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauh, D.</span><span> </span><span class="NLM_article-title">Displacement assay for the detection of stabilizers of inactive kinase conformations</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901297e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=357-367&author=S.+Kluterauthor=C.+Grutterauthor=T.+Naqviauthor=M.+Rabillerauthor=J.+R.+Simardauthor=V.+Pawarauthor=M.+Getlikauthor=D.+Rauh&title=Displacement+assay+for+the+detection+of+stabilizers+of+inactive+kinase+conformations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fjm901297e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901297e%26sid%3Dliteratum%253Aachs%26aulast%3DKluter%26aufirst%3DS.%26aulast%3DGrutter%26aufirst%3DC.%26aulast%3DNaqvi%26aufirst%3DT.%26aulast%3DRabiller%26aufirst%3DM.%26aulast%3DSimard%26aufirst%3DJ.%2BR.%26aulast%3DPawar%26aufirst%3DV.%26aulast%3DGetlik%26aufirst%3DM.%26aulast%3DRauh%26aufirst%3DD.%26atitle%3DDisplacement%2520assay%2520for%2520the%2520detection%2520of%2520stabilizers%2520of%2520inactive%2520kinase%2520conformations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D357%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Ahn, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clare, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ensinger, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patt, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogeti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petillo, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wise, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abendroth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feese, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, D. L.</span><span> </span><span class="NLM_article-title">Switch control pocket inhibitors of p38-MAP kinase. Durable type II inhibitors that do not require binding into the canonical ATP hinge region</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">5793</span><span class="NLM_x">–</span> <span class="NLM_lpage">5798</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2Fj.bmcl.2010.07.134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=20800479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFGnt77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=5793-5798&author=Y.+M.+Ahnauthor=M.+Clareauthor=C.+L.+Ensingerauthor=M.+M.+Hoodauthor=J.+W.+Lordauthor=W.-P.+Luauthor=D.+F.+Millerauthor=W.+C.+Pattauthor=B.+D.+Smithauthor=L.+Vogetiauthor=M.+D.+Kaufmanauthor=P.+A.+Petilloauthor=S.+C.+Wiseauthor=J.+Abendrothauthor=L.+Chunauthor=R.+Clarkauthor=M.+Feeseauthor=H.+Kimauthor=L.+Stewartauthor=D.+L.+Flynn&title=Switch+control+pocket+inhibitors+of+p38-MAP+kinase.+Durable+type+II+inhibitors+that+do+not+require+binding+into+the+canonical+ATP+hinge+region"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Switch control pocket inhibitors of p38-MAP kinase. Durable type II inhibitors that do not require binding into the canonical ATP hinge region</span></div><div class="casAuthors">Ahn, Yu Mi; Clare, Michael; Ensinger, Carol L.; Hood, Molly M.; Lord, John W.; Lu, Wei-Ping; Miller, David F.; Patt, William C.; Smith, Bryan D.; Vogeti, Lakshminarayana; Kaufman, Michael D.; Petillo, Peter A.; Wise, Scott C.; Abendroth, Jan; Chun, Lawrence; Clark, Robin; Feese, Michael; Kim, Hidong; Stewart, Lance; Flynn, Daniel L.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5793-5798</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Switch control pocket inhibitors of p38-alpha kinase are described.  Durable type II inhibitors were designed which bind to arginines (Arg67 or Arg70) that function as key residues for mediating phospho-threonine 180 dependent conformational fluxing of p38-alpha from an inactive type II state to an active type I state.  Binding to Arg70 in particular led to potent inhibitors, exemplified by DP-802, which also exhibited high kinase selectivity.  Binding to Arg70 obviated the requirement for binding into the ATP Hinge region.  X-ray crystallog. revealed that DP-802 and analogs induce an enhanced type II conformation upon binding to either the unphosphorylated or the doubly phosphorylated form of p38-alpha kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYLXzhdkQYULVg90H21EOLACvtfcHk0lhNkhXwh0vDjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFGnt77F&md5=d226d6462d6f9f2118e48525af214af0</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.07.134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.07.134%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DY.%2BM.%26aulast%3DClare%26aufirst%3DM.%26aulast%3DEnsinger%26aufirst%3DC.%2BL.%26aulast%3DHood%26aufirst%3DM.%2BM.%26aulast%3DLord%26aufirst%3DJ.%2BW.%26aulast%3DLu%26aufirst%3DW.-P.%26aulast%3DMiller%26aufirst%3DD.%2BF.%26aulast%3DPatt%26aufirst%3DW.%2BC.%26aulast%3DSmith%26aufirst%3DB.%2BD.%26aulast%3DVogeti%26aufirst%3DL.%26aulast%3DKaufman%26aufirst%3DM.%2BD.%26aulast%3DPetillo%26aufirst%3DP.%2BA.%26aulast%3DWise%26aufirst%3DS.%2BC.%26aulast%3DAbendroth%26aufirst%3DJ.%26aulast%3DChun%26aufirst%3DL.%26aulast%3DClark%26aufirst%3DR.%26aulast%3DFeese%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DStewart%26aufirst%3DL.%26aulast%3DFlynn%26aufirst%3DD.%2BL.%26atitle%3DSwitch%2520control%2520pocket%2520inhibitors%2520of%2520p38-MAP%2520kinase.%2520Durable%2520type%2520II%2520inhibitors%2520that%2520do%2520not%2520require%2520binding%2520into%2520the%2520canonical%2520ATP%2520hinge%2520region%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D5793%26epage%3D5798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Blair, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Q.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rode, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Structure-guided development of affinity probes for tyrosine kinases using chemical genetics</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">238</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1038%2Fnchembio866" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=17334377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtFKnsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=229-238&author=J.+A.+Blairauthor=D.+Rauhauthor=C.+Kungauthor=C.-H.+Yunauthor=Q.-W.+Fanauthor=H.+Rodeauthor=C.+Zhangauthor=M.+J.+Eckauthor=W.+A.+Weissauthor=K.+M.+Shokat&title=Structure-guided+development+of+affinity+probes+for+tyrosine+kinases+using+chemical+genetics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided development of affinity probes for tyrosine kinases using chemical genetics</span></div><div class="casAuthors">Blair, Jimmy A.; Rauh, Daniel; Kung, Charles; Yun, Cai-Hong; Fan, Qi-Wen; Rode, Haridas; Zhang, Chao; Eck, Michael J.; Weiss, William A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">229-238</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">As key components in nearly every signal transduction pathway, protein kinases are attractive targets for the regulation of cellular signaling by small-mol. inhibitors.  The authors report the structure-guided development of 6-acrylamido-4-anilinoquinazoline irreversible kinase inhibitors that potently and selectively target rationally designed kinases bearing two selectivity elements that are not found together in any wild-type kinase: an electrophile-targeted cysteine residue and a glycine gatekeeper residue.  Cocrystal structures of two irreversible quinazoline inhibitors bound to either epidermal growth factor receptor (EGFR) or engineered c-Src show covalent inhibitor binding to the targeted cysteine (Cys797 in EGFR and Cys345 in engineered c-Src).  Cocrystal structures of two irreversible quinazoline inhibitors (I, II) bound to either epidermal growth factor receptor (EGFR) or engineered c-Src show covalent inhibitor binding to the targeted cysteine (Cys797 in EGFR and Cys345 in engineered c-Src).  Based on these structures, the authors developed a fluorescent 6-acrylamido-4-anilinoquinazoline affinity probe (III) to report the fraction of kinase necessary for cellular signaling, and the authors used these reagents to quantitate the relationship between EGFR stimulation by EGF and its downstream outputs-Akt, Erk1 and Erk2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG0KmYAm-skrVg90H21EOLACvtfcHk0lgfKhUxSEfFwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtFKnsr0%253D&md5=ce4d24a8d65d7080645bf382cd65dbca</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1038%2Fnchembio866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio866%26sid%3Dliteratum%253Aachs%26aulast%3DBlair%26aufirst%3DJ.%2BA.%26aulast%3DRauh%26aufirst%3DD.%26aulast%3DKung%26aufirst%3DC.%26aulast%3DYun%26aufirst%3DC.-H.%26aulast%3DFan%26aufirst%3DQ.-W.%26aulast%3DRode%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DStructure-guided%2520development%2520of%2520affinity%2520probes%2520for%2520tyrosine%2520kinases%2520using%2520chemical%2520genetics%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2007%26volume%3D3%26spage%3D229%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Yun, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mengwasser, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toms, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greulich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span> </span><span class="NLM_article-title">The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">2070</span><span class="NLM_x">–</span> <span class="NLM_lpage">2075</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1073%2Fpnas.0709662105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=18227510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitl2mu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=2070-2075&author=C.-H.+Yunauthor=K.+E.+Mengwasserauthor=A.+V.+Tomsauthor=M.+S.+Wooauthor=H.+Greulichauthor=K.-K.+Wongauthor=M.+Meyersonauthor=M.+J.+Eck&title=The+T790M+mutation+in+EGFR+kinase+causes+drug+resistance+by+increasing+the+affinity+for+ATP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP</span></div><div class="casAuthors">Yun, Cai-Hong; Mengwasser, Kristen E.; Toms, Angela V.; Woo, Michele S.; Greulich, Heidi; Wong, Kwok-Kin; Meyerson, Matthew; Eck, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2070-2075</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Lung cancers caused by activating mutations in the epidermal growth factor receptor (EGFR) are initially responsive to small mol. tyrosine kinase inhibitors (TKIs), but the efficacy of these agents is often limited because of the emergence of drug resistance conferred by a second mutation, T790M.  Threonine 790 is the "gatekeeper" residue, an important determinant of inhibitor specificity in the ATP binding pocket.  The T790M mutation has been thought to cause resistance by sterically blocking binding of TKIs such as gefitinib and erlotinib, but this explanation is difficult to reconcile with the fact that it remains sensitive to structurally similar irreversible inhibitors.  Here, we show by using a direct binding assay that T790M mutants retain low-nanomolar affinity for gefitinib.  Furthermore, we show that the T790M mutation activates WT EGFR and that introduction of the T790M mutation increases the ATP affinity of the oncogenic L858R mutant by more than an order of magnitude.  The increased ATP affinity is the primary mechanism by which the T790M mutation confers drug resistance.  Crystallog. anal. of the T790M mutant shows how it can adapt to accommodate tight binding of diverse inhibitors, including the irreversible inhibitor HKI-272, and also suggests a structural mechanism for catalytic activation.  We conclude that the T790M mutation is a "generic" resistance mutation that will reduce the potency of any ATP-competitive kinase inhibitor and that irreversible inhibitors overcome this resistance simply through covalent binding, not as a result of an alternative binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXXP7TBlyrdrVg90H21EOLACvtfcHk0lgfKhUxSEfFwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitl2mu7k%253D&md5=f5f5d791a65f73ca628d95e9922b8ea8</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0709662105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0709662105%26sid%3Dliteratum%253Aachs%26aulast%3DYun%26aufirst%3DC.-H.%26aulast%3DMengwasser%26aufirst%3DK.%2BE.%26aulast%3DToms%26aufirst%3DA.%2BV.%26aulast%3DWoo%26aufirst%3DM.%2BS.%26aulast%3DGreulich%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DK.-K.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520T790M%2520mutation%2520in%2520EGFR%2520kinase%2520causes%2520drug%2520resistance%2520by%2520increasing%2520the%2520affinity%2520for%2520ATP%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D2070%26epage%3D2075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ercan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capelletti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortot, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirieac, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iacob, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padera, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engen, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janne, P. A.</span><span> </span><span class="NLM_article-title">Novel mutant-selective EGFR kinase inhibitors against EGFR T790M</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">462</span><span class="NLM_x">, </span> <span class="NLM_fpage">1070</span><span class="NLM_x">–</span> <span class="NLM_lpage">1074</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1038%2Fnature08622" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=20033049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1SktbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=462&publication_year=2009&pages=1070-1074&author=W.+Zhouauthor=D.+Ercanauthor=L.+Chenauthor=C.-H.+Yunauthor=D.+Liauthor=M.+Capellettiauthor=A.+B.+Cortotauthor=L.+Chirieacauthor=R.+E.+Iacobauthor=R.+Paderaauthor=J.+R.+Engenauthor=K.-K.+Wongauthor=M.+J.+Eckauthor=N.+S.+Grayauthor=P.+A.+Janne&title=Novel+mutant-selective+EGFR+kinase+inhibitors+against+EGFR+T790M"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Novel mutant-selective EGFR kinase inhibitors against EGFR T790M</span></div><div class="casAuthors">Zhou, Wenjun; Ercan, Dalia; Chen, Liang; Yun, Cai-Hong; Li, Danan; Capelletti, Marzia; Cortot, Alexis B.; Chirieac, Lucian; Iacob, Roxana E.; Padera, Robert; Engen, John R.; Wong, Kwok-Kin; Eck, Michael J.; Gray, Nathanael S.; Janne, Pasi A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">462</span>
        (<span class="NLM_cas:issue">7276</span>),
    <span class="NLM_cas:pages">1070-1074</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The clin. efficacy of epidermal growth factor receptor (EGFR) kinase inhibitors in EGFR-mutant non-small-cell lung cancer (NSCLC) is limited by the development of drug-resistance mutations, including the gatekeeper T790M mutation.  Strategies targeting EGFR T790M with irreversible inhibitors have had limited success and are assocd. with toxicity due to concurrent inhibition of wild-type EGFR.  All current EGFR inhibitors possess a structurally related quinazoline-based core scaffold and were identified as ATP-competitive inhibitors of wild-type EGFR.  Here we identify a covalent pyrimidine EGFR inhibitor by screening an irreversible kinase inhibitor library specifically against EGFR T790M.  These agents are 30- to 100-fold more potent against EGFR T790M, and up to 100-fold less potent against wild-type EGFR, than quinazoline-based EGFR inhibitors in vitro.  They are also effective in murine models of lung cancer driven by EGFR T790M.  Co-crystn. studies reveal a structural basis for the increased potency and mutant selectivity of these agents.  These mutant-selective irreversible EGFR kinase inhibitors may be clin. more effective and better tolerated than quinazoline-based inhibitors.  Our findings demonstrate that functional pharmacol. screens against clin. important mutant kinases represent a powerful strategy to identify new classes of mutant-selective kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcksZlIe-1bbVg90H21EOLACvtfcHk0lgfKhUxSEfFwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1SktbvI&md5=9b5d41a2be401c67a4b9f04a41cf1725</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1038%2Fnature08622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08622%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DErcan%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DYun%26aufirst%3DC.-H.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DCapelletti%26aufirst%3DM.%26aulast%3DCortot%26aufirst%3DA.%2BB.%26aulast%3DChirieac%26aufirst%3DL.%26aulast%3DIacob%26aufirst%3DR.%2BE.%26aulast%3DPadera%26aufirst%3DR.%26aulast%3DEngen%26aufirst%3DJ.%2BR.%26aulast%3DWong%26aufirst%3DK.-K.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DJanne%26aufirst%3DP.%2BA.%26atitle%3DNovel%2520mutant-selective%2520EGFR%2520kinase%2520inhibitors%2520against%2520EGFR%2520T790M%26jtitle%3DNature%26date%3D2009%26volume%3D462%26spage%3D1070%26epage%3D1074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Wood, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shewchuk, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brignola, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brashear, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caferro, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickerson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donaldson, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaul, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassell, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrov, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reno, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusnak, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadepalli, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulrich, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderwall, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterson, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uehling, D. E.</span><span> </span><span class="NLM_article-title">6-Ethynylthieno[3,2-<i>d</i>]- and 6-ethynylthieno[2,3-<i>d</i>]pyrimidin-4-anilines as tunable covalent modifiers of ErbB kinases</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">2773</span><span class="NLM_x">–</span> <span class="NLM_lpage">2778</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=2773-2778&author=E.+R.+Woodauthor=L.+M.+Shewchukauthor=B.+Ellisauthor=P.+Brignolaauthor=R.+L.+Brashearauthor=T.+R.+Caferroauthor=S.+H.+Dickersonauthor=H.+D.+Dicksonauthor=K.+H.+Donaldsonauthor=M.+Gaulauthor=R.+J.+Griffinauthor=A.+M.+Hassellauthor=B.+Keithauthor=R.+Mullinauthor=K.+G.+Petrovauthor=M.+J.+Renoauthor=D.+W.+Rusnakauthor=S.+M.+Tadepalliauthor=J.+C.+Ulrichauthor=C.+D.+Wagnerauthor=D.+E.+Vanderwallauthor=A.+G.+Watersonauthor=J.+D.+Williamsauthor=W.+L.+Whiteauthor=D.+E.+Uehling&title=6-Ethynylthieno%5B3%2C2-d%5D-+and+6-ethynylthieno%5B2%2C3-d%5Dpyrimidin-4-anilines+as+tunable+covalent+modifiers+of+ErbB+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DE.%2BR.%26aulast%3DShewchuk%26aufirst%3DL.%2BM.%26aulast%3DEllis%26aufirst%3DB.%26aulast%3DBrignola%26aufirst%3DP.%26aulast%3DBrashear%26aufirst%3DR.%2BL.%26aulast%3DCaferro%26aufirst%3DT.%2BR.%26aulast%3DDickerson%26aufirst%3DS.%2BH.%26aulast%3DDickson%26aufirst%3DH.%2BD.%26aulast%3DDonaldson%26aufirst%3DK.%2BH.%26aulast%3DGaul%26aufirst%3DM.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DHassell%26aufirst%3DA.%2BM.%26aulast%3DKeith%26aufirst%3DB.%26aulast%3DMullin%26aufirst%3DR.%26aulast%3DPetrov%26aufirst%3DK.%2BG.%26aulast%3DReno%26aufirst%3DM.%2BJ.%26aulast%3DRusnak%26aufirst%3DD.%2BW.%26aulast%3DTadepalli%26aufirst%3DS.%2BM.%26aulast%3DUlrich%26aufirst%3DJ.%2BC.%26aulast%3DWagner%26aufirst%3DC.%2BD.%26aulast%3DVanderwall%26aufirst%3DD.%2BE.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DWilliams%26aufirst%3DJ.%2BD.%26aulast%3DWhite%26aufirst%3DW.%2BL.%26aulast%3DUehling%26aufirst%3DD.%2BE.%26atitle%3D6-Ethynylthieno%255B3%252C2-d%255D-%2520and%25206-ethynylthieno%255B2%252C3-d%255Dpyrimidin-4-anilines%2520as%2520tunable%2520covalent%2520modifiers%2520of%2520ErbB%2520kinases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D2773%26epage%3D2778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Kim, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maderna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnute, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyashiro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lussier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrocklage, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickerson-Nutter, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittwer, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soutter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunussi-Joannopoulos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douhan, J.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissner, A.</span><span> </span><span class="NLM_article-title">Imidazo[1,5-<i>a</i>]quinoxalines as irreversible BTK inhibitors for the treatment of rheumatoid arthritis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6258</span><span class="NLM_x">–</span> <span class="NLM_lpage">6263</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6258-6263&author=K.-H.+Kimauthor=A.+Madernaauthor=M.+E.+Schnuteauthor=M.+Hegenauthor=S.+Mohanauthor=J.+Miyashiroauthor=L.+Linauthor=E.+Liauthor=S.+Keeganauthor=J.+Lussierauthor=C.+Wrocklageauthor=C.+L.+Nickerson-Nutterauthor=A.+J.+Wittwerauthor=H.+Soutterauthor=N.+Caspersauthor=S.+Hanauthor=R.+Kurumbailauthor=K.+Dunussi-Joannopoulosauthor=J.+Douhanauthor=A.+Wissner&title=Imidazo%5B1%2C5-a%5Dquinoxalines+as+irreversible+BTK+inhibitors+for+the+treatment+of+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.-H.%26aulast%3DMaderna%26aufirst%3DA.%26aulast%3DSchnute%26aufirst%3DM.%2BE.%26aulast%3DHegen%26aufirst%3DM.%26aulast%3DMohan%26aufirst%3DS.%26aulast%3DMiyashiro%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DE.%26aulast%3DKeegan%26aufirst%3DS.%26aulast%3DLussier%26aufirst%3DJ.%26aulast%3DWrocklage%26aufirst%3DC.%26aulast%3DNickerson-Nutter%26aufirst%3DC.%2BL.%26aulast%3DWittwer%26aufirst%3DA.%2BJ.%26aulast%3DSoutter%26aufirst%3DH.%26aulast%3DCaspers%26aufirst%3DN.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DKurumbail%26aufirst%3DR.%26aulast%3DDunussi-Joannopoulos%26aufirst%3DK.%26aulast%3DDouhan%26aufirst%3DJ.%26aulast%3DWissner%26aufirst%3DA.%26atitle%3DImidazo%255B1%252C5-a%255Dquinoxalines%2520as%2520irreversible%2520BTK%2520inhibitors%2520for%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6258%26epage%3D6263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Zapf, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerstenberger, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limburg, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aulabaugh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shakya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spaulding, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czerwinski, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seth, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medley, Q. G.</span><span> </span><span class="NLM_article-title">Covalent inhibitors of interleukin-2 inducible T cell kinase (Itk) with nanomolar potency in a whole-blood assay</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10047</span><span class="NLM_x">–</span> <span class="NLM_lpage">10063</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301190s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFOlsbnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10047-10063&author=C.+W.+Zapfauthor=B.+S.+Gerstenbergerauthor=L.+Xingauthor=D.+C.+Limburgauthor=D.+R.+Andersonauthor=N.+Caspersauthor=S.+Hanauthor=A.+Aulabaughauthor=R.+Kurumbailauthor=S.+Shakyaauthor=X.+Liauthor=V.+Spauldingauthor=R.+M.+Czerwinskiauthor=N.+Sethauthor=Q.+G.+Medley&title=Covalent+inhibitors+of+interleukin-2+inducible+T+cell+kinase+%28Itk%29+with+nanomolar+potency+in+a+whole-blood+assay"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent Inhibitors of Interleukin-2 Inducible T Cell Kinase (Itk) with Nanomolar Potency in a Whole-Blood Assay</span></div><div class="casAuthors">Zapf, Christoph W.; Gerstenberger, Brian S.; Xing, Li; Limburg, David C.; Anderson, David R.; Caspers, Nicole; Han, Seungil; Aulabaugh, Ann; Kurumbail, Ravi; Shakya, Subarna; Li, Xin; Spaulding, Vikki; Czerwinski, Robert M.; Seth, Nilufer; Medley, Quintus G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10047-10063</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We wish to report a strategy that targets interleukin-2 inducible T cell kinase (Itk) with covalent inhibitors.  Thus far, covalent inhibition of Itk has not been disclosed in the literature.  Structure-based drug design was utilized to achieve low nanomolar potency of the disclosed series even at high ATP concns.  Kinetic measurements confirmed an irreversible binding mode with off-rate half-lives exceeding 24 h and moderate on-rates.  The analogs are highly potent in a cellular IP1 assay as well as in a human whole-blood (hWB) assay.  Despite a half-life of approx. 2 h in resting primary T cells, the covalent inhibition of Itk resulted in functional silencing of the TCR pathway for more than 24 h.  This prolonged effect indicates that covalent inhibition is a viable strategy to target the inactivation of Itk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnh9j28SM8jbVg90H21EOLACvtfcHk0ljALvUrT1-y6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFOlsbnP&md5=7e39a17151dc9493d13439bc48fa83a3</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1021%2Fjm301190s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301190s%26sid%3Dliteratum%253Aachs%26aulast%3DZapf%26aufirst%3DC.%2BW.%26aulast%3DGerstenberger%26aufirst%3DB.%2BS.%26aulast%3DXing%26aufirst%3DL.%26aulast%3DLimburg%26aufirst%3DD.%2BC.%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DCaspers%26aufirst%3DN.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DAulabaugh%26aufirst%3DA.%26aulast%3DKurumbail%26aufirst%3DR.%26aulast%3DShakya%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DSpaulding%26aufirst%3DV.%26aulast%3DCzerwinski%26aufirst%3DR.%2BM.%26aulast%3DSeth%26aufirst%3DN.%26aulast%3DMedley%26aufirst%3DQ.%2BG.%26atitle%3DCovalent%2520inhibitors%2520of%2520interleukin-2%2520inducible%2520T%2520cell%2520kinase%2520%2528Itk%2529%2520with%2520nanomolar%2520potency%2520in%2520a%2520whole-blood%2520assay%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10047%26epage%3D10063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Zhang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inesta-Vaquera, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niepel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ficarro, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machleidt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marto, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laughlin, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoGrasso, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patricelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorger, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Discovery of potent and selective covalent inhibitors of JNK</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2Fj.chembiol.2011.11.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=22284361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Ghurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=140-154&author=T.+Zhangauthor=F.+Inesta-Vaqueraauthor=M.+Niepelauthor=J.+Zhangauthor=S.+B.+Ficarroauthor=T.+Machleidtauthor=T.+Xieauthor=J.+A.+Martoauthor=N.+Kimauthor=T.+Simauthor=J.+D.+Laughlinauthor=H.+Parkauthor=P.+V.+LoGrassoauthor=M.+Patricelliauthor=T.+K.+Nomanbhoyauthor=P.+K.+Sorgerauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Discovery+of+potent+and+selective+covalent+inhibitors+of+JNK"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Covalent Inhibitors of JNK</span></div><div class="casAuthors">Zhang, Tinghu; Inesta-Vaquera, Francisco; Niepel, Mario; Zhang, Jianming; Ficarro, Scott B.; Machleidt, Thomas; Xie, Ting; Marto, Jarrod A.; Kim, Nam Doo; Sim, Taebo; Laughlin, John D.; Park, Hajeung; LoGrasso, Philip V.; Patricelli, Matt; Nomanbhoy, Tyzoon K.; Sorger, Peter K.; Alessi, Dario R.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">140-154</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The mitogen-activated kinases JNK1/2/3 are key enzymes in signaling modules that transduce and integrate extracellular stimuli into coordinated cellular response.  Here, we report the discovery of irreversible inhibitors of JNK1/2/3.  We describe two JNK3 cocrystal structures at 2.60 and 2.97 Å resoln. that show the compds. form covalent bonds with a conserved cysteine residue.  JNK-IN-8 is a selective JNK inhibitor that inhibits phosphorylation of c-Jun, a direct substrate of JNK, in cells exposed to submicromolar drug in a manner that depends on covalent modification of the conserved cysteine residue.  Extensive biochem., cellular, and pathway-based profiling establish the selectivity of JNK-IN-8 for JNK and suggests that the compd. will be broadly useful as a pharmacol. probe of JNK-dependent signal transduction.  Potential lead compds. have also been identified for kinases, including IRAK1, PIK3C3, PIP4K2C, and PIP5K3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXs0FY7FSmt7Vg90H21EOLACvtfcHk0lipJ2erO0TnaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Ghurw%253D&md5=f7d9647fb2be162c637b1d31a778ceb4</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DInesta-Vaquera%26aufirst%3DF.%26aulast%3DNiepel%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DFicarro%26aufirst%3DS.%2BB.%26aulast%3DMachleidt%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DT.%26aulast%3DMarto%26aufirst%3DJ.%2BA.%26aulast%3DKim%26aufirst%3DN.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DLaughlin%26aufirst%3DJ.%2BD.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DLoGrasso%26aufirst%3DP.%2BV.%26aulast%3DPatricelli%26aufirst%3DM.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DSorger%26aufirst%3DP.%2BK.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520covalent%2520inhibitors%2520of%2520JNK%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D140%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Erlanson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arndt, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cancilla, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elling, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">English, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hession, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumaravel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lind, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miatkowski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pathan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penny, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romanowski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tangonan, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span> </span><span class="NLM_article-title">Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discovery</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3078</span><span class="NLM_x">–</span> <span class="NLM_lpage">3083</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2Fj.bmcl.2011.03.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=21459573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVCmu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3078-3083&author=D.+A.+Erlansonauthor=J.+W.+Arndtauthor=M.+T.+Cancillaauthor=K.+Caoauthor=R.+A.+Ellingauthor=N.+Englishauthor=J.+Friedmanauthor=S.+K.+Hansenauthor=C.+Hessionauthor=I.+Josephauthor=G.+Kumaravelauthor=W.-C.+Leeauthor=K.+E.+Lindauthor=R.+S.+McDowellauthor=K.+Miatkowskiauthor=C.+Nguyenauthor=T.+B.+Nguyenauthor=S.+Parkauthor=N.+Pathanauthor=D.+M.+Pennyauthor=M.+J.+Romanowskiauthor=D.+Scottauthor=L.+Silvianauthor=R.+L.+Simmonsauthor=B.+T.+Tangonanauthor=W.+Yangauthor=L.+Sun&title=Discovery+of+a+potent+and+highly+selective+PDK1+inhibitor+via+fragment-based+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discovery</span></div><div class="casAuthors">Erlanson, Daniel A.; Arndt, Joseph W.; Cancilla, Mark T.; Cao, Kathy; Elling, Robert A.; English, Nicki; Friedman, Jessica; Hansen, Stig K.; Hession, Cathy; Joseph, Ingrid; Kumaravel, Gnanasambandam; Lee, Wen-Cherng; Lind, Ken E.; McDowell, Robert S.; Miatkowski, Konrad; Nguyen, Christine; Nguyen, Thinh B.; Park, Sophia; Pathan, Nuzhat; Penny, David M.; Romanowski, Michael J.; Scott, Daniel; Silvian, Laura; Simmons, Robert L.; Tangonan, Bradley T.; Yang, Wenjin; Sun, Lihong</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3078-3083</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We report the use of a fragment-based lead discovery method, Tethering with extenders, to discover a pyridinone fragment that binds in an adaptive site of the protein PDK1.  With subsequent medicinal chem., this led to the discovery of the potent and highly selective inhibitor of PDK1 33 (I), which binds in the 'DFG-out' conformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm3lOuGCLc6bVg90H21EOLACvtfcHk0lipJ2erO0TnaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVCmu7c%253D&md5=d11982e2dcc4a94d24dd5522735d46fb</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.03.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.03.032%26sid%3Dliteratum%253Aachs%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DArndt%26aufirst%3DJ.%2BW.%26aulast%3DCancilla%26aufirst%3DM.%2BT.%26aulast%3DCao%26aufirst%3DK.%26aulast%3DElling%26aufirst%3DR.%2BA.%26aulast%3DEnglish%26aufirst%3DN.%26aulast%3DFriedman%26aufirst%3DJ.%26aulast%3DHansen%26aufirst%3DS.%2BK.%26aulast%3DHession%26aufirst%3DC.%26aulast%3DJoseph%26aufirst%3DI.%26aulast%3DKumaravel%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DW.-C.%26aulast%3DLind%26aufirst%3DK.%2BE.%26aulast%3DMcDowell%26aufirst%3DR.%2BS.%26aulast%3DMiatkowski%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DC.%26aulast%3DNguyen%26aufirst%3DT.%2BB.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DPathan%26aufirst%3DN.%26aulast%3DPenny%26aufirst%3DD.%2BM.%26aulast%3DRomanowski%26aufirst%3DM.%2BJ.%26aulast%3DScott%26aufirst%3DD.%26aulast%3DSilvian%26aufirst%3DL.%26aulast%3DSimmons%26aufirst%3DR.%2BL.%26aulast%3DTangonan%26aufirst%3DB.%2BT.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DSun%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520highly%2520selective%2520PDK1%2520inhibitor%2520via%2520fragment-based%2520drug%2520discovery%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3078%26epage%3D3083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Serafimova, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pufall, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maglathlin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFarland, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frödin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taunton, J.</span><span> </span><span class="NLM_article-title">Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">471</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1038%2Fnchembio.925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=22466421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvVKitrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=471-476&author=I.+M.+Serafimovaauthor=M.+A.+Pufallauthor=S.+Krishnanauthor=K.+Dudaauthor=M.+S.+Cohenauthor=R.+L.+Maglathlinauthor=J.+M.+McFarlandauthor=R.+M.+Millerauthor=M.+Fr%C3%B6dinauthor=J.+Taunton&title=Reversible+targeting+of+noncatalytic+cysteines+with+chemically+tuned+electrophiles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles</span></div><div class="casAuthors">Serafimova, Iana M.; Pufall, Miles A.; Krishnan, Shyam; Duda, Katarzyna; Cohen, Michael S.; Maglathlin, Rebecca L.; McFarland, Jesse M.; Miller, Rand M.; Froedin, Morten; Taunton, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">471-476</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Targeting noncatalytic cysteine residues with irreversible acrylamide-based inhibitors is a powerful approach for enhancing pharmacol. potency and selectivity.  Nevertheless, concerns about off-target modification motivate the development of reversible cysteine-targeting strategies.  Here we show that electron-deficient olefins, including acrylamides, can be tuned to react with cysteine thiols in a rapidly reversible manner.  Installation of a nitrile group increased the olefins' intrinsic reactivity, but, paradoxically, eliminated the formation of irreversible adducts.  Incorporation of these electrophiles into a noncovalent kinase-recognition scaffold produced slowly dissocg., covalent inhibitors of the p90 ribosomal protein S6 kinase RSK2.  A cocrystal structure revealed specific noncovalent interactions that stabilize the complex by positioning the electrophilic carbon near the targeted cysteine.  Disruption of these interactions by protein unfolding or proteolysis promoted instantaneous cleavage of the covalent bond.  Our results establish a chem.-based framework for engineering sustained covalent inhibition without accumulating permanently modified proteins and peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlcv3GjPOB6rVg90H21EOLACvtfcHk0lipJ2erO0TnaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvVKitrw%253D&md5=6455a9a029714beb317286f71ac1326b</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.925%26sid%3Dliteratum%253Aachs%26aulast%3DSerafimova%26aufirst%3DI.%2BM.%26aulast%3DPufall%26aufirst%3DM.%2BA.%26aulast%3DKrishnan%26aufirst%3DS.%26aulast%3DDuda%26aufirst%3DK.%26aulast%3DCohen%26aufirst%3DM.%2BS.%26aulast%3DMaglathlin%26aufirst%3DR.%2BL.%26aulast%3DMcFarland%26aufirst%3DJ.%2BM.%26aulast%3DMiller%26aufirst%3DR.%2BM.%26aulast%3DFr%25C3%25B6din%26aufirst%3DM.%26aulast%3DTaunton%26aufirst%3DJ.%26atitle%3DReversible%2520targeting%2520of%2520noncatalytic%2520cysteines%2520with%2520chemically%2520tuned%2520electrophiles%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2012%26volume%3D8%26spage%3D471%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Yongye, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina-Franco, J. L.</span><span> </span><span class="NLM_article-title">Data mining of protein-binding profiling data identifies structural modifications that distinguish selective and promiscuous compounds</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2454</span><span class="NLM_x">–</span> <span class="NLM_lpage">2461</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci3002606" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFaru7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=2454-2461&author=A.+B.+Yongyeauthor=J.+L.+Medina-Franco&title=Data+mining+of+protein-binding+profiling+data+identifies+structural+modifications+that+distinguish+selective+and+promiscuous+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Data Mining of Protein-Binding Profiling Data Identifies Structural Modifications that Distinguish Selective and Promiscuous Compounds</span></div><div class="casAuthors">Yongye, Austin B.; Medina-Franco, Jose L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2454-2461</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activity profiling of compd. collections across multiple targets is increasingly being used in probe and drug discovery.  Herein, an approach to systematically analyze the structure-activity relations of a large screening profile data with emphasis on identifying structural changes that have a significant impact on the no. of proteins to which a compd. binds are discussed.  As a case study, the authors analyzed a recently released public data set of >15,000 compds. screened across 100 sequence-unrelated proteins.  The screened compds. have different origins and include natural products, synthetic mols. from academic groups, and com. compds.  Similar synthetic structures from academic groups showed, overall, greater promiscuity differences than do natural products and com. compds.  The method implemented in this work readily identified structural changes that differentiated highly specific from promiscuous compds.  This approach is general and can be applied to analyze any other large-scale protein-binding profile data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0o0ddIiz1z7Vg90H21EOLACvtfcHk0ljC_VR76-zumA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFaru7rL&md5=823505c29125c3502dfaad1de752bff5</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1021%2Fci3002606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci3002606%26sid%3Dliteratum%253Aachs%26aulast%3DYongye%26aufirst%3DA.%2BB.%26aulast%3DMedina-Franco%26aufirst%3DJ.%2BL.%26atitle%3DData%2520mining%2520of%2520protein-binding%2520profiling%2520data%2520identifies%2520structural%2520modifications%2520that%2520distinguish%2520selective%2520and%2520promiscuous%2520compounds%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D2454%26epage%3D2461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Muegge, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enyedy, I. J.</span><span> </span><span class="NLM_article-title">Virtual screening for kinase targets</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">693</span><span class="NLM_x">–</span> <span class="NLM_lpage">707</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.2174%2F0929867043455684" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=15032724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFWgs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=693-707&author=I.+Mueggeauthor=I.+J.+Enyedy&title=Virtual+screening+for+kinase+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual screening for kinase targets</span></div><div class="casAuthors">Muegge, Ingo; Enyedy, Istvan J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">693-707</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Kinases have become a major area of drug discovery and structure-based design.  Hundreds of 3D structures for more than thirty different kinases are available to the public.  High structural and sequence homol. within the kinase gene family makes the remaining kinases ideal targets for homol. modeling and virtual screening.  Somewhat surprisingly, however, the no. of publications about virtual screening of kinases is very low.  Therefore, rather than reviewing the field of virtual screening for kinases, we attempt here a hybrid approach of presenting what is known and common practice together with new studies on CDK2 and SRC kinase.  To illustrate the challenges and pitfalls of virtual screening for kinase targets we focus on the question of how ranking is influenced by the database screened, the docking scheme, the scoring function, the activity of the compds. used for testing, and small changes in the binding pocket.  In addn., a case study of finding irreversible inhibitors of ErbB2 through in silico screening is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1lWP4Dz47UbVg90H21EOLACvtfcHk0ljC_VR76-zumA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFWgs7o%253D&md5=262341fad24c20f217770c93299130f3</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.2174%2F0929867043455684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043455684%26sid%3Dliteratum%253Aachs%26aulast%3DMuegge%26aufirst%3DI.%26aulast%3DEnyedy%26aufirst%3DI.%2BJ.%26atitle%3DVirtual%2520screening%2520for%2520kinase%2520targets%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D693%26epage%3D707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Perola, E.</span><span> </span><span class="NLM_article-title">Minimizing false positives in kinase virtual screens</span> <span class="citation_source-journal">Proteins: Struct., Funct., Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">422</span><span class="NLM_x">–</span> <span class="NLM_lpage">435</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2006&pages=422-435&author=E.+Perola&title=Minimizing+false+positives+in+kinase+virtual+screens"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerola%26aufirst%3DE.%26atitle%3DMinimizing%2520false%2520positives%2520in%2520kinase%2520virtual%2520screens%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Bioinf.%26date%3D2006%26volume%3D64%26spage%3D422%26epage%3D435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">van Linden, O. P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farenc, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoutman, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hameetman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijtmans, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tensen, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegal, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Esch, I. J. P.</span><span> </span><span class="NLM_article-title">Fragment based lead discovery of small molecule inhibitors for the EPHA4 receptor tyrosine kinase</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">493</span><span class="NLM_x">–</span> <span class="NLM_lpage">500</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2012&pages=493-500&author=O.+P.+J.+van+Lindenauthor=C.+Farencauthor=W.+H.+Zoutmanauthor=L.+Hameetmanauthor=M.+Wijtmansauthor=R.+Leursauthor=C.+P.+Tensenauthor=G.+Siegalauthor=I.+J.+P.+de+Esch&title=Fragment+based+lead+discovery+of+small+molecule+inhibitors+for+the+EPHA4+receptor+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BLinden%26aufirst%3DO.%2BP.%2BJ.%26aulast%3DFarenc%26aufirst%3DC.%26aulast%3DZoutman%26aufirst%3DW.%2BH.%26aulast%3DHameetman%26aufirst%3DL.%26aulast%3DWijtmans%26aufirst%3DM.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DTensen%26aufirst%3DC.%2BP.%26aulast%3DSiegal%26aufirst%3DG.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26atitle%3DFragment%2520based%2520lead%2520discovery%2520of%2520small%2520molecule%2520inhibitors%2520for%2520the%2520EPHA4%2520receptor%2520tyrosine%2520kinase%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D47%26spage%3D493%26epage%3D500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Wood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlieg, J. d.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagener, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritschel, T.</span><span> </span><span class="NLM_article-title">Pharmacophore fingerprint-based approach to binding site subpocket similarity and its application to bioisostere replacement</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2031</span><span class="NLM_x">–</span> <span class="NLM_lpage">2043</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci3000776" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVylur%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=2031-2043&author=D.+J.+Woodauthor=J.+d.+Vliegauthor=M.+Wagenerauthor=T.+Ritschel&title=Pharmacophore+fingerprint-based+approach+to+binding+site+subpocket+similarity+and+its+application+to+bioisostere+replacement"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacophore Fingerprint-Based Approach to Binding Site Subpocket Similarity and Its Application to Bioisostere Replacement</span></div><div class="casAuthors">Wood, David J.; Vlieg, Jacob de; Wagener, Markus; Ritschel, Tina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2031-2043</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bioisosteres have been defined as structurally different mols. or substructures that can form comparable intermol. interactions, and therefore, fragments that bind to similar protein structures exhibit a degree of bioisosterism.  We present KRIPO (Key Representation of Interaction in POckets): a new method for quantifying the similarities of binding site subpockets based on pharmacophore fingerprints.  The binding site fingerprints have been optimized to improve their performance for both intra- and interprotein family comparisons.  A range of attributes of the fingerprints was considered in the optimization, including the placement of pharmacophore features, whether or not the fingerprints are fuzzified, and the resoln. and complexity of the pharmacophore fingerprints (2-, 3-, and 4-point fingerprints).  Fuzzy 3-point pharmacophore fingerprints were found to represent the optimal balance between computational resource requirements and the identification of potential replacements.  The complete PDB was converted into a database comprising almost 300 000 optimized fingerprints of local binding sites together with their assocd. ligand fragments.  The value of the approach is demonstrated by application to two crystal structures from the Protein Data Bank: (1) a MAP kinase P38 structure in complex with a pyridinylimidazole inhibitor (1A9U) and (2) a complex of thrombin with melagatran (1K22).  Potentially valuable bioisosteric replacements for all subpockets of the two studied protein are identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWRQTi8-dp_rVg90H21EOLACvtfcHk0ljC_VR76-zumA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVylur%252FF&md5=f344aa0423546f08ea347327f56ef7cb</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1021%2Fci3000776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci3000776%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DD.%2BJ.%26aulast%3DVlieg%26aufirst%3DJ.%2Bd.%26aulast%3DWagener%26aufirst%3DM.%26aulast%3DRitschel%26aufirst%3DT.%26atitle%3DPharmacophore%2520fingerprint-based%2520approach%2520to%2520binding%2520site%2520subpocket%2520similarity%2520and%2520its%2520application%2520to%2520bioisostere%2520replacement%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D2031%26epage%3D2043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Subramanian, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sud, M.</span><span> </span><span class="NLM_article-title">Computational modeling of kinase inhibitor selectivity</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml1001097" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=395-399&author=G.+Subramanianauthor=M.+Sud&title=Computational+modeling+of+kinase+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1021%2Fml1001097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1001097%26sid%3Dliteratum%253Aachs%26aulast%3DSubramanian%26aufirst%3DG.%26aulast%3DSud%26aufirst%3DM.%26atitle%3DComputational%2520modeling%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D395%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group">Schalon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgand, J.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellenberger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span> </span><span class="NLM_article-title">A simple and fuzzy method to align and compare druggable ligand-binding sites</span> <span class="citation_source-journal">Proteins: Struct., Funct., Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">1755</span><span class="NLM_x">–</span> <span class="NLM_lpage">1778</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2008&pages=1755-1778&author=C.+Schalonauthor=J.-S.+Surgandauthor=E.+Kellenbergerauthor=D.+Rognan&title=A+simple+and+fuzzy+method+to+align+and+compare+druggable+ligand-binding+sites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchalon%26aufirst%3DC.%26aulast%3DSurgand%26aufirst%3DJ.-S.%26aulast%3DKellenberger%26aufirst%3DE.%26aulast%3DRognan%26aufirst%3DD.%26atitle%3DA%2520simple%2520and%2520fuzzy%2520method%2520to%2520align%2520and%2520compare%2520druggable%2520ligand-binding%2520sites%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Bioinf.%26date%3D2008%26volume%3D71%26spage%3D1755%26epage%3D1778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Sciabola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flocco, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruciani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perruccio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. S.</span><span> </span><span class="NLM_article-title">High-throughput virtual screening of proteins using GRID molecular interaction fields</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci9003317" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=155-169&author=S.+Sciabolaauthor=R.+V.+Stantonauthor=J.+E.+Millsauthor=M.+M.+Floccoauthor=M.+Baroniauthor=G.+Crucianiauthor=F.+Perruccioauthor=J.+S.+Mason&title=High-throughput+virtual+screening+of+proteins+using+GRID+molecular+interaction+fields"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1021%2Fci9003317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci9003317%26sid%3Dliteratum%253Aachs%26aulast%3DSciabola%26aufirst%3DS.%26aulast%3DStanton%26aufirst%3DR.%2BV.%26aulast%3DMills%26aufirst%3DJ.%2BE.%26aulast%3DFlocco%26aufirst%3DM.%2BM.%26aulast%3DBaroni%26aufirst%3DM.%26aulast%3DCruciani%26aufirst%3DG.%26aulast%3DPerruccio%26aufirst%3DF.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26atitle%3DHigh-throughput%2520virtual%2520screening%2520of%2520proteins%2520using%2520GRID%2520molecular%2520interaction%2520fields%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2009%26volume%3D50%26spage%3D155%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Akritopoulou-Zanze, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduk, P. J.</span><span> </span><span class="NLM_article-title">Kinase-targeted libraries: the design and synthesis of novel, potent, and selective kinase inhibitors</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=291-297&author=I.+Akritopoulou-Zanzeauthor=P.+J.+Hajduk&title=Kinase-targeted+libraries%3A+the+design+and+synthesis+of+novel%2C+potent%2C+and+selective+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAkritopoulou-Zanze%26aufirst%3DI.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26atitle%3DKinase-targeted%2520libraries%253A%2520the%2520design%2520and%2520synthesis%2520of%2520novel%252C%2520potent%252C%2520and%2520selective%2520kinase%2520inhibitors%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26spage%3D291%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group">Morphy, R.</span><span> </span><span class="NLM_article-title">Selectively nonselective kinase inhibition: striking the right balance</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1413</span><span class="NLM_x">–</span> <span class="NLM_lpage">1437</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=1413-1437&author=R.+Morphy&title=Selectively+nonselective+kinase+inhibition%3A+striking+the+right+balance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26atitle%3DSelectively%2520nonselective%2520kinase%2520inhibition%253A%2520striking%2520the%2520right%2520balance%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D53%26spage%3D1413%26epage%3D1437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 148 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ariane Nunes-Alves, Fabian Ormersbach, <span class="NLM_string-name hlFld-ContribAuthor">Rebecca C. Wade</span>. </span><span class="cited-content_cbyCitation_article-title">Prediction of the Drug–Target Binding Kinetics for Flexible Proteins by Comparative Binding Energy Analysis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2021,</strong> <em>61 </em>
                                    (7)
                                     , 3708-3721. <a href="https://doi.org/10.1021/acs.jcim.1c00639" title="DOI URL">https://doi.org/10.1021/acs.jcim.1c00639</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.1c00639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.1c00639%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DPrediction%252Bof%252Bthe%252BDrug%2525E2%252580%252593Target%252BBinding%252BKinetics%252Bfor%252BFlexible%252BProteins%252Bby%252BComparative%252BBinding%252BEnergy%252BAnalysis%26aulast%3DNunes-Alves%26aufirst%3DAriane%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D04062021%26date%3D01072021%26volume%3D61%26issue%3D7%26spage%3D3708%26epage%3D3721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ashley N. Matthew, Florian Leidner, Gordon J. Lockbaum, Mina Henes, Jacqueto Zephyr, Shurong Hou, Desaboini Nageswara Rao, Jennifer Timm, Linah N. Rusere, Debra A. Ragland, Janet L. Paulsen, Kristina Prachanronarong, Djade I. Soumana, Ellen A. Nalivaika, Nese Kurt Yilmaz, Akbar Ali, <span class="NLM_string-name hlFld-ContribAuthor">Celia A. Schiffer</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2021,</strong> <em>121 </em>
                                    (6)
                                     , 3238-3270. <a href="https://doi.org/10.1021/acs.chemrev.0c00648" title="DOI URL">https://doi.org/10.1021/acs.chemrev.0c00648</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.0c00648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.0c00648%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DDrug%252BDesign%252BStrategies%252Bto%252BAvoid%252BResistance%252Bin%252BDirect-Acting%252BAntivirals%252Band%252BBeyond%26aulast%3DMatthew%26aufirst%3DAshley%2BN.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D22062020%26date%3D07012021%26volume%3D121%26issue%3D6%26spage%3D3238%26epage%3D3270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Oliver Laufkötter, Huabin Hu, Filip Miljković, <span class="NLM_string-name hlFld-ContribAuthor">Jürgen Bajorath</span>. </span><span class="cited-content_cbyCitation_article-title">Structure- and Similarity-Based Survey of Allosteric Kinase Inhibitors, Activators, and Closely Related Compounds. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02076%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-%252Band%252BSimilarity-Based%252BSurvey%252Bof%252BAllosteric%252BKinase%252BInhibitors%25252C%252BActivators%25252C%252Band%252BClosely%252BRelated%252BCompounds%26aulast%3DLaufk%25C3%25B6tter%26aufirst%3DOliver%26date%3D2021%26date%3D2020%26date%3D30112020%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Steven K. Albanese, John D. Chodera, Andrea Volkamer, Simon Keng, Robert Abel, <span class="NLM_string-name hlFld-ContribAuthor">Lingle Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Is Structure-Based Drug Design Ready for Selectivity Optimization?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2020,</strong> <em>60 </em>
                                    (12)
                                     , 6211-6227. <a href="https://doi.org/10.1021/acs.jcim.0c00815" title="DOI URL">https://doi.org/10.1021/acs.jcim.0c00815</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.0c00815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.0c00815%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DIs%252BStructure-Based%252BDrug%252BDesign%252BReady%252Bfor%252BSelectivity%252BOptimization%25253F%26aulast%3DAlbanese%26aufirst%3DSteven%2BK.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D17072020%26date%3D29102020%26volume%3D60%26issue%3D12%26spage%3D6211%26epage%3D6227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dominique Sydow, Paula Schmiel, Jérémie Mortier, <span class="NLM_string-name hlFld-ContribAuthor">Andrea Volkamer</span>. </span><span class="cited-content_cbyCitation_article-title">KinFragLib: Exploring the Kinase Inhibitor Space Using Subpocket-Focused Fragmentation and Recombination. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2020,</strong> <em>60 </em>
                                    (12)
                                     , 6081-6094. <a href="https://doi.org/10.1021/acs.jcim.0c00839" title="DOI URL">https://doi.org/10.1021/acs.jcim.0c00839</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.0c00839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.0c00839%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DKinFragLib%25253A%252BExploring%252Bthe%252BKinase%252BInhibitor%252BSpace%252BUsing%252BSubpocket-Focused%252BFragmentation%252Band%252BRecombination%26aulast%3DSydow%26aufirst%3DDominique%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D23072020%26date%3D06112020%26volume%3D60%26issue%3D12%26spage%3D6081%26epage%3D6094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Fabian Paul, Trayder Thomas, <span class="NLM_string-name hlFld-ContribAuthor">Benoît Roux</span>. </span><span class="cited-content_cbyCitation_article-title">Diversity of Long-Lived Intermediates along the Binding Pathway of Imatinib to Abl Kinase Revealed by MD Simulations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Theory and Computation</span><span> <strong>2020,</strong> <em>16 </em>
                                    (12)
                                     , 7852-7865. <a href="https://doi.org/10.1021/acs.jctc.0c00739" title="DOI URL">https://doi.org/10.1021/acs.jctc.0c00739</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jctc.0c00739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jctc.0c00739%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Theory%2520and%2520Computation%26atitle%3DDiversity%252Bof%252BLong-Lived%252BIntermediates%252Balong%252Bthe%252BBinding%252BPathway%252Bof%252BImatinib%252Bto%252BAbl%252BKinase%252BRevealed%252Bby%252BMD%252BSimulations%26aulast%3DPaul%26aufirst%3DFabian%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D15072020%26date%3D05112020%26volume%3D16%26issue%3D12%26spage%3D7852%26epage%3D7865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Filip Miljković, Raquel Rodríguez-Pérez, <span class="NLM_string-name hlFld-ContribAuthor">Jürgen Bajorath</span>. </span><span class="cited-content_cbyCitation_article-title">Machine Learning Models for Accurate Prediction of Kinase Inhibitors with Different Binding Modes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (16)
                                     , 8738-8748. <a href="https://doi.org/10.1021/acs.jmedchem.9b00867" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00867</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00867%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMachine%252BLearning%252BModels%252Bfor%252BAccurate%252BPrediction%252Bof%252BKinase%252BInhibitors%252Bwith%252BDifferent%252BBinding%252BModes%26aulast%3DMiljkovi%25C4%2587%26aufirst%3DFilip%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D29052019%26date%3D30082019%26volume%3D63%26issue%3D16%26spage%3D8738%26epage%3D8748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Fabian Paul, Yilin Meng, <span class="NLM_string-name hlFld-ContribAuthor">Benoît Roux</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Druggable Kinase Target Conformations Using Markov Model Metastable States Analysis of apo-Abl. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Theory and Computation</span><span> <strong>2020,</strong> <em>16 </em>
                                    (3)
                                     , 1896-1912. <a href="https://doi.org/10.1021/acs.jctc.9b01158" title="DOI URL">https://doi.org/10.1021/acs.jctc.9b01158</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jctc.9b01158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jctc.9b01158%26sid%3Dliteratum%253Aachs%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2018%26volume%3D14%26spage%3D2721%26epage%3D2732%26jtitle%3DJournal%2520of%2520Chemical%2520Theory%2520and%2520Computation%26atitle%3DIdentification%252Bof%252BDruggable%252BKinase%252BTarget%252BConformations%252BUsing%252BMarkov%252BModel%252BMetastable%252BStates%252BAnalysis%252Bof%252Bapo-Abl%26aulast%3DPaul%26aufirst%3DFabian%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D21112019%26date%3D13022020%26date%3D30012020%26volume%3D16%26issue%3D3%26spage%3D1896%26epage%3D1912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ananthasri Sailapathi, Gopinath Murugan, Kanagasabai Somarathinam, Seshan Gunalan, Rahul Jagadeesan, Niyaz Yoosuf, Sekar Kanagaraj, <span class="NLM_string-name hlFld-ContribAuthor">Gugan Kothandan</span>. </span><span class="cited-content_cbyCitation_article-title">Proposing the Promiscuous Protein Structures in JNK1 and JNK3 for Virtual Screening in Pursuit of Potential Leads. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2020,</strong> <em>5 </em>
                                    (8)
                                     , 3969-3978. <a href="https://doi.org/10.1021/acsomega.9b03458" title="DOI URL">https://doi.org/10.1021/acsomega.9b03458</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.9b03458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.9b03458%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DProposing%252Bthe%252BPromiscuous%252BProtein%252BStructures%252Bin%252BJNK1%252Band%252BJNK3%252Bfor%252BVirtual%252BScreening%252Bin%252BPursuit%252Bof%252BPotential%252BLeads%26aulast%3DSailapathi%26aufirst%3DAnanthasri%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D17102019%26date%3D11022020%26date%3D21022020%26volume%3D5%26issue%3D8%26spage%3D3969%26epage%3D3978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xingye Chen, Haichun Liu, Wuchen Xie, Yan Yang, Yuchen Wang, Yuanrong Fan, Yi Hua, Lu Zhu, Junnan Zhao, Tao Lu, Yadong Chen, <span class="NLM_string-name hlFld-ContribAuthor">Yanmin Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Investigation of Crystal Structures in Structure-Based Virtual Screening for Protein Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2019,</strong> <em>59 </em>
                                    (12)
                                     , 5244-5262. <a href="https://doi.org/10.1021/acs.jcim.9b00684" title="DOI URL">https://doi.org/10.1021/acs.jcim.9b00684</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.9b00684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.9b00684%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DInvestigation%252Bof%252BCrystal%252BStructures%252Bin%252BStructure-Based%252BVirtual%252BScreening%252Bfor%252BProtein%252BKinase%252BInhibitors%26aulast%3DChen%26aufirst%3DXingye%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D17082019%26date%3D15112019%26date%3D05112019%26volume%3D59%26issue%3D12%26spage%3D5244%26epage%3D5262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jin Chen, Anhui Wang, Bing Liu, Ye Zhou, Pan Luo, Zhichao Zhang, Guohui Li, Quentin Liu, <span class="NLM_string-name hlFld-ContribAuthor">Fangjun Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Quantitative Lysine Reactivity Profiling Reveals Conformational Inhibition Dynamics and Potency of Aurora A Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Analytical Chemistry</span><span> <strong>2019,</strong> <em>91 </em>
                                    (20)
                                     , 13222-13229. <a href="https://doi.org/10.1021/acs.analchem.9b03647" title="DOI URL">https://doi.org/10.1021/acs.analchem.9b03647</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.analchem.9b03647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.analchem.9b03647%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Chemistry%26atitle%3DQuantitative%252BLysine%252BReactivity%252BProfiling%252BReveals%252BConformational%252BInhibition%252BDynamics%252Band%252BPotency%252Bof%252BAurora%252BA%252BKinase%252BInhibitors%26aulast%3DChen%26aufirst%3DJin%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D10082019%26date%3D17092019%26date%3D26092019%26date%3D17092019%26volume%3D91%26issue%3D20%26spage%3D13222%26epage%3D13229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Cheng-Chieh Tsai, Zhi Yue, <span class="NLM_string-name hlFld-ContribAuthor">Jana Shen</span>. </span><span class="cited-content_cbyCitation_article-title">How Electrostatic Coupling Enables Conformational Plasticity in a Tyrosine Kinase. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2019,</strong> <em>141 </em>
                                    (38)
                                     , 15092-15101. <a href="https://doi.org/10.1021/jacs.9b06064" title="DOI URL">https://doi.org/10.1021/jacs.9b06064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.9b06064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.9b06064%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DHow%252BElectrostatic%252BCoupling%252BEnables%252BConformational%252BPlasticity%252Bin%252Ba%252BTyrosine%252BKinase%26aulast%3DTsai%26aufirst%3DCheng-Chieh%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D06062019%26date%3D13092019%26date%3D03092019%26volume%3D141%26issue%3D38%26spage%3D15092%26epage%3D15101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jianwen A. Feng, Patrick Lee, Moulay Hicham Alaoui, Kathy Barrett, Georgette Castanedo, Robert Godemann, Paul McEwan, Xiaolu Wang, Ping Wu, Yamin Zhang, Seth F. Harris, <span class="NLM_string-name hlFld-ContribAuthor">Steven T. Staben</span>. </span><span class="cited-content_cbyCitation_article-title">Structure Based Design of Potent Selective Inhibitors of Protein Kinase D1 (PKD1). </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (9)
                                     , 1260-1265. <a href="https://doi.org/10.1021/acsmedchemlett.8b00658" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00658</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00658%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%252BBased%252BDesign%252Bof%252BPotent%252BSelective%252BInhibitors%252Bof%252BProtein%252BKinase%252BD1%252B%252528PKD1%252529%26aulast%3DFeng%26aufirst%3DJianwen%2BA.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D31122018%26date%3D24072019%26date%3D12082019%26date%3D24072019%26volume%3D10%26issue%3D9%26spage%3D1260%26epage%3D1265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yuanxun Wang, Qiuyu Fu, Yu Zhou, Yunfei Du, <span class="NLM_string-name hlFld-ContribAuthor">Niu Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Replacement of Protein Binding-Site Waters Contributes to Favorable Halogen Bond Interactions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2019,</strong> <em>59 </em>
                                    (7)
                                     , 3136-3143. <a href="https://doi.org/10.1021/acs.jcim.9b00128" title="DOI URL">https://doi.org/10.1021/acs.jcim.9b00128</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.9b00128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.9b00128%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DReplacement%252Bof%252BProtein%252BBinding-Site%252BWaters%252BContributes%252Bto%252BFavorable%252BHalogen%252BBond%252BInteractions%26aulast%3DWang%26aufirst%3DYuanxun%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D12022019%26date%3D25062019%26date%3D12062019%26volume%3D59%26issue%3D7%26spage%3D3136%26epage%3D3143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ruibin Liu, Zhi Yue, Cheng-Chieh Tsai, <span class="NLM_string-name hlFld-ContribAuthor">Jana Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Assessing Lysine and Cysteine Reactivities for Designing Targeted Covalent Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2019,</strong> <em>141 </em>
                                    (16)
                                     , 6553-6560. <a href="https://doi.org/10.1021/jacs.8b13248" title="DOI URL">https://doi.org/10.1021/jacs.8b13248</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.8b13248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.8b13248%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DAssessing%252BLysine%252Band%252BCysteine%252BReactivities%252Bfor%252BDesigning%252BTargeted%252BCovalent%252BKinase%252BInhibitors%26aulast%3DLiu%26aufirst%3DRuibin%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D11122018%26date%3D16042019%26date%3D04042019%26volume%3D141%26issue%3D16%26spage%3D6553%26epage%3D6560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Victoria Georgi, Felix Schiele, Benedict-Tilman Berger, Andreas Steffen, Paula A. Marin Zapata, Hans Briem, Stephan Menz, Cornelia Preusse, James D. Vasta, Matthew B. Robers, Michael Brands, Stefan Knapp, <span class="NLM_string-name hlFld-ContribAuthor">Amaury Fernández-Montalván</span>. </span><span class="cited-content_cbyCitation_article-title">Binding Kinetics Survey of the Drugged Kinome. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2018,</strong> <em>140 </em>
                                    (46)
                                     , 15774-15782. <a href="https://doi.org/10.1021/jacs.8b08048" title="DOI URL">https://doi.org/10.1021/jacs.8b08048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.8b08048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.8b08048%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DBinding%252BKinetics%252BSurvey%252Bof%252Bthe%252BDrugged%252BKinome%26aulast%3DGeorgi%26aufirst%3DVictoria%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D10082018%26date%3D06112018%26date%3D26102018%26volume%3D140%26issue%3D46%26spage%3D15774%26epage%3D15782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Darwin Y.  Fu</span> and <span class="hlFld-ContribAuthor ">Jens  Meiler</span>  . </span><span class="cited-content_cbyCitation_article-title">Predictive Power of Different Types of Experimental Restraints in Small Molecule Docking: A Review. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2018,</strong> <em>58 </em>
                                    (2)
                                     , 225-233. <a href="https://doi.org/10.1021/acs.jcim.7b00418" title="DOI URL">https://doi.org/10.1021/acs.jcim.7b00418</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.7b00418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.7b00418%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DPredictive%252BPower%252Bof%252BDifferent%252BTypes%252Bof%252BExperimental%252BRestraints%252Bin%252BSmall%252BMolecule%252BDocking%25253A%252BA%252BReview%26aulast%3DFu%26aufirst%3DDarwin%2BY.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D13072017%26date%3D18012018%26date%3D26022018%26date%3D29122017%26volume%3D58%26issue%3D2%26spage%3D225%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Filip  Miljković</span> and <span class="hlFld-ContribAuthor ">Jürgen  Bajorath</span>  . </span><span class="cited-content_cbyCitation_article-title">Exploring Selectivity of Multikinase Inhibitors across the Human Kinome. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2018,</strong> <em>3 </em>
                                    (1)
                                     , 1147-1153. <a href="https://doi.org/10.1021/acsomega.7b01960" title="DOI URL">https://doi.org/10.1021/acsomega.7b01960</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.7b01960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.7b01960%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DExploring%252BSelectivity%252Bof%252BMultikinase%252BInhibitors%252Bacross%252Bthe%252BHuman%252BKinome%26aulast%3DMiljkovi%25C4%2587%26aufirst%3DFilip%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D08122017%26date%3D18012018%26date%3D31012018%26volume%3D3%26issue%3D1%26spage%3D1147%26epage%3D1153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanmin  Zhang</span>, <span class="hlFld-ContribAuthor ">Yadong  Chen</span>, <span class="hlFld-ContribAuthor ">Danfeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Tao  Lu</span>, and <span class="hlFld-ContribAuthor ">Yu  Jiao</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Potent VEGFR-2 Inhibitors Exerting Significant Antiproliferative Activity against Cancer Cell Lines. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (1)
                                     , 140-157. <a href="https://doi.org/10.1021/acs.jmedchem.7b01091" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01091</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01091%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BPotent%252BVEGFR-2%252BInhibitors%252BExerting%252BSignificant%252BAntiproliferative%252BActivity%252Bagainst%252BCancer%252BCell%252BLines%26aulast%3DZhang%26aufirst%3DYanmin%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D25072017%26date%3D19122017%26date%3D11012018%26date%3D30112017%26volume%3D61%26issue%3D1%26spage%3D140%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chenzhou  Hao</span>, <span class="hlFld-ContribAuthor ">Fan  Zhao</span>, <span class="hlFld-ContribAuthor ">Hongyan  Song</span>, <span class="hlFld-ContribAuthor ">Jing  Guo</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Li</span>, <span class="hlFld-ContribAuthor ">Xiaolin  Jiang</span>, <span class="hlFld-ContribAuthor ">Ran  Huan</span>, <span class="hlFld-ContribAuthor ">Shuai  Song</span>, <span class="hlFld-ContribAuthor ">Qiaoling  Zhang</span>, <span class="hlFld-ContribAuthor ">Ruifeng  Wang</span>, <span class="hlFld-ContribAuthor ">Kai  Wang</span>, <span class="hlFld-ContribAuthor ">Yu  Pang</span>, <span class="hlFld-ContribAuthor ">Tongchao  Liu</span>, <span class="hlFld-ContribAuthor ">Tianqi  Lu</span>, <span class="hlFld-ContribAuthor ">Wanxu  Huang</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Bin  Lin</span>, <span class="hlFld-ContribAuthor ">Zhonggui  He</span>, <span class="hlFld-ContribAuthor ">Haitao  Li</span>, <span class="hlFld-ContribAuthor ">Feng  Li</span>, <span class="hlFld-ContribAuthor ">Dongmei  Zhao</span>, and <span class="hlFld-ContribAuthor ">Maosheng  Cheng</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of 6-Chloro-4-aminoquinazoline-2-carboxamide Derivatives as Potent and Selective p21-Activated Kinase 4 (PAK4) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (1)
                                     , 265-285. <a href="https://doi.org/10.1021/acs.jmedchem.7b01342" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01342</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01342%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252B6-Chloro-4-aminoquinazoline-2-carboxamide%252BDerivatives%252Bas%252BPotent%252Band%252BSelective%252Bp21-Activated%252BKinase%252B4%252B%252528PAK4%252529%252BInhibitors%26aulast%3DHao%26aufirst%3DChenzhou%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D09092017%26date%3D30122017%26date%3D11012018%26date%3D30112017%26volume%3D61%26issue%3D1%26spage%3D265%26epage%3D285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prasenjit  Mukherjee</span>, <span class="hlFld-ContribAuthor ">Jörg  Bentzien</span>, <span class="hlFld-ContribAuthor ">Todd  Bosanac</span>, <span class="hlFld-ContribAuthor ">Wang  Mao</span>, <span class="hlFld-ContribAuthor ">Michael  Burke</span>, and <span class="hlFld-ContribAuthor ">Ingo  Muegge</span>  . </span><span class="cited-content_cbyCitation_article-title">Kinase Crystal Miner: A Powerful Approach to Repurposing 3D Hinge Binding Fragments and Its Application to Finding Novel Bruton Tyrosine Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2017,</strong> <em>57 </em>
                                    (9)
                                     , 2152-2160. <a href="https://doi.org/10.1021/acs.jcim.7b00213" title="DOI URL">https://doi.org/10.1021/acs.jcim.7b00213</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.7b00213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.7b00213%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DKinase%252BCrystal%252BMiner%25253A%252BA%252BPowerful%252BApproach%252Bto%252BRepurposing%252B3D%252BHinge%252BBinding%252BFragments%252Band%252BIts%252BApplication%252Bto%252BFinding%252BNovel%252BBruton%252BTyrosine%252BKinase%252BInhibitors%26aulast%3DMukherjee%26aufirst%3DPrasenjit%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D15042017%26date%3D28082017%26date%3D25092017%26date%3D09082017%26volume%3D57%26issue%3D9%26spage%3D2152%26epage%3D2160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanmin  Zhang</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Qing  Zhang</span>, <span class="hlFld-ContribAuthor ">Gaoyuan  Zhu</span>, <span class="hlFld-ContribAuthor ">Zhimin  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiang  Zhou</span>, <span class="hlFld-ContribAuthor ">Yadong  Chen</span>, <span class="hlFld-ContribAuthor ">Tao  Lu</span>, and <span class="hlFld-ContribAuthor ">Weifang  Tang</span>  . </span><span class="cited-content_cbyCitation_article-title">Potent Pan-Raf and Receptor Tyrosine Kinase Inhibitors Based on a Cyclopropyl Formamide Fragment Overcome Resistance. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2017,</strong> <em>57 </em>
                                    (6)
                                     , 1439-1452. <a href="https://doi.org/10.1021/acs.jcim.6b00795" title="DOI URL">https://doi.org/10.1021/acs.jcim.6b00795</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.6b00795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.6b00795%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DPotent%252BPan-Raf%252Band%252BReceptor%252BTyrosine%252BKinase%252BInhibitors%252BBased%252Bon%252Ba%252BCyclopropyl%252BFormamide%252BFragment%252BOvercome%252BResistance%26aulast%3DZhang%26aufirst%3DYanmin%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D31122016%26date%3D19052017%26date%3D26062017%26date%3D09052017%26volume%3D57%26issue%3D6%26spage%3D1439%26epage%3D1452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheng  Zhao</span>, <span class="hlFld-ContribAuthor ">Qingsong  Liu</span>, <span class="hlFld-ContribAuthor ">Spencer  Bliven</span>, <span class="hlFld-ContribAuthor ">Lei  Xie</span>, and <span class="hlFld-ContribAuthor ">Philip E.  Bourne</span>  . </span><span class="cited-content_cbyCitation_article-title">Determining Cysteines Available for Covalent Inhibition Across the Human Kinome. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (7)
                                     , 2879-2889. <a href="https://doi.org/10.1021/acs.jmedchem.6b01815" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01815</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01815%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDetermining%252BCysteines%252BAvailable%252Bfor%252BCovalent%252BInhibition%252BAcross%252Bthe%252BHuman%252BKinome%26aulast%3DZhao%26aufirst%3DZheng%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D13122016%26date%3D04042017%26date%3D13042017%26date%3D22032017%26volume%3D60%26issue%3D7%26spage%3D2879%26epage%3D2889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ross  McGuire</span>, <span class="hlFld-ContribAuthor ">Stefan  Verhoeven</span>, <span class="hlFld-ContribAuthor ">Márton  Vass</span>, <span class="hlFld-ContribAuthor ">Gerrit  Vriend</span>, <span class="hlFld-ContribAuthor ">Iwan J. P.  de Esch</span>, <span class="hlFld-ContribAuthor ">Scott J.  Lusher</span>, <span class="hlFld-ContribAuthor ">Rob  Leurs</span>, <span class="hlFld-ContribAuthor ">Lars  Ridder</span>, <span class="hlFld-ContribAuthor ">Albert J.  Kooistra</span>, <span class="hlFld-ContribAuthor ">Tina  Ritschel</span>, and <span class="hlFld-ContribAuthor ">Chris  de Graaf</span>  . </span><span class="cited-content_cbyCitation_article-title">3D-e-Chem-VM: Structural Cheminformatics Research Infrastructure in a Freely Available Virtual Machine. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2017,</strong> <em>57 </em>
                                    (2)
                                     , 115-121. <a href="https://doi.org/10.1021/acs.jcim.6b00686" title="DOI URL">https://doi.org/10.1021/acs.jcim.6b00686</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.6b00686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.6b00686%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3D3D-e-Chem-VM%25253A%252BStructural%252BCheminformatics%252BResearch%252BInfrastructure%252Bin%252Ba%252BFreely%252BAvailable%252BVirtual%252BMachine%26aulast%3DMcGuire%26aufirst%3DRoss%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D16112016%26date%3D14022017%26date%3D27022017%26date%3D26012017%26volume%3D57%26issue%3D2%26spage%3D115%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chimed  Jansen</span>, <span class="hlFld-ContribAuthor ">Albert J.  Kooistra</span>, <span class="hlFld-ContribAuthor ">Georgi K.  Kanev</span>, <span class="hlFld-ContribAuthor ">Rob  Leurs</span>, <span class="hlFld-ContribAuthor ">Iwan J. P.  de Esch</span>, and <span class="hlFld-ContribAuthor ">Chris  de Graaf</span>  . </span><span class="cited-content_cbyCitation_article-title">PDEStrIAn: A Phosphodiesterase Structure and Ligand Interaction Annotated Database As a Tool for Structure-Based Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (15)
                                     , 7029-7065. <a href="https://doi.org/10.1021/acs.jmedchem.5b01813" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01813</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01813%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPDEStrIAn%25253A%252BA%252BPhosphodiesterase%252BStructure%252Band%252BLigand%252BInteraction%252BAnnotated%252BDatabase%252BAs%252Ba%252BTool%252Bfor%252BStructure-Based%252BDrug%252BDesign%26aulast%3DJansen%26aufirst%3DChimed%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D20112015%26date%3D18032016%26date%3D11082016%26date%3D23022016%26volume%3D59%26issue%3D15%26spage%3D7029%26epage%3D7065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frank E.  Kwarcinski</span>, <span class="hlFld-ContribAuthor ">Kristoffer R.  Brandvold</span>, <span class="hlFld-ContribAuthor ">Sameer  Phadke</span>, <span class="hlFld-ContribAuthor ">Omar M.  Beleh</span>, <span class="hlFld-ContribAuthor ">Taylor K.  Johnson</span>, <span class="hlFld-ContribAuthor ">Jennifer L.  Meagher</span>, <span class="hlFld-ContribAuthor ">Markus A.  Seeliger</span>, <span class="hlFld-ContribAuthor ">Jeanne A.  Stuckey</span>, and <span class="hlFld-ContribAuthor ">Matthew B.  Soellner</span>  . </span><span class="cited-content_cbyCitation_article-title">Conformation-Selective Analogues of Dasatinib Reveal Insight into Kinase Inhibitor Binding and Selectivity. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2016,</strong> <em>11 </em>
                                    (5)
                                     , 1296-1304. <a href="https://doi.org/10.1021/acschembio.5b01018" title="DOI URL">https://doi.org/10.1021/acschembio.5b01018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.5b01018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.5b01018%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DConformation-Selective%252BAnalogues%252Bof%252BDasatinib%252BReveal%252BInsight%252Binto%252BKinase%252BInhibitor%252BBinding%252Band%252BSelectivity%26aulast%3DKwarcinski%26aufirst%3DFrank%2BE.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D10122015%26date%3D19022016%26date%3D01032016%26date%3D20052016%26date%3D19022016%26volume%3D11%26issue%3D5%26spage%3D1296%26epage%3D1304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheng  Zhao</span>, <span class="hlFld-ContribAuthor ">Li  Xie</span>, <span class="hlFld-ContribAuthor ">Lei  Xie</span>, and <span class="hlFld-ContribAuthor ">Philip E.  Bourne</span>  . </span><span class="cited-content_cbyCitation_article-title">Delineation of Polypharmacology across the Human Structural Kinome Using a Functional Site Interaction Fingerprint Approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (9)
                                     , 4326-4341. <a href="https://doi.org/10.1021/acs.jmedchem.5b02041" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b02041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b02041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b02041%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDelineation%252Bof%252BPolypharmacology%252Bacross%252Bthe%252BHuman%252BStructural%252BKinome%252BUsing%252Ba%252BFunctional%252BSite%252BInteraction%252BFingerprint%252BApproach%26aulast%3DZhao%26aufirst%3DZheng%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D31122015%26date%3D17032016%26date%3D12052016%26date%3D01032016%26volume%3D59%26issue%3D9%26spage%3D4326%26epage%3D4341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Albert J.  Kooistra</span>, <span class="hlFld-ContribAuthor ">Rob  Leurs</span>, <span class="hlFld-ContribAuthor ">Iwan J. P.  de Esch</span>, and <span class="hlFld-ContribAuthor ">Chris  de Graaf</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2015,</strong> <em>55 </em>
                                    (5)
                                     , 1045-1061. <a href="https://doi.org/10.1021/acs.jcim.5b00066" title="DOI URL">https://doi.org/10.1021/acs.jcim.5b00066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.5b00066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.5b00066%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DStructure-Based%252BPrediction%252Bof%252BG-Protein-Coupled%252BReceptor%252BLigand%252BFunction%25253A%252BA%252B%2525CE%2525B2-Adrenoceptor%252BCase%252BStudy%26aulast%3DKooistra%26aufirst%3DAlbert%2BJ.%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D20112014%26date%3D01052015%26date%3D26052015%26date%3D07042015%26volume%3D55%26issue%3D5%26spage%3D1045%26epage%3D1061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Volkamer</span>, <span class="hlFld-ContribAuthor ">Sameh  Eid</span>, <span class="hlFld-ContribAuthor ">Samo  Turk</span>, <span class="hlFld-ContribAuthor ">Sabrina  Jaeger</span>, <span class="hlFld-ContribAuthor ">Friedrich  Rippmann</span>, and <span class="hlFld-ContribAuthor ">Simone  Fulle</span>  . </span><span class="cited-content_cbyCitation_article-title">Pocketome of Human Kinases: Prioritizing the ATP Binding Sites of (Yet) Untapped Protein Kinases for Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2015,</strong> <em>55 </em>
                                    (3)
                                     , 538-549. <a href="https://doi.org/10.1021/ci500624s" title="DOI URL">https://doi.org/10.1021/ci500624s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci500624s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci500624s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DPocketome%252Bof%252BHuman%252BKinases%25253A%252BPrioritizing%252Bthe%252BATP%252BBinding%252BSites%252Bof%252B%252528Yet%252529%252BUntapped%252BProtein%252BKinases%252Bfor%252BDrug%252BDiscovery%26aulast%3DVolkamer%26aufirst%3DAndrea%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D16102014%26date%3D20012015%26date%3D23032015%26date%3D31122014%26volume%3D55%26issue%3D3%26spage%3D538%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oscar  Méndez-Lucio</span>, <span class="hlFld-ContribAuthor ">Albert J.  Kooistra</span>, <span class="hlFld-ContribAuthor ">Chris de  Graaf</span>, <span class="hlFld-ContribAuthor ">Andreas  Bender</span>, and <span class="hlFld-ContribAuthor ">José L.  Medina-Franco</span>  . </span><span class="cited-content_cbyCitation_article-title">Analyzing Multitarget Activity Landscapes Using Protein–Ligand Interaction Fingerprints: Interaction Cliffs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2015,</strong> <em>55 </em>
                                    (2)
                                     , 251-262. <a href="https://doi.org/10.1021/ci500721x" title="DOI URL">https://doi.org/10.1021/ci500721x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci500721x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci500721x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DAnalyzing%252BMultitarget%252BActivity%252BLandscapes%252BUsing%252BProtein%2525E2%252580%252593Ligand%252BInteraction%252BFingerprints%25253A%252BInteraction%252BCliffs%26aulast%3DM%25C3%25A9ndez-Lucio%26aufirst%3DOscar%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D04122014%26date%3D06022015%26date%3D23022015%26date%3D23012015%26volume%3D55%26issue%3D2%26spage%3D251%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ye  Hu</span>, <span class="hlFld-ContribAuthor ">Norbert  Furtmann</span>, and <span class="hlFld-ContribAuthor ">Jürgen  Bajorath</span>  . </span><span class="cited-content_cbyCitation_article-title">Current Compound Coverage of the Kinome. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (1)
                                     , 30-40. <a href="https://doi.org/10.1021/jm5008159" title="DOI URL">https://doi.org/10.1021/jm5008159</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5008159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5008159%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCurrent%252BCompound%252BCoverage%252Bof%252Bthe%252BKinome%26aulast%3DHu%26aufirst%3DYe%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D28052014%26date%3D30072014%26date%3D08012015%26date%3D22072014%26volume%3D58%26issue%3D1%26spage%3D30%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Norbert  Furtmann</span>, <span class="hlFld-ContribAuthor ">Ye  Hu</span>, and <span class="hlFld-ContribAuthor ">Jürgen  Bajorath</span>  . </span><span class="cited-content_cbyCitation_article-title">Comprehensive Analysis of Three-Dimensional Activity Cliffs Formed by Kinase Inhibitors with Different Binding Modes and Cliff Mapping of Structural Analogues. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (1)
                                     , 252-264. <a href="https://doi.org/10.1021/jm5009264" title="DOI URL">https://doi.org/10.1021/jm5009264</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5009264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5009264%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DComprehensive%252BAnalysis%252Bof%252BThree-Dimensional%252BActivity%252BCliffs%252BFormed%252Bby%252BKinase%252BInhibitors%252Bwith%252BDifferent%252BBinding%252BModes%252Band%252BCliff%252BMapping%252Bof%252BStructural%252BAnalogues%26aulast%3DFurtmann%26aufirst%3DNorbert%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D18062014%26date%3D31072014%26date%3D08012015%26date%3D23072014%26volume%3D58%26issue%3D1%26spage%3D252%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R. S. K.  Vijayan</span>, <span class="hlFld-ContribAuthor ">Peng  He</span>, <span class="hlFld-ContribAuthor ">Vivek  Modi</span>, <span class="hlFld-ContribAuthor ">Krisna C.  Duong-Ly</span>, <span class="hlFld-ContribAuthor ">Haiching  Ma</span>, <span class="hlFld-ContribAuthor ">Jeffrey R.  Peterson</span>, <span class="hlFld-ContribAuthor ">Roland L.  Dunbrack, Jr.</span>, and <span class="hlFld-ContribAuthor ">Ronald M.  Levy</span>  . </span><span class="cited-content_cbyCitation_article-title">Conformational Analysis of the DFG-Out Kinase Motif and Biochemical Profiling of Structurally Validated Type II Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (1)
                                     , 466-479. <a href="https://doi.org/10.1021/jm501603h" title="DOI URL">https://doi.org/10.1021/jm501603h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501603h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501603h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DConformational%252BAnalysis%252Bof%252Bthe%252BDFG-Out%252BKinase%252BMotif%252Band%252BBiochemical%252BProfiling%252Bof%252BStructurally%252BValidated%252BType%252BII%252BInhibitors%26aulast%3DVijayan%26aufirst%3DR.%2BS.%2BK.%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D15102014%26date%3D12122014%26date%3D08012015%26date%3D05122014%26volume%3D58%26issue%3D1%26spage%3D466%26epage%3D479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shawn J.  Stachel</span>, <span class="hlFld-ContribAuthor ">John M.  Sanders</span>, <span class="hlFld-ContribAuthor ">Darrell A.  Henze</span>, <span class="hlFld-ContribAuthor ">Mike T.  Rudd</span>, <span class="hlFld-ContribAuthor ">Hua-Poo  Su</span>, <span class="hlFld-ContribAuthor ">Yiwei  Li</span>, <span class="hlFld-ContribAuthor ">Kausik K.  Nanda</span>, <span class="hlFld-ContribAuthor ">Melissa S.  Egbertson</span>, <span class="hlFld-ContribAuthor ">Peter J.  Manley</span>, <span class="hlFld-ContribAuthor ">Kristen L. G.  Jones</span>, <span class="hlFld-ContribAuthor ">Edward J.  Brnardic</span>, <span class="hlFld-ContribAuthor ">Ahren  Green</span>, <span class="hlFld-ContribAuthor ">Jay A.  Grobler</span>, <span class="hlFld-ContribAuthor ">Barbara  Hanney</span>, <span class="hlFld-ContribAuthor ">Michael  Leitl</span>, <span class="hlFld-ContribAuthor ">Ming-Tain  Lai</span>, <span class="hlFld-ContribAuthor ">Vandna  Munshi</span>, <span class="hlFld-ContribAuthor ">Dennis  Murphy</span>, <span class="hlFld-ContribAuthor ">Keith  Rickert</span>, <span class="hlFld-ContribAuthor ">Daniel  Riley</span>, <span class="hlFld-ContribAuthor ">Alicja  Krasowska-Zoladek</span>, <span class="hlFld-ContribAuthor ">Christopher  Daley</span>, <span class="hlFld-ContribAuthor ">Paul  Zuck</span>, <span class="hlFld-ContribAuthor ">Stephanie A.  Kane</span>, and <span class="hlFld-ContribAuthor ">Mark T.  Bilodeau</span>  . </span><span class="cited-content_cbyCitation_article-title">Maximizing Diversity from a Kinase Screen: Identification of Novel and Selective pan-Trk Inhibitors for Chronic Pain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (13)
                                     , 5800-5816. <a href="https://doi.org/10.1021/jm5006429" title="DOI URL">https://doi.org/10.1021/jm5006429</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5006429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5006429%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMaximizing%252BDiversity%252Bfrom%252Ba%252BKinase%252BScreen%25253A%252BIdentification%252Bof%252BNovel%252Band%252BSelective%252Bpan-Trk%252BInhibitors%252Bfor%252BChronic%252BPain%26aulast%3DStachel%26aufirst%3DShawn%2BJ.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D01052014%26date%3D19062014%26date%3D10072014%26date%3D10062014%26volume%3D57%26issue%3D13%26spage%3D5800%26epage%3D5816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheng  Zhao</span>, <span class="hlFld-ContribAuthor ">Hong  Wu</span>, <span class="hlFld-ContribAuthor ">Li  Wang</span>, <span class="hlFld-ContribAuthor ">Yi  Liu</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, <span class="hlFld-ContribAuthor ">Qingsong  Liu</span>, and <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>  . </span><span class="cited-content_cbyCitation_article-title">Exploration of Type II Binding Mode: A Privileged Approach for Kinase Inhibitor Focused Drug Discovery?. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2014,</strong> <em>9 </em>
                                    (6)
                                     , 1230-1241. <a href="https://doi.org/10.1021/cb500129t" title="DOI URL">https://doi.org/10.1021/cb500129t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb500129t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb500129t%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DExploration%252Bof%252BType%252BII%252BBinding%252BMode%25253A%252BA%252BPrivileged%252BApproach%252Bfor%252BKinase%252BInhibitor%252BFocused%252BDrug%252BDiscovery%25253F%26aulast%3DZhao%26aufirst%3DZheng%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D19022014%26date%3D14042014%26date%3D29042014%26date%3D20062014%26date%3D14042014%26volume%3D9%26issue%3D6%26spage%3D1230%26epage%3D1241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ibrahim  Abdelbaky</span>, <span class="hlFld-ContribAuthor ">Hilal  Tayara</span>, <span class="hlFld-ContribAuthor ">Kil To  Chong</span>. </span><span class="cited-content_cbyCitation_article-title">Prediction of kinase inhibitors binding modes with machine learning and reduced descriptor sets. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-80758-4" title="DOI URL">https://doi.org/10.1038/s41598-020-80758-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-80758-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-80758-4%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DPrediction%252Bof%252Bkinase%252Binhibitors%252Bbinding%252Bmodes%252Bwith%252Bmachine%252Blearning%252Band%252Breduced%252Bdescriptor%252Bsets%26aulast%3DAbdelbaky%26aufirst%3DIbrahim%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ni Made Pitri  Susanti</span>, <span class="hlFld-ContribAuthor ">Daryono Hadi  Tjahjono</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclin-Dependent Kinase 4 and 6 Inhibitors in Cell Cycle Dysregulation for Breast Cancer Treatment. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (15)
                                     , 4462. <a href="https://doi.org/10.3390/molecules26154462" title="DOI URL">https://doi.org/10.3390/molecules26154462</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26154462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26154462%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DCyclin-Dependent%252BKinase%252B4%252Band%252B6%252BInhibitors%252Bin%252BCell%252BCycle%252BDysregulation%252Bfor%252BBreast%252BCancer%252BTreatment%26aulast%3DSusanti%26aufirst%3DNi%2BMade%2BPitri%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D15%26spage%3D4462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhi-Zheng  Wang</span>, <span class="hlFld-ContribAuthor ">Xing-Xing  Shi</span>, <span class="hlFld-ContribAuthor ">Guang-Yi  Huang</span>, <span class="hlFld-ContribAuthor ">Ge-Fei  Hao</span>, <span class="hlFld-ContribAuthor ">Guang-Fu  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-based drug design facilitates selective kinase inhibitor discovery. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2021,</strong> <em>42 </em>
                                    (7)
                                     , 551-565. <a href="https://doi.org/10.1016/j.tips.2021.04.001" title="DOI URL">https://doi.org/10.1016/j.tips.2021.04.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2021.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2021.04.001%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DFragment-based%252Bdrug%252Bdesign%252Bfacilitates%252Bselective%252Bkinase%252Binhibitor%252Bdiscovery%26aulast%3DWang%26aufirst%3DZhi-Zheng%26date%3D2021%26volume%3D42%26issue%3D7%26spage%3D551%26epage%3D565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huabin  Hu</span>, <span class="hlFld-ContribAuthor ">Jürgen  Bajorath</span>. </span><span class="cited-content_cbyCitation_article-title">Systematic assessment of structure-promiscuity relationships between different types of kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>41 </em>, 116226. <a href="https://doi.org/10.1016/j.bmc.2021.116226" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116226</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116226%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSystematic%252Bassessment%252Bof%252Bstructure-promiscuity%252Brelationships%252Bbetween%252Bdifferent%252Btypes%252Bof%252Bkinase%252Binhibitors%26aulast%3DHu%26aufirst%3DHuabin%26date%3D2021%26volume%3D41%26spage%3D116226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Roskoski</span>. </span><span class="cited-content_cbyCitation_article-title">Hydrophobic and polar interactions of FDA-approved small molecule protein kinase inhibitors with their target enzymes. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2021,</strong> <em>169 </em>, 105660. <a href="https://doi.org/10.1016/j.phrs.2021.105660" title="DOI URL">https://doi.org/10.1016/j.phrs.2021.105660</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2021.105660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2021.105660%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DHydrophobic%252Band%252Bpolar%252Binteractions%252Bof%252BFDA-approved%252Bsmall%252Bmolecule%252Bprotein%252Bkinase%252Binhibitors%252Bwith%252Btheir%252Btarget%252Benzymes%26aulast%3DRoskoski%26aufirst%3DRobert%26date%3D2021%26volume%3D169%26spage%3D105660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Milagros  Mateos-Olivares</span>, <span class="hlFld-ContribAuthor ">Luis  García-Onrubia</span>, <span class="hlFld-ContribAuthor ">Fco. Javier  Valentín-Bravo</span>, <span class="hlFld-ContribAuthor ">Rogelio  González-Sarmiento</span>, <span class="hlFld-ContribAuthor ">Maribel  Lopez-Galvez</span>, <span class="hlFld-ContribAuthor ">J. Carlos  Pastor</span>, <span class="hlFld-ContribAuthor ">Ricardo  Usategui-Martín</span>, <span class="hlFld-ContribAuthor ">Salvador  Pastor-Idoate</span>. </span><span class="cited-content_cbyCitation_article-title">Rho-Kinase Inhibitors for the Treatment of Refractory Diabetic Macular Oedema. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2021,</strong> <em>10 </em>
                                    (7)
                                     , 1683. <a href="https://doi.org/10.3390/cells10071683" title="DOI URL">https://doi.org/10.3390/cells10071683</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells10071683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells10071683%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DRho-Kinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BRefractory%252BDiabetic%252BMacular%252BOedema%26aulast%3DMateos-Olivares%26aufirst%3DMilagros%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D7%26spage%3D1683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Roskoski</span>. </span><span class="cited-content_cbyCitation_article-title">Properties of FDA-approved small molecule phosphatidylinositol 3-kinase inhibitors prescribed for the treatment of malignancies. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2021,</strong> <em>168 </em>, 105579. <a href="https://doi.org/10.1016/j.phrs.2021.105579" title="DOI URL">https://doi.org/10.1016/j.phrs.2021.105579</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2021.105579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2021.105579%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DProperties%252Bof%252BFDA-approved%252Bsmall%252Bmolecule%252Bphosphatidylinositol%252B3-kinase%252Binhibitors%252Bprescribed%252Bfor%252Bthe%252Btreatment%252Bof%252Bmalignancies%26aulast%3DRoskoski%26aufirst%3DRobert%26date%3D2021%26volume%3D168%26spage%3D105579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huabin  Hu</span>, <span class="hlFld-ContribAuthor ">Oliver  Laufkötter</span>, <span class="hlFld-ContribAuthor ">Filip  Miljković</span>, <span class="hlFld-ContribAuthor ">Jürgen  Bajorath</span>. </span><span class="cited-content_cbyCitation_article-title">Data set of competitive and allosteric protein kinase inhibitors confirmed by X-ray crystallography. </span><span class="cited-content_cbyCitation_journal-name">Data in Brief</span><span> <strong>2021,</strong> <em>35 </em>, 106816. <a href="https://doi.org/10.1016/j.dib.2021.106816" title="DOI URL">https://doi.org/10.1016/j.dib.2021.106816</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.dib.2021.106816&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.dib.2021.106816%26sid%3Dliteratum%253Aachs%26jtitle%3DData%2520in%2520Brief%26atitle%3DData%252Bset%252Bof%252Bcompetitive%252Band%252Ballosteric%252Bprotein%252Bkinase%252Binhibitors%252Bconfirmed%252Bby%252BX-ray%252Bcrystallography%26aulast%3DHu%26aufirst%3DHuabin%26date%3D2021%26volume%3D35%26spage%3D106816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samdani  Ansar</span>, <span class="hlFld-ContribAuthor ">Umashankar  Vetrivel</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design of small molecule and peptide inhibitors for selective targeting of ROCK1: an integrative computational approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>10 </em>, 1-19. <a href="https://doi.org/10.1080/07391102.2021.1898470" title="DOI URL">https://doi.org/10.1080/07391102.2021.1898470</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2021.1898470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2021.1898470%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DStructure-based%252Bdesign%252Bof%252Bsmall%252Bmolecule%252Band%252Bpeptide%252Binhibitors%252Bfor%252Bselective%252Btargeting%252Bof%252BROCK1%25253A%252Ban%252Bintegrative%252Bcomputational%252Bapproach%26aulast%3DAnsar%26aufirst%3DSamdani%26date%3D2021%26date%3D2021%26volume%3D10%26spage%3D1%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi  Long</span>, <span class="hlFld-ContribAuthor ">Mingfeng  Yu</span>, <span class="hlFld-ContribAuthor ">Aleksandra M.  Ochnik</span>, <span class="hlFld-ContribAuthor ">Jasmine D.  Karanjia</span>, <span class="hlFld-ContribAuthor ">Sunita KC.  Basnet</span>, <span class="hlFld-ContribAuthor ">Alemwork A.  Kebede</span>, <span class="hlFld-ContribAuthor ">Lianmeng  Kou</span>, <span class="hlFld-ContribAuthor ">Shudong  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel 4-azaaryl-N-phenylpyrimidin-2-amine derivatives as potent and selective FLT3 inhibitors for acute myeloid leukaemia with FLT3 mutations. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>213 </em>, 113215. <a href="https://doi.org/10.1016/j.ejmech.2021.113215" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113215</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113215%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252B4-azaaryl-N-phenylpyrimidin-2-amine%252Bderivatives%252Bas%252Bpotent%252Band%252Bselective%252BFLT3%252Binhibitors%252Bfor%252Bacute%252Bmyeloid%252Bleukaemia%252Bwith%252BFLT3%252Bmutations%26aulast%3DLong%26aufirst%3DYi%26date%3D2021%26volume%3D213%26spage%3D113215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Roskoski</span>. </span><span class="cited-content_cbyCitation_article-title">Orally effective FDA-approved protein kinase targeted covalent inhibitors (TCIs). </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2021,</strong> <em>165 </em>, 105422. <a href="https://doi.org/10.1016/j.phrs.2021.105422" title="DOI URL">https://doi.org/10.1016/j.phrs.2021.105422</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2021.105422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2021.105422%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DOrally%252Beffective%252BFDA-approved%252Bprotein%252Bkinase%252Btargeted%252Bcovalent%252Binhibitors%252B%252528TCIs%252529%26aulast%3DRoskoski%26aufirst%3DRobert%26date%3D2021%26volume%3D165%26spage%3D105422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Roskoski</span>. </span><span class="cited-content_cbyCitation_article-title">Properties of FDA-approved small molecule protein kinase inhibitors: A 2021 update. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2021,</strong> <em>165 </em>, 105463. <a href="https://doi.org/10.1016/j.phrs.2021.105463" title="DOI URL">https://doi.org/10.1016/j.phrs.2021.105463</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2021.105463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2021.105463%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DProperties%252Bof%252BFDA-approved%252Bsmall%252Bmolecule%252Bprotein%252Bkinase%252Binhibitors%25253A%252BA%252B2021%252Bupdate%26aulast%3DRoskoski%26aufirst%3DRobert%26date%3D2021%26volume%3D165%26spage%3D105463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Zhu</span>, <span class="hlFld-ContribAuthor ">Saad  Alqahtani</span>, <span class="hlFld-ContribAuthor ">Xiche  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Aromatic Rings as Molecular Determinants for the Molecular Recognition of Protein Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (6)
                                     , 1776. <a href="https://doi.org/10.3390/molecules26061776" title="DOI URL">https://doi.org/10.3390/molecules26061776</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26061776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26061776%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DAromatic%252BRings%252Bas%252BMolecular%252BDeterminants%252Bfor%252Bthe%252BMolecular%252BRecognition%252Bof%252BProtein%252BKinase%252BInhibitors%26aulast%3DZhu%26aufirst%3DYan%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D6%26spage%3D1776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huabin  Hu</span>, <span class="hlFld-ContribAuthor ">Oliver  Laufkötter</span>, <span class="hlFld-ContribAuthor ">Filip  Miljković</span>, <span class="hlFld-ContribAuthor ">Jürgen  Bajorath</span>. </span><span class="cited-content_cbyCitation_article-title">Systematic comparison of competitive and allosteric kinase inhibitors reveals common structural characteristics. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>214 </em>, 113206. <a href="https://doi.org/10.1016/j.ejmech.2021.113206" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113206</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113206%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSystematic%252Bcomparison%252Bof%252Bcompetitive%252Band%252Ballosteric%252Bkinase%252Binhibitors%252Breveals%252Bcommon%252Bstructural%252Bcharacteristics%26aulast%3DHu%26aufirst%3DHuabin%26date%3D2021%26volume%3D214%26spage%3D113206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Denis  Schmidt</span>, <span class="hlFld-ContribAuthor ">Magdalena M.  Scharf</span>, <span class="hlFld-ContribAuthor ">Dominique  Sydow</span>, <span class="hlFld-ContribAuthor ">Eva  Aßmann</span>, <span class="hlFld-ContribAuthor ">Maria  Martí-Solano</span>, <span class="hlFld-ContribAuthor ">Marina  Keul</span>, <span class="hlFld-ContribAuthor ">Andrea  Volkamer</span>, <span class="hlFld-ContribAuthor ">Peter  Kolb</span>. </span><span class="cited-content_cbyCitation_article-title">Analyzing Kinase Similarity in Small Molecule and Protein Structural Space to Explore the Limits of Multi-Target Screening. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (3)
                                     , 629. <a href="https://doi.org/10.3390/molecules26030629" title="DOI URL">https://doi.org/10.3390/molecules26030629</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26030629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26030629%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DAnalyzing%252BKinase%252BSimilarity%252Bin%252BSmall%252BMolecule%252Band%252BProtein%252BStructural%252BSpace%252Bto%252BExplore%252Bthe%252BLimits%252Bof%252BMulti-Target%252BScreening%26aulast%3DSchmidt%26aufirst%3DDenis%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D3%26spage%3D629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nichole E. M.  Kaufman</span>, <span class="hlFld-ContribAuthor ">Simran  Dhingra</span>, <span class="hlFld-ContribAuthor ">Seetharama D.  Jois</span>, <span class="hlFld-ContribAuthor ">Maria da Graça H.  Vicente</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Targeting of Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor Receptor (VEGFR). </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (4)
                                     , 1076. <a href="https://doi.org/10.3390/molecules26041076" title="DOI URL">https://doi.org/10.3390/molecules26041076</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26041076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26041076%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DMolecular%252BTargeting%252Bof%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252B%252528EGFR%252529%252Band%252BVascular%252BEndothelial%252BGrowth%252BFactor%252BReceptor%252B%252528VEGFR%252529%26aulast%3DKaufman%26aufirst%3DNichole%2BE.%2BM.%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D4%26spage%3D1076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V.  Subbiah</span>, <span class="hlFld-ContribAuthor ">T.  Shen</span>, <span class="hlFld-ContribAuthor ">S.S.  Terzyan</span>, <span class="hlFld-ContribAuthor ">X.  Liu</span>, <span class="hlFld-ContribAuthor ">X.  Hu</span>, <span class="hlFld-ContribAuthor ">K.P.  Patel</span>, <span class="hlFld-ContribAuthor ">M.  Hu</span>, <span class="hlFld-ContribAuthor ">M.  Cabanillas</span>, <span class="hlFld-ContribAuthor ">A.  Behrang</span>, <span class="hlFld-ContribAuthor ">F.  Meric-Bernstam</span>, <span class="hlFld-ContribAuthor ">P.T.T.  Vo</span>, <span class="hlFld-ContribAuthor ">B.H.M.  Mooers</span>, <span class="hlFld-ContribAuthor ">J.  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations. </span><span class="cited-content_cbyCitation_journal-name">Annals of Oncology</span><span> <strong>2021,</strong> <em>32 </em>
                                    (2)
                                     , 261-268. <a href="https://doi.org/10.1016/j.annonc.2020.10.599" title="DOI URL">https://doi.org/10.1016/j.annonc.2020.10.599</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.annonc.2020.10.599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.annonc.2020.10.599%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnals%2520of%2520Oncology%26atitle%3DStructural%252Bbasis%252Bof%252Bacquired%252Bresistance%252Bto%252Bselpercatinib%252Band%252Bpralsetinib%252Bmediated%252Bby%252Bnon-gatekeeper%252BRET%252Bmutations%26aulast%3DSubbiah%26aufirst%3DV.%26date%3D2021%26volume%3D32%26issue%3D2%26spage%3D261%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Georgi K  Kanev</span>, <span class="hlFld-ContribAuthor ">Chris  de Graaf</span>, <span class="hlFld-ContribAuthor ">Bart A  Westerman</span>, <span class="hlFld-ContribAuthor ">Iwan J P  de Esch</span>, <span class="hlFld-ContribAuthor ">Albert J  Kooistra</span>. </span><span class="cited-content_cbyCitation_article-title">KLIFS: an overhaul after the first 5 years of supporting kinase research. </span><span class="cited-content_cbyCitation_journal-name">Nucleic Acids Research</span><span> <strong>2021,</strong> <em>49 </em>
                                    (D1)
                                     , D562-D569. <a href="https://doi.org/10.1093/nar/gkaa895" title="DOI URL">https://doi.org/10.1093/nar/gkaa895</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/nar/gkaa895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnar%2Fgkaa895%26sid%3Dliteratum%253Aachs%26jtitle%3DNucleic%2520Acids%2520Research%26atitle%3DKLIFS%25253A%252Ban%252Boverhaul%252Bafter%252Bthe%252Bfirst%252B5%252Byears%252Bof%252Bsupporting%252Bkinase%252Bresearch%26aulast%3DKanev%26aufirst%3DGeorgi%2BK%26date%3D2021%26date%3D2020%26volume%3D49%26issue%3DD1%26spage%3DD562%26epage%3DD569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rongyan  Zhao</span>, <span class="hlFld-ContribAuthor ">Leilei  Fu</span>, <span class="hlFld-ContribAuthor ">Zhaoxin  Yuan</span>, <span class="hlFld-ContribAuthor ">Yi  Liu</span>, <span class="hlFld-ContribAuthor ">Kai  Zhang</span>, <span class="hlFld-ContribAuthor ">Yanmei  Chen</span>, <span class="hlFld-ContribAuthor ">Leiming  Wang</span>, <span class="hlFld-ContribAuthor ">Dejuan  Sun</span>, <span class="hlFld-ContribAuthor ">Lixia  Chen</span>, <span class="hlFld-ContribAuthor ">Bo  Liu</span>, <span class="hlFld-ContribAuthor ">Lan  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a novel small-molecule inhibitor of Fam20C that induces apoptosis and inhibits migration in triple negative breast cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>210 </em>, 113088. <a href="https://doi.org/10.1016/j.ejmech.2020.113088" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113088</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113088%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252Bnovel%252Bsmall-molecule%252Binhibitor%252Bof%252BFam20C%252Bthat%252Binduces%252Bapoptosis%252Band%252Binhibits%252Bmigration%252Bin%252Btriple%252Bnegative%252Bbreast%252Bcancer%26aulast%3DZhao%26aufirst%3DRongyan%26date%3D2021%26volume%3D210%26spage%3D113088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shiyang  Zhou</span>, <span class="hlFld-ContribAuthor ">Gangliang  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel 7H-benzo [c] [1, 3] dioxolo [4, 5-f] chromen-7-one derivatives with potential anti-tumor activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>105 </em>, 104381. <a href="https://doi.org/10.1016/j.bioorg.2020.104381" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104381</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104381%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B7H-benzo%252B%25255Bc%25255D%252B%25255B1%25252C%252B3%25255D%252Bdioxolo%252B%25255B4%25252C%252B5-f%25255D%252Bchromen-7-one%252Bderivatives%252Bwith%252Bpotential%252Banti-tumor%252Bactivity%26aulast%3DZhou%26aufirst%3DShiyang%26date%3D2020%26volume%3D105%26spage%3D104381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiomaris M.  Cotto-Rios</span>, <span class="hlFld-ContribAuthor ">Bogos  Agianian</span>, <span class="hlFld-ContribAuthor ">Nadege  Gitego</span>, <span class="hlFld-ContribAuthor ">Emmanouil  Zacharioudakis</span>, <span class="hlFld-ContribAuthor ">Orsi  Giricz</span>, <span class="hlFld-ContribAuthor ">Yang  Wu</span>, <span class="hlFld-ContribAuthor ">Yiyu  Zou</span>, <span class="hlFld-ContribAuthor ">Amit  Verma</span>, <span class="hlFld-ContribAuthor ">Poulikos I.  Poulikakos</span>, <span class="hlFld-ContribAuthor ">Evripidis  Gavathiotis</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of BRAF dimers using an allosteric site. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-020-18123-2" title="DOI URL">https://doi.org/10.1038/s41467-020-18123-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-020-18123-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-020-18123-2%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DInhibitors%252Bof%252BBRAF%252Bdimers%252Busing%252Ban%252Ballosteric%252Bsite%26aulast%3DCotto-Rios%26aufirst%3DXiomaris%2BM.%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raquel  Rodríguez-Pérez</span>, <span class="hlFld-ContribAuthor ">Filip  Miljković</span>, <span class="hlFld-ContribAuthor ">Jürgen  Bajorath</span>. </span><span class="cited-content_cbyCitation_article-title">Assessing the information content of structural and protein–ligand interaction representations for the classification of kinase inhibitor binding modes via machine learning and active learning. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cheminformatics</span><span> <strong>2020,</strong> <em>12 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13321-020-00434-7" title="DOI URL">https://doi.org/10.1186/s13321-020-00434-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13321-020-00434-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13321-020-00434-7%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cheminformatics%26atitle%3DAssessing%252Bthe%252Binformation%252Bcontent%252Bof%252Bstructural%252Band%252Bprotein%2525E2%252580%252593ligand%252Binteraction%252Brepresentations%252Bfor%252Bthe%252Bclassification%252Bof%252Bkinase%252Binhibitor%252Bbinding%252Bmodes%252Bvia%252Bmachine%252Blearning%252Band%252Bactive%252Blearning%26aulast%3DRodr%25C3%25ADguez-P%25C3%25A9rez%26aufirst%3DRaquel%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara R.  Savage</span>, <span class="hlFld-ContribAuthor ">Bing  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Using phosphoproteomics data to understand cellular signaling: a comprehensive guide to bioinformatics resources. </span><span class="cited-content_cbyCitation_journal-name">Clinical Proteomics</span><span> <strong>2020,</strong> <em>17 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12014-020-09290-x" title="DOI URL">https://doi.org/10.1186/s12014-020-09290-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12014-020-09290-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12014-020-09290-x%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Proteomics%26atitle%3DUsing%252Bphosphoproteomics%252Bdata%252Bto%252Bunderstand%252Bcellular%252Bsignaling%25253A%252Ba%252Bcomprehensive%252Bguide%252Bto%252Bbioinformatics%252Bresources%26aulast%3DSavage%26aufirst%3DSara%2BR.%26date%3D2020%26date%3D2020%26volume%3D17%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael P.  Mazanetz</span>, <span class="hlFld-ContribAuthor ">Charlotte H.F.  Goode</span>, <span class="hlFld-ContribAuthor ">Ewa I.  Chudyk</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand- and Structure-Based Drug Design and Optimization using KNIME. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2020,</strong> <em>27 </em>
                                    (38)
                                     , 6458-6479. <a href="https://doi.org/10.2174/0929867326666190409141016" title="DOI URL">https://doi.org/10.2174/0929867326666190409141016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867326666190409141016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867326666190409141016%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DLigand-%252Band%252BStructure-Based%252BDrug%252BDesign%252Band%252BOptimization%252Busing%252BKNIME%26aulast%3DMazanetz%26aufirst%3DMichael%2BP.%26date%3D2020%26volume%3D27%26issue%3D38%26spage%3D6458%26epage%3D6479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuka  Murakawa</span>, <span class="hlFld-ContribAuthor ">Shirly  Valter</span>, <span class="hlFld-ContribAuthor ">Haim  Barr</span>, <span class="hlFld-ContribAuthor ">Nir  London</span>, <span class="hlFld-ContribAuthor ">Takayoshi  Kinoshita</span>. </span><span class="cited-content_cbyCitation_article-title">Structural basis for producing selective MAP2K7 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (22)
                                     , 127546. <a href="https://doi.org/10.1016/j.bmcl.2020.127546" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127546</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127546%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructural%252Bbasis%252Bfor%252Bproducing%252Bselective%252BMAP2K7%252Binhibitors%26aulast%3DMurakawa%26aufirst%3DYuka%26date%3D2020%26volume%3D30%26issue%3D22%26spage%3D127546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samdani  Ansar</span>, <span class="hlFld-ContribAuthor ">Umashankar  Vetrivel</span>. </span><span class="cited-content_cbyCitation_article-title">KinomeRun: An interactive utility for kinome target screening and interaction fingerprint analysis towards holistic visualization on kinome tree. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2020,</strong> <em>96 </em>
                                    (4)
                                     , 1162-1175. <a href="https://doi.org/10.1111/cbdd.13705" title="DOI URL">https://doi.org/10.1111/cbdd.13705</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13705&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13705%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DKinomeRun%25253A%252BAn%252Binteractive%252Butility%252Bfor%252Bkinome%252Btarget%252Bscreening%252Band%252Binteraction%252Bfingerprint%252Banalysis%252Btowards%252Bholistic%252Bvisualization%252Bon%252Bkinome%252Btree%26aulast%3DAnsar%26aufirst%3DSamdani%26date%3D2020%26date%3D2020%26volume%3D96%26issue%3D4%26spage%3D1162%26epage%3D1175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher R. M.  Asquith</span>, <span class="hlFld-ContribAuthor ">Graham J.  Tizzard</span>, <span class="hlFld-ContribAuthor ">James M.  Bennett</span>, <span class="hlFld-ContribAuthor ">Carrow I.  Wells</span>, <span class="hlFld-ContribAuthor ">Jonathan M.  Elkins</span>, <span class="hlFld-ContribAuthor ">Timothy M.  Willson</span>, <span class="hlFld-ContribAuthor ">Antti  Poso</span>, <span class="hlFld-ContribAuthor ">Tuomo  Laitinen</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the Water Network in Cyclin G‐Associated Kinase (GAK) with 4‐Anilino‐quin(az)oline Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (13)
                                     , 1200-1215. <a href="https://doi.org/10.1002/cmdc.202000150" title="DOI URL">https://doi.org/10.1002/cmdc.202000150</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000150%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DTargeting%252Bthe%252BWater%252BNetwork%252Bin%252BCyclin%252BG%2525E2%252580%252590Associated%252BKinase%252B%252528GAK%252529%252Bwith%252B4%2525E2%252580%252590Anilino%2525E2%252580%252590quin%252528az%252529oline%252BInhibitors%26aulast%3DAsquith%26aufirst%3DChristopher%2BR.%2BM.%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D13%26spage%3D1200%26epage%3D1215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kei  Moritsugu</span>, <span class="hlFld-ContribAuthor ">Yoshihiko  Nishino</span>, <span class="hlFld-ContribAuthor ">Akinori  Kidera</span>. </span><span class="cited-content_cbyCitation_article-title">Inter-lobe Motions Allosterically Regulate the Structure and Function of EGFR Kinase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Biology</span><span> <strong>2020,</strong> <em>432 </em>
                                    (16)
                                     , 4561-4575. <a href="https://doi.org/10.1016/j.jmb.2020.06.007" title="DOI URL">https://doi.org/10.1016/j.jmb.2020.06.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmb.2020.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmb.2020.06.007%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Biology%26atitle%3DInter-lobe%252BMotions%252BAllosterically%252BRegulate%252Bthe%252BStructure%252Band%252BFunction%252Bof%252BEGFR%252BKinase%26aulast%3DMoritsugu%26aufirst%3DKei%26date%3D2020%26volume%3D432%26issue%3D16%26spage%3D4561%26epage%3D4575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrés Felipe  Vásquez</span>, <span class="hlFld-ContribAuthor ">Alejandro  Reyes Muñoz</span>, <span class="hlFld-ContribAuthor ">Jorge  Duitama</span>, <span class="hlFld-ContribAuthor ">Andrés  González Barrios</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of new potential CDK2/VEGFR2 type II inhibitors by fragmentation and virtual screening of natural products. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>10 </em>, 1-15. <a href="https://doi.org/10.1080/07391102.2020.1763839" title="DOI URL">https://doi.org/10.1080/07391102.2020.1763839</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1763839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1763839%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DDiscovery%252Bof%252Bnew%252Bpotential%252BCDK2%25252FVEGFR2%252Btype%252BII%252Binhibitors%252Bby%252Bfragmentation%252Band%252Bvirtual%252Bscreening%252Bof%252Bnatural%252Bproducts%26aulast%3DV%25C3%25A1squez%26aufirst%3DAndr%25C3%25A9s%2BFelipe%26date%3D2020%26date%3D2020%26volume%3D10%26spage%3D1%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Roskoski</span>. </span><span class="cited-content_cbyCitation_article-title">The role of small molecule Flt3 receptor protein-tyrosine kinase inhibitors in the treatment of Flt3-positive acute myelogenous leukemias. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2020,</strong> <em>155 </em>, 104725. <a href="https://doi.org/10.1016/j.phrs.2020.104725" title="DOI URL">https://doi.org/10.1016/j.phrs.2020.104725</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2020.104725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2020.104725%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DThe%252Brole%252Bof%252Bsmall%252Bmolecule%252BFlt3%252Breceptor%252Bprotein-tyrosine%252Bkinase%252Binhibitors%252Bin%252Bthe%252Btreatment%252Bof%252BFlt3-positive%252Bacute%252Bmyelogenous%252Bleukemias%26aulast%3DRoskoski%26aufirst%3DRobert%26date%3D2020%26volume%3D155%26spage%3D104725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Upasana  Yadav</span>, <span class="hlFld-ContribAuthor ">Akash P.  Sakla</span>, <span class="hlFld-ContribAuthor ">Ramya  Tokala</span>, <span class="hlFld-ContribAuthor ">Sai Teja  Nyalam</span>, <span class="hlFld-ContribAuthor ">Amit  Khurana</span>, <span class="hlFld-ContribAuthor ">Chander Singh  Digwal</span>, <span class="hlFld-ContribAuthor ">Venu  Talla</span>, <span class="hlFld-ContribAuthor ">Chandraiah  Godugu</span>, <span class="hlFld-ContribAuthor ">Nagula  Shankaraiah</span>, <span class="hlFld-ContribAuthor ">Ahmed  Kamal</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of 5‐Morpholino‐Thiophene‐Indole/ Oxindole Hybrids as Cytotoxic Agents. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2020,</strong> <em>5 </em>
                                    (14)
                                     , 4356-4363. <a href="https://doi.org/10.1002/slct.201904845" title="DOI URL">https://doi.org/10.1002/slct.201904845</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201904845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201904845%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252B5%2525E2%252580%252590Morpholino%2525E2%252580%252590Thiophene%2525E2%252580%252590Indole%25252F%252BOxindole%252BHybrids%252Bas%252BCytotoxic%252BAgents%26aulast%3DYadav%26aufirst%3DUpasana%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D14%26spage%3D4356%26epage%3D4363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heba T.  Abdel‐Mohsen</span>, <span class="hlFld-ContribAuthor ">Eman A.  Abd El‐Meguid</span>, <span class="hlFld-ContribAuthor ">Ahmed M.  El Kerdawy</span>, <span class="hlFld-ContribAuthor ">Abeer E. E.  Mahmoud</span>, <span class="hlFld-ContribAuthor ">Mamdouh M.  Ali</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and molecular docking of novel 2‐arylbenzothiazole multiangiokinase inhibitors targeting breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2020,</strong> <em>353 </em>
                                    (4)
                                     , 1900340. <a href="https://doi.org/10.1002/ardp.201900340" title="DOI URL">https://doi.org/10.1002/ardp.201900340</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201900340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201900340%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bmolecular%252Bdocking%252Bof%252Bnovel%252B2%2525E2%252580%252590arylbenzothiazole%252Bmultiangiokinase%252Binhibitors%252Btargeting%252Bbreast%252Bcancer%26aulast%3DAbdel%25E2%2580%2590Mohsen%26aufirst%3DHeba%2BT.%26date%3D2020%26volume%3D353%26issue%3D4%26spage%3D1900340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Roskoski</span>. </span><span class="cited-content_cbyCitation_article-title">Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2020,</strong> <em>152 </em>, 104609. <a href="https://doi.org/10.1016/j.phrs.2019.104609" title="DOI URL">https://doi.org/10.1016/j.phrs.2019.104609</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2019.104609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2019.104609%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DProperties%252Bof%252BFDA-approved%252Bsmall%252Bmolecule%252Bprotein%252Bkinase%252Binhibitors%25253A%252BA%252B2020%252Bupdate%26aulast%3DRoskoski%26aufirst%3DRobert%26date%3D2020%26volume%3D152%26spage%3D104609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher R. M.  Asquith</span>, <span class="hlFld-ContribAuthor ">Tuomo  Laitinen</span>, <span class="hlFld-ContribAuthor ">James M.  Bennett</span>, <span class="hlFld-ContribAuthor ">Carrow I.  Wells</span>, <span class="hlFld-ContribAuthor ">Jonathan M.  Elkins</span>, <span class="hlFld-ContribAuthor ">William J.  Zuercher</span>, <span class="hlFld-ContribAuthor ">Graham J.  Tizzard</span>, <span class="hlFld-ContribAuthor ">Antti  Poso</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Analysis of the 4‐Anilinoquin(az)oline Kinase Inhibition Profiles of GAK/SLK/STK10 Using Quantitative Structure‐Activity Relationships. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (1)
                                     , 26-49. <a href="https://doi.org/10.1002/cmdc.201900521" title="DOI URL">https://doi.org/10.1002/cmdc.201900521</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900521%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDesign%252Band%252BAnalysis%252Bof%252Bthe%252B4%2525E2%252580%252590Anilinoquin%252528az%252529oline%252BKinase%252BInhibition%252BProfiles%252Bof%252BGAK%25252FSLK%25252FSTK10%252BUsing%252BQuantitative%252BStructure%2525E2%252580%252590Activity%252BRelationships%26aulast%3DAsquith%26aufirst%3DChristopher%2BR.%2BM.%26date%3D2020%26date%3D2019%26volume%3D15%26issue%3D1%26spage%3D26%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Babs  Briels</span>, <span class="hlFld-ContribAuthor ">Chris  Graaf</span>, <span class="hlFld-ContribAuthor ">Andreas  Bender</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Chemogenomics. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 53-77. <a href="https://doi.org/10.1002/9781118681121.ch3" title="DOI URL">https://doi.org/10.1002/9781118681121.ch3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118681121.ch3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118681121.ch3%26sid%3Dliteratum%253Aachs%26atitle%3DStructural%252BChemogenomics%26aulast%3DBriels%26aufirst%3DBabs%26date%3D2020%26date%3D2020%26spage%3D53%26epage%3D77%26pub%3DWiley%26atitle%3DStructural%252BBiology%252Bin%252BDrug%252BDiscovery%26aulast%3DRenaud%26aufirst%3DJean%25E2%2580%2590Paul%26date%3D2020%26date%3D2020%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandra  Röhm</span>, <span class="hlFld-ContribAuthor ">Andreas  Krämer</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>. </span><span class="cited-content_cbyCitation_article-title">Function, Structure and Topology of Protein Kinases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 1-24. <a href="https://doi.org/10.1007/7355_2020_97" title="DOI URL">https://doi.org/10.1007/7355_2020_97</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2020_97&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2020_97%26sid%3Dliteratum%253Aachs%26atitle%3DFunction%25252C%252BStructure%252Band%252BTopology%252Bof%252BProtein%252BKinases%26aulast%3DR%25C3%25B6hm%26aufirst%3DSandra%26date%3D2020%26date%3D2020%26spage%3D1%26epage%3D24%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DProteinkinase%252BInhibitors%26aulast%3DLaufer%26aufirst%3DStefan%26date%3D2021%26volume%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheng  Zhao</span>, <span class="hlFld-ContribAuthor ">Philip E.  Bourne</span>. </span><span class="cited-content_cbyCitation_article-title">Overview of Current Type I/II Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 13-28. <a href="https://doi.org/10.1007/978-3-030-48283-1_2" title="DOI URL">https://doi.org/10.1007/978-3-030-48283-1_2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-48283-1_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-48283-1_2%26sid%3Dliteratum%253Aachs%26atitle%3DOverview%252Bof%252BCurrent%252BType%252BI%25252FII%252BKinase%252BInhibitors%26aulast%3DZhao%26aufirst%3DZheng%26date%3D2020%26date%3D2020%26spage%3D13%26epage%3D28%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DNext%252BGeneration%252BKinase%252BInhibitors%26aulast%3DShapiro%26aufirst%3DPaul%26date%3D2020%26volume%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sohini  Chakraborti</span>, <span class="hlFld-ContribAuthor ">Pushpaveni  Chakravarthi</span>, <span class="hlFld-ContribAuthor ">Narayanaswamy  Srinivasan</span>. </span><span class="cited-content_cbyCitation_article-title">A ligand-centric approach to identify potential drugs for repurposing. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 15-54. <a href="https://doi.org/10.1016/B978-0-12-819668-7.00002-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-819668-7.00002-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-819668-7.00002-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-819668-7.00002-6%26sid%3Dliteratum%253Aachs%26atitle%3DA%252Bligand-centric%252Bapproach%252Bto%252Bidentify%252Bpotential%252Bdrugs%252Bfor%252Brepurposing%26aulast%3DChakraborti%26aufirst%3DSohini%26date%3D2020%26spage%3D15%26epage%3D54%26pub%3DElsevier%26atitle%3DDrug%252BRepurposing%252Bin%252BCancer%252BTherapy%26date%3D2020%26volume%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Roskoski</span>. </span><span class="cited-content_cbyCitation_article-title">The role of fibroblast growth factor receptor (FGFR) protein-tyrosine kinase inhibitors in the treatment of cancers including those of the urinary bladder. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2020,</strong> <em>151 </em>, 104567. <a href="https://doi.org/10.1016/j.phrs.2019.104567" title="DOI URL">https://doi.org/10.1016/j.phrs.2019.104567</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2019.104567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2019.104567%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DThe%252Brole%252Bof%252Bfibroblast%252Bgrowth%252Bfactor%252Breceptor%252B%252528FGFR%252529%252Bprotein-tyrosine%252Bkinase%252Binhibitors%252Bin%252Bthe%252Btreatment%252Bof%252Bcancers%252Bincluding%252Bthose%252Bof%252Bthe%252Burinary%252Bbladder%26aulast%3DRoskoski%26aufirst%3DRobert%26date%3D2020%26volume%3D151%26spage%3D104567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vivek  Modi</span>, <span class="hlFld-ContribAuthor ">Roland L.  Dunbrack</span>. </span><span class="cited-content_cbyCitation_article-title">A Structurally-Validated Multiple Sequence Alignment of 497 Human Protein Kinase Domains. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-019-56499-4" title="DOI URL">https://doi.org/10.1038/s41598-019-56499-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-019-56499-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-019-56499-4%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DA%252BStructurally-Validated%252BMultiple%252BSequence%252BAlignment%252Bof%252B497%252BHuman%252BProtein%252BKinase%252BDomains%26aulast%3DModi%26aufirst%3DVivek%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kaiwen  Li</span>, <span class="hlFld-ContribAuthor ">Zean  Li</span>, <span class="hlFld-ContribAuthor ">Yiran  Tao</span>, <span class="hlFld-ContribAuthor ">Qiong  Wang</span>, <span class="hlFld-ContribAuthor ">Yiming  Lai</span>, <span class="hlFld-ContribAuthor ">Wanhua  Wu</span>, <span class="hlFld-ContribAuthor ">Shirong  Peng</span>, <span class="hlFld-ContribAuthor ">Zhenghui  Guo</span>, <span class="hlFld-ContribAuthor ">Hai  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovering novel P38α inhibitors for the treatment of prostate cancer through virtual screening methods. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2019,</strong> <em>11 </em>
                                    (24)
                                     , 3125-3137. <a href="https://doi.org/10.4155/fmc-2019-0223" title="DOI URL">https://doi.org/10.4155/fmc-2019-0223</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2019-0223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2019-0223%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDiscovering%252Bnovel%252BP38%2525CE%2525B1%2525C2%2525A0inhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bprostate%252Bcancer%252Bthrough%252Bvirtual%252Bscreening%252Bmethods%26aulast%3DLi%26aufirst%3DKaiwen%26date%3D2019%26volume%3D11%26issue%3D24%26spage%3D3125%26epage%3D3137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Govindan  Subramanian</span>, <span class="hlFld-ContribAuthor ">Yaqi  Zhu</span>, <span class="hlFld-ContribAuthor ">Scott J.  Bowen</span>, <span class="hlFld-ContribAuthor ">Nicole  Roush</span>, <span class="hlFld-ContribAuthor ">Julie A.  White</span>, <span class="hlFld-ContribAuthor ">Dennis  Huczek</span>, <span class="hlFld-ContribAuthor ">Theresa  Zachary</span>, <span class="hlFld-ContribAuthor ">Christopher  Javens</span>, <span class="hlFld-ContribAuthor ">Tracey  Williams</span>, <span class="hlFld-ContribAuthor ">Ann  Janssen</span>, <span class="hlFld-ContribAuthor ">Andrea  Gonzales</span>. </span><span class="cited-content_cbyCitation_article-title">Lead identification and characterization of hTrkA type 2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (22)
                                     , 126680. <a href="https://doi.org/10.1016/j.bmcl.2019.126680" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126680</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126680%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DLead%252Bidentification%252Band%252Bcharacterization%252Bof%252BhTrkA%252Btype%252B2%252Binhibitors%26aulast%3DSubramanian%26aufirst%3DGovindan%26date%3D2019%26volume%3D29%26issue%3D22%26spage%3D126680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Astolfi</span>, <span class="hlFld-ContribAuthor ">Mark  Kudolo</span>, <span class="hlFld-ContribAuthor ">Jose  Brea</span>, <span class="hlFld-ContribAuthor ">Giorgia  Manni</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Manfroni</span>, <span class="hlFld-ContribAuthor ">Deborah  Palazzotti</span>, <span class="hlFld-ContribAuthor ">Stefano  Sabatini</span>, <span class="hlFld-ContribAuthor ">Federica  Cecchetti</span>, <span class="hlFld-ContribAuthor ">Tommaso  Felicetti</span>, <span class="hlFld-ContribAuthor ">Rolando  Cannalire</span>, <span class="hlFld-ContribAuthor ">Serena  Massari</span>, <span class="hlFld-ContribAuthor ">Oriana  Tabarrini</span>, <span class="hlFld-ContribAuthor ">Maria Isabel  Loza</span>, <span class="hlFld-ContribAuthor ">Francesca  Fallarino</span>, <span class="hlFld-ContribAuthor ">Violetta  Cecchetti</span>, <span class="hlFld-ContribAuthor ">Stefan A.  Laufer</span>, <span class="hlFld-ContribAuthor ">Maria Letizia  Barreca</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>182 </em>, 111624. <a href="https://doi.org/10.1016/j.ejmech.2019.111624" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111624</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111624%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bpotent%252Bp38%2525CE%2525B1%252BMAPK%252Binhibitors%252Bthrough%252Ba%252Bfunnel%252Blike%252Bworkflow%252Bcombining%252Bin%252Bsilico%252Bscreening%252Band%252Bin%2525C2%2525A0vitro%252Bvalidation%26aulast%3DAstolfi%26aufirst%3DAndrea%26date%3D2019%26volume%3D182%26spage%3D111624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Georgi K.  Kanev</span>, <span class="hlFld-ContribAuthor ">Chris  de Graaf</span>, <span class="hlFld-ContribAuthor ">Iwan J.P.  de Esch</span>, <span class="hlFld-ContribAuthor ">Rob  Leurs</span>, <span class="hlFld-ContribAuthor ">Thomas  Würdinger</span>, <span class="hlFld-ContribAuthor ">Bart A.  Westerman</span>, <span class="hlFld-ContribAuthor ">Albert J.  Kooistra</span>. </span><span class="cited-content_cbyCitation_article-title">The Landscape of Atypical and Eukaryotic Protein Kinases. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2019,</strong> <em>40 </em>
                                    (11)
                                     , 818-832. <a href="https://doi.org/10.1016/j.tips.2019.09.002" title="DOI URL">https://doi.org/10.1016/j.tips.2019.09.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2019.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2019.09.002%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DThe%252BLandscape%252Bof%252BAtypical%252Band%252BEukaryotic%252BProtein%252BKinases%26aulast%3DKanev%26aufirst%3DGeorgi%2BK.%26date%3D2019%26volume%3D40%26issue%3D11%26spage%3D818%26epage%3D832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guilin  Chen</span>, <span class="hlFld-ContribAuthor ">Minxia  Fan</span>, <span class="hlFld-ContribAuthor ">Ye  Liu</span>, <span class="hlFld-ContribAuthor ">Baoqing  Sun</span>, <span class="hlFld-ContribAuthor ">Meixian  Liu</span>, <span class="hlFld-ContribAuthor ">Jianlin  Wu</span>, <span class="hlFld-ContribAuthor ">Na  Li</span>, <span class="hlFld-ContribAuthor ">Mingquan  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in MS Based Strategies for Probing Ligand-Target Interactions: Focus on Soft Ionization Mass Spectrometric Techniques. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2019,</strong> <em>7 </em><a href="https://doi.org/10.3389/fchem.2019.00703" title="DOI URL">https://doi.org/10.3389/fchem.2019.00703</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2019.00703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2019.00703%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DAdvances%252Bin%252BMS%252BBased%252BStrategies%252Bfor%252BProbing%252BLigand-Target%252BInteractions%25253A%252BFocus%252Bon%252BSoft%252BIonization%252BMass%252BSpectrometric%252BTechniques%26aulast%3DChen%26aufirst%3DGuilin%26date%3D2019%26date%3D2019%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Govindan  Subramanian</span>, <span class="hlFld-ContribAuthor ">Scott J.  Bowen</span>, <span class="hlFld-ContribAuthor ">Yaqi  Zhu</span>, <span class="hlFld-ContribAuthor ">Nicole  Roush</span>, <span class="hlFld-ContribAuthor ">Theresa  Zachary</span>, <span class="hlFld-ContribAuthor ">Christopher  Javens</span>, <span class="hlFld-ContribAuthor ">Tracey  Williams</span>, <span class="hlFld-ContribAuthor ">Ann  Janssen</span>, <span class="hlFld-ContribAuthor ">Andrea  Gonzales</span>. </span><span class="cited-content_cbyCitation_article-title">Type 2 inhibitor leads of human tropomyosin receptor kinase (hTrkA). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (19)
                                     , 126624. <a href="https://doi.org/10.1016/j.bmcl.2019.126624" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126624</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126624%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DType%252B2%252Binhibitor%252Bleads%252Bof%252Bhuman%252Btropomyosin%252Breceptor%252Bkinase%252B%252528hTrkA%252529%26aulast%3DSubramanian%26aufirst%3DGovindan%26date%3D2019%26volume%3D29%26issue%3D19%26spage%3D126624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heba T.  Abdel-Mohsen</span>, <span class="hlFld-ContribAuthor ">Mohamed A.  Omar</span>, <span class="hlFld-ContribAuthor ">Ahmed M.  El Kerdawy</span>, <span class="hlFld-ContribAuthor ">Abeer E.E.  Mahmoud</span>, <span class="hlFld-ContribAuthor ">Mamdouh M.  Ali</span>, <span class="hlFld-ContribAuthor ">Hoda I.  El Diwani</span>. </span><span class="cited-content_cbyCitation_article-title">Novel potent substituted 4-amino-2-thiopyrimidines as dual VEGFR-2 and BRAF kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>179 </em>, 707-722. <a href="https://doi.org/10.1016/j.ejmech.2019.06.063" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.06.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.06.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.06.063%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bpotent%252Bsubstituted%252B4-amino-2-thiopyrimidines%252Bas%252Bdual%252BVEGFR-2%252Band%252BBRAF%252Bkinase%252Binhibitors%26aulast%3DAbdel-Mohsen%26aufirst%3DHeba%2BT.%26date%3D2019%26volume%3D179%26spage%3D707%26epage%3D722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Suyong  Re</span>, <span class="hlFld-ContribAuthor ">Hiraku  Oshima</span>, <span class="hlFld-ContribAuthor ">Kento  Kasahara</span>, <span class="hlFld-ContribAuthor ">Motoshi  Kamiya</span>, <span class="hlFld-ContribAuthor ">Yuji  Sugita</span>. </span><span class="cited-content_cbyCitation_article-title">Encounter complexes and hidden poses of kinase-inhibitor binding on the free-energy landscape. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2019,</strong> <em>116 </em>
                                    (37)
                                     , 18404-18409. <a href="https://doi.org/10.1073/pnas.1904707116" title="DOI URL">https://doi.org/10.1073/pnas.1904707116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1904707116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1904707116%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DEncounter%252Bcomplexes%252Band%252Bhidden%252Bposes%252Bof%252Bkinase-inhibitor%252Bbinding%252Bon%252Bthe%252Bfree-energy%252Blandscape%26aulast%3DRe%26aufirst%3DSuyong%26date%3D2019%26date%3D2019%26volume%3D116%26issue%3D37%26spage%3D18404%26epage%3D18409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simon S.  Terzyan</span>, <span class="hlFld-ContribAuthor ">Tao  Shen</span>, <span class="hlFld-ContribAuthor ">Xuan  Liu</span>, <span class="hlFld-ContribAuthor ">Qingling  Huang</span>, <span class="hlFld-ContribAuthor ">Peng  Teng</span>, <span class="hlFld-ContribAuthor ">Mi  Zhou</span>, <span class="hlFld-ContribAuthor ">Frank  Hilberg</span>, <span class="hlFld-ContribAuthor ">Jianfeng  Cai</span>, <span class="hlFld-ContribAuthor ">Blaine H.M.  Mooers</span>, <span class="hlFld-ContribAuthor ">Jie  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Structural basis of resistance of mutant RET protein-tyrosine kinase to its inhibitors nintedanib and vandetanib. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2019,</strong> <em>294 </em>
                                    (27)
                                     , 10428-10437. <a href="https://doi.org/10.1074/jbc.RA119.007682" title="DOI URL">https://doi.org/10.1074/jbc.RA119.007682</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.RA119.007682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.RA119.007682%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DStructural%252Bbasis%252Bof%252Bresistance%252Bof%252Bmutant%252BRET%252Bprotein-tyrosine%252Bkinase%252Bto%252Bits%252Binhibitors%252Bnintedanib%252Band%252Bvandetanib%26aulast%3DTerzyan%26aufirst%3DSimon%2BS.%26date%3D2019%26volume%3D294%26issue%3D27%26spage%3D10428%26epage%3D10437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Roskoski</span>. </span><span class="cited-content_cbyCitation_article-title">Properties of FDA-approved small molecule protein kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2019,</strong> <em>144 </em>, 19-50. <a href="https://doi.org/10.1016/j.phrs.2019.03.006" title="DOI URL">https://doi.org/10.1016/j.phrs.2019.03.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2019.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2019.03.006%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DProperties%252Bof%252BFDA-approved%252Bsmall%252Bmolecule%252Bprotein%252Bkinase%252Binhibitors%26aulast%3DRoskoski%26aufirst%3DRobert%26date%3D2019%26volume%3D144%26spage%3D19%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sourabh  Palrecha</span>, <span class="hlFld-ContribAuthor ">Dushant  Lakade</span>, <span class="hlFld-ContribAuthor ">Abhijeet  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Jayanta K.  Pal</span>, <span class="hlFld-ContribAuthor ">Manali  Joshi</span>. </span><span class="cited-content_cbyCitation_article-title">Computational insights into the interaction of small molecule inhibitors with HRI kinase domain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2019,</strong> <em>37 </em>
                                    (7)
                                     , 1715-1723. <a href="https://doi.org/10.1080/07391102.2018.1465850" title="DOI URL">https://doi.org/10.1080/07391102.2018.1465850</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2018.1465850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2018.1465850%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DComputational%252Binsights%252Binto%252Bthe%252Binteraction%252Bof%252Bsmall%252Bmolecule%252Binhibitors%252Bwith%252BHRI%252Bkinase%252Bdomain%26aulast%3DPalrecha%26aufirst%3DSourabh%26date%3D2019%26date%3D2018%26volume%3D37%26issue%3D7%26spage%3D1715%26epage%3D1723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vivek  Modi</span>, <span class="hlFld-ContribAuthor ">Roland L.  Dunbrack</span>. </span><span class="cited-content_cbyCitation_article-title">Defining a new nomenclature for the structures of active and inactive kinases. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2019,</strong> <em>116 </em>
                                    (14)
                                     , 6818-6827. <a href="https://doi.org/10.1073/pnas.1814279116" title="DOI URL">https://doi.org/10.1073/pnas.1814279116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1814279116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1814279116%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DDefining%252Ba%252Bnew%252Bnomenclature%252Bfor%252Bthe%252Bstructures%252Bof%252Bactive%252Band%252Binactive%252Bkinases%26aulast%3DModi%26aufirst%3DVivek%26date%3D2019%26date%3D2019%26volume%3D116%26issue%3D14%26spage%3D6818%26epage%3D6827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Attila  Egyed</span>, <span class="hlFld-ContribAuthor ">Dávid  Bajusz</span>, <span class="hlFld-ContribAuthor ">György M.  Keserű</span>. </span><span class="cited-content_cbyCitation_article-title">The impact of binding site waters on the activity/selectivity trade-off of Janus kinase 2 (JAK2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (8)
                                     , 1497-1508. <a href="https://doi.org/10.1016/j.bmc.2019.02.029" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.02.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.02.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.02.029%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bimpact%252Bof%252Bbinding%252Bsite%252Bwaters%252Bon%252Bthe%252Bactivity%25252Fselectivity%252Btrade-off%252Bof%252BJanus%252Bkinase%252B2%252B%252528JAK2%252529%252Binhibitors%26aulast%3DEgyed%26aufirst%3DAttila%26date%3D2019%26volume%3D27%26issue%3D8%26spage%3D1497%26epage%3D1508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Roskoski</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting ERK1/2 protein-serine/threonine kinases in human cancers. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2019,</strong> <em>142 </em>, 151-168. <a href="https://doi.org/10.1016/j.phrs.2019.01.039" title="DOI URL">https://doi.org/10.1016/j.phrs.2019.01.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2019.01.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2019.01.039%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DTargeting%252BERK1%25252F2%252Bprotein-serine%25252Fthreonine%252Bkinases%252Bin%252Bhuman%252Bcancers%26aulast%3DRoskoski%26aufirst%3DRobert%26date%3D2019%26volume%3D142%26spage%3D151%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Agnieszka  Szamborska-Gbur</span>, <span class="hlFld-ContribAuthor ">Ewelina  Rutkowska</span>, <span class="hlFld-ContribAuthor ">Agnieszka  Dreas</span>, <span class="hlFld-ContribAuthor ">Michael  Frid</span>, <span class="hlFld-ContribAuthor ">Maria  Vilenchik</span>, <span class="hlFld-ContribAuthor ">Mariusz  Milik</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Brzózka</span>, <span class="hlFld-ContribAuthor ">Marcin  Król</span>. </span><span class="cited-content_cbyCitation_article-title">How to design potent and selective DYRK1B inhibitors? Molecular modeling study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Modeling</span><span> <strong>2019,</strong> <em>25 </em>
                                    (2)
                                     <a href="https://doi.org/10.1007/s00894-018-3921-3" title="DOI URL">https://doi.org/10.1007/s00894-018-3921-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00894-018-3921-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00894-018-3921-3%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Modeling%26atitle%3DHow%252Bto%252Bdesign%252Bpotent%252Band%252Bselective%252BDYRK1B%252Binhibitors%25253F%252BMolecular%252Bmodeling%252Bstudy%26aulast%3DSzamborska-Gbur%26aufirst%3DAgnieszka%26date%3D2019%26date%3D2019%26volume%3D25%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maaged  Abdullah</span>, <span class="hlFld-ContribAuthor ">Lalitha  Guruprasad</span>. </span><span class="cited-content_cbyCitation_article-title">Computational fragment-based design of Wee1 kinase inhibitors with tricyclic core scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Structural Chemistry</span><span> <strong>2019,</strong> <em>30 </em>
                                    (1)
                                     , 213-226. <a href="https://doi.org/10.1007/s11224-018-1176-3" title="DOI URL">https://doi.org/10.1007/s11224-018-1176-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11224-018-1176-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11224-018-1176-3%26sid%3Dliteratum%253Aachs%26jtitle%3DStructural%2520Chemistry%26atitle%3DComputational%252Bfragment-based%252Bdesign%252Bof%252BWee1%252Bkinase%252Binhibitors%252Bwith%252Btricyclic%252Bcore%252Bscaffolds%26aulast%3DAbdullah%26aufirst%3DMaaged%26date%3D2019%26date%3D2018%26volume%3D30%26issue%3D1%26spage%3D213%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wagdy M.  Eldehna</span>, <span class="hlFld-ContribAuthor ">Ahmed M.  El Kerdawy</span>, <span class="hlFld-ContribAuthor ">Ghada H.  Al-Ansary</span>, <span class="hlFld-ContribAuthor ">Sara T.  Al-Rashood</span>, <span class="hlFld-ContribAuthor ">Mamdouh M.  Ali</span>, <span class="hlFld-ContribAuthor ">Abeer E.  Mahmoud</span>. </span><span class="cited-content_cbyCitation_article-title">Type IIA - Type IIB protein tyrosine kinase inhibitors hybridization as an efficient approach for potent multikinase inhibitor development: Design, synthesis, anti-proliferative activity, multikinase inhibitory activity and molecular modeling of novel indolinone-based ureides and amides. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>163 </em>, 37-53. <a href="https://doi.org/10.1016/j.ejmech.2018.11.061" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.11.061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.11.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.11.061%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DType%252BIIA%252B-%252BType%252BIIB%252Bprotein%252Btyrosine%252Bkinase%252Binhibitors%252Bhybridization%252Bas%252Ban%252Befficient%252Bapproach%252Bfor%252Bpotent%252Bmultikinase%252Binhibitor%252Bdevelopment%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Banti-proliferative%252Bactivity%25252C%252Bmultikinase%252Binhibitory%252Bactivity%252Band%252Bmolecular%252Bmodeling%252Bof%252Bnovel%252Bindolinone-based%252Bureides%252Band%252Bamides%26aulast%3DEldehna%26aufirst%3DWagdy%2BM.%26date%3D2019%26volume%3D163%26spage%3D37%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rayees  Rahman</span>, <span class="hlFld-ContribAuthor ">Peter Man-Un  Ung</span>, <span class="hlFld-ContribAuthor ">Avner  Schlessinger</span>. </span><span class="cited-content_cbyCitation_article-title">KinaMetrix: a web resource to investigate kinase conformations and inhibitor space. </span><span class="cited-content_cbyCitation_journal-name">Nucleic Acids Research</span><span> <strong>2019,</strong> <em>47 </em>
                                    (D1)
                                     , D361-D366. <a href="https://doi.org/10.1093/nar/gky916" title="DOI URL">https://doi.org/10.1093/nar/gky916</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/nar/gky916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnar%2Fgky916%26sid%3Dliteratum%253Aachs%26jtitle%3DNucleic%2520Acids%2520Research%26atitle%3DKinaMetrix%25253A%252Ba%252Bweb%252Bresource%252Bto%252Binvestigate%252Bkinase%252Bconformations%252Band%252Binhibitor%252Bspace%26aulast%3DRahman%26aufirst%3DRayees%26date%3D2019%26date%3D2018%26volume%3D47%26issue%3DD1%26spage%3DD361%26epage%3DD366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Roskoski</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2019,</strong> <em>139 </em>, 395-411. <a href="https://doi.org/10.1016/j.phrs.2018.11.014" title="DOI URL">https://doi.org/10.1016/j.phrs.2018.11.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2018.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2018.11.014%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DSmall%252Bmolecule%252Binhibitors%252Btargeting%252Bthe%252BEGFR%25252FErbB%252Bfamily%252Bof%252Bprotein-tyrosine%252Bkinases%252Bin%252Bhuman%252Bcancers%26aulast%3DRoskoski%26aufirst%3DRobert%26date%3D2019%26volume%3D139%26spage%3D395%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Roskoski</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2019,</strong> <em>139 </em>, 471-488. <a href="https://doi.org/10.1016/j.phrs.2018.11.035" title="DOI URL">https://doi.org/10.1016/j.phrs.2018.11.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2018.11.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2018.11.035%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DCyclin-dependent%252Bprotein%252Bserine%25252Fthreonine%252Bkinase%252Binhibitors%252Bas%252Banticancer%252Bdrugs%26aulast%3DRoskoski%26aufirst%3DRobert%26date%3D2019%26volume%3D139%26spage%3D471%26epage%3D488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peng‐Fei  Wang</span>, <span class="hlFld-ContribAuthor ">Ze‐Feng  Wang</span>, <span class="hlFld-ContribAuthor ">Han‐Yue  Qiu</span>, <span class="hlFld-ContribAuthor ">Yue  Huang</span>, <span class="hlFld-ContribAuthor ">Hui‐Min  Hu</span>, <span class="hlFld-ContribAuthor ">Zhong‐Chang  Wang</span>, <span class="hlFld-ContribAuthor ">Hai‐Liang  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and Biological Evaluation of Novel Type II B‐Raf
              V600E
              Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (23)
                                     , 2558-2566. <a href="https://doi.org/10.1002/cmdc.201800574" title="DOI URL">https://doi.org/10.1002/cmdc.201800574</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800574%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DIdentification%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BType%2525E2%252580%252585II%252BB%2525E2%252580%252590Raf%252BV600E%252BInhibitors%26aulast%3DWang%26aufirst%3DPeng%25E2%2580%2590Fei%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D23%26spage%3D2558%26epage%3D2566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Zou</span>, <span class="hlFld-ContribAuthor ">Victor H. F.  Lee</span>, <span class="hlFld-ContribAuthor ">Hong  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Prediction of sensitivity to gefitinib/erlotinib for EGFR mutations in NSCLC based on structural interaction fingerprints and multilinear principal component analysis. </span><span class="cited-content_cbyCitation_journal-name">BMC Bioinformatics</span><span> <strong>2018,</strong> <em>19 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12859-018-2093-6" title="DOI URL">https://doi.org/10.1186/s12859-018-2093-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12859-018-2093-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12859-018-2093-6%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Bioinformatics%26atitle%3DPrediction%252Bof%252Bsensitivity%252Bto%252Bgefitinib%25252Ferlotinib%252Bfor%252BEGFR%252Bmutations%252Bin%252BNSCLC%252Bbased%252Bon%252Bstructural%252Binteraction%252Bfingerprints%252Band%252Bmultilinear%252Bprincipal%252Bcomponent%252Banalysis%26aulast%3DZou%26aufirst%3DBin%26date%3D2018%26date%3D2018%26volume%3D19%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anita  Rácz</span>, <span class="hlFld-ContribAuthor ">Dávid  Bajusz</span>, <span class="hlFld-ContribAuthor ">Károly  Héberger</span>. </span><span class="cited-content_cbyCitation_article-title">Life beyond the Tanimoto coefficient: similarity measures for interaction fingerprints. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cheminformatics</span><span> <strong>2018,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13321-018-0302-y" title="DOI URL">https://doi.org/10.1186/s13321-018-0302-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13321-018-0302-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13321-018-0302-y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cheminformatics%26atitle%3DLife%252Bbeyond%252Bthe%252BTanimoto%252Bcoefficient%25253A%252Bsimilarity%252Bmeasures%252Bfor%252Binteraction%252Bfingerprints%26aulast%3DR%25C3%25A1cz%26aufirst%3DAnita%26date%3D2018%26date%3D2018%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Shen</span>, <span class="hlFld-ContribAuthor ">Zhe  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Yao</span>, <span class="hlFld-ContribAuthor ">Youyong  Li</span>, <span class="hlFld-ContribAuthor ">Tailong  Lei</span>, <span class="hlFld-ContribAuthor ">Ercheng  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Xu</span>, <span class="hlFld-ContribAuthor ">Feng  Zhu</span>, <span class="hlFld-ContribAuthor ">Dan  Li</span>, <span class="hlFld-ContribAuthor ">Tingjun  Hou</span>. </span><span class="cited-content_cbyCitation_article-title">Comprehensive assessment of nine docking programs on type II kinase inhibitors: prediction accuracy of sampling power, scoring power and screening power. </span><span class="cited-content_cbyCitation_journal-name">Briefings in Bioinformatics</span><span> <strong>2018,</strong> <em>17 </em><a href="https://doi.org/10.1093/bib/bby103" title="DOI URL">https://doi.org/10.1093/bib/bby103</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/bib/bby103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fbib%2Fbby103%26sid%3Dliteratum%253Aachs%26jtitle%3DBriefings%2520in%2520Bioinformatics%26atitle%3DComprehensive%252Bassessment%252Bof%252Bnine%252Bdocking%252Bprograms%252Bon%252Btype%252BII%252Bkinase%252Binhibitors%25253A%252Bprediction%252Baccuracy%252Bof%252Bsampling%252Bpower%25252C%252Bscoring%252Bpower%252Band%252Bscreening%252Bpower%26aulast%3DShen%26aufirst%3DChao%26date%3D2018%26date%3D2018%26volume%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Roskoski</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting oncogenic Raf protein-serine/threonine kinases in human cancers. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2018,</strong> <em>135 </em>, 239-258. <a href="https://doi.org/10.1016/j.phrs.2018.08.013" title="DOI URL">https://doi.org/10.1016/j.phrs.2018.08.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2018.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2018.08.013%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DTargeting%252Boncogenic%252BRaf%252Bprotein-serine%25252Fthreonine%252Bkinases%252Bin%252Bhuman%252Bcancers%26aulast%3DRoskoski%26aufirst%3DRobert%26date%3D2018%26volume%3D135%26spage%3D239%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm400378w&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm400378w%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-2%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=148&amp;pagesCount=2&amp;pageNumber=-1" title="Load all citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load all citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0022.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Molecular structures of 20 approved small molecule kinase inhibitors. For these inhibitors crystal structures are available in the PDB with the exception of <b>9</b> (regorafenib), <b>11</b> (ruxolitinib), <b>16</b> (pazopanib), <b>18b</b> (dabrafenib),<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and <b>18c</b> (trametinib).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Atoms that make hydrogen bond interactions with the kinase hinge region and gatekeeper residue are colored red and green, respectively. The blue colored atoms extend out of the protein and into the solvent, while the orange colored atoms interact in the hydrophobic back pocket(s) (see Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> and Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). References to PDB entries are provided in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Table S1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Structure of the kinase domain, with important structural elements labeled and a close-up of the kinase catalytic cleft with carbon atoms Cα shown as spheres. The front cleft, gate area, and back cleft are indicated. (B) Conservation of the 85 amino acids in the catalytic cleft of 1252 kinase-inhibitor complexes. The same residue numbering scheme is used consistently throughout the manuscript: [amino acid]<sup>[kinase region in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A].[residue number in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B]</sup> (e.g., K<sup>III.17</sup>, the conserved lysine residue in β sheet III, residue number 17). Abbreviations for definition of kinase binding site regions are as follows: I–VIII = β-sheets I–VIII; g.l. = G-rich loop, b.l. = loop connecting αC-helix to IV; GK = gatekeeper; linker = loop connecting the hinge to αD-helix; c.l. = catalytic loop; xDFG = DFG-motif plus one preceding amino acid residue; a.l. = activation loop.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Schematic overview of available pockets in the catalytic cleft in both DFG-in (A) and DFG-out (B) kinases. The color coding for the front cleft, gate area, back cleft, and backbone of the hinge, DFG-motif, and αC-helix is similar to that of Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. (A) Schematic binding mode of <b>15</b> in ABL1 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2gqg">2gqg</a>, DFG-in, 3D binding mode is presented in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B). (B) Schematic binding mode of <b>7</b> in ABL1 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3cs9">3cs9</a>, DFG-out, 3D binding mode is presented in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>D).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Flowchart of the KLIFS database preparation. GI numbers<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> (i, 946) and mRNA RefSeq IDs<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> (ii, 630) were collected for all human kinases and converted into 2125 Uniprot entries.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> By use of the Uniprot entries, all available human protein structures in the PDB were collected (iii, 2373). A sequence similarity check was performed to select structures that contain a kinase domain (iv, 1734). Structures with a kinase domain were aligned against a structural reference alignment (v). After extraction of cofactors, ATP containing structures, etc., the KLIFS database was created (vi, 1257) that contains separate MOL2 files for the pocket and ligand (vii). (B) Phylogenetic tree of the human kinome. The number of human kinase–ligand complexes and kinase apo structures present in the KLIFS database is presented for each group. (C) Interaction fingerprint bit-string panel contains an example of an IFP analysis, using the pocket and ligand information (viii, 1252), and describes the binding mode of two distinct kinase inhibitors. Different interaction types (hydrophobic (gray), aromatic face-to-face (dark green), aromatic face-to-edge (light green), protein H-bond acceptor to ligand H-bond donor (red), protein H-bond donor to ligand H-bond acceptor (dark blue), negatively ionizable group in the protein to positively ionizable group in the ligand (orange), and positively ionizable group in the protein to negatively ionizable group in the ligand (cyan)) define the IFP.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> From the IFP bit-string, inhibitor positioning in catalytic cleft, H-bond interaction patterns with the protein, and probing of selectivity pockets can be derived (ix). The numbers between brackets refer to the number of kinase structures or the paragraph number in which the binding modes in these pockets are discussed. The kinome tree depicted in 4B was prepared using Kinome Mapper from Reaction Biology.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Ligand–protein interaction fingerprint (IFP) analysis<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> of four marketed kinase inhibitors:<a onclick="showRef(event, 'ref13 ref14 ref18'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref18">(13, 14, 18)</a> binding poses of (A) <b>14</b> (cyan carbon atoms) in c-MET (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2wgj">2wgj</a>),<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> (B) <b>15</b> (cyan carbon atoms) in ABL1 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2gqg">2gqg</a>),<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> (C) <b>5</b> (cyan carbon atoms) in EGFR (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1xkk">1xkk</a>),<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (D) <b>7</b> (cyan carbon atoms) in ABL1 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3cs9">3cs9</a>).<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Important binding residues are depicted as sticks with salmon colored carbon atoms. Oxygen, nitrogen, and sulfur atoms are colored red, blue, and yellow, respectively. H-Bonds described in the text are depicted by gold colored dots. The viewing orientation and colors used for proteins and ligands are used consistently throughout the manuscript. (E) IFP bit-strings describing the binding poses of ligands <b>14</b>, <b>15</b>, <b>5</b>, and <b>7</b> (A–D), encoding different interaction types with each residue in the binding site. For reasons of clarity, only the bit strings of the residues that are visible in the corresponding images above are shown. IFP color coding is as indicated in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>. This is presented in this fashion consistently throughout the manuscript. 2D structures of the molecules are presented in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> or <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Figure S1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0013.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Hydrogen-bond interactions at the gate area. (A) Inhibitor <b>23</b> in complex with PDK1 is involved in hydrogen-bonding to the gate area by accepting a hydrogen bond from T<sup>xDFG.80</sup>(<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1uu9">1uu9</a>).<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> (B) Inhibitor <b>24</b> in complex with Erk2 is involved in hydrogen-bonding to the gate area by donating a hydrogen bond to the gatekeeper Q<sup>V.45</sup> and accepting a hydrogen bond from the protonated K<sup>III.17</sup> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ojg">2ojg</a>).<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> (C) Inhibitor <b>25</b> in complex with Chk1 is involved in hydrogen bonding to the gate area by accepting a hydrogen bond from the protonated K<sup>III.17</sup> and donating a hydrogen bond to the side chain of the catalytic D<sup>xDFG8</sup> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3tki">3tki</a>).<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> (D) Inhibitor <b>26</b> stabilizes a DFG-out-like form of the NEK2 kinase by interacting with protonated K<sup>III.17</sup> and the amide nitrogen atom of the D<sup>xDFG81</sup> backbone. (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2xk4">2xk4</a>).<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> Rendering and IFP color coding are as indicated in Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0014.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Utilization of pockets in the front cleft. (A) Compound <b>28</b> probes into FP-II of ROCK1 with the phenyl ring (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3v8s">3v8s</a>).<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> (B) The JAK inhibitor <b>12</b> in complex with JAK3 probes FP-I with its methylpiperidine moiety and FP-II with the nitrile group (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3lxk">3lxk</a>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Another example of a compound binding in FP-I is shown by the binding mode of <b>14</b> in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A. (C) Via a fragment-based approach, <b>29</b> and <b>30</b> were identified and optimized into <b>31</b>. (D) PKB inhibitor <b>31</b> in complex with human PKBβ (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2uw9">2uw9</a>).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The chlorophenyl ring probes up into FP-II. Rendering and IFP color coding are as indicated in Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0015.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Front cleft binders entering the gate area (BP-I-A, BP-I-B). (A) Inhibitor <b>32</b> in complex with ABL1 forms three hydrogen bonds to the kinase hinge and curves back into gate area and probes BP-I-B, while it is hydrogen bonding with the D<sup>xDFG.81</sup> side chain (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2f4j">2f4j</a>).<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> (B) ABL1 in complex with inhibitor <b>4</b>. The substituted phenyl ring probes BP-I-B, while the methoxy group probes up into BP-I-A. The kinase is in the DFG-out-like conformation (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ue4">3ue4</a>).<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> (C) The hybrid compound <b>33</b> penetrates into BP-I-B of Jak2 and forms hydrogen bonds with the backbone of F<sup>xDFG.82</sup> and side chain of E<sup>αC.24</sup> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3kck">3kck</a>).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Rendering and IFP color coding are as indicated in Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0016.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Compounds targeting BP-II and subpockets of BP-II. (A) Compound <b>34</b> extends through the gate area into BP-II, while the p38α kinase is in the DFG-in form (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3s4q">3s4q</a>).<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> (B) Compound <b>5</b> probes into the deeper buried BP-II-A of the DFG-in EGFR kinase (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1xkk">1xkk</a>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (C) The inhibitor <b>35</b>, probes into BP-II-B of c-Met, with the fluorophenyl ring (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3efk">3efk</a>).<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> (D) Binding mode of the MEK inhibitor <b>36</b>, which probes BP-II in MEK-1 (<a href="https://" class="ext-link">3sls</a>).<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> Rendering and IFP color coding are as indicated in Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0017.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Switching from probing BP-II-in, toward probing BP-II-out. (A) The cyclopropyl group of <b>37</b> probes BP-II-in of VEGFR2 in the DFG-in form (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3b8r">3b8r</a>).<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> (B) The para-Cl phenyl ring of <b>38</b> (cyan carbon atoms) induces a DFG-out form of VEGFR2 and probes deep into BP-II-out (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3b8q">3b8q</a>).<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Rendering and IFP color code are as indicated in Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0018.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Compounds binding in DFG-out pockets. (A) Inhibitor <b>39</b> probes BP-III of the DFG-out c-Met kinase (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3lq8">3lq8</a>).<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> (B) Inhibitor <b>40</b> in complex with the αC-helix disrupted DFG-out PDK1. The 3,4-difluorobenzyl moiety probes into BP-III (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3nax">3nax</a>).<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> (C) Inhibitor <b>6</b> in complex with DFG-out LCK. The methylpiperazine ring binds in the partially hydrophobic BP-IV (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2pl0">2pl0</a>).<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> (D) Inhibitor <b>41</b> in complex with DFG-out ABL1. The <i>tert</i>-butyl moiety probes into BP-III, while the quinoline ring binds in BP-V (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3qri">3qri</a>).<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Rendering and IFP color coding are as indicated in Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0019.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Fragment based optimization of a BP-III targeting p38 inhibitor. (A) Fragment <b>42</b> binds to the hinge via two hydrogen bonds and probes into the gate area (DFG-in, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1w7h">1w7h</a>).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (B) Fragment <b>43</b> in the DFG-out form of p38 probing BP-III with its trimethyl group (DFG-out, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1w82">1w82</a>).<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> (C) Fragment linking of <b>42</b> and <b>43</b> into <b>44</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1wbn">1wbn</a>) and (D) subsequent optimization of <b>44</b> into <b>45</b> (DFG-out, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1w83">1w83</a>).<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Rendering and IFP color coding are as indicated in Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/medium/jm-2013-00378w_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0020.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Identification of kinase inhibitor merging strategies by analysis of superimposed kinase inhibitor scaffolds of p38 (panels A–C) that target different binding pockets (schematic depiction in panel D). Inhibitor <b>46</b> (orange carbon atoms, orange ribbon) occupies the AP and binds BP-I-A and BP-I-B (DFG-in, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1wbw">1wbw</a>),<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> while inhibitor <b>47</b> (green, DFG-out, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3o8u">3o8u</a>)<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> and inhibitor <b>48</b> (cream, DFG-out, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3nnv">3nnv</a>)<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> do not target the AP but bind BP-I-A, BP-I-B, BP-II-out, BP-III, and BP-V. Inhibitor <b>49</b> (gold, DFG-out, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1kv2">1kv2</a>)<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> binds BP-I-A, BP-I-B, BP-II-out, BP-III, and BP-V and targets the hinge. Rendering and IFP color coding are as indicated in Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-2/jm400378w/production/images/large/jm-2013-00378w_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400378w&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i46">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57157" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57157" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 145 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pogacic, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rellos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullock, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">20523</span><span class="NLM_x">–</span> <span class="NLM_lpage">20528</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=20523-20528&author=O.+Fedorovauthor=B.+Marsdenauthor=V.+Pogacicauthor=P.+Rellosauthor=S.+M%C3%BCllerauthor=A.+N.+Bullockauthor=J.+Schwallerauthor=M.+Sundstr%C3%B6mauthor=S.+Knapp&title=A+systematic+interaction+map+of+validated+kinase+inhibitors+with+Ser%2FThr+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DMarsden%26aufirst%3DB.%26aulast%3DPogacic%26aufirst%3DV.%26aulast%3DRellos%26aufirst%3DP.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DBullock%26aufirst%3DA.%2BN.%26aulast%3DSchwaller%26aufirst%3DJ.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DA%2520systematic%2520interaction%2520map%2520of%2520validated%2520kinase%2520inhibitors%2520with%2520Ser%252FThr%2520kinases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D20523%26epage%3D20528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Targeting cancer with small molecule kinase inhibitors</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1038%2Fnrc2559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=19104514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1yg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=28-39&author=J.+Zhangauthor=P.+L.+Yangauthor=N.+S.+Gray&title=Targeting+cancer+with+small+molecule+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer with small molecule kinase inhibitors</span></div><div class="casAuthors">Zhang, Jianming; Yang, Priscilla L.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-39</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Deregulation of kinase activity has emerged as a major mechanism by which cancer cells evade normal physiol. constraints on growth and survival.  To date, 11 kinase inhibitors have received US Food and Drug Administration approval as cancer treatments, and there are considerable efforts to develop selective small mol. inhibitors for a host of other kinases that are implicated in cancer and other diseases.  Herein we discuss the current challenges in the field, such as designing selective inhibitors and developing strategies to overcome resistance mutations.  This Review provides a broad overview of some of the approaches currently used to discover and characterize new kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriSM3BN_uEz7Vg90H21EOLACvtfcHk0lj_QkZRNhUKxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1yg&md5=35bc38f414cd21eef5e61ce181b580fb</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrc2559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2559%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DP.%2BL.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DTargeting%2520cancer%2520with%2520small%2520molecule%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D28%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">The (un)targeted cancer kinome</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1038%2Fnchembio.297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=20154661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFGntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=166-169&author=O.+Fedorovauthor=S.+Mullerauthor=S.+Knapp&title=The+%28un%29targeted+cancer+kinome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The (un)targeted cancer kinome</span></div><div class="casAuthors">Fedorov, Oleg; Mueller, Susanne; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">166-169</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review and discussion.  The complexity of cancer signaling and the resulting difficulties in target selection have strongly biased kinase drug discovery towards clin. validated targets.  Recently, novel kinase targets that are uncharacterized have emerged from genome sequencing and RNAi studies.  Chem. probes are urgently needed to functionally annotate these kinases and to stimulate new drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwcnq0-qjPirVg90H21EOLACvtfcHk0lj_QkZRNhUKxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFGntbk%253D&md5=198ae8d39d40247e17aef5e9de0f2a99</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.297%26sid%3Dliteratum%253Aachs%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DMuller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DThe%2520%2528un%2529targeted%2520cancer%2520kinome%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D166%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Muller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Targeting kinases for the treatment of inflammatory diseases</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">867</span><span class="NLM_x">–</span> <span class="NLM_lpage">881</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=867-881&author=S.+Mullerauthor=S.+Knapp&title=Targeting+kinases+for+the+treatment+of+inflammatory+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DTargeting%2520kinases%2520for%2520the%2520treatment%2520of%2520inflammatory%2520diseases%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2010%26volume%3D5%26spage%3D867%26epage%3D881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Manning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whyte, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudarsanam, S.</span><span> </span><span class="NLM_article-title">The protein kinase complement of the human genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">1912</span><span class="NLM_x">–</span> <span class="NLM_lpage">1934</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1126%2Fscience.1075762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=12471243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1912-1934&author=G.+Manningauthor=D.+B.+Whyteauthor=R.+Martinezauthor=T.+Hunterauthor=S.+Sudarsanam&title=The+protein+kinase+complement+of+the+human+genome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Kinase Complement of the Human Genome</span></div><div class="casAuthors">Manning, G.; Whyte, D. B.; Martinez, R.; Hunter, T.; Sudarsanam, S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5600</span>),
    <span class="NLM_cas:pages">1912-1916, 1933-1934</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We have catalogued the protein kinase complement of the human genome (the "kinome") using public and proprietary genomic, complementary DNA, and expressed sequence tag (EST) sequences.  This provides a starting point for comprehensive anal. of protein phosphorylation in normal and disease states, as well as a detailed view of the current state of human genome anal. through a focus on one large gene family.  We identify 518 putative protein kinase genes, of which 71 have not previously been reported or described as kinases, and we extend or correct the protein sequences of 56 more kinases.  New genes include members of well-studied families as well as previously unidentified families, some of which are conserved in model organisms.  Classification and comparison with model organism kinomes identified orthologous groups and highlighted expansions specific to human and other lineages.  We also identified 106 protein kinase pseudogenes.  Chromosomal mapping revealed several small clusters of kinase genes and revealed that 244 kinases map to disease loci or cancer amplicons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTj1hf_0cQcrVg90H21EOLACvtfcHk0lgq_FJtD0BHNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D&md5=b3def83bace52257a3252a3347b8bb92</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1075762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1075762%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DG.%26aulast%3DWhyte%26aufirst%3DD.%2BB.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DSudarsanam%26aufirst%3DS.%26atitle%3DThe%2520protein%2520kinase%2520complement%2520of%2520the%2520human%2520genome%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1912%26epage%3D1934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">Protein kinases—the major drug targets of the twenty-first century?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=309-315&author=P.+Cohen&title=Protein+kinases%E2%80%94the+major+drug+targets+of+the+twenty-first+century%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DProtein%2520kinases%25E2%2580%2594the%2520major%2520drug%2520targets%2520of%2520the%2520twenty-first%2520century%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2002%26volume%3D1%26spage%3D309%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Chico, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Eldik, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watterson, D. M.</span><span> </span><span class="NLM_article-title">Targeting protein kinases in central nervous system disorders</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">892</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1038%2Fnrd2999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=19876042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCjtrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=892-909&author=L.+K.+Chicoauthor=L.+J.+Van+Eldikauthor=D.+M.+Watterson&title=Targeting+protein+kinases+in+central+nervous+system+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein kinases in central nervous system disorders</span></div><div class="casAuthors">Chico, Laura K.; Van Eldik, Linda J.; Watterson, D. Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">892-909</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein kinases are a growing drug target class in disorders in peripheral tissues, but the development of kinase-targeted therapies for central nervous system (CNS) diseases remains a challenge, largely owing to issues assocd. specifically with CNS drug discovery.  However, several candidate therapeutics that target CNS protein kinases are now in various stages of preclin. and clin. development.  We review candidate compds. and discuss selected CNS protein kinases that are emerging as important therapeutic targets.  In addn., we analyze trends in small-mol. properties that correlate with key challenges in CNS drug discovery, such as blood-brain barrier penetrance and cytochrome P 450-mediated metab., and discuss the potential of future approaches that will integrate mol.-fragment expansion with pharmacoinformatics to address these challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzQo2JmuPNlrVg90H21EOLACvtfcHk0lgq_FJtD0BHNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCjtrzO&md5=4dc1f6b7542e59c99f91525d37c49973</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrd2999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2999%26sid%3Dliteratum%253Aachs%26aulast%3DChico%26aufirst%3DL.%2BK.%26aulast%3DVan%2BEldik%26aufirst%3DL.%2BJ.%26aulast%3DWatterson%26aufirst%3DD.%2BM.%26atitle%3DTargeting%2520protein%2520kinases%2520in%2520central%2520nervous%2520system%2520disorders%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D892%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">Targeting protein kinases for the development of anti-inflammatory drugs</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2Fj.ceb.2009.01.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=19217767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVCksrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=317-324&author=P.+Cohen&title=Targeting+protein+kinases+for+the+development+of+anti-inflammatory+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein kinases for the development of anti-inflammatory drugs</span></div><div class="casAuthors">Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">317-324</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In recent years, protein kinases have become the pharmaceutical industry's most studied class of drug target, and some 10 protein kinase inhibitors have so far been approved for the treatment of cancer.  However, whether safe drugs that modulate protein kinase activities can also be developed for the treatment of chronic diseases, where they may need to be taken for decades, is an issue that is still unresolved.  A no. of compds. that inhibit the p38α MAPK have entered clin. trials for the treatment of rheumatoid arthritis and psoriasis, but side effects have prevented their progression to Phase III clin. trials.  Here the author briefly reviews the potential problems in targeting p38 MAPK and discusses other protein kinases that regulate the innate immune system, such as Tpl2, MAPKAP-K2/3, MSK1/2, and IRAK4, which may be better targets for the treatment of chronic inflammatory diseases, and NIK, which is an attractive target for the treatment of multiple myeloma, a late stage B-cell malignancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSeBhN9qJzqrVg90H21EOLACvtfcHk0ljyNk44hCNNnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVCksrg%253D&md5=b7e7a33f18d0c8c1e33160c092cf411b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2009.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2009.01.015%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DTargeting%2520protein%2520kinases%2520for%2520the%2520development%2520of%2520anti-inflammatory%2520drugs%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2009%26volume%3D21%26spage%3D317%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Kumar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, K. M.</span><span> </span><span class="NLM_article-title">Kinase inhibitors for cardiovascular disease</span> <span class="citation_source-journal">J. Mol. Cell. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2Fj.yjmcc.2006.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=17059822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1Cnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2007&pages=1-11&author=R.+Kumarauthor=V.+P.+Singhauthor=K.+M.+Baker&title=Kinase+inhibitors+for+cardiovascular+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase inhibitors for cardiovascular disease</span></div><div class="casAuthors">Kumar, Rajesh; Singh, Vivek P.; Baker, Kenneth M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Over the last decade, there was substantial progress toward understanding the pathophysiol. and treatment of cardiovascular diseases (CVDs).  Elucidating cellular responses to the extracellular environment and signal transduction mechanisms have provided the opportunity to explore novel mol. therapeutic approaches for the treatment of CVDs.  Neurohormonal stimulation was implicated in these diseases; blockade of the renin-angiotensin and β-adrenergic systems are examples of therapeutic effectiveness.  There are multiple cell signaling cascades, some of which are beneficial or compensatory and others deleterious.  The balance between these pathways, which in large part is dictated by the cellular environment, dets. the outcome as a diseased or non-diseased state.  Selective targeting of signaling pathways using protein kinase inhibitors, would have a potential advantage over receptor blockers.  We review potential protein kinase targets and recent evidence supporting therapeutic interventional value in CVDs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOvrcVNUqdprVg90H21EOLACvtfcHk0ljyNk44hCNNnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1Cnuw%253D%253D&md5=8b05f4f7c07fb4b704089caeee02e7c3</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.yjmcc.2006.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yjmcc.2006.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DSingh%26aufirst%3DV.%2BP.%26aulast%3DBaker%26aufirst%3DK.%2BM.%26atitle%3DKinase%2520inhibitors%2520for%2520cardiovascular%2520disease%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D2007%26volume%3D42%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Doerig, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billker, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endicott, J.</span><span> </span><span class="NLM_article-title">Protein kinases as targets for antimalarial intervention: kinomics, structure-based design, transmission-blockade, and targeting host cell enzymes</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Proteins Proteomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1754</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2Fj.bbapap.2005.08.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=16271522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlags7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1754&publication_year=2005&pages=132-150&author=C.+Doerigauthor=O.+Billkerauthor=D.+Prattauthor=J.+Endicott&title=Protein+kinases+as+targets+for+antimalarial+intervention%3A+kinomics%2C+structure-based+design%2C+transmission-blockade%2C+and+targeting+host+cell+enzymes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinases as targets for antimalarial intervention: Kinomics, structure-based design, transmission-blockade, and targeting host cell enzymes</span></div><div class="casAuthors">Doerig, Christian; Billker, Oliver; Pratt, David; Endicott, Jane</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1754</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">132-150</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The surge of interest in protein kinases as targets for chemotherapeutic intervention in a no. of diseases such as cancer and neurodegenerative disorders has stimulated research aimed at detg. whether enzymes of this class might also be considered as targets in the context of diseases caused by parasitic protists.  Here, we present an overview of recent developments in this field, concg. (i) on the benefits gained from the availability of genomic databases for a no. of parasitic protozoa, (ii) on the emerging field of structure-aided design of inhibitors targeting protein kinases of parasitic protists, (iii) on the concept known as transmission-blockade, whereby kinases implicated in the development of the parasite in their arthropod vector might be targeted to interfere with disease transmission, and (iv) on the possibility of controlling parasitic diseases through the inhibition of host cell protein kinases that are required for the establishment of infection by the parasites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbWgJzDzDmiLVg90H21EOLACvtfcHk0ljyNk44hCNNnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlags7nP&md5=d826579930268e41ef81ee49cc8a6784</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2005.08.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2005.08.027%26sid%3Dliteratum%253Aachs%26aulast%3DDoerig%26aufirst%3DC.%26aulast%3DBillker%26aufirst%3DO.%26aulast%3DPratt%26aufirst%3DD.%26aulast%3DEndicott%26aufirst%3DJ.%26atitle%3DProtein%2520kinases%2520as%2520targets%2520for%2520antimalarial%2520intervention%253A%2520kinomics%252C%2520structure-based%2520design%252C%2520transmission-blockade%252C%2520and%2520targeting%2520host%2520cell%2520enzymes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2005%26volume%3D1754%26spage%3D132%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Solowiej, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergqvist, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTigue, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marrone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quenzer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobbs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diehl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, B. W.</span><span> </span><span class="NLM_article-title">Characterizing the effects of the juxtamembrane domain on vascular endothelial growth factor receptor-2 enzymatic activity, autophosphorylation, and inhibition by axitinib</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7019</span><span class="NLM_x">–</span> <span class="NLM_lpage">7031</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi900522y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=7019-7031&author=J.+Solowiejauthor=S.+Bergqvistauthor=M.+A.+McTigueauthor=T.+Marroneauthor=T.+Quenzerauthor=M.+Cobbsauthor=K.+Ryanauthor=R.+S.+Kaniaauthor=W.+Diehlauthor=B.+W.+Murray&title=Characterizing+the+effects+of+the+juxtamembrane+domain+on+vascular+endothelial+growth+factor+receptor-2+enzymatic+activity%2C+autophosphorylation%2C+and+inhibition+by+axitinib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fbi900522y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi900522y%26sid%3Dliteratum%253Aachs%26aulast%3DSolowiej%26aufirst%3DJ.%26aulast%3DBergqvist%26aufirst%3DS.%26aulast%3DMcTigue%26aufirst%3DM.%2BA.%26aulast%3DMarrone%26aufirst%3DT.%26aulast%3DQuenzer%26aufirst%3DT.%26aulast%3DCobbs%26aufirst%3DM.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DDiehl%26aufirst%3DW.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26atitle%3DCharacterizing%2520the%2520effects%2520of%2520the%2520juxtamembrane%2520domain%2520on%2520vascular%2520endothelial%2520growth%2520factor%2520receptor-2%2520enzymatic%2520activity%252C%2520autophosphorylation%252C%2520and%2520inhibition%2520by%2520axitinib%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D7019%26epage%3D7031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Golas, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arndt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Etienne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nardin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boschelli, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boschelli, F.</span><span> </span><span class="NLM_article-title">SKI-606, a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases, is a potent antiproliferative agent against chronic myelogenous leukemia cells in culture and causes regression of K562 xenografts in nude mice</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=12543790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1Krsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=375-381&author=J.+M.+Golasauthor=K.+Arndtauthor=C.+Etienneauthor=J.+Lucasauthor=D.+Nardinauthor=J.+Gibbonsauthor=P.+Frostauthor=F.+Yeauthor=D.+H.+Boschelliauthor=F.+Boschelli&title=SKI-606%2C+a+4-anilino-3-quinolinecarbonitrile+dual+inhibitor+of+Src+and+Abl+kinases%2C+is+a+potent+antiproliferative+agent+against+chronic+myelogenous+leukemia+cells+in+culture+and+causes+regression+of+K562+xenografts+in+nude+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">SKI-606, a 4-Anilino-3-quinolinecarbonitrile Dual Inhibitor of Src and Abl Kinases, Is a Potent Antiproliferative Agent against Chronic Myelogenous Leukemia Cells in Culture and Causes Regression of K562 Xenografts in Nude Mice</span></div><div class="casAuthors">Golas, Jennifer M.; Arndt, Kim; Etienne, Carlo; Lucas, Judy; Nardin, Danielle; Gibbons, James; Frost, Philip; Ye, Fei; Boschelli, Diane H.; Boschelli, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">375-381</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Constitutive tyrosine kinase activity of Bcr-Abl promotes proliferation and survival of chronic myelogenous leukemia (CML) cells.  Inhibition of Bcr-Abl tyrosine kinase activity or signaling proteins activated by Bcr-Abl in CML cells blocks proliferation and causes apoptotic cell death.  The selective Abl kinase inhibitor, STI-571 (marketed as Gleevec), is toxic to CML cells in culture, causes regression of CML tumors in nude mice, and is currently used to treat CML patients.  Here we describe a p.o. active, dual Src/Abl kinase inhibitor with potent antiproliferative activity against CML cells in culture.  This 4-anilino-3-quinolinecarbonitrile (SKI-606) ablates tyrosine phosphorylation of Bcr-Abl in CML cells and of v-Abl expressed in fibroblasts.  SKI-606 inhibits phosphorylation of cellular proteins, including STAT5, at concns. that inhibit proliferation in CML cells.  Phosphorylation of the autoactivation site of the Src family kinases Lyn and/or Hck is also reduced by treatment with SKI-606.  Once daily oral administration of this compd. at 100 mg/kg for 5 days causes complete regression of large K562 xenografts in nude mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ0DM9Z0QjjLVg90H21EOLACvtfcHk0lj_Nij_0JATPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1Krsg%253D%253D&md5=e7b5e5ffee0238543dc9c31b7e86b3d2</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGolas%26aufirst%3DJ.%2BM.%26aulast%3DArndt%26aufirst%3DK.%26aulast%3DEtienne%26aufirst%3DC.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DNardin%26aufirst%3DD.%26aulast%3DGibbons%26aufirst%3DJ.%26aulast%3DFrost%26aufirst%3DP.%26aulast%3DYe%26aufirst%3DF.%26aulast%3DBoschelli%26aufirst%3DD.%2BH.%26aulast%3DBoschelli%26aufirst%3DF.%26atitle%3DSKI-606%252C%2520a%25204-anilino-3-quinolinecarbonitrile%2520dual%2520inhibitor%2520of%2520Src%2520and%2520Abl%2520kinases%252C%2520is%2520a%2520potent%2520antiproliferative%2520agent%2520against%2520chronic%2520myelogenous%2520leukemia%2520cells%2520in%2520culture%2520and%2520causes%2520regression%2520of%2520K562%2520xenografts%2520in%2520nude%2520mice%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D375%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Zou, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arango, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koudriakova, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Los, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span> </span><span class="NLM_article-title">An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">4408</span><span class="NLM_x">–</span> <span class="NLM_lpage">4417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1158%2F0008-5472.CAN-06-4443" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=17483355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltVyrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=4408-4417&author=H.+Y.+Zouauthor=Q.+Liauthor=J.+H.+Leeauthor=M.+E.+Arangoauthor=S.+R.+McDonnellauthor=S.+Yamazakiauthor=T.+B.+Koudriakovaauthor=G.+Altonauthor=J.+J.+Cuiauthor=P.-P.+Kungauthor=M.+D.+Nambuauthor=G.+Losauthor=S.+L.+Benderauthor=B.+Mroczkowskiauthor=J.+G.+Christensen&title=An+orally+available+small-molecule+inhibitor+of+c-Met%2C+PF-2341066%2C+exhibits+cytoreductive+antitumor+efficacy+through+antiproliferative+and+antiangiogenic+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms</span></div><div class="casAuthors">Zou, Helen Y.; Li, Qiuhua; Lee, Joseph H.; Arango, Maria E.; McDonnell, Scott R.; Yamazaki, Shinji; Koudriakova, Tatiana B.; Alton, Gordon; Cui, Jingrong J.; Kung, Pei-Pei; Nambu, Mitchell D.; Los, Gerrit; Bender, Steven L.; Mroczkowski, Barbara; Christensen, James G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4408-4417</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The c-Met receptor tyrosine kinase and its ligand, hepatocyte growth factor (HGF), have been implicated in the progression of several human cancers and are attractive therapeutic targets.  PF-2341066 was identified as a potent, orally bioavailable, ATP-competitive small-mol. inhibitor of the catalytic activity of c-Met kinase.  PF-2341066 was selective for c-Met (and anaplastic lymphoma kinase) compared with a panel of >120 diverse tyrosine and serine-threonine kinases.  PF-2341066 potently inhibited c-Met phosphorylation and c-Met-dependent proliferation, migration, or invasion of human tumor cells in vitro (IC50 values, 5-20 nmol/L).  In addn., PF-2341066 potently inhibited HGF-stimulated endothelial cell survival or invasion and serum-stimulated tubulogenesis in vitro, suggesting that this agent also exhibits antiangiogenic properties.  PF-2341066 showed efficacy at well-tolerated doses, including marked cytoreductive antitumor activity, in several tumor models that expressed activated c-Met.  The antitumor efficacy of PF-2341066 was dose dependent and showed a strong correlation to inhibition of c-Met phosphorylation in vivo.  Near-maximal inhibition of c-Met activity for the full dosing interval was necessary to maximize the efficacy of PF-2341066.  Addnl. mechanism-of-action studies showed dose-dependent inhibition of c-Met-dependent signal transduction, tumor cell proliferation (Ki67), induction of apoptosis (caspase-3), and redn. of microvessel d. (CD31).  These results indicated that the antitumor activity of PF-2341066 may be mediated by direct effects on tumor cell growth or survival as well as antiangiogenic mechanisms.  Collectively, these results show the therapeutic potential of targeting c-Met with selective small-mol. inhibitors for the treatment of human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEAWtGPOBHC7Vg90H21EOLACvtfcHk0lj_Nij_0JATPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltVyrsbg%253D&md5=798bf93e6cf8d5e9897e27485cba9002</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-4443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-4443%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DArango%26aufirst%3DM.%2BE.%26aulast%3DMcDonnell%26aufirst%3DS.%2BR.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DKoudriakova%26aufirst%3DT.%2BB.%26aulast%3DAlton%26aufirst%3DG.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DKung%26aufirst%3DP.-P.%26aulast%3DNambu%26aufirst%3DM.%2BD.%26aulast%3DLos%26aufirst%3DG.%26aulast%3DBender%26aufirst%3DS.%2BL.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26atitle%3DAn%2520orally%2520available%2520small-molecule%2520inhibitor%2520of%2520c-Met%252C%2520PF-2341066%252C%2520exhibits%2520cytoreductive%2520antitumor%2520efficacy%2520through%2520antiproliferative%2520and%2520antiangiogenic%2520mechanisms%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D4408%26epage%3D4417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">O’Hare, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoffregen, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manley, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mestan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan-Jacob, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrich, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, M. W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druker, B. J.</span><span> </span><span class="NLM_article-title">In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">4500</span><span class="NLM_x">–</span> <span class="NLM_lpage">4505</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=4500-4505&author=T.+O%E2%80%99Hareauthor=D.+K.+Waltersauthor=E.+P.+Stoffregenauthor=T.+Jiaauthor=P.+W.+Manleyauthor=J.+Mestanauthor=S.+W.+Cowan-Jacobauthor=F.+Y.+Leeauthor=M.+C.+Heinrichauthor=M.+W.+N.+Deiningerauthor=B.+J.+Druker&title=In+vitro+activity+of+Bcr-Abl+inhibitors+AMN107+and+BMS-354825+against+clinically+relevant+imatinib-resistant+Abl+kinase+domain+mutants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Hare%26aufirst%3DT.%26aulast%3DWalters%26aufirst%3DD.%2BK.%26aulast%3DStoffregen%26aufirst%3DE.%2BP.%26aulast%3DJia%26aufirst%3DT.%26aulast%3DManley%26aufirst%3DP.%2BW.%26aulast%3DMestan%26aufirst%3DJ.%26aulast%3DCowan-Jacob%26aufirst%3DS.%2BW.%26aulast%3DLee%26aufirst%3DF.%2BY.%26aulast%3DHeinrich%26aufirst%3DM.%2BC.%26aulast%3DDeininger%26aufirst%3DM.%2BW.%2BN.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26atitle%3DIn%2520vitro%2520activity%2520of%2520Bcr-Abl%2520inhibitors%2520AMN107%2520and%2520BMS-354825%2520against%2520clinically%2520relevant%2520imatinib-resistant%2520Abl%2520kinase%2520domain%2520mutants%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D4500%26epage%3D4505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Moyer, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacci, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiOrio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doty, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neveu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollack, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pustilnik, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theleman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, P.</span><span> </span><span class="NLM_article-title">Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4838</span><span class="NLM_x">–</span> <span class="NLM_lpage">4848</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=9354447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADyaK2sXnt12nsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=4838-4848&author=J.+D.+Moyerauthor=E.+G.+Barbacciauthor=K.+K.+Iwataauthor=L.+Arnoldauthor=B.+Bomanauthor=A.+Cunninghamauthor=C.+DiOrioauthor=J.+Dotyauthor=M.+J.+Morinauthor=M.+P.+Moyerauthor=M.+Neveuauthor=V.+A.+Pollackauthor=L.+R.+Pustilnikauthor=M.+M.+Reynoldsauthor=D.+Sloanauthor=A.+Thelemanauthor=P.+Miller&title=Induction+of+apoptosis+and+cell+cycle+arrest+by+CP-358%2C774%2C+an+inhibitor+of+epidermal+growth+factor+receptor+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of apoptosis and cell cycle arrest by CP-358774, an inhibitor of epidermal growth factor receptor tyrosine kinase</span></div><div class="casAuthors">Moyer, James D.; Barbacci, Elsa G.; Iwata, Kenneth K.; Arnold, Lee; Boman, Bruce; Cunningham, Ann; Diorio, Catherine; Doty, Jonathan; Morin, Michael J.; Moyer, Mikel P.; Neveu, Mark; Pollack, Vincent A.; Pustilnik, Leslie R.; Reynolds, Margaret M.; Sloan, Don; Theleman, April; Miller, Penny</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4838-4848</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The epidermal growth factor receptor (EGFR) is overexpressed in a significant percentage of carcinomas and contributes to the malignant phenotype.  CP-358774 is a directly acting inhibitor of human EGFR tyrosine kinase with an IC50 of 2 nM and reduces EGFR autophosphorylation in intact tumor cells with an IC50 of 20 nM.  This inhibition is selective for EGFR tyrosine kinase relative to other tyrosine kinases we have examd., both in assays of isolated kinases and whole cells.  At doses of 100 mg/kg, CP-358774 completely prevents EGF-induced autophosphorylation of EGFR in human HN5 tumors growing as xenografts in athymic mice and of the hepatic EGFR of the treated mice.  CP-358774 inhibits the proliferation of DiFi human colon tumor cells at submicromolar concns. in cell culture and blocks cell cycle progression at the G1 phase.  This inhibitor produces a marked accumulation of retinoblastoma protein in its underphosphorylated form and accumulation of p27KIP1 in DiFi cells, which may contribute to the cell cycle block.  Inhibition of the EGFR also triggers apoptosis in these cells as detd. by formation of DNA fragments and other criteria.  These results indicate that CP-358774 has potential for the treatment of tumors that are dependent on the EGFR pathway for proliferation or survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpghArQOnGlkbVg90H21EOLACvtfcHk0ljfvhthqDDyAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnt12nsr4%253D&md5=0a6e9697bf290d8e7c44cbe2a125e0b1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoyer%26aufirst%3DJ.%2BD.%26aulast%3DBarbacci%26aufirst%3DE.%2BG.%26aulast%3DIwata%26aufirst%3DK.%2BK.%26aulast%3DArnold%26aufirst%3DL.%26aulast%3DBoman%26aufirst%3DB.%26aulast%3DCunningham%26aufirst%3DA.%26aulast%3DDiOrio%26aufirst%3DC.%26aulast%3DDoty%26aufirst%3DJ.%26aulast%3DMorin%26aufirst%3DM.%2BJ.%26aulast%3DMoyer%26aufirst%3DM.%2BP.%26aulast%3DNeveu%26aufirst%3DM.%26aulast%3DPollack%26aufirst%3DV.%2BA.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DReynolds%26aufirst%3DM.%2BM.%26aulast%3DSloan%26aufirst%3DD.%26aulast%3DTheleman%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DP.%26atitle%3DInduction%2520of%2520apoptosis%2520and%2520cell%2520cycle%2520arrest%2520by%2520CP-358%252C774%252C%2520an%2520inhibitor%2520of%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D4838%26epage%3D4848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Wakeling, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guy, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodburn, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashton, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curry, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, K. H.</span><span> </span><span class="NLM_article-title">ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">5749</span><span class="NLM_x">–</span> <span class="NLM_lpage">5754</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=12384534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD38XotFyktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=5749-5754&author=A.+E.+Wakelingauthor=S.+P.+Guyauthor=J.+R.+Woodburnauthor=S.+E.+Ashtonauthor=B.+J.+Curryauthor=A.+J.+Barkerauthor=K.+H.+Gibson&title=ZD1839+%28Iressa%29%3A+an+orally+active+inhibitor+of+epidermal+growth+factor+signaling+with+potential+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">ZD1839 (Iressa): An orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy</span></div><div class="casAuthors">Wakeling, Alan E.; Guy, Simon P.; Woodburn, Jim R.; Ashton, Susan E.; Curry, Brenda J.; Barker, Andrew J.; Gibson, Keith H.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5749-5754</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The epidermal growth factor receptor (EGFR) is a promising target for anticancer therapy because of its role in tumor growth, metastasis and angiogenesis, and tumor resistance to chemotherapy and radiotherapy.  We have developed a low-mol.-wt. EGFR tyrosine kinase inhibitor (EGFR-TKI), ZD1839 (Iressa).  ZD1839, a substituted anilinoquinazoline, is a potent EGFR-TKI (IC50 = 0.033 μM) that selectively inhibits EGF-stimulated tumor cell growth (IC50 = 0.054 μM) and that blocks EGF-stimulated EGFR autophosphorylation in tumor cells.  In studies with mice bearing a range of human tumor-derived xenografts, ZD1839 given p.o. once a day inhibited tumor growth in a dose-dependent manner.  The level of expression of EGFR did not det. xenograft tumor sensitivity to ZD1839.  Long-term ZD1839 (>3 mo) treatment of mice bearing A431 xenografts was well tolerated, and ZD1839 completely inhibited tumor growth and induced regression of established tumors.  No drug-resistant tumors appeared during ZD1839 treatment, but some tumors regrew after drug withdrawal.  These studies indicate the potential utility of ZD1839 in the treatment of many human tumors and indicate that continuous once-a-day p.o. dosing might be a suitable therapeutic regimen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkoHZ9zL06abVg90H21EOLACvtfcHk0ljfvhthqDDyAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotFyktr8%253D&md5=f5f86c652786db476a2d23b5bbd1a9e9</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWakeling%26aufirst%3DA.%2BE.%26aulast%3DGuy%26aufirst%3DS.%2BP.%26aulast%3DWoodburn%26aufirst%3DJ.%2BR.%26aulast%3DAshton%26aufirst%3DS.%2BE.%26aulast%3DCurry%26aufirst%3DB.%2BJ.%26aulast%3DBarker%26aufirst%3DA.%2BJ.%26aulast%3DGibson%26aufirst%3DK.%2BH.%26atitle%3DZD1839%2520%2528Iressa%2529%253A%2520an%2520orally%2520active%2520inhibitor%2520of%2520epidermal%2520growth%2520factor%2520signaling%2520with%2520potential%2520for%2520cancer%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D5749%26epage%3D5754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Dar, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Small molecule recognition of c-Src via the imatinib-binding conformation</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1015</span><span class="NLM_x">–</span> <span class="NLM_lpage">1022</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2Fj.chembiol.2008.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=18940662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1KmsrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=1015-1022&author=A.+C.+Darauthor=M.+S.+Lopezauthor=K.+M.+Shokat&title=Small+molecule+recognition+of+c-Src+via+the+imatinib-binding+conformation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Recognition of c-Src via the Imatinib-Binding Conformation</span></div><div class="casAuthors">Dar, Arvin C.; Lopez, Michael S.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1015-1022</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: The cancer drug, Imatinib, is a selective Abl kinase inhibitor that does not inhibit the closely related kinase c-Src.  This one drug and its ability to selectively inhibit Abl over c-Src has been a guiding principle in virtually all kinase drug discovery efforts in the last 15 years.  A prominent hypothesis explaining the selectivity of Imatinib is that Abl has an intrinsic ability to adopt an inactive conformation (termed DFG-out), whereas c-Src appears to pay a high intrinsic energetic penalty for adopting this conformation, effectively excluding Imatinib from its ATP pocket.  This explanation of the difference in binding affinity of Imatinib for Abl vs. c-Src makes the striking prediction that it would not be possible to design an inhibitor that binds to the DFG-out conformation of c-Src with high affinity.  The authors report the discovery of a series of such inhibitors.  The authors use structure-activity relationships and x-ray crystallog. to confirm the authors' findings.  These studies suggest that small mols. are capable of inducing the generally unfavorable DFG-out conformation in c-Src.  Structural comparison between c-Src in complex with these inhibitors allows the authors to speculate on the differential selectivity of Imatinib for c-Src and Abl.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgbxnfmxtR-LVg90H21EOLACvtfcHk0lis220jThoVvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1KmsrfP&md5=f1047f4a56359511939164a3c2604cb6</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2008.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2008.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DDar%26aufirst%3DA.%2BC.%26aulast%3DLopez%26aufirst%3DM.%2BS.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DSmall%2520molecule%2520recognition%2520of%2520c-Src%2520via%2520the%2520imatinib-binding%2520conformation%26jtitle%3DChem.%2520Biol.%26date%3D2008%26volume%3D15%26spage%3D1015%26epage%3D1022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Wood, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truesdale, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickerson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennisi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lackey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alligood, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusnak, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shewchuk, L.</span><span> </span><span class="NLM_article-title">A unique structure for epidermal growth factor receptor bound to GW572016 (lapatinib)</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">6652</span><span class="NLM_x">–</span> <span class="NLM_lpage">6659</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1158%2F0008-5472.CAN-04-1168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=15374980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsFOlu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=6652-6659&author=E.+R.+Woodauthor=A.+T.+Truesdaleauthor=O.+B.+McDonaldauthor=D.+Yuanauthor=A.+Hassellauthor=S.+H.+Dickersonauthor=B.+Ellisauthor=C.+Pennisiauthor=E.+Horneauthor=K.+Lackeyauthor=K.+J.+Alligoodauthor=D.+W.+Rusnakauthor=T.+M.+Gilmerauthor=L.+Shewchuk&title=A+unique+structure+for+epidermal+growth+factor+receptor+bound+to+GW572016+%28lapatinib%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells</span></div><div class="casAuthors">Wood, Edgar R.; Truesdale, Anne T.; McDonald, Octerloney B.; Yuan, Derek; Hassell, Anne; Dickerson, Scott H.; Ellis, Byron; Pennisi, Christopher; Horne, Earnest; Lackey, Karen; Alligood, Krystal J.; Rusnak, David W.; Gilmer, Tona M.; Shewchuk, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6652-6659</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">GW572016 (Lapatinib) is a tyrosine kinase inhibitor in clin. development for cancer that is a potent dual inhibitor of epidermal growth factor receptor (EGFR, ErbB-1) and ErbB-2.  The authors detd. the crystal structure of EGFR bound to GW572016.  The compd. is bound to an inactive-like conformation of EGFR that is very different from the active-like structure bound by the selective EGFR inhibitor OSI-774 (Tarceva) described previously.  Surprisingly, the authors found that GW572016 has a very slow off-rate from the purified intracellular domains of EGFR and ErbB-2 compared with OSI-774 and another EGFR selective inhibitor, ZD-1839 (Iressa).  Treatment of tumor cells with these inhibitors results in down-regulation of receptor tyrosine phosphorylation.  The authors evaluated the duration of the drug effect after washing away free compd. and found that the rate of recovery of receptor phosphorylation in the tumor cells reflected the inhibitor off-rate from the purified intracellular domain.  The slow off-rate of GW572016 correlates with a prolonged down-regulation of receptor tyrosine phosphorylation in tumor cells.  The differences in the off-rates of these drugs and the ability of GW572016 to inhibit ErbB-2 can be explained by the enzyme-inhibitor structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXjJPy6XYk4rVg90H21EOLACvtfcHk0lis220jThoVvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsFOlu7g%253D&md5=788d92fc5db9f1ecf9d3fbf3142e5c9f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-1168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-1168%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DE.%2BR.%26aulast%3DTruesdale%26aufirst%3DA.%2BT.%26aulast%3DMcDonald%26aufirst%3DO.%2BB.%26aulast%3DYuan%26aufirst%3DD.%26aulast%3DHassell%26aufirst%3DA.%26aulast%3DDickerson%26aufirst%3DS.%2BH.%26aulast%3DEllis%26aufirst%3DB.%26aulast%3DPennisi%26aufirst%3DC.%26aulast%3DHorne%26aufirst%3DE.%26aulast%3DLackey%26aufirst%3DK.%26aulast%3DAlligood%26aufirst%3DK.%2BJ.%26aulast%3DRusnak%26aufirst%3DD.%2BW.%26aulast%3DGilmer%26aufirst%3DT.%2BM.%26aulast%3DShewchuk%26aufirst%3DL.%26atitle%3DA%2520unique%2520structure%2520for%2520epidermal%2520growth%2520factor%2520receptor%2520bound%2520to%2520GW572016%2520%2528lapatinib%2529%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D6652%26epage%3D6659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Kumar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knick, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crouthamel, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopper, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onori, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truesdale, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epperly, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boloor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stafford, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luttrell, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, M.</span><span> </span><span class="NLM_article-title">Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">2012</span><span class="NLM_x">–</span> <span class="NLM_lpage">2021</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1158%2F1535-7163.MCT-07-0193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=17620431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsV2jsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=2012-2021&author=R.+Kumarauthor=V.+B.+Knickauthor=S.+K.+Rudolphauthor=J.+H.+Johnsonauthor=R.+M.+Crosbyauthor=M.-C.+Crouthamelauthor=T.+M.+Hopperauthor=C.+G.+Millerauthor=L.+E.+Harringtonauthor=J.+A.+Onoriauthor=R.+J.+Mullinauthor=T.+M.+Gilmerauthor=A.+T.+Truesdaleauthor=A.+H.+Epperlyauthor=A.+Boloorauthor=J.+A.+Staffordauthor=D.+K.+Luttrellauthor=M.+Cheung&title=Pharmacokinetic-pharmacodynamic+correlation+from+mouse+to+human+with+pazopanib%2C+a+multikinase+angiogenesis+inhibitor+with+potent+antitumor+and+antiangiogenic+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity</span></div><div class="casAuthors">Kumar, Rakesh; Knick, Victoria B.; Rudolph, Sharon K.; Johnson, Jennifer H.; Crosby, Renae M.; Crouthamel, Ming-Chih; Hopper, Teresa M.; Miller, Charles G.; Harrington, Laura E.; Onori, James A.; Mullin, Robert J.; Gilmer, Tona M.; Truesdale, Anne T.; Epperly, Andrea H.; Boloor, Amogh; Stafford, Jeffrey A.; Luttrell, Deirdre K.; Cheung, Mui</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2012-2021</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">With the development of targeted therapeutics, esp. for small-mol. inhibitors, it is important to understand whether the obsd. in vivo efficacy correlates with the modulation of desired/intended target in vivo.  The authors have developed a small-mol. inhibitor of all three vascular endothelial growth factor (VEGF) receptors (VEGFR), platelet-derived growth factor receptor, and c-Kit tyrosine kinases, pazopanib (GW786034), which selectively inhibits VEGF-induced endothelial cell proliferation.  It has good oral exposure and inhibits angiogenesis and tumor growth in mice.  Because bolus administration of the compd. results in large differences in Cmax and Ctrough, the authors investigated the effect of continuous infusion of a VEGFR inhibitor on tumor growth and angiogenesis.  GW771806, which has similar enzyme and cellular profiles to GW786034, was used for these studies due to higher soly. requirements for infusion studies.  Comparing the pharmacokinetics by two different routes of administration (bolus p.o. dosing and continuous infusion), the authors showed that the antitumor and antiangiogenic activity of VEGFR inhibitors is dependent on steady-state concn. of the compd. above a threshold.  The steady-state concn. required for these effects is consistent with the concn. required for the inhibition of VEGF-induced VEGFR2 phosphorylation in mouse lungs.  Furthermore, the steady-state concn. of pazopanib detd. from preclin. activity showed a strong correlation with the pharmacodynamic effects and antitumor activity in the phase I clin. trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3hDCy5B0DMLVg90H21EOLACvtfcHk0lis220jThoVvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsV2jsrk%253D&md5=b0dde2f214757af0a1d5c73f71555207</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0193%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DKnick%26aufirst%3DV.%2BB.%26aulast%3DRudolph%26aufirst%3DS.%2BK.%26aulast%3DJohnson%26aufirst%3DJ.%2BH.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DCrouthamel%26aufirst%3DM.-C.%26aulast%3DHopper%26aufirst%3DT.%2BM.%26aulast%3DMiller%26aufirst%3DC.%2BG.%26aulast%3DHarrington%26aufirst%3DL.%2BE.%26aulast%3DOnori%26aufirst%3DJ.%2BA.%26aulast%3DMullin%26aufirst%3DR.%2BJ.%26aulast%3DGilmer%26aufirst%3DT.%2BM.%26aulast%3DTruesdale%26aufirst%3DA.%2BT.%26aulast%3DEpperly%26aufirst%3DA.%2BH.%26aulast%3DBoloor%26aufirst%3DA.%26aulast%3DStafford%26aufirst%3DJ.%2BA.%26aulast%3DLuttrell%26aufirst%3DD.%2BK.%26aulast%3DCheung%26aufirst%3DM.%26atitle%3DPharmacokinetic-pharmacodynamic%2520correlation%2520from%2520mouse%2520to%2520human%2520with%2520pazopanib%252C%2520a%2520multikinase%2520angiogenesis%2520inhibitor%2520with%2520potent%2520antitumor%2520and%2520antiangiogenic%2520activity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D2012%26epage%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Wilhelm, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adnane, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schütz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thierauch, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zopf, D.</span><span> </span><span class="NLM_article-title">Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1002%2Fijc.25864" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=21170960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltFGlu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2011&pages=245-255&author=S.+M.+Wilhelmauthor=J.+Dumasauthor=L.+Adnaneauthor=M.+Lynchauthor=C.+A.+Carterauthor=G.+Sch%C3%BCtzauthor=K.-H.+Thierauchauthor=D.+Zopf&title=Regorafenib+%28BAY+73-4506%29%3A+a+new+oral+multikinase+inhibitor+of+angiogenic%2C+stromal+and+oncogenic+receptor+tyrosine+kinases+with+potent+preclinical+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Regorafenib (BAY 73-4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity</span></div><div class="casAuthors">Wilhelm, Scott M.; Dumas, Jacques; Adnane, Lila; Lynch, Mark; Carter, Christopher A.; Schuetz, Gunnar; Thierauch, Karl-Heinz; Zopf, Dieter</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">245-255</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Angiogenesis, a crit. driver of tumor development, is controlled by interconnected signaling pathways.  Vascular endothelial growth factor receptor (VEGFR) 2 and tyrosine kinase with Ig and epidermal growth factor homol. domain 2 play crucial roles in the biol. of normal and tumor vasculature.  Regorafenib (BAY 73-4506), a novel oral multikinase inhibitor, potently inhibits these endothelial cell kinases in biochem. and cellular kinase phosphorylation assays.  Furthermore, regorafenib inhibits addnl. angiogenic kinases (VEGFR1/3, platelet-derived growth factor receptor-β and fibroblast growth factor receptor 1) and the mutant oncogenic kinases KIT, RET and B-RAF.  The antiangiogenic effect of regorafenib was demonstrated in vivo by dynamic contrast-enhanced magnetic resonance imaging.  Regorafenib administered once orally at 10 mg/kg significantly decreased the extravasation of Gadomer in the vasculature of rat GS9L glioblastoma tumor xenografts.  In a daily (qd)×4 dosing study, the pharmacodynamic effects persisted for 48 h after the last dosing and correlated with tumor growth inhibition (TGI).  A significant redn. in tumor microvessel area was obsd. in a human colorectal xenograft after qd×5 dosing at 10 and 30 mg/kg.  Regorafenib exhibited potent dose-dependent TGI in various preclin. human xenograft models in mice, with tumor shrinkages obsd. in breast MDA-MB-231 and renal 786-O carcinoma models.  Pharmacodynamic analyses of the breast model revealed strong redn. in staining of proliferation marker Ki-67 and phosphorylated extracellular regulated kinases 1/2.  These data demonstrate that regorafenib is a well-tolerated, orally active multikinase inhibitor with a distinct target profile that may have therapeutic benefit in human malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtQpQXfCq04rVg90H21EOLACvtfcHk0ljiLBosXzyE9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltFGlu7c%253D&md5=13eee29ef1f1f03fd1ed311ea613f566</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fijc.25864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.25864%26sid%3Dliteratum%253Aachs%26aulast%3DWilhelm%26aufirst%3DS.%2BM.%26aulast%3DDumas%26aufirst%3DJ.%26aulast%3DAdnane%26aufirst%3DL.%26aulast%3DLynch%26aufirst%3DM.%26aulast%3DCarter%26aufirst%3DC.%2BA.%26aulast%3DSch%25C3%25BCtz%26aufirst%3DG.%26aulast%3DThierauch%26aufirst%3DK.-H.%26aulast%3DZopf%26aufirst%3DD.%26atitle%3DRegorafenib%2520%2528BAY%252073-4506%2529%253A%2520a%2520new%2520oral%2520multikinase%2520inhibitor%2520of%2520angiogenic%252C%2520stromal%2520and%2520oncogenic%2520receptor%2520tyrosine%2520kinases%2520with%2520potent%2520preclinical%2520antitumor%2520activity%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2011%26volume%3D129%26spage%3D245%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Quintás-Cardam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaddi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manshouri, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherle, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caulder, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waeltz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covington, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarjian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verstovsek, S.</span><span> </span><span class="NLM_article-title">Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">3109</span><span class="NLM_x">–</span> <span class="NLM_lpage">3117</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=3109-3117&author=A.+Quint%C3%A1s-Cardamauthor=K.+Vaddiauthor=P.+Liuauthor=T.+Manshouriauthor=J.+Liauthor=P.+A.+Scherleauthor=E.+Caulderauthor=X.+Wenauthor=Y.+Liauthor=P.+Waeltzauthor=M.+Ruparauthor=T.+Burnauthor=Y.+Loauthor=J.+Kelleyauthor=M.+Covingtonauthor=S.+Shepardauthor=J.+D.+Rodgersauthor=P.+Haleyauthor=H.+Kantarjianauthor=J.+S.+Fridmanauthor=S.+Verstovsek&title=Preclinical+characterization+of+the+selective+JAK1%2F2+inhibitor+INCB018424%3A+therapeutic+implications+for+the+treatment+of+myeloproliferative+neoplasms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQuint%25C3%25A1s-Cardam%26aufirst%3DA.%26aulast%3DVaddi%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DManshouri%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DScherle%26aufirst%3DP.%2BA.%26aulast%3DCaulder%26aufirst%3DE.%26aulast%3DWen%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWaeltz%26aufirst%3DP.%26aulast%3DRupar%26aufirst%3DM.%26aulast%3DBurn%26aufirst%3DT.%26aulast%3DLo%26aufirst%3DY.%26aulast%3DKelley%26aufirst%3DJ.%26aulast%3DCovington%26aufirst%3DM.%26aulast%3DShepard%26aufirst%3DS.%26aulast%3DRodgers%26aufirst%3DJ.%2BD.%26aulast%3DHaley%26aufirst%3DP.%26aulast%3DKantarjian%26aufirst%3DH.%26aulast%3DFridman%26aufirst%3DJ.%2BS.%26aulast%3DVerstovsek%26aufirst%3DS.%26atitle%3DPreclinical%2520characterization%2520of%2520the%2520selective%2520JAK1%252F2%2520inhibitor%2520INCB018424%253A%2520therapeutic%2520implications%2520for%2520the%2520treatment%2520of%2520myeloproliferative%2520neoplasms%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26spage%3D3109%26epage%3D3117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Wilhelm, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNabola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shujath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gawlak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eveleigh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adnane, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auclair, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gedrich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voznesensky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedl, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Post, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollag, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trail, P. A.</span><span> </span><span class="NLM_article-title">BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">7099</span><span class="NLM_x">–</span> <span class="NLM_lpage">7109</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=7099-7109&author=S.+M.+Wilhelmauthor=C.+Carterauthor=L.+Tangauthor=D.+Wilkieauthor=A.+McNabolaauthor=H.+Rongauthor=C.+Chenauthor=X.+Zhangauthor=P.+Vincentauthor=M.+McHughauthor=Y.+Caoauthor=J.+Shujathauthor=S.+Gawlakauthor=D.+Eveleighauthor=B.+Rowleyauthor=L.+Liuauthor=L.+Adnaneauthor=M.+Lynchauthor=D.+Auclairauthor=I.+Taylorauthor=R.+Gedrichauthor=A.+Voznesenskyauthor=B.+Riedlauthor=L.+E.+Postauthor=G.+Bollagauthor=P.+A.+Trail&title=BAY+43-9006+exhibits+broad+spectrum+oral+antitumor+activity+and+targets+the+RAF%2FMEK%2FERK+pathway+and+receptor+tyrosine+kinases+involved+in+tumor+progression+and+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilhelm%26aufirst%3DS.%2BM.%26aulast%3DCarter%26aufirst%3DC.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DWilkie%26aufirst%3DD.%26aulast%3DMcNabola%26aufirst%3DA.%26aulast%3DRong%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DVincent%26aufirst%3DP.%26aulast%3DMcHugh%26aufirst%3DM.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DShujath%26aufirst%3DJ.%26aulast%3DGawlak%26aufirst%3DS.%26aulast%3DEveleigh%26aufirst%3DD.%26aulast%3DRowley%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DAdnane%26aufirst%3DL.%26aulast%3DLynch%26aufirst%3DM.%26aulast%3DAuclair%26aufirst%3DD.%26aulast%3DTaylor%26aufirst%3DI.%26aulast%3DGedrich%26aufirst%3DR.%26aulast%3DVoznesensky%26aufirst%3DA.%26aulast%3DRiedl%26aufirst%3DB.%26aulast%3DPost%26aufirst%3DL.%2BE.%26aulast%3DBollag%26aufirst%3DG.%26aulast%3DTrail%26aufirst%3DP.%2BA.%26atitle%3DBAY%252043-9006%2520exhibits%2520broad%2520spectrum%2520oral%2520antitumor%2520activity%2520and%2520targets%2520the%2520RAF%252FMEK%252FERK%2520pathway%2520and%2520receptor%2520tyrosine%2520kinases%2520involved%2520in%2520tumor%2520progression%2520and%2520angiogenesis%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D7099%26epage%3D7109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Mendel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laird, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreck, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrams, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngai, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carver, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haznedar, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukbuntherng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirazian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherrington, J. M.</span><span> </span><span class="NLM_article-title">In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">337</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=12538485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1OrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=327-337&author=D.+B.+Mendelauthor=A.+D.+Lairdauthor=X.+Xinauthor=S.+G.+Louieauthor=J.+G.+Christensenauthor=G.+Liauthor=R.+E.+Schreckauthor=T.+J.+Abramsauthor=T.+J.+Ngaiauthor=L.+B.+Leeauthor=L.+J.+Murrayauthor=J.+Carverauthor=E.+Chanauthor=K.+G.+Mossauthor=J.+O.+Haznedarauthor=J.+Sukbuntherngauthor=R.+A.+Blakeauthor=L.+Sunauthor=C.+Tangauthor=T.+Millerauthor=S.+Shirazianauthor=G.+McMahonauthor=J.+M.+Cherrington&title=In+vivo+antitumor+activity+of+SU11248%2C+a+novel+tyrosine+kinase+inhibitor+targeting+vascular+endothelial+growth+factor+and+platelet-derived+growth+factor+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">In Vivo Antitumor Activity of SU11248, a Novel Tyrosine Kinase Inhibitor Targeting Vascular Endothelial Growth Factor and Platelet-derived Growth Factor Receptors: Determination of a Pharmacokinetic/Pharmacodynamic Relationship</span></div><div class="casAuthors">Mendel, Dirk B.; Laird, A. Douglas; Xin, Xiaohua; Louie, Sharianne G.; Christensen, James G.; Li, Guangmin; Schreck, Randall E.; Abrams, Tinya J.; Ngai, Theresa J.; Lee, Leslie B.; Murray, Lesley J.; Carver, Jeremy; Chan, Emily; Moss, Katherine G.; Haznedar, Joshua O.; Sukbuntherng, Juthamas; Blake, Robert A.; Sun, Li; Tang, Cho; Miller, Todd; Shirazian, Sheri; McMahon, Gerald; Cherrington, Julie M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">327-337</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">One challenging aspect in the clin. development of molecularly targeted therapies, which represent a new and promising approach to treating cancers, has been the identification of a biol. active dose rather than a max. tolerated dose.  The goal of the present study was to identify a pharmacokinetic/pharmacodynamic relationship in preclin. models that could be used to help guide selection of a clin. dose.  SU11248, a novel small mol. receptor tyrosine kinase inhibitor with direct antitumor as well as antiangiogenic activity via targeting the vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), KIT, and FLT3 receptor tyrosine kinases, was used as the pharmacol. agent in these studies.  In mouse xenograft models, SU11248 exhibited broad and potent antitumor activity causing regression, growth arrest, or substantially reduced growth of various established xenografts derived from human or rat tumor cell lines.  To predict the target SU11248 exposure required to achieve antitumor activity in mouse xenograft models, we directly measured target phosphorylation in tumor xenografts before and after SU11248 treatment and correlated this with plasma inhibitor levels.  In target modulation studies in vivo, SU11248 selectively inhibited Flk-1/KDR (VEGF receptor 2) and PDGF receptor β phosphorylation (in a time- and dose-dependent manner) when plasma concns. of inhibitor reached or exceeded 50-100 ng/mL.  Similar results were obtained in a functional assay of VEGF-induced vascular permeability in vivo.  Const. inhibition of VEGFR2 and PDGF receptor β phosphorylation was not required for efficacy; at highly efficacious doses, inhibition was sustained for 12 h of a 24-h dosing interval.  The pharmacokinetic/pharmacodynamic relationship established for SU11248 in these preclin. studies has aided in the design, selection, and evaluation of dosing regimens being tested in human trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH8BrUNdo50rVg90H21EOLACvtfcHk0liCFQTM3ETrdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1OrtA%253D%253D&md5=faafdec68a96d6cdf02ab347f69422b6</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMendel%26aufirst%3DD.%2BB.%26aulast%3DLaird%26aufirst%3DA.%2BD.%26aulast%3DXin%26aufirst%3DX.%26aulast%3DLouie%26aufirst%3DS.%2BG.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DSchreck%26aufirst%3DR.%2BE.%26aulast%3DAbrams%26aufirst%3DT.%2BJ.%26aulast%3DNgai%26aufirst%3DT.%2BJ.%26aulast%3DLee%26aufirst%3DL.%2BB.%26aulast%3DMurray%26aufirst%3DL.%2BJ.%26aulast%3DCarver%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DE.%26aulast%3DMoss%26aufirst%3DK.%2BG.%26aulast%3DHaznedar%26aufirst%3DJ.%2BO.%26aulast%3DSukbuntherng%26aufirst%3DJ.%26aulast%3DBlake%26aufirst%3DR.%2BA.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DMiller%26aufirst%3DT.%26aulast%3DShirazian%26aufirst%3DS.%26aulast%3DMcMahon%26aufirst%3DG.%26aulast%3DCherrington%26aufirst%3DJ.%2BM.%26atitle%3DIn%2520vivo%2520antitumor%2520activity%2520of%2520SU11248%252C%2520a%2520novel%2520tyrosine%2520kinase%2520inhibitor%2520targeting%2520vascular%2520endothelial%2520growth%2520factor%2520and%2520platelet-derived%2520growth%2520factor%2520receptors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2003%26volume%3D9%26spage%3D327%26epage%3D337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Carlomagno, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitagliano, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciardiello, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortora, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vecchio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontanini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fusco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santoro, M.</span><span> </span><span class="NLM_article-title">ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">7284</span><span class="NLM_x">–</span> <span class="NLM_lpage">7290</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=7284-7290&author=F.+Carlomagnoauthor=D.+Vitaglianoauthor=T.+Guidaauthor=F.+Ciardielloauthor=G.+Tortoraauthor=G.+Vecchioauthor=A.+J.+Ryanauthor=G.+Fontaniniauthor=A.+Fuscoauthor=M.+Santoro&title=ZD6474%2C+an+orally+available+inhibitor+of+KDR+tyrosine+kinase+activity%2C+efficiently+blocks+oncogenic+RET+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarlomagno%26aufirst%3DF.%26aulast%3DVitagliano%26aufirst%3DD.%26aulast%3DGuida%26aufirst%3DT.%26aulast%3DCiardiello%26aufirst%3DF.%26aulast%3DTortora%26aufirst%3DG.%26aulast%3DVecchio%26aufirst%3DG.%26aulast%3DRyan%26aufirst%3DA.%2BJ.%26aulast%3DFontanini%26aufirst%3DG.%26aulast%3DFusco%26aufirst%3DA.%26aulast%3DSantoro%26aufirst%3DM.%26atitle%3DZD6474%252C%2520an%2520orally%2520available%2520inhibitor%2520of%2520KDR%2520tyrosine%2520kinase%2520activity%252C%2520efficiently%2520blocks%2520oncogenic%2520RET%2520kinases%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D7284%26epage%3D7290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Bollag, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spevak, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habets, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shellooe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marimuthu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K. Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artis, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Andrea, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koehler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stumm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grippo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puzanov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McArthur, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sosman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flaherty, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nathanson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolop, K.</span><span> </span><span class="NLM_article-title">Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">467</span><span class="NLM_x">, </span> <span class="NLM_fpage">596</span><span class="NLM_x">–</span> <span class="NLM_lpage">599</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1038%2Fnature09454" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=20823850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1ajtbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=467&publication_year=2010&pages=596-599&author=G.+Bollagauthor=P.+Hirthauthor=J.+Tsaiauthor=J.+Zhangauthor=P.+N.+Ibrahimauthor=H.+Choauthor=W.+Spevakauthor=C.+Zhangauthor=Y.+Zhangauthor=G.+Habetsauthor=E.+A.+Burtonauthor=B.+Wongauthor=G.+Tsangauthor=B.+L.+Westauthor=B.+Powellauthor=R.+Shellooeauthor=A.+Marimuthuauthor=H.+Nguyenauthor=K.+Y.+J.+Zhangauthor=D.+R.+Artisauthor=J.+Schlessingerauthor=F.+Suauthor=B.+Higginsauthor=R.+Iyerauthor=K.+D%E2%80%99Andreaauthor=A.+Koehlerauthor=M.+Stummauthor=P.+S.+Linauthor=R.+J.+Leeauthor=J.+Grippoauthor=I.+Puzanovauthor=K.+B.+Kimauthor=A.+Ribasauthor=G.+A.+McArthurauthor=J.+A.+Sosmanauthor=P.+B.+Chapmanauthor=K.+T.+Flahertyauthor=X.+Xuauthor=K.+L.+Nathansonauthor=K.+Nolop&title=Clinical+efficacy+of+a+RAF+inhibitor+needs+broad+target+blockade+in+BRAF-mutant+melanoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma</span></div><div class="casAuthors">Bollag, Gideon; Hirth, Peter; Tsai, James; Zhang, Jiazhong; Ibrahim, Prabha N.; Cho, Hanna; Spevak, Wayne; Zhang, Chao; Zhang, Ying; Habets, Gaston; Burton, Elizabeth A.; Wong, Bernice; Tsang, Garson; West, Brian L.; Powell, Ben; Shellooe, Rafe; Marimuthu, Adhirai; Nguyen, Hoa; Zhang, Kam Y. J.; Artis, Dean R.; Schlessinger, Joseph; Su, Fei; Higgins, Brian; Iyer, Raman; D'Andrea, Kurt; Koehler, Astrid; Stumm, Michael; Lin, Paul S.; Lee, Richard J.; Grippo, Joseph; Puzanov, Igor; Kim, Kevin B.; Ribas, Antoni; McArthur, Grant A.; Sosman, Jeffrey A.; Chapman, Paul B.; Flaherty, Keith T.; Xu, Xiaowei; Nathanson, Katherine L.; Nolop, Keith</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">467</span>
        (<span class="NLM_cas:issue">7315</span>),
    <span class="NLM_cas:pages">596-599</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">B-RAF is the most frequently mutated protein kinase in human cancers.  The finding that oncogenic mutations in BRAF are common in melanoma, followed by the demonstration that these tumors are dependent on the RAF/MEK/ERK pathway, offered hope that inhibition of B-RAF kinase activity could benefit melanoma patients.  Herein, we describe the structure-guided discovery of PLX4032 (RG7204), a potent inhibitor of oncogenic B-RAF kinase activity.  Preclin. expts. demonstrated that PLX4032 selectively blocked the RAF/MEK/ERK pathway in BRAF mutant cells and caused regression of BRAF mutant xenografts.  Toxicol. studies confirmed a wide safety margin consistent with the high degree of selectivity, enabling Phase 1 clin. trials using a cryst. formulation of PLX4032 (ref. 5).  In a subset of melanoma patients, pathway inhibition was monitored in paired biopsy specimens collected before treatment initiation and following 2 wk of treatment.  This anal. revealed substantial inhibition of ERK phosphorylation, yet clin. evaluation did not show tumor regressions.  At higher drug exposures afforded by a new amorphous drug formulation, greater than 80% inhibition of ERK phosphorylation in the tumors of patients correlated with clin. response.  Indeed, the Phase 1 clin. data revealed a remarkably high 81% response rate in metastatic melanoma patients treated at an oral dose of 960 mg twice daily.  These data demonstrate that BRAF-mutant melanomas are highly dependent on B-RAF kinase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpYwlns1EfcLVg90H21EOLACvtfcHk0liCFQTM3ETrdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1ajtbfK&md5=8a26d0ab41970f39a109ddafff2f17b4</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnature09454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09454%26sid%3Dliteratum%253Aachs%26aulast%3DBollag%26aufirst%3DG.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DTsai%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DIbrahim%26aufirst%3DP.%2BN.%26aulast%3DCho%26aufirst%3DH.%26aulast%3DSpevak%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHabets%26aufirst%3DG.%26aulast%3DBurton%26aufirst%3DE.%2BA.%26aulast%3DWong%26aufirst%3DB.%26aulast%3DTsang%26aufirst%3DG.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DShellooe%26aufirst%3DR.%26aulast%3DMarimuthu%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DK.%2BY.%2BJ.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DF.%26aulast%3DHiggins%26aufirst%3DB.%26aulast%3DIyer%26aufirst%3DR.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DK.%26aulast%3DKoehler%26aufirst%3DA.%26aulast%3DStumm%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DP.%2BS.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26aulast%3DGrippo%26aufirst%3DJ.%26aulast%3DPuzanov%26aufirst%3DI.%26aulast%3DKim%26aufirst%3DK.%2BB.%26aulast%3DRibas%26aufirst%3DA.%26aulast%3DMcArthur%26aufirst%3DG.%2BA.%26aulast%3DSosman%26aufirst%3DJ.%2BA.%26aulast%3DChapman%26aufirst%3DP.%2BB.%26aulast%3DFlaherty%26aufirst%3DK.%2BT.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DNathanson%26aufirst%3DK.%2BL.%26aulast%3DNolop%26aufirst%3DK.%26atitle%3DClinical%2520efficacy%2520of%2520a%2520RAF%2520inhibitor%2520needs%2520broad%2520target%2520blockade%2520in%2520BRAF-mutant%2520melanoma%26jtitle%3DNature%26date%3D2010%26volume%3D467%26spage%3D596%26epage%3D599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">O’Hare, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shakespeare, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eide, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adrian, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyner, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loriaux, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbin, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wardwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ning, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keats, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundaramoorthi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snodgrass, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Commodore, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalgarno, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, M. W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clackson, T.</span><span> </span><span class="NLM_article-title">AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">412</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=401-412&author=T.+O%E2%80%99Hareauthor=W.+C.+Shakespeareauthor=X.+Zhuauthor=C.+A.+Eideauthor=V.+M.+Riveraauthor=F.+Wangauthor=L.+T.+Adrianauthor=T.+Zhouauthor=W.-S.+Huangauthor=Q.+Xuauthor=C.+A.+Metcalfauthor=J.+W.+Tynerauthor=M.+M.+Loriauxauthor=A.+S.+Corbinauthor=S.+Wardwellauthor=Y.+Ningauthor=J.+A.+Keatsauthor=Y.+Wangauthor=R.+Sundaramoorthiauthor=M.+Thomasauthor=D.+Zhouauthor=J.+Snodgrassauthor=L.+Commodoreauthor=T.+K.+Sawyerauthor=D.+C.+Dalgarnoauthor=M.+W.+N.+Deiningerauthor=B.+J.+Drukerauthor=T.+Clackson&title=AP24534%2C+a+pan-BCR-ABL+inhibitor+for+chronic+myeloid+leukemia%2C+potently+inhibits+the+T315I+mutant+and+overcomes+mutation-based+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Hare%26aufirst%3DT.%26aulast%3DShakespeare%26aufirst%3DW.%2BC.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DEide%26aufirst%3DC.%2BA.%26aulast%3DRivera%26aufirst%3DV.%2BM.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DAdrian%26aufirst%3DL.%2BT.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DW.-S.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DMetcalf%26aufirst%3DC.%2BA.%26aulast%3DTyner%26aufirst%3DJ.%2BW.%26aulast%3DLoriaux%26aufirst%3DM.%2BM.%26aulast%3DCorbin%26aufirst%3DA.%2BS.%26aulast%3DWardwell%26aufirst%3DS.%26aulast%3DNing%26aufirst%3DY.%26aulast%3DKeats%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSundaramoorthi%26aufirst%3DR.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DSnodgrass%26aufirst%3DJ.%26aulast%3DCommodore%26aufirst%3DL.%26aulast%3DSawyer%26aufirst%3DT.%2BK.%26aulast%3DDalgarno%26aufirst%3DD.%2BC.%26aulast%3DDeininger%26aufirst%3DM.%2BW.%2BN.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DClackson%26aufirst%3DT.%26atitle%3DAP24534%252C%2520a%2520pan-BCR-ABL%2520inhibitor%2520for%2520chronic%2520myeloid%2520leukemia%252C%2520potently%2520inhibits%2520the%2520T315I%2520mutant%2520and%2520overcomes%2520mutation-based%2520resistance%26jtitle%3DCancer%2520Cell%26date%3D2009%26volume%3D16%26spage%3D401%26epage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Chrencik, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patny, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korniski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmons, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gormley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommers, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenbrink, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, T. E.</span><span> </span><span class="NLM_article-title">Structural and thermodynamic characterization of the TYK2 and JAK3 kinase domains in complex with CP-690550 and CMP-6</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">400</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">433</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2Fj.jmb.2010.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=20478313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1ylt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=2010&pages=413-433&author=J.+E.+Chrencikauthor=A.+Patnyauthor=I.+K.+Leungauthor=B.+Korniskiauthor=T.+L.+Emmonsauthor=T.+Hallauthor=R.+A.+Weinbergauthor=J.+A.+Gormleyauthor=J.+M.+Williamsauthor=J.+E.+Dayauthor=J.+L.+Hirschauthor=J.+R.+Kieferauthor=J.+W.+Leoneauthor=H.+D.+Fischerauthor=C.+D.+Sommersauthor=H.-C.+Huangauthor=E.+J.+Jacobsenauthor=R.+E.+Tenbrinkauthor=A.+G.+Tomasselliauthor=T.+E.+Benson&title=Structural+and+thermodynamic+characterization+of+the+TYK2+and+JAK3+kinase+domains+in+complex+with+CP-690550+and+CMP-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6</span></div><div class="casAuthors">Chrencik, Jill E.; Patny, Akshay; Leung, Iris K.; Korniski, Brian; Emmons, Thomas L.; Hall, Troii; Weinberg, Robin A.; Gormley, Jennifer A.; Williams, Jennifer M.; Day, Jacqueline E.; Hirsch, Jeffrey L.; Kiefer, James R.; Leone, Joseph W.; Fischer, H. David; Sommers, Cynthia D.; Huang, Horng-Chih; Jacobsen, E. J.; Tenbrink, Ruth E.; Tomasselli, Alfredo G.; Benson, Timothy E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">400</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">413-433</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Janus kinases (JAKs) are crit. regulators of cytokine pathways and attractive targets of therapeutic value in both inflammatory and myeloproliferative diseases.  Although the crystal structures of active JAK1 and JAK2 kinase domains have been reported recently with the clin. compd. CP-690550, the structures of both TYK2 and JAK3 with CP-690550 have remained outstanding.  Here, we report the crystal structures of TYK2, a first in class structure, and JAK3 in complex with PAN-JAK inhibitors CP-690550 ((3R,4R)-3-[4-methyl-3-[N-methyl-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropionitrile) and CMP-6 (tetracyclic pyridone 2-t-butyl-9-fluoro-3,6-dihydro-7H-benz[h]-imidaz[4,5-f]isoquinoline-7-one), both of which bind in the ATP-binding cavities of both JAK isoenzymes in orientations similar to that obsd. in crystal structures of JAK1 and JAK2.  Addnl., a complete thermodn. characterization of JAK/CP-690550 complex formation was completed by isothermal titrn. calorimetry, indicating the crit. role of the nitrile group from the CP-690550 compd.  Finally, computational anal. using WaterMap further highlights the crit. positioning of the CP-690550 nitrile group in the displacement of an unfavorable water mol. beneath the glycine-rich loop.  Taken together, the data emphasize the outstanding properties of the kinome-selective JAK inhibitor CP-690550, as well as the challenges in obtaining JAK isoenzyme-selective inhibitors due to the overall structural and sequence similarities between the TYK2, JAK1, JAK2 and JAK3 isoenzymes.  Nevertheless, subtle amino acid variations of residues lining the ligand-binding cavity of the JAK enzymes, as well as the global positioning of the glycine-rich loop, might provide the initial clues to obtaining JAK-isoenzyme selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5dnGkvq0jPbVg90H21EOLACvtfcHk0liN3E2M7-lEyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1ylt7g%253D&md5=1b1efc3d6f913143dc9113e4ac1c4c60</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2010.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2010.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DChrencik%26aufirst%3DJ.%2BE.%26aulast%3DPatny%26aufirst%3DA.%26aulast%3DLeung%26aufirst%3DI.%2BK.%26aulast%3DKorniski%26aufirst%3DB.%26aulast%3DEmmons%26aufirst%3DT.%2BL.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26aulast%3DGormley%26aufirst%3DJ.%2BA.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DDay%26aufirst%3DJ.%2BE.%26aulast%3DHirsch%26aufirst%3DJ.%2BL.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DLeone%26aufirst%3DJ.%2BW.%26aulast%3DFischer%26aufirst%3DH.%2BD.%26aulast%3DSommers%26aufirst%3DC.%2BD.%26aulast%3DHuang%26aufirst%3DH.-C.%26aulast%3DJacobsen%26aufirst%3DE.%2BJ.%26aulast%3DTenbrink%26aufirst%3DR.%2BE.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26atitle%3DStructural%2520and%2520thermodynamic%2520characterization%2520of%2520the%2520TYK2%2520and%2520JAK3%2520kinase%2520domains%2520in%2520complex%2520with%2520CP-690550%2520and%2520CMP-6%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D400%26spage%3D413%26epage%3D433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Greger, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastman, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleam, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smitheman, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickerson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laquerre, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmer, T. M.</span><span> </span><span class="NLM_article-title">Combinations of BRAF, MEK, and PI3K/mTOR inhibitors overcome acquired resistance to the BRAF inhibitor GSK2118436 dabrafenib, mediated by NRAS or MEK mutations</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">920</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1158%2F1535-7163.MCT-11-0989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=22389471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC38Xltl2ntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=909-920&author=J.+G.+Gregerauthor=S.+D.+Eastmanauthor=V.+Zhangauthor=M.+R.+Bleamauthor=A.+M.+Hughesauthor=K.+N.+Smithemanauthor=S.+H.+Dickersonauthor=S.+G.+Laquerreauthor=L.+Liuauthor=T.+M.+Gilmer&title=Combinations+of+BRAF%2C+MEK%2C+and+PI3K%2FmTOR+inhibitors+overcome+acquired+resistance+to+the+BRAF+inhibitor+GSK2118436+dabrafenib%2C+mediated+by+NRAS+or+MEK+mutations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Combinations of BRAF, MEK, and PI3K/mTOR Inhibitors Overcome Acquired Resistance to the BRAF Inhibitor GSK2118436 Dabrafenib, Mediated by NRAS or MEK Mutations</span></div><div class="casAuthors">Greger, James G.; Eastman, Stephen D.; Zhang, Vivian; Bleam, Maureen R.; Hughes, Ashley M.; Smitheman, Kimberly N.; Dickerson, Scott H.; Laquerre, Sylvie G.; Liu, Li; Gilmer, Tona M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">909-920</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Recent results from clin. trials with the BRAF inhibitors GSK2118436 (dabrafenib) and PLX4032 (vemurafenib) have shown encouraging response rates; however, the duration of response has been limited.  To identify determinants of acquired resistance to GSK2118436 and strategies to overcome the resistance, we isolated GSK2118436 drug-resistant clones from the A375 BRAFV600E and the YUSIT1 BRAFV600K melanoma cell lines.  These clones also showed reduced sensitivity to the allosteric mitogen-activated protein/extracellular signal-regulated kinase (MEK) inhibitor GSK1120212 (trametinib).  Genetic characterization of these clones identified an in-frame deletion in MEK1 (MEK1K59del) or NRAS mutation (NRASQ61K and/or NRASA146T) with and without MEK1P387S in the BRAFV600E background and NRASQ61K in the BRAFV600K background.  Stable knockdown of NRAS with short hairpin RNA partially restored GSK2118436 sensitivity in mutant NRAS clones, whereas expression of NRASQ61K or NRASA146T in the A375 parental cells decreased sensitivity to GSK2118436.  Similarly, expression of MEK1K59del, but not MEK1P387S, decreased sensitivity of A375 cells to GSK2118436.  The combination of GSK2118436 and GSK1120212 effectively inhibited cell growth, decreased ERK phosphorylation, decreased cyclin D1 protein, and increased p27kip1 protein in the resistant clones.  Moreover, the combination of GSK2118436 or GSK1120212 with the phosphoinositide 3-kinase/mTOR inhibitor GSK2126458 enhanced cell growth inhibition and decreased S6 ribosomal protein phosphorylation in these clones.  Our results show that NRAS and/or MEK mutations contribute to BRAF inhibitor resistance in vitro, and the combination of GSK2118436 and GSK1120212 overcomes this resistance.  In addn., these resistant clones respond to the combination of GSK2126458 with GSK2118436 or GSK1120212.  Clin. trials are ongoing or planned to test these combinations.  Mol Cancer Ther; 11(4); 909-20.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-aBjkeaBsgLVg90H21EOLACvtfcHk0liN3E2M7-lEyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xltl2ntbY%253D&md5=416c0679440a16f76f3622e0b26cf3a2</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0989%26sid%3Dliteratum%253Aachs%26aulast%3DGreger%26aufirst%3DJ.%2BG.%26aulast%3DEastman%26aufirst%3DS.%2BD.%26aulast%3DZhang%26aufirst%3DV.%26aulast%3DBleam%26aufirst%3DM.%2BR.%26aulast%3DHughes%26aufirst%3DA.%2BM.%26aulast%3DSmitheman%26aufirst%3DK.%2BN.%26aulast%3DDickerson%26aufirst%3DS.%2BH.%26aulast%3DLaquerre%26aufirst%3DS.%2BG.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DGilmer%26aufirst%3DT.%2BM.%26atitle%3DCombinations%2520of%2520BRAF%252C%2520MEK%252C%2520and%2520PI3K%252FmTOR%2520inhibitors%2520overcome%2520acquired%2520resistance%2520to%2520the%2520BRAF%2520inhibitor%2520GSK2118436%2520dabrafenib%252C%2520mediated%2520by%2520NRAS%2520or%2520MEK%2520mutations%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2012%26volume%3D11%26spage%3D909%26epage%3D920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Gilmartin, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleam, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minthorn, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rominger, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erskine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zappacosta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laquerre, S. G.</span><span> </span><span class="NLM_article-title">GSK1120212 (JTP-74057) is an inhibitor of MEK activity and activation with favorable pharmacokinetic properties for sustained in vivo pathway inhibition</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">989</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1158%2F1078-0432.CCR-10-2200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=21245089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXis1eit7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=989-1000&author=A.+G.+Gilmartinauthor=M.+R.+Bleamauthor=A.+Groyauthor=K.+G.+Mossauthor=E.+A.+Minthornauthor=S.+G.+Kulkarniauthor=C.+M.+Romingerauthor=S.+Erskineauthor=K.+E.+Fisherauthor=J.+Yangauthor=F.+Zappacostaauthor=R.+Annanauthor=D.+Suttonauthor=S.+G.+Laquerre&title=GSK1120212+%28JTP-74057%29+is+an+inhibitor+of+MEK+activity+and+activation+with+favorable+pharmacokinetic+properties+for+sustained+in+vivo+pathway+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">GSK1120212 (JTP-74057) Is an Inhibitor of MEK Activity and Activation with Favorable Pharmacokinetic Properties for Sustained In Vivo Pathway Inhibition</span></div><div class="casAuthors">Gilmartin, Aidan G.; Bleam, Maureen R.; Groy, Arthur; Moss, Katherine G.; Minthorn, Elisabeth A.; Kulkarni, Swarupa G.; Rominger, Cynthia M.; Erskine, Symon; Fisher, Kelly E.; Yang, Jing-Song; Zappacosta, Francesca; Annan, Roland; Sutton, David; Laquerre, Sylvie G.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">989-1000</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Despite their preclin. promise, previous MEK inhibitors have shown little benefit for patients.  This likely reflects the narrow therapeutic window for MEK inhibitors due to the essential role of the P42/44 MAPK pathway in many nontumor tissues.  GSK1120212 is a potent and selective allosteric inhibitor of the MEK1 and MEK2 (MEK1/2) enzymes with promising antitumor activity in a phase I clin. trial (ASCO 2010).  Our studies characterize GSK1120212' enzymic, cellular, and in vivo activities, describing its unusually long circulating half-life.  Exptl. Design: Enzymic studies were conducted to det. GSK1120212 inhibition of recombinant MEK, following or preceding RAF kinase activation.  Cellular studies examd. GSK1120212 inhibition of ERK1 and 2 phosphorylation (p-ERK1/2) as well as MEK1/2 phosphorylation and activation.  Further studies explored the sensitivity of cancer cell lines, and drug pharmacokinetics and efficacy in multiple tumor xenograft models.  Results: In enzymic and cellular studies, GSK1120212 inhibits MEK1/2 kinase activity and prevents Raf-dependent MEK phosphorylation (S217 for MEK1), producing prolonged p-ERK1/2 inhibition.  Potent cell growth inhibition was evident in most tumor lines with mutant BRAF or Ras.  In xenografted tumor models, GSK1120212 orally dosed once daily had a long circulating half-life and sustained suppression of p-ERK1/2 for more than 24 h; GSK1120212 also reduced tumor Ki67, increased p27Kip1/CDKN1B, and caused tumor growth inhibition in multiple tumor models.  The largest antitumor effect was among tumors harboring mutant BRAF or Ras.  Conclusions: GSK1120212 combines high potency, selectivity, and long circulating half-life, offering promise for successfully targeting the narrow therapeutic window anticipated for clin. MEK inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMOQvgszKIfbVg90H21EOLACvtfcHk0li5CTfgK5Ke2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXis1eit7k%253D&md5=6154be5fa0afb034c6a5995508d7ea9e</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-10-2200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-10-2200%26sid%3Dliteratum%253Aachs%26aulast%3DGilmartin%26aufirst%3DA.%2BG.%26aulast%3DBleam%26aufirst%3DM.%2BR.%26aulast%3DGroy%26aufirst%3DA.%26aulast%3DMoss%26aufirst%3DK.%2BG.%26aulast%3DMinthorn%26aufirst%3DE.%2BA.%26aulast%3DKulkarni%26aufirst%3DS.%2BG.%26aulast%3DRominger%26aufirst%3DC.%2BM.%26aulast%3DErskine%26aufirst%3DS.%26aulast%3DFisher%26aufirst%3DK.%2BE.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DZappacosta%26aufirst%3DF.%26aulast%3DAnnan%26aufirst%3DR.%26aulast%3DSutton%26aufirst%3DD.%26aulast%3DLaquerre%26aufirst%3DS.%2BG.%26atitle%3DGSK1120212%2520%2528JTP-74057%2529%2520is%2520an%2520inhibitor%2520of%2520MEK%2520activity%2520and%2520activation%2520with%2520favorable%2520pharmacokinetic%2520properties%2520for%2520sustained%2520in%2520vivo%2520pathway%2520inhibition%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26spage%3D989%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Liao, J. J.</span><span> </span><span class="NLM_article-title">Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0608107" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1Cmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=409-424&author=J.+J.+Liao&title=Molecular+recognition+of+protein+kinase+binding+pockets+for+design+of+potent+and+selective+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Recognition of Protein Kinase Binding Pockets for Design of Potent and Selective Kinase Inhibitors</span></div><div class="casAuthors">Liao, Jeffrey Jie-Lou</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">409-424</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Many kinase inhibitors have failed in preclin. or clin. development because of the lack of such selectivity that induces intolerable side effects, mostly because the catalytic cleft is highly conserved in sequence and conformation.  Systematic anal. of the crystal structures of protein kinases can offer insight into the design of highly selective kinase inhibitors to overcome these effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroDTl2SBUfbbVg90H21EOLACvtfcHk0li5CTfgK5Ke2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1Cmsg%253D%253D&md5=77542d3ba589bd834a0d2b97a24eea05</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm0608107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0608107%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DJ.%2BJ.%26atitle%3DMolecular%2520recognition%2520of%2520protein%2520kinase%2520binding%2520pockets%2520for%2520design%2520of%2520potent%2520and%2520selective%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D409%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">McGregor, M. J.</span><span> </span><span class="NLM_article-title">A pharmacophore map of small molecule protein kinase inhibitors</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2374</span><span class="NLM_x">–</span> <span class="NLM_lpage">2382</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci700244t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFKksL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=2374-2382&author=M.+J.+McGregor&title=A+pharmacophore+map+of+small+molecule+protein+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A Pharmacophore Map of Small Molecule Protein Kinase Inhibitors</span></div><div class="casAuthors">McGregor, Malcolm J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2374-2382</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein kinases have emerged as one of the major drug target classes that are amenable to the development of small mol. inhibitors.  They share a conserved structural similarity in the region of the ATP binding site, where most inhibitors interact.  Using a pharmacophore approach, we have explored the features of protein-ligand interactions for a set of 220 kinase crystal structures from the Protein Data Bank (PDB).  The resulting "pharmacophore map" shows the interactions made by all ligands with their receptors simultaneously.  This gives insight that has been applied in the design of kinase screening sets and combinatorial libraries.  An algorithm is described that scores small mol. structures for goodness of fit to the resulting binding site description obtained from the anal.  The algorithm identifies a pose that is close to the crystal structure pose for the majority of ligands, with only the 2D chem. structure as input and no knowledge of the crystal structure from which it was derived.  Application of the algorithm to a test screening set gave a useful enrichment of active compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-PlOGvAO_Z7Vg90H21EOLACvtfcHk0li5CTfgK5Ke2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFKksL%252FO&md5=38d2b55c3fbb1232fd7d091f95414633</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fci700244t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci700244t%26sid%3Dliteratum%253Aachs%26aulast%3DMcGregor%26aufirst%3DM.%2BJ.%26atitle%3DA%2520pharmacophore%2520map%2520of%2520small%2520molecule%2520protein%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2007%26volume%3D47%26spage%3D2374%26epage%3D2382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Rational design of inhibitors that bind to inactive kinase conformations</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1038%2Fnchembio799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=16783341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFGjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=358-364&author=Y.+Liuauthor=N.+S.+Gray&title=Rational+design+of+inhibitors+that+bind+to+inactive+kinase+conformations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design of inhibitors that bind to inactive kinase conformations</span></div><div class="casAuthors">Liu, Yi; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">358-364</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The majority of kinase inhibitors, known as type I inhibitors that have been developed so far target the ATP binding site of the kinase in its active conformation, in which the activation loop is phosphorylated.  Recently, crystal structures of inhibitors such as imatinib, BIRB796, and sorafenib (BAY43-9006), known as type II inhibitors, have revealed a new binding mode that exploits an addnl. binding site immediately adjacent to the region occupied by ATP.  This pocket is made accessible by an activation-loop rearrangement that is characteristic of kinases in an inactive conformation.  The examn. of binding features of known type II inhibitors is discussed and a pharmacophore model currently used in the design of a new generation of structurally diverse type II inhibitors is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxahsMPlhgDbVg90H21EOLACvtfcHk0li5CTfgK5Ke2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFGjs7g%253D&md5=4a9347a44a2cf4a412c9741fdcc5696b</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnchembio799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio799%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DRational%2520design%2520of%2520inhibitors%2520that%2520bind%2520to%2520inactive%2520kinase%2520conformations%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2006%26volume%3D2%26spage%3D358%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Liao, J. J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, R. C.</span><span> </span><span class="NLM_article-title">Targeting protein multiple conformations: a structure-based strategy for kinase drug design</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1394</span><span class="NLM_x">–</span> <span class="NLM_lpage">1407</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.2174%2F156802607781696783" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=17692028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1SmtbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=1394-1407&author=J.+J.+L.+Liaoauthor=R.+C.+Andrews&title=Targeting+protein+multiple+conformations%3A+a+structure-based+strategy+for+kinase+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein multiple conformations: a structure-based strategy for kinase drug design</span></div><div class="casAuthors">Liao, Jeffrey Jie-Lou; Andrews, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1394-1407</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Multiple conformations of a protein kinase target offer an opportunity to design small-mol. inhibitors with distinct but clin. useful profiles.  This article analyzes and classifies the binding pockets in the kinase catalytic cleft in different conformational states.  Targeting kinase multiple conformations as an emerging strategy in the field is exemplified with important small-mol. agents in the clinic.  The structure-based anal. in the paper provides a rationale for thwarting the development of drug-resistant mutations in antikinase therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWOkJq0JBN2rVg90H21EOLACvtfcHk0lgvy52FgHQ1eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1SmtbrF&md5=db6aa8c76bf20857cfe31c71625ffa9e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.2174%2F156802607781696783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607781696783%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DJ.%2BJ.%2BL.%26aulast%3DAndrews%26aufirst%3DR.%2BC.%26atitle%3DTargeting%2520protein%2520multiple%2520conformations%253A%2520a%2520structure-based%2520strategy%2520for%2520kinase%2520drug%2520design%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D1394%26epage%3D1407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Ghose, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbertz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pippin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvino, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallamo, J. P.</span><span> </span><span class="NLM_article-title">Knowledge based prediction of ligand binding modes and rational inhibitor design for kinase drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5149</span><span class="NLM_x">–</span> <span class="NLM_lpage">5171</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800475y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWmurnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5149-5171&author=A.+K.+Ghoseauthor=T.+Herbertzauthor=D.+A.+Pippinauthor=J.+M.+Salvinoauthor=J.+P.+Mallamo&title=Knowledge+based+prediction+of+ligand+binding+modes+and+rational+inhibitor+design+for+kinase+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Knowledge Based Prediction of Ligand Binding Modes and Rational Inhibitor Design for Kinase Drug Discovery</span></div><div class="casAuthors">Ghose, Arup K.; Herbertz, Torsten; Pippin, Douglas A.; Salvino, Joseph M.; Mallamo, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5149-5171</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review describing the use of Protein Data Bank (PDB) entries specifically for kinase inhibitor drug discovery.  Topics discussed include: the current state of structure-aided ligand design, kinase structure queries and extn. from the PDB, alignment of protein structures, structural classification of ligands, anal. of ligands and binding modes, and ligand design strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDINDYVE15cbVg90H21EOLACvtfcHk0lgvy52FgHQ1eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWmurnM&md5=a1afc4d6c7f6fa4dd6aa9da8d78f1ee3</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm800475y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800475y%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DHerbertz%26aufirst%3DT.%26aulast%3DPippin%26aufirst%3DD.%2BA.%26aulast%3DSalvino%26aufirst%3DJ.%2BM.%26aulast%3DMallamo%26aufirst%3DJ.%2BP.%26atitle%3DKnowledge%2520based%2520prediction%2520of%2520ligand%2520binding%2520modes%2520and%2520rational%2520inhibitor%2520design%2520for%2520kinase%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5149%26epage%3D5171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Lamba, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, I.</span><span> </span><span class="NLM_article-title">New directions in targeting protein kinases: focusing upon true allosteric and bivalent inhibitors</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2936</span><span class="NLM_x">–</span> <span class="NLM_lpage">2945</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.2174%2F138161212800672813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=22571662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFaltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=2936-2945&author=V.+Lambaauthor=I.+Ghosh&title=New+directions+in+targeting+protein+kinases%3A+focusing+upon+true+allosteric+and+bivalent+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">New directions in targeting protein kinases: focusing upon true allosteric and bivalent inhibitors</span></div><div class="casAuthors">Lamba, Vandana; Ghosh, Indraneel</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2936-2945</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Over the past decade, therapeutics that target subsets of the 518 human protein kinases have played a vital role in the fight against cancer.  Protein kinases are typically targeted at the ATP-binding cleft by type I and II inhibitors; however, the high sequence and structural homol. shared by protein kinases, esp. at the ATP-binding site, inherently leads to polypharmacol.  In order to discover or design truly selective protein kinase inhibitors as both pharmacol. reagents and safer therapeutic leads, new efforts are needed to target kinases outside the ATP cleft.  Recent advances include the serendipitous discovery of type III inhibitors that bind a site proximal to the ATP pocket as well as the truly allosteric type IV inhibitors that target protein kinases distal to the substrate-binding pocket.  These new classes of inhibitors are often selective, but usually display moderate affinities.  Here, the authors discuss the different classes of inhibitors with an emphasis on bisubstrate and bivalent inhibitors (type V) that combine different inhibitor classes.  These inhibitors have the potential to couple the high affinity and potency of traditional active site-targeted small-mol. inhibitors with the selectivity of inhibitors that target the protein kinase surface outside ATP cleft.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkIIgeMxhCrrVg90H21EOLACvtfcHk0lgvy52FgHQ1eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFaltrk%253D&md5=36a44e36709507b5053bfdfe7d09e5e9</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2174%2F138161212800672813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161212800672813%26sid%3Dliteratum%253Aachs%26aulast%3DLamba%26aufirst%3DV.%26aulast%3DGhosh%26aufirst%3DI.%26atitle%3DNew%2520directions%2520in%2520targeting%2520protein%2520kinases%253A%2520focusing%2520upon%2520true%2520allosteric%2520and%2520bivalent%2520inhibitors%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2012%26volume%3D18%26spage%3D2936%26epage%3D2945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">Comprehensive analysis of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1046</span><span class="NLM_x">–</span> <span class="NLM_lpage">1051</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1038%2Fnbt.1990" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=22037378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1046-1051&author=M.+I.+Davisauthor=J.+P.+Huntauthor=S.+Herrgardauthor=P.+Ciceriauthor=L.+M.+Wodickaauthor=G.+Pallaresauthor=M.+Hockerauthor=D.+K.+Treiberauthor=P.+P.+Zarrinkar&title=Comprehensive+analysis+of+kinase+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Davis, Mindy I.; Hunt, Jeremy P.; Herrgard, Sanna; Ciceri, Pietro; Wodicka, Lisa M.; Pallares, Gabriel; Hocker, Michael; Treiber, Daniel K.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1046-1051</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We tested the interaction of 72 kinase inhibitors with 442 kinases covering >80% of the human catalytic protein kinome.  Our data show that, as a class, type II inhibitors are more selective than type I inhibitors, but that there are important exceptions to this trend.  The data further illustrate that selective inhibitors have been developed against the majority of kinases targeted by the compds. tested.  Anal. of the interaction patterns reveals a class of 'group-selective' inhibitors broadly active against a single subfamily of kinases, but selective outside that subfamily.  The data set suggests compds. to use as tools to study kinases for which no dedicated inhibitors exist.  It also provides a foundation for further exploring kinase inhibitor biol. and toxicity, as well as for studying the structural basis of the obsd. interaction patterns.  Our findings will help to realize the direct enabling potential of genomics for drug development and basic research about cellular signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEZnKVs6Xt5rVg90H21EOLACvtfcHk0ljo2I11fDldzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK&md5=67639f702cb48ffb2c60e9a250f0df5e</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1990%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DHocker%26aufirst%3DM.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DComprehensive%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D1046%26epage%3D1051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Karaman, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraoni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">A quantitative analysis of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1038%2Fnbt1358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=18183025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=127-132&author=M.+W.+Karamanauthor=S.+Herrgardauthor=D.+K.+Treiberauthor=P.+Gallantauthor=C.+E.+Atteridgeauthor=B.+T.+Campbellauthor=K.+W.+Chanauthor=P.+Ciceriauthor=M.+I.+Davisauthor=P.+T.+Edeenauthor=R.+Faraoniauthor=M.+Floydauthor=J.+P.+Huntauthor=D.+J.+Lockhartauthor=Z.+V.+Milanovauthor=M.+J.+Morrisonauthor=G.+Pallaresauthor=H.+K.+Patelauthor=S.+Pritchardauthor=L.+M.+Wodickaauthor=P.+P.+Zarrinkar&title=A+quantitative+analysis+of+kinase+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Karaman, Mazen W.; Herrgard, Sanna; Treiber, Daniel K.; Gallant, Paul; Atteridge, Corey E.; Campbell, Brian T.; Chan, Katrina W.; Ciceri, Pietro; Davis, Mindy I.; Edeen, Philip T.; Faraoni, Raffaella; Floyd, Mark; Hunt, Jeremy P.; Lockhart, Daniel J.; Milanov, Zdravko V.; Morrison, Michael J.; Pallares, Gabriel; Patel, Hitesh K.; Pritchard, Stephanie; Wodicka, Lisa M.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-132</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets.  The biol. consequences of multikinase activity are poorly defined, and an important step toward understanding the relationship between selectivity, efficacy and safety is the exploration of how inhibitors interact with the human kinome.  The authors present interaction maps for 38 kinase inhibitors across a panel of 317 kinases representing >50% of the predicted human protein kinome.  The data constitute the most comprehensive study of kinase inhibitor selectivity to date and reveal a wide diversity of interaction patterns.  To enable a global anal. of the results, the authors introduce the concept of a selectivity score as a general tool to quantify and differentiate the obsd. interaction patterns.  The authors further investigate the impact of panel size and find that small assay panels do not provide a robust measure of selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiArJSq2_lPrVg90H21EOLACvtfcHk0ljo2I11fDldzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D&md5=346265d412853ced636ad4128ed8a76f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fnbt1358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1358%26sid%3Dliteratum%253Aachs%26aulast%3DKaraman%26aufirst%3DM.%2BW.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DCampbell%26aufirst%3DB.%2BT.%26aulast%3DChan%26aufirst%3DK.%2BW.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFaraoni%26aufirst%3DR.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DMorrison%26aufirst%3DM.%2BJ.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DPritchard%26aufirst%3DS.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DA%2520quantitative%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D127%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Aronov, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClain, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moody, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murcko, M. A.</span><span> </span><span class="NLM_article-title">Kinase-likeness and kinase-privileged fragments: toward virtual polypharmacology</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1214</span><span class="NLM_x">–</span> <span class="NLM_lpage">1222</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701021b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1214-1222&author=A.+M.+Aronovauthor=B.+McClainauthor=C.+S.+Moodyauthor=M.+A.+Murcko&title=Kinase-likeness+and+kinase-privileged+fragments%3A+toward+virtual+polypharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm701021b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701021b%26sid%3Dliteratum%253Aachs%26aulast%3DAronov%26aufirst%3DA.%2BM.%26aulast%3DMcClain%26aufirst%3DB.%26aulast%3DMoody%26aufirst%3DC.%2BS.%26aulast%3DMurcko%26aufirst%3DM.%2BA.%26atitle%3DKinase-likeness%2520and%2520kinase-privileged%2520fragments%253A%2520toward%2520virtual%2520polypharmacology%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1214%26epage%3D1222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Gill, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederickson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleasby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodhead, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodhead, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congreve, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devine, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tisi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Reilly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seavers, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhoti, H.</span><span> </span><span class="NLM_article-title">Identification of novel p38alpha MAP kinase inhibitors using fragment-based lead generation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">414</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049575n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=414-26&author=A.+L.+Gillauthor=M.+Fredericksonauthor=A.+Cleasbyauthor=S.+J.+Woodheadauthor=M.+G.+Carrauthor=A.+J.+Woodheadauthor=M.+T.+Walkerauthor=M.+S.+Congreveauthor=L.+A.+Devineauthor=D.+Tisiauthor=M.+O%E2%80%99Reillyauthor=L.+C.+Seaversauthor=D.+J.+Davisauthor=J.+Curryauthor=R.+Anthonyauthor=A.+Padovaauthor=C.+W.+Murrayauthor=R.+A.+Carrauthor=H.+Jhoti&title=Identification+of+novel+p38alpha+MAP+kinase+inhibitors+using+fragment-based+lead+generation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm049575n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049575n%26sid%3Dliteratum%253Aachs%26aulast%3DGill%26aufirst%3DA.%2BL.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DWoodhead%26aufirst%3DS.%2BJ.%26aulast%3DCarr%26aufirst%3DM.%2BG.%26aulast%3DWoodhead%26aufirst%3DA.%2BJ.%26aulast%3DWalker%26aufirst%3DM.%2BT.%26aulast%3DCongreve%26aufirst%3DM.%2BS.%26aulast%3DDevine%26aufirst%3DL.%2BA.%26aulast%3DTisi%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%26aulast%3DSeavers%26aufirst%3DL.%2BC.%26aulast%3DDavis%26aufirst%3DD.%2BJ.%26aulast%3DCurry%26aufirst%3DJ.%26aulast%3DAnthony%26aufirst%3DR.%26aulast%3DPadova%26aufirst%3DA.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DCarr%26aufirst%3DR.%2BA.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520novel%2520p38alpha%2520MAP%2520kinase%2520inhibitors%2520using%2520fragment-based%2520lead%2520generation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D414%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Hartshorn, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleasby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederickson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tickle, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhoti, H.</span><span> </span><span class="NLM_article-title">Fragment-based lead discovery using X-ray crystallography</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0495778" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFCiu7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=403-13&author=M.+J.+Hartshornauthor=C.+W.+Murrayauthor=A.+Cleasbyauthor=M.+Fredericksonauthor=I.+J.+Tickleauthor=H.+Jhoti&title=Fragment-based+lead+discovery+using+X-ray+crystallography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Lead Discovery Using X-ray Crystallography</span></div><div class="casAuthors">Hartshorn, Michael J.; Murray, Christopher W.; Cleasby, Anne; Frederickson, Martyn; Tickle, Ian J.; Jhoti, Harren</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">403-413</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment screening offers an alternative to traditional screening for discovering new leads in drug discovery programs.  This paper describes a fragment screening methodol. based on high throughput x-ray crystallog.  The method is illustrated against five proteins (p38 MAP kinase, CDK2, thrombin, RNase A, and PTP1B).  The fragments identified have weak potency (>100 μM) but are efficient binders relative to their size and may therefore represent suitable starting points for evolution to good quality lead compds.  The examples illustrate that a range of mol. interactions (i.e., lipophilic, charge-charge, neutral hydrogen bonds) can drive fragment binding and also that fragments can induce protein movement.  The authors believe that the method has great potential for the discovery of novel lead compds. against a range of targets, and the companion paper illustrates how lead compds. have been identified for p38 MAP kinase starting from fragments such as those described in this paper.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeepqN9_V8prVg90H21EOLACvtfcHk0lj3fI_2b9Vh5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFCiu7nK&md5=41f6e394812669bde519ab7366fea9d6</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm0495778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0495778%26sid%3Dliteratum%253Aachs%26aulast%3DHartshorn%26aufirst%3DM.%2BJ.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DTickle%26aufirst%3DI.%2BJ.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DFragment-based%2520lead%2520discovery%2520using%2520X-ray%2520crystallography%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D403%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Saxty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodhead, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdonk, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyatt, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barford, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R. A.</span><span> </span><span class="NLM_article-title">Identification of inhibitors of protein kinase B using fragment-based lead discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2293</span><span class="NLM_x">–</span> <span class="NLM_lpage">2296</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070091b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksVKjur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2293-2296&author=G.+Saxtyauthor=S.+J.+Woodheadauthor=V.+Berdiniauthor=T.+G.+Daviesauthor=M.+L.+Verdonkauthor=P.+G.+Wyattauthor=R.+G.+Boyleauthor=D.+Barfordauthor=R.+Downhamauthor=M.+D.+Garrettauthor=R.+A.+Carr&title=Identification+of+inhibitors+of+protein+kinase+B+using+fragment-based+lead+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Inhibitors of Protein Kinase B Using Fragment-Based Lead Discovery</span></div><div class="casAuthors">Saxty, Gordon; Woodhead, Steven J.; Berdini, Valerio; Davies, Thomas G.; Verdonk, Marcel L.; Wyatt, Paul G.; Boyle, Robert G.; Barford, David; Downham, Robert; Garrett, Michelle D.; Carr, Robin A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2293-2296</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using fragment-based screening techniques, 5-methyl-4-phenyl-1H-pyrazole (IC50 80 μM) was identified as a novel, low mol. wt. inhibitor of protein kinase B (PKB).  Herein we describe the rapid elaboration of highly potent and ligand efficient analogs using a fragment growing approach.  Iterative structure-based design was supported by protein-ligand structure detns. using a PKA-PKB "chimera" and a final protein-ligand structure of a lead compd. in PKBβ itself.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlCYaIT8Xn87Vg90H21EOLACvtfcHk0lj3fI_2b9Vh5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksVKjur8%253D&md5=2a09e4bbaca1493be8e215927e7e72e1</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm070091b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070091b%26sid%3Dliteratum%253Aachs%26aulast%3DSaxty%26aufirst%3DG.%26aulast%3DWoodhead%26aufirst%3DS.%2BJ.%26aulast%3DBerdini%26aufirst%3DV.%26aulast%3DDavies%26aufirst%3DT.%2BG.%26aulast%3DVerdonk%26aufirst%3DM.%2BL.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DBoyle%26aufirst%3DR.%2BG.%26aulast%3DBarford%26aufirst%3DD.%26aulast%3DDownham%26aufirst%3DR.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DCarr%26aufirst%3DR.%2BA.%26atitle%3DIdentification%2520of%2520inhibitors%2520of%2520protein%2520kinase%2520B%2520using%2520fragment-based%2520lead%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2293%26epage%3D2296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ledeboer, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuccola, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shlyakter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogan, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennani, Y. L.</span><span> </span><span class="NLM_article-title">A novel chemotype of kinase inhibitors: discovery of 3,4-ring fused 7-azaindoles and deazapurines as potent JAK2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=153-156&author=T.+Wangauthor=M.+W.+Ledeboerauthor=J.+P.+Duffyauthor=A.+C.+Pierceauthor=H.+J.+Zuccolaauthor=E.+Blockauthor=D.+Shlyakterauthor=J.+K.+Hoganauthor=Y.+L.+Bennani&title=A+novel+chemotype+of+kinase+inhibitors%3A+discovery+of+3%2C4-ring+fused+7-azaindoles+and+deazapurines+as+potent+JAK2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DLedeboer%26aufirst%3DM.%2BW.%26aulast%3DDuffy%26aufirst%3DJ.%2BP.%26aulast%3DPierce%26aufirst%3DA.%2BC.%26aulast%3DZuccola%26aufirst%3DH.%2BJ.%26aulast%3DBlock%26aufirst%3DE.%26aulast%3DShlyakter%26aufirst%3DD.%26aulast%3DHogan%26aufirst%3DJ.%2BK.%26aulast%3DBennani%26aufirst%3DY.%2BL.%26atitle%3DA%2520novel%2520chemotype%2520of%2520kinase%2520inhibitors%253A%2520discovery%2520of%25203%252C4-ring%2520fused%25207-azaindoles%2520and%2520deazapurines%2520as%2520potent%2520JAK2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D153%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Bernstein, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koetzle, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brice, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennard, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimanouchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasumi, M.</span><span> </span><span class="NLM_article-title">The Protein Data Bank</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1111%2Fj.1432-1033.1977.tb11885.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=923582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADyaE1cXhslKkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1977&pages=319-324&author=F.+C.+Bernsteinauthor=T.+F.+Koetzleauthor=G.+J.+B.+Williamsauthor=E.+F.+Meyerauthor=M.+D.+Briceauthor=J.+R.+Rodgersauthor=O.+Kennardauthor=T.+Shimanouchiauthor=M.+Tasumi&title=The+Protein+Data+Bank"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Data Bank.  A computer-based archival file for macromolecular structures</span></div><div class="casAuthors">Bernstein, Frances C.; Koetzle, Thomas F.; Williams, Graheme J. B.; Meyer, Edgar F., Jr.; Brice, Michael D.; Rodgers, John R.; Kennard, Olga; Shimanouchi, Takehiko; Tasumi, Mitsuo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">319-24</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">The Protein Data Bank is a computer-based archival file for macromol. structures.  The Bank stores in a uniform format at. coordinates and partial bond connectivities, as derived from crystallog. studies.  Text included in each data entry gives pertinent information for the structure at hand (e.g., species from which the mol. was obtained, resoln. of diffraction data, literature citations, and specifications of secondary structure).  In addn. to at. coordinates and connectivities, the Protein Data Bank stores structure factors and phases, although these latter data are not placed in any uniform format.  Input of data to the Bank and general maintenance functions are carried out at Brookhaven National Lab.  All data stored in the Bank are available on magnetic tape for public distribution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGromu-1LkSAkLVg90H21EOLACvtfcHk0lj3fI_2b9Vh5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXhslKkug%253D%253D&md5=2eceab71b303b040300e47107130321b</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1977.tb11885.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1977.tb11885.x%26sid%3Dliteratum%253Aachs%26aulast%3DBernstein%26aufirst%3DF.%2BC.%26aulast%3DKoetzle%26aufirst%3DT.%2BF.%26aulast%3DWilliams%26aufirst%3DG.%2BJ.%2BB.%26aulast%3DMeyer%26aufirst%3DE.%2BF.%26aulast%3DBrice%26aufirst%3DM.%2BD.%26aulast%3DRodgers%26aufirst%3DJ.%2BR.%26aulast%3DKennard%26aufirst%3DO.%26aulast%3DShimanouchi%26aufirst%3DT.%26aulast%3DTasumi%26aufirst%3DM.%26atitle%3DThe%2520Protein%2520Data%2520Bank%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1977%26volume%3D80%26spage%3D319%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Kellenberger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schalon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bret, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span> </span><span class="NLM_article-title">sc-PDB: an annotated database of druggable binding sites from the Protein Data Bank</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">727</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci050372x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFCgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2006&pages=717-727&author=E.+Kellenbergerauthor=P.+Mullerauthor=C.+Schalonauthor=G.+Bretauthor=N.+Foataauthor=D.+Rognan&title=sc-PDB%3A+an+annotated+database+of+druggable+binding+sites+from+the+Protein+Data+Bank"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">sc-PDB: An Annotated Database of Druggable Binding Sites from the Protein Data Bank</span></div><div class="casAuthors">Kellenberger, Esther; Muller, Pascal; Schalon, Claire; Bret, Guillaume; Foata, Nicolas; Rognan, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">717-727</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The s.c.-PDB is a collection of 6,415 three-dimensional structures of binding sites found in the Protein Data Bank (PDB).  Binding sites were extd. from all high-resoln. crystal structures in which a complex between a protein cavity and a small-mol.-wt. ligand could be identified.  Importantly, ligands are considered from a pharmacol. and not a structural point of view.  Therefore, solvents, detergents, and most metal ions are not stored in the s.c.-PDB.  Ligands are classified into four main categories: nucleotides (< 4-mer), peptides (< 9-mer), cofactors, and org. compds.  The corresponding binding site is formed by all protein residues (including amino acids, cofactors, and important metal ions) with at least one atom within 6.5 Å of any ligand atom.  The database was carefully annotated by browsing several protein databases (PDB, UniProt, and GO) and storing, for every s.c.-PDB entry, the following features: protein name, function, source, domain and mutations, ligand name, and structure.  The repository of ligands has also been archived by diversity anal. of mol. scaffolds, and several chemoinformatics descriptors were computed to better understand the chem. space covered by stored ligands.  The s.c.-PDB may be used for several purposes: (i) screening a collection of binding sites for predicting the most likely target(s) of any ligand, (ii) analyzing the mol. similarity between different cavities, and (iii) deriving rules that describe the relationship between ligand pharmacophoric points and active-site properties.  The database is periodically updated and accessible on the web at http://bioinfo-pharma.u-strasbg.fr/scPDB/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNlZ_WkpBUQrVg90H21EOLACvtfcHk0lgfF1Vhdd_tUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFCgtQ%253D%253D&md5=d035f998192ff55026c619b38f4b82ab</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fci050372x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci050372x%26sid%3Dliteratum%253Aachs%26aulast%3DKellenberger%26aufirst%3DE.%26aulast%3DMuller%26aufirst%3DP.%26aulast%3DSchalon%26aufirst%3DC.%26aulast%3DBret%26aufirst%3DG.%26aulast%3DFoata%26aufirst%3DN.%26aulast%3DRognan%26aufirst%3DD.%26atitle%3Dsc-PDB%253A%2520an%2520annotated%2520database%2520of%2520druggable%2520binding%2520sites%2520from%2520the%2520Protein%2520Data%2520Bank%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2006%26volume%3D46%26spage%3D717%26epage%3D727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Harris, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A. P.</span><span> </span><span class="NLM_article-title">Chemogenomics: structuring the drug discovery process to gene families</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">880</span><span class="NLM_x">–</span> <span class="NLM_lpage">888</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=880-888&author=C.+J.+Harrisauthor=A.+P.+Stevens&title=Chemogenomics%3A+structuring+the+drug+discovery+process+to+gene+families"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DC.%2BJ.%26aulast%3DStevens%26aufirst%3DA.%2BP.%26atitle%3DChemogenomics%253A%2520structuring%2520the%2520drug%2520discovery%2520process%2520to%2520gene%2520families%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2006%26volume%3D11%26spage%3D880%26epage%3D888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Weill, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span> </span><span class="NLM_article-title">Alignment-free ultra-high-throughput comparison of druggable protein-ligand binding sites</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">135</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci900349y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjt1yjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=123-135&author=N.+Weillauthor=D.+Rognan&title=Alignment-free+ultra-high-throughput+comparison+of+druggable+protein-ligand+binding+sites"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Alignment-Free Ultra-High-Throughput Comparison of Druggable Protein-Ligand Binding Sites</span></div><div class="casAuthors">Weill, Nathanael; Rognan, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">123-135</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inferring the biol. function of a protein from its three-dimensional structure as well as explaining why a drug may bind to various targets is of crucial importance to modern drug discovery.  Here we present a generic 4833-integer vector describing druggable protein-ligand binding sites that can be applied to any protein and any binding cavity.  The fingerprint registers counts of pharmacophoric triplets from the Cα at. coordinates of binding-site-lining residues.  Starting from a customized data set of diverse protein-ligand binding site pairs, the most appropriate metric and a similarity threshold could be defined for similar binding sites.  The method (FuzCav) has been used in various scenarios: (i) screening a collection of 6000 binding sites for similarity to different queries; (ii) classifying protein families (serine endopeptidases, protein kinases) by binding site diversity; (iii) discriminating adenine-binding cavities from decoys.  The fingerprint generation and comparison supports ultra-high throughput (ca. 1000 measures/s), does not require prior alignment of protein binding sites, and is able to detect local similarity among subpockets.  It is thus particularly well suited to the functional annotation of novel genomic structures with low sequence identity to known X-ray templates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7OYklk3JFxLVg90H21EOLACvtfcHk0lgfF1Vhdd_tUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjt1yjsg%253D%253D&md5=541a9800a3aa0891f179316412f1df24</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fci900349y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci900349y%26sid%3Dliteratum%253Aachs%26aulast%3DWeill%26aufirst%3DN.%26aulast%3DRognan%26aufirst%3DD.%26atitle%3DAlignment-free%2520ultra-high-throughput%2520comparison%2520of%2520druggable%2520protein-ligand%2520binding%2520sites%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D123%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Niijima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiraishi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuno, Y.</span><span> </span><span class="NLM_article-title">Dissecting kinase profiling data to predict activity and understand cross-reactivity of kinase inhibitors</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">901</span><span class="NLM_x">–</span> <span class="NLM_lpage">912</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci200607f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Clsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=901-912&author=S.+Niijimaauthor=A.+Shiraishiauthor=Y.+Okuno&title=Dissecting+kinase+profiling+data+to+predict+activity+and+understand+cross-reactivity+of+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Dissecting Kinase Profiling Data to Predict Activity and Understand Cross-Reactivity of Kinase Inhibitors</span></div><div class="casAuthors">Niijima, Satoshi; Shiraishi, Akira; Okuno, Yasushi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">901-912</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of selective and multitargeted kinase inhibitors has received much attention, because cross-reactivity with unintended targets may cause toxic side effects, while it can also give rise to efficacious multitargeted drugs.  Here we describe a deconvolution approach to dissecting kinase profiling data in order to gain knowledge about cross-reactivity of inhibitors from large-scale profiling data.  This approach not only enables activity predictions of given compds. on a kinome-wide scale, but also allows to ext. residue-fragment pairs that are assocd. with activity.  We demonstrate its effectiveness using a large-scale public chemogenomics data set and also apply our proposed model to a recently published bioactivity data set.  We further illustrate that the preference of given compds. for kinases of interest is better understood by residue-fragment pairs, which could provide both biol. and chem. insights into cross-reactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNgeRgAJen8LVg90H21EOLACvtfcHk0lgfF1Vhdd_tUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Clsbo%253D&md5=5b3d8d0938f8109e21d17a3fb3c9da30</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fci200607f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci200607f%26sid%3Dliteratum%253Aachs%26aulast%3DNiijima%26aufirst%3DS.%26aulast%3DShiraishi%26aufirst%3DA.%26aulast%3DOkuno%26aufirst%3DY.%26atitle%3DDissecting%2520kinase%2520profiling%2520data%2520to%2520predict%2520activity%2520and%2520understand%2520cross-reactivity%2520of%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D901%26epage%3D912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Insights for the development of specific kinase inhibitors by targeted structural genomics</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=365-72&author=O.+Fedorovauthor=M.+Sundstromauthor=B.+Marsdenauthor=S.+Knapp&title=Insights+for+the+development+of+specific+kinase+inhibitors+by+targeted+structural+genomics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DSundstrom%26aufirst%3DM.%26aulast%3DMarsden%26aufirst%3DB.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DInsights%2520for%2520the%2520development%2520of%2520specific%2520kinase%2520inhibitors%2520by%2520targeted%2520structural%2520genomics%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D365%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Patel, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doerksen, R. J.</span><span> </span><span class="NLM_article-title">Protein kinase-inhibitor database: structural variability of and inhibitor interactions with the protein kinase P-loop</span> <span class="citation_source-journal">J. Proteome Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">4433</span><span class="NLM_x">–</span> <span class="NLM_lpage">4442</span></span><div class="citationLinks">[<a href="/doi/10.1021/pr100662s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXps1WhsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=4433-4442&author=R.+Y.+Patelauthor=R.+J.+Doerksen&title=Protein+kinase-inhibitor+database%3A+structural+variability+of+and+inhibitor+interactions+with+the+protein+kinase+P-loop"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Protein Kinase-Inhibitor Database: Structural Variability of and Inhibitor Interactions with the Protein Kinase P-Loop</span></div><div class="casAuthors">Patel, Ronak Y.; Doerksen, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteome Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4433-4442</span>CODEN:
                <span class="NLM_cas:coden">JPROBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-3893</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-based drug design of protein-kinase inhibitors has been facilitated by availability of an enormous no. of structures in the Protein Databank (PDB), systematic analyses of which can provide insight into the factors that govern ligand-protein kinase interactions and into the conformational variability of the protein kinases.  A nonredundant database contg. 755 unique, curated, and annotated PDB protein kinase-inhibitor complexes (each consisting of a single protein kinase chain, a ligand, and water mols. around the ligand) was created.  With this dataset, analyses were performed of protein conformational variability and interactions of ligands with 11 P-loop residues.  Anal. of ligand-protein interactions included ligand atom preference, ligand-protein hydrogen bonds, and the no. and position of crystallog. water mols. around important P-loop residues.  Anal. of variability in the conformation of the P-loop considered backbone and side-chain dihedral angles, and solvent accessible surface area (SASA).  A distorted conformation of the P-loop was obsd. for some of the protein kinase structures.  Lower SASA was obsd. for the hydrophobic residue in β1 of several members of the AGC family of protein kinases.  The authors' systematic studies were performed amino acid-by-amino acid, which is unusual for analyses of protein kinase-inhibitor complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6z-PG0UgDDbVg90H21EOLACvtfcHk0liGR26JwxKrsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXps1WhsL8%253D&md5=28fc939adbc1d1791a09e63a4c582053</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fpr100662s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fpr100662s%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DR.%2BY.%26aulast%3DDoerksen%26aufirst%3DR.%2BJ.%26atitle%3DProtein%2520kinase-inhibitor%2520database%253A%2520structural%2520variability%2520of%2520and%2520inhibitor%2520interactions%2520with%2520the%2520protein%2520kinase%2520P-loop%26jtitle%3DJ.%2520Proteome%2520Res.%26date%3D2010%26volume%3D9%26spage%3D4433%26epage%3D4442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Zuccotto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casale, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angiolini, M.</span><span> </span><span class="NLM_article-title">Through the “gatekeeper door”: exploiting the active kinase conformation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2681</span><span class="NLM_x">–</span> <span class="NLM_lpage">2694</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=2681-2694&author=F.+Zuccottoauthor=E.+Ardiniauthor=E.+Casaleauthor=M.+Angiolini&title=Through+the+%E2%80%9Cgatekeeper+door%E2%80%9D%3A+exploiting+the+active+kinase+conformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZuccotto%26aufirst%3DF.%26aulast%3DArdini%26aufirst%3DE.%26aulast%3DCasale%26aufirst%3DE.%26aulast%3DAngiolini%26aufirst%3DM.%26atitle%3DThrough%2520the%2520%25E2%2580%259Cgatekeeper%2520door%25E2%2580%259D%253A%2520exploiting%2520the%2520active%2520kinase%2520conformation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D53%26spage%3D2681%26epage%3D2694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Deng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuaqui, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, J.</span><span> </span><span class="NLM_article-title">Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030331x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps1yrsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=337-344&author=Z.+Dengauthor=C.+Chuaquiauthor=J.+Singh&title=Structural+interaction+fingerprint+%28SIFt%29%3A+a+novel+method+for+analyzing+three-dimensional+protein-ligand+binding+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Interaction Fingerprint (SIFt): A Novel Method for Analyzing Three-Dimensional Protein-Ligand Binding Interactions</span></div><div class="casAuthors">Deng, Zhan; Chuaqui, Claudio; Singh, Juswinder</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">337-344</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Representing and understanding the three-dimensional (3D) structural information of protein-ligand complexes is a crit. step in the rational drug discovery process.  Traditional anal. methods are proving inadequate and inefficient in dealing with the massive amt. of structural information being generated from x-ray crystallog., NMR, and in silico approaches such as structure-based docking expts.  Here, we present SIFt (structural interaction fingerprint), a novel method for representing and analyzing 3D protein-ligand binding interactions.  Key to this approach is the generation of an interaction fingerprint that translates 3D structural binding information from a protein-ligand complex into a one-dimensional binary string.  Each fingerprint represents the "structural interaction profile" of the complex that can be used to organize, analyze, and visualize the rich amt. of information encoded in ligand-receptor complexes and also to assist database mining.  We have applied SIFt to tackle three common tasks in structure-based drug design.  The first involved the anal. and organization of a typical set of results generated from a docking study.  Using SIFt, docking poses with similar binding modes were identified, clustered, and subsequently compared with conventional scoring function information.  A second application of SIFt was to analyze ∼90 known x-ray crystal structures of protein kinase-inhibitor complexes obtained from the Protein Databank.  Using SIFt, we were able to organize the structures and reveal striking similarities and diversity between their small mol. binding interactions.  Finally, we have shown how SIFt can be used as an effective mol. filter during the virtual chem. library screening process to select mols. with desirable binding mode(s) and/or desirable interaction patterns with the protein target.  In summary, SIFt shows promise to fully leverage the wealth of information being generated in rational drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkjji1ni0HHbVg90H21EOLACvtfcHk0liGR26JwxKrsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps1yrsrs%253D&md5=a652b70184155c107202cbe3bc74596a</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm030331x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030331x%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DZ.%26aulast%3DChuaqui%26aufirst%3DC.%26aulast%3DSingh%26aufirst%3DJ.%26atitle%3DStructural%2520interaction%2520fingerprint%2520%2528SIFt%2529%253A%2520a%2520novel%2520method%2520for%2520analyzing%2520three-dimensional%2520protein-ligand%2520binding%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D337%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Kinnings, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, R. M.</span><span> </span><span class="NLM_article-title">Binding site similarity analysis for the functional classification of the protein kinase family</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">318</span><span class="NLM_x">–</span> <span class="NLM_lpage">329</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci800289y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltF2qsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=318-329&author=S.+L.+Kinningsauthor=R.+M.+Jackson&title=Binding+site+similarity+analysis+for+the+functional+classification+of+the+protein+kinase+family"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Binding Site Similarity Analysis for the Functional Classification of the Protein Kinase Family</span></div><div class="casAuthors">Kinnings, Sarah L.; Jackson, Richard M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">318-329</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Methods for analyzing complete gene families are becoming of increasing importance to the drug discovery process, because similarities and differences within a family are often the key to understanding functional differences that can be exploited in drug design.  We undertake a large-scale structural comparison of protein kinase ATP-binding sites using a geometric hashing method.  Subsequently, we propose a relevant classification of the protein kinase family based on the structural similarity of its binding sites.  Our classification is not only able to reveal the great diversity of different protein kinases and therefore their different potential for inhibitor selectivity, but it is also able to distinguish subtle differences within binding site conformation reflecting the protein activation state.  Furthermore, using exptl. inhibition profiling, we demonstrate that our classification can be used to identify protein kinase binding sites that are known exptl. to bind the same drug, demonstrating that it has potential as an inverse (protein) virtual screening tool, by identifying which other sites have the potential to bind a given drug.  In this way the cross-reactivities of the anticancer drugs Tarceva and Gleevec are rationalized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6kpf80r8s5LVg90H21EOLACvtfcHk0liGR26JwxKrsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltF2qsg%253D%253D&md5=742343601ca1e3c0549fa4f383c2566b</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fci800289y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci800289y%26sid%3Dliteratum%253Aachs%26aulast%3DKinnings%26aufirst%3DS.%2BL.%26aulast%3DJackson%26aufirst%3DR.%2BM.%26atitle%3DBinding%2520site%2520similarity%2520analysis%2520for%2520the%2520functional%2520classification%2520of%2520the%2520protein%2520kinase%2520family%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2009%26volume%3D49%26spage%3D318%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Vidović, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muskal, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schurer, S. C.</span><span> </span><span class="NLM_article-title">Novel kinase inhibitors by reshuffling ligand functionalities across the human kinome</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3107</span><span class="NLM_x">–</span> <span class="NLM_lpage">3115</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci3003842" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Wjt7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=3107-3115&author=D.+Vidovi%C4%87author=S.+M.+Muskalauthor=S.+C.+Schurer&title=Novel+kinase+inhibitors+by+reshuffling+ligand+functionalities+across+the+human+kinome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Kinase Inhibitors by Reshuffling Ligand Functionalities Across the Human Kinome</span></div><div class="casAuthors">Vidovic, Dusica; Muskal, Steven M.; Schurer, Stephan C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3107-3115</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein kinases remain among the most versatile and prospective therapeutic drug targets with currently 15 distinct compds. approved for use in humans and numerous clin. development programs.  The vast majority of kinase inhibitors bind at the ATP site.  Here we present an integrated work-flow to amplify the rapidly increasing space of structurally resolved small mol. kinase ligands to generate novel inhibitors.  Our approach considers both receptor-based similarity constraints in co-complexes and ligand-based filtering/refinement methods to generate novel, drug-like matter.  After building a comprehensive database of the structural kinome and identifying ATP-competitive ligands, we leverage local site similarities and site alignments to shuffle ligand fragments across the kinome.  After extensive curation and standardization, our automated protocol starting from 936 cocrystal ATP-competitive binding sites generated about 150 000 new ligand structures among them over 26 000 lead-/drug-like compds.; the majority of those are novel based on structural similarity and scaffolds.  In a retrospective anal. we demonstrate that our protocol produced known potent kinase inhibitors and we show how docking can be applied to prioritize the most likely efficacious compds.  Our workflow emulates a common strategy in medicinal chem. to identify and swap corresponding moieties from known inhibitors to generate novel and potent leads.  Here, we systematize and automate this approach leveraging available knowledge covering the entire human Kinome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2rUakSgslBLVg90H21EOLACvtfcHk0lhcsc42t96PMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Wjt7nP&md5=b3339f93e20d0aa07d57519454fd3baf</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fci3003842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci3003842%26sid%3Dliteratum%253Aachs%26aulast%3DVidovi%25C4%2587%26aufirst%3DD.%26aulast%3DMuskal%26aufirst%3DS.%2BM.%26aulast%3DSchurer%26aufirst%3DS.%2BC.%26atitle%3DNovel%2520kinase%2520inhibitors%2520by%2520reshuffling%2520ligand%2520functionalities%2520across%2520the%2520human%2520kinome%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D3107%26epage%3D3115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Buzko, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">A kinase sequence database: sequence alignments and family assignment</span> <span class="citation_source-journal">Bioinformatics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1274</span><span class="NLM_x">–</span> <span class="NLM_lpage">1275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2002&pages=1274-1275&author=O.+Buzkoauthor=K.+M.+Shokat&title=A+kinase+sequence+database%3A+sequence+alignments+and+family+assignment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuzko%26aufirst%3DO.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DA%2520kinase%2520sequence%2520database%253A%2520sequence%2520alignments%2520and%2520family%2520assignment%26jtitle%3DBioinformatics%26date%3D2002%26volume%3D18%26spage%3D1274%26epage%3D1275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Niedner, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzko, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haste, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribskov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span> </span><span class="NLM_article-title">Protein kinase resource: an integrated environment for phosphorylation research</span> <span class="citation_source-journal">Proteins: Struct., Funct., Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2006&pages=78-86&author=R.+H.+Niednerauthor=O.+V.+Buzkoauthor=N.+M.+Hasteauthor=A.+Taylorauthor=M.+Gribskovauthor=S.+S.+Taylor&title=Protein+kinase+resource%3A+an+integrated+environment+for+phosphorylation+research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNiedner%26aufirst%3DR.%2BH.%26aulast%3DBuzko%26aufirst%3DO.%2BV.%26aulast%3DHaste%26aufirst%3DN.%2BM.%26aulast%3DTaylor%26aufirst%3DA.%26aulast%3DGribskov%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26atitle%3DProtein%2520kinase%2520resource%253A%2520an%2520integrated%2520environment%2520for%2520phosphorylation%2520research%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Bioinf.%26date%3D2006%26volume%3D63%26spage%3D78%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span>Kinase.com: Genomics, Evolution and Function of Protein Kinases. <a href="http://www.kinase.com" class="extLink">http://www.kinase.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kinase.com%3A+Genomics%2C+Evolution+and+Function+of+Protein+Kinases.+http%3A%2F%2Fwww.kinase.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span>Kinase SARfari. <a href="http://www.ebi.ac.uk/chembl/sarfari/kinasesarfari" class="extLink">http://www.ebi.ac.uk/chembl/sarfari/kinasesarfari</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kinase+SARfari.+http%3A%2F%2Fwww.ebi.ac.uk%2Fchembl%2Fsarfari%2Fkinasesarfari."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Y.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobilio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span> </span><span class="NLM_article-title">An enriched structural kinase database to enable kinome-wide structure-based analyses and drug discovery</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">763</span><span class="NLM_x">–</span> <span class="NLM_lpage">774</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1002%2Fpro.355" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=20135687" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktFyrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=763-774&author=N.+Brooijmansauthor=Y.-W.+Changauthor=D.+Mobilioauthor=R.+A.+Dennyauthor=C.+Humblet&title=An+enriched+structural+kinase+database+to+enable+kinome-wide+structure-based+analyses+and+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">An enriched structural kinase database to enable kinome-wide structure-based analyses and drug discovery</span></div><div class="casAuthors">Brooijmans, Natasja; Chang, Yu-Wei; Mobilio, Dominick; Denny, Rajiah A.; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">763-774</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The development of a kinase structural database, the kinase knowledge base (KKB), is described.  It covers all human kinase domain structures that have been deposited in the Protein Data Bank.  All structures are renumbered using a common scheme, which enables efficient cross-comparisons and multiple queries of interest to the kinase field.  The common numbering scheme is also used to automatically annotate conserved residues and motifs, and conformationally classify the structures based on the DFG-loop and Helix C. Analyses of residue conservation in the ATP binding site using the full human-kinome-sequence alignment lead to the identification of a conserved hydrogen bond between the hinge region backbone and a glycine in the specificity surface.  Furthermore, 90% of kinases are found to have at least one stabilizing interaction for the hinge region, which has not been described before.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxGHmLofxIH7Vg90H21EOLACvtfcHk0lhcsc42t96PMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktFyrtb8%253D&md5=d6b66fb4114b942060e6dba7d1da9c96</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fpro.355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.355%26sid%3Dliteratum%253Aachs%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DChang%26aufirst%3DY.-W.%26aulast%3DMobilio%26aufirst%3DD.%26aulast%3DDenny%26aufirst%3DR.%2BA.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DAn%2520enriched%2520structural%2520kinase%2520database%2520to%2520enable%2520kinome-wide%2520structure-based%2520analyses%2520and%2520drug%2520discovery%26jtitle%3DProtein%2520Sci.%26date%3D2010%26volume%3D19%26spage%3D763%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Koike, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagi, T.</span><span> </span><span class="NLM_article-title">Kinase pathway database: an integrated protein-kinase and NLP-based protein-interaction resource</span> <span class="citation_source-journal">Genome Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1231</span><span class="NLM_x">–</span> <span class="NLM_lpage">1243</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1101%2Fgr.835903" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=12799355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksFegs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1231-1243&author=A.+Koikeauthor=Y.+Kobayashiauthor=T.+Takagi&title=Kinase+pathway+database%3A+an+integrated+protein-kinase+and+NLP-based+protein-interaction+resource"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase pathway database: An integrated protein-kinase and NLP-based protein-interaction resource</span></div><div class="casAuthors">Koike, Asako; Kobayashi, Yoshiyuki; Takagi, Toshihisa</div><div class="citationInfo"><span class="NLM_cas:title">Genome Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6a</span>),
    <span class="NLM_cas:pages">1231-1243</span>CODEN:
                <span class="NLM_cas:coden">GEREFS</span>;
        ISSN:<span class="NLM_cas:issn">1088-9051</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Protein kinases play a crucial role in the regulation of cellular functions.  Various kinds of information about these mols. are important for understanding signaling pathways and organism characteristics.  We have developed the Kinase Pathway Database, an integrated database involving major completely sequenced eukaryotes.  It contains the classification of protein kinases and their functional conservation, ortholog tables among species, protein-protein, protein-gene, and protein-compd. interaction data, domain information, and structural information.  It also provides an automatic pathway graphic image interface.  The protein, gene, and compd. interactions are automatically extd. from abstrs. for all genes and proteins by natural-language processing (NLP).  The method of automatic extn. uses phrase patterns and the GENA protein, gene, and compd. name dictionary, which was developed by our group.  With this database, pathways are easily compared among species using data with more than 47,000 protein interactions and protein kinase ortholog tables.  The database is available for querying and browsing at http://kinasedb.ontol.ims.u-tokyo.ac.jp/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6TI4Fd6KGy7Vg90H21EOLACvtfcHk0lhcsc42t96PMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksFegs74%253D&md5=823277b26108ce1d36ce808a0aa2b8cc</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1101%2Fgr.835903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgr.835903%26sid%3Dliteratum%253Aachs%26aulast%3DKoike%26aufirst%3DA.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DTakagi%26aufirst%3DT.%26atitle%3DKinase%2520pathway%2520database%253A%2520an%2520integrated%2520protein-kinase%2520and%2520NLP-based%2520protein-interaction%2520resource%26jtitle%3DGenome%2520Res.%26date%3D2003%26volume%3D13%26spage%3D1231%26epage%3D1243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span>Phospho.ELM: A Database of S/T/Y Phosphorylation Sites. <a href="http://phospho.elm.eu.org/" class="extLink">http://phospho.elm.eu.org/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Phospho.ELM%3A+A+Database+of+S%2FT%2FY+Phosphorylation+Sites.+http%3A%2F%2Fphospho.elm.eu.org%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Dinkel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chica, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Via, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diella, F.</span><span> </span><span class="NLM_article-title">Phospho.ELM: a database of phosphorylation sites—update 2011</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">D261</span><span class="NLM_x">–</span> <span class="NLM_lpage">D267</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=D261-D267&author=H.+Dinkelauthor=C.+Chicaauthor=A.+Viaauthor=C.+M.+Gouldauthor=L.+J.+Jensenauthor=T.+J.+Gibsonauthor=F.+Diella&title=Phospho.ELM%3A+a+database+of+phosphorylation+sites%E2%80%94update+2011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDinkel%26aufirst%3DH.%26aulast%3DChica%26aufirst%3DC.%26aulast%3DVia%26aufirst%3DA.%26aulast%3DGould%26aufirst%3DC.%2BM.%26aulast%3DJensen%26aufirst%3DL.%2BJ.%26aulast%3DGibson%26aufirst%3DT.%2BJ.%26aulast%3DDiella%26aufirst%3DF.%26atitle%3DPhospho.ELM%253A%2520a%2520database%2520of%2520phosphorylation%2520sites%25E2%2580%2594update%25202011%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2011%26volume%3D39%26spage%3DD261%26epage%3DD267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Bellis, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akhtar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Lazikani, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bento, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaulton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hersey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruger, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Light, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGlinchey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauch, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overington, J. P.</span><span> </span><span class="NLM_article-title">Collation and data-mining of literature bioactivity data for drug discovery</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1365</span><span class="NLM_x">–</span> <span class="NLM_lpage">1370</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1042%2FBST0391365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=21936816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1ajs73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=1365-1370&author=L.+J.+Bellisauthor=R.+Akhtarauthor=B.+Al-Lazikaniauthor=F.+Atkinsonauthor=A.+P.+Bentoauthor=J.+Chambersauthor=M.+Daviesauthor=A.+Gaultonauthor=A.+Herseyauthor=K.+Ikedaauthor=F.+A.+Krugerauthor=Y.+Lightauthor=S.+McGlincheyauthor=R.+Santosauthor=B.+Stauchauthor=J.+P.+Overington&title=Collation+and+data-mining+of+literature+bioactivity+data+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Collation and data-mining of literature bioactivity data for drug discovery</span></div><div class="casAuthors">Bellis, Louisa J.; Akhtar, Ruth; Al-Lazikani, Bissan; Atkinson, Francis; Bento, A. Patricia; Chambers, Jon; Davies, Mark; Gaulton, Anna; Hersey, Anne; Ikeda, Kazuyoshi; Krueger, Felix A.; Light, Yvonne; McGlinchey, Shaun; Santos, Rita; Stauch, Benjamin; Overington, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1365-1370</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The challenge of translating the huge amt. of genomic and biochem. data into new drugs is a costly and challenging task.  Historically, there has been comparatively little focus on linking the biochem. and chem. worlds.  To address this need, we have developed ChEMBL, an online resource of small-mol. SAR (structure-activity relationship) data, which can be used to support chem. biol., lead discovery and target selection in drug discovery.  The database contains the abstracted structures, properties and biol. activities for over 700000 distinct compds. and in excess of more than 3 million bioactivity records abstracted from over 40000 publications.  Addnl. public domain resources can be readily integrated into the same data model (e.g. PubChem BioAssay data).  The compds. in ChEMBL are largely extd. from the primary medicinal chem. literature, and are therefore usually  drug-like' or  lead-like' small mols. with full exptl. context.  The data cover a significant fraction of the discovery of modern drugs, and are useful in a wide range of drug design and discovery tasks.  In addn. to the compd. data, ChEMBL also contains information for over 8000 protein, cell line and whole-organism  targets', with over 4000 of those being proteins linked to their underlying genes.  The database is searchable both chem., using an interactive compd. sketch tool, protein sequences, family hierarchies, SMILES strings, compd. research codes and key words, and biol., using a variety of gene identifiers, protein sequence similarity and protein families.  The information retrieved can then be readily filtered and downloaded into various formats.  ChEMBL can be accessed online at https://www.ebi.ac.uk/chembldb.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBU0D0lDPl9bVg90H21EOLACvtfcHk0ljLRAjSeAa5zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1ajs73L&md5=77c9e09de8274d03045dae5312f4869d</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1042%2FBST0391365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0391365%26sid%3Dliteratum%253Aachs%26aulast%3DBellis%26aufirst%3DL.%2BJ.%26aulast%3DAkhtar%26aufirst%3DR.%26aulast%3DAl-Lazikani%26aufirst%3DB.%26aulast%3DAtkinson%26aufirst%3DF.%26aulast%3DBento%26aufirst%3DA.%2BP.%26aulast%3DChambers%26aufirst%3DJ.%26aulast%3DDavies%26aufirst%3DM.%26aulast%3DGaulton%26aufirst%3DA.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DIkeda%26aufirst%3DK.%26aulast%3DKruger%26aufirst%3DF.%2BA.%26aulast%3DLight%26aufirst%3DY.%26aulast%3DMcGlinchey%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DR.%26aulast%3DStauch%26aufirst%3DB.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26atitle%3DCollation%2520and%2520data-mining%2520of%2520literature%2520bioactivity%2520data%2520for%2520drug%2520discovery%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2011%26volume%3D39%26spage%3D1365%26epage%3D1370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Meslamani, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellenberger, E.</span><span> </span><span class="NLM_article-title">sc-PDB: a database for identifying variations and multiplicity of “druggable” binding sites in proteins</span> <span class="citation_source-journal">Bioinformatics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1324</span><span class="NLM_x">–</span> <span class="NLM_lpage">1326</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2011&pages=1324-1326&author=J.+Meslamaniauthor=D.+Rognanauthor=E.+Kellenberger&title=sc-PDB%3A+a+database+for+identifying+variations+and+multiplicity+of+%E2%80%9Cdruggable%E2%80%9D+binding+sites+in+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeslamani%26aufirst%3DJ.%26aulast%3DRognan%26aufirst%3DD.%26aulast%3DKellenberger%26aufirst%3DE.%26atitle%3Dsc-PDB%253A%2520a%2520database%2520for%2520identifying%2520variations%2520and%2520multiplicity%2520of%2520%25E2%2580%259Cdruggable%25E2%2580%259D%2520binding%2520sites%2520in%2520proteins%26jtitle%3DBioinformatics%26date%3D2011%26volume%3D27%26spage%3D1324%26epage%3D1326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Marcou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span> </span><span class="NLM_article-title">Optimizing fragment and scaffold docking by use of molecular interaction fingerprints</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci600342e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12iurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=195-207&author=G.+Marcouauthor=D.+Rognan&title=Optimizing+fragment+and+scaffold+docking+by+use+of+molecular+interaction+fingerprints"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Optimizing Fragment and Scaffold Docking by Use of Molecular Interaction Fingerprints</span></div><div class="casAuthors">Marcou, Gilles; Rognan, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">195-207</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein-ligand interaction fingerprints have been used to postprocess docking poses of three ligand data sets: a set of 40 low-mol.-wt. compds. from the Protein Data Bank, a collection of 40 scaffolds from pharmaceutically relevant protein ligands, and a database of 19 scaffolds extd. from true cdk2 inhibitors seeded in 2230 scaffold decoys.  Four popular docking tools (FlexX, Glide, Gold, and Surflex) were used to generate poses for ligands of the three data sets.  In all cases, scoring by the similarity of interaction fingerprints to a given ref. was statistically superior to conventional scoring functions in posing low-mol.-wt. fragments, predicting protein-bound scaffold coordinates according to the known binding mode of related ligands, and screening a scaffold library to enrich a hit list in true cdk2-targeted scaffolds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHLbVKxK-BfLVg90H21EOLACvtfcHk0ljLRAjSeAa5zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12iurzL&md5=0c9137a39d40fbcc83546aec17b595ba</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fci600342e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci600342e%26sid%3Dliteratum%253Aachs%26aulast%3DMarcou%26aufirst%3DG.%26aulast%3DRognan%26aufirst%3DD.%26atitle%3DOptimizing%2520fragment%2520and%2520scaffold%2520docking%2520by%2520use%2520of%2520molecular%2520interaction%2520fingerprints%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2007%26volume%3D47%26spage%3D195%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">de Graaf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kooistra, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vischer, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuijer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiroishi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Esch, I. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurs, R.</span><span> </span><span class="NLM_article-title">Crystal structure-based virtual screening for fragment-like ligands of the human histamine H1 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8195</span><span class="NLM_x">–</span> <span class="NLM_lpage">8206</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2011589" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8195-8206&author=C.+de+Graafauthor=A.+J.+Kooistraauthor=H.+F.+Vischerauthor=V.+Katritchauthor=M.+Kuijerauthor=M.+Shiroishiauthor=S.+Iwataauthor=T.+Shimamuraauthor=R.+C.+Stevensauthor=I.+J.+P.+de+Eschauthor=R.+Leurs&title=Crystal+structure-based+virtual+screening+for+fragment-like+ligands+of+the+human+histamine+H1+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm2011589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2011589%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BGraaf%26aufirst%3DC.%26aulast%3DKooistra%26aufirst%3DA.%2BJ.%26aulast%3DVischer%26aufirst%3DH.%2BF.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DKuijer%26aufirst%3DM.%26aulast%3DShiroishi%26aufirst%3DM.%26aulast%3DIwata%26aufirst%3DS.%26aulast%3DShimamura%26aufirst%3DT.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DLeurs%26aufirst%3DR.%26atitle%3DCrystal%2520structure-based%2520virtual%2520screening%2520for%2520fragment-like%2520ligands%2520of%2520the%2520human%2520histamine%2520H1%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8195%26epage%3D8206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Ohren, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavlovsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitehead, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuffa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConnell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spessard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banotai, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebolt-Leopold, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudley, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flamme, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warmus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tecle, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasemann, C. A.</span><span> </span><span class="NLM_article-title">Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1192</span><span class="NLM_x">–</span> <span class="NLM_lpage">1197</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1038%2Fnsmb859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=15543157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVens7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=1192-1197&author=J.+F.+Ohrenauthor=H.+Chenauthor=A.+Pavlovskyauthor=C.+Whiteheadauthor=E.+Zhangauthor=P.+Kuffaauthor=C.+Yanauthor=P.+McConnellauthor=C.+Spessardauthor=C.+Banotaiauthor=W.+T.+Muellerauthor=A.+Delaneyauthor=C.+Omerauthor=J.+Sebolt-Leopoldauthor=D.+T.+Dudleyauthor=I.+K.+Leungauthor=C.+Flammeauthor=J.+Warmusauthor=M.+Kaufmanauthor=S.+Barrettauthor=H.+Tecleauthor=C.+A.+Hasemann&title=Structures+of+human+MAP+kinase+kinase+1+%28MEK1%29+and+MEK2+describe+novel+noncompetitive+kinase+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition</span></div><div class="casAuthors">Ohren, Jeffrey F.; Chen, Huifen; Pavlovsky, Alexander; Whitehead, Christopher; Zhang, Erli; Kuffa, Peter; Yan, Chunhong; McConnell, Patrick; Spessard, Cindy; Banotai, Craig; Mueller, W. Thomas; Delaney, Amy; Omer, Charles; Sebolt-Leopold, Judith; Dudley, David T.; Leung, Iris K.; Flamme, Cathlin; Warmus, Joseph; Kaufman, Michael; Barrett, Stephen; Tecle, Haile; Hasemann, Charles A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1192-1197</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">MEK1 and MEK2 kinases are closely related, dual-specificity tyrosine/threonine protein kinases found in the Ras/Raf/MEK/ERK MAP kinase (MAPK) signaling pathway.  Approx. 30% of all human cancers have a constitutively activated MAPK pathway, and constitutive activation of MEK1 results in cellular transformation.  Here, the authors present the x-ray crystal structures of human MEK1 and MEK2 kinases, each detd. as a ternary complex with MgATP and an inhibitor to a resoln. of 2.4 and 3.2 Å, resp.  The structures revealed that MEK1 and MEK2 each had a unique inhibitor-binding pocket adjacent to the MgATP-binding site.  The presence of the potent inhibitors induced several conformational changes in the unphosphorylated MEK1 and MEK2 kinases that locked them into a closed but catalytically inactive species.  Thus, the structures reported here reveal a novel, noncompetitive mechanism for protein kinase inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIY9begVVfW7Vg90H21EOLACvtfcHk0lj9tpdVQR22Jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVens7jM&md5=79ebbc2e3a9cdd3fbecb8bb35ea9dba3</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fnsmb859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb859%26sid%3Dliteratum%253Aachs%26aulast%3DOhren%26aufirst%3DJ.%2BF.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DPavlovsky%26aufirst%3DA.%26aulast%3DWhitehead%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DE.%26aulast%3DKuffa%26aufirst%3DP.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DMcConnell%26aufirst%3DP.%26aulast%3DSpessard%26aufirst%3DC.%26aulast%3DBanotai%26aufirst%3DC.%26aulast%3DMueller%26aufirst%3DW.%2BT.%26aulast%3DDelaney%26aufirst%3DA.%26aulast%3DOmer%26aufirst%3DC.%26aulast%3DSebolt-Leopold%26aufirst%3DJ.%26aulast%3DDudley%26aufirst%3DD.%2BT.%26aulast%3DLeung%26aufirst%3DI.%2BK.%26aulast%3DFlamme%26aufirst%3DC.%26aulast%3DWarmus%26aufirst%3DJ.%26aulast%3DKaufman%26aufirst%3DM.%26aulast%3DBarrett%26aufirst%3DS.%26aulast%3DTecle%26aufirst%3DH.%26aulast%3DHasemann%26aufirst%3DC.%2BA.%26atitle%3DStructures%2520of%2520human%2520MAP%2520kinase%2520kinase%25201%2520%2528MEK1%2529%2520and%2520MEK2%2520describe%2520novel%2520noncompetitive%2520kinase%2520inhibition%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D11%26spage%3D1192%26epage%3D1197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><a href="http://sequoia.ucsf.edu/ksd/" class="extLink">http://sequoia.ucsf.edu/ksd/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fsequoia.ucsf.edu%2Fksd%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><a href="http://kinase.com/human/kinome/" class="extLink">http://kinase.com/human/kinome/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fkinase.com%2Fhuman%2Fkinome%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><a href="http://biodbnet.abcc.ncifcrf.gov/" class="extLink">http://biodbnet.abcc.ncifcrf.gov/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fbiodbnet.abcc.ncifcrf.gov%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran-DubeÌ, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pairish, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botrous, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTigue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grodsky, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padrique, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timofeevski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span> </span><span class="NLM_article-title">Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6342</span><span class="NLM_x">–</span> <span class="NLM_lpage">6363</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2007613" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVegtLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6342-6363&author=J.+J.+Cuiauthor=M.+Tran-Dube%C3%8Cauthor=H.+Shenauthor=M.+Nambuauthor=P.-P.+Kungauthor=M.+Pairishauthor=L.+Jiaauthor=J.+Mengauthor=L.+Funkauthor=I.+Botrousauthor=M.+McTigueauthor=N.+Grodskyauthor=K.+Ryanauthor=E.+Padriqueauthor=G.+Altonauthor=S.+Timofeevskiauthor=S.+Yamazakiauthor=Q.+Liauthor=H.+Zouauthor=J.+Christensenauthor=B.+Mroczkowskiauthor=S.+Benderauthor=R.+S.+Kaniaauthor=M.+P.+Edwards&title=Structure+based+drug+design+of+crizotinib+%28PF-02341066%29%2C+a+potent+and+selective+dual+inhibitor+of+mesenchymal-epithelial+transition+factor+%28c-MET%29+kinase+and+anaplastic+lymphoma+kinase+%28ALK%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal-Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)</span></div><div class="casAuthors">Cui, J. Jean; Tran-Dube, Michelle; Shen, Hong; Nambu, Mitchell; Kung, Pei-Pei; Pairish, Mason; Jia, Lei; Meng, Jerry; Funk, Lee; Botrous, Iriny; McTigue, Michele; Grodsky, Neil; Ryan, Kevin; Padrique, Ellen; Alton, Gordon; Timofeevski, Sergei; Yamazaki, Shinji; Li, Qiuhua; Zou, Helen; Christensen, James; Mroczkowski, Barbara; Bender, Steve; Kania, Robert S.; Edwards, Martin P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6342-6363</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Because of the crit. roles of aberrant signaling in cancer, both c-MET and ALK receptor tyrosine kinases are attractive oncol. targets for therapeutic intervention.  The cocrystal structure of 3 (PHA-665752), bound to c-MET kinase domain, revealed a novel ATP site environment, which served as the target to guide parallel, multiattribute drug design.  A novel 2-amino-5-aryl-3-benzyloxypyridine series was created to more effectively make the key interactions achieved with 3.  In the novel series, the 2-aminopyridine core allowed a 3-benzyloxy group to reach into the same pocket as the 2,6-dichlorophenyl group of 3 via a more direct vector and thus with a better ligand efficiency (LE).  Further optimization of the lead series generated the clin. candidate crizotinib (PF-02341066), which demonstrated potent in vitro and in vivo c-MET kinase and ALK inhibition, effective tumor growth inhibition, and good pharmaceutical properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHs_cKJ-U3t7Vg90H21EOLACvtfcHk0lj9tpdVQR22Jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVegtLrN&md5=dbab4c1b3e7c76180dbad04be2b6a474</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjm2007613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2007613%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DTran-Dube%25C3%258C%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DNambu%26aufirst%3DM.%26aulast%3DKung%26aufirst%3DP.-P.%26aulast%3DPairish%26aufirst%3DM.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DMeng%26aufirst%3DJ.%26aulast%3DFunk%26aufirst%3DL.%26aulast%3DBotrous%26aufirst%3DI.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DGrodsky%26aufirst%3DN.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DPadrique%26aufirst%3DE.%26aulast%3DAlton%26aufirst%3DG.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DBender%26aufirst%3DS.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DStructure%2520based%2520drug%2520design%2520of%2520crizotinib%2520%2528PF-02341066%2529%252C%2520a%2520potent%2520and%2520selective%2520dual%2520inhibitor%2520of%2520mesenchymal-epithelial%2520transition%2520factor%2520%2528c-MET%2529%2520kinase%2520and%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6342%26epage%3D6363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newitt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittekind, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borzillerri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klei, H. E.</span><span> </span><span class="NLM_article-title">The structure of dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutants</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">5790</span><span class="NLM_x">–</span> <span class="NLM_lpage">5797</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=5790-5797&author=J.+S.+Tokarskiauthor=J.+A.+Newittauthor=C.+Y.+Changauthor=J.+D.+Chengauthor=M.+Wittekindauthor=S.+E.+Kieferauthor=K.+Kishauthor=F.+Y.+Leeauthor=R.+Borzillerriauthor=L.+J.+Lombardoauthor=D.+Xieauthor=Y.+Zhangauthor=H.+E.+Klei&title=The+structure+of+dasatinib+%28BMS-354825%29+bound+to+activated+ABL+kinase+domain+elucidates+its+inhibitory+activity+against+imatinib-resistant+ABL+mutants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DNewitt%26aufirst%3DJ.%2BA.%26aulast%3DChang%26aufirst%3DC.%2BY.%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26aulast%3DWittekind%26aufirst%3DM.%26aulast%3DKiefer%26aufirst%3DS.%2BE.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DF.%2BY.%26aulast%3DBorzillerri%26aufirst%3DR.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DXie%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKlei%26aufirst%3DH.%2BE.%26atitle%3DThe%2520structure%2520of%2520dasatinib%2520%2528BMS-354825%2529%2520bound%2520to%2520activated%2520ABL%2520kinase%2520domain%2520elucidates%2520its%2520inhibitory%2520activity%2520against%2520imatinib-resistant%2520ABL%2520mutants%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D5790%26epage%3D5797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Weisberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manley, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitenstein, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan-Jacob, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntly, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fendrich, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall-Meyers, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mestan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daley, G. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavazza, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, J. D.</span><span> </span><span class="NLM_article-title">Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2Fj.ccr.2005.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=15710326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitFygu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=129-141&author=E.+Weisbergauthor=P.+W.+Manleyauthor=W.+Breitensteinauthor=J.+Bruggenauthor=S.+W.+Cowan-Jacobauthor=A.+Rayauthor=B.+Huntlyauthor=D.+Fabbroauthor=G.+Fendrichauthor=E.+Hall-Meyersauthor=A.+L.+Kungauthor=J.+Mestanauthor=G.+Q.+Daleyauthor=L.+Callahanauthor=L.+Catleyauthor=C.+Cavazzaauthor=M.+Azamauthor=D.+Neubergauthor=R.+D.+Wrightauthor=D.+G.+Gillilandauthor=J.+D.+Griffin&title=Characterization+of+AMN107%2C+a+selective+inhibitor+of+native+and+mutant+Bcr-Abl"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl</span></div><div class="casAuthors">Weisberg, Ellen; Manley, Paul W.; Breitenstein, Werner; Brueggen, Josef; Cowan-Jacob, Sandra W.; Ray, Arghya; Huntly, Brian; Fabbro, Doriano; Fendrich, Gabriele; Hall-Meyers, Elizabeth; Kung, Andrew L.; Mestan, Juergen; Daley, George Q.; Callahan, Linda; Catley, Laurie; Cavazza, Cara; Mohammed, Azam; Neuberg, Donna; Wright, Renee D.; Gilliland, D. Gary; Griffin, James D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">129-141</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The Bcr-Abl tyrosine kinase oncogene causes chronic myelogenous leukemia (CML) and Philadelphia chromosome-pos. (Ph+) acute lymphoblastic leukemia (ALL).  We describe a novel selective inhibitor of Bcr-Abl, AMN107 (IC50 < 30 nM), which is significantly more potent than imatinib, and active against a no. of imatinib-resistant Bcr-Abl mutants.  Crystallog. anal. of Abl-AMN107 complexes provides a structural explanation for the differential activity of AMN107 and imatinib against imatinib-resistant Bcr-Abl.  Consistent with its in vitro and pharmacokinetic profile, AMN107 prolonged survival of mice injected with Bcr-Abl-transformed hematopoietic cell lines or primary marrow cells, and prolonged survival in imatinib-resistant CML mouse models.  AMN107 is a promising new inhibitor for the therapy of CML and Ph+ ALL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow6QF3qX2uO7Vg90H21EOLACvtfcHk0ljg9AyPiTgVUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitFygu7o%253D&md5=d28e1a54b982951f8d3e6ef1d2d3b2eb</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2005.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2005.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DWeisberg%26aufirst%3DE.%26aulast%3DManley%26aufirst%3DP.%2BW.%26aulast%3DBreitenstein%26aufirst%3DW.%26aulast%3DBruggen%26aufirst%3DJ.%26aulast%3DCowan-Jacob%26aufirst%3DS.%2BW.%26aulast%3DRay%26aufirst%3DA.%26aulast%3DHuntly%26aufirst%3DB.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DFendrich%26aufirst%3DG.%26aulast%3DHall-Meyers%26aufirst%3DE.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DMestan%26aufirst%3DJ.%26aulast%3DDaley%26aufirst%3DG.%2BQ.%26aulast%3DCallahan%26aufirst%3DL.%26aulast%3DCatley%26aufirst%3DL.%26aulast%3DCavazza%26aufirst%3DC.%26aulast%3DAzam%26aufirst%3DM.%26aulast%3DNeuberg%26aufirst%3DD.%26aulast%3DWright%26aufirst%3DR.%2BD.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26aulast%3DGriffin%26aufirst%3DJ.%2BD.%26atitle%3DCharacterization%2520of%2520AMN107%252C%2520a%2520selective%2520inhibitor%2520of%2520native%2520and%2520mutant%2520Bcr-Abl%26jtitle%3DCancer%2520Cell%26date%3D2005%26volume%3D7%26spage%3D129%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Wyatt, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodhead, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulstridge, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devine, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Early, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feltell, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Reilly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reule, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seavers, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Squires, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trewartha, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolford, A. J.</span><span> </span><span class="NLM_article-title">Identification of <i>N</i>-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1<i>H</i>-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4986</span><span class="NLM_x">–</span> <span class="NLM_lpage">4999</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800382h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4986-4999&author=P.+G.+Wyattauthor=A.+J.+Woodheadauthor=V.+Berdiniauthor=J.+A.+Boulstridgeauthor=M.+G.+Carrauthor=D.+M.+Crossauthor=D.+J.+Davisauthor=L.+A.+Devineauthor=T.+R.+Earlyauthor=R.+E.+Feltellauthor=E.+J.+Lewisauthor=R.+L.+McMenaminauthor=E.+F.+Navarroauthor=M.+A.+O%E2%80%99Brienauthor=M.+O%E2%80%99Reillyauthor=M.+Reuleauthor=G.+Saxtyauthor=L.+C.+Seaversauthor=D.+M.+Smithauthor=M.+S.+Squiresauthor=G.+Trewarthaauthor=M.+T.+Walkerauthor=A.+J.+Woolford&title=Identification+of+N-%284-piperidinyl%29-4-%282%2C6-dichlorobenzoylamino%29-1H-pyrazole-3-carboxamide+%28AT7519%29%2C+a+novel+cyclin+dependent+kinase+inhibitor+using+fragment-based+X-ray+crystallography+and+structure+based+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm800382h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800382h%26sid%3Dliteratum%253Aachs%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DWoodhead%26aufirst%3DA.%2BJ.%26aulast%3DBerdini%26aufirst%3DV.%26aulast%3DBoulstridge%26aufirst%3DJ.%2BA.%26aulast%3DCarr%26aufirst%3DM.%2BG.%26aulast%3DCross%26aufirst%3DD.%2BM.%26aulast%3DDavis%26aufirst%3DD.%2BJ.%26aulast%3DDevine%26aufirst%3DL.%2BA.%26aulast%3DEarly%26aufirst%3DT.%2BR.%26aulast%3DFeltell%26aufirst%3DR.%2BE.%26aulast%3DLewis%26aufirst%3DE.%2BJ.%26aulast%3DMcMenamin%26aufirst%3DR.%2BL.%26aulast%3DNavarro%26aufirst%3DE.%2BF.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DM.%2BA.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%26aulast%3DReule%26aufirst%3DM.%26aulast%3DSaxty%26aufirst%3DG.%26aulast%3DSeavers%26aufirst%3DL.%2BC.%26aulast%3DSmith%26aufirst%3DD.%2BM.%26aulast%3DSquires%26aufirst%3DM.%2BS.%26aulast%3DTrewartha%26aufirst%3DG.%26aulast%3DWalker%26aufirst%3DM.%2BT.%26aulast%3DWoolford%26aufirst%3DA.%2BJ.%26atitle%3DIdentification%2520of%2520N-%25284-piperidinyl%2529-4-%25282%252C6-dichlorobenzoylamino%2529-1H-pyrazole-3-carboxamide%2520%2528AT7519%2529%252C%2520a%2520novel%2520cyclin%2520dependent%2520kinase%2520inhibitor%2520using%2520fragment-based%2520X-ray%2520crystallography%2520and%2520structure%2520based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4986%26epage%3D4999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Arris, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvert, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endicott, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garman, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewsbury, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrie, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, W.</span><span> </span><span class="NLM_article-title">Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2797</span><span class="NLM_x">–</span> <span class="NLM_lpage">2804</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990628o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2797-2804&author=C.+E.+Arrisauthor=F.+T.+Boyleauthor=A.+H.+Calvertauthor=N.+J.+Curtinauthor=J.+A.+Endicottauthor=E.+F.+Garmanauthor=A.+E.+Gibsonauthor=B.+T.+Goldingauthor=S.+Grantauthor=R.+J.+Griffinauthor=P.+Jewsburyauthor=L.+N.+Johnsonauthor=A.+M.+Lawrieauthor=D.+R.+Newellauthor=M.+E.+Nobleauthor=E.+A.+Sausvilleauthor=R.+Schultzauthor=W.+Yu&title=Identification+of+novel+purine+and+pyrimidine+cyclin-dependent+kinase+inhibitors+with+distinct+molecular+interactions+and+tumor+cell+growth+inhibition+profiles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fjm990628o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990628o%26sid%3Dliteratum%253Aachs%26aulast%3DArris%26aufirst%3DC.%2BE.%26aulast%3DBoyle%26aufirst%3DF.%2BT.%26aulast%3DCalvert%26aufirst%3DA.%2BH.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DGarman%26aufirst%3DE.%2BF.%26aulast%3DGibson%26aufirst%3DA.%2BE.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26aulast%3DGrant%26aufirst%3DS.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DJewsbury%26aufirst%3DP.%26aulast%3DJohnson%26aufirst%3DL.%2BN.%26aulast%3DLawrie%26aufirst%3DA.%2BM.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DNoble%26aufirst%3DM.%2BE.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26aulast%3DSchultz%26aufirst%3DR.%26aulast%3DYu%26aufirst%3DW.%26atitle%3DIdentification%2520of%2520novel%2520purine%2520and%2520pyrimidine%2520cyclin-dependent%2520kinase%2520inhibitors%2520with%2520distinct%2520molecular%2520interactions%2520and%2520tumor%2520cell%2520growth%2520inhibition%2520profiles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2797%26epage%3D2804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Jorda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havlicek, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNae, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walkinshaw, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturc, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navratilova, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuzma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mistrik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strnad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krystof, V.</span><span> </span><span class="NLM_article-title">Pyrazolo[4,3-<i>d</i>]pyrimidine bioisostere of roscovitine: evaluation of a novel selective inhibitor of cyclin-dependent kinases with antiproliferative activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2980</span><span class="NLM_x">–</span> <span class="NLM_lpage">2993</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200064p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2980-2993&author=R.+Jordaauthor=L.+Havlicekauthor=I.+W.+McNaeauthor=M.+D.+Walkinshawauthor=J.+Vollerauthor=A.+Sturcauthor=J.+Navratilovaauthor=M.+Kuzmaauthor=M.+Mistrikauthor=J.+Bartekauthor=M.+Strnadauthor=V.+Krystof&title=Pyrazolo%5B4%2C3-d%5Dpyrimidine+bioisostere+of+roscovitine%3A+evaluation+of+a+novel+selective+inhibitor+of+cyclin-dependent+kinases+with+antiproliferative+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjm200064p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200064p%26sid%3Dliteratum%253Aachs%26aulast%3DJorda%26aufirst%3DR.%26aulast%3DHavlicek%26aufirst%3DL.%26aulast%3DMcNae%26aufirst%3DI.%2BW.%26aulast%3DWalkinshaw%26aufirst%3DM.%2BD.%26aulast%3DVoller%26aufirst%3DJ.%26aulast%3DSturc%26aufirst%3DA.%26aulast%3DNavratilova%26aufirst%3DJ.%26aulast%3DKuzma%26aufirst%3DM.%26aulast%3DMistrik%26aufirst%3DM.%26aulast%3DBartek%26aufirst%3DJ.%26aulast%3DStrnad%26aufirst%3DM.%26aulast%3DKrystof%26aufirst%3DV.%26atitle%3DPyrazolo%255B4%252C3-d%255Dpyrimidine%2520bioisostere%2520of%2520roscovitine%253A%2520evaluation%2520of%2520a%2520novel%2520selective%2520inhibitor%2520of%2520cyclin-dependent%2520kinases%2520with%2520antiproliferative%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2980%26epage%3D2993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Medina, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackledge, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duquenne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heerding, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romeril, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherzer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bobko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chadderton, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumble, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardiner, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudakin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campobasso, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axten, J. M.</span><span> </span><span class="NLM_article-title">Structure-based design of potent and selective 3-phosphoinositide-dependent kinase-1 (PDK1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1871</span><span class="NLM_x">–</span> <span class="NLM_lpage">1895</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101527u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVWksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1871-1895&author=J.+R.+Medinaauthor=C.+J.+Beckerauthor=C.+W.+Blackledgeauthor=C.+Duquenneauthor=Y.+Fengauthor=S.+W.+Grantauthor=D.+Heerdingauthor=W.+H.+Liauthor=W.+H.+Millerauthor=S.+P.+Romerilauthor=D.+Scherzerauthor=A.+Shuauthor=M.+A.+Bobkoauthor=A.+R.+Chaddertonauthor=M.+Dumbleauthor=C.+M.+Gardinerauthor=S.+Gilbertauthor=Q.+Liuauthor=S.+K.+Rabindranauthor=V.+Sudakinauthor=H.+Xiangauthor=P.+G.+Bradyauthor=N.+Campobassoauthor=P.+Wardauthor=J.+M.+Axten&title=Structure-based+design+of+potent+and+selective+3-phosphoinositide-dependent+kinase-1+%28PDK1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Potent and Selective 3-Phosphoinositide-Dependent Kinase-1 (PDK1) Inhibitors</span></div><div class="casAuthors">Medina, Jesus R.; Becker, Christopher J.; Blackledge, Charles W.; Duquenne, Celine; Feng, Yanhong; Grant, Seth W.; Heerding, Dirk; Li, William H.; Miller, William H.; Romeril, Stuart P.; Scherzer, Daryl; Shu, Arthur; Bobko, Mark A.; Chadderton, Antony R.; Dumble, Melissa; Gardiner, Christine M.; Gilbert, Seth; Liu, Qi; Rabindran, Sridhar K.; Sudakin, Valery; Xiang, Hong; Brady, Pat G.; Campobasso, Nino; Ward, Paris; Axten, Jeffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1871-1895</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphoinositide-dependent protein kinase-1 (PDK1) is a master regulator of the AGC family of kinases and an integral component of the PI3K/AKT/mTOR pathway.  As this pathway is among the most commonly deregulated across all cancers, a selective inhibitor of PDK1 might have utility as an anticancer agent.  Herein, the lead optimization of compd. I (R1 = R2 = H) toward highly potent and selective PDK1 inhibitors via a structure-based design strategy is described.  A series of (amino)(aminopyrimidinyl)indazoles I (R1 = H, Me, Et; R2 = Me, i-Pr, PhNH, 1-piperidinyl, etc.) was synthesized, and the inhibiting activity of the products towards PDK1 was studied.  The most potent and selective inhibitors, e.g. I [R1 = Me; R2 = (3S,6R)-3-(cyclohexylaminocarbonyl)-6-methyl-1-piperidinyl], demonstrated submicromolar activity as measured by inhibition of phosphorylation of PDK1 substrates as well as antiproliferative activity against a subset of AML cell lines.  In addn., redn. of phosphorylation of PDK1 substrates was demonstrated in vivo in mice bearing OCl-AML2 xenografts.  These observations demonstrate the utility of these mols. as tools to further delineate the biol. of PDK1 and the potential pharmacol. uses of a PDK1 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd83HnbHh5j7Vg90H21EOLACvtfcHk0likq637MKb4Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVWksrk%253D&md5=2911a5b7dbfa944a7c523da0be1026ac</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjm101527u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101527u%26sid%3Dliteratum%253Aachs%26aulast%3DMedina%26aufirst%3DJ.%2BR.%26aulast%3DBecker%26aufirst%3DC.%2BJ.%26aulast%3DBlackledge%26aufirst%3DC.%2BW.%26aulast%3DDuquenne%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DGrant%26aufirst%3DS.%2BW.%26aulast%3DHeerding%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DW.%2BH.%26aulast%3DMiller%26aufirst%3DW.%2BH.%26aulast%3DRomeril%26aufirst%3DS.%2BP.%26aulast%3DScherzer%26aufirst%3DD.%26aulast%3DShu%26aufirst%3DA.%26aulast%3DBobko%26aufirst%3DM.%2BA.%26aulast%3DChadderton%26aufirst%3DA.%2BR.%26aulast%3DDumble%26aufirst%3DM.%26aulast%3DGardiner%26aufirst%3DC.%2BM.%26aulast%3DGilbert%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DSudakin%26aufirst%3DV.%26aulast%3DXiang%26aufirst%3DH.%26aulast%3DBrady%26aufirst%3DP.%2BG.%26aulast%3DCampobasso%26aufirst%3DN.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DAxten%26aufirst%3DJ.%2BM.%26atitle%3DStructure-based%2520design%2520of%2520potent%2520and%2520selective%25203-phosphoinositide-dependent%2520kinase-1%2520%2528PDK1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1871%26epage%3D1895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Forns, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteve, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taboada, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orellana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maldonado, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreno, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramis, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miralpeix, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, B.</span><span> </span><span class="NLM_article-title">Pyrazine-based Syk kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2784</span><span class="NLM_x">–</span> <span class="NLM_lpage">2788</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2784-2788&author=P.+Fornsauthor=C.+Esteveauthor=L.+Taboadaauthor=J.+A.+Alonsoauthor=A.+Orellanaauthor=M.+Maldonadoauthor=C.+Carrenoauthor=I.+Ramisauthor=M.+Lopezauthor=M.+Miralpeixauthor=B.+Vidal&title=Pyrazine-based+Syk+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DForns%26aufirst%3DP.%26aulast%3DEsteve%26aufirst%3DC.%26aulast%3DTaboada%26aufirst%3DL.%26aulast%3DAlonso%26aufirst%3DJ.%2BA.%26aulast%3DOrellana%26aufirst%3DA.%26aulast%3DMaldonado%26aufirst%3DM.%26aulast%3DCarreno%26aufirst%3DC.%26aulast%3DRamis%26aufirst%3DI.%26aulast%3DLopez%26aufirst%3DM.%26aulast%3DMiralpeix%26aufirst%3DM.%26aulast%3DVidal%26aufirst%3DB.%26atitle%3DPyrazine-based%2520Syk%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2784%26epage%3D2788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Murphy, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxi, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chappie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermolieff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferre, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greasley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kablaoui, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazmirski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kupchinsky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingardo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marx, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanis, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X. H.</span><span> </span><span class="NLM_article-title">Discovery of novel, potent, and selective inhibitors of 3-phosphoinositide-dependent kinase (PDK1)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8490</span><span class="NLM_x">–</span> <span class="NLM_lpage">8500</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201019k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8490-8500&author=S.+T.+Murphyauthor=G.+Altonauthor=S.+Baileyauthor=S.+M.+Baxiauthor=B.+J.+Burkeauthor=T.+A.+Chappieauthor=J.+Ermolieffauthor=R.+Ferreauthor=S.+Greasleyauthor=M.+Hickeyauthor=J.+Humphreyauthor=N.+Kablaouiauthor=J.+Kathauthor=S.+Kazmirskiauthor=M.+Krausauthor=S.+Kupchinskyauthor=J.+Liauthor=L.+Lingardoauthor=M.+A.+Marxauthor=D.+Richterauthor=S.+P.+Tanisauthor=K.+Tranauthor=W.+Vernierauthor=Z.+Xieauthor=M.+J.+Yinauthor=X.+H.+Yu&title=Discovery+of+novel%2C+potent%2C+and+selective+inhibitors+of+3-phosphoinositide-dependent+kinase+%28PDK1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fjm201019k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201019k%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DS.%2BT.%26aulast%3DAlton%26aufirst%3DG.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DBaxi%26aufirst%3DS.%2BM.%26aulast%3DBurke%26aufirst%3DB.%2BJ.%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DErmolieff%26aufirst%3DJ.%26aulast%3DFerre%26aufirst%3DR.%26aulast%3DGreasley%26aufirst%3DS.%26aulast%3DHickey%26aufirst%3DM.%26aulast%3DHumphrey%26aufirst%3DJ.%26aulast%3DKablaoui%26aufirst%3DN.%26aulast%3DKath%26aufirst%3DJ.%26aulast%3DKazmirski%26aufirst%3DS.%26aulast%3DKraus%26aufirst%3DM.%26aulast%3DKupchinsky%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLingardo%26aufirst%3DL.%26aulast%3DMarx%26aufirst%3DM.%2BA.%26aulast%3DRichter%26aufirst%3DD.%26aulast%3DTanis%26aufirst%3DS.%2BP.%26aulast%3DTran%26aufirst%3DK.%26aulast%3DVernier%26aufirst%3DW.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DYin%26aufirst%3DM.%2BJ.%26aulast%3DYu%26aufirst%3DX.%2BH.%26atitle%3DDiscovery%2520of%2520novel%252C%2520potent%252C%2520and%2520selective%2520inhibitors%2520of%25203-phosphoinositide-dependent%2520kinase%2520%2528PDK1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8490%26epage%3D8500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Li, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pireddu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haura, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schonbrunn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span> </span><span class="NLM_article-title">Fragment-based and structure-guided discovery and optimization of rho kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2474</span><span class="NLM_x">–</span> <span class="NLM_lpage">2478</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201289r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFems70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2474-2478&author=R.+Liauthor=M.+P.+Martinauthor=Y.+Liuauthor=B.+Wangauthor=R.+A.+Patelauthor=J.-Y.+Zhuauthor=N.+Sunauthor=R.+Piredduauthor=N.+J.+Lawrenceauthor=J.+Liauthor=E.+B.+Hauraauthor=S.-S.+Sungauthor=W.+C.+Guidaauthor=E.+Schonbrunnauthor=S.+M.+Sebti&title=Fragment-based+and+structure-guided+discovery+and+optimization+of+rho+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based and Structure-Guided Discovery and Optimization of Rho Kinase Inhibitors</span></div><div class="casAuthors">Li, Rongshi; Martin, Mathew P.; Liu, Yan; Wang, Binglin; Patel, Ronil A.; Zhu, Jin-Yi; Sun, Nan; Pireddu, Roberta; Lawrence, Nicholas J.; Li, Jiannong; Haura, Eric B.; Sung, Shen-Shu; Guida, Wayne C.; Schonbrunn, Ernst; Sebti, Said M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2474-2478</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using high concn. biochem. assays and fragment-based screening assisted by structure-guided design, we discovered a novel class of Rho-kinase inhibitors.  Compd. 18 (I) was equipotent for ROCK1 (IC50 = 650 nM) and ROCK2 (IC50 = 670 nM), whereas compd. 24 was more selective for ROCK2 (IC50 = 100 nM) over ROCK1 (IC50 = 1690 nM).  The crystal structure of the compd. 18-ROCK1 complex revealed that 18 is a type 1 inhibitor that binds the hinge region in the ATP binding site.  Compds. 18 and 24 inhibited potently the phosphorylation of the ROCK substrate MLC2 in intact human breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX0qbi1-9GyLVg90H21EOLACvtfcHk0ljoT-hp2BcIUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFems70%253D&md5=ed3298d8fa7148d6c6a0599eb3886779</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fjm201289r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201289r%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DR.%26aulast%3DMartin%26aufirst%3DM.%2BP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DZhu%26aufirst%3DJ.-Y.%26aulast%3DSun%26aufirst%3DN.%26aulast%3DPireddu%26aufirst%3DR.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHaura%26aufirst%3DE.%2BB.%26aulast%3DSung%26aufirst%3DS.-S.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DSchonbrunn%26aufirst%3DE.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26atitle%3DFragment-based%2520and%2520structure-guided%2520discovery%2520and%2520optimization%2520of%2520rho%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2474%26epage%3D2478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Schenkel, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deak, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emkey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunaydin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivieri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pistillo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geuns-Meyer, S.</span><span> </span><span class="NLM_article-title">Discovery of potent and highly selective thienopyridine Janus kinase 2 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8440</span><span class="NLM_x">–</span> <span class="NLM_lpage">8450</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200911r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8440-8450&author=L.+B.+Schenkelauthor=X.+Huangauthor=A.+Chengauthor=H.+L.+Deakauthor=E.+Dohertyauthor=R.+Emkeyauthor=Y.+Guauthor=H.+Gunaydinauthor=J.+L.+Kimauthor=J.+Leeauthor=R.+Lobergauthor=P.+Olivieriauthor=J.+Pistilloauthor=J.+Tangauthor=Q.+Wanauthor=H.+L.+Wangauthor=S.+W.+Wangauthor=M.+C.+Wellsauthor=B.+Wuauthor=V.+Yuauthor=L.+Liuauthor=S.+Geuns-Meyer&title=Discovery+of+potent+and+highly+selective+thienopyridine+Janus+kinase+2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fjm200911r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200911r%26sid%3Dliteratum%253Aachs%26aulast%3DSchenkel%26aufirst%3DL.%2BB.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DA.%26aulast%3DDeak%26aufirst%3DH.%2BL.%26aulast%3DDoherty%26aufirst%3DE.%26aulast%3DEmkey%26aufirst%3DR.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLoberg%26aufirst%3DR.%26aulast%3DOlivieri%26aufirst%3DP.%26aulast%3DPistillo%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DH.%2BL.%26aulast%3DWang%26aufirst%3DS.%2BW.%26aulast%3DWells%26aufirst%3DM.%2BC.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DGeuns-Meyer%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520highly%2520selective%2520thienopyridine%2520Janus%2520kinase%25202%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8440%26epage%3D8450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Koester, H.; Craan, T.; Brass, S.; Heine, A.; Klebe, G.</span><span> </span><span class="NLM_article-title">Human cAMP-Dependent Protein Kinase in Complex with an Inhibitor</span>. Protein Data Bank (PDB),<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.2210/pdb3p0m/pdb</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.2210%2Fpdb3p0m%2Fpdb" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=H.+Koester&author=T.+Craan&author=S.+Brass&author=A.+Heine&author=G.+Klebe&title=Human+cAMP-Dependent+Protein+Kinase+in+Complex+with+an+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.2210%2Fpdb3p0m%2Fpdb&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.2210%252Fpdb3p0m%252Fpdb%26sid%3Dliteratum%253Aachs%26aulast%3DKoester%26aufirst%3DH.%26atitle%3DHuman%2520cAMP-Dependent%2520Protein%2520Kinase%2520in%2520Complex%2520with%2520an%2520Inhibitor%26jtitle%3DProtein%2520Data%2520Bank%2520%2528PDB%2529%26date%3D2012%26doi%3D10.2210%2Fpdb3p0m%2Fpdb" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Hellwig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miduturu, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salah, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hur, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smithgall, T. E.</span><span> </span><span class="NLM_article-title">Small-molecule inhibitors of the c-Fes protein-tyrosine kinase</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">529</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2Fj.chembiol.2012.01.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=22520759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvFyhsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=529-540&author=S.+Hellwigauthor=C.+V.+Miduturuauthor=S.+Kandaauthor=J.+Zhangauthor=P.+Filippakopoulosauthor=E.+Salahauthor=X.+Dengauthor=H.+G.+Choiauthor=W.+Zhouauthor=W.+Hurauthor=S.+Knappauthor=N.+S.+Grayauthor=T.+E.+Smithgall&title=Small-molecule+inhibitors+of+the+c-Fes+protein-tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule Inhibitors of the c-Fes Protein-Tyrosine Kinase</span></div><div class="casAuthors">Hellwig, Sabine; Miduturu, Chandra V.; Kanda, Shigeru; Zhang, Jianming; Filippakopoulos, Panagis; Salah, Eidarus; Deng, Xianming; Choi, Hwan Geun; Zhou, Wenjun; Hur, Wooyoung; Knapp, Stefan; Gray, Nathanael S.; Smithgall, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">529-540</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The c-Fes protein-tyrosine kinase modulates cellular signaling pathways governing differentiation, the innate immune response, and vasculogenesis.  Here, we report the identification of types I and II kinase inhibitors with potent activity against c-Fes both in vitro and in cell-based assays.  One of the most potent inhibitors is the previously described anaplastic lymphoma kinase inhibitor TAE684.  The crystal structure of TAE684 in complex with the c-Fes SH2-kinase domain showed excellent shape complementarity with the ATP-binding pocket and a key role for the gatekeeper methionine in the inhibitory mechanism.  TAE684 and two pyrazolopyrimidines with nanomolar potency against c-Fes in vitro were used to establish a role for this kinase in osteoclastogenesis, illustrating the value of these inhibitors as tool compds. to probe the diverse biol. functions assocd. with this unique kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAe24jiEkQf7Vg90H21EOLACvtfcHk0lj78_FgE-pETA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvFyhsbo%253D&md5=6c2cde2ae6d412684b0a12dd47b58b56</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.01.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.01.020%26sid%3Dliteratum%253Aachs%26aulast%3DHellwig%26aufirst%3DS.%26aulast%3DMiduturu%26aufirst%3DC.%2BV.%26aulast%3DKanda%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DSalah%26aufirst%3DE.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DHur%26aufirst%3DW.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DSmithgall%26aufirst%3DT.%2BE.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520the%2520c-Fes%2520protein-tyrosine%2520kinase%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D529%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Okaniwa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirose, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yabuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakoi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsutsumi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tottori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aertgeerts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, T.</span><span> </span><span class="NLM_article-title">Design and synthesis of novel DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors. 1. Exploration of [5,6]-fused bicyclic scaffolds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3452</span><span class="NLM_x">–</span> <span class="NLM_lpage">3478</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300126x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3452-3478&author=M.+Okaniwaauthor=M.+Hiroseauthor=T.+Imadaauthor=T.+Ohashiauthor=Y.+Hayashiauthor=T.+Miyazakiauthor=T.+Aritaauthor=M.+Yabukiauthor=K.+Kakoiauthor=J.+Katoauthor=T.+Takagiauthor=T.+Kawamotoauthor=S.+Yaoauthor=A.+Sumitaauthor=S.+Tsutsumiauthor=T.+Tottoriauthor=H.+Okiauthor=B.+C.+Sangauthor=J.+Yanoauthor=K.+Aertgeertsauthor=S.+Yoshidaauthor=T.+Ishikawa&title=Design+and+synthesis+of+novel+DFG-out+RAF%2Fvascular+endothelial+growth+factor+receptor+2+%28VEGFR2%29+inhibitors.+1.+Exploration+of+%5B5%2C6%5D-fused+bicyclic+scaffolds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fjm300126x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300126x%26sid%3Dliteratum%253Aachs%26aulast%3DOkaniwa%26aufirst%3DM.%26aulast%3DHirose%26aufirst%3DM.%26aulast%3DImada%26aufirst%3DT.%26aulast%3DOhashi%26aufirst%3DT.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DMiyazaki%26aufirst%3DT.%26aulast%3DArita%26aufirst%3DT.%26aulast%3DYabuki%26aufirst%3DM.%26aulast%3DKakoi%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DJ.%26aulast%3DTakagi%26aufirst%3DT.%26aulast%3DKawamoto%26aufirst%3DT.%26aulast%3DYao%26aufirst%3DS.%26aulast%3DSumita%26aufirst%3DA.%26aulast%3DTsutsumi%26aufirst%3DS.%26aulast%3DTottori%26aufirst%3DT.%26aulast%3DOki%26aufirst%3DH.%26aulast%3DSang%26aufirst%3DB.%2BC.%26aulast%3DYano%26aufirst%3DJ.%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DIshikawa%26aufirst%3DT.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520DFG-out%2520RAF%252Fvascular%2520endothelial%2520growth%2520factor%2520receptor%25202%2520%2528VEGFR2%2529%2520inhibitors.%25201.%2520Exploration%2520of%2520%255B5%252C6%255D-fused%2520bicyclic%2520scaffolds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3452%26epage%3D3478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Gould, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adhikari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aertgeerts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afroze, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chouitar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffey, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">England, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsyth, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaulin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenspan, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iartchouk, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janowick, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langston, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paske, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renou, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rezaei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sintchak, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroud, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tregay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veiby, O. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vos, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyskocil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, K. M.</span><span> </span><span class="NLM_article-title">Design and optimization of potent and orally bioavailable tetrahydronaphthalene Raf inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1836</span><span class="NLM_x">–</span> <span class="NLM_lpage">1846</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101479y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVWls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1836-1846&author=A.+E.+Gouldauthor=R.+Adamsauthor=S.+Adhikariauthor=K.+Aertgeertsauthor=R.+Afrozeauthor=C.+Blackburnauthor=E.+F.+Calderwoodauthor=R.+Chauauthor=J.+Chouitarauthor=M.+O.+Duffeyauthor=D.+B.+Englandauthor=C.+Farrerauthor=N.+Forsythauthor=K.+Garciaauthor=J.+Gaulinauthor=P.+D.+Greenspanauthor=R.+Guoauthor=S.+J.+Harrisonauthor=S.+C.+Huangauthor=N.+Iartchoukauthor=D.+Janowickauthor=M.+S.+Kimauthor=B.+Kulkarniauthor=S.+P.+Langstonauthor=J.+X.+Liuauthor=L.+T.+Maauthor=S.+Menonauthor=H.+Mizutaniauthor=E.+Paskeauthor=C.+C.+Renouauthor=M.+Rezaeiauthor=R.+S.+Rowlandauthor=M.+D.+Sintchakauthor=M.+D.+Smithauthor=S.+G.+Stroudauthor=M.+Tregayauthor=Y.+Tianauthor=O.+P.+Veibyauthor=T.+J.+Vosauthor=S.+Vyskocilauthor=J.+Williamsauthor=T.+Xuauthor=J.+J.+Yangauthor=J.+Yanoauthor=H.+Zengauthor=D.+M.+Zhangauthor=Q.+Zhangauthor=K.+M.+Galvin&title=Design+and+optimization+of+potent+and+orally+bioavailable+tetrahydronaphthalene+Raf+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Optimization of Potent and Orally Bioavailable Tetrahydronaphthalene Raf Inhibitors</span></div><div class="casAuthors">Gould, Alexandra E.; Adams, Ruth; Adhikari, Sharmila; Aertgeerts, Kathleen; Afroze, Roushan; Blackburn, Christopher; Calderwood, Emily F.; Chau, Ryan; Chouitar, Jouhara; Duffey, Matthew O.; England, Dylan B.; Farrer, Cheryl; Forsyth, Nancy; Garcia, Khristofer; Gaulin, Jeffery; Greenspan, Paul D.; Guo, Ribo; Harrison, Sean J.; Huang, Shih-Chung; Iartchouk, Natalia; Janowick, Dave; Kim, Mi-Sook; Kulkarni, Bheemashankar; Langston, Steven P.; Liu, Jane X.; Ma, Li-Ting; Menon, Saurabh; Mizutani, Hirotake; Paske, Erin; Renou, Christelle C.; Rezaei, Mansoureh; Rowland, R. Scott; Sintchak, Michael D.; Smith, Michael D.; Stroud, Stephen G.; Tregay, Ming; Tian, Yuan; Veiby, Ole P.; Vos, Tricia J.; Vyskocil, Stepan; Williams, Juliet; Xu, Tianlin; Yang, Johnny J.; Yano, Jason; Zeng, Hongbo; Zhang, Dong Mei; Zhang, Qin; Galvin, Katherine M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1836-1846</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of mutant B-Raf signaling, through either direct inhibition of the enzyme or inhibition of MEK, the direct substrate of Raf, has been demonstrated preclinically to inhibit tumor growth.  Very recently, treatment of B-Raf mutant melanoma patients with a selective B-Raf inhibitor has resulted in promising preliminary evidence of antitumor activity.  This article describes the design and optimization of tetrahydronaphthalene-derived compds. as potent inhibitors of the Raf pathway in vitro and in vivo.  These compds. possess good pharmacokinetic properties in rodents and inhibit B-Raf mutant tumor growth in mouse xenograft models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNulHRlb4oULVg90H21EOLACvtfcHk0lj78_FgE-pETA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVWls7g%253D&md5=568fb1b26a6685df082ac0337494a9c5</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fjm101479y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101479y%26sid%3Dliteratum%253Aachs%26aulast%3DGould%26aufirst%3DA.%2BE.%26aulast%3DAdams%26aufirst%3DR.%26aulast%3DAdhikari%26aufirst%3DS.%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DAfroze%26aufirst%3DR.%26aulast%3DBlackburn%26aufirst%3DC.%26aulast%3DCalderwood%26aufirst%3DE.%2BF.%26aulast%3DChau%26aufirst%3DR.%26aulast%3DChouitar%26aufirst%3DJ.%26aulast%3DDuffey%26aufirst%3DM.%2BO.%26aulast%3DEngland%26aufirst%3DD.%2BB.%26aulast%3DFarrer%26aufirst%3DC.%26aulast%3DForsyth%26aufirst%3DN.%26aulast%3DGarcia%26aufirst%3DK.%26aulast%3DGaulin%26aufirst%3DJ.%26aulast%3DGreenspan%26aufirst%3DP.%2BD.%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DHarrison%26aufirst%3DS.%2BJ.%26aulast%3DHuang%26aufirst%3DS.%2BC.%26aulast%3DIartchouk%26aufirst%3DN.%26aulast%3DJanowick%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DM.%2BS.%26aulast%3DKulkarni%26aufirst%3DB.%26aulast%3DLangston%26aufirst%3DS.%2BP.%26aulast%3DLiu%26aufirst%3DJ.%2BX.%26aulast%3DMa%26aufirst%3DL.%2BT.%26aulast%3DMenon%26aufirst%3DS.%26aulast%3DMizutani%26aufirst%3DH.%26aulast%3DPaske%26aufirst%3DE.%26aulast%3DRenou%26aufirst%3DC.%2BC.%26aulast%3DRezaei%26aufirst%3DM.%26aulast%3DRowland%26aufirst%3DR.%2BS.%26aulast%3DSintchak%26aufirst%3DM.%2BD.%26aulast%3DSmith%26aufirst%3DM.%2BD.%26aulast%3DStroud%26aufirst%3DS.%2BG.%26aulast%3DTregay%26aufirst%3DM.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DVeiby%26aufirst%3DO.%2BP.%26aulast%3DVos%26aufirst%3DT.%2BJ.%26aulast%3DVyskocil%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DJ.%2BJ.%26aulast%3DYano%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DD.%2BM.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DGalvin%26aufirst%3DK.%2BM.%26atitle%3DDesign%2520and%2520optimization%2520of%2520potent%2520and%2520orally%2520bioavailable%2520tetrahydronaphthalene%2520Raf%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1836%26epage%3D1846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Koolman, H.; Heinrich, T.; Musil, D.</span><span> </span><span class="NLM_article-title">Co-Crystal Structures of FAK with an Unprecedented Pyrrolo[2,3-<i>d</i>]thiazole</span>. Protein Data Bank (PDB),<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.2210/pdb3pxk/pdb</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.2210%2Fpdb3pxk%2Fpdb" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=H.+Koolman&author=T.+Heinrich&author=D.+Musil&title=Co-Crystal+Structures+of+FAK+with+an+Unprecedented+Pyrrolo%5B2%2C3-d%5Dthiazole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.2210%2Fpdb3pxk%2Fpdb&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.2210%252Fpdb3pxk%252Fpdb%26sid%3Dliteratum%253Aachs%26aulast%3DKoolman%26aufirst%3DH.%26atitle%3DCo-Crystal%2520Structures%2520of%2520FAK%2520with%2520an%2520Unprecedented%2520Pyrrolo%255B2%252C3-d%255Dthiazole%26jtitle%3DProtein%2520Data%2520Bank%2520%2528PDB%2529%26date%3D2012%26doi%3D10.2210%2Fpdb3pxk%2Fpdb" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Chaikuad, A.; Sanvitale, C.; Cooper, C.; Canning, P.; Mahajan, P.; Daga, N.; Petrie, K.; Alfano, I.; Gileadi, O.; Fedorov, O.; Krojer, T.; Filippakopoulos, P.; Muniz, J. R. C.; von Delft, F.; Weigelt, J.; Arrowsmith, C. H.; Edwards, A. M.; Bountra, C.; Bullock, A.; Consortium, S. G.</span><span> </span><span class="NLM_article-title">Crystal Structure of the ACVR1 Kinase Domain in Complex with the Imidazo[1,2-<i>b</i>]pyridazine Inhibitor K00135</span>. Protein Data Bank (PDB),<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.2210/pdb4dym/pdb</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.2210%2Fpdb4dym%2Fpdb" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+Chaikuad&author=C.+Sanvitale&author=C.+Cooper&author=P.+Canning&author=P.+Mahajan&author=N.+Daga&author=K.+Petrie&author=I.+Alfano&author=O.+Gileadi&author=O.+Fedorov&author=T.+Krojer&author=P.+Filippakopoulos&author=J.+R.+C.+Muniz&author=F.+von+Delft&author=J.+Weigelt&author=C.+H.+Arrowsmith&author=A.+M.+Edwards&author=C.+Bountra&author=A.+Bullock&author=S.+G.+Consortium&title=Crystal+Structure+of+the+ACVR1+Kinase+Domain+in+Complex+with+the+Imidazo%5B1%2C2-b%5Dpyridazine+Inhibitor+K00135"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.2210%2Fpdb4dym%2Fpdb&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.2210%252Fpdb4dym%252Fpdb%26sid%3Dliteratum%253Aachs%26aulast%3DChaikuad%26aufirst%3DA.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520ACVR1%2520Kinase%2520Domain%2520in%2520Complex%2520with%2520the%2520Imidazo%255B1%252C2-b%255Dpyridazine%2520Inhibitor%2520K00135%26jtitle%3DProtein%2520Data%2520Bank%2520%2528PDB%2529%26date%3D2012%26doi%3D10.2210%2Fpdb4dym%2Fpdb" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Levinson, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxer, S. G.</span><span> </span><span class="NLM_article-title">Structural and spectroscopic analysis of the kinase inhibitor bosutinib and an isomer of bosutinib binding to the Abl tyrosine kinase domain</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e29828</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1371%2Fjournal.pone.0029828" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=22493660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvFekt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e29828&author=N.+M.+Levinsonauthor=S.+G.+Boxer&title=Structural+and+spectroscopic+analysis+of+the+kinase+inhibitor+bosutinib+and+an+isomer+of+bosutinib+binding+to+the+Abl+tyrosine+kinase+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and spectroscopic analysis of the kinase inhibitor bosutinib and an isomer of bosutinib binding to the Abl tyrosine kinase domain</span></div><div class="casAuthors">Levinson, Nicholas M.; Boxer, Steven G.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e29828</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Chronic myeloid leukemia (CML) is caused by the kinase activity of the BCR-Abl fusion protein.  The Abl inhibitors imatinib, nilotinib and dasatinib are currently used to treat CML, but resistance to these inhibitors is a significant clin. problem.  The kinase inhibitor bosutinib has shown efficacy in clin. trials for imatinib-resistant CML, but its binding mode is unknown.  We present the 2.4 Å structure of bosutinib bound to the kinase domain of Abl, which explains the inhibitor's activity against several imatinib-resistant mutants, and reveals that similar inhibitors that lack a nitrile moiety could be effective against the common T315I mutant.  We also report that two distinct chem. compds. are currently being sold under the name "bosutinib", and report spectroscopic and structural characterizations of both.  We show that the fluorescence properties of these compds. allow inhibitor binding to be measured quant., and that the IR absorption of the nitrile group reveals a different electrostatic environment in the conserved ATP-binding sites of Abl and Src kinases.  Exploiting such differences could lead to inhibitors with improved selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpV2tAfVGUdSbVg90H21EOLACvtfcHk0ljijYY3i6K3kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvFekt7o%253D&md5=4a8a00c6786d62293a05fe5ddd757174</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0029828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0029828%26sid%3Dliteratum%253Aachs%26aulast%3DLevinson%26aufirst%3DN.%2BM.%26aulast%3DBoxer%26aufirst%3DS.%2BG.%26atitle%3DStructural%2520and%2520spectroscopic%2520analysis%2520of%2520the%2520kinase%2520inhibitor%2520bosutinib%2520and%2520an%2520isomer%2520of%2520bosutinib%2520binding%2520to%2520the%2520Abl%2520tyrosine%2520kinase%2520domain%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De29828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Heikkila, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheatley, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crighton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroder, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boakes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mezna, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rushbrooke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnbull, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, M. F.</span><span> </span><span class="NLM_article-title">Co-crystal structures of inhibitors with MRCKbeta, a key regulator of tumor cell invasion</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e24825</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e24825&author=T.+Heikkilaauthor=E.+Wheatleyauthor=D.+Crightonauthor=E.+Schroderauthor=A.+Boakesauthor=S.+J.+Kayeauthor=M.+Meznaauthor=L.+Pangauthor=M.+Rushbrookeauthor=A.+Turnbullauthor=M.+F.+Olson&title=Co-crystal+structures+of+inhibitors+with+MRCKbeta%2C+a+key+regulator+of+tumor+cell+invasion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeikkila%26aufirst%3DT.%26aulast%3DWheatley%26aufirst%3DE.%26aulast%3DCrighton%26aufirst%3DD.%26aulast%3DSchroder%26aufirst%3DE.%26aulast%3DBoakes%26aufirst%3DA.%26aulast%3DKaye%26aufirst%3DS.%2BJ.%26aulast%3DMezna%26aufirst%3DM.%26aulast%3DPang%26aufirst%3DL.%26aulast%3DRushbrooke%26aufirst%3DM.%26aulast%3DTurnbull%26aufirst%3DA.%26aulast%3DOlson%26aufirst%3DM.%2BF.%26atitle%3DCo-crystal%2520structures%2520of%2520inhibitors%2520with%2520MRCKbeta%252C%2520a%2520key%2520regulator%2520of%2520tumor%2520cell%2520invasion%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De24825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Dyckman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillooly, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newitt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span> </span><span class="NLM_article-title">Discovery of pyrrolo[2,1-<i>f</i>][1,2,4]triazine C6-ketones as potent, orally active p38α MAP kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4633</span><span class="NLM_x">–</span> <span class="NLM_lpage">4637</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4633-4637&author=A.+J.+Dyckmanauthor=T.+Liauthor=S.+Pittauthor=R.+Zhangauthor=D.+R.+Shenauthor=K.+W.+McIntyreauthor=K.+M.+Gilloolyauthor=D.+J.+Shusterauthor=A.+M.+Doweykoauthor=J.+S.+Sackauthor=K.+Kishauthor=S.+E.+Kieferauthor=J.+A.+Newittauthor=H.+Zhangauthor=P.+H.+Maratheauthor=M.+McKinnonauthor=J.+C.+Barrishauthor=J.+H.+Doddauthor=G.+L.+Schievenauthor=K.+Leftheris&title=Discovery+of+pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazine+C6-ketones+as+potent%2C+orally+active+p38%CE%B1+MAP+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DGillooly%26aufirst%3DK.%2BM.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DKiefer%26aufirst%3DS.%2BE.%26aulast%3DNewitt%26aufirst%3DJ.%2BA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMarathe%26aufirst%3DP.%2BH.%26aulast%3DMcKinnon%26aufirst%3DM.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DDodd%26aufirst%3DJ.%2BH.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazine%2520C6-ketones%2520as%2520potent%252C%2520orally%2520active%2520p38%25CE%25B1%2520MAP%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4633%26epage%3D4637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Filippakopoulos, P.; Fedorov, O.; King, O.; Bullock, A.; Muniz, J. R. C.; von Delft, F.; Arrowsmith, C. H.; Edwards, A. M.; Weigelt, J.; Bountra, C.; Knapp, S.; Consortium, S. G.</span><span> </span><span class="NLM_article-title">Crystal Structure of Human CDC-like Kinase 3 Isoform in Complex with Leucettine L41</span>. Protein Data Bank (PDB),<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.2210/pdb3raw/pdb</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.2210%2Fpdb3raw%2Fpdb" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=P.+Filippakopoulos&author=O.+Fedorov&author=O.+King&author=A.+Bullock&author=J.+R.+C.+Muniz&author=F.+von+Delft&author=C.+H.+Arrowsmith&author=A.+M.+Edwards&author=J.+Weigelt&author=C.+Bountra&author=S.+Knapp&author=S.+G.+Consortium&title=Crystal+Structure+of+Human+CDC-like+Kinase+3+Isoform+in+Complex+with+Leucettine+L41"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.2210%2Fpdb3raw%2Fpdb&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.2210%252Fpdb3raw%252Fpdb%26sid%3Dliteratum%253Aachs%26aulast%3DFilippakopoulos%26aufirst%3DP.%26atitle%3DCrystal%2520Structure%2520of%2520Human%2520CDC-like%2520Kinase%25203%2520Isoform%2520in%2520Complex%2520with%2520Leucettine%2520L41%26jtitle%3DProtein%2520Data%2520Bank%2520%2528PDB%2529%26date%3D2012%26doi%3D10.2210%2Fpdb3raw%2Fpdb" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Nishiguchi, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atallah, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellamacina, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feucht, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klivansky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindvall, M.</span><span> </span><span class="NLM_article-title">Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6366</span><span class="NLM_x">–</span> <span class="NLM_lpage">6369</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2Fj.bmcl.2011.08.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=21945284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12jtr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6366-6369&author=G.+A.+Nishiguchiauthor=G.+Atallahauthor=C.+Bellamacinaauthor=M.+T.+Burgerauthor=Y.+Dingauthor=P.+H.+Feuchtauthor=P.+D.+Garciaauthor=W.+Hanauthor=L.+Klivanskyauthor=M.+Lindvall&title=Discovery+of+novel+3%2C5-disubstituted+indole+derivatives+as+potent+inhibitors+of+Pim-1%2C+Pim-2%2C+and+Pim-3+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases</span></div><div class="casAuthors">Nishiguchi, Gisele A.; Atallah, Gordana; Bellamacina, Cornelia; Burger, Matthew T.; Ding, Yu; Feucht, Paul H.; Garcia, Pablo D.; Han, Woo-Seok; Klivansky, Liana; Lindvall, Mika</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6366-6369</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of novel 3,5-disubstituted indole e. g., I and pyrazolopyridine e. g., II derivs. as potent and selective inhibitors of all three members of the Pim kinase family is described.  High throughput screen identified a pan-Pim kinase inhibitor with a promiscuous scaffold.  Guided by structure-based drug design, SAR of the series afforded a highly selective indole chemotype that was further developed into a potent set of compds. against Pim-1, 2, and 3 (Pim-1 and Pim-3: IC50 ≤ 2 nM and Pim-2: IC50 ≤ 100 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraW5ZPCZ1p-7Vg90H21EOLACvtfcHk0ljSaOcsrWpybA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12jtr%252FK&md5=9b8f859027daa006c85b6bbf7696ef18</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.08.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.08.105%26sid%3Dliteratum%253Aachs%26aulast%3DNishiguchi%26aufirst%3DG.%2BA.%26aulast%3DAtallah%26aufirst%3DG.%26aulast%3DBellamacina%26aufirst%3DC.%26aulast%3DBurger%26aufirst%3DM.%2BT.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DFeucht%26aufirst%3DP.%2BH.%26aulast%3DGarcia%26aufirst%3DP.%2BD.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DKlivansky%26aufirst%3DL.%26aulast%3DLindvall%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520novel%25203%252C5-disubstituted%2520indole%2520derivatives%2520as%2520potent%2520inhibitors%2520of%2520Pim-1%252C%2520Pim-2%252C%2520and%2520Pim-3%2520protein%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6366%26epage%3D6369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Tsai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bremer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillette, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sproesser, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smalley, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marimuthu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settachatgul, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shellooe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantwell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habets, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artis, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herlyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollag, G.</span><span> </span><span class="NLM_article-title">Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">3041</span><span class="NLM_x">–</span> <span class="NLM_lpage">3046</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1073%2Fpnas.0711741105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=18287029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtVSitrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=3041-3046&author=J.+Tsaiauthor=J.+T.+Leeauthor=W.+Wangauthor=J.+Zhangauthor=H.+Choauthor=S.+Mamoauthor=R.+Bremerauthor=S.+Gilletteauthor=J.+Kongauthor=N.+K.+Haassauthor=K.+Sproesserauthor=L.+Liauthor=K.+S.+Smalleyauthor=D.+Fongauthor=Y.+L.+Zhuauthor=A.+Marimuthuauthor=H.+Nguyenauthor=B.+Lamauthor=J.+Liuauthor=I.+Cheungauthor=J.+Riceauthor=Y.+Suzukiauthor=C.+Luuauthor=C.+Settachatgulauthor=R.+Shellooeauthor=J.+Cantwellauthor=S.+H.+Kimauthor=J.+Schlessingerauthor=K.+Y.+Zhangauthor=B.+L.+Westauthor=B.+Powellauthor=G.+Habetsauthor=C.+Zhangauthor=P.+N.+Ibrahimauthor=P.+Hirthauthor=D.+R.+Artisauthor=M.+Herlynauthor=G.+Bollag&title=Discovery+of+a+selective+inhibitor+of+oncogenic+B-Raf+kinase+with+potent+antimelanoma+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity</span></div><div class="casAuthors">Tsai, James; Lee, John T.; Wang, Weiru; Zhang, Jiazhong; Cho, Hanna; Mamo, Shumeye; Bremer, Ryan; Gillette, Sam; Kong, Jun; Haass, Nikolas K.; Sproesser, Katrin; Li, Ling; Smalley, Keiran S. M.; Fong, Daniel; Zhu, Yong-Liang; Marimuthu, Adhirai; Nguyen, Hoa; Lam, Billy; Liu, Jennifer; Cheung, Ivana; Rice, Julie; Suzuki, Yoshihisa; Luu, Catherine; Settachatgul, Calvin; Shellooe, Rafe; Cantwell, John; Kim, Sung-Hou; Schlessinger, Joseph; Zhang, Kam Y. J.; West, Brian L.; Powell, Ben; Habets, Gaston; Zhang, Chao; Ibrahim, Prabha N.; Hirth, Peter; Artis, Dean R.; Herlyn, Meenhard; Bollag, Gideon</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3041-3046</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">BRAFV600E is the most frequent oncogenic protein kinase mutation known.  Furthermore, inhibitors targeting "active" protein kinases have demonstrated significant utility in the therapeutic repertoire against cancer.  Therefore, the authors pursued the development of specific kinase inhibitors targeting B-Raf, and the V600E allele in particular.  By using a structure-guided discovery approach, a potent and selective inhibitor of active B-Raf has been discovered.  PLX4720, a 7-azaindole deriv. that inhibits B-RafV600E with an IC50 of 13 nM, defines a class of kinase inhibitor with marked selectivity in both biochem. and cellular assays.  PLX4720 preferentially inhibits the active B-RafV600E kinase compared with a broad spectrum of other kinases, and potent cytotoxic effects are also exclusive to cells bearing the V600E allele.  Consistent with the high degree of selectivity, ERK phosphorylation is potently inhibited by PLX4720 in B-RafV600E-bearing tumor cell lines but not in cells lacking oncogenic B-Raf.  In melanoma models, PLX4720 induces cell cycle arrest and apoptosis exclusively in B-RafV600E-pos. cells.  In B-RafV600E-dependent tumor xenograft models, orally dosed PLX4720 causes significant tumor growth delays, including tumor regressions, without evidence of toxicity.  The work described here represents the entire discovery process, from initial identification through structural and biol. studies in animal models to a promising therapeutic for testing in cancer patients bearing B-RafV600E-driven tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPX53IQCbDJ7Vg90H21EOLACvtfcHk0ljSaOcsrWpybA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtVSitrk%253D&md5=273b94202f99984e6eb24723d0c6141f</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0711741105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0711741105%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%2BT.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DCho%26aufirst%3DH.%26aulast%3DMamo%26aufirst%3DS.%26aulast%3DBremer%26aufirst%3DR.%26aulast%3DGillette%26aufirst%3DS.%26aulast%3DKong%26aufirst%3DJ.%26aulast%3DHaass%26aufirst%3DN.%2BK.%26aulast%3DSproesser%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DSmalley%26aufirst%3DK.%2BS.%26aulast%3DFong%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DY.%2BL.%26aulast%3DMarimuthu%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DLam%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DCheung%26aufirst%3DI.%26aulast%3DRice%26aufirst%3DJ.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DLuu%26aufirst%3DC.%26aulast%3DSettachatgul%26aufirst%3DC.%26aulast%3DShellooe%26aufirst%3DR.%26aulast%3DCantwell%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DK.%2BY.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DHabets%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DIbrahim%26aufirst%3DP.%2BN.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DHerlyn%26aufirst%3DM.%26aulast%3DBollag%26aufirst%3DG.%26atitle%3DDiscovery%2520of%2520a%2520selective%2520inhibitor%2520of%2520oncogenic%2520B-Raf%2520kinase%2520with%2520potent%2520antimelanoma%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D3041%26epage%3D3046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Shafer, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindvall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellamacina, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gesner, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yabannavar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, A.</span><span> </span><span class="NLM_article-title">4-(1<i>H</i>-Indazol-5-yl)-6-phenylpyrimidin-2(1<i>H</i>)-one analogs as potent CDC7 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4482</span><span class="NLM_x">–</span> <span class="NLM_lpage">4485</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4482-4485&author=C.+M.+Shaferauthor=M.+Lindvallauthor=C.+Bellamacinaauthor=T.+G.+Gesnerauthor=A.+Yabannavarauthor=W.+Jiaauthor=S.+Linauthor=A.+Walter&title=4-%281H-Indazol-5-yl%29-6-phenylpyrimidin-2%281H%29-one+analogs+as+potent+CDC7+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShafer%26aufirst%3DC.%2BM.%26aulast%3DLindvall%26aufirst%3DM.%26aulast%3DBellamacina%26aufirst%3DC.%26aulast%3DGesner%26aufirst%3DT.%2BG.%26aulast%3DYabannavar%26aufirst%3DA.%26aulast%3DJia%26aufirst%3DW.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DWalter%26aufirst%3DA.%26atitle%3D4-%25281H-Indazol-5-yl%2529-6-phenylpyrimidin-2%25281H%2529-one%2520analogs%2520as%2520potent%2520CDC7%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4482%26epage%3D4485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Lountos, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jobson, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tropea, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Self, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waugh, D. S.</span><span> </span><span class="NLM_article-title">Structural characterization of inhibitor complexes with checkpoint kinase 2 (Chk2), a drug target for cancer therapy</span> <span class="citation_source-journal">J. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">301</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2011&pages=292-301&author=G.+T.+Lountosauthor=A.+G.+Jobsonauthor=J.+E.+Tropeaauthor=C.+R.+Selfauthor=G.+Zhangauthor=Y.+Pommierauthor=R.+H.+Shoemakerauthor=D.+S.+Waugh&title=Structural+characterization+of+inhibitor+complexes+with+checkpoint+kinase+2+%28Chk2%29%2C+a+drug+target+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLountos%26aufirst%3DG.%2BT.%26aulast%3DJobson%26aufirst%3DA.%2BG.%26aulast%3DTropea%26aufirst%3DJ.%2BE.%26aulast%3DSelf%26aufirst%3DC.%2BR.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DShoemaker%26aufirst%3DR.%2BH.%26aulast%3DWaugh%26aufirst%3DD.%2BS.%26atitle%3DStructural%2520characterization%2520of%2520inhibitor%2520complexes%2520with%2520checkpoint%2520kinase%25202%2520%2528Chk2%2529%252C%2520a%2520drug%2520target%2520for%2520cancer%2520therapy%26jtitle%3DJ.%2520Struct.%2520Biol.%26date%3D2011%26volume%3D176%26spage%3D292%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenreich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullock, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szklarczyk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trappe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bracher, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2Fj.chembiol.2010.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=21276940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlarsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=67-76&author=O.+Fedorovauthor=K.+Huberauthor=A.+Eisenreichauthor=P.+Filippakopoulosauthor=O.+Kingauthor=A.+N.+Bullockauthor=D.+Szklarczykauthor=L.+J.+Jensenauthor=D.+Fabbroauthor=J.+Trappeauthor=U.+Rauchauthor=F.+Bracherauthor=S.+Knapp&title=Specific+CLK+inhibitors+from+a+novel+chemotype+for+regulation+of+alternative+splicing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Specific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing</span></div><div class="casAuthors">Fedorov, Oleg; Huber, Kilian; Eisenreich, Andreas; Filippakopoulos, Panagis; King, Oliver; Bullock, Alex N.; Szklarczyk, Damian; Jensen, Lars J.; Fabbro, Doriano; Trappe, Jorg; Rauch, Ursula; Bracher, Franz; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-76</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">There is a growing recognition of the importance of protein kinases in the control of alternative splicing.  To define the underlying regulatory mechanisms, highly selective inhibitors are needed.  Here, we report the discovery and characterization of the dichloroindolyl enaminonitrile KH-CB19, a potent and highly specific inhibitor of the CDC2-like kinase isoforms 1 and 4 (CLK1/CLK4).  Cocrystal structures of KH-CB19 with CLK1 and CLK3 revealed a non-ATP mimetic binding mode, conformational changes in helix αC and the phosphate binding loop and halogen bonding to the kinase hinge region.  KH-CB19 effectively suppressed phosphorylation of SR (serine/arginine) proteins in cells, consistent with its expected mechanism of action.  Chem. inhibition of CLK1/CLK4 generated a unique pattern of splicing factor dephosphorylation and had at low nM concn. a profound effect on splicing of the two tissue factor isoforms flTF (full-length TF) and asHTF (alternatively spliced human TF).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqnKjNEjPBHbVg90H21EOLACvtfcHk0lgDS3wZt6fI9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlarsLw%253D&md5=b2b17a9934f15f2d0d9a76a8d3179e95</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2010.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2010.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DHuber%26aufirst%3DK.%26aulast%3DEisenreich%26aufirst%3DA.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DKing%26aufirst%3DO.%26aulast%3DBullock%26aufirst%3DA.%2BN.%26aulast%3DSzklarczyk%26aufirst%3DD.%26aulast%3DJensen%26aufirst%3DL.%2BJ.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DTrappe%26aufirst%3DJ.%26aulast%3DRauch%26aufirst%3DU.%26aulast%3DBracher%26aufirst%3DF.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DSpecific%2520CLK%2520inhibitors%2520from%2520a%2520novel%2520chemotype%2520for%2520regulation%2520of%2520alternative%2520splicing%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D67%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Bischoff, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raaf, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bretner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Issinger, O. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niefind, K.</span><span> </span><span class="NLM_article-title">Structure of the human protein kinase CK2 catalytic subunit CK2alpha' and interaction thermodynamics with the regulatory subunit CK2beta</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">407</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2011&pages=1-12&author=N.+Bischoffauthor=B.+Olsenauthor=J.+Raafauthor=M.+Bretnerauthor=O.+G.+Issingerauthor=K.+Niefind&title=Structure+of+the+human+protein+kinase+CK2+catalytic+subunit+CK2alpha%27+and+interaction+thermodynamics+with+the+regulatory+subunit+CK2beta"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBischoff%26aufirst%3DN.%26aulast%3DOlsen%26aufirst%3DB.%26aulast%3DRaaf%26aufirst%3DJ.%26aulast%3DBretner%26aufirst%3DM.%26aulast%3DIssinger%26aufirst%3DO.%2BG.%26aulast%3DNiefind%26aufirst%3DK.%26atitle%3DStructure%2520of%2520the%2520human%2520protein%2520kinase%2520CK2%2520catalytic%2520subunit%2520CK2alpha%2527%2520and%2520interaction%2520thermodynamics%2520with%2520the%2520regulatory%2520subunit%2520CK2beta%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D407%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Pierce, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandretto, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, G. W.</span><span> </span><span class="NLM_article-title">Kinase inhibitors and the case for CH···O hydrogen bonds in protein–ligand binding</span> <span class="citation_source-journal">Proteins: Structure, Function, Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">–</span> <span class="NLM_lpage">576</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1002%2Fprot.10259" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=12402365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD38XptlGru7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2002&pages=567-576&author=A.+C.+Pierceauthor=K.+L.+Sandrettoauthor=G.+W.+Bemis&title=Kinase+inhibitors+and+the+case+for+CH%C2%B7%C2%B7%C2%B7O+hydrogen+bonds+in+protein%E2%80%93ligand+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase inhibitors and the case for CH···O hydrogen bonds in protein-ligand binding</span></div><div class="casAuthors">Pierce, Albert C.; Sandretto, Kathryn L.; Bemis, Guy W.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Genetics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">567-576</span>CODEN:
                <span class="NLM_cas:coden">PSFGEY</span>;
        ISSN:<span class="NLM_cas:issn">0887-3585</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Although the hydrogen bond is known to be an important mediator of intermol. interactions, there has yet to be an anal. of the role of CH···O hydrogen bonds in protein-ligand complexes.  In this work, we present evidence for such nonstandard hydrogen bonds from a survey of arom. ligands in 184 kinase crystal structures and 358 high-resoln. structures from the Protein Data Bank.  CH groups adjacent to the pos. charged nitrogen of nicotinamide exhibit geometric preferences strongly suggestive of hydrogen bonding interactions, as do heterocyclic CH groups in kinase ligands, while other arom. CH groups do not exhibit these characteristics.  Ab initio calcns. reveal a considerable range of CH···O hydrogen bonding potentials among different arom. ring systems, with nicotinamide and heterocycles preferred in kinase inhibitors showing particularly favorable interactions.  These results provide compelling evidence for the existence of CH···O hydrogen bonds in protein-ligand interactions, as well as information on the relative strength of various arom. CH donors.  Such knowledge will be of considerable value in protein modeling, ligand design, and structure-activity anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0ALx7F6vIXLVg90H21EOLACvtfcHk0lgDS3wZt6fI9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptlGru7c%253D&md5=641cc069501f9243df3ddc35cd3aa449</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1002%2Fprot.10259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.10259%26sid%3Dliteratum%253Aachs%26aulast%3DPierce%26aufirst%3DA.%2BC.%26aulast%3DSandretto%26aufirst%3DK.%2BL.%26aulast%3DBemis%26aufirst%3DG.%2BW.%26atitle%3DKinase%2520inhibitors%2520and%2520the%2520case%2520for%2520CH%25C2%25B7%25C2%25B7%25C2%25B7O%2520hydrogen%2520bonds%2520in%2520protein%25E2%2580%2593ligand%2520binding%26jtitle%3DProteins%253A%2520Structure%252C%2520Function%252C%2520Bioinf.%26date%3D2002%26volume%3D49%26spage%3D567%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Stamos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sliwkowski, M. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenbrot, C.</span><span> </span><span class="NLM_article-title">Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">46265</span><span class="NLM_x">–</span> <span class="NLM_lpage">46272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1074%2Fjbc.M207135200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=12196540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD38XovFKhsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=46265-46272&author=J.+Stamosauthor=M.+X.+Sliwkowskiauthor=C.+Eigenbrot&title=Structure+of+the+epidermal+growth+factor+receptor+kinase+domain+alone+and+in+complex+with+a+4-anilinoquinazoline+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor</span></div><div class="casAuthors">Stamos, Jennifer; Sliwkowski, Mark X.; Eigenbrot, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">46265-46272</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The crystal structure of the kinase domain from the epidermal growth factor receptor (EGFRK) including forty amino acids from the carboxyl-terminal tail has been detd. to 2.6-Å resoln., both with and without an EGFRK-specific inhibitor currently in Phase III clin. trials as an anti-cancer agent, erlotinib (OSI-774, CP-358,774, Tarceva).  The EGFR family members are distinguished from all other known receptor tyrosine kinases in possessing constitutive kinase activity without a phosphorylation event within their kinase domains.  Despite its lack of phosphorylation, we find that the EGFRK activation loop adopts a conformation similar to that of the phosphorylated active form of the kinase domain from the insulin receptor.  Surprisingly, key residues of a putative dimerization motif lying between the EGFRK domain and carboxyl-terminal substrate docking sites are found in close contact with the kinase domain.  Significant intermol. contacts involving the carboxyl-terminal tail are discussed with respect to receptor oligomerization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsObp1WYFaC7Vg90H21EOLACvtfcHk0ljF7ZNqh2vjuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovFKhsL4%253D&md5=c63c60b93756bd45fb2375c56ba38941</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M207135200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M207135200%26sid%3Dliteratum%253Aachs%26aulast%3DStamos%26aufirst%3DJ.%26aulast%3DSliwkowski%26aufirst%3DM.%2BX.%26aulast%3DEigenbrot%26aufirst%3DC.%26atitle%3DStructure%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520kinase%2520domain%2520alone%2520and%2520in%2520complex%2520with%2520a%25204-anilinoquinazoline%2520inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D46265%26epage%3D46272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Jacobs, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swenson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hare, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, K.</span><span> </span><span class="NLM_article-title">Pim-1 ligand-bound structures reveal the mechanism of serine/threonine kinase inhibition by LY294002</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">13728</span><span class="NLM_x">–</span> <span class="NLM_lpage">13734</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=13728-13734&author=M.+D.+Jacobsauthor=J.+Blackauthor=O.+Futerauthor=L.+Swensonauthor=B.+Hareauthor=M.+Flemingauthor=K.+Saxena&title=Pim-1+ligand-bound+structures+reveal+the+mechanism+of+serine%2Fthreonine+kinase+inhibition+by+LY294002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJacobs%26aufirst%3DM.%2BD.%26aulast%3DBlack%26aufirst%3DJ.%26aulast%3DFuter%26aufirst%3DO.%26aulast%3DSwenson%26aufirst%3DL.%26aulast%3DHare%26aufirst%3DB.%26aulast%3DFleming%26aufirst%3DM.%26aulast%3DSaxena%26aufirst%3DK.%26atitle%3DPim-1%2520ligand-bound%2520structures%2520reveal%2520the%2520mechanism%2520of%2520serine%252Fthreonine%2520kinase%2520inhibition%2520by%2520LY294002%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D13728%26epage%3D13734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Xing, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shieh, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selness, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devadas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hope, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compton, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stegeman, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broadus, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walden, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monahan, J. B.</span><span> </span><span class="NLM_article-title">Structural bioinformatics-based prediction of exceptional selectivity of p38 MAP kinase inhibitor PH-797804</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6402</span><span class="NLM_x">–</span> <span class="NLM_lpage">6411</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi900655f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=6402-6411&author=L.+Xingauthor=H.+S.+Shiehauthor=S.+R.+Selnessauthor=R.+V.+Devrajauthor=J.+K.+Walkerauthor=B.+Devadasauthor=H.+R.+Hopeauthor=R.+P.+Comptonauthor=J.+F.+Schindlerauthor=J.+L.+Hirschauthor=A.+G.+Bensonauthor=R.+G.+Kurumbailauthor=R.+A.+Stegemanauthor=J.+M.+Williamsauthor=R.+M.+Broadusauthor=Z.+Waldenauthor=J.+B.+Monahan&title=Structural+bioinformatics-based+prediction+of+exceptional+selectivity+of+p38+MAP+kinase+inhibitor+PH-797804"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1021%2Fbi900655f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi900655f%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DL.%26aulast%3DShieh%26aufirst%3DH.%2BS.%26aulast%3DSelness%26aufirst%3DS.%2BR.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DWalker%26aufirst%3DJ.%2BK.%26aulast%3DDevadas%26aufirst%3DB.%26aulast%3DHope%26aufirst%3DH.%2BR.%26aulast%3DCompton%26aufirst%3DR.%2BP.%26aulast%3DSchindler%26aufirst%3DJ.%2BF.%26aulast%3DHirsch%26aufirst%3DJ.%2BL.%26aulast%3DBenson%26aufirst%3DA.%2BG.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DStegeman%26aufirst%3DR.%2BA.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DBroadus%26aufirst%3DR.%2BM.%26aulast%3DWalden%26aufirst%3DZ.%26aulast%3DMonahan%26aufirst%3DJ.%2BB.%26atitle%3DStructural%2520bioinformatics-based%2520prediction%2520of%2520exceptional%2520selectivity%2520of%2520p38%2520MAP%2520kinase%2520inhibitor%2520PH-797804%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D6402%26epage%3D6411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Martz, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baur, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schattel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goettert, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer-Wrangowski, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, S. A.</span><span> </span><span class="NLM_article-title">Targeting the hinge glycine flip and the activation loop: novel approach to potent p38α inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7862</span><span class="NLM_x">–</span> <span class="NLM_lpage">7874</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300951u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1SlsrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7862-7874&author=K.+E.+Martzauthor=A.+Dornauthor=B.+Baurauthor=V.+Schattelauthor=M.+I.+Goettertauthor=S.+C.+Mayer-Wrangowskiauthor=D.+Rauhauthor=S.+A.+Laufer&title=Targeting+the+hinge+glycine+flip+and+the+activation+loop%3A+novel+approach+to+potent+p38%CE%B1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Hinge Glycine Flip and the Activation Loop: Novel Approach to Potent p38α Inhibitors</span></div><div class="casAuthors">Martz, Kathrin E.; Dorn, Angelika; Baur, Benjamin; Schattel, Verena; Goettert, Marcia I.; Mayer-Wrangowski, Svenja C.; Rauh, Daniel; Laufer, Stefan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7862-7874</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The p38 MAP kinase is a key player in signaling pathways regulating the biosynthesis of inflammatory cytokines.  Small mol. p38 inhibitors suppress the prodn. of these cytokines.  Therefore p38 is a promising drug target for novel anti-inflammatory drugs.  In this study, we report novel dibenzepinones, dibenzoxepines, and benzosuberones as p38α MAP kinase inhibitors.  Previously reported dibenzepinones and dibenzoxepines were chem. modified by introduction of functional groups or removal of a Ph ring.  This should result in targeting of the hydrophobic region I, the "deep pocket", and the hinge glycine flip of the kinase.  Potent inhibitors with IC50 values in the single digit nanomolar range (up to 3 nM) were identified.  Instead of targeting the "deep pocket" in the DFG-out conformation, interactions with the DFG-motif in the in-conformation could be obsd. by protein x-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9ZkVG97Ru-bVg90H21EOLACvtfcHk0ljF7ZNqh2vjuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1SlsrbP&md5=c1e76ed9bac1b5c1c4c5b4c630c845b8</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Fjm300951u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300951u%26sid%3Dliteratum%253Aachs%26aulast%3DMartz%26aufirst%3DK.%2BE.%26aulast%3DDorn%26aufirst%3DA.%26aulast%3DBaur%26aufirst%3DB.%26aulast%3DSchattel%26aufirst%3DV.%26aulast%3DGoettert%26aufirst%3DM.%2BI.%26aulast%3DMayer-Wrangowski%26aufirst%3DS.%2BC.%26aulast%3DRauh%26aufirst%3DD.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DTargeting%2520the%2520hinge%2520glycine%2520flip%2520and%2520the%2520activation%2520loop%253A%2520novel%2520approach%2520to%2520potent%2520p38%25CE%25B1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7862%26epage%3D7874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Stelmach, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pivnichny, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hop, C. E. C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strauss, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Keefe, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmatz, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaller, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, J. B.</span><span> </span><span class="NLM_article-title">Design and synthesis of potent, orally bioavailable dihydroquinazolinone inhibitors of p38 MAP kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">280</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2FS0960-894X%2802%2900752-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=12482439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVemu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=277-280&author=J.+E.+Stelmachauthor=L.+Liuauthor=S.+B.+Patelauthor=J.+V.+Pivnichnyauthor=G.+Scapinauthor=S.+Singhauthor=C.+E.+C.+A.+Hopauthor=Z.+Wangauthor=J.+R.+Straussauthor=P.+M.+Cameronauthor=E.+A.+Nicholsauthor=S.+J.+O%E2%80%99Keefeauthor=E.+A.+O%E2%80%99Neillauthor=D.+M.+Schmatzauthor=C.+D.+Schwartzauthor=C.+M.+Thompsonauthor=D.+M.+Zallerauthor=J.+B.+Doherty&title=Design+and+synthesis+of+potent%2C+orally+bioavailable+dihydroquinazolinone+inhibitors+of+p38+MAP+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of potent, orally bioavailable dihydroquinazolinone inhibitors of p38 MAP kinase</span></div><div class="casAuthors">Stelmach, John E.; Liu, Luping; Patel, Sangita B.; Pivnichny, James V.; Scapin, Giovanna; Singh, Suresh; Hop, Cornelis E. C. A.; Wang, Zhen; Strauss, John R.; Cameron, Patricia M.; Nichols, Elizabeth A.; O'Keefe, Stephen J.; O'Neill, Edward A.; Schmatz, Dennis M.; Schwartz, Cheryl D.; Thompson, Chris M.; Zaller, Dennis M.; Doherty, James B.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">277-280</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The development of potent, orally bioavailable (in rat) and selective dihydroquinazolinone inhibitors I (R = CO2Me, R1 = H, Br, 2-FC6H4, etc.; R = OMe, R1 = 2-Cl-4-FC6H3, 2,4-F2C6H3, 2-ClC6H4), II (R1 = 2-Cl-4-FC6H3, 2,4-F2C6H3, 2-ClC6H4, X = none, O, NH, CH2, CO, Y = CH, N) and III (R2 = Me, Et, CHMe2, etc.) of p38α MAP kinase is described.  For example, III (R2 = CMe3) was prepd. via the Still coupling of I (R = OSO2CF3, R1 = 2-Cl-4-FC6H3) with 1-tert-butyl-4-(trimethylstannyl)-1,2,3,6-tetrahydropyridine.  These analogs are hybrids of a pyridinylimidazole p38α inhibitor reported by Merck Research Labs. and VX-745.  Optimization of the C-5 Ph and the C-7 piperidinyl substituents led to the identification of III (R2 = CMe3) which gave excellent suppression of TNF-α prodn. in LPS-stimulated whole blood (IC50=10 nM) and good oral exposure in rats (F=68%, AUCn PO=0.58 μM h).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeEsr0ksZsw7Vg90H21EOLACvtfcHk0ljE4rqH3bCu1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVemu7c%253D&md5=489ab070411bc48e879737d57d98d745</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900752-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900752-7%26sid%3Dliteratum%253Aachs%26aulast%3DStelmach%26aufirst%3DJ.%2BE.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DPivnichny%26aufirst%3DJ.%2BV.%26aulast%3DScapin%26aufirst%3DG.%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DHop%26aufirst%3DC.%2BE.%2BC.%2BA.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DStrauss%26aufirst%3DJ.%2BR.%26aulast%3DCameron%26aufirst%3DP.%2BM.%26aulast%3DNichols%26aufirst%3DE.%2BA.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DS.%2BJ.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DE.%2BA.%26aulast%3DSchmatz%26aufirst%3DD.%2BM.%26aulast%3DSchwartz%26aufirst%3DC.%2BD.%26aulast%3DThompson%26aufirst%3DC.%2BM.%26aulast%3DZaller%26aufirst%3DD.%2BM.%26aulast%3DDoherty%26aufirst%3DJ.%2BB.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%252C%2520orally%2520bioavailable%2520dihydroquinazolinone%2520inhibitors%2520of%2520p38%2520MAP%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D277%26epage%3D280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Selness, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monahan, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devadas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durley, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shieh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hepperle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rucker, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jerome, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marrufo, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Promo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickory, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvira, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naing, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blevis-Bal, R.</span><span> </span><span class="NLM_article-title">Discovery of N-substituted pyridinones as potent and selective inhibitors of p38 kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5851</span><span class="NLM_x">–</span> <span class="NLM_lpage">5856</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2Fj.bmcl.2009.08.082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=19751974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtF2hurrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5851-5856&author=S.+R.+Selnessauthor=R.+V.+Devrajauthor=J.+B.+Monahanauthor=T.+L.+Boehmauthor=J.+K.+Walkerauthor=B.+Devadasauthor=R.+C.+Durleyauthor=R.+Kurumbailauthor=H.+Shiehauthor=L.+Xingauthor=M.+Hepperleauthor=P.+V.+Ruckerauthor=K.+D.+Jeromeauthor=A.+G.+Bensonauthor=L.+D.+Marrufoauthor=H.+M.+Madsenauthor=J.+Hitchcockauthor=T.+J.+Owenauthor=L.+Christieauthor=M.+A.+Promoauthor=B.+S.+Hickoryauthor=E.+Alviraauthor=W.+Naingauthor=R.+Blevis-Bal&title=Discovery+of+N-substituted+pyridinones+as+potent+and+selective+inhibitors+of+p38+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-substituted pyridinones as potent and selective inhibitors of p38 kinase</span></div><div class="casAuthors">Selness, Shaun R.; Devraj, Rajesh V.; Monahan, Joseph B.; Boehm, Terri L.; Walker, John K.; Devadas, Balekudru; Durley, Richard C.; Kurumbail, Ravi; Shieh, Huey; Xing, Li; Hepperle, Michael; Rucker, Paul V.; Jerome, Kevin D.; Benson, Alan G.; Marrufo, Laura D.; Madsen, Heather M.; Hitchcock, Jeff; Owen, Tom J.; Christie, Lance; Promo, Michele A.; Hickory, Brian S.; Alvira, Edgardo; Naing, Win; Blevis-Bal, Radhika</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5851-5856</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The identification and evolution of a series of potent and selective p38 inhibitors is described.  P38 inhibitors based on a N-benzyl pyridinone high-throughput screening hit were prepd. and their SAR explored.  Their design was guided by ligand bound co-crystals of p38α.  These efforts resulted in the identification of I and II as orally active inhibitors of p38 with significant efficacy in both acute and chronic models of inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraSKP6sKqHObVg90H21EOLACvtfcHk0ljE4rqH3bCu1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtF2hurrL&md5=bd43337cce34422c9501586a27857f5c</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.082%26sid%3Dliteratum%253Aachs%26aulast%3DSelness%26aufirst%3DS.%2BR.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DMonahan%26aufirst%3DJ.%2BB.%26aulast%3DBoehm%26aufirst%3DT.%2BL.%26aulast%3DWalker%26aufirst%3DJ.%2BK.%26aulast%3DDevadas%26aufirst%3DB.%26aulast%3DDurley%26aufirst%3DR.%2BC.%26aulast%3DKurumbail%26aufirst%3DR.%26aulast%3DShieh%26aufirst%3DH.%26aulast%3DXing%26aufirst%3DL.%26aulast%3DHepperle%26aufirst%3DM.%26aulast%3DRucker%26aufirst%3DP.%2BV.%26aulast%3DJerome%26aufirst%3DK.%2BD.%26aulast%3DBenson%26aufirst%3DA.%2BG.%26aulast%3DMarrufo%26aufirst%3DL.%2BD.%26aulast%3DMadsen%26aufirst%3DH.%2BM.%26aulast%3DHitchcock%26aufirst%3DJ.%26aulast%3DOwen%26aufirst%3DT.%2BJ.%26aulast%3DChristie%26aufirst%3DL.%26aulast%3DPromo%26aufirst%3DM.%2BA.%26aulast%3DHickory%26aufirst%3DB.%2BS.%26aulast%3DAlvira%26aufirst%3DE.%26aulast%3DNaing%26aufirst%3DW.%26aulast%3DBlevis-Bal%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520N-substituted%2520pyridinones%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520p38%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5851%26epage%3D5856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Pargellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churchill, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grob, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, J.</span><span> </span><span class="NLM_article-title">Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1038%2Fnsb770" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1Kisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=268-272&author=C.+Pargellisauthor=L.+Tongauthor=L.+Churchillauthor=P.+F.+Cirilloauthor=T.+Gilmoreauthor=A.+G.+Grahamauthor=P.+M.+Grobauthor=E.+R.+Hickeyauthor=N.+Mossauthor=S.+Pavauthor=J.+Regan&title=Inhibition+of+p38+MAP+kinase+by+utilizing+a+novel+allosteric+binding+site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site</span></div><div class="casAuthors">Pargellis, Christopher; Tong, Liang; Churchill, Laurie; Cirillo, Pier F.; Gilmore, Thomas; Graham, Anne G.; Grob, Peter M.; Hickey, Eugene R.; Moss, Neil; Pav, Susan; Regan, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">268-272</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">The p38 MAP kinase plays a crucial role in regulating the prodn. of proinflammatory cytokines, such as tumor necrosis factor and interleukin-1.  Blocking this kinase may offer an effective therapy for treating many inflammatory diseases.  Here we report a new allosteric binding site for a diaryl urea class of highly potent and selective inhibitors against human p38 MAP kinase.  The formation of this binding site requires a large conformational change not obsd. previously for any of the protein Ser/Thr kinases.  This change is in the highly conserved Asp-Phe-Gly motif within the active site of the kinase.  Soln. studies demonstrate that this class of compds. has slow binding kinetics, consistent with the requirement for conformational change.  Improving interactions in this allosteric pocket, as well as establishing binding interactions in the ATP pocket, enhanced the affinity of the inhibitors by 12,000-fold.  One of the most potent compds. in this series, BIRB 796, has picomolar affinity for the kinase and low nanomolar inhibitory activity in cell culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqT8_QT7_pbYrVg90H21EOLACvtfcHk0ljIA5WmNJRNzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1Kisbk%253D&md5=68850ecdbe08df4285ba38cfa2c93ea4</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1038%2Fnsb770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb770%26sid%3Dliteratum%253Aachs%26aulast%3DPargellis%26aufirst%3DC.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DChurchill%26aufirst%3DL.%26aulast%3DCirillo%26aufirst%3DP.%2BF.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DA.%2BG.%26aulast%3DGrob%26aufirst%3DP.%2BM.%26aulast%3DHickey%26aufirst%3DE.%2BR.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DRegan%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520p38%2520MAP%2520kinase%2520by%2520utilizing%2520a%2520novel%2520allosteric%2520binding%2520site%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D268%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Komander, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kular, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuttelkopf, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prakash, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrido-Franco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Aalten, D. M.</span><span> </span><span class="NLM_article-title">Interactions of LY333531 and other bisindolyl maleimide inhibitors with PDK1</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=215-226&author=D.+Komanderauthor=G.+S.+Kularauthor=A.+W.+Schuttelkopfauthor=M.+Deakauthor=K.+R.+Prakashauthor=J.+Bainauthor=M.+Elliottauthor=M.+Garrido-Francoauthor=A.+P.+Kozikowskiauthor=D.+R.+Alessiauthor=D.+M.+van+Aalten&title=Interactions+of+LY333531+and+other+bisindolyl+maleimide+inhibitors+with+PDK1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKomander%26aufirst%3DD.%26aulast%3DKular%26aufirst%3DG.%2BS.%26aulast%3DSchuttelkopf%26aufirst%3DA.%2BW.%26aulast%3DDeak%26aufirst%3DM.%26aulast%3DPrakash%26aufirst%3DK.%2BR.%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DGarrido-Franco%26aufirst%3DM.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3Dvan%2BAalten%26aufirst%3DD.%2BM.%26atitle%3DInteractions%2520of%2520LY333531%2520and%2520other%2520bisindolyl%2520maleimide%2520inhibitors%2520with%2520PDK1%26jtitle%3DStructure%26date%3D2004%26volume%3D12%26spage%3D215%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Aronov, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germann, U. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janetka, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltais, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Botella, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namchuk, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straub, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X.</span><span> </span><span class="NLM_article-title">Flipped out: structure-guided design of selective pyrazolylpyrrole ERK inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1280</span><span class="NLM_x">–</span> <span class="NLM_lpage">1287</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061381f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1280-1287&author=A.+M.+Aronovauthor=C.+Bakerauthor=G.+W.+Bemisauthor=J.+Caoauthor=G.+Chenauthor=P.+J.+Fordauthor=U.+A.+Germannauthor=J.+Greenauthor=M.+R.+Haleauthor=M.+Jacobsauthor=J.+W.+Janetkaauthor=F.+Maltaisauthor=G.+Martinez-Botellaauthor=M.+N.+Namchukauthor=J.+Straubauthor=Q.+Tangauthor=X.+Xie&title=Flipped+out%3A+structure-guided+design+of+selective+pyrazolylpyrrole+ERK+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1021%2Fjm061381f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061381f%26sid%3Dliteratum%253Aachs%26aulast%3DAronov%26aufirst%3DA.%2BM.%26aulast%3DBaker%26aufirst%3DC.%26aulast%3DBemis%26aufirst%3DG.%2BW.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DFord%26aufirst%3DP.%2BJ.%26aulast%3DGermann%26aufirst%3DU.%2BA.%26aulast%3DGreen%26aufirst%3DJ.%26aulast%3DHale%26aufirst%3DM.%2BR.%26aulast%3DJacobs%26aufirst%3DM.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26aulast%3DMaltais%26aufirst%3DF.%26aulast%3DMartinez-Botella%26aufirst%3DG.%26aulast%3DNamchuk%26aufirst%3DM.%2BN.%26aulast%3DStraub%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DQ.%26aulast%3DXie%26aufirst%3DX.%26atitle%3DFlipped%2520out%253A%2520structure-guided%2520design%2520of%2520selective%2520pyrazolylpyrrole%2520ERK%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1280%26epage%3D1287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Dudkin, V. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreatsoulas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrington, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikuta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stirdivant, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drakas, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobell, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepp-Lorenzino, L.</span><span> </span><span class="NLM_article-title">Pyridyl aminothiazoles as potent inhibitors of Chk1 with slow dissociation rates</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2609</span><span class="NLM_x">–</span> <span class="NLM_lpage">2612</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2609-2612&author=V.+Y.+Dudkinauthor=K.+Rickertauthor=C.+Kreatsoulasauthor=C.+Wangauthor=K.+L.+Arringtonauthor=M.+E.+Fraleyauthor=G.+D.+Hartmanauthor=Y.+Yanauthor=M.+Ikutaauthor=S.+M.+Stirdivantauthor=R.+A.+Drakasauthor=E.+S.+Walshauthor=K.+Hamiltonauthor=C.+A.+Buserauthor=R.+B.+Lobellauthor=L.+Sepp-Lorenzino&title=Pyridyl+aminothiazoles+as+potent+inhibitors+of+Chk1+with+slow+dissociation+rates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDudkin%26aufirst%3DV.%2BY.%26aulast%3DRickert%26aufirst%3DK.%26aulast%3DKreatsoulas%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DArrington%26aufirst%3DK.%2BL.%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DIkuta%26aufirst%3DM.%26aulast%3DStirdivant%26aufirst%3DS.%2BM.%26aulast%3DDrakas%26aufirst%3DR.%2BA.%26aulast%3DWalsh%26aufirst%3DE.%2BS.%26aulast%3DHamilton%26aufirst%3DK.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26aulast%3DLobell%26aufirst%3DR.%2BB.%26aulast%3DSepp-Lorenzino%26aufirst%3DL.%26atitle%3DPyridyl%2520aminothiazoles%2520as%2520potent%2520inhibitors%2520of%2520Chk1%2520with%2520slow%2520dissociation%2520rates%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2609%26epage%3D2612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Whelligan, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solanki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K.-M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mas-Droux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barillari, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grummitt, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Montfort, R. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayliss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelder, S.</span><span> </span><span class="NLM_article-title">Aminopyrazine inhibitors binding to an unusual inactive conformation of the mitotic kinase Nek2: SAR and structural characterization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7682</span><span class="NLM_x">–</span> <span class="NLM_lpage">7698</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1008727" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Krs7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7682-7698&author=D.+K.+Whelliganauthor=S.+Solankiauthor=D.+Taylorauthor=D.+W.+Thomsonauthor=K.-M.+J.+Cheungauthor=K.+Boxallauthor=C.+Mas-Drouxauthor=C.+Barillariauthor=S.+Burnsauthor=C.+G.+Grummittauthor=I.+Collinsauthor=R.+L.+M.+van+Montfortauthor=G.+W.+Aherneauthor=R.+Baylissauthor=S.+Hoelder&title=Aminopyrazine+inhibitors+binding+to+an+unusual+inactive+conformation+of+the+mitotic+kinase+Nek2%3A+SAR+and+structural+characterization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Aminopyrazine Inhibitors Binding to an Unusual Inactive Conformation of the Mitotic Kinase Nek2: SAR and Structural Characterization</span></div><div class="casAuthors">Whelligan, Daniel K.; Solanki, Savade; Taylor, Dawn; Thomson, Douglas W.; Cheung, Kwai-Ming J.; Boxall, Kathy; Mas-Droux, Corine; Barillari, Caterina; Burns, Samantha; Grummitt, Charles G.; Collins, Ian; van Montfort, Rob L. M.; Aherne, G. Wynne; Bayliss, Richard; Hoelder, Swen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7682-7698</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report herein the first systematic exploration of inhibitors of the mitotic kinase Nek2.  Starting from HTS hit aminopyrazine I, compds. with improved activity were identified using structure-based design.  Our structural biol. investigations reveal two notable observations.  First, I and related compds. bind to an unusual, inactive conformation of the kinase which to the best of our knowledge has not been reported for other types of kinase inhibitors.  Second, a phenylalanine residue at the center of the ATP pocket strongly affects the ability of the inhibitor to bind to the protein.  The implications of these observations are discussed, and the work described here defines key features for potent and selective Nek2 inhibition, which will aid the identification of more advanced inhibitors of Nek2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhzgVaRXbQkrVg90H21EOLACvtfcHk0lgdyqOSnrkMGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Krs7nI&md5=d1a4af6869319bed0a340e8ff7db4397</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1021%2Fjm1008727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1008727%26sid%3Dliteratum%253Aachs%26aulast%3DWhelligan%26aufirst%3DD.%2BK.%26aulast%3DSolanki%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DD.%26aulast%3DThomson%26aufirst%3DD.%2BW.%26aulast%3DCheung%26aufirst%3DK.-M.%2BJ.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DMas-Droux%26aufirst%3DC.%26aulast%3DBarillari%26aufirst%3DC.%26aulast%3DBurns%26aufirst%3DS.%26aulast%3DGrummitt%26aufirst%3DC.%2BG.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3Dvan%2BMontfort%26aufirst%3DR.%2BL.%2BM.%26aulast%3DAherne%26aufirst%3DG.%2BW.%26aulast%3DBayliss%26aufirst%3DR.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DAminopyrazine%2520inhibitors%2520binding%2520to%2520an%2520unusual%2520inactive%2520conformation%2520of%2520the%2520mitotic%2520kinase%2520Nek2%253A%2520SAR%2520and%2520structural%2520characterization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7682%26epage%3D7698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuruganti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruslim, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramphal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherrington, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendel, D. B.</span><span> </span><span class="NLM_article-title">A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">7345</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=7345-55&author=J.+G.+Christensenauthor=R.+Schreckauthor=J.+Burrowsauthor=P.+Kurugantiauthor=E.+Chanauthor=P.+Leauthor=J.+Chenauthor=X.+Wangauthor=L.+Ruslimauthor=R.+Blakeauthor=K.+E.+Lipsonauthor=J.+Ramphalauthor=S.+Doauthor=J.+J.+Cuiauthor=J.+M.+Cherringtonauthor=D.+B.+Mendel&title=A+selective+small+molecule+inhibitor+of+c-Met+kinase+inhibits+c-Met-dependent+phenotypes+in+vitro+and+exhibits+cytoreductive+antitumor+activity+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DSchreck%26aufirst%3DR.%26aulast%3DBurrows%26aufirst%3DJ.%26aulast%3DKuruganti%26aufirst%3DP.%26aulast%3DChan%26aufirst%3DE.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DRuslim%26aufirst%3DL.%26aulast%3DBlake%26aufirst%3DR.%26aulast%3DLipson%26aufirst%3DK.%2BE.%26aulast%3DRamphal%26aufirst%3DJ.%26aulast%3DDo%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DCherrington%26aufirst%3DJ.%2BM.%26aulast%3DMendel%26aufirst%3DD.%2BB.%26atitle%3DA%2520selective%2520small%2520molecule%2520inhibitor%2520of%2520c-Met%2520kinase%2520inhibits%2520c-Met-dependent%2520phenotypes%2520in%2520vitro%2520and%2520exhibits%2520cytoreductive%2520antitumor%2520activity%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D7345%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Young, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeliger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggs, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyan, J.</span><span> </span><span class="NLM_article-title">Structure of the kinase domain of an imatinib-resistant Abl mutant in complex with the aurora kinase inhibitor VX-680</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1014</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1158%2F0008-5472.CAN-05-2788" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=16424036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsFOhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=1007-1014&author=M.+A.+Youngauthor=N.+P.+Shahauthor=L.+H.+Chaoauthor=M.+Seeligerauthor=Z.+V.+Milanovauthor=W.+H.+Biggsauthor=D.+K.+Treiberauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhartauthor=C.+L.+Sawyersauthor=J.+Kuriyan&title=Structure+of+the+kinase+domain+of+an+imatinib-resistant+Abl+mutant+in+complex+with+the+aurora+kinase+inhibitor+VX-680"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the Kinase Domain of an Imatinib-Resistant Abl Mutant in Complex with the Aurora Kinase Inhibitor VX-680</span></div><div class="casAuthors">Young, Matthew A.; Shah, Neil P.; Chao, Luke H.; Seeliger, Markus; Milanov, Zdravko V.; Biggs, William H., III; Treiber, Daniel K.; Patel, Hitesh K.; Zarrinkar, Patrick P.; Lockhart, David J.; Sawyers, Charles L.; Kuriyan, John</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1007-1014</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We present a high-resoln. (2.0 Å) crystal structure of the catalytic domain of a mutant form of the Abl tyrosine kinase (H396P; Abl-1a numbering) that is resistant to the Abl inhibitor imatinib.  The structure is detd. in complex with the small-mol. inhibitor VX-680 (Vertex Pharmaceuticals, Cambridge, MA), which blocks the activity of various imatinib-resistant mutant forms of Abl, including one (T315I) that is resistant to both imatinib and BMS-354825 (dasatinib), a dual Src/Abl inhibitor that seems to be clin. effective against all other imatinib-resistant forms of BCR-Abl.  VX-680 is shown to have significant inhibitory activity against BCR-Abl bearing the T315I mutation in patient-derived samples.  The Abl kinase domain bound to VX-680 is not phosphorylated on the activation loop in the crystal structure but is nevertheless in an active conformation, previously unobserved for Abl and inconsistent with the binding of imatinib.  The adoption of an active conformation is most likely the result of synergy between the His396Pro mutation, which destabilizes the inactive conformation required for imatinib binding, and the binding of VX-680, which favors the active conformation through hydrogen bonding and steric effects.  VX-680 is bound to Abl in a mode that accommodates the substitution of isoleucine for threonine at residue 315 (the "gatekeeper" position).  The avoidance of the innermost cavity of the Abl kinase domain by VX-680 and the specific recognition of the active conformation explain the effectiveness of this compd. against mutant forms of BCR-Abl, including those with mutations at the gatekeeper position.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNV6YSmt1NWrVg90H21EOLACvtfcHk0lgdyqOSnrkMGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsFOhtw%253D%253D&md5=a31ed99bdc51cf266c8c10dfceb1800c</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-2788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-2788%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DM.%2BA.%26aulast%3DShah%26aufirst%3DN.%2BP.%26aulast%3DChao%26aufirst%3DL.%2BH.%26aulast%3DSeeliger%26aufirst%3DM.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26aulast%3DKuriyan%26aufirst%3DJ.%26atitle%3DStructure%2520of%2520the%2520kinase%2520domain%2520of%2520an%2520imatinib-resistant%2520Abl%2520mutant%2520in%2520complex%2520with%2520the%2520aurora%2520kinase%2520inhibitor%2520VX-680%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D1007%26epage%3D1014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Petrov, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockerill, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickerson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mook, R. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusnak, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lackey, K. E.</span><span> </span><span class="NLM_article-title">Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4686</span><span class="NLM_x">–</span> <span class="NLM_lpage">4691</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2Fj.bmcl.2006.05.090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=16777410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsFOlu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4686-4691&author=K.+G.+Petrovauthor=Y.-M.+Zhangauthor=M.+Carterauthor=G.+S.+Cockerillauthor=S.+Dickersonauthor=C.+A.+Gauthierauthor=Y.+Guoauthor=R.+A.+Mookauthor=D.+W.+Rusnakauthor=A.+L.+Walkerauthor=E.+R.+Woodauthor=K.+E.+Lackey&title=Optimization+and+SAR+for+dual+ErbB-1%2FErbB-2+tyrosine+kinase+inhibition+in+the+6-furanylquinazoline+series"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series</span></div><div class="casAuthors">Petrov, Kimberly G.; Zhang, Yue-Mei; Carter, Malcolm; Cockerill, G. Stuart; Dickerson, Scott; Gauthier, Cassandra A.; Guo, Yu; Mook, Robert A.; Rusnak, David W.; Walker, Ann L.; Wood, Edgar R.; Lackey, Karen E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4686-4691</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Synthetic modifications on a 6-furanylquinazoline scaffold to optimize the dual ErbB-1/ErbB-2 tyrosine kinase inhibition afforded consistent SAR whereby a 4-(3-fluorobenzyloxy)-3-haloanilino structure provided the best enzyme potency and cellular selectivity.  Changes made to the 6-furanyl group had little impact on the enzyme activity, but appeared to dramatically affect the cellular efficacy.  The discovery of lapatinib emerged from this work.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtejUjyH9in7Vg90H21EOLACvtfcHk0lgOcTvgeO5REQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsFOlu7o%253D&md5=946712927ab1a7940ea3ef2fea7574b5</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.05.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.05.090%26sid%3Dliteratum%253Aachs%26aulast%3DPetrov%26aufirst%3DK.%2BG.%26aulast%3DZhang%26aufirst%3DY.-M.%26aulast%3DCarter%26aufirst%3DM.%26aulast%3DCockerill%26aufirst%3DG.%2BS.%26aulast%3DDickerson%26aufirst%3DS.%26aulast%3DGauthier%26aufirst%3DC.%2BA.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DMook%26aufirst%3DR.%2BA.%26aulast%3DRusnak%26aufirst%3DD.%2BW.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26aulast%3DWood%26aufirst%3DE.%2BR.%26aulast%3DLackey%26aufirst%3DK.%2BE.%26atitle%3DOptimization%2520and%2520SAR%2520for%2520dual%2520ErbB-1%252FErbB-2%2520tyrosine%2520kinase%2520inhibition%2520in%2520the%25206-furanylquinazoline%2520series%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4686%26epage%3D4691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">D’Angelo, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booker, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fellows, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan-Lefko, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rainbeau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reider, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rex, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegmund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasker, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dussault, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. S.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of potent c-Met inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5766</span><span class="NLM_x">–</span> <span class="NLM_lpage">5779</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8006189" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5766-5779&author=N.+D.+D%E2%80%99Angeloauthor=S.+F.+Bellonauthor=S.+K.+Bookerauthor=Y.+Chengauthor=A.+Coxonauthor=C.+Dominguezauthor=I.+Fellowsauthor=D.+Hoffmanauthor=R.+Hungateauthor=P.+Kaplan-Lefkoauthor=M.+R.+Leeauthor=C.+Liauthor=L.+Liuauthor=E.+Rainbeauauthor=P.+J.+Reiderauthor=K.+Rexauthor=A.+Siegmundauthor=Y.+Sunauthor=A.+S.+Taskerauthor=N.+Xiauthor=S.+Xuauthor=Y.+Yangauthor=Y.+Zhangauthor=T.+L.+Burgessauthor=I.+Dussaultauthor=T.+S.+Kim&title=Design%2C+synthesis%2C+and+biological+evaluation+of+potent+c-Met+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1021%2Fjm8006189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8006189%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Angelo%26aufirst%3DN.%2BD.%26aulast%3DBellon%26aufirst%3DS.%2BF.%26aulast%3DBooker%26aufirst%3DS.%2BK.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DDominguez%26aufirst%3DC.%26aulast%3DFellows%26aufirst%3DI.%26aulast%3DHoffman%26aufirst%3DD.%26aulast%3DHungate%26aufirst%3DR.%26aulast%3DKaplan-Lefko%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DRainbeau%26aufirst%3DE.%26aulast%3DReider%26aufirst%3DP.%2BJ.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DSiegmund%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DTasker%26aufirst%3DA.%2BS.%26aulast%3DXi%26aufirst%3DN.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBurgess%26aufirst%3DT.%2BL.%26aulast%3DDussault%26aufirst%3DI.%26aulast%3DKim%26aufirst%3DT.%2BS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520potent%2520c-Met%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5766%26epage%3D5779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Meier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brookings, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceska, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMillan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saville, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mushtaq, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savva, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, R. A.</span><span> </span><span class="NLM_article-title">Engineering human MEK-1 for structural studies: a case study of combinatorial domain hunting</span> <span class="citation_source-journal">J. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">177</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2012&pages=329-334&author=C.+Meierauthor=D.+C.+Brookingsauthor=T.+A.+Ceskaauthor=C.+Doyleauthor=H.+Gongauthor=D.+McMillanauthor=G.+P.+Savilleauthor=A.+Mushtaqauthor=D.+Knightauthor=S.+Reichauthor=L.+H.+Pearlauthor=K.+A.+Powellauthor=R.+Savvaauthor=R.+A.+Allen&title=Engineering+human+MEK-1+for+structural+studies%3A+a+case+study+of+combinatorial+domain+hunting"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeier%26aufirst%3DC.%26aulast%3DBrookings%26aufirst%3DD.%2BC.%26aulast%3DCeska%26aufirst%3DT.%2BA.%26aulast%3DDoyle%26aufirst%3DC.%26aulast%3DGong%26aufirst%3DH.%26aulast%3DMcMillan%26aufirst%3DD.%26aulast%3DSaville%26aufirst%3DG.%2BP.%26aulast%3DMushtaq%26aufirst%3DA.%26aulast%3DKnight%26aufirst%3DD.%26aulast%3DReich%26aufirst%3DS.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DPowell%26aufirst%3DK.%2BA.%26aulast%3DSavva%26aufirst%3DR.%26aulast%3DAllen%26aufirst%3DR.%2BA.%26atitle%3DEngineering%2520human%2520MEK-1%2520for%2520structural%2520studies%253A%2520a%2520case%2520study%2520of%2520combinatorial%2520domain%2520hunting%26jtitle%3DJ.%2520Struct.%2520Biol.%26date%3D2012%26volume%3D177%26spage%3D329%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Betzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubbers, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakkaraj, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georg, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schonbrunn, E.</span><span> </span><span class="NLM_article-title">Discovery of a potential allosteric ligand binding site in CDK2</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">492</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb100410m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1Gisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=492-501&author=S.+Betziauthor=R.+Alamauthor=M.+Martinauthor=D.+J.+Lubbersauthor=H.+Hanauthor=S.+R.+Jakkarajauthor=G.+I.+Georgauthor=E.+Schonbrunn&title=Discovery+of+a+potential+allosteric+ligand+binding+site+in+CDK2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potential Allosteric Ligand Binding Site in CDK2</span></div><div class="casAuthors">Betzi, Stephane; Alam, Riazul; Martin, Mathew; Lubbers, Donna J.; Han, Huijong; Jakkaraj, Sudhakar R.; Georg, Gunda I.; Schonbrunn, Ernst</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">492-501</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclin-dependent kinases (CDKs) are key regulatory enzymes in cell cycle progression and transcription.  Aberrant activity of CDKs has been implicated in a no. of medical conditions, and numerous small mol. CDK inhibitors have been reported as potential drug leads.  However, these inhibitors exclusively bind to the ATP site, which is largely conserved among protein kinases, and clin. trials have not resulted in viable drug candidates, attributed in part to the lack of target selectivity.  CDKs are unique among protein kinases, as their functionality strictly depends on assocn. with their partner proteins, the cyclins.  In an effort to identify potential target sites for disruption of the CDK-cyclin interaction, we probed the extrinsic fluorophore 8-anilino-1-naphthalene sulfonate (ANS) with human CDK2 and cyclin A using fluorescence spectroscopy and protein crystallog.  ANS interacts with free CDK2 in a satn.-dependent manner with an apparent Kd of 37 μM, and cyclin A displaced ANS from CDK2 with an EC50 value of 0.6 μM.  Co-crystal structures with ANS alone and in ternary complex with ATP site-directed inhibitors revealed two ANS mols. bound adjacent to one another, away from the ATP site, in a large pocket that extends from the DFG region above the C-helix.  Binding of ANS is accompanied by substantial structural changes in CDK2, resulting in a C-helix conformation that is incompatible for cyclin A assocn.  These findings indicate the potential of the ANS binding pocket as a new target site for allosteric inhibitors disrupting the interaction of CDKs and cyclins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGlhg8YO4Yl7Vg90H21EOLACvtfcHk0lgOcTvgeO5REQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1Gisb4%253D&md5=893aed13b1638f7626fbb4851014fe6e</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1021%2Fcb100410m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb100410m%26sid%3Dliteratum%253Aachs%26aulast%3DBetzi%26aufirst%3DS.%26aulast%3DAlam%26aufirst%3DR.%26aulast%3DMartin%26aufirst%3DM.%26aulast%3DLubbers%26aufirst%3DD.%2BJ.%26aulast%3DHan%26aufirst%3DH.%26aulast%3DJakkaraj%26aufirst%3DS.%2BR.%26aulast%3DGeorg%26aufirst%3DG.%2BI.%26aulast%3DSchonbrunn%26aufirst%3DE.%26atitle%3DDiscovery%2520of%2520a%2520potential%2520allosteric%2520ligand%2520binding%2520site%2520in%2520CDK2%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2011%26volume%3D6%26spage%3D492%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Axten, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romeril, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heerding, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minthorn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mencken, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigethy, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomberlin, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassell, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahler, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shewchuk, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gampe, R. T.</span><span> </span><span class="NLM_article-title">Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1<i>H</i>-indol-5-yl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7193</span><span class="NLM_x">–</span> <span class="NLM_lpage">7207</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300713s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7193-7207&author=J.+M.+Axtenauthor=J.+R.+Medinaauthor=Y.+Fengauthor=A.+Shuauthor=S.+P.+Romerilauthor=S.+W.+Grantauthor=W.+H.+Liauthor=D.+A.+Heerdingauthor=E.+Minthornauthor=T.+Menckenauthor=C.+Atkinsauthor=Q.+Liuauthor=S.+Rabindranauthor=R.+Kumarauthor=X.+Hongauthor=A.+Goetzauthor=T.+Stanleyauthor=J.+D.+Taylorauthor=S.+D.+Sigethyauthor=G.+H.+Tomberlinauthor=A.+M.+Hassellauthor=K.+M.+Kahlerauthor=L.+M.+Shewchukauthor=R.+T.+Gampe&title=Discovery+of+7-methyl-5-%281-%7B%5B3-%28trifluoromethyl%29phenyl%5Dacetyl%7D-2%2C3-dihydro-1H-indol-5-yl%29-7H-pyrrolo%5B2%2C3-d%5Dpyrimidin-4-amine+%28GSK2606414%29%2C+a+potent+and+selective+first-in-class+inhibitor+of+protein+kinase+R+%28PKR%29-like+endoplasmic+reticulum+kinase+%28PERK%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1021%2Fjm300713s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300713s%26sid%3Dliteratum%253Aachs%26aulast%3DAxten%26aufirst%3DJ.%2BM.%26aulast%3DMedina%26aufirst%3DJ.%2BR.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DShu%26aufirst%3DA.%26aulast%3DRomeril%26aufirst%3DS.%2BP.%26aulast%3DGrant%26aufirst%3DS.%2BW.%26aulast%3DLi%26aufirst%3DW.%2BH.%26aulast%3DHeerding%26aufirst%3DD.%2BA.%26aulast%3DMinthorn%26aufirst%3DE.%26aulast%3DMencken%26aufirst%3DT.%26aulast%3DAtkins%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DRabindran%26aufirst%3DS.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DHong%26aufirst%3DX.%26aulast%3DGoetz%26aufirst%3DA.%26aulast%3DStanley%26aufirst%3DT.%26aulast%3DTaylor%26aufirst%3DJ.%2BD.%26aulast%3DSigethy%26aufirst%3DS.%2BD.%26aulast%3DTomberlin%26aufirst%3DG.%2BH.%26aulast%3DHassell%26aufirst%3DA.%2BM.%26aulast%3DKahler%26aufirst%3DK.%2BM.%26aulast%3DShewchuk%26aufirst%3DL.%2BM.%26aulast%3DGampe%26aufirst%3DR.%2BT.%26atitle%3DDiscovery%2520of%25207-methyl-5-%25281-%257B%255B3-%2528trifluoromethyl%2529phenyl%255Dacetyl%257D-2%252C3-dihydro-1H-indol-5-yl%2529-7H-pyrrolo%255B2%252C3-d%255Dpyrimidin-4-amine%2520%2528GSK2606414%2529%252C%2520a%2520potent%2520and%2520selective%2520first-in-class%2520inhibitor%2520of%2520protein%2520kinase%2520R%2520%2528PKR%2529-like%2520endoplasmic%2520reticulum%2520kinase%2520%2528PERK%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7193%26epage%3D7207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Bellon, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan-Lefko, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rex, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dussault, I.</span><span> </span><span class="NLM_article-title">c-Met inhibitors with novel binding mode show activity against several hereditary papillary renal cell carcinoma-related mutations</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">2675</span><span class="NLM_x">–</span> <span class="NLM_lpage">2683</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=2675-2683&author=S.+F.+Bellonauthor=P.+Kaplan-Lefkoauthor=Y.+Yangauthor=Y.+Zhangauthor=J.+Moriguchiauthor=K.+Rexauthor=C.+W.+Johnsonauthor=P.+E.+Roseauthor=A.+M.+Longauthor=A.+B.+O%E2%80%99Connorauthor=Y.+Guauthor=A.+Coxonauthor=T.+S.+Kimauthor=A.+Taskerauthor=T.+L.+Burgessauthor=I.+Dussault&title=c-Met+inhibitors+with+novel+binding+mode+show+activity+against+several+hereditary+papillary+renal+cell+carcinoma-related+mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBellon%26aufirst%3DS.%2BF.%26aulast%3DKaplan-Lefko%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMoriguchi%26aufirst%3DJ.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DC.%2BW.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DLong%26aufirst%3DA.%2BM.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DA.%2BB.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DT.%2BS.%26aulast%3DTasker%26aufirst%3DA.%26aulast%3DBurgess%26aufirst%3DT.%2BL.%26aulast%3DDussault%26aufirst%3DI.%26atitle%3Dc-Met%2520inhibitors%2520with%2520novel%2520binding%2520mode%2520show%2520activity%2520against%2520several%2520hereditary%2520papillary%2520renal%2520cell%2520carcinoma-related%2520mutations%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D2675%26epage%3D2683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Norman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fellows, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Angelo, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rex, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dussault, I.</span><span> </span><span class="NLM_article-title">Structure-based design of novel class II c-Met inhibitors: 1. Identification of pyrazolone-based derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1858</span><span class="NLM_x">–</span> <span class="NLM_lpage">1867</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201330u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1858-1867&author=M.+H.+Normanauthor=L.+Liuauthor=M.+Leeauthor=N.+Xiauthor=I.+Fellowsauthor=N.+D.+D%E2%80%99Angeloauthor=C.+Dominguezauthor=K.+Rexauthor=S.+F.+Bellonauthor=T.+S.+Kimauthor=I.+Dussault&title=Structure-based+design+of+novel+class+II+c-Met+inhibitors%3A+1.+Identification+of+pyrazolone-based+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Fjm201330u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201330u%26sid%3Dliteratum%253Aachs%26aulast%3DNorman%26aufirst%3DM.%2BH.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DXi%26aufirst%3DN.%26aulast%3DFellows%26aufirst%3DI.%26aulast%3DD%25E2%2580%2599Angelo%26aufirst%3DN.%2BD.%26aulast%3DDominguez%26aufirst%3DC.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DBellon%26aufirst%3DS.%2BF.%26aulast%3DKim%26aufirst%3DT.%2BS.%26aulast%3DDussault%26aufirst%3DI.%26atitle%3DStructure-based%2520design%2520of%2520novel%2520class%2520II%2520c-Met%2520inhibitors%253A%25201.%2520Identification%2520of%2520pyrazolone-based%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1858%26epage%3D1867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polverino, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bready, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choquette, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMelfi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doerr, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neervannan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potashman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roveto, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrag, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starnes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teffera, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanon, R.</span><span> </span><span class="NLM_article-title">Evaluation of a series of naphthamides as potent, orally active vascular endothelial growth factor receptor-2 tyrosine kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1668</span><span class="NLM_x">–</span> <span class="NLM_lpage">1680</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701098w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1668-1680&author=M.+M.+Weissauthor=J.-C.+Harmangeauthor=A.+J.+Polverinoauthor=D.+Bauerauthor=L.+Berryauthor=V.+Berryauthor=G.+Borgauthor=J.+Breadyauthor=D.+Chenauthor=D.+Choquetteauthor=A.+Coxonauthor=T.+DeMelfiauthor=N.+Doerrauthor=J.+Estradaauthor=J.+Flynnauthor=R.+F.+Graceffaauthor=S.+P.+Harrimanauthor=S.+Kaufmanauthor=D.+S.+Laauthor=A.+Longauthor=S.+Neervannanauthor=V.+F.+Patelauthor=M.+Potashmanauthor=K.+Regalauthor=P.+M.+Rovetoauthor=M.+L.+Schragauthor=C.+Starnesauthor=A.+Taskerauthor=Y.+Tefferaauthor=D.+A.+Whittingtonauthor=R.+Zanon&title=Evaluation+of+a+series+of+naphthamides+as+potent%2C+orally+active+vascular+endothelial+growth+factor+receptor-2+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1021%2Fjm701098w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701098w%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DPolverino%26aufirst%3DA.%2BJ.%26aulast%3DBauer%26aufirst%3DD.%26aulast%3DBerry%26aufirst%3DL.%26aulast%3DBerry%26aufirst%3DV.%26aulast%3DBorg%26aufirst%3DG.%26aulast%3DBready%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DChoquette%26aufirst%3DD.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DDeMelfi%26aufirst%3DT.%26aulast%3DDoerr%26aufirst%3DN.%26aulast%3DEstrada%26aufirst%3DJ.%26aulast%3DFlynn%26aufirst%3DJ.%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DHarriman%26aufirst%3DS.%2BP.%26aulast%3DKaufman%26aufirst%3DS.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLong%26aufirst%3DA.%26aulast%3DNeervannan%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DPotashman%26aufirst%3DM.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DRoveto%26aufirst%3DP.%2BM.%26aulast%3DSchrag%26aufirst%3DM.%2BL.%26aulast%3DStarnes%26aufirst%3DC.%26aulast%3DTasker%26aufirst%3DA.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DZanon%26aufirst%3DR.%26atitle%3DEvaluation%2520of%2520a%2520series%2520of%2520naphthamides%2520as%2520potent%252C%2520orally%2520active%2520vascular%2520endothelial%2520growth%2520factor%2520receptor-2%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1668%26epage%3D1680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmer, T. M.</span><span> </span><span class="NLM_article-title">Synergistic effects of foretinib with HER-targeted agents in MET and HER1- or HER2-coactivated tumor cells</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">518</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1158%2F1535-7163.MCT-10-0698" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=21252284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVCrsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=518-530&author=L.+Liuauthor=H.+Shiauthor=Y.+Liuauthor=A.+Andersonauthor=J.+Petersonauthor=J.+Gregerauthor=A.-M.+Martinauthor=T.+M.+Gilmer&title=Synergistic+effects+of+foretinib+with+HER-targeted+agents+in+MET+and+HER1-+or+HER2-coactivated+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic Effects of Foretinib with HER-Targeted Agents in MET and HER1- or HER2-Coactivated Tumor Cells</span></div><div class="casAuthors">Liu, Li; Shi, Hong; Liu, Yuan; Anderson, Amber; Peterson, John; Greger, James; Martin, Anne-Marie; Gilmer, Tona M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">518-530</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The HER and MET receptor tyrosine kinases (RTK) are coactivated in a subset of human tumors.  This study characterizes MET and HER expression and signaling in a panel of human tumor cell lines and the differential susceptibility of these cell lines to single agents or combinations of foretinib, a multikinase MET inhibitor, with HER-targeted agents, erlotinib or lapatinib.  Most MET-amplified tumor lines without HER1 or HER2 amplification are sensitive to foretinib, whereas MET-amplified lines with HER1 or HER2 amplification are more sensitive to the combination of foretinib with lapatinib or erlotinib.  Interestingly, MET-overexpressing tumor cell lines with HER1 or HER2 amplification also exhibited reduced sensitivity to lapatinib or erlotinib in the presence of hepatocyte growth factor (HGF), indicating MET activation can decrease the effectiveness of HER1/2 inhibitors in some cell lines.  Consistent with this observation, the effect of HGF on lapatinib or erlotinib sensitivity in these cells was reversed by foretinib, other MET inhibitors, or siRNA to MET.  Western blot analyses showed that combining foretinib with erlotinib or lapatinib effectively decreased the phosphorylation of MET, HER1, HER2, HER3, AKT, and ERK in these cells.  Furthermore, HER2-pos. advanced or metastatic breast cancer patients treated with lapatinib who had higher tumor MET expression showed shorter progression-free survival (19.29 wk in MET-high patients vs. 28.14 wk in MET-low patients, P < 0.0225).  These data suggest that combination therapy with foretinib and HER-targeted agents should be tested as a treatment option for HER1- or HER2-pos. patients with MET-amplified or -overexpressing tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFGurHJ0AthrVg90H21EOLACvtfcHk0ljcgVoUA1p5Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVCrsrg%253D&md5=4e33b2abefafb8decd9bb6f4f31b5c75</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-10-0698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-10-0698%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DAnderson%26aufirst%3DA.%26aulast%3DPeterson%26aufirst%3DJ.%26aulast%3DGreger%26aufirst%3DJ.%26aulast%3DMartin%26aufirst%3DA.-M.%26aulast%3DGilmer%26aufirst%3DT.%2BM.%26atitle%3DSynergistic%2520effects%2520of%2520foretinib%2520with%2520HER-targeted%2520agents%2520in%2520MET%2520and%2520HER1-%2520or%2520HER2-coactivated%2520tumor%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D518%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Qian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Won, K.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mock, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lougheed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakes, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentzien, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaks, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wooster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greshock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joly, A. H.</span><span> </span><span class="NLM_article-title">Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">8009</span><span class="NLM_x">–</span> <span class="NLM_lpage">8016</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=8009-8016&author=F.+Qianauthor=S.+Engstauthor=K.+Yamaguchiauthor=P.+Yuauthor=K.-A.+Wonauthor=L.+Mockauthor=T.+Louauthor=J.+Tanauthor=C.+Liauthor=D.+Tamauthor=J.+Lougheedauthor=F.+M.+Yakesauthor=F.+Bentzienauthor=W.+Xuauthor=T.+Zaksauthor=R.+Woosterauthor=J.+Greshockauthor=A.+H.+Joly&title=Inhibition+of+tumor+cell+growth%2C+invasion%2C+and+metastasis+by+EXEL-2880+%28XL880%2C+GSK1363089%29%2C+a+novel+inhibitor+of+HGF+and+VEGF+receptor+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DF.%26aulast%3DEngst%26aufirst%3DS.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DWon%26aufirst%3DK.-A.%26aulast%3DMock%26aufirst%3DL.%26aulast%3DLou%26aufirst%3DT.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DTam%26aufirst%3DD.%26aulast%3DLougheed%26aufirst%3DJ.%26aulast%3DYakes%26aufirst%3DF.%2BM.%26aulast%3DBentzien%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DZaks%26aufirst%3DT.%26aulast%3DWooster%26aufirst%3DR.%26aulast%3DGreshock%26aufirst%3DJ.%26aulast%3DJoly%26aufirst%3DA.%2BH.%26atitle%3DInhibition%2520of%2520tumor%2520cell%2520growth%252C%2520invasion%252C%2520and%2520metastasis%2520by%2520EXEL-2880%2520%2528XL880%252C%2520GSK1363089%2529%252C%2520a%2520novel%2520inhibitor%2520of%2520HGF%2520and%2520VEGF%2520receptor%2520tyrosine%2520kinases%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D8009%26epage%3D8016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Nagashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shumway, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sathyanarayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolinski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilhack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiznerowicz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutterbach, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paweletz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allison, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klippel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bobkova, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewczak, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, B.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollock, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blume-Jensen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Northrup, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, J. N.</span><span> </span><span class="NLM_article-title">Genetic and pharmacological inhibition of PDK1 in cancer cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">6433</span><span class="NLM_x">–</span> <span class="NLM_lpage">6448</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=6433-6448&author=K.+Nagashimaauthor=S.+D.+Shumwayauthor=S.+Sathyanarayananauthor=A.+H.+Chenauthor=B.+Dolinskiauthor=Y.+Xuauthor=H.+Keilhackauthor=T.+Nguyenauthor=M.+Wiznerowiczauthor=L.+Liauthor=B.+A.+Lutterbachauthor=A.+Chiauthor=C.+Paweletzauthor=T.+Allisonauthor=Y.+Yanauthor=S.+K.+Munshiauthor=A.+Klippelauthor=M.+Krausauthor=E.+V.+Bobkovaauthor=S.+Deshmukhauthor=Z.+Xuauthor=U.+Muellerauthor=A.+A.+Szewczakauthor=B.-S.+Panauthor=V.+Richonauthor=R.+Pollockauthor=P.+Blume-Jensenauthor=A.+Northrupauthor=J.+N.+Andersen&title=Genetic+and+pharmacological+inhibition+of+PDK1+in+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNagashima%26aufirst%3DK.%26aulast%3DShumway%26aufirst%3DS.%2BD.%26aulast%3DSathyanarayanan%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DA.%2BH.%26aulast%3DDolinski%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DWiznerowicz%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLutterbach%26aufirst%3DB.%2BA.%26aulast%3DChi%26aufirst%3DA.%26aulast%3DPaweletz%26aufirst%3DC.%26aulast%3DAllison%26aufirst%3DT.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DMunshi%26aufirst%3DS.%2BK.%26aulast%3DKlippel%26aufirst%3DA.%26aulast%3DKraus%26aufirst%3DM.%26aulast%3DBobkova%26aufirst%3DE.%2BV.%26aulast%3DDeshmukh%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DMueller%26aufirst%3DU.%26aulast%3DSzewczak%26aufirst%3DA.%2BA.%26aulast%3DPan%26aufirst%3DB.-S.%26aulast%3DRichon%26aufirst%3DV.%26aulast%3DPollock%26aufirst%3DR.%26aulast%3DBlume-Jensen%26aufirst%3DP.%26aulast%3DNorthrup%26aufirst%3DA.%26aulast%3DAndersen%26aufirst%3DJ.%2BN.%26atitle%3DGenetic%2520and%2520pharmacological%2520inhibition%2520of%2520PDK1%2520in%2520cancer%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D6433%26epage%3D6448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Jacobs, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hare, B. J.</span><span> </span><span class="NLM_article-title">Classifying protein kinase structures guides use of ligand-selectivity profiles to predict inactive conformations: structure of lck/imatinib complex</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1451</span><span class="NLM_x">–</span> <span class="NLM_lpage">1460</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2008&pages=1451-1460&author=M.+D.+Jacobsauthor=P.+R.+Caronauthor=B.+J.+Hare&title=Classifying+protein+kinase+structures+guides+use+of+ligand-selectivity+profiles+to+predict+inactive+conformations%3A+structure+of+lck%2Fimatinib+complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJacobs%26aufirst%3DM.%2BD.%26aulast%3DCaron%26aufirst%3DP.%2BR.%26aulast%3DHare%26aufirst%3DB.%2BJ.%26atitle%3DClassifying%2520protein%2520kinase%2520structures%2520guides%2520use%2520of%2520ligand-selectivity%2520profiles%2520to%2520predict%2520inactive%2520conformations%253A%2520structure%2520of%2520lck%252Fimatinib%2520complex%26jtitle%3DProteins%26date%3D2008%26volume%3D70%26spage%3D1451%26epage%3D1460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Chan, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wise, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ensinger, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haack, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patt, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petillo, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutkoski, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telikepalli, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogeti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evangelista, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavrilescu, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarides, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaleskas, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Etten, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, D. L.</span><span> </span><span class="NLM_article-title">Conformational control inhibition of the BCR-ABL1 tyrosine kinase, including the gatekeeper T315I mutant, by the switch-control inhibitor DCC-2036</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">556</span><span class="NLM_x">–</span> <span class="NLM_lpage">568</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2Fj.ccr.2011.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=21481795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXks1Wqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=556-568&author=W.+W.+Chanauthor=S.+C.+Wiseauthor=M.+D.+Kaufmanauthor=Y.+M.+Ahnauthor=C.+L.+Ensingerauthor=T.+Haackauthor=M.+M.+Hoodauthor=J.+Jonesauthor=J.+W.+Lordauthor=W.+P.+Luauthor=D.+Millerauthor=W.+C.+Pattauthor=B.+D.+Smithauthor=P.+A.+Petilloauthor=T.+J.+Rutkoskiauthor=H.+Telikepalliauthor=L.+Vogetiauthor=T.+Yaoauthor=L.+Chunauthor=R.+Clarkauthor=P.+Evangelistaauthor=L.+C.+Gavrilescuauthor=K.+Lazaridesauthor=V.+M.+Zaleskasauthor=L.+J.+Stewartauthor=R.+A.+Van+Ettenauthor=D.+L.+Flynn&title=Conformational+control+inhibition+of+the+BCR-ABL1+tyrosine+kinase%2C+including+the+gatekeeper+T315I+mutant%2C+by+the+switch-control+inhibitor+DCC-2036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational Control Inhibition of the BCR-ABL1 Tyrosine Kinase, Including the Gatekeeper T315I Mutant, by the Switch-Control Inhibitor DCC-2036</span></div><div class="casAuthors">Chan, Wayne W.; Wise, Scott C.; Kaufman, Michael D.; Ahn, Yu-Mi; Ensinger, Carol L.; Haack, Torsten; Hood, Molly M.; Jones, Jennifer; Lord, John W.; Lu, Wei-Ping; Miller, David; Patt, William C.; Smith, Bryan D.; Petillo, Peter A.; Rutkoski, Thomas J.; Telikepalli, Hanumaiah; Vogeti, Lakshminarayana; Yao, Tony; Chun, Lawrence; Clark, Robin; Evangelista, Peter; Gavrilescu, L. Cristina; Lazarides, Katherine; Zaleskas, Virginia M.; Stewart, Lance J.; Van Etten, Richard A.; Flynn, Daniel L.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">556-568</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Acquired resistance to ABL1 tyrosine kinase inhibitors (TKIs) through ABL1 kinase domain mutations, particularly the gatekeeper mutant T315I, is a significant problem for patients with chronic myeloid leukemia (CML).  Using structure-based drug design, we developed compds. that bind to residues (Arg386/Glu282) ABL1 uses to switch between inactive and active conformations.  The lead "switch-control" inhibitor, DCC-2036, potently inhibits both unphosphorylated and phosphorylated ABL1 by inducing a type II inactive conformation, and retains efficacy against the majority of clin. relevant CML-resistance mutants, including T315I.  DCC-2036 inhibits BCR-ABL1T315I-expressing cell lines, prolongs survival in mouse models of T315I mutant CML and B-lymphoblastic leukemia, and inhibits primary patient leukemia cells expressing T315I in vitro and in vivo, supporting its clin. development in TKI-resistant Ph+ leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPJdMSW1VeYbVg90H21EOLACvtfcHk0ljTkCqChONErg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXks1Wqsbg%253D&md5=1d7fae5f3719a8240b144b906dc5f2c7</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2011.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2011.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DW.%2BW.%26aulast%3DWise%26aufirst%3DS.%2BC.%26aulast%3DKaufman%26aufirst%3DM.%2BD.%26aulast%3DAhn%26aufirst%3DY.%2BM.%26aulast%3DEnsinger%26aufirst%3DC.%2BL.%26aulast%3DHaack%26aufirst%3DT.%26aulast%3DHood%26aufirst%3DM.%2BM.%26aulast%3DJones%26aufirst%3DJ.%26aulast%3DLord%26aufirst%3DJ.%2BW.%26aulast%3DLu%26aufirst%3DW.%2BP.%26aulast%3DMiller%26aufirst%3DD.%26aulast%3DPatt%26aufirst%3DW.%2BC.%26aulast%3DSmith%26aufirst%3DB.%2BD.%26aulast%3DPetillo%26aufirst%3DP.%2BA.%26aulast%3DRutkoski%26aufirst%3DT.%2BJ.%26aulast%3DTelikepalli%26aufirst%3DH.%26aulast%3DVogeti%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DT.%26aulast%3DChun%26aufirst%3DL.%26aulast%3DClark%26aufirst%3DR.%26aulast%3DEvangelista%26aufirst%3DP.%26aulast%3DGavrilescu%26aufirst%3DL.%2BC.%26aulast%3DLazarides%26aufirst%3DK.%26aulast%3DZaleskas%26aufirst%3DV.%2BM.%26aulast%3DStewart%26aufirst%3DL.%2BJ.%26aulast%3DVan%2BEtten%26aufirst%3DR.%2BA.%26aulast%3DFlynn%26aufirst%3DD.%2BL.%26atitle%3DConformational%2520control%2520inhibition%2520of%2520the%2520BCR-ABL1%2520tyrosine%2520kinase%252C%2520including%2520the%2520gatekeeper%2520T315I%2520mutant%252C%2520by%2520the%2520switch-control%2520inhibitor%2520DCC-2036%26jtitle%3DCancer%2520Cell%26date%3D2011%26volume%3D19%26spage%3D556%26epage%3D568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Namboodiri, H. V.; Springman, E. B.; Karpusas, M.; Bukhtiyarova, M.; Ramcharan, J.</span><span> </span><span class="NLM_article-title">Conformational Plasticity of p38 MAP Kinase DFG Motif Mutants in Response to Inhibitor Binding</span>. Protein Data Bank (PDB),<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.2210/pdb3o8u/pdb</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.2210%2Fpdb3o8u%2Fpdb" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=H.+V.+Namboodiri&author=E.+B.+Springman&author=M.+Karpusas&author=M.+Bukhtiyarova&author=J.+Ramcharan&title=Conformational+Plasticity+of+p38+MAP+Kinase+DFG+Motif+Mutants+in+Response+to+Inhibitor+Binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.2210%2Fpdb3o8u%2Fpdb&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.2210%252Fpdb3o8u%252Fpdb%26sid%3Dliteratum%253Aachs%26aulast%3DNamboodiri%26aufirst%3DH.%2BV.%26atitle%3DConformational%2520Plasticity%2520of%2520p38%2520MAP%2520Kinase%2520DFG%2520Motif%2520Mutants%2520in%2520Response%2520to%2520Inhibitor%2520Binding%26jtitle%3DProtein%2520Data%2520Bank%2520%2528PDB%2529%26date%3D2012%26doi%3D10.2210%2Fpdb3o8u%2Fpdb" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Kluter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grutter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naqvi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabiller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simard, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Getlik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauh, D.</span><span> </span><span class="NLM_article-title">Displacement assay for the detection of stabilizers of inactive kinase conformations</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901297e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=357-367&author=S.+Kluterauthor=C.+Grutterauthor=T.+Naqviauthor=M.+Rabillerauthor=J.+R.+Simardauthor=V.+Pawarauthor=M.+Getlikauthor=D.+Rauh&title=Displacement+assay+for+the+detection+of+stabilizers+of+inactive+kinase+conformations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fjm901297e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901297e%26sid%3Dliteratum%253Aachs%26aulast%3DKluter%26aufirst%3DS.%26aulast%3DGrutter%26aufirst%3DC.%26aulast%3DNaqvi%26aufirst%3DT.%26aulast%3DRabiller%26aufirst%3DM.%26aulast%3DSimard%26aufirst%3DJ.%2BR.%26aulast%3DPawar%26aufirst%3DV.%26aulast%3DGetlik%26aufirst%3DM.%26aulast%3DRauh%26aufirst%3DD.%26atitle%3DDisplacement%2520assay%2520for%2520the%2520detection%2520of%2520stabilizers%2520of%2520inactive%2520kinase%2520conformations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D357%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Ahn, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clare, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ensinger, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patt, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogeti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petillo, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wise, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abendroth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feese, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, D. L.</span><span> </span><span class="NLM_article-title">Switch control pocket inhibitors of p38-MAP kinase. Durable type II inhibitors that do not require binding into the canonical ATP hinge region</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">5793</span><span class="NLM_x">–</span> <span class="NLM_lpage">5798</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2Fj.bmcl.2010.07.134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=20800479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFGnt77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=5793-5798&author=Y.+M.+Ahnauthor=M.+Clareauthor=C.+L.+Ensingerauthor=M.+M.+Hoodauthor=J.+W.+Lordauthor=W.-P.+Luauthor=D.+F.+Millerauthor=W.+C.+Pattauthor=B.+D.+Smithauthor=L.+Vogetiauthor=M.+D.+Kaufmanauthor=P.+A.+Petilloauthor=S.+C.+Wiseauthor=J.+Abendrothauthor=L.+Chunauthor=R.+Clarkauthor=M.+Feeseauthor=H.+Kimauthor=L.+Stewartauthor=D.+L.+Flynn&title=Switch+control+pocket+inhibitors+of+p38-MAP+kinase.+Durable+type+II+inhibitors+that+do+not+require+binding+into+the+canonical+ATP+hinge+region"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Switch control pocket inhibitors of p38-MAP kinase. Durable type II inhibitors that do not require binding into the canonical ATP hinge region</span></div><div class="casAuthors">Ahn, Yu Mi; Clare, Michael; Ensinger, Carol L.; Hood, Molly M.; Lord, John W.; Lu, Wei-Ping; Miller, David F.; Patt, William C.; Smith, Bryan D.; Vogeti, Lakshminarayana; Kaufman, Michael D.; Petillo, Peter A.; Wise, Scott C.; Abendroth, Jan; Chun, Lawrence; Clark, Robin; Feese, Michael; Kim, Hidong; Stewart, Lance; Flynn, Daniel L.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5793-5798</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Switch control pocket inhibitors of p38-alpha kinase are described.  Durable type II inhibitors were designed which bind to arginines (Arg67 or Arg70) that function as key residues for mediating phospho-threonine 180 dependent conformational fluxing of p38-alpha from an inactive type II state to an active type I state.  Binding to Arg70 in particular led to potent inhibitors, exemplified by DP-802, which also exhibited high kinase selectivity.  Binding to Arg70 obviated the requirement for binding into the ATP Hinge region.  X-ray crystallog. revealed that DP-802 and analogs induce an enhanced type II conformation upon binding to either the unphosphorylated or the doubly phosphorylated form of p38-alpha kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYLXzhdkQYULVg90H21EOLACvtfcHk0ljTkCqChONErg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFGnt77F&md5=d226d6462d6f9f2118e48525af214af0</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.07.134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.07.134%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DY.%2BM.%26aulast%3DClare%26aufirst%3DM.%26aulast%3DEnsinger%26aufirst%3DC.%2BL.%26aulast%3DHood%26aufirst%3DM.%2BM.%26aulast%3DLord%26aufirst%3DJ.%2BW.%26aulast%3DLu%26aufirst%3DW.-P.%26aulast%3DMiller%26aufirst%3DD.%2BF.%26aulast%3DPatt%26aufirst%3DW.%2BC.%26aulast%3DSmith%26aufirst%3DB.%2BD.%26aulast%3DVogeti%26aufirst%3DL.%26aulast%3DKaufman%26aufirst%3DM.%2BD.%26aulast%3DPetillo%26aufirst%3DP.%2BA.%26aulast%3DWise%26aufirst%3DS.%2BC.%26aulast%3DAbendroth%26aufirst%3DJ.%26aulast%3DChun%26aufirst%3DL.%26aulast%3DClark%26aufirst%3DR.%26aulast%3DFeese%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DStewart%26aufirst%3DL.%26aulast%3DFlynn%26aufirst%3DD.%2BL.%26atitle%3DSwitch%2520control%2520pocket%2520inhibitors%2520of%2520p38-MAP%2520kinase.%2520Durable%2520type%2520II%2520inhibitors%2520that%2520do%2520not%2520require%2520binding%2520into%2520the%2520canonical%2520ATP%2520hinge%2520region%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D5793%26epage%3D5798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Blair, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Q.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rode, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Structure-guided development of affinity probes for tyrosine kinases using chemical genetics</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">238</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1038%2Fnchembio866" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=17334377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtFKnsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=229-238&author=J.+A.+Blairauthor=D.+Rauhauthor=C.+Kungauthor=C.-H.+Yunauthor=Q.-W.+Fanauthor=H.+Rodeauthor=C.+Zhangauthor=M.+J.+Eckauthor=W.+A.+Weissauthor=K.+M.+Shokat&title=Structure-guided+development+of+affinity+probes+for+tyrosine+kinases+using+chemical+genetics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided development of affinity probes for tyrosine kinases using chemical genetics</span></div><div class="casAuthors">Blair, Jimmy A.; Rauh, Daniel; Kung, Charles; Yun, Cai-Hong; Fan, Qi-Wen; Rode, Haridas; Zhang, Chao; Eck, Michael J.; Weiss, William A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">229-238</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">As key components in nearly every signal transduction pathway, protein kinases are attractive targets for the regulation of cellular signaling by small-mol. inhibitors.  The authors report the structure-guided development of 6-acrylamido-4-anilinoquinazoline irreversible kinase inhibitors that potently and selectively target rationally designed kinases bearing two selectivity elements that are not found together in any wild-type kinase: an electrophile-targeted cysteine residue and a glycine gatekeeper residue.  Cocrystal structures of two irreversible quinazoline inhibitors bound to either epidermal growth factor receptor (EGFR) or engineered c-Src show covalent inhibitor binding to the targeted cysteine (Cys797 in EGFR and Cys345 in engineered c-Src).  Cocrystal structures of two irreversible quinazoline inhibitors (I, II) bound to either epidermal growth factor receptor (EGFR) or engineered c-Src show covalent inhibitor binding to the targeted cysteine (Cys797 in EGFR and Cys345 in engineered c-Src).  Based on these structures, the authors developed a fluorescent 6-acrylamido-4-anilinoquinazoline affinity probe (III) to report the fraction of kinase necessary for cellular signaling, and the authors used these reagents to quantitate the relationship between EGFR stimulation by EGF and its downstream outputs-Akt, Erk1 and Erk2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG0KmYAm-skrVg90H21EOLACvtfcHk0ljwUALgTSHQDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtFKnsr0%253D&md5=ce4d24a8d65d7080645bf382cd65dbca</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1038%2Fnchembio866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio866%26sid%3Dliteratum%253Aachs%26aulast%3DBlair%26aufirst%3DJ.%2BA.%26aulast%3DRauh%26aufirst%3DD.%26aulast%3DKung%26aufirst%3DC.%26aulast%3DYun%26aufirst%3DC.-H.%26aulast%3DFan%26aufirst%3DQ.-W.%26aulast%3DRode%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DStructure-guided%2520development%2520of%2520affinity%2520probes%2520for%2520tyrosine%2520kinases%2520using%2520chemical%2520genetics%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2007%26volume%3D3%26spage%3D229%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Yun, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mengwasser, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toms, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greulich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span> </span><span class="NLM_article-title">The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">2070</span><span class="NLM_x">–</span> <span class="NLM_lpage">2075</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1073%2Fpnas.0709662105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=18227510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitl2mu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=2070-2075&author=C.-H.+Yunauthor=K.+E.+Mengwasserauthor=A.+V.+Tomsauthor=M.+S.+Wooauthor=H.+Greulichauthor=K.-K.+Wongauthor=M.+Meyersonauthor=M.+J.+Eck&title=The+T790M+mutation+in+EGFR+kinase+causes+drug+resistance+by+increasing+the+affinity+for+ATP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP</span></div><div class="casAuthors">Yun, Cai-Hong; Mengwasser, Kristen E.; Toms, Angela V.; Woo, Michele S.; Greulich, Heidi; Wong, Kwok-Kin; Meyerson, Matthew; Eck, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2070-2075</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Lung cancers caused by activating mutations in the epidermal growth factor receptor (EGFR) are initially responsive to small mol. tyrosine kinase inhibitors (TKIs), but the efficacy of these agents is often limited because of the emergence of drug resistance conferred by a second mutation, T790M.  Threonine 790 is the "gatekeeper" residue, an important determinant of inhibitor specificity in the ATP binding pocket.  The T790M mutation has been thought to cause resistance by sterically blocking binding of TKIs such as gefitinib and erlotinib, but this explanation is difficult to reconcile with the fact that it remains sensitive to structurally similar irreversible inhibitors.  Here, we show by using a direct binding assay that T790M mutants retain low-nanomolar affinity for gefitinib.  Furthermore, we show that the T790M mutation activates WT EGFR and that introduction of the T790M mutation increases the ATP affinity of the oncogenic L858R mutant by more than an order of magnitude.  The increased ATP affinity is the primary mechanism by which the T790M mutation confers drug resistance.  Crystallog. anal. of the T790M mutant shows how it can adapt to accommodate tight binding of diverse inhibitors, including the irreversible inhibitor HKI-272, and also suggests a structural mechanism for catalytic activation.  We conclude that the T790M mutation is a "generic" resistance mutation that will reduce the potency of any ATP-competitive kinase inhibitor and that irreversible inhibitors overcome this resistance simply through covalent binding, not as a result of an alternative binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXXP7TBlyrdrVg90H21EOLACvtfcHk0ljwUALgTSHQDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitl2mu7k%253D&md5=f5f5d791a65f73ca628d95e9922b8ea8</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0709662105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0709662105%26sid%3Dliteratum%253Aachs%26aulast%3DYun%26aufirst%3DC.-H.%26aulast%3DMengwasser%26aufirst%3DK.%2BE.%26aulast%3DToms%26aufirst%3DA.%2BV.%26aulast%3DWoo%26aufirst%3DM.%2BS.%26aulast%3DGreulich%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DK.-K.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520T790M%2520mutation%2520in%2520EGFR%2520kinase%2520causes%2520drug%2520resistance%2520by%2520increasing%2520the%2520affinity%2520for%2520ATP%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D2070%26epage%3D2075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ercan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capelletti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortot, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirieac, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iacob, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padera, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engen, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janne, P. A.</span><span> </span><span class="NLM_article-title">Novel mutant-selective EGFR kinase inhibitors against EGFR T790M</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">462</span><span class="NLM_x">, </span> <span class="NLM_fpage">1070</span><span class="NLM_x">–</span> <span class="NLM_lpage">1074</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1038%2Fnature08622" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=20033049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1SktbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=462&publication_year=2009&pages=1070-1074&author=W.+Zhouauthor=D.+Ercanauthor=L.+Chenauthor=C.-H.+Yunauthor=D.+Liauthor=M.+Capellettiauthor=A.+B.+Cortotauthor=L.+Chirieacauthor=R.+E.+Iacobauthor=R.+Paderaauthor=J.+R.+Engenauthor=K.-K.+Wongauthor=M.+J.+Eckauthor=N.+S.+Grayauthor=P.+A.+Janne&title=Novel+mutant-selective+EGFR+kinase+inhibitors+against+EGFR+T790M"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Novel mutant-selective EGFR kinase inhibitors against EGFR T790M</span></div><div class="casAuthors">Zhou, Wenjun; Ercan, Dalia; Chen, Liang; Yun, Cai-Hong; Li, Danan; Capelletti, Marzia; Cortot, Alexis B.; Chirieac, Lucian; Iacob, Roxana E.; Padera, Robert; Engen, John R.; Wong, Kwok-Kin; Eck, Michael J.; Gray, Nathanael S.; Janne, Pasi A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">462</span>
        (<span class="NLM_cas:issue">7276</span>),
    <span class="NLM_cas:pages">1070-1074</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The clin. efficacy of epidermal growth factor receptor (EGFR) kinase inhibitors in EGFR-mutant non-small-cell lung cancer (NSCLC) is limited by the development of drug-resistance mutations, including the gatekeeper T790M mutation.  Strategies targeting EGFR T790M with irreversible inhibitors have had limited success and are assocd. with toxicity due to concurrent inhibition of wild-type EGFR.  All current EGFR inhibitors possess a structurally related quinazoline-based core scaffold and were identified as ATP-competitive inhibitors of wild-type EGFR.  Here we identify a covalent pyrimidine EGFR inhibitor by screening an irreversible kinase inhibitor library specifically against EGFR T790M.  These agents are 30- to 100-fold more potent against EGFR T790M, and up to 100-fold less potent against wild-type EGFR, than quinazoline-based EGFR inhibitors in vitro.  They are also effective in murine models of lung cancer driven by EGFR T790M.  Co-crystn. studies reveal a structural basis for the increased potency and mutant selectivity of these agents.  These mutant-selective irreversible EGFR kinase inhibitors may be clin. more effective and better tolerated than quinazoline-based inhibitors.  Our findings demonstrate that functional pharmacol. screens against clin. important mutant kinases represent a powerful strategy to identify new classes of mutant-selective kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcksZlIe-1bbVg90H21EOLACvtfcHk0ljwUALgTSHQDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1SktbvI&md5=9b5d41a2be401c67a4b9f04a41cf1725</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1038%2Fnature08622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08622%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DErcan%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DYun%26aufirst%3DC.-H.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DCapelletti%26aufirst%3DM.%26aulast%3DCortot%26aufirst%3DA.%2BB.%26aulast%3DChirieac%26aufirst%3DL.%26aulast%3DIacob%26aufirst%3DR.%2BE.%26aulast%3DPadera%26aufirst%3DR.%26aulast%3DEngen%26aufirst%3DJ.%2BR.%26aulast%3DWong%26aufirst%3DK.-K.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DJanne%26aufirst%3DP.%2BA.%26atitle%3DNovel%2520mutant-selective%2520EGFR%2520kinase%2520inhibitors%2520against%2520EGFR%2520T790M%26jtitle%3DNature%26date%3D2009%26volume%3D462%26spage%3D1070%26epage%3D1074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Wood, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shewchuk, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brignola, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brashear, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caferro, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickerson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donaldson, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaul, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassell, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrov, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reno, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusnak, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadepalli, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulrich, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderwall, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterson, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uehling, D. E.</span><span> </span><span class="NLM_article-title">6-Ethynylthieno[3,2-<i>d</i>]- and 6-ethynylthieno[2,3-<i>d</i>]pyrimidin-4-anilines as tunable covalent modifiers of ErbB kinases</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">2773</span><span class="NLM_x">–</span> <span class="NLM_lpage">2778</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=2773-2778&author=E.+R.+Woodauthor=L.+M.+Shewchukauthor=B.+Ellisauthor=P.+Brignolaauthor=R.+L.+Brashearauthor=T.+R.+Caferroauthor=S.+H.+Dickersonauthor=H.+D.+Dicksonauthor=K.+H.+Donaldsonauthor=M.+Gaulauthor=R.+J.+Griffinauthor=A.+M.+Hassellauthor=B.+Keithauthor=R.+Mullinauthor=K.+G.+Petrovauthor=M.+J.+Renoauthor=D.+W.+Rusnakauthor=S.+M.+Tadepalliauthor=J.+C.+Ulrichauthor=C.+D.+Wagnerauthor=D.+E.+Vanderwallauthor=A.+G.+Watersonauthor=J.+D.+Williamsauthor=W.+L.+Whiteauthor=D.+E.+Uehling&title=6-Ethynylthieno%5B3%2C2-d%5D-+and+6-ethynylthieno%5B2%2C3-d%5Dpyrimidin-4-anilines+as+tunable+covalent+modifiers+of+ErbB+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DE.%2BR.%26aulast%3DShewchuk%26aufirst%3DL.%2BM.%26aulast%3DEllis%26aufirst%3DB.%26aulast%3DBrignola%26aufirst%3DP.%26aulast%3DBrashear%26aufirst%3DR.%2BL.%26aulast%3DCaferro%26aufirst%3DT.%2BR.%26aulast%3DDickerson%26aufirst%3DS.%2BH.%26aulast%3DDickson%26aufirst%3DH.%2BD.%26aulast%3DDonaldson%26aufirst%3DK.%2BH.%26aulast%3DGaul%26aufirst%3DM.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DHassell%26aufirst%3DA.%2BM.%26aulast%3DKeith%26aufirst%3DB.%26aulast%3DMullin%26aufirst%3DR.%26aulast%3DPetrov%26aufirst%3DK.%2BG.%26aulast%3DReno%26aufirst%3DM.%2BJ.%26aulast%3DRusnak%26aufirst%3DD.%2BW.%26aulast%3DTadepalli%26aufirst%3DS.%2BM.%26aulast%3DUlrich%26aufirst%3DJ.%2BC.%26aulast%3DWagner%26aufirst%3DC.%2BD.%26aulast%3DVanderwall%26aufirst%3DD.%2BE.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DWilliams%26aufirst%3DJ.%2BD.%26aulast%3DWhite%26aufirst%3DW.%2BL.%26aulast%3DUehling%26aufirst%3DD.%2BE.%26atitle%3D6-Ethynylthieno%255B3%252C2-d%255D-%2520and%25206-ethynylthieno%255B2%252C3-d%255Dpyrimidin-4-anilines%2520as%2520tunable%2520covalent%2520modifiers%2520of%2520ErbB%2520kinases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D2773%26epage%3D2778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Kim, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maderna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnute, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyashiro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lussier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrocklage, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickerson-Nutter, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittwer, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soutter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunussi-Joannopoulos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douhan, J.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissner, A.</span><span> </span><span class="NLM_article-title">Imidazo[1,5-<i>a</i>]quinoxalines as irreversible BTK inhibitors for the treatment of rheumatoid arthritis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6258</span><span class="NLM_x">–</span> <span class="NLM_lpage">6263</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6258-6263&author=K.-H.+Kimauthor=A.+Madernaauthor=M.+E.+Schnuteauthor=M.+Hegenauthor=S.+Mohanauthor=J.+Miyashiroauthor=L.+Linauthor=E.+Liauthor=S.+Keeganauthor=J.+Lussierauthor=C.+Wrocklageauthor=C.+L.+Nickerson-Nutterauthor=A.+J.+Wittwerauthor=H.+Soutterauthor=N.+Caspersauthor=S.+Hanauthor=R.+Kurumbailauthor=K.+Dunussi-Joannopoulosauthor=J.+Douhanauthor=A.+Wissner&title=Imidazo%5B1%2C5-a%5Dquinoxalines+as+irreversible+BTK+inhibitors+for+the+treatment+of+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.-H.%26aulast%3DMaderna%26aufirst%3DA.%26aulast%3DSchnute%26aufirst%3DM.%2BE.%26aulast%3DHegen%26aufirst%3DM.%26aulast%3DMohan%26aufirst%3DS.%26aulast%3DMiyashiro%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DE.%26aulast%3DKeegan%26aufirst%3DS.%26aulast%3DLussier%26aufirst%3DJ.%26aulast%3DWrocklage%26aufirst%3DC.%26aulast%3DNickerson-Nutter%26aufirst%3DC.%2BL.%26aulast%3DWittwer%26aufirst%3DA.%2BJ.%26aulast%3DSoutter%26aufirst%3DH.%26aulast%3DCaspers%26aufirst%3DN.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DKurumbail%26aufirst%3DR.%26aulast%3DDunussi-Joannopoulos%26aufirst%3DK.%26aulast%3DDouhan%26aufirst%3DJ.%26aulast%3DWissner%26aufirst%3DA.%26atitle%3DImidazo%255B1%252C5-a%255Dquinoxalines%2520as%2520irreversible%2520BTK%2520inhibitors%2520for%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6258%26epage%3D6263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Zapf, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerstenberger, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limburg, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aulabaugh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shakya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spaulding, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czerwinski, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seth, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medley, Q. G.</span><span> </span><span class="NLM_article-title">Covalent inhibitors of interleukin-2 inducible T cell kinase (Itk) with nanomolar potency in a whole-blood assay</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10047</span><span class="NLM_x">–</span> <span class="NLM_lpage">10063</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301190s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFOlsbnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10047-10063&author=C.+W.+Zapfauthor=B.+S.+Gerstenbergerauthor=L.+Xingauthor=D.+C.+Limburgauthor=D.+R.+Andersonauthor=N.+Caspersauthor=S.+Hanauthor=A.+Aulabaughauthor=R.+Kurumbailauthor=S.+Shakyaauthor=X.+Liauthor=V.+Spauldingauthor=R.+M.+Czerwinskiauthor=N.+Sethauthor=Q.+G.+Medley&title=Covalent+inhibitors+of+interleukin-2+inducible+T+cell+kinase+%28Itk%29+with+nanomolar+potency+in+a+whole-blood+assay"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent Inhibitors of Interleukin-2 Inducible T Cell Kinase (Itk) with Nanomolar Potency in a Whole-Blood Assay</span></div><div class="casAuthors">Zapf, Christoph W.; Gerstenberger, Brian S.; Xing, Li; Limburg, David C.; Anderson, David R.; Caspers, Nicole; Han, Seungil; Aulabaugh, Ann; Kurumbail, Ravi; Shakya, Subarna; Li, Xin; Spaulding, Vikki; Czerwinski, Robert M.; Seth, Nilufer; Medley, Quintus G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10047-10063</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We wish to report a strategy that targets interleukin-2 inducible T cell kinase (Itk) with covalent inhibitors.  Thus far, covalent inhibition of Itk has not been disclosed in the literature.  Structure-based drug design was utilized to achieve low nanomolar potency of the disclosed series even at high ATP concns.  Kinetic measurements confirmed an irreversible binding mode with off-rate half-lives exceeding 24 h and moderate on-rates.  The analogs are highly potent in a cellular IP1 assay as well as in a human whole-blood (hWB) assay.  Despite a half-life of approx. 2 h in resting primary T cells, the covalent inhibition of Itk resulted in functional silencing of the TCR pathway for more than 24 h.  This prolonged effect indicates that covalent inhibition is a viable strategy to target the inactivation of Itk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnh9j28SM8jbVg90H21EOLACvtfcHk0lju8pw9aVfjIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFOlsbnP&md5=7e39a17151dc9493d13439bc48fa83a3</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1021%2Fjm301190s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301190s%26sid%3Dliteratum%253Aachs%26aulast%3DZapf%26aufirst%3DC.%2BW.%26aulast%3DGerstenberger%26aufirst%3DB.%2BS.%26aulast%3DXing%26aufirst%3DL.%26aulast%3DLimburg%26aufirst%3DD.%2BC.%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DCaspers%26aufirst%3DN.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DAulabaugh%26aufirst%3DA.%26aulast%3DKurumbail%26aufirst%3DR.%26aulast%3DShakya%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DSpaulding%26aufirst%3DV.%26aulast%3DCzerwinski%26aufirst%3DR.%2BM.%26aulast%3DSeth%26aufirst%3DN.%26aulast%3DMedley%26aufirst%3DQ.%2BG.%26atitle%3DCovalent%2520inhibitors%2520of%2520interleukin-2%2520inducible%2520T%2520cell%2520kinase%2520%2528Itk%2529%2520with%2520nanomolar%2520potency%2520in%2520a%2520whole-blood%2520assay%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10047%26epage%3D10063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Zhang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inesta-Vaquera, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niepel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ficarro, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machleidt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marto, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laughlin, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoGrasso, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patricelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorger, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Discovery of potent and selective covalent inhibitors of JNK</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2Fj.chembiol.2011.11.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=22284361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Ghurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=140-154&author=T.+Zhangauthor=F.+Inesta-Vaqueraauthor=M.+Niepelauthor=J.+Zhangauthor=S.+B.+Ficarroauthor=T.+Machleidtauthor=T.+Xieauthor=J.+A.+Martoauthor=N.+Kimauthor=T.+Simauthor=J.+D.+Laughlinauthor=H.+Parkauthor=P.+V.+LoGrassoauthor=M.+Patricelliauthor=T.+K.+Nomanbhoyauthor=P.+K.+Sorgerauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Discovery+of+potent+and+selective+covalent+inhibitors+of+JNK"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Covalent Inhibitors of JNK</span></div><div class="casAuthors">Zhang, Tinghu; Inesta-Vaquera, Francisco; Niepel, Mario; Zhang, Jianming; Ficarro, Scott B.; Machleidt, Thomas; Xie, Ting; Marto, Jarrod A.; Kim, Nam Doo; Sim, Taebo; Laughlin, John D.; Park, Hajeung; LoGrasso, Philip V.; Patricelli, Matt; Nomanbhoy, Tyzoon K.; Sorger, Peter K.; Alessi, Dario R.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">140-154</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The mitogen-activated kinases JNK1/2/3 are key enzymes in signaling modules that transduce and integrate extracellular stimuli into coordinated cellular response.  Here, we report the discovery of irreversible inhibitors of JNK1/2/3.  We describe two JNK3 cocrystal structures at 2.60 and 2.97 Å resoln. that show the compds. form covalent bonds with a conserved cysteine residue.  JNK-IN-8 is a selective JNK inhibitor that inhibits phosphorylation of c-Jun, a direct substrate of JNK, in cells exposed to submicromolar drug in a manner that depends on covalent modification of the conserved cysteine residue.  Extensive biochem., cellular, and pathway-based profiling establish the selectivity of JNK-IN-8 for JNK and suggests that the compd. will be broadly useful as a pharmacol. probe of JNK-dependent signal transduction.  Potential lead compds. have also been identified for kinases, including IRAK1, PIK3C3, PIP4K2C, and PIP5K3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXs0FY7FSmt7Vg90H21EOLACvtfcHk0lju8pw9aVfjIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Ghurw%253D&md5=f7d9647fb2be162c637b1d31a778ceb4</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DInesta-Vaquera%26aufirst%3DF.%26aulast%3DNiepel%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DFicarro%26aufirst%3DS.%2BB.%26aulast%3DMachleidt%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DT.%26aulast%3DMarto%26aufirst%3DJ.%2BA.%26aulast%3DKim%26aufirst%3DN.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DLaughlin%26aufirst%3DJ.%2BD.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DLoGrasso%26aufirst%3DP.%2BV.%26aulast%3DPatricelli%26aufirst%3DM.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DSorger%26aufirst%3DP.%2BK.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520covalent%2520inhibitors%2520of%2520JNK%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D140%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Erlanson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arndt, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cancilla, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elling, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">English, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hession, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumaravel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lind, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miatkowski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pathan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penny, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romanowski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tangonan, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span> </span><span class="NLM_article-title">Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discovery</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3078</span><span class="NLM_x">–</span> <span class="NLM_lpage">3083</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1016%2Fj.bmcl.2011.03.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=21459573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVCmu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3078-3083&author=D.+A.+Erlansonauthor=J.+W.+Arndtauthor=M.+T.+Cancillaauthor=K.+Caoauthor=R.+A.+Ellingauthor=N.+Englishauthor=J.+Friedmanauthor=S.+K.+Hansenauthor=C.+Hessionauthor=I.+Josephauthor=G.+Kumaravelauthor=W.-C.+Leeauthor=K.+E.+Lindauthor=R.+S.+McDowellauthor=K.+Miatkowskiauthor=C.+Nguyenauthor=T.+B.+Nguyenauthor=S.+Parkauthor=N.+Pathanauthor=D.+M.+Pennyauthor=M.+J.+Romanowskiauthor=D.+Scottauthor=L.+Silvianauthor=R.+L.+Simmonsauthor=B.+T.+Tangonanauthor=W.+Yangauthor=L.+Sun&title=Discovery+of+a+potent+and+highly+selective+PDK1+inhibitor+via+fragment-based+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discovery</span></div><div class="casAuthors">Erlanson, Daniel A.; Arndt, Joseph W.; Cancilla, Mark T.; Cao, Kathy; Elling, Robert A.; English, Nicki; Friedman, Jessica; Hansen, Stig K.; Hession, Cathy; Joseph, Ingrid; Kumaravel, Gnanasambandam; Lee, Wen-Cherng; Lind, Ken E.; McDowell, Robert S.; Miatkowski, Konrad; Nguyen, Christine; Nguyen, Thinh B.; Park, Sophia; Pathan, Nuzhat; Penny, David M.; Romanowski, Michael J.; Scott, Daniel; Silvian, Laura; Simmons, Robert L.; Tangonan, Bradley T.; Yang, Wenjin; Sun, Lihong</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3078-3083</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We report the use of a fragment-based lead discovery method, Tethering with extenders, to discover a pyridinone fragment that binds in an adaptive site of the protein PDK1.  With subsequent medicinal chem., this led to the discovery of the potent and highly selective inhibitor of PDK1 33 (I), which binds in the 'DFG-out' conformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm3lOuGCLc6bVg90H21EOLACvtfcHk0liem7LerGDF5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVCmu7c%253D&md5=d11982e2dcc4a94d24dd5522735d46fb</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.03.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.03.032%26sid%3Dliteratum%253Aachs%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DArndt%26aufirst%3DJ.%2BW.%26aulast%3DCancilla%26aufirst%3DM.%2BT.%26aulast%3DCao%26aufirst%3DK.%26aulast%3DElling%26aufirst%3DR.%2BA.%26aulast%3DEnglish%26aufirst%3DN.%26aulast%3DFriedman%26aufirst%3DJ.%26aulast%3DHansen%26aufirst%3DS.%2BK.%26aulast%3DHession%26aufirst%3DC.%26aulast%3DJoseph%26aufirst%3DI.%26aulast%3DKumaravel%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DW.-C.%26aulast%3DLind%26aufirst%3DK.%2BE.%26aulast%3DMcDowell%26aufirst%3DR.%2BS.%26aulast%3DMiatkowski%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DC.%26aulast%3DNguyen%26aufirst%3DT.%2BB.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DPathan%26aufirst%3DN.%26aulast%3DPenny%26aufirst%3DD.%2BM.%26aulast%3DRomanowski%26aufirst%3DM.%2BJ.%26aulast%3DScott%26aufirst%3DD.%26aulast%3DSilvian%26aufirst%3DL.%26aulast%3DSimmons%26aufirst%3DR.%2BL.%26aulast%3DTangonan%26aufirst%3DB.%2BT.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DSun%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520highly%2520selective%2520PDK1%2520inhibitor%2520via%2520fragment-based%2520drug%2520discovery%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3078%26epage%3D3083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Serafimova, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pufall, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maglathlin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFarland, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frödin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taunton, J.</span><span> </span><span class="NLM_article-title">Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">471</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.1038%2Fnchembio.925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=22466421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvVKitrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=471-476&author=I.+M.+Serafimovaauthor=M.+A.+Pufallauthor=S.+Krishnanauthor=K.+Dudaauthor=M.+S.+Cohenauthor=R.+L.+Maglathlinauthor=J.+M.+McFarlandauthor=R.+M.+Millerauthor=M.+Fr%C3%B6dinauthor=J.+Taunton&title=Reversible+targeting+of+noncatalytic+cysteines+with+chemically+tuned+electrophiles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles</span></div><div class="casAuthors">Serafimova, Iana M.; Pufall, Miles A.; Krishnan, Shyam; Duda, Katarzyna; Cohen, Michael S.; Maglathlin, Rebecca L.; McFarland, Jesse M.; Miller, Rand M.; Froedin, Morten; Taunton, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">471-476</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Targeting noncatalytic cysteine residues with irreversible acrylamide-based inhibitors is a powerful approach for enhancing pharmacol. potency and selectivity.  Nevertheless, concerns about off-target modification motivate the development of reversible cysteine-targeting strategies.  Here we show that electron-deficient olefins, including acrylamides, can be tuned to react with cysteine thiols in a rapidly reversible manner.  Installation of a nitrile group increased the olefins' intrinsic reactivity, but, paradoxically, eliminated the formation of irreversible adducts.  Incorporation of these electrophiles into a noncovalent kinase-recognition scaffold produced slowly dissocg., covalent inhibitors of the p90 ribosomal protein S6 kinase RSK2.  A cocrystal structure revealed specific noncovalent interactions that stabilize the complex by positioning the electrophilic carbon near the targeted cysteine.  Disruption of these interactions by protein unfolding or proteolysis promoted instantaneous cleavage of the covalent bond.  Our results establish a chem.-based framework for engineering sustained covalent inhibition without accumulating permanently modified proteins and peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlcv3GjPOB6rVg90H21EOLACvtfcHk0liem7LerGDF5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvVKitrw%253D&md5=6455a9a029714beb317286f71ac1326b</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.925%26sid%3Dliteratum%253Aachs%26aulast%3DSerafimova%26aufirst%3DI.%2BM.%26aulast%3DPufall%26aufirst%3DM.%2BA.%26aulast%3DKrishnan%26aufirst%3DS.%26aulast%3DDuda%26aufirst%3DK.%26aulast%3DCohen%26aufirst%3DM.%2BS.%26aulast%3DMaglathlin%26aufirst%3DR.%2BL.%26aulast%3DMcFarland%26aufirst%3DJ.%2BM.%26aulast%3DMiller%26aufirst%3DR.%2BM.%26aulast%3DFr%25C3%25B6din%26aufirst%3DM.%26aulast%3DTaunton%26aufirst%3DJ.%26atitle%3DReversible%2520targeting%2520of%2520noncatalytic%2520cysteines%2520with%2520chemically%2520tuned%2520electrophiles%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2012%26volume%3D8%26spage%3D471%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Yongye, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina-Franco, J. L.</span><span> </span><span class="NLM_article-title">Data mining of protein-binding profiling data identifies structural modifications that distinguish selective and promiscuous compounds</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2454</span><span class="NLM_x">–</span> <span class="NLM_lpage">2461</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci3002606" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFaru7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=2454-2461&author=A.+B.+Yongyeauthor=J.+L.+Medina-Franco&title=Data+mining+of+protein-binding+profiling+data+identifies+structural+modifications+that+distinguish+selective+and+promiscuous+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Data Mining of Protein-Binding Profiling Data Identifies Structural Modifications that Distinguish Selective and Promiscuous Compounds</span></div><div class="casAuthors">Yongye, Austin B.; Medina-Franco, Jose L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2454-2461</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activity profiling of compd. collections across multiple targets is increasingly being used in probe and drug discovery.  Herein, an approach to systematically analyze the structure-activity relations of a large screening profile data with emphasis on identifying structural changes that have a significant impact on the no. of proteins to which a compd. binds are discussed.  As a case study, the authors analyzed a recently released public data set of >15,000 compds. screened across 100 sequence-unrelated proteins.  The screened compds. have different origins and include natural products, synthetic mols. from academic groups, and com. compds.  Similar synthetic structures from academic groups showed, overall, greater promiscuity differences than do natural products and com. compds.  The method implemented in this work readily identified structural changes that differentiated highly specific from promiscuous compds.  This approach is general and can be applied to analyze any other large-scale protein-binding profile data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0o0ddIiz1z7Vg90H21EOLACvtfcHk0lifbxA0TeZ7VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFaru7rL&md5=823505c29125c3502dfaad1de752bff5</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1021%2Fci3002606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci3002606%26sid%3Dliteratum%253Aachs%26aulast%3DYongye%26aufirst%3DA.%2BB.%26aulast%3DMedina-Franco%26aufirst%3DJ.%2BL.%26atitle%3DData%2520mining%2520of%2520protein-binding%2520profiling%2520data%2520identifies%2520structural%2520modifications%2520that%2520distinguish%2520selective%2520and%2520promiscuous%2520compounds%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D2454%26epage%3D2461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Muegge, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enyedy, I. J.</span><span> </span><span class="NLM_article-title">Virtual screening for kinase targets</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">693</span><span class="NLM_x">–</span> <span class="NLM_lpage">707</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Fjm400378w&amp;key=10.2174%2F0929867043455684" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Fjm400378w&amp;key=15032724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFWgs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=693-707&author=I.+Mueggeauthor=I.+J.+Enyedy&title=Virtual+screening+for+kinase+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual screening for kinase targets</span></div><div class="casAuthors">Muegge, Ingo; Enyedy, Istvan J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">693-707</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Kinases have become a major area of drug discovery and structure-based design.  Hundreds of 3D structures for more than thirty different kinases are available to the public.  High structural and sequence homol. within the kinase gene family makes the remaining kinases ideal targets for homol. modeling and virtual screening.  Somewhat surprisingly, however, the no. of publications about virtual screening of kinases is very low.  Therefore, rather than reviewing the field of virtual screening for kinases, we attempt here a hybrid approach of presenting what is known and common practice together with new studies on CDK2 and SRC kinase.  To illustrate the challenges and pitfalls of virtual screening for kinase targets we focus on the question of how ranking is influenced by the database screened, the docking scheme, the scoring function, the activity of the compds. used for testing, and small changes in the binding pocket.  In addn., a case study of finding irreversible inhibitors of ErbB2 through in silico screening is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1lWP4Dz47UbVg90H21EOLACvtfcHk0lifbxA0TeZ7VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFWgs7o%253D&md5=262341fad24c20f217770c93299130f3</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.2174%2F0929867043455684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043455684%26sid%3Dliteratum%253Aachs%26aulast%3DMuegge%26aufirst%3DI.%26aulast%3DEnyedy%26aufirst%3DI.%2BJ.%26atitle%3DVirtual%2520screening%2520for%2520kinase%2520targets%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D693%26epage%3D707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Perola, E.</span><span> </span><span class="NLM_article-title">Minimizing false positives in kinase virtual screens</span> <span class="citation_source-journal">Proteins: Struct., Funct., Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">422</span><span class="NLM_x">–</span> <span class="NLM_lpage">435</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2006&pages=422-435&author=E.+Perola&title=Minimizing+false+positives+in+kinase+virtual+screens"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerola%26aufirst%3DE.%26atitle%3DMinimizing%2520false%2520positives%2520in%2520kinase%2520virtual%2520screens%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Bioinf.%26date%3D2006%26volume%3D64%26spage%3D422%26epage%3D435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">van Linden, O. P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farenc, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoutman, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hameetman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijtmans, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tensen, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegal, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Esch, I. J. P.</span><span> </span><span class="NLM_article-title">Fragment based lead discovery of small molecule inhibitors for the EPHA4 receptor tyrosine kinase</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">493</span><span class="NLM_x">–</span> <span class="NLM_lpage">500</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2012&pages=493-500&author=O.+P.+J.+van+Lindenauthor=C.+Farencauthor=W.+H.+Zoutmanauthor=L.+Hameetmanauthor=M.+Wijtmansauthor=R.+Leursauthor=C.+P.+Tensenauthor=G.+Siegalauthor=I.+J.+P.+de+Esch&title=Fragment+based+lead+discovery+of+small+molecule+inhibitors+for+the+EPHA4+receptor+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BLinden%26aufirst%3DO.%2BP.%2BJ.%26aulast%3DFarenc%26aufirst%3DC.%26aulast%3DZoutman%26aufirst%3DW.%2BH.%26aulast%3DHameetman%26aufirst%3DL.%26aulast%3DWijtmans%26aufirst%3DM.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DTensen%26aufirst%3DC.%2BP.%26aulast%3DSiegal%26aufirst%3DG.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26atitle%3DFragment%2520based%2520lead%2520discovery%2520of%2520small%2520molecule%2520inhibitors%2520for%2520the%2520EPHA4%2520receptor%2520tyrosine%2520kinase%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D47%26spage%3D493%26epage%3D500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Wood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlieg, J. d.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagener, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritschel, T.</span><span> </span><span class="NLM_article-title">Pharmacophore fingerprint-based approach to binding site subpocket similarity and its application to bioisostere replacement</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2031</span><span class="NLM_x">–</span> <span class="NLM_lpage">2043</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci3000776" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Fjm400378w&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVylur%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=2031-2043&author=D.+J.+Woodauthor=J.+d.+Vliegauthor=M.+Wagenerauthor=T.+Ritschel&title=Pharmacophore+fingerprint-based+approach+to+binding+site+subpocket+similarity+and+its+application+to+bioisostere+replacement"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacophore Fingerprint-Based Approach to Binding Site Subpocket Similarity and Its Application to Bioisostere Replacement</span></div><div class="casAuthors">Wood, David J.; Vlieg, Jacob de; Wagener, Markus; Ritschel, Tina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2031-2043</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bioisosteres have been defined as structurally different mols. or substructures that can form comparable intermol. interactions, and therefore, fragments that bind to similar protein structures exhibit a degree of bioisosterism.  We present KRIPO (Key Representation of Interaction in POckets): a new method for quantifying the similarities of binding site subpockets based on pharmacophore fingerprints.  The binding site fingerprints have been optimized to improve their performance for both intra- and interprotein family comparisons.  A range of attributes of the fingerprints was considered in the optimization, including the placement of pharmacophore features, whether or not the fingerprints are fuzzified, and the resoln. and complexity of the pharmacophore fingerprints (2-, 3-, and 4-point fingerprints).  Fuzzy 3-point pharmacophore fingerprints were found to represent the optimal balance between computational resource requirements and the identification of potential replacements.  The complete PDB was converted into a database comprising almost 300 000 optimized fingerprints of local binding sites together with their assocd. ligand fragments.  The value of the approach is demonstrated by application to two crystal structures from the Protein Data Bank: (1) a MAP kinase P38 structure in complex with a pyridinylimidazole inhibitor (1A9U) and (2) a complex of thrombin with melagatran (1K22).  Potentially valuable bioisosteric replacements for all subpockets of the two studied protein are identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWRQTi8-dp_rVg90H21EOLACvtfcHk0lifbxA0TeZ7VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVylur%252FF&md5=f344aa0423546f08ea347327f56ef7cb</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1021%2Fci3000776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci3000776%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DD.%2BJ.%26aulast%3DVlieg%26aufirst%3DJ.%2Bd.%26aulast%3DWagener%26aufirst%3DM.%26aulast%3DRitschel%26aufirst%3DT.%26atitle%3DPharmacophore%2520fingerprint-based%2520approach%2520to%2520binding%2520site%2520subpocket%2520similarity%2520and%2520its%2520application%2520to%2520bioisostere%2520replacement%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D2031%26epage%3D2043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Subramanian, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sud, M.</span><span> </span><span class="NLM_article-title">Computational modeling of kinase inhibitor selectivity</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml1001097" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=395-399&author=G.+Subramanianauthor=M.+Sud&title=Computational+modeling+of+kinase+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1021%2Fml1001097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1001097%26sid%3Dliteratum%253Aachs%26aulast%3DSubramanian%26aufirst%3DG.%26aulast%3DSud%26aufirst%3DM.%26atitle%3DComputational%2520modeling%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D395%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group">Schalon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgand, J.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellenberger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span> </span><span class="NLM_article-title">A simple and fuzzy method to align and compare druggable ligand-binding sites</span> <span class="citation_source-journal">Proteins: Struct., Funct., Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">1755</span><span class="NLM_x">–</span> <span class="NLM_lpage">1778</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2008&pages=1755-1778&author=C.+Schalonauthor=J.-S.+Surgandauthor=E.+Kellenbergerauthor=D.+Rognan&title=A+simple+and+fuzzy+method+to+align+and+compare+druggable+ligand-binding+sites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchalon%26aufirst%3DC.%26aulast%3DSurgand%26aufirst%3DJ.-S.%26aulast%3DKellenberger%26aufirst%3DE.%26aulast%3DRognan%26aufirst%3DD.%26atitle%3DA%2520simple%2520and%2520fuzzy%2520method%2520to%2520align%2520and%2520compare%2520druggable%2520ligand-binding%2520sites%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Bioinf.%26date%3D2008%26volume%3D71%26spage%3D1755%26epage%3D1778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Sciabola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flocco, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruciani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perruccio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. S.</span><span> </span><span class="NLM_article-title">High-throughput virtual screening of proteins using GRID molecular interaction fields</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci9003317" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=155-169&author=S.+Sciabolaauthor=R.+V.+Stantonauthor=J.+E.+Millsauthor=M.+M.+Floccoauthor=M.+Baroniauthor=G.+Crucianiauthor=F.+Perruccioauthor=J.+S.+Mason&title=High-throughput+virtual+screening+of+proteins+using+GRID+molecular+interaction+fields"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1021%2Fci9003317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci9003317%26sid%3Dliteratum%253Aachs%26aulast%3DSciabola%26aufirst%3DS.%26aulast%3DStanton%26aufirst%3DR.%2BV.%26aulast%3DMills%26aufirst%3DJ.%2BE.%26aulast%3DFlocco%26aufirst%3DM.%2BM.%26aulast%3DBaroni%26aufirst%3DM.%26aulast%3DCruciani%26aufirst%3DG.%26aulast%3DPerruccio%26aufirst%3DF.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26atitle%3DHigh-throughput%2520virtual%2520screening%2520of%2520proteins%2520using%2520GRID%2520molecular%2520interaction%2520fields%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2009%26volume%3D50%26spage%3D155%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Akritopoulou-Zanze, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduk, P. J.</span><span> </span><span class="NLM_article-title">Kinase-targeted libraries: the design and synthesis of novel, potent, and selective kinase inhibitors</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=291-297&author=I.+Akritopoulou-Zanzeauthor=P.+J.+Hajduk&title=Kinase-targeted+libraries%3A+the+design+and+synthesis+of+novel%2C+potent%2C+and+selective+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAkritopoulou-Zanze%26aufirst%3DI.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26atitle%3DKinase-targeted%2520libraries%253A%2520the%2520design%2520and%2520synthesis%2520of%2520novel%252C%2520potent%252C%2520and%2520selective%2520kinase%2520inhibitors%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26spage%3D291%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group">Morphy, R.</span><span> </span><span class="NLM_article-title">Selectively nonselective kinase inhibition: striking the right balance</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1413</span><span class="NLM_x">–</span> <span class="NLM_lpage">1437</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=1413-1437&author=R.+Morphy&title=Selectively+nonselective+kinase+inhibition%3A+striking+the+right+balance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26atitle%3DSelectively%2520nonselective%2520kinase%2520inhibition%253A%2520striking%2520the%2520right%2520balance%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D53%26spage%3D1413%26epage%3D1437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2gqg" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2gqg','PDB','2gqg'); return false;">PDB: 2gqg</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3cs9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3cs9','PDB','3cs9'); return false;">PDB: 3cs9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2wgj" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2wgj','PDB','2wgj'); return false;">PDB: 2wgj</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1xkk" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1xkk','PDB','1xkk'); return false;">PDB: 1xkk</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2vtl" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2vtl','PDB','2vtl'); return false;">PDB: 2vtl</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1e1v" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1e1v','PDB','1e1v'); return false;">PDB: 1e1v</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3pj8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3pj8','PDB','3pj8'); return false;">PDB: 3pj8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3qd4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3qd4','PDB','3qd4'); return false;">PDB: 3qd4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4dfl" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4dfl','PDB','4dfl'); return false;">PDB: 4dfl</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3rwp" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3rwp','PDB','3rwp'); return false;">PDB: 3rwp</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3v8s" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3v8s','PDB','3v8s'); return false;">PDB: 3v8s</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3tjc" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3tjc','PDB','3tjc'); return false;">PDB: 3tjc</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3p0m" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3p0m','PDB','3p0m'); return false;">PDB: 3p0m</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4e93" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4e93','PDB','4e93'); return false;">PDB: 4e93</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2vts" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2vts','PDB','2vts'); return false;">PDB: 2vts</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4dbn" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4dbn','PDB','4dbn'); return false;">PDB: 4dbn</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3q96" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3q96','PDB','3q96'); return false;">PDB: 3q96</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3pxk" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3pxk','PDB','3pxk'); return false;">PDB: 3pxk</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4dym" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4dym','PDB','4dym'); return false;">PDB: 4dym</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ue4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ue4','PDB','3ue4'); return false;">PDB: 3ue4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3tku" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3tku','PDB','3tku'); return false;">PDB: 3tku</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3s4q" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3s4q','PDB','3s4q'); return false;">PDB: 3s4q</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3raw" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3raw','PDB','3raw'); return false;">PDB: 3raw</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3t9i" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3t9i','PDB','3t9i'); return false;">PDB: 3t9i</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3c4e" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3c4e','PDB','3c4e'); return false;">PDB: 3c4e</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3dcv" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3dcv','PDB','3dcv'); return false;">PDB: 3dcv</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ycs" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ycs','PDB','2ycs'); return false;">PDB: 2ycs</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2wu7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2wu7','PDB','2wu7'); return false;">PDB: 2wu7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ofm" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ofm','PDB','3ofm'); return false;">PDB: 3ofm</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1yi3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1yi3','PDB','1yi3'); return false;">PDB: 1yi3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1m7q" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1m7q','PDB','1m7q'); return false;">PDB: 1m7q</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3hp2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3hp2','PDB','3hp2'); return false;">PDB: 3hp2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1kv2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1kv2','PDB','1kv2'); return false;">PDB: 1kv2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1uu9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1uu9','PDB','1uu9'); return false;">PDB: 1uu9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ojg" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ojg','PDB','2ojg'); return false;">PDB: 2ojg</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3tki" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3tki','PDB','3tki'); return false;">PDB: 3tki</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2xk4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2xk4','PDB','2xk4'); return false;">PDB: 2xk4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2wkm" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2wkm','PDB','2wkm'); return false;">PDB: 2wkm</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3lxk" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3lxk','PDB','3lxk'); return false;">PDB: 3lxk</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2uw3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2uw3','PDB','2uw3'); return false;">PDB: 2uw3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2uw4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2uw4','PDB','2uw4'); return false;">PDB: 2uw4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2uw9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2uw9','PDB','2uw9'); return false;">PDB: 2uw9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2f4j" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2f4j','PDB','2f4j'); return false;">PDB: 2f4j</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3kck" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3kck','PDB','3kck'); return false;">PDB: 3kck</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3efk" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3efk','PDB','3efk'); return false;">PDB: 3efk</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3sls" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3sls','PDB','3sls'); return false;">PDB: 3sls</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3pxz" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3pxz','PDB','3pxz'); return false;">PDB: 3pxz</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3py1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3py1','PDB','3py1'); return false;">PDB: 3py1</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4g31" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4g31','PDB','4g31'); return false;">PDB: 4g31</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4g34" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4g34','PDB','4g34'); return false;">PDB: 4g34</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2rfn" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2rfn','PDB','2rfn'); return false;">PDB: 2rfn</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3efj" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3efj','PDB','3efj'); return false;">PDB: 3efj</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3u6h" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3u6h','PDB','3u6h'); return false;">PDB: 3u6h</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3u6i" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3u6i','PDB','3u6i'); return false;">PDB: 3u6i</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3b8r" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3b8r','PDB','3b8r'); return false;">PDB: 3b8r</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3b8q" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3b8q','PDB','3b8q'); return false;">PDB: 3b8q</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3lq8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3lq8','PDB','3lq8'); return false;">PDB: 3lq8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3nax" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3nax','PDB','3nax'); return false;">PDB: 3nax</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2pl0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2pl0','PDB','2pl0'); return false;">PDB: 2pl0</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3qri" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3qri','PDB','3qri'); return false;">PDB: 3qri</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1w7h" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1w7h','PDB','1w7h'); return false;">PDB: 1w7h</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1w82" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1w82','PDB','1w82'); return false;">PDB: 1w82</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1wbn" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1wbn','PDB','1wbn'); return false;">PDB: 1wbn</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1w83" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1w83','PDB','1w83'); return false;">PDB: 1w83</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1wbw" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1wbw','PDB','1wbw'); return false;">PDB: 1wbw</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3o8u" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3o8u','PDB','3o8u'); return false;">PDB: 3o8u</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3nnv" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3nnv','PDB','3nnv'); return false;">PDB: 3nnv</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2j5f" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2j5f','PDB','2j5f'); return false;">PDB: 2j5f</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2jiv" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2jiv','PDB','2jiv'); return false;">PDB: 2jiv</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2r4b" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2r4b','PDB','2r4b'); return false;">PDB: 2r4b</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3t9t" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3t9t','PDB','3t9t'); return false;">PDB: 3t9t</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4hcu" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4hcu','PDB','4hcu'); return false;">PDB: 4hcu</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4hcv" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4hcv','PDB','4hcv'); return false;">PDB: 4hcv</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4hct" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4hct','PDB','4hct'); return false;">PDB: 4hct</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3v6r" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3v6r','PDB','3v6r'); return false;">PDB: 3v6r</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3v6s" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3v6s','PDB','3v6s'); return false;">PDB: 3v6s</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3pwy" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3pwy','PDB','3pwy'); return false;">PDB: 3pwy</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4d9u" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4d9u','PDB','4d9u'); return false;">PDB: 4d9u</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i36"><a href="/doi/suppl/10.1021/jm400378w">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_68442"></div></div></div></div></div><hr /></hr><p class="last">2D structures of compounds that are not presented in other figures, a list of crystal structures of approved kinase inhibitors in the PDB, a table of all crystal structures used for the structural reference alignment, and the methodology of the KLIFS database preparation and analysis, including description of PDB collection, kinase domain sequence alignment, pocket selection, database creation, IFP generation, and DFG and αC-helix classification. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>. The KLIFS database is periodically updated and accessible on the Web at <a class="extLink" href="http://www.vu-compmedchem.nl">http://www.vu-compmedchem.nl</a>, including all structure files and corresponding annotations.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400378w/suppl_file/jm400378w_si_001.pdf">jm400378w_si_001.pdf (414.21 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm400378w&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm400378w%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-2%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm400378w" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                19MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677a95bc5dde3c2e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
